GOBP FATTY ACID BETA OXIDATION USING ACYL COA DEHYDROGENASE
|
12
|
4.12e-08
|
9.14e-01
|
1.02e-06
|
GOBP PROTON MOTIVE FORCE DRIVEN ATP SYNTHESIS
|
47
|
3.33e-23
|
8.36e-01
|
6.73e-21
|
GOCC NADH DEHYDROGENASE COMPLEX
|
43
|
3.05e-21
|
8.33e-01
|
4.80e-19
|
GOBP MITOCHONDRIAL ELECTRON TRANSPORT UBIQUINOL TO CYTOCHROME C
|
12
|
6.78e-07
|
8.28e-01
|
1.24e-05
|
GOMF NATURAL KILLER CELL LECTIN LIKE RECEPTOR BINDING
|
12
|
8.10e-07
|
-8.22e-01
|
1.45e-05
|
GOMF OXIDOREDUCTASE ACTIVITY ACTING ON THE CH CH GROUP OF DONORS WITH A FLAVIN AS ACCEPTOR
|
13
|
3.08e-07
|
8.20e-01
|
6.15e-06
|
GOCC MHC CLASS I PROTEIN COMPLEX
|
10
|
8.17e-06
|
-8.14e-01
|
1.14e-04
|
GOCC RESPIRASOME
|
80
|
9.17e-36
|
8.06e-01
|
5.93e-33
|
GOBP MITOCHONDRIAL ELECTRON TRANSPORT NADH TO UBIQUINONE
|
28
|
2.24e-13
|
8.00e-01
|
1.38e-11
|
GOBP AEROBIC ELECTRON TRANSPORT CHAIN
|
59
|
4.41e-26
|
7.94e-01
|
1.19e-23
|
GOCC MITOCHONDRIAL RESPIRATORY CHAIN COMPLEX III
|
12
|
2.27e-06
|
7.88e-01
|
3.71e-05
|
GOMF NADH DEHYDROGENASE UBIQUINONE ACTIVITY
|
16
|
4.97e-08
|
7.87e-01
|
1.20e-06
|
GOBP NADH DEHYDROGENASE COMPLEX ASSEMBLY
|
55
|
1.64e-23
|
7.78e-01
|
3.43e-21
|
GOCC RESPIRATORY CHAIN COMPLEX IV
|
22
|
3.39e-10
|
7.73e-01
|
1.39e-08
|
GOCC CYTOCHROME COMPLEX
|
33
|
2.02e-14
|
7.69e-01
|
1.47e-12
|
GOCC MHC PROTEIN COMPLEX
|
17
|
4.21e-08
|
-7.68e-01
|
1.03e-06
|
GOBP MITOCHONDRIAL ELECTRON TRANSPORT CYTOCHROME C TO OXYGEN
|
15
|
3.52e-07
|
7.59e-01
|
6.92e-06
|
GOCC MHC CLASS I PEPTIDE LOADING COMPLEX
|
12
|
8.44e-06
|
-7.42e-01
|
1.17e-04
|
GOBP NEGATIVE REGULATION OF PLATELET AGGREGATION
|
10
|
4.84e-05
|
-7.42e-01
|
5.38e-04
|
GOBP BRANCHED CHAIN AMINO ACID METABOLIC PROCESS
|
23
|
8.47e-10
|
7.39e-01
|
3.11e-08
|
GOBP ATP SYNTHESIS COUPLED ELECTRON TRANSPORT
|
69
|
4.05e-26
|
7.35e-01
|
1.14e-23
|
GOMF PEPTIDE ANTIGEN BINDING
|
21
|
6.00e-09
|
-7.33e-01
|
1.80e-07
|
GOBP BRANCHED CHAIN AMINO ACID CATABOLIC PROCESS
|
20
|
1.44e-08
|
7.32e-01
|
3.95e-07
|
GOCC INNER MITOCHONDRIAL MEMBRANE PROTEIN COMPLEX
|
113
|
5.15e-39
|
7.10e-01
|
4.16e-36
|
GOBP MITOCHONDRIAL RESPIRATORY CHAIN COMPLEX ASSEMBLY
|
87
|
1.25e-29
|
7.00e-01
|
4.74e-27
|
GOMF OLIGOPEPTIDE BINDING
|
15
|
2.74e-06
|
6.99e-01
|
4.36e-05
|
GOCC TIM23 MITOCHONDRIAL IMPORT INNER MEMBRANE TRANSLOCASE COMPLEX
|
12
|
2.82e-05
|
6.98e-01
|
3.39e-04
|
GOMF ELECTRON TRANSFER ACTIVITY
|
42
|
4.84e-15
|
6.98e-01
|
3.91e-13
|
GOMF OXIDOREDUCTION DRIVEN ACTIVE TRANSMEMBRANE TRANSPORTER ACTIVITY
|
29
|
1.03e-10
|
6.93e-01
|
4.72e-09
|
GOMF NADH DEHYDROGENASE ACTIVITY
|
11
|
7.28e-05
|
6.91e-01
|
7.61e-04
|
GOBP ASPARTATE FAMILY AMINO ACID CATABOLIC PROCESS
|
10
|
1.65e-04
|
6.88e-01
|
1.53e-03
|
GOCC MITOCHONDRIAL PROTEIN CONTAINING COMPLEX
|
240
|
4.37e-75
|
6.85e-01
|
7.06e-72
|
GOBP ANTIGEN PROCESSING AND PRESENTATION VIA MHC CLASS IB
|
18
|
5.24e-07
|
-6.83e-01
|
9.81e-06
|
GOBP HEME A METABOLIC PROCESS
|
10
|
1.88e-04
|
6.82e-01
|
1.71e-03
|
GOCC MITOCHONDRIAL LARGE RIBOSOMAL SUBUNIT
|
55
|
3.35e-18
|
6.78e-01
|
4.01e-16
|
GOBP BENZENE CONTAINING COMPOUND METABOLIC PROCESS
|
14
|
1.16e-05
|
6.77e-01
|
1.54e-04
|
GOCC TRICARBOXYLIC ACID CYCLE HETEROMERIC ENZYME COMPLEX
|
20
|
1.65e-07
|
6.76e-01
|
3.52e-06
|
GOCC IRON SULFUR CLUSTER ASSEMBLY COMPLEX
|
10
|
2.32e-04
|
6.72e-01
|
2.07e-03
|
GOBP ELECTRON TRANSPORT CHAIN
|
95
|
1.24e-29
|
6.70e-01
|
4.74e-27
|
GOCC CMG COMPLEX
|
11
|
1.23e-04
|
-6.69e-01
|
1.19e-03
|
GOBP MITOCHONDRIAL PROTEIN PROCESSING
|
12
|
7.21e-05
|
6.62e-01
|
7.56e-04
|
GOBP OXALOACETATE METABOLIC PROCESS
|
10
|
3.22e-04
|
6.57e-01
|
2.70e-03
|
GOBP PROTEIN IMPORT INTO MITOCHONDRIAL MATRIX
|
18
|
1.44e-06
|
6.56e-01
|
2.46e-05
|
GOCC ORGANELLAR RIBOSOME
|
89
|
1.09e-26
|
6.55e-01
|
3.19e-24
|
GOBP DNA STRAND ELONGATION INVOLVED IN DNA REPLICATION
|
13
|
4.43e-05
|
-6.54e-01
|
5.02e-04
|
GOBP CRISTAE FORMATION
|
16
|
5.99e-06
|
6.54e-01
|
8.71e-05
|
GOBP OXIDATIVE PHOSPHORYLATION
|
112
|
9.91e-33
|
6.51e-01
|
4.58e-30
|
GOBP POSITIVE REGULATION OF MITOCHONDRIAL TRANSLATION
|
16
|
7.24e-06
|
6.48e-01
|
1.03e-04
|
GOBP RESPONSE TO INTERFERON ALPHA
|
24
|
5.46e-08
|
-6.41e-01
|
1.30e-06
|
GOBP NUCLEOSIDE BISPHOSPHATE CATABOLIC PROCESS
|
10
|
4.58e-04
|
6.40e-01
|
3.58e-03
|
GOBP ACETYL COA METABOLIC PROCESS
|
32
|
4.06e-10
|
6.38e-01
|
1.63e-08
|
GOBP FATTY ACID DERIVATIVE CATABOLIC PROCESS
|
13
|
6.93e-05
|
6.37e-01
|
7.37e-04
|
GOBP MITOCHONDRIAL TRANSLATION
|
125
|
2.50e-34
|
6.32e-01
|
1.24e-31
|
GOBP CELLULAR RESPONSE TO INTERFERON ALPHA
|
15
|
2.41e-05
|
-6.30e-01
|
2.95e-04
|
GOBP ACETYL COA BIOSYNTHETIC PROCESS FROM PYRUVATE
|
12
|
1.77e-04
|
6.25e-01
|
1.62e-03
|
GOCC MITOCHONDRIAL SMALL RIBOSOMAL SUBUNIT
|
33
|
5.12e-10
|
6.25e-01
|
2.01e-08
|
GOCC ATPASE DEPENDENT TRANSMEMBRANE TRANSPORT COMPLEX
|
10
|
6.37e-04
|
6.24e-01
|
4.66e-03
|
GOCC ALPHA KETOACID DEHYDROGENASE COMPLEX
|
15
|
3.77e-05
|
6.14e-01
|
4.35e-04
|
GOBP MEIOTIC SPINDLE ASSEMBLY
|
10
|
7.90e-04
|
-6.13e-01
|
5.60e-03
|
GOBP REGULATION OF CARDIAC CONDUCTION
|
11
|
4.39e-04
|
6.12e-01
|
3.47e-03
|
GOBP AV NODE CELL TO BUNDLE OF HIS CELL SIGNALING
|
11
|
4.64e-04
|
6.10e-01
|
3.60e-03
|
GOMF 2 IRON 2 SULFUR CLUSTER BINDING
|
22
|
7.73e-07
|
6.09e-01
|
1.39e-05
|
GOBP DOUBLE STRAND BREAK REPAIR VIA BREAK INDUCED REPLICATION
|
11
|
4.87e-04
|
-6.07e-01
|
3.75e-03
|
GOBP ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS ANTIGEN
|
20
|
2.79e-06
|
-6.05e-01
|
4.44e-05
|
GOBP AEROBIC RESPIRATION
|
154
|
2.38e-38
|
6.04e-01
|
1.71e-35
|
GOBP ATP BIOSYNTHETIC PROCESS
|
69
|
4.42e-18
|
6.03e-01
|
5.20e-16
|
GOBP NEGATIVE REGULATION OF GLIAL CELL APOPTOTIC PROCESS
|
10
|
9.71e-04
|
-6.02e-01
|
6.61e-03
|
GOMF OXIDOREDUCTASE ACTIVITY ACTING ON THE CH CH GROUP OF DONORS
|
54
|
2.42e-14
|
6.00e-01
|
1.72e-12
|
GOCC CIS GOLGI NETWORK MEMBRANE
|
13
|
2.27e-04
|
-5.90e-01
|
2.04e-03
|
GOBP RESPONSE TO INTERFERON BETA
|
49
|
1.07e-12
|
-5.88e-01
|
5.98e-11
|
GOCC INTERSTITIAL MATRIX
|
15
|
8.45e-05
|
-5.86e-01
|
8.65e-04
|
GOBP REGULATION OF MITOCHONDRIAL TRANSLATION
|
25
|
3.95e-07
|
5.86e-01
|
7.62e-06
|
GOCC OXIDOREDUCTASE COMPLEX
|
104
|
6.67e-25
|
5.84e-01
|
1.60e-22
|
GOBP REGULATION OF RIBONUCLEASE ACTIVITY
|
12
|
4.57e-04
|
-5.84e-01
|
3.58e-03
|
GOBP ADHESION OF SYMBIONT TO HOST
|
11
|
8.17e-04
|
-5.83e-01
|
5.74e-03
|
GOBP FATTY ACYL COA METABOLIC PROCESS
|
17
|
3.39e-05
|
5.81e-01
|
3.97e-04
|
GOBP ACETYL COA BIOSYNTHETIC PROCESS
|
19
|
1.28e-05
|
5.78e-01
|
1.68e-04
|
GOBP REGULATION OF ATTACHMENT OF SPINDLE MICROTUBULES TO KINETOCHORE
|
19
|
1.29e-05
|
-5.78e-01
|
1.69e-04
|
GOCC MCM COMPLEX
|
11
|
9.19e-04
|
-5.77e-01
|
6.32e-03
|
GOBP REGULATION OF ODONTOGENESIS
|
15
|
1.10e-04
|
-5.77e-01
|
1.09e-03
|
GOMF GLUTATHIONE TRANSFERASE ACTIVITY
|
25
|
6.63e-07
|
5.74e-01
|
1.21e-05
|
GOBP REGULATION OF XENOPHAGY
|
12
|
5.71e-04
|
-5.74e-01
|
4.25e-03
|
GOBP XENOBIOTIC CATABOLIC PROCESS
|
15
|
1.18e-04
|
5.74e-01
|
1.15e-03
|
GOBP SERINE FAMILY AMINO ACID CATABOLIC PROCESS
|
10
|
1.70e-03
|
5.73e-01
|
1.06e-02
|
GOBP AMINO ACID ACTIVATION
|
26
|
4.71e-07
|
5.71e-01
|
8.99e-06
|
GOBP PEPTIDE ANTIGEN ASSEMBLY WITH MHC PROTEIN COMPLEX
|
10
|
1.86e-03
|
-5.68e-01
|
1.14e-02
|
GOBP ACYL COA METABOLIC PROCESS
|
74
|
3.18e-17
|
5.67e-01
|
3.48e-15
|
GOBP NEGATIVE REGULATION OF VIRAL LIFE CYCLE
|
27
|
3.42e-07
|
-5.67e-01
|
6.77e-06
|
GOBP MITOCHONDRIAL GENE EXPRESSION
|
158
|
2.16e-34
|
5.63e-01
|
1.16e-31
|
GOCC NUCLEOID
|
44
|
1.63e-10
|
5.57e-01
|
7.09e-09
|
GOCC PHOSPHOLIPID TRANSLOCATING ATPASE COMPLEX
|
11
|
1.39e-03
|
-5.57e-01
|
8.89e-03
|
GOBP 2 OXOGLUTARATE METABOLIC PROCESS
|
15
|
1.99e-04
|
5.55e-01
|
1.80e-03
|
GOBP PROTEIN MATURATION BY IRON SULFUR CLUSTER TRANSFER
|
12
|
9.02e-04
|
5.53e-01
|
6.24e-03
|
GOBP REGULATION OF CHROMOSOME CONDENSATION
|
10
|
2.47e-03
|
-5.53e-01
|
1.42e-02
|
GOBP QUINONE BIOSYNTHETIC PROCESS
|
14
|
3.51e-04
|
5.52e-01
|
2.89e-03
|
GOMF BETA 2 MICROGLOBULIN BINDING
|
11
|
1.54e-03
|
-5.51e-01
|
9.68e-03
|
GOMF INTRAMOLECULAR OXIDOREDUCTASE ACTIVITY TRANSPOSING C C BONDS
|
12
|
9.41e-04
|
5.51e-01
|
6.47e-03
|
GOMF OXIDOREDUCTASE ACTIVITY ACTING ON THE CH CH GROUP OF DONORS NAD OR NADP AS ACCEPTOR
|
24
|
3.06e-06
|
5.50e-01
|
4.75e-05
|
GOBP RESPIRATORY CHAIN COMPLEX IV ASSEMBLY
|
22
|
8.21e-06
|
5.49e-01
|
1.14e-04
|
GOMF GLYCEROPHOSPHOLIPID FLIPPASE ACTIVITY
|
10
|
2.67e-03
|
-5.48e-01
|
1.51e-02
|
GOMF LIGASE ACTIVITY FORMING CARBON OXYGEN BONDS
|
22
|
8.53e-06
|
5.48e-01
|
1.18e-04
|
GOCC DNA REPLICATION PREINITIATION COMPLEX
|
13
|
6.24e-04
|
-5.48e-01
|
4.59e-03
|
GOBP SHORT CHAIN FATTY ACID METABOLIC PROCESS
|
13
|
6.31e-04
|
5.47e-01
|
4.62e-03
|
GOMF MHC CLASS I PROTEIN BINDING
|
18
|
6.04e-05
|
-5.46e-01
|
6.55e-04
|
GOCC ER MEMBRANE INSERTION COMPLEX
|
11
|
1.74e-03
|
5.45e-01
|
1.08e-02
|
GOCC MITOCHONDRIAL MATRIX
|
275
|
1.58e-54
|
5.44e-01
|
2.05e-51
|
GOMF POTASSIUM PROTON ANTIPORTER ACTIVITY
|
10
|
2.91e-03
|
5.44e-01
|
1.62e-02
|
GOBP TRICARBOXYLIC ACID CYCLE
|
31
|
1.67e-07
|
5.43e-01
|
3.54e-06
|
GOMF SOLUTE POTASSIUM ANTIPORTER ACTIVITY
|
12
|
1.16e-03
|
5.42e-01
|
7.71e-03
|
GOBP BLEB ASSEMBLY
|
13
|
7.28e-04
|
-5.41e-01
|
5.23e-03
|
GOBP REGULATION OF CARDIAC EPITHELIAL TO MESENCHYMAL TRANSITION
|
11
|
1.90e-03
|
-5.41e-01
|
1.16e-02
|
GOBP DNA UNWINDING INVOLVED IN DNA REPLICATION
|
19
|
4.80e-05
|
-5.39e-01
|
5.36e-04
|
GOBP AMINO ACID BETAINE METABOLIC PROCESS
|
12
|
1.24e-03
|
5.38e-01
|
8.11e-03
|
GOCC ORGANELLE INNER MEMBRANE
|
488
|
2.45e-92
|
5.38e-01
|
7.91e-89
|
GOBP REGULATION OF MITOCHONDRIAL GENE EXPRESSION
|
31
|
2.19e-07
|
5.38e-01
|
4.51e-06
|
GOBP MITOCHONDRIAL CYTOCHROME C OXIDASE ASSEMBLY
|
18
|
8.16e-05
|
5.36e-01
|
8.40e-04
|
GOMF CARD DOMAIN BINDING
|
12
|
1.30e-03
|
-5.36e-01
|
8.44e-03
|
GOBP INNER MITOCHONDRIAL MEMBRANE ORGANIZATION
|
33
|
9.91e-08
|
5.36e-01
|
2.25e-06
|
GOCC OUTER MITOCHONDRIAL MEMBRANE PROTEIN COMPLEX
|
12
|
1.36e-03
|
5.34e-01
|
8.73e-03
|
GOBP NEGATIVE REGULATION OF VIRAL GENOME REPLICATION
|
40
|
5.31e-09
|
-5.33e-01
|
1.65e-07
|
GOBP FATTY ACID DERIVATIVE METABOLIC PROCESS
|
31
|
2.79e-07
|
5.33e-01
|
5.60e-06
|
GOBP POSITIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS
|
17
|
1.43e-04
|
-5.33e-01
|
1.35e-03
|
GOBP FATTY ACID BETA OXIDATION
|
64
|
1.78e-13
|
5.32e-01
|
1.12e-11
|
GOBP METALLO SULFUR CLUSTER ASSEMBLY
|
20
|
3.86e-05
|
5.32e-01
|
4.43e-04
|
GOBP CYTOCHROME COMPLEX ASSEMBLY
|
30
|
4.80e-07
|
5.31e-01
|
9.13e-06
|
GOBP LONG CHAIN FATTY ACID BIOSYNTHETIC PROCESS
|
13
|
9.65e-04
|
5.29e-01
|
6.58e-03
|
GOMF ADENYL NUCLEOTIDE EXCHANGE FACTOR ACTIVITY
|
14
|
6.25e-04
|
5.28e-01
|
4.59e-03
|
GOCC PHAGOCYTIC VESICLE MEMBRANE
|
22
|
1.83e-05
|
-5.28e-01
|
2.30e-04
|
GOBP REGULATION OF GLIAL CELL APOPTOTIC PROCESS
|
15
|
4.09e-04
|
-5.27e-01
|
3.29e-03
|
GOBP REGULATION OF T CELL MEDIATED CYTOTOXICITY
|
27
|
2.25e-06
|
-5.26e-01
|
3.69e-05
|
GOBP CHEMOKINE C X C MOTIF LIGAND 2 PRODUCTION
|
21
|
3.43e-05
|
-5.22e-01
|
4.01e-04
|
GOBP POSITIVE REGULATION OF ATTACHMENT OF SPINDLE MICROTUBULES TO KINETOCHORE
|
11
|
2.84e-03
|
-5.20e-01
|
1.59e-02
|
GOBP ATTACHMENT OF MITOTIC SPINDLE MICROTUBULES TO KINETOCHORE
|
20
|
6.05e-05
|
-5.18e-01
|
6.55e-04
|
GOBP POSITIVE REGULATION OF PLATELET ACTIVATION
|
10
|
4.61e-03
|
-5.17e-01
|
2.35e-02
|
GOBP FRUCTOSE METABOLIC PROCESS
|
12
|
1.94e-03
|
5.17e-01
|
1.17e-02
|
GOBP CARNITINE METABOLIC PROCESS
|
11
|
3.08e-03
|
5.15e-01
|
1.69e-02
|
GOBP CELLULAR RESPIRATION
|
197
|
1.50e-35
|
5.14e-01
|
8.83e-33
|
GOCC MICROBODY LUMEN
|
26
|
5.97e-06
|
5.13e-01
|
8.69e-05
|
GOBP XENOPHAGY
|
16
|
3.82e-04
|
-5.13e-01
|
3.12e-03
|
GOBP AMINO ACID CATABOLIC PROCESS
|
72
|
5.54e-14
|
5.12e-01
|
3.77e-12
|
GOBP POSITIVE REGULATION OF SPINDLE CHECKPOINT
|
12
|
2.12e-03
|
-5.12e-01
|
1.26e-02
|
GOMF QUATERNARY AMMONIUM GROUP TRANSMEMBRANE TRANSPORTER ACTIVITY
|
11
|
3.44e-03
|
5.09e-01
|
1.85e-02
|
GOBP THIOESTER BIOSYNTHETIC PROCESS
|
26
|
7.28e-06
|
5.08e-01
|
1.03e-04
|
GOCC LUMENAL SIDE OF ENDOPLASMIC RETICULUM MEMBRANE
|
10
|
5.55e-03
|
-5.06e-01
|
2.71e-02
|
GOBP NUCLEOSIDE BISPHOSPHATE METABOLIC PROCESS
|
89
|
1.62e-16
|
5.06e-01
|
1.61e-14
|
GOMF I SMAD BINDING
|
16
|
4.74e-04
|
-5.05e-01
|
3.68e-03
|
GOCC U4 SNRNP
|
10
|
5.74e-03
|
5.04e-01
|
2.78e-02
|
GOMF MHC PROTEIN COMPLEX BINDING
|
11
|
3.82e-03
|
-5.04e-01
|
2.02e-02
|
GOBP SERINE FAMILY AMINO ACID METABOLIC PROCESS
|
27
|
6.39e-06
|
5.02e-01
|
9.17e-05
|
GOBP POSITIVE REGULATION OF CHROMOSOME SEGREGATION
|
27
|
6.40e-06
|
-5.02e-01
|
9.17e-05
|
GOBP FATTY ACID CATABOLIC PROCESS
|
88
|
5.54e-16
|
4.99e-01
|
5.12e-14
|
GOBP POSITIVE REGULATION OF TRIGLYCERIDE BIOSYNTHETIC PROCESS
|
16
|
5.53e-04
|
4.99e-01
|
4.16e-03
|
GOBP GLYCERALDEHYDE 3 PHOSPHATE BIOSYNTHETIC PROCESS
|
12
|
2.79e-03
|
4.98e-01
|
1.57e-02
|
GOCC RIBONUCLEASE P COMPLEX
|
12
|
2.81e-03
|
4.98e-01
|
1.57e-02
|
GOMF SODIUM PROTON ANTIPORTER ACTIVITY
|
10
|
6.47e-03
|
4.97e-01
|
3.05e-02
|
GOBP NUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS
|
87
|
1.07e-15
|
4.97e-01
|
9.62e-14
|
GOMF ACYL COA BINDING
|
21
|
8.54e-05
|
4.95e-01
|
8.71e-04
|
GOBP MITOTIC DNA REPLICATION
|
15
|
9.51e-04
|
-4.93e-01
|
6.50e-03
|
GOMF T CELL RECEPTOR BINDING
|
16
|
6.50e-04
|
-4.92e-01
|
4.75e-03
|
GOBP NEGATIVE REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY
|
21
|
9.55e-05
|
-4.92e-01
|
9.60e-04
|
GOBP ANTIGEN PROCESSING AND PRESENTATION OF EXOGENOUS PEPTIDE ANTIGEN
|
23
|
4.60e-05
|
-4.91e-01
|
5.18e-04
|
GOCC CILIARY TRANSITION FIBER
|
10
|
7.19e-03
|
-4.91e-01
|
3.34e-02
|
GOMF PHOSPHOLIPASE A2 ACTIVITY
|
16
|
6.80e-04
|
4.91e-01
|
4.94e-03
|
GOBP ENDOCARDIAL CUSHION FORMATION
|
28
|
7.22e-06
|
-4.90e-01
|
1.03e-04
|
GOBP COLLAGEN ACTIVATED SIGNALING PATHWAY
|
15
|
1.04e-03
|
-4.89e-01
|
7.00e-03
|
GOMF EXTRACELLULAR MATRIX STRUCTURAL CONSTITUENT CONFERRING TENSILE STRENGTH
|
35
|
6.02e-07
|
-4.87e-01
|
1.11e-05
|
GOCC CANONICAL INFLAMMASOME COMPLEX
|
14
|
1.62e-03
|
-4.86e-01
|
1.02e-02
|
GOBP WOUND HEALING INVOLVED IN INFLAMMATORY RESPONSE
|
10
|
7.73e-03
|
-4.86e-01
|
3.50e-02
|
GOBP ALPHA AMINO ACID CATABOLIC PROCESS
|
59
|
1.05e-10
|
4.86e-01
|
4.77e-09
|
GOBP ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN VIA MHC CLASS I
|
29
|
6.06e-06
|
-4.85e-01
|
8.76e-05
|
GOBP SPINDLE MIDZONE ASSEMBLY
|
10
|
8.23e-03
|
-4.83e-01
|
3.67e-02
|
GOBP TRIGLYCERIDE CATABOLIC PROCESS
|
16
|
8.38e-04
|
4.82e-01
|
5.88e-03
|
GOBP GLUTATHIONE METABOLIC PROCESS
|
51
|
2.60e-09
|
4.82e-01
|
8.56e-08
|
GOBP ALDEHYDE CATABOLIC PROCESS
|
11
|
5.65e-03
|
4.82e-01
|
2.75e-02
|
GOMF OXIDOREDUCTASE ACTIVITY ACTING ON NAD P H QUINONE OR SIMILAR COMPOUND AS ACCEPTOR
|
28
|
1.10e-05
|
4.80e-01
|
1.46e-04
|
GOBP ENDOCARDIAL CUSHION MORPHOGENESIS
|
36
|
6.33e-07
|
-4.80e-01
|
1.17e-05
|
GOBP NEGATIVE REGULATION OF HOMOTYPIC CELL CELL ADHESION
|
15
|
1.34e-03
|
-4.78e-01
|
8.60e-03
|
GOCC MITOTIC SPINDLE MIDZONE
|
14
|
1.95e-03
|
-4.78e-01
|
1.17e-02
|
GOCC SARCOPLASMIC RETICULUM MEMBRANE
|
22
|
1.10e-04
|
4.76e-01
|
1.09e-03
|
GOBP AV NODE CELL TO BUNDLE OF HIS CELL COMMUNICATION
|
12
|
4.29e-03
|
4.76e-01
|
2.21e-02
|
GOBP ODONTOBLAST DIFFERENTIATION
|
15
|
1.43e-03
|
-4.76e-01
|
9.03e-03
|
GOBP PROTEIN TRANSMEMBRANE IMPORT INTO INTRACELLULAR ORGANELLE
|
35
|
1.13e-06
|
4.75e-01
|
1.99e-05
|
GOMF POLY A SPECIFIC RIBONUCLEASE ACTIVITY
|
13
|
3.04e-03
|
-4.75e-01
|
1.68e-02
|
GOBP CARDIOLIPIN METABOLIC PROCESS
|
14
|
2.20e-03
|
4.73e-01
|
1.29e-02
|
GOBP NEGATIVE REGULATION OF CENTROSOME DUPLICATION
|
10
|
9.75e-03
|
-4.72e-01
|
4.20e-02
|
GOMF STEROID DEHYDROGENASE ACTIVITY
|
22
|
1.27e-04
|
4.72e-01
|
1.22e-03
|
GOBP GLYCERALDEHYDE 3 PHOSPHATE METABOLIC PROCESS
|
19
|
3.82e-04
|
4.71e-01
|
3.12e-03
|
GOMF DEATH DOMAIN BINDING
|
12
|
4.82e-03
|
-4.70e-01
|
2.43e-02
|
GOBP REGULATION OF ARTERY MORPHOGENESIS
|
10
|
1.01e-02
|
-4.70e-01
|
4.33e-02
|
GOBP NEGATIVE REGULATION OF VIRAL PROCESS
|
78
|
7.86e-13
|
-4.69e-01
|
4.50e-11
|
GOBP EPITHELIAL TO MESENCHYMAL TRANSITION INVOLVED IN ENDOCARDIAL CUSHION FORMATION
|
16
|
1.20e-03
|
-4.68e-01
|
7.87e-03
|
GOBP POSITIVE REGULATION OF TRIGLYCERIDE METABOLIC PROCESS
|
19
|
4.23e-04
|
4.67e-01
|
3.37e-03
|
GOCC ESC E Z COMPLEX
|
14
|
2.49e-03
|
-4.67e-01
|
1.43e-02
|
GOBP TRNA 5 END PROCESSING
|
14
|
2.59e-03
|
4.65e-01
|
1.48e-02
|
GOBP PULMONARY VALVE DEVELOPMENT
|
22
|
1.62e-04
|
-4.65e-01
|
1.52e-03
|
GOCC COMPLEX OF COLLAGEN TRIMERS
|
17
|
9.14e-04
|
-4.65e-01
|
6.30e-03
|
GOBP POSITIVE REGULATION OF MONOCYTE CHEMOTACTIC PROTEIN 1 PRODUCTION
|
13
|
3.77e-03
|
-4.64e-01
|
2.00e-02
|
GOCC LARGE RIBOSOMAL SUBUNIT
|
110
|
4.38e-17
|
4.64e-01
|
4.64e-15
|
GOBP AROMATIC AMINO ACID METABOLIC PROCESS
|
20
|
3.46e-04
|
4.62e-01
|
2.85e-03
|
GOBP NUCLEOSIDE BISPHOSPHATE BIOSYNTHETIC PROCESS
|
38
|
8.62e-07
|
4.61e-01
|
1.53e-05
|
GOCC MITOCHONDRIAL ENVELOPE
|
655
|
4.64e-90
|
4.61e-01
|
1.00e-86
|
GOBP MONOCARBOXYLIC ACID CATABOLIC PROCESS
|
109
|
1.21e-16
|
4.59e-01
|
1.25e-14
|
GOCC CELL TRAILING EDGE
|
12
|
5.92e-03
|
-4.59e-01
|
2.85e-02
|
GOBP CD8 POSITIVE ALPHA BETA T CELL DIFFERENTIATION
|
15
|
2.12e-03
|
-4.58e-01
|
1.26e-02
|
GOBP NERVOUS SYSTEM PROCESS INVOLVED IN REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE
|
14
|
3.06e-03
|
4.57e-01
|
1.68e-02
|
GOMF MHC PROTEIN BINDING
|
22
|
2.19e-04
|
-4.55e-01
|
1.97e-03
|
GOBP NEGATIVE REGULATION OF B CELL APOPTOTIC PROCESS
|
12
|
6.34e-03
|
-4.55e-01
|
3.01e-02
|
GOBP METHIONINE METABOLIC PROCESS
|
12
|
6.35e-03
|
4.55e-01
|
3.01e-02
|
GOMF TUMOR NECROSIS FACTOR RECEPTOR BINDING
|
20
|
4.32e-04
|
-4.55e-01
|
3.42e-03
|
GOBP L AMINO ACID CATABOLIC PROCESS
|
45
|
1.45e-07
|
4.53e-01
|
3.17e-06
|
GOBP CHONDROCYTE DEVELOPMENT
|
26
|
6.38e-05
|
-4.53e-01
|
6.86e-04
|
GOBP COENZYME A BIOSYNTHETIC PROCESS
|
12
|
6.63e-03
|
4.53e-01
|
3.12e-02
|
GOMF ACYL COA HYDROLASE ACTIVITY
|
23
|
1.72e-04
|
4.53e-01
|
1.59e-03
|
GOMF STRUCTURAL CONSTITUENT OF RIBOSOME
|
157
|
1.39e-22
|
4.52e-01
|
2.64e-20
|
GOBP INTERFERON MEDIATED SIGNALING PATHWAY
|
67
|
2.02e-10
|
-4.49e-01
|
8.55e-09
|
GOBP GLIAL CELL APOPTOTIC PROCESS
|
20
|
5.11e-04
|
-4.49e-01
|
3.90e-03
|
GOMF DIACYLGLYCEROL DEPENDENT SERINE THREONINE KINASE ACTIVITY
|
16
|
1.95e-03
|
-4.47e-01
|
1.17e-02
|
GOBP NEGATIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY
|
12
|
7.36e-03
|
-4.47e-01
|
3.39e-02
|
GOMF SINGLE STRANDED DNA HELICASE ACTIVITY
|
21
|
4.07e-04
|
-4.46e-01
|
3.27e-03
|
GOBP GLYCINE METABOLIC PROCESS
|
11
|
1.06e-02
|
4.45e-01
|
4.49e-02
|
GOBP CHONDROITIN SULFATE BIOSYNTHETIC PROCESS
|
14
|
3.94e-03
|
-4.45e-01
|
2.07e-02
|
GOBP REGULATION OF CENTRIOLE REPLICATION
|
21
|
4.19e-04
|
-4.45e-01
|
3.35e-03
|
GOBP RESPONSE TO LEAD ION
|
11
|
1.08e-02
|
4.44e-01
|
4.57e-02
|
GOBP DNA REPLICATION INITIATION
|
30
|
2.59e-05
|
-4.44e-01
|
3.15e-04
|
GOCC SEX CHROMOSOME
|
32
|
1.40e-05
|
-4.44e-01
|
1.81e-04
|
GOBP REGULATION OF TOLERANCE INDUCTION
|
12
|
7.79e-03
|
-4.44e-01
|
3.52e-02
|
GOBP ATTACHMENT OF SPINDLE MICROTUBULES TO KINETOCHORE
|
38
|
2.27e-06
|
-4.43e-01
|
3.71e-05
|
GOBP PROTON TRANSPORTING TWO SECTOR ATPASE COMPLEX ASSEMBLY
|
12
|
7.93e-03
|
4.43e-01
|
3.57e-02
|
GOBP ERYTHROSE 4 PHOSPHATE PHOSPHOENOLPYRUVATE FAMILY AMINO ACID METABOLIC PROCESS
|
14
|
4.23e-03
|
4.42e-01
|
2.19e-02
|
GOBP NEGATIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING
|
10
|
1.58e-02
|
-4.41e-01
|
6.18e-02
|
GOBP REGULATION OF PLATELET AGGREGATION
|
23
|
2.55e-04
|
-4.41e-01
|
2.23e-03
|
GOBP NEGATIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN
|
13
|
6.18e-03
|
-4.39e-01
|
2.96e-02
|
GOBP ASPARTATE FAMILY AMINO ACID METABOLIC PROCESS
|
32
|
1.77e-05
|
4.38e-01
|
2.23e-04
|
GOMF GLUTATHIONE PEROXIDASE ACTIVITY
|
19
|
9.46e-04
|
4.38e-01
|
6.49e-03
|
GOBP PROTEIN TARGETING TO MITOCHONDRION
|
66
|
7.82e-10
|
4.38e-01
|
2.90e-08
|
GOBP QUINONE METABOLIC PROCESS
|
20
|
7.33e-04
|
4.36e-01
|
5.26e-03
|
GOBP CHROMOSOME CONDENSATION
|
26
|
1.21e-04
|
-4.36e-01
|
1.17e-03
|
GOCC RIBOSOMAL SUBUNIT
|
183
|
3.98e-24
|
4.34e-01
|
8.87e-22
|
GOBP ORGANIC ACID CATABOLIC PROCESS
|
190
|
6.68e-25
|
4.34e-01
|
1.60e-22
|
GOMF ENOYL COA HYDRATASE ACTIVITY
|
10
|
1.76e-02
|
4.34e-01
|
6.67e-02
|
GOMF DNA REPLICATION ORIGIN BINDING
|
14
|
4.98e-03
|
-4.33e-01
|
2.49e-02
|
GOMF C ACYLTRANSFERASE ACTIVITY
|
17
|
2.00e-03
|
4.33e-01
|
1.20e-02
|
GOBP QUATERNARY AMMONIUM GROUP TRANSPORT
|
12
|
9.51e-03
|
4.32e-01
|
4.11e-02
|
GOMF DELTA CATENIN BINDING
|
10
|
1.79e-02
|
-4.32e-01
|
6.76e-02
|
GOMF AROMATIC AMINO ACID TRANSMEMBRANE TRANSPORTER ACTIVITY
|
10
|
1.82e-02
|
4.31e-01
|
6.83e-02
|
GOBP PLASMA LIPOPROTEIN PARTICLE ASSEMBLY
|
17
|
2.08e-03
|
4.31e-01
|
1.24e-02
|
GOBP CELLULAR RESPONSE TO SALT STRESS
|
11
|
1.34e-02
|
4.31e-01
|
5.42e-02
|
GOBP NEUROEPITHELIAL CELL DIFFERENTIATION
|
33
|
1.91e-05
|
-4.30e-01
|
2.38e-04
|
GOBP MITOCHONDRIAL RNA PROCESSING
|
19
|
1.19e-03
|
4.30e-01
|
7.85e-03
|
GOBP ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN
|
45
|
6.29e-07
|
-4.29e-01
|
1.16e-05
|
GOMF K63 LINKED DEUBIQUITINASE ACTIVITY
|
13
|
7.45e-03
|
-4.29e-01
|
3.41e-02
|
GOMF COLLAGEN BINDING
|
60
|
9.99e-09
|
-4.28e-01
|
2.86e-07
|
GOBP RESPONSE TO MERCURY ION
|
10
|
1.92e-02
|
4.28e-01
|
7.17e-02
|
GOBP REGULATION OF MODIFICATION OF POSTSYNAPTIC ACTIN CYTOSKELETON
|
11
|
1.44e-02
|
-4.26e-01
|
5.72e-02
|
GOBP POSITIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS
|
53
|
8.22e-08
|
-4.26e-01
|
1.90e-06
|
GOBP POSITIVE REGULATION OF OSTEOBLAST PROLIFERATION
|
11
|
1.47e-02
|
-4.25e-01
|
5.82e-02
|
GOBP RESPONSE TO PROTOZOAN
|
31
|
4.21e-05
|
-4.25e-01
|
4.80e-04
|
GOBP MITOCHONDRIAL TRNA PROCESSING
|
11
|
1.49e-02
|
4.24e-01
|
5.89e-02
|
GOBP REGULATION OF NUCLEASE ACTIVITY
|
22
|
5.84e-04
|
-4.24e-01
|
4.35e-03
|
GOBP FEMALE MEIOTIC NUCLEAR DIVISION
|
27
|
1.42e-04
|
-4.23e-01
|
1.35e-03
|
GOBP POSITIVE REGULATION OF PODOSOME ASSEMBLY
|
10
|
2.07e-02
|
-4.23e-01
|
7.56e-02
|
GOBP T CELL MEDIATED CYTOTOXICITY
|
35
|
1.56e-05
|
-4.22e-01
|
1.98e-04
|
GOMF PROTON TRANSMEMBRANE TRANSPORTER ACTIVITY
|
87
|
1.09e-11
|
4.21e-01
|
5.40e-10
|
GOCC CD40 RECEPTOR COMPLEX
|
11
|
1.55e-02
|
-4.21e-01
|
6.08e-02
|
GOMF 3 5 DNA HELICASE ACTIVITY
|
15
|
4.72e-03
|
-4.21e-01
|
2.38e-02
|
GOBP SPINDLE ELONGATION
|
12
|
1.15e-02
|
-4.21e-01
|
4.82e-02
|
GOBP TOLERANCE INDUCTION
|
17
|
2.65e-03
|
-4.21e-01
|
1.51e-02
|
GOCC MYOFILAMENT
|
24
|
3.60e-04
|
4.21e-01
|
2.95e-03
|
GOBP NEURONAL ACTION POTENTIAL
|
30
|
6.84e-05
|
4.20e-01
|
7.30e-04
|
GOCC MULTIMERIC RIBONUCLEASE P COMPLEX
|
10
|
2.15e-02
|
4.20e-01
|
7.80e-02
|
GOMF RIBONUCLEASE P ACTIVITY
|
10
|
2.15e-02
|
4.20e-01
|
7.80e-02
|
GOBP RESPONSE TO TYPE I INTERFERON
|
58
|
3.27e-08
|
-4.20e-01
|
8.37e-07
|
GOBP POSITIVE REGULATION OF CHROMATIN ORGANIZATION
|
11
|
1.61e-02
|
-4.19e-01
|
6.27e-02
|
GOBP MITOTIC CHROMOSOME CONDENSATION
|
14
|
6.65e-03
|
-4.19e-01
|
3.12e-02
|
GOBP MITOCHONDRIAL RNA METABOLIC PROCESS
|
48
|
5.14e-07
|
4.19e-01
|
9.69e-06
|
GOBP CD8 POSITIVE ALPHA BETA T CELL ACTIVATION
|
22
|
6.80e-04
|
-4.18e-01
|
4.94e-03
|
GOBP SUPPRESSION OF VIRAL RELEASE BY HOST
|
19
|
1.61e-03
|
-4.18e-01
|
1.01e-02
|
GOBP KINETOCHORE ORGANIZATION
|
15
|
5.14e-03
|
-4.17e-01
|
2.54e-02
|
GOMF CHEMOKINE BINDING
|
20
|
1.26e-03
|
-4.17e-01
|
8.17e-03
|
GOMF PATTERN RECOGNITION RECEPTOR ACTIVITY
|
26
|
2.44e-04
|
-4.16e-01
|
2.15e-03
|
GOMF ACETYLGALACTOSAMINYLTRANSFERASE ACTIVITY
|
21
|
9.96e-04
|
-4.15e-01
|
6.77e-03
|
GOCC FIBRILLAR COLLAGEN TRIMER
|
11
|
1.77e-02
|
-4.13e-01
|
6.70e-02
|
GOMF METALLOENDOPEPTIDASE INHIBITOR ACTIVITY
|
11
|
1.77e-02
|
-4.13e-01
|
6.70e-02
|
GOMF ACID THIOL LIGASE ACTIVITY
|
24
|
4.64e-04
|
4.13e-01
|
3.60e-03
|
GOBP SULFUR COMPOUND CATABOLIC PROCESS
|
36
|
1.83e-05
|
4.13e-01
|
2.30e-04
|
GOBP POSITIVE REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE
|
10
|
2.44e-02
|
-4.11e-01
|
8.55e-02
|
GOBP ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRIAL MEMBRANE
|
22
|
8.63e-04
|
4.10e-01
|
6.03e-03
|
GOCC GOLGI CISTERNA MEMBRANE
|
18
|
2.59e-03
|
-4.10e-01
|
1.48e-02
|
GOBP RIBOSE PHOSPHATE BIOSYNTHETIC PROCESS
|
164
|
1.49e-19
|
4.10e-01
|
2.05e-17
|
GOMF OXIDOREDUCTASE ACTIVITY ACTING ON CH OH GROUP OF DONORS
|
94
|
6.98e-12
|
4.09e-01
|
3.58e-10
|
GOBP VERY LONG CHAIN FATTY ACID METABOLIC PROCESS
|
27
|
2.34e-04
|
4.09e-01
|
2.08e-03
|
GOBP NEUTRAL LIPID CATABOLIC PROCESS
|
26
|
3.09e-04
|
4.09e-01
|
2.61e-03
|
GOBP ANTIGEN PROCESSING AND PRESENTATION OF EXOGENOUS ANTIGEN
|
29
|
1.40e-04
|
-4.09e-01
|
1.33e-03
|
GOBP CELLULAR RESPONSE TO GLUCOCORTICOID STIMULUS
|
38
|
1.32e-05
|
-4.08e-01
|
1.72e-04
|
GOBP PHOSPHATIDYLETHANOLAMINE METABOLIC PROCESS
|
16
|
4.74e-03
|
4.08e-01
|
2.39e-02
|
GOMF OXIDOREDUCTASE ACTIVITY ACTING ON THE CH CH GROUP OF DONORS OXYGEN AS ACCEPTOR
|
10
|
2.59e-02
|
4.07e-01
|
8.94e-02
|
GOBP ANTIGEN PROCESSING AND PRESENTATION OF EXOGENOUS PEPTIDE ANTIGEN VIA MHC CLASS II
|
15
|
6.42e-03
|
-4.06e-01
|
3.04e-02
|
GOBP NON PROTEINOGENIC AMINO ACID CATABOLIC PROCESS
|
12
|
1.48e-02
|
4.06e-01
|
5.85e-02
|
GOBP RESPONSE TO AMINE
|
16
|
5.07e-03
|
4.05e-01
|
2.52e-02
|
GOBP TRICARBOXYLIC ACID METABOLIC PROCESS
|
16
|
5.10e-03
|
4.04e-01
|
2.53e-02
|
GOBP ESTABLISHMENT OF BLOOD BRAIN BARRIER
|
13
|
1.16e-02
|
-4.04e-01
|
4.84e-02
|
GOMF TRIGLYCERIDE LIPASE ACTIVITY
|
10
|
2.69e-02
|
4.04e-01
|
9.20e-02
|
GOBP NEGATIVE REGULATION OF PLATELET ACTIVATION
|
14
|
9.14e-03
|
-4.02e-01
|
4.00e-02
|
GOBP TYPE II INTERFERON MEDIATED SIGNALING PATHWAY
|
20
|
1.89e-03
|
-4.01e-01
|
1.15e-02
|
GOBP NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION
|
28
|
2.37e-04
|
-4.01e-01
|
2.10e-03
|
GOBP REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY
|
37
|
2.51e-05
|
-4.00e-01
|
3.06e-04
|
GOMF FLIPPASE ACTIVITY
|
13
|
1.25e-02
|
-4.00e-01
|
5.13e-02
|
GOBP MACROPHAGE PROLIFERATION
|
10
|
2.85e-02
|
-4.00e-01
|
9.56e-02
|
GOBP CELLULAR RESPONSE TO ANTIBIOTIC
|
11
|
2.17e-02
|
-4.00e-01
|
7.84e-02
|
GOMF K63 LINKED POLYUBIQUITIN MODIFICATION DEPENDENT PROTEIN BINDING
|
23
|
9.10e-04
|
-4.00e-01
|
6.28e-03
|
GOBP ELASTIC FIBER ASSEMBLY
|
11
|
2.18e-02
|
-4.00e-01
|
7.86e-02
|
GOBP PYROPTOSIS
|
26
|
4.22e-04
|
-4.00e-01
|
3.37e-03
|
GOMF TRANSFERASE ACTIVITY TRANSFERRING ALKYL OR ARYL OTHER THAN METHYL GROUPS
|
57
|
1.84e-07
|
3.99e-01
|
3.86e-06
|
GOMF STRUCTURAL CONSTITUENT OF POSTSYNAPTIC SPECIALIZATION
|
13
|
1.27e-02
|
3.99e-01
|
5.21e-02
|
GOBP NICOTINAMIDE NUCLEOTIDE BIOSYNTHETIC PROCESS
|
10
|
2.90e-02
|
3.99e-01
|
9.68e-02
|
GOBP DICARBOXYLIC ACID BIOSYNTHETIC PROCESS
|
10
|
2.92e-02
|
3.98e-01
|
9.71e-02
|
GOCC DOPAMINERGIC SYNAPSE
|
10
|
2.92e-02
|
3.98e-01
|
9.71e-02
|
GOMF TYPE I TRANSFORMING GROWTH FACTOR BETA RECEPTOR BINDING
|
12
|
1.70e-02
|
-3.98e-01
|
6.53e-02
|
GOBP PULMONARY VALVE MORPHOGENESIS
|
18
|
3.49e-03
|
-3.98e-01
|
1.87e-02
|
GOCC COLLAGEN TRIMER
|
57
|
2.13e-07
|
-3.97e-01
|
4.41e-06
|
GOBP NEGATIVE REGULATION OF TYPE II INTERFERON PRODUCTION
|
24
|
7.56e-04
|
-3.97e-01
|
5.41e-03
|
GOMF EXCITATORY EXTRACELLULAR LIGAND GATED MONOATOMIC ION CHANNEL ACTIVITY
|
11
|
2.29e-02
|
3.96e-01
|
8.15e-02
|
GOBP ASYMMETRIC CELL DIVISION
|
18
|
3.61e-03
|
-3.96e-01
|
1.93e-02
|
GOBP POSITIVE REGULATION OF MACROPHAGE DIFFERENTIATION
|
15
|
7.91e-03
|
-3.96e-01
|
3.56e-02
|
GOBP SULFUR AMINO ACID BIOSYNTHETIC PROCESS
|
13
|
1.34e-02
|
3.96e-01
|
5.43e-02
|
GOBP SPINDLE CHECKPOINT SIGNALING
|
42
|
9.08e-06
|
-3.96e-01
|
1.25e-04
|
GOBP REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE
|
19
|
2.84e-03
|
-3.96e-01
|
1.59e-02
|
GOBP NADPH REGENERATION
|
23
|
1.03e-03
|
3.95e-01
|
6.98e-03
|
GOBP NEGATIVE REGULATION OF SMAD PROTEIN SIGNAL TRANSDUCTION
|
14
|
1.05e-02
|
-3.95e-01
|
4.47e-02
|
GOBP INTERLEUKIN 18 PRODUCTION
|
10
|
3.06e-02
|
-3.95e-01
|
1.01e-01
|
GOBP LONG CHAIN FATTY ACYL COA METABOLIC PROCESS
|
10
|
3.06e-02
|
3.95e-01
|
1.01e-01
|
GOBP IMPORT INTO THE MITOCHONDRION
|
45
|
4.62e-06
|
3.95e-01
|
6.91e-05
|
GOBP MEIOTIC SPINDLE ORGANIZATION
|
17
|
4.91e-03
|
-3.94e-01
|
2.46e-02
|
GOBP LEUKOCYTE AGGREGATION
|
15
|
8.24e-03
|
-3.94e-01
|
3.67e-02
|
GOBP SPONTANEOUS SYNAPTIC TRANSMISSION
|
11
|
2.37e-02
|
-3.94e-01
|
8.34e-02
|
GOBP DETECTION OF OTHER ORGANISM
|
13
|
1.39e-02
|
-3.94e-01
|
5.57e-02
|
GOBP FATTY ACID DERIVATIVE BIOSYNTHETIC PROCESS
|
13
|
1.40e-02
|
3.93e-01
|
5.61e-02
|
GOCC U5 SNRNP
|
16
|
6.45e-03
|
3.93e-01
|
3.05e-02
|
GOBP HEMATOPOIETIC STEM CELL HOMEOSTASIS
|
26
|
5.18e-04
|
-3.93e-01
|
3.95e-03
|
GOMF INWARD RECTIFIER POTASSIUM CHANNEL ACTIVITY
|
14
|
1.09e-02
|
3.93e-01
|
4.61e-02
|
GOMF POLY A BINDING
|
20
|
2.35e-03
|
-3.93e-01
|
1.37e-02
|
GOBP REGULATION OF VIRAL GENOME REPLICATION
|
66
|
3.46e-08
|
-3.93e-01
|
8.78e-07
|
GOBP HEME BIOSYNTHETIC PROCESS
|
24
|
8.81e-04
|
3.92e-01
|
6.15e-03
|
GOBP REGULATION OF MITOTIC SISTER CHROMATID SEGREGATION
|
45
|
5.36e-06
|
-3.92e-01
|
7.92e-05
|
GOCC SCAR COMPLEX
|
12
|
1.87e-02
|
-3.92e-01
|
7.01e-02
|
GOBP NEGATIVE REGULATION OF GENE EXPRESSION VIA CHROMOSOMAL CPG ISLAND METHYLATION
|
20
|
2.48e-03
|
-3.91e-01
|
1.42e-02
|
GOCC SPINDLE MIDZONE
|
36
|
4.99e-05
|
-3.91e-01
|
5.52e-04
|
GOCC XY BODY
|
17
|
5.30e-03
|
-3.91e-01
|
2.61e-02
|
GOBP POSITIVE REGULATION OF MACROPHAGE CYTOKINE PRODUCTION
|
27
|
4.55e-04
|
-3.90e-01
|
3.58e-03
|
GOMF MEMBRANE INSERTASE ACTIVITY
|
16
|
6.97e-03
|
3.90e-01
|
3.26e-02
|
GOMF DNA SECONDARY STRUCTURE BINDING
|
31
|
1.78e-04
|
-3.89e-01
|
1.63e-03
|
GOMF THIOLESTER HYDROLASE ACTIVITY
|
41
|
1.66e-05
|
3.89e-01
|
2.10e-04
|
GOMF FMN BINDING
|
14
|
1.18e-02
|
3.89e-01
|
4.92e-02
|
GOBP PYRIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS
|
16
|
7.14e-03
|
3.89e-01
|
3.32e-02
|
GOBP NEGATIVE REGULATION OF ALPHA BETA T CELL PROLIFERATION
|
12
|
2.00e-02
|
-3.88e-01
|
7.37e-02
|
GOBP MESENCHYME MORPHOGENESIS
|
49
|
2.68e-06
|
-3.88e-01
|
4.28e-05
|
GOBP STEROL BIOSYNTHETIC PROCESS
|
51
|
1.73e-06
|
3.87e-01
|
2.91e-05
|
GOMF DNA APURINIC OR APYRIMIDINIC SITE ENDONUCLEASE ACTIVITY
|
11
|
2.63e-02
|
3.87e-01
|
9.03e-02
|
GOBP HYDROGEN PEROXIDE CATABOLIC PROCESS
|
16
|
7.41e-03
|
3.87e-01
|
3.40e-02
|
GOMF TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY BINDING
|
32
|
1.55e-04
|
-3.86e-01
|
1.46e-03
|
GOCC OUTER KINETOCHORE
|
16
|
7.48e-03
|
-3.86e-01
|
3.42e-02
|
GOMF FIBRONECTIN BINDING
|
31
|
1.99e-04
|
-3.86e-01
|
1.80e-03
|
GOBP PROTON TRANSMEMBRANE TRANSPORT
|
61
|
1.84e-07
|
3.86e-01
|
3.86e-06
|
GOBP RESPONSE TO CAFFEINE
|
13
|
1.60e-02
|
3.86e-01
|
6.24e-02
|
GOBP TOLL LIKE RECEPTOR 3 SIGNALING PATHWAY
|
28
|
4.19e-04
|
-3.85e-01
|
3.35e-03
|
GOBP SPINAL CORD PATTERNING
|
13
|
1.63e-02
|
-3.85e-01
|
6.32e-02
|
GOCC ORGANELLE ENVELOPE LUMEN
|
74
|
1.12e-08
|
3.84e-01
|
3.12e-07
|
GOMF TRANSFERASE ACTIVITY TRANSFERRING NITROGENOUS GROUPS
|
18
|
4.79e-03
|
3.84e-01
|
2.41e-02
|
GOBP COLLAGEN ACTIVATED TYROSINE KINASE RECEPTOR SIGNALING PATHWAY
|
11
|
2.76e-02
|
-3.84e-01
|
9.35e-02
|
GOMF ANTIGEN BINDING
|
39
|
3.39e-05
|
-3.84e-01
|
3.97e-04
|
GOBP DICARBOXYLIC ACID METABOLIC PROCESS
|
77
|
5.98e-09
|
3.84e-01
|
1.80e-07
|
GOMF MONOATOMIC ANION SODIUM SYMPORTER ACTIVITY
|
11
|
2.77e-02
|
3.83e-01
|
9.36e-02
|
GOBP PHOSPHATIDYLGLYCEROL METABOLIC PROCESS
|
21
|
2.36e-03
|
3.83e-01
|
1.37e-02
|
GOBP NAD METABOLIC PROCESS
|
48
|
4.33e-06
|
3.83e-01
|
6.51e-05
|
GOCC RPAP3 R2TP PREFOLDIN LIKE COMPLEX
|
10
|
3.58e-02
|
3.83e-01
|
1.14e-01
|
GOBP MEDIUM CHAIN FATTY ACID METABOLIC PROCESS
|
12
|
2.15e-02
|
3.83e-01
|
7.80e-02
|
GOBP REGULATION OF CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS
|
21
|
2.36e-03
|
-3.83e-01
|
1.37e-02
|
GOCC INTEGRIN COMPLEX
|
30
|
2.83e-04
|
-3.83e-01
|
2.44e-03
|
GOBP REGULATION OF MACROPHAGE DIFFERENTIATION
|
20
|
3.04e-03
|
-3.83e-01
|
1.68e-02
|
GOCC SODIUM CHANNEL COMPLEX
|
15
|
1.03e-02
|
3.83e-01
|
4.39e-02
|
GOMF FLAVIN ADENINE DINUCLEOTIDE BINDING
|
78
|
5.17e-09
|
3.83e-01
|
1.61e-07
|
GOBP UBIQUINONE METABOLIC PROCESS
|
17
|
6.46e-03
|
3.82e-01
|
3.05e-02
|
GOCC MICROBODY
|
124
|
2.28e-13
|
3.81e-01
|
1.39e-11
|
GOBP DNA REPLICATION CHECKPOINT SIGNALING
|
15
|
1.06e-02
|
-3.81e-01
|
4.49e-02
|
GOBP REGULATION OF SISTER CHROMATID COHESION
|
14
|
1.36e-02
|
-3.81e-01
|
5.46e-02
|
GOMF STRUCTURAL CONSTITUENT OF MUSCLE
|
19
|
4.04e-03
|
3.81e-01
|
2.11e-02
|
GOCC SMALL RIBOSOMAL SUBUNIT
|
78
|
6.23e-09
|
3.81e-01
|
1.87e-07
|
GOMF NADPLUS PROTEIN ADP RIBOSYLTRANSFERASE ACTIVITY
|
22
|
2.01e-03
|
-3.81e-01
|
1.20e-02
|
GOMF FAD BINDING
|
36
|
7.89e-05
|
3.80e-01
|
8.15e-04
|
GOBP CELLULAR RESPONSE TO DEXAMETHASONE STIMULUS
|
19
|
4.16e-03
|
-3.80e-01
|
2.16e-02
|
GOBP NEGATIVE REGULATION OF AMYLOID FIBRIL FORMATION
|
12
|
2.28e-02
|
3.80e-01
|
8.12e-02
|
GOBP AROMATIC AMINO ACID TRANSPORT
|
10
|
3.84e-02
|
3.78e-01
|
1.20e-01
|
GOBP SEMI LUNAR VALVE DEVELOPMENT
|
37
|
6.97e-05
|
-3.78e-01
|
7.40e-04
|
GOBP DICARBOXYLIC ACID CATABOLIC PROCESS
|
14
|
1.45e-02
|
3.77e-01
|
5.77e-02
|
GOBP PROTEIN LIPID COMPLEX ASSEMBLY
|
21
|
2.77e-03
|
3.77e-01
|
1.56e-02
|
GOBP REGULATION OF NUCLEAR CELL CYCLE DNA REPLICATION
|
10
|
3.90e-02
|
-3.77e-01
|
1.21e-01
|
GOBP DENDRITIC CELL CYTOKINE PRODUCTION
|
16
|
9.16e-03
|
-3.76e-01
|
4.00e-02
|
GOMF OXIDOREDUCTASE ACTIVITY ACTING ON THE ALDEHYDE OR OXO GROUP OF DONORS
|
46
|
1.02e-05
|
3.76e-01
|
1.37e-04
|
GOBP NEGATIVE REGULATION OF DNA REPLICATION
|
18
|
5.78e-03
|
-3.76e-01
|
2.80e-02
|
GOBP POSITIVE REGULATION OF T CELL MEDIATED IMMUNITY
|
43
|
2.10e-05
|
-3.75e-01
|
2.60e-04
|
GOBP SARCOPLASMIC RETICULUM CALCIUM ION TRANSPORT
|
28
|
5.97e-04
|
3.75e-01
|
4.43e-03
|
GOMF PRENYLTRANSFERASE ACTIVITY
|
15
|
1.20e-02
|
3.75e-01
|
4.97e-02
|
GOBP NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION
|
19
|
4.77e-03
|
-3.74e-01
|
2.40e-02
|
GOBP NEGATIVE REGULATION OF SYNAPSE ORGANIZATION
|
14
|
1.54e-02
|
-3.74e-01
|
6.06e-02
|
GOBP REGULATION OF PLASMA MEMBRANE ORGANIZATION
|
17
|
7.63e-03
|
-3.74e-01
|
3.47e-02
|
GOBP B CELL HOMEOSTASIS
|
37
|
8.56e-05
|
-3.73e-01
|
8.72e-04
|
GOBP POSITIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE
|
21
|
3.08e-03
|
-3.73e-01
|
1.69e-02
|
GOBP CELLULAR RESPONSE TO CORTICOSTEROID STIMULUS
|
42
|
2.87e-05
|
-3.73e-01
|
3.44e-04
|
GOMF ALCOHOL DEHYDROGENASE NAD P PLUS ACTIVITY
|
12
|
2.53e-02
|
3.73e-01
|
8.78e-02
|
GOBP SERINE FAMILY AMINO ACID BIOSYNTHETIC PROCESS
|
13
|
1.99e-02
|
3.73e-01
|
7.36e-02
|
GOBP ENERGY DERIVATION BY OXIDATION OF ORGANIC COMPOUNDS
|
285
|
3.51e-27
|
3.72e-01
|
1.13e-24
|
GOBP MITOTIC SISTER CHROMATID COHESION
|
21
|
3.17e-03
|
-3.72e-01
|
1.72e-02
|
GOBP NEURON FATE SPECIFICATION
|
16
|
1.00e-02
|
-3.72e-01
|
4.29e-02
|
GOBP PROTEIN LOCALIZATION TO CHROMOSOME CENTROMERIC REGION
|
20
|
4.03e-03
|
-3.71e-01
|
2.11e-02
|
GOBP REGULATION OF LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY
|
22
|
2.57e-03
|
-3.71e-01
|
1.47e-02
|
GOBP REGULATION OF CD8 POSITIVE ALPHA BETA T CELL ACTIVATION
|
15
|
1.28e-02
|
-3.71e-01
|
5.23e-02
|
GOBP ENDOCARDIAL CUSHION DEVELOPMENT
|
46
|
1.33e-05
|
-3.71e-01
|
1.73e-04
|
GOBP REGULATION OF TRANSLATION IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS
|
12
|
2.61e-02
|
-3.71e-01
|
9.00e-02
|
GOBP LYMPH VESSEL MORPHOGENESIS
|
23
|
2.09e-03
|
-3.71e-01
|
1.24e-02
|
GOBP DEFENSE RESPONSE TO GRAM POSITIVE BACTERIUM
|
54
|
2.56e-06
|
-3.70e-01
|
4.13e-05
|
GOBP REGULATION OF PHOSPHOLIPID BIOSYNTHETIC PROCESS
|
17
|
8.39e-03
|
3.69e-01
|
3.72e-02
|
GOBP LIPID OXIDATION
|
100
|
1.90e-10
|
3.69e-01
|
8.08e-09
|
GOBP RIBOSOMAL SMALL SUBUNIT ASSEMBLY
|
19
|
5.52e-03
|
3.68e-01
|
2.70e-02
|
GOBP SODIUM ION IMPORT ACROSS PLASMA MEMBRANE
|
16
|
1.09e-02
|
3.67e-01
|
4.63e-02
|
GOMF PLATELET DERIVED GROWTH FACTOR BINDING
|
11
|
3.49e-02
|
-3.67e-01
|
1.12e-01
|
GOBP REGULATION OF SEQUESTERING OF TRIGLYCERIDE
|
14
|
1.74e-02
|
3.67e-01
|
6.61e-02
|
GOCC FLEMMING BODY
|
17
|
8.90e-03
|
-3.67e-01
|
3.91e-02
|
GOBP MODULATION BY SYMBIONT OF ENTRY INTO HOST
|
43
|
3.28e-05
|
-3.66e-01
|
3.87e-04
|
GOBP ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE OR POLYSACCHARIDE ANTIGEN VIA MHC CLASS II
|
19
|
5.76e-03
|
-3.66e-01
|
2.79e-02
|
GOBP COLLAGEN FIBRIL ORGANIZATION
|
56
|
2.21e-06
|
-3.66e-01
|
3.64e-05
|
GOBP PYRIDINE NUCLEOTIDE BIOSYNTHETIC PROCESS
|
13
|
2.26e-02
|
3.65e-01
|
8.09e-02
|
GOBP RESPONSE TO DEXAMETHASONE
|
23
|
2.44e-03
|
-3.65e-01
|
1.41e-02
|
GOBP UV DAMAGE EXCISION REPAIR
|
10
|
4.57e-02
|
-3.65e-01
|
1.35e-01
|
GOBP AMINO ACID METABOLIC PROCESS
|
207
|
1.73e-19
|
3.64e-01
|
2.29e-17
|
GOMF CYCLIN DEPENDENT PROTEIN SERINE THREONINE KINASE ACTIVATOR ACTIVITY
|
11
|
3.65e-02
|
-3.64e-01
|
1.15e-01
|
GOMF NAD BINDING
|
56
|
2.59e-06
|
3.63e-01
|
4.16e-05
|
GOBP NEGATIVE REGULATION OF MONONUCLEAR CELL MIGRATION
|
20
|
4.96e-03
|
-3.63e-01
|
2.48e-02
|
GOBP ASPARTATE FAMILY AMINO ACID BIOSYNTHETIC PROCESS
|
18
|
7.70e-03
|
3.63e-01
|
3.49e-02
|
GOMF STRUCTURAL CONSTITUENT OF POSTSYNAPTIC DENSITY
|
11
|
3.72e-02
|
3.63e-01
|
1.17e-01
|
GOMF G PROTEIN COUPLED AMINE RECEPTOR ACTIVITY
|
12
|
2.96e-02
|
3.63e-01
|
9.83e-02
|
GOBP MITOCHONDRIAL TRANSMEMBRANE TRANSPORT
|
80
|
2.09e-08
|
3.63e-01
|
5.51e-07
|
GOBP REGULATION OF T CELL DIFFERENTIATION IN THYMUS
|
18
|
7.75e-03
|
-3.63e-01
|
3.51e-02
|
GOCC CENTRIOLAR SUBDISTAL APPENDAGE
|
10
|
4.72e-02
|
-3.62e-01
|
1.39e-01
|
GOBP DETECTION OF EXTERNAL BIOTIC STIMULUS
|
22
|
3.26e-03
|
-3.62e-01
|
1.77e-02
|
GOBP POLYAMINE TRANSPORT
|
10
|
4.74e-02
|
3.62e-01
|
1.39e-01
|
GOBP SCHWANN CELL MIGRATION
|
11
|
3.76e-02
|
-3.62e-01
|
1.18e-01
|
GOBP PROTEOGLYCAN CATABOLIC PROCESS
|
10
|
4.75e-02
|
3.62e-01
|
1.39e-01
|
GOBP SMALL MOLECULE CATABOLIC PROCESS
|
265
|
3.95e-24
|
3.62e-01
|
8.87e-22
|
GOBP CELLULAR RESPONSE TO NITRIC OXIDE
|
11
|
3.78e-02
|
-3.62e-01
|
1.18e-01
|
GOMF TRANSFORMING GROWTH FACTOR BETA RECEPTOR BINDING
|
26
|
1.42e-03
|
-3.62e-01
|
9.02e-03
|
GOBP REGULATION OF MITOCHONDRIAL FUSION
|
13
|
2.40e-02
|
3.61e-01
|
8.44e-02
|
GOBP POSITIVE REGULATION OF ANIMAL ORGAN MORPHOGENESIS
|
26
|
1.42e-03
|
-3.61e-01
|
9.03e-03
|
GOBP PROTEIN INSERTION INTO ER MEMBRANE BY STOP TRANSFER MEMBRANE ANCHOR SEQUENCE
|
11
|
3.80e-02
|
3.61e-01
|
1.19e-01
|
GOBP NEGATIVE REGULATION OF CGAS STING SIGNALING PATHWAY
|
12
|
3.04e-02
|
-3.61e-01
|
1.01e-01
|
GOBP SIGNAL PEPTIDE PROCESSING
|
13
|
2.44e-02
|
3.60e-01
|
8.55e-02
|
GOBP RELAXATION OF CARDIAC MUSCLE
|
15
|
1.58e-02
|
3.60e-01
|
6.18e-02
|
GOBP CHOLESTEROL IMPORT
|
12
|
3.09e-02
|
3.60e-01
|
1.02e-01
|
GOBP REGULATION OF BIOLOGICAL PROCESS INVOLVED IN SYMBIOTIC INTERACTION
|
47
|
2.00e-05
|
-3.60e-01
|
2.49e-04
|
GOMF MISMATCH REPAIR COMPLEX BINDING
|
10
|
4.92e-02
|
-3.59e-01
|
1.44e-01
|
GOBP POTASSIUM ION IMPORT ACROSS PLASMA MEMBRANE
|
35
|
2.39e-04
|
3.59e-01
|
2.11e-03
|
GOBP REGULATION OF METAPHASE PLATE CONGRESSION
|
14
|
2.03e-02
|
-3.58e-01
|
7.47e-02
|
GOBP POTASSIUM ION HOMEOSTASIS
|
25
|
1.95e-03
|
3.58e-01
|
1.17e-02
|
GOBP POSITIVE REGULATION OF SKELETAL MUSCLE ACETYLCHOLINE GATED CHANNEL CLUSTERING
|
11
|
4.00e-02
|
-3.58e-01
|
1.23e-01
|
GOMF DOUBLE STRANDED RNA BINDING
|
70
|
2.31e-07
|
-3.58e-01
|
4.75e-06
|
GOBP POSITIVE REGULATION OF CHEMOKINE C X C MOTIF LIGAND 2 PRODUCTION
|
11
|
4.02e-02
|
-3.57e-01
|
1.23e-01
|
GOBP DNA DUPLEX UNWINDING
|
40
|
9.83e-05
|
-3.56e-01
|
9.87e-04
|
GOBP CELL FATE COMMITMENT INVOLVED IN FORMATION OF PRIMARY GERM LAYER
|
18
|
9.04e-03
|
-3.55e-01
|
3.96e-02
|
GOBP ENDODERM FORMATION
|
30
|
7.72e-04
|
-3.55e-01
|
5.51e-03
|
GOBP ION CHANNEL MODULATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY
|
11
|
4.17e-02
|
-3.55e-01
|
1.26e-01
|
GOBP TETRAPYRROLE METABOLIC PROCESS
|
47
|
2.61e-05
|
3.55e-01
|
3.16e-04
|
GOMF C C CHEMOKINE BINDING
|
11
|
4.18e-02
|
-3.55e-01
|
1.26e-01
|
GOCC CLEAVAGE FURROW
|
32
|
5.21e-04
|
-3.54e-01
|
3.96e-03
|
GOBP TAIL ANCHORED MEMBRANE PROTEIN INSERTION INTO ER MEMBRANE
|
15
|
1.75e-02
|
3.54e-01
|
6.65e-02
|
GOCC MICROBODY MEMBRANE
|
44
|
4.79e-05
|
3.54e-01
|
5.35e-04
|
GOBP PHOSPHATE ION TRANSMEMBRANE TRANSPORT
|
14
|
2.18e-02
|
3.54e-01
|
7.86e-02
|
GOBP REGULATION OF FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY
|
14
|
2.20e-02
|
-3.54e-01
|
7.92e-02
|
GOBP POSITIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA PRODUCTION
|
13
|
2.74e-02
|
-3.53e-01
|
9.33e-02
|
GOBP NEGATIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION
|
22
|
4.15e-03
|
-3.53e-01
|
2.16e-02
|
GOBP REGULATION OF SPINDLE CHECKPOINT
|
20
|
6.29e-03
|
-3.53e-01
|
2.98e-02
|
GOBP REGULATION OF B CELL APOPTOTIC PROCESS
|
18
|
9.65e-03
|
-3.52e-01
|
4.16e-02
|
GOBP TETRAHYDROFOLATE INTERCONVERSION
|
12
|
3.48e-02
|
-3.52e-01
|
1.12e-01
|
GOBP BRANCHED CHAIN AMINO ACID TRANSPORT
|
10
|
5.40e-02
|
3.52e-01
|
1.53e-01
|
GOBP REGULATION OF RESPONSE TO TYPE II INTERFERON
|
13
|
2.81e-02
|
-3.52e-01
|
9.46e-02
|
GOBP REGULATION OF SYNAPTIC VESICLE CYCLE
|
14
|
2.28e-02
|
-3.52e-01
|
8.12e-02
|
GOBP DNA DOUBLE STRAND BREAK PROCESSING
|
17
|
1.22e-02
|
-3.51e-01
|
5.03e-02
|
GOBP CELLULAR RESPONSE TO REACTIVE NITROGEN SPECIES
|
13
|
2.85e-02
|
-3.51e-01
|
9.56e-02
|
GOBP POSITIVE REGULATION OF LIPID STORAGE
|
22
|
4.40e-03
|
3.51e-01
|
2.26e-02
|
GOBP ORGAN INDUCTION
|
15
|
1.87e-02
|
-3.51e-01
|
7.01e-02
|
GOBP NUCLEOSOME ASSEMBLY
|
48
|
2.69e-05
|
-3.50e-01
|
3.25e-04
|
GOBP REGULATION OF T CELL MEDIATED IMMUNITY
|
62
|
1.85e-06
|
-3.50e-01
|
3.10e-05
|
GOBP GLIAL CELL FATE COMMITMENT
|
12
|
3.61e-02
|
-3.50e-01
|
1.14e-01
|
GOBP SEX CHROMOSOME DOSAGE COMPENSATION
|
18
|
1.03e-02
|
-3.49e-01
|
4.39e-02
|
GOBP REGULATION OF APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT
|
12
|
3.62e-02
|
-3.49e-01
|
1.15e-01
|
GOCC LAMELLAR BODY
|
10
|
5.60e-02
|
3.49e-01
|
1.58e-01
|
GOBP RIBOSOMAL LARGE SUBUNIT ASSEMBLY
|
21
|
5.67e-03
|
3.49e-01
|
2.75e-02
|
GOCC GOLGI MEDIAL CISTERNA
|
21
|
5.69e-03
|
-3.49e-01
|
2.76e-02
|
GOBP SUCKLING BEHAVIOR
|
12
|
3.68e-02
|
-3.48e-01
|
1.16e-01
|
GOBP CARDIAC EPITHELIAL TO MESENCHYMAL TRANSITION
|
33
|
5.41e-04
|
-3.48e-01
|
4.08e-03
|
GOCC MITOCHONDRION
|
1542
|
0.00e+00
|
3.48e-01
|
0.00e+00
|
GOBP NADH METABOLIC PROCESS
|
37
|
2.55e-04
|
3.47e-01
|
2.23e-03
|
GOBP POSITIVE REGULATION OF VASCULAR ENDOTHELIAL CELL PROLIFERATION
|
17
|
1.33e-02
|
-3.47e-01
|
5.38e-02
|
GOBP TRNA THREONYLCARBAMOYLADENOSINE METABOLIC PROCESS
|
15
|
2.03e-02
|
3.46e-01
|
7.47e-02
|
GOCC CONTRACTILE RING
|
11
|
4.69e-02
|
-3.46e-01
|
1.38e-01
|
GOMF CARBON OXYGEN LYASE ACTIVITY
|
60
|
3.61e-06
|
3.46e-01
|
5.51e-05
|
GOBP REGULATION OF HETEROCHROMATIN FORMATION
|
19
|
9.17e-03
|
-3.45e-01
|
4.00e-02
|
GOBP REGULATION OF PODOSOME ASSEMBLY
|
14
|
2.55e-02
|
-3.45e-01
|
8.84e-02
|
GOBP CHAPERONE MEDIATED PROTEIN COMPLEX ASSEMBLY
|
17
|
1.39e-02
|
3.45e-01
|
5.56e-02
|
GOBP TRNA DECAY
|
16
|
1.70e-02
|
-3.45e-01
|
6.53e-02
|
GOBP RESPONSE TO ELECTRICAL STIMULUS
|
18
|
1.14e-02
|
-3.44e-01
|
4.80e-02
|
GOBP CHONDROCYTE DIFFERENTIATION INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS
|
12
|
3.90e-02
|
-3.44e-01
|
1.21e-01
|
GOBP REGULATION OF VIRAL LIFE CYCLE
|
109
|
5.48e-10
|
-3.44e-01
|
2.12e-08
|
GOBP T HELPER 1 CELL DIFFERENTIATION
|
18
|
1.15e-02
|
-3.44e-01
|
4.81e-02
|
GOBP INDOLE CONTAINING COMPOUND METABOLIC PROCESS
|
16
|
1.72e-02
|
3.44e-01
|
6.56e-02
|
GOBP REGULATION OF DNA METHYLATION DEPENDENT HETEROCHROMATIN FORMATION
|
13
|
3.17e-02
|
-3.44e-01
|
1.04e-01
|
GOMF OXIDOREDUCTASE ACTIVITY ACTING ON NAD P H
|
55
|
1.02e-05
|
3.44e-01
|
1.37e-04
|
GOBP DOPAMINE METABOLIC PROCESS
|
33
|
6.53e-04
|
3.43e-01
|
4.76e-03
|
GOMF GLUCOSE BINDING
|
10
|
6.06e-02
|
3.43e-01
|
1.66e-01
|
GOBP NEURONAL STEM CELL POPULATION MAINTENANCE
|
20
|
7.99e-03
|
-3.43e-01
|
3.59e-02
|
GOBP PROTEIN LOCALIZATION TO CONDENSED CHROMOSOME
|
13
|
3.25e-02
|
-3.43e-01
|
1.06e-01
|
GOBP MAINTENANCE OF SISTER CHROMATID COHESION
|
10
|
6.08e-02
|
-3.42e-01
|
1.66e-01
|
GOBP POSITIVE REGULATION OF HEPATOCYTE PROLIFERATION
|
12
|
4.00e-02
|
-3.42e-01
|
1.23e-01
|
GOBP PROTEIN LOCALIZATION TO MITOCHONDRION
|
86
|
4.15e-08
|
3.42e-01
|
1.02e-06
|
GOBP REGULATION OF RIG I SIGNALING PATHWAY
|
15
|
2.18e-02
|
-3.42e-01
|
7.87e-02
|
GOBP POSITIVE REGULATION OF TYPE 2 IMMUNE RESPONSE
|
11
|
4.97e-02
|
-3.42e-01
|
1.45e-01
|
GOBP DORSAL VENTRAL NEURAL TUBE PATTERNING
|
18
|
1.21e-02
|
-3.42e-01
|
5.00e-02
|
GOMF VOLTAGE GATED MONOATOMIC ANION CHANNEL ACTIVITY
|
15
|
2.23e-02
|
3.41e-01
|
7.99e-02
|
GOBP REGULATION OF CHROMATIN BINDING
|
17
|
1.50e-02
|
-3.41e-01
|
5.91e-02
|
GOBP NEGATIVE REGULATION OF INTERLEUKIN 17 PRODUCTION
|
12
|
4.11e-02
|
-3.41e-01
|
1.25e-01
|
GOBP POSITIVE REGULATION OF DEFENSE RESPONSE TO BACTERIUM
|
12
|
4.15e-02
|
-3.40e-01
|
1.26e-01
|
GOBP MITOTIC G2 DNA DAMAGE CHECKPOINT SIGNALING
|
34
|
6.05e-04
|
-3.40e-01
|
4.47e-03
|
GOMF LIPID PHOSPHATASE ACTIVITY
|
12
|
4.15e-02
|
3.40e-01
|
1.26e-01
|
GOBP DETECTION OF MOLECULE OF BACTERIAL ORIGIN
|
14
|
2.77e-02
|
-3.40e-01
|
9.38e-02
|
GOBP POSITIVE REGULATION OF POST TRANSCRIPTIONAL GENE SILENCING
|
12
|
4.17e-02
|
-3.40e-01
|
1.26e-01
|
GOBP SULFUR AMINO ACID METABOLIC PROCESS
|
26
|
2.76e-03
|
3.39e-01
|
1.55e-02
|
GOBP CELL CYCLE DNA REPLICATION
|
39
|
2.48e-04
|
-3.39e-01
|
2.18e-03
|
GOBP NEGATIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION
|
11
|
5.17e-02
|
-3.39e-01
|
1.49e-01
|
GOBP DETECTION OF LIGHT STIMULUS
|
19
|
1.06e-02
|
3.39e-01
|
4.50e-02
|
GOBP CELLULAR LIPID CATABOLIC PROCESS
|
170
|
2.88e-14
|
3.38e-01
|
2.03e-12
|
GOBP NEGATIVE REGULATION OF INTERLEUKIN 2 PRODUCTION
|
21
|
7.29e-03
|
-3.38e-01
|
3.37e-02
|
GOMF DNA BINDING BENDING
|
11
|
5.23e-02
|
-3.38e-01
|
1.50e-01
|
GOMF CARBOHYDRATE TRANSMEMBRANE TRANSPORTER ACTIVITY
|
24
|
4.17e-03
|
3.38e-01
|
2.17e-02
|
GOCC CELL DIVISION SITE
|
41
|
1.82e-04
|
-3.38e-01
|
1.66e-03
|
GOBP MODIFICATION OF POSTSYNAPTIC ACTIN CYTOSKELETON
|
21
|
7.44e-03
|
-3.37e-01
|
3.41e-02
|
GOBP PROTEIN HETEROTETRAMERIZATION
|
11
|
5.28e-02
|
-3.37e-01
|
1.51e-01
|
GOBP NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE
|
12
|
4.33e-02
|
-3.37e-01
|
1.30e-01
|
GOCC CYTOPLASMIC SIDE OF LYSOSOMAL MEMBRANE
|
10
|
6.51e-02
|
3.37e-01
|
1.74e-01
|
GOBP TETRAPYRROLE BIOSYNTHETIC PROCESS
|
29
|
1.69e-03
|
3.37e-01
|
1.06e-02
|
GOBP ANTIGEN PROCESSING AND PRESENTATION
|
81
|
1.62e-07
|
-3.37e-01
|
3.48e-06
|
GOBP POSITIVE REGULATION OF FILOPODIUM ASSEMBLY
|
27
|
2.48e-03
|
-3.36e-01
|
1.42e-02
|
GOMF SUGAR TRANSMEMBRANE TRANSPORTER ACTIVITY
|
18
|
1.35e-02
|
3.36e-01
|
5.43e-02
|
GOBP FC RECEPTOR SIGNALING PATHWAY
|
12
|
4.37e-02
|
-3.36e-01
|
1.30e-01
|
GOBP SERTOLI CELL DEVELOPMENT
|
16
|
1.99e-02
|
-3.36e-01
|
7.36e-02
|
GOBP RENAL SODIUM ION TRANSPORT
|
13
|
3.60e-02
|
3.36e-01
|
1.14e-01
|
GOBP SKELETAL MUSCLE TISSUE GROWTH
|
10
|
6.59e-02
|
-3.36e-01
|
1.76e-01
|
GOMF FOUR WAY JUNCTION DNA BINDING
|
16
|
2.01e-02
|
-3.36e-01
|
7.40e-02
|
GOBP NUCLEOSOME ORGANIZATION
|
65
|
2.88e-06
|
-3.36e-01
|
4.55e-05
|
GOBP NEGATIVE REGULATION OF CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS
|
11
|
5.39e-02
|
-3.36e-01
|
1.53e-01
|
GOBP REGULATION OF ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION
|
18
|
1.38e-02
|
-3.35e-01
|
5.52e-02
|
GOBP ATRIOVENTRICULAR VALVE DEVELOPMENT
|
28
|
2.16e-03
|
-3.35e-01
|
1.28e-02
|
GOMF 1 PHOSPHATIDYLINOSITOL BINDING
|
13
|
3.66e-02
|
-3.35e-01
|
1.15e-01
|
GOCC CYCLIN DEPENDENT PROTEIN KINASE HOLOENZYME COMPLEX
|
48
|
5.99e-05
|
-3.35e-01
|
6.51e-04
|
GOBP ENDODERMAL CELL DIFFERENTIATION
|
22
|
6.56e-03
|
-3.35e-01
|
3.09e-02
|
GOBP MATURE B CELL DIFFERENTIATION
|
32
|
1.06e-03
|
-3.35e-01
|
7.08e-03
|
GOMF SNRNP BINDING
|
14
|
3.06e-02
|
3.34e-01
|
1.01e-01
|
GOCC SPECIFIC GRANULE
|
10
|
6.76e-02
|
-3.34e-01
|
1.79e-01
|
GOBP NEGATIVE REGULATION OF CHOLESTEROL STORAGE
|
10
|
6.80e-02
|
3.33e-01
|
1.80e-01
|
GOBP FATTY ACID HOMEOSTASIS
|
14
|
3.10e-02
|
3.33e-01
|
1.02e-01
|
GOBP EATING BEHAVIOR
|
25
|
3.96e-03
|
3.33e-01
|
2.08e-02
|
GOBP COENZYME A METABOLIC PROCESS
|
18
|
1.45e-02
|
3.33e-01
|
5.77e-02
|
GOMF HISTONE H3K9 METHYLTRANSFERASE ACTIVITY
|
11
|
5.61e-02
|
-3.33e-01
|
1.58e-01
|
GOBP ISOPRENOID BIOSYNTHETIC PROCESS
|
28
|
2.33e-03
|
3.32e-01
|
1.36e-02
|
GOBP MITOCHONDRIAL TRANSCRIPTION
|
19
|
1.21e-02
|
3.32e-01
|
5.01e-02
|
GOBP POSITIVE REGULATION OF CELL CYCLE CHECKPOINT
|
15
|
2.58e-02
|
-3.32e-01
|
8.92e-02
|
GOCC PLATELET ALPHA GRANULE
|
17
|
1.78e-02
|
-3.32e-01
|
6.73e-02
|
GOBP REGULATION OF NUCLEOBASE CONTAINING COMPOUND TRANSPORT
|
16
|
2.16e-02
|
-3.32e-01
|
7.83e-02
|
GOBP CELLULAR RESPONSE TO VIRUS
|
37
|
4.85e-04
|
-3.32e-01
|
3.74e-03
|
GOBP DENDRITIC CELL DIFFERENTIATION
|
29
|
2.01e-03
|
-3.31e-01
|
1.20e-02
|
GOBP HEMATOPOIETIC STEM CELL MIGRATION
|
11
|
5.73e-02
|
-3.31e-01
|
1.60e-01
|
GOBP ALPHA AMINO ACID METABOLIC PROCESS
|
157
|
8.90e-13
|
3.31e-01
|
5.00e-11
|
GOBP NEGATIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION
|
34
|
8.49e-04
|
-3.31e-01
|
5.94e-03
|
GOBP POSITIVE REGULATION OF OSTEOBLAST DIFFERENTIATION
|
58
|
1.33e-05
|
-3.31e-01
|
1.73e-04
|
GOBP HEME METABOLIC PROCESS
|
33
|
1.02e-03
|
3.30e-01
|
6.90e-03
|
GOBP POSITIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION
|
48
|
7.57e-05
|
-3.30e-01
|
7.86e-04
|
GOBP CHONDROITIN SULFATE METABOLIC PROCESS
|
22
|
7.34e-03
|
-3.30e-01
|
3.38e-02
|
GOBP RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL BY ENDOPLASMIC RETICULUM
|
24
|
5.11e-03
|
3.30e-01
|
2.53e-02
|
GOCC RIBOSOME
|
229
|
8.37e-18
|
3.30e-01
|
9.49e-16
|
GOBP REGULATION OF MONOCYTE DIFFERENTIATION
|
15
|
2.70e-02
|
-3.30e-01
|
9.24e-02
|
GOBP DIACYLGLYCEROL METABOLIC PROCESS
|
23
|
6.23e-03
|
3.30e-01
|
2.97e-02
|
GOBP MITOTIC METAPHASE CHROMOSOME ALIGNMENT
|
50
|
5.59e-05
|
-3.29e-01
|
6.11e-04
|
GOBP PHOSPHOLIPASE C ACTIVATING G PROTEIN COUPLED ACETYLCHOLINE RECEPTOR SIGNALING PATHWAY
|
10
|
7.13e-02
|
-3.29e-01
|
1.86e-01
|
GOBP MESODERMAL CELL DIFFERENTIATION
|
13
|
4.01e-02
|
-3.29e-01
|
1.23e-01
|
GOCC PODOSOME
|
29
|
2.19e-03
|
-3.29e-01
|
1.29e-02
|
GOBP DNA STRAND ELONGATION
|
35
|
7.74e-04
|
-3.28e-01
|
5.52e-03
|
GOMF HISTONE UBIQUITIN LIGASE ACTIVITY
|
12
|
4.90e-02
|
-3.28e-01
|
1.43e-01
|
GOBP REGULATION OF CHROMOSOME SEGREGATION
|
106
|
5.41e-09
|
-3.28e-01
|
1.67e-07
|
GOBP REGULATION OF HOMOTYPIC CELL CELL ADHESION
|
32
|
1.32e-03
|
-3.28e-01
|
8.54e-03
|
GOBP INTERFERON ALPHA PRODUCTION
|
30
|
1.88e-03
|
-3.28e-01
|
1.15e-02
|
GOBP NONRIBOSOMAL PEPTIDE BIOSYNTHETIC PROCESS
|
13
|
4.08e-02
|
3.28e-01
|
1.25e-01
|
GOMF NADPH BINDING
|
18
|
1.61e-02
|
3.28e-01
|
6.27e-02
|
GOBP FOREBRAIN MORPHOGENESIS
|
10
|
7.29e-02
|
-3.28e-01
|
1.89e-01
|
GOBP GENERATION OF PRECURSOR METABOLITES AND ENERGY
|
389
|
2.00e-28
|
3.27e-01
|
6.79e-26
|
GOBP REGULATION OF OXIDATIVE PHOSPHORYLATION
|
22
|
7.89e-03
|
3.27e-01
|
3.56e-02
|
GOBP MYELIN ASSEMBLY
|
21
|
9.49e-03
|
-3.27e-01
|
4.10e-02
|
GOBP POSITIVE REGULATION OF DENDRITE DEVELOPMENT
|
18
|
1.64e-02
|
-3.27e-01
|
6.34e-02
|
GOCC MICROFIBRIL
|
13
|
4.14e-02
|
-3.27e-01
|
1.26e-01
|
GOBP POSITIVE REGULATION OF INTERFERON ALPHA PRODUCTION
|
23
|
6.72e-03
|
-3.27e-01
|
3.15e-02
|
GOBP NEGATIVE REGULATION OF ANOIKIS
|
15
|
2.86e-02
|
-3.26e-01
|
9.59e-02
|
GOBP NEGATIVE REGULATION OF TYPE 2 IMMUNE RESPONSE
|
10
|
7.46e-02
|
-3.26e-01
|
1.92e-01
|
GOBP SYNAPTIC TRANSMISSION CHOLINERGIC
|
16
|
2.41e-02
|
3.26e-01
|
8.47e-02
|
GOCC MEIOTIC SPINDLE
|
11
|
6.18e-02
|
-3.25e-01
|
1.68e-01
|
GOBP LAMELLIPODIUM MORPHOGENESIS
|
16
|
2.44e-02
|
-3.25e-01
|
8.55e-02
|
GOMF ZINC ION TRANSMEMBRANE TRANSPORTER ACTIVITY
|
17
|
2.04e-02
|
-3.25e-01
|
7.49e-02
|
GOBP REGULATION OF VASCULOGENESIS
|
16
|
2.45e-02
|
-3.25e-01
|
8.55e-02
|
GOBP REGULATION OF CHROMATIN ORGANIZATION
|
32
|
1.49e-03
|
-3.25e-01
|
9.39e-03
|
GOBP NEGATIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL MIGRATION
|
11
|
6.24e-02
|
-3.25e-01
|
1.69e-01
|
GOBP BRANCHING INVOLVED IN LABYRINTHINE LAYER MORPHOGENESIS
|
10
|
7.57e-02
|
3.24e-01
|
1.94e-01
|
GOMF MISMATCHED DNA BINDING
|
10
|
7.64e-02
|
-3.24e-01
|
1.96e-01
|
GOBP REGULATION OF PROTON TRANSPORT
|
16
|
2.51e-02
|
3.24e-01
|
8.74e-02
|
GOBP CELLULAR RESPONSE TO DSRNA
|
16
|
2.54e-02
|
-3.23e-01
|
8.82e-02
|
GOBP REGULATION OF AEROBIC RESPIRATION
|
31
|
1.87e-03
|
3.23e-01
|
1.15e-02
|
GOBP NEGATIVE REGULATION OF LEUKOCYTE MIGRATION
|
34
|
1.13e-03
|
-3.23e-01
|
7.52e-03
|
GOMF SMAD BINDING
|
74
|
1.63e-06
|
-3.22e-01
|
2.76e-05
|
GOBP CELLULAR MODIFIED AMINO ACID BIOSYNTHETIC PROCESS
|
35
|
9.71e-04
|
3.22e-01
|
6.61e-03
|
GOMF SULFURTRANSFERASE ACTIVITY
|
11
|
6.43e-02
|
3.22e-01
|
1.73e-01
|
GOBP REGULATION OF MODIFICATION OF POSTSYNAPTIC STRUCTURE
|
19
|
1.50e-02
|
-3.22e-01
|
5.93e-02
|
GOBP REGULATION OF B CELL RECEPTOR SIGNALING PATHWAY
|
13
|
4.47e-02
|
-3.22e-01
|
1.33e-01
|
GOMF HISTONE H3 KINASE ACTIVITY
|
11
|
6.49e-02
|
-3.21e-01
|
1.74e-01
|
GOBP POSITIVE REGULATION OF MACROPHAGE CHEMOTAXIS
|
17
|
2.18e-02
|
-3.21e-01
|
7.86e-02
|
GOBP XENOBIOTIC METABOLIC PROCESS
|
57
|
2.72e-05
|
3.21e-01
|
3.27e-04
|
GOMF MYOSIN HEAVY CHAIN BINDING
|
12
|
5.39e-02
|
-3.21e-01
|
1.53e-01
|
GOBP CELLULAR RESPONSE TO PURINE CONTAINING COMPOUND
|
10
|
7.85e-02
|
3.21e-01
|
1.99e-01
|
GOMF WNT PROTEIN BINDING
|
27
|
3.86e-03
|
-3.21e-01
|
2.04e-02
|
GOBP RAP PROTEIN SIGNAL TRANSDUCTION
|
13
|
4.50e-02
|
-3.21e-01
|
1.34e-01
|
GOBP ENDOLYSOSOMAL TOLL LIKE RECEPTOR SIGNALING PATHWAY
|
43
|
2.73e-04
|
-3.21e-01
|
2.36e-03
|
GOCC TRAPPII PROTEIN COMPLEX
|
10
|
7.98e-02
|
3.20e-01
|
2.01e-01
|
GOBP REGULATION OF TRANSLATIONAL INITIATION IN RESPONSE TO STRESS
|
17
|
2.26e-02
|
-3.20e-01
|
8.09e-02
|
GOBP REGULATION OF TRANSMISSION OF NERVE IMPULSE
|
10
|
8.02e-02
|
3.19e-01
|
2.02e-01
|
GOMF METAL CATION PROTON ANTIPORTER ACTIVITY
|
17
|
2.26e-02
|
3.19e-01
|
8.09e-02
|
GOBP REGULATION OF DEVELOPMENT HETEROCHRONIC
|
12
|
5.54e-02
|
-3.19e-01
|
1.57e-01
|
GOBP DNA METHYLATION DEPENDENT HETEROCHROMATIN FORMATION
|
29
|
2.93e-03
|
-3.19e-01
|
1.63e-02
|
GOBP LONG CHAIN FATTY ACID METABOLIC PROCESS
|
64
|
1.02e-05
|
3.19e-01
|
1.37e-04
|
GOMF APOLIPOPROTEIN BINDING
|
16
|
2.73e-02
|
-3.19e-01
|
9.28e-02
|
GOBP POSITIVE REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS
|
20
|
1.36e-02
|
-3.19e-01
|
5.46e-02
|
GOBP NEGATIVE REGULATION OF REGULATED SECRETORY PATHWAY
|
19
|
1.62e-02
|
-3.19e-01
|
6.30e-02
|
GOBP MITOCHONDRIAL MEMBRANE ORGANIZATION
|
97
|
6.03e-08
|
3.18e-01
|
1.41e-06
|
GOBP KINETOCHORE ASSEMBLY
|
12
|
5.61e-02
|
-3.18e-01
|
1.58e-01
|
GOBP PHOSPHATIDYLSERINE METABOLIC PROCESS
|
14
|
3.93e-02
|
3.18e-01
|
1.22e-01
|
GOBP SISTER CHROMATID COHESION
|
41
|
4.30e-04
|
-3.18e-01
|
3.41e-03
|
GOMF U6 SNRNA BINDING
|
11
|
6.82e-02
|
3.18e-01
|
1.80e-01
|
GOBP NEURAL TUBE PATTERNING
|
31
|
2.23e-03
|
-3.17e-01
|
1.31e-02
|
GOMF CERAMIDE BINDING
|
14
|
4.00e-02
|
3.17e-01
|
1.23e-01
|
GOBP P BODY ASSEMBLY
|
18
|
2.00e-02
|
-3.17e-01
|
7.37e-02
|
GOMF OXIDOREDUCTASE ACTIVITY ACTING ON SINGLE DONORS WITH INCORPORATION OF MOLECULAR OXYGEN
|
15
|
3.37e-02
|
3.17e-01
|
1.09e-01
|
GOBP DORSAL VENTRAL PATTERN FORMATION
|
57
|
3.59e-05
|
-3.17e-01
|
4.16e-04
|
GOBP PHOSPHATIDYLCHOLINE CATABOLIC PROCESS
|
12
|
5.78e-02
|
3.16e-01
|
1.60e-01
|
GOMF FERROUS IRON BINDING
|
23
|
8.65e-03
|
3.16e-01
|
3.82e-02
|
GOBP POSITIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE
|
101
|
4.06e-08
|
-3.16e-01
|
1.00e-06
|
GOBP POSITIVE REGULATION OF MYELOID LEUKOCYTE CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE
|
36
|
1.04e-03
|
-3.16e-01
|
7.01e-03
|
GOBP POSITIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION
|
41
|
4.80e-04
|
-3.15e-01
|
3.72e-03
|
GOBP NUCLEOSIDE PHOSPHATE BIOSYNTHETIC PROCESS
|
201
|
1.52e-14
|
3.15e-01
|
1.15e-12
|
GOBP REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION
|
58
|
3.44e-05
|
-3.15e-01
|
4.01e-04
|
GOBP POSITIVE REGULATION OF DNA TEMPLATED DNA REPLICATION
|
14
|
4.17e-02
|
-3.14e-01
|
1.26e-01
|
GOBP REGULATION OF CARDIAC MUSCLE CONTRACTION BY CALCIUM ION SIGNALING
|
13
|
4.98e-02
|
3.14e-01
|
1.45e-01
|
GOBP POSITIVE REGULATION OF CHOLESTEROL METABOLIC PROCESS
|
15
|
3.52e-02
|
3.14e-01
|
1.13e-01
|
GOBP CD4 POSITIVE ALPHA BETA T CELL PROLIFERATION
|
19
|
1.79e-02
|
-3.14e-01
|
6.74e-02
|
GOMF VITAMIN B6 BINDING
|
36
|
1.13e-03
|
3.14e-01
|
7.55e-03
|
GOBP REGULATION OF TRIGLYCERIDE BIOSYNTHETIC PROCESS
|
23
|
9.29e-03
|
3.13e-01
|
4.04e-02
|
GOBP CALCIUM IMPORT INTO THE MITOCHONDRION
|
12
|
6.02e-02
|
3.13e-01
|
1.65e-01
|
GOBP GOLGI LOCALIZATION
|
12
|
6.08e-02
|
-3.13e-01
|
1.66e-01
|
GOBP CYTOPLASM ORGANIZATION
|
11
|
7.32e-02
|
-3.12e-01
|
1.90e-01
|
GOBP ANTIVIRAL INNATE IMMUNE RESPONSE
|
41
|
5.53e-04
|
-3.12e-01
|
4.16e-03
|
GOBP REGULATION OF AUTOPHAGY OF MITOCHONDRION IN RESPONSE TO MITOCHONDRIAL DEPOLARIZATION
|
13
|
5.18e-02
|
3.12e-01
|
1.49e-01
|
GOCC TRANSCRIPTION PREINITIATION COMPLEX
|
14
|
4.36e-02
|
3.12e-01
|
1.30e-01
|
GOMF NUCLEAR STEROID RECEPTOR ACTIVITY
|
15
|
3.70e-02
|
3.11e-01
|
1.16e-01
|
GOBP REGULATION OF NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY
|
20
|
1.61e-02
|
-3.11e-01
|
6.26e-02
|
GOBP POSITIVE REGULATION OF GLIAL CELL PROLIFERATION
|
27
|
5.23e-03
|
-3.11e-01
|
2.58e-02
|
GOBP REGULATION OF CELLULAR RESPONSE TO OSMOTIC STRESS
|
10
|
8.91e-02
|
3.10e-01
|
2.18e-01
|
GOBP MATURE B CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE
|
25
|
7.27e-03
|
-3.10e-01
|
3.37e-02
|
GOBP PHOSPHATIDYLCHOLINE ACYL CHAIN REMODELING
|
10
|
8.95e-02
|
3.10e-01
|
2.18e-01
|
GOBP DEFENSE RESPONSE TO VIRUS
|
233
|
3.81e-16
|
-3.10e-01
|
3.68e-14
|
GOBP DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR RESULTING IN CELL CYCLE ARREST
|
12
|
6.30e-02
|
-3.10e-01
|
1.70e-01
|
GOBP POSITIVE REGULATION OF G1 S TRANSITION OF MITOTIC CELL CYCLE
|
45
|
3.22e-04
|
-3.10e-01
|
2.70e-03
|
GOBP REGULATION OF CELLULAR AMINO ACID METABOLIC PROCESS
|
10
|
9.04e-02
|
3.09e-01
|
2.20e-01
|
GOBP RANDOM INACTIVATION OF X CHROMOSOME
|
10
|
9.05e-02
|
-3.09e-01
|
2.20e-01
|
GOBP REGULATION OF DEFENSE RESPONSE TO BACTERIUM
|
17
|
2.76e-02
|
-3.09e-01
|
9.36e-02
|
GOBP DNA CONFORMATION CHANGE
|
54
|
8.90e-05
|
-3.08e-01
|
9.02e-04
|
GOBP POSITIVE REGULATION OF INTERFERON BETA PRODUCTION
|
45
|
3.55e-04
|
-3.08e-01
|
2.92e-03
|
GOBP EPITHELIAL CELL FATE COMMITMENT
|
11
|
7.72e-02
|
-3.08e-01
|
1.97e-01
|
GOBP NEGATIVE REGULATION OF LIPASE ACTIVITY
|
10
|
9.21e-02
|
3.08e-01
|
2.22e-01
|
GOMF BH DOMAIN BINDING
|
14
|
4.63e-02
|
-3.08e-01
|
1.37e-01
|
GOBP BEHAVIORAL RESPONSE TO COCAINE
|
15
|
3.92e-02
|
3.08e-01
|
1.21e-01
|
GOMF RNA EXONUCLEASE ACTIVITY
|
35
|
1.64e-03
|
-3.08e-01
|
1.03e-02
|
GOBP NEGATIVE REGULATION OF CELL CYCLE G2 M PHASE TRANSITION
|
61
|
3.29e-05
|
-3.08e-01
|
3.87e-04
|
GOMF LYSOPHOSPHOLIPASE ACTIVITY
|
17
|
2.82e-02
|
3.07e-01
|
9.49e-02
|
GOBP CHROMOSOME SEPARATION
|
65
|
1.85e-05
|
-3.07e-01
|
2.32e-04
|
GOBP ENDOTHELIAL CELL APOPTOTIC PROCESS
|
46
|
3.14e-04
|
-3.07e-01
|
2.64e-03
|
GOBP MACROPHAGE CYTOKINE PRODUCTION
|
45
|
3.69e-04
|
-3.07e-01
|
3.02e-03
|
GOMF PROTEOGLYCAN BINDING
|
30
|
3.63e-03
|
-3.07e-01
|
1.94e-02
|
GOBP REGULATION OF TRANSLATION IN RESPONSE TO STRESS
|
23
|
1.09e-02
|
-3.07e-01
|
4.61e-02
|
GOBP TYROSINE PHOSPHORYLATION OF STAT PROTEIN
|
47
|
2.77e-04
|
-3.07e-01
|
2.39e-03
|
GOBP NEURON INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO OXIDATIVE STRESS
|
17
|
2.87e-02
|
-3.07e-01
|
9.59e-02
|
GOBP REGULATION OF VIRAL PROCESS
|
134
|
9.21e-10
|
-3.07e-01
|
3.34e-08
|
GOBP REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION
|
40
|
8.02e-04
|
-3.06e-01
|
5.67e-03
|
GOBP NEGATIVE REGULATION OF SIGNAL TRANSDUCTION IN ABSENCE OF LIGAND
|
25
|
8.05e-03
|
-3.06e-01
|
3.61e-02
|
GOMF U1 SNRNP BINDING
|
10
|
9.38e-02
|
3.06e-01
|
2.25e-01
|
GOBP NEGATIVE REGULATION OF NUCLEAR DIVISION
|
51
|
1.57e-04
|
-3.06e-01
|
1.47e-03
|
GOMF PHOSPHATIDYLINOSITOL 3 4 BISPHOSPHATE BINDING
|
26
|
6.93e-03
|
-3.06e-01
|
3.24e-02
|
GOBP REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION
|
39
|
9.48e-04
|
-3.06e-01
|
6.50e-03
|
GOBP GLYCEROL METABOLIC PROCESS
|
16
|
3.41e-02
|
3.06e-01
|
1.10e-01
|
GOBP ANTERIOR POSTERIOR AXIS SPECIFICATION
|
37
|
1.29e-03
|
-3.06e-01
|
8.39e-03
|
GOBP CELLULAR RESPONSE TO EXOGENOUS DSRNA
|
11
|
7.92e-02
|
-3.06e-01
|
2.00e-01
|
GOBP TRANSLESION SYNTHESIS
|
21
|
1.54e-02
|
-3.06e-01
|
6.04e-02
|
GOMF PRIMARY ACTIVE TRANSMEMBRANE TRANSPORTER ACTIVITY
|
106
|
5.56e-08
|
3.06e-01
|
1.32e-06
|
GOCC MYOSIN II COMPLEX
|
19
|
2.12e-02
|
3.06e-01
|
7.70e-02
|
GOBP CELLULAR RESPONSE TO COLD
|
10
|
9.45e-02
|
3.05e-01
|
2.26e-01
|
GOBP VIRAL GENOME REPLICATION
|
96
|
2.45e-07
|
-3.05e-01
|
5.01e-06
|
GOBP L AMINO ACID METABOLIC PROCESS
|
132
|
1.53e-09
|
3.05e-01
|
5.34e-08
|
GOBP LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY
|
48
|
2.62e-04
|
-3.05e-01
|
2.28e-03
|
GOBP REGULATION OF TYPE B PANCREATIC CELL PROLIFERATION
|
13
|
5.73e-02
|
-3.05e-01
|
1.60e-01
|
GOBP AORTIC VALVE MORPHOGENESIS
|
27
|
6.18e-03
|
-3.04e-01
|
2.96e-02
|
GOBP NEGATIVE REGULATION OF ALPHA BETA T CELL ACTIVATION
|
35
|
1.84e-03
|
-3.04e-01
|
1.13e-02
|
GOBP DEFINITIVE HEMOPOIESIS
|
22
|
1.35e-02
|
-3.04e-01
|
5.43e-02
|
GOBP GLUCOSE 6 PHOSPHATE METABOLIC PROCESS
|
27
|
6.22e-03
|
3.04e-01
|
2.97e-02
|
GOBP RESPONSE TO MURAMYL DIPEPTIDE
|
17
|
2.99e-02
|
-3.04e-01
|
9.93e-02
|
GOBP GLOMERULAR BASEMENT MEMBRANE DEVELOPMENT
|
10
|
9.60e-02
|
-3.04e-01
|
2.28e-01
|
GOBP URINARY TRACT SMOOTH MUSCLE CONTRACTION
|
10
|
9.61e-02
|
3.04e-01
|
2.28e-01
|
GOBP DETECTION OF LIGHT STIMULUS INVOLVED IN SENSORY PERCEPTION
|
11
|
8.11e-02
|
3.04e-01
|
2.03e-01
|
GOBP REGULATION OF HEPATOCYTE APOPTOTIC PROCESS
|
10
|
9.66e-02
|
-3.03e-01
|
2.29e-01
|
GOBP POSITIVE REGULATION OF CHROMOSOME SEPARATION
|
26
|
7.45e-03
|
-3.03e-01
|
3.41e-02
|
GOBP POSITIVE REGULATION OF ERYTHROCYTE DIFFERENTIATION
|
27
|
6.40e-03
|
-3.03e-01
|
3.03e-02
|
GOBP METAPHASE CHROMOSOME ALIGNMENT
|
79
|
3.22e-06
|
-3.03e-01
|
4.97e-05
|
GOBP REGULATION OF DNA TEMPLATED DNA REPLICATION
|
35
|
1.92e-03
|
-3.03e-01
|
1.16e-02
|
GOBP MITOTIC G2 M TRANSITION CHECKPOINT
|
49
|
2.44e-04
|
-3.03e-01
|
2.15e-03
|
GOMF CATALYTIC ACTIVITY ACTING ON A TRNA
|
105
|
8.29e-08
|
3.03e-01
|
1.91e-06
|
GOMF WNT RECEPTOR ACTIVITY
|
16
|
3.59e-02
|
-3.03e-01
|
1.14e-01
|
GOBP PROTEIN LIPID COMPLEX ORGANIZATION
|
31
|
3.52e-03
|
3.03e-01
|
1.88e-02
|
GOBP PROTEIN INSERTION INTO MEMBRANE
|
35
|
1.95e-03
|
3.03e-01
|
1.17e-02
|
GOBP SKELETAL MUSCLE ADAPTATION
|
20
|
1.92e-02
|
3.03e-01
|
7.15e-02
|
GOBP RENAL SODIUM ION ABSORPTION
|
12
|
6.98e-02
|
3.02e-01
|
1.83e-01
|
GOBP RESPONSE TO DSRNA
|
35
|
1.98e-03
|
-3.02e-01
|
1.19e-02
|
GOBP PLASMA MEMBRANE PHOSPHOLIPID SCRAMBLING
|
13
|
5.92e-02
|
-3.02e-01
|
1.64e-01
|
GOMF TRNA SPECIFIC RIBONUCLEASE ACTIVITY
|
15
|
4.28e-02
|
3.02e-01
|
1.29e-01
|
GOBP NEGATIVE REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR
|
13
|
5.94e-02
|
-3.02e-01
|
1.64e-01
|
GOBP POSITIVE REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY
|
17
|
3.12e-02
|
-3.02e-01
|
1.02e-01
|
GOBP PROGESTERONE METABOLIC PROCESS
|
10
|
9.84e-02
|
3.02e-01
|
2.32e-01
|
GOMF CARBOXYLIC ESTER HYDROLASE ACTIVITY
|
101
|
1.62e-07
|
3.02e-01
|
3.48e-06
|
GOBP POSITIVE REGULATION OF CHEMOKINE PRODUCTION
|
56
|
9.48e-05
|
-3.02e-01
|
9.54e-04
|
GOBP VASCULAR ASSOCIATED SMOOTH MUSCLE CELL MIGRATION
|
36
|
1.76e-03
|
-3.01e-01
|
1.09e-02
|
GOBP REGULATION OF CENTROSOME CYCLE
|
54
|
1.29e-04
|
-3.01e-01
|
1.23e-03
|
GOBP SINGLE STRANDED VIRAL RNA REPLICATION VIA DOUBLE STRANDED DNA INTERMEDIATE
|
11
|
8.42e-02
|
-3.01e-01
|
2.09e-01
|
GOBP REGULATION OF MACROPHAGE CHEMOTAXIS
|
22
|
1.46e-02
|
-3.01e-01
|
5.82e-02
|
GOBP REGULATION OF ANOIKIS
|
20
|
2.00e-02
|
-3.01e-01
|
7.38e-02
|
GOBP POSITIVE REGULATION OF T HELPER CELL DIFFERENTIATION
|
16
|
3.75e-02
|
-3.00e-01
|
1.18e-01
|
GOBP NEGATIVE REGULATION OF STEM CELL PROLIFERATION
|
21
|
1.72e-02
|
-3.00e-01
|
6.58e-02
|
GOBP RESPONSE TO NITRIC OXIDE
|
14
|
5.18e-02
|
-3.00e-01
|
1.49e-01
|
GOCC DNA POLYMERASE COMPLEX
|
18
|
2.75e-02
|
-3.00e-01
|
9.35e-02
|
GOBP NEGATIVE REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT
|
21
|
1.73e-02
|
-3.00e-01
|
6.60e-02
|
GOMF C4 DICARBOXYLATE TRANSMEMBRANE TRANSPORTER ACTIVITY
|
11
|
8.53e-02
|
3.00e-01
|
2.11e-01
|
GOBP NEGATIVE REGULATION OF KERATINOCYTE PROLIFERATION
|
23
|
1.29e-02
|
-3.00e-01
|
5.25e-02
|
GOBP IRON ION TRANSMEMBRANE TRANSPORT
|
21
|
1.75e-02
|
3.00e-01
|
6.64e-02
|
GOBP ATRIAL CARDIAC MUSCLE CELL TO AV NODE CELL COMMUNICATION
|
14
|
5.23e-02
|
3.00e-01
|
1.50e-01
|
GOBP MITOTIC CYTOKINESIS
|
81
|
3.21e-06
|
-2.99e-01
|
4.97e-05
|
GOBP PLATELET AGGREGATION
|
49
|
2.89e-04
|
-2.99e-01
|
2.48e-03
|
GOBP DENSE CORE GRANULE TRANSPORT
|
12
|
7.28e-02
|
-2.99e-01
|
1.89e-01
|
GOCC U2 SNRNP
|
21
|
1.77e-02
|
2.99e-01
|
6.69e-02
|
GOBP PORPHYRIN CONTAINING COMPOUND METABOLIC PROCESS
|
38
|
1.42e-03
|
2.99e-01
|
9.03e-03
|
GOBP NEGATIVE REGULATION OF MITOTIC CELL CYCLE PHASE TRANSITION
|
153
|
1.82e-10
|
-2.99e-01
|
7.78e-09
|
GOBP RELAXATION OF MUSCLE
|
28
|
6.20e-03
|
2.99e-01
|
2.96e-02
|
GOBP REGULATION OF CHOLESTEROL METABOLIC PROCESS
|
36
|
1.92e-03
|
2.99e-01
|
1.16e-02
|
GOMF 1 PHOSPHATIDYLINOSITOL 3 KINASE REGULATOR ACTIVITY
|
13
|
6.25e-02
|
-2.98e-01
|
1.69e-01
|
GOMF CAMP RESPONSE ELEMENT BINDING
|
10
|
1.03e-01
|
-2.98e-01
|
2.38e-01
|
GOBP NEGATIVE REGULATION OF LEUKOCYTE CHEMOTAXIS
|
11
|
8.70e-02
|
-2.98e-01
|
2.14e-01
|
GOBP POSITIVE REGULATION OF T CELL APOPTOTIC PROCESS
|
12
|
7.39e-02
|
-2.98e-01
|
1.91e-01
|
GOBP POSITIVE REGULATION OF EPIDERMAL CELL DIFFERENTIATION
|
13
|
6.30e-02
|
-2.98e-01
|
1.70e-01
|
GOBP NEGATIVE REGULATION OF INTERLEUKIN 8 PRODUCTION
|
12
|
7.41e-02
|
-2.98e-01
|
1.91e-01
|
GOBP POSITIVE REGULATION OF MITOPHAGY IN RESPONSE TO MITOCHONDRIAL DEPOLARIZATION
|
10
|
1.03e-01
|
2.97e-01
|
2.40e-01
|
GOBP NEGATIVE REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY
|
10
|
1.04e-01
|
2.97e-01
|
2.40e-01
|
GOBP ALPHA AMINO ACID BIOSYNTHETIC PROCESS
|
50
|
2.79e-04
|
2.97e-01
|
2.40e-03
|
GOBP REGULATION OF PINOCYTOSIS
|
12
|
7.47e-02
|
-2.97e-01
|
1.92e-01
|
GOBP RIBOSE PHOSPHATE METABOLIC PROCESS
|
365
|
2.29e-22
|
2.97e-01
|
4.24e-20
|
GOBP ENDOTHELIAL CELL DIFFERENTIATION
|
103
|
1.93e-07
|
-2.97e-01
|
4.03e-06
|
GOMF MONOCARBOXYLIC ACID BINDING
|
51
|
2.45e-04
|
2.97e-01
|
2.16e-03
|
GOMF PRIMARY MIRNA BINDING
|
10
|
1.04e-01
|
-2.97e-01
|
2.41e-01
|
GOBP CYTOSKELETON DEPENDENT CYTOKINESIS
|
89
|
1.31e-06
|
-2.97e-01
|
2.27e-05
|
GOBP PROTEIN AUTO ADP RIBOSYLATION
|
11
|
8.83e-02
|
-2.97e-01
|
2.16e-01
|
GOBP MITOCHONDRIAL TRANSPORT
|
153
|
2.46e-10
|
2.97e-01
|
1.02e-08
|
GOCC EMC COMPLEX
|
11
|
8.86e-02
|
2.97e-01
|
2.17e-01
|
GOBP VASCULAR ENDOTHELIAL GROWTH FACTOR SIGNALING PATHWAY
|
35
|
2.42e-03
|
-2.96e-01
|
1.40e-02
|
GOBP POSITIVE REGULATION OF ACTIN NUCLEATION
|
13
|
6.47e-02
|
-2.96e-01
|
1.73e-01
|
GOBP NEGATIVE REGULATION OF STEM CELL POPULATION MAINTENANCE
|
21
|
1.89e-02
|
-2.96e-01
|
7.07e-02
|
GOBP PRIMARY MIRNA PROCESSING
|
15
|
4.73e-02
|
-2.96e-01
|
1.39e-01
|
GOMF CARBON CARBON LYASE ACTIVITY
|
40
|
1.22e-03
|
2.96e-01
|
7.97e-03
|
GOBP MITRAL VALVE DEVELOPMENT
|
15
|
4.76e-02
|
-2.96e-01
|
1.40e-01
|
GOBP GLYCEROLIPID CATABOLIC PROCESS
|
46
|
5.28e-04
|
2.95e-01
|
4.00e-03
|
GOBP THROMBIN ACTIVATED RECEPTOR SIGNALING PATHWAY
|
10
|
1.06e-01
|
-2.95e-01
|
2.43e-01
|
GOBP RESPONSE TO SALT STRESS
|
19
|
2.58e-02
|
2.95e-01
|
8.92e-02
|
GOBP POSTSYNAPTIC DENSITY PROTEIN 95 CLUSTERING
|
10
|
1.06e-01
|
-2.95e-01
|
2.43e-01
|
GOBP BLASTOCYST GROWTH
|
26
|
9.17e-03
|
-2.95e-01
|
4.00e-02
|
GOBP PROTEIN INSERTION INTO ER MEMBRANE
|
24
|
1.24e-02
|
2.95e-01
|
5.10e-02
|
GOBP ISOPRENOID METABOLIC PROCESS
|
64
|
4.55e-05
|
2.95e-01
|
5.14e-04
|
GOMF ANTIOXIDANT ACTIVITY
|
55
|
1.56e-04
|
2.95e-01
|
1.47e-03
|
GOBP ALDITOL METABOLIC PROCESS
|
19
|
2.61e-02
|
2.95e-01
|
9.00e-02
|
GOBP RESPONSE TO TYPE II INTERFERON
|
103
|
2.49e-07
|
-2.94e-01
|
5.07e-06
|
GOBP PROSTAGLANDIN SECRETION
|
14
|
5.66e-02
|
-2.94e-01
|
1.58e-01
|
GOBP REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION
|
57
|
1.23e-04
|
-2.94e-01
|
1.19e-03
|
GOBP POSITIVE THYMIC T CELL SELECTION
|
11
|
9.12e-02
|
-2.94e-01
|
2.21e-01
|
GOBP MESENCHYMAL CELL PROLIFERATION
|
50
|
3.23e-04
|
-2.94e-01
|
2.70e-03
|
GOBP MITOCHONDRIAL FUSION
|
26
|
9.49e-03
|
2.94e-01
|
4.10e-02
|
GOBP REGULATION OF PHOSPHOLIPID TRANSPORT
|
13
|
6.66e-02
|
2.94e-01
|
1.77e-01
|
GOBP TELENCEPHALON GLIAL CELL MIGRATION
|
23
|
1.47e-02
|
-2.94e-01
|
5.85e-02
|
GOBP FACULTATIVE HETEROCHROMATIN FORMATION
|
41
|
1.14e-03
|
-2.94e-01
|
7.57e-03
|
GOBP DNA SYNTHESIS INVOLVED IN DNA REPAIR
|
30
|
5.37e-03
|
-2.94e-01
|
2.63e-02
|
GOBP MIRNA PROCESSING
|
36
|
2.29e-03
|
-2.94e-01
|
1.34e-02
|
GOBP MICROTUBULE ORGANIZING CENTER LOCALIZATION
|
31
|
4.69e-03
|
-2.93e-01
|
2.37e-02
|
GOBP POSITIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN
|
31
|
4.71e-03
|
-2.93e-01
|
2.38e-02
|
GOBP FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY
|
17
|
3.64e-02
|
-2.93e-01
|
1.15e-01
|
GOMF HISTONE H3K36 METHYLTRANSFERASE ACTIVITY
|
10
|
1.09e-01
|
-2.93e-01
|
2.47e-01
|
GOBP REGULATION OF MAMMARY GLAND EPITHELIAL CELL PROLIFERATION
|
16
|
4.26e-02
|
-2.93e-01
|
1.28e-01
|
GOBP NEURON FATE COMMITMENT
|
38
|
1.79e-03
|
-2.93e-01
|
1.10e-02
|
GOBP FIBROBLAST APOPTOTIC PROCESS
|
30
|
5.57e-03
|
-2.92e-01
|
2.71e-02
|
GOBP INTEGRIN MEDIATED SIGNALING PATHWAY
|
86
|
2.81e-06
|
-2.92e-01
|
4.45e-05
|
GOMF C2H2 ZINC FINGER DOMAIN BINDING
|
11
|
9.32e-02
|
-2.92e-01
|
2.24e-01
|
GOCC ENDOCYTIC VESICLE MEMBRANE
|
43
|
9.18e-04
|
-2.92e-01
|
6.32e-03
|
GOBP GAMMA AMINOBUTYRIC ACID TRANSPORT
|
10
|
1.10e-01
|
-2.92e-01
|
2.49e-01
|
GOBP SECRETION OF LYSOSOMAL ENZYMES
|
10
|
1.10e-01
|
2.92e-01
|
2.49e-01
|
GOBP REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING
|
32
|
4.27e-03
|
-2.92e-01
|
2.21e-02
|
GOBP PURINE CONTAINING COMPOUND METABOLIC PROCESS
|
440
|
1.30e-25
|
2.92e-01
|
3.36e-23
|
GOBP TRANSLATIONAL TERMINATION
|
11
|
9.42e-02
|
2.91e-01
|
2.25e-01
|
GOBP POSITIVE REGULATION OF CELL KILLING
|
46
|
6.30e-04
|
-2.91e-01
|
4.62e-03
|
GOBP MITOTIC CELL CYCLE CHECKPOINT SIGNALING
|
124
|
2.15e-08
|
-2.91e-01
|
5.63e-07
|
GOMF TRNA GUANINE METHYLTRANSFERASE ACTIVITY
|
10
|
1.11e-01
|
2.91e-01
|
2.51e-01
|
GOMF PHOSPHATIDYLINOSITOL 3 KINASE REGULATOR ACTIVITY
|
13
|
6.97e-02
|
-2.91e-01
|
1.83e-01
|
GOBP REGULATION OF CATECHOLAMINE METABOLIC PROCESS
|
15
|
5.15e-02
|
2.90e-01
|
1.49e-01
|
GOBP POSITIVE REGULATION OF INTERLEUKIN 1 PRODUCTION
|
52
|
3.01e-04
|
-2.90e-01
|
2.55e-03
|
GOBP ATP METABOLIC PROCESS
|
180
|
2.11e-11
|
2.90e-01
|
1.03e-09
|
GOCC TRAPP COMPLEX
|
14
|
6.06e-02
|
2.90e-01
|
1.66e-01
|
GOBP MONOCYTE CHEMOTACTIC PROTEIN 1 PRODUCTION
|
19
|
2.88e-02
|
-2.90e-01
|
9.62e-02
|
GOBP REGULATION OF GRANULOCYTE CHEMOTAXIS
|
44
|
8.91e-04
|
-2.90e-01
|
6.20e-03
|
GOBP SKELETAL MUSCLE CONTRACTION
|
29
|
6.97e-03
|
2.90e-01
|
3.26e-02
|
GOMF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY
|
92
|
1.61e-06
|
2.90e-01
|
2.74e-05
|
GOBP ATRIAL CARDIAC MUSCLE TISSUE DEVELOPMENT
|
14
|
6.08e-02
|
2.89e-01
|
1.66e-01
|
GOBP PARAXIAL MESODERM MORPHOGENESIS
|
10
|
1.13e-01
|
-2.89e-01
|
2.54e-01
|
GOBP NEGATIVE REGULATION OF MOTOR NEURON APOPTOTIC PROCESS
|
12
|
8.29e-02
|
-2.89e-01
|
2.06e-01
|
GOBP PLATELET DERIVED GROWTH FACTOR RECEPTOR BETA SIGNALING PATHWAY
|
13
|
7.11e-02
|
-2.89e-01
|
1.86e-01
|
GOBP REGULATION OF ADAPTIVE IMMUNE RESPONSE
|
156
|
4.83e-10
|
-2.89e-01
|
1.90e-08
|
GOBP DETECTION OF BIOTIC STIMULUS
|
30
|
6.20e-03
|
-2.89e-01
|
2.96e-02
|
GOMF STRUCTURAL CONSTITUENT OF POSTSYNAPSE
|
21
|
2.20e-02
|
2.89e-01
|
7.93e-02
|
GOBP SMOOTH MUSCLE CELL CHEMOTAXIS
|
11
|
9.75e-02
|
-2.89e-01
|
2.31e-01
|
GOMF CATALYTIC ACTIVITY ACTING ON A RRNA
|
17
|
3.95e-02
|
2.89e-01
|
1.22e-01
|
GOMF DEATH RECEPTOR BINDING
|
15
|
5.32e-02
|
-2.88e-01
|
1.52e-01
|
GOBP POSITIVE REGULATION OF URINE VOLUME
|
11
|
9.78e-02
|
2.88e-01
|
2.31e-01
|
GOBP HEPATIC STELLATE CELL ACTIVATION
|
14
|
6.19e-02
|
-2.88e-01
|
1.68e-01
|
GOBP RESPONSE TO VIRUS
|
278
|
1.52e-16
|
-2.88e-01
|
1.54e-14
|
GOMF ATP DEPENDENT ACTIVITY ACTING ON DNA
|
104
|
3.94e-07
|
-2.88e-01
|
7.62e-06
|
GOBP T CELL MEDIATED IMMUNITY
|
88
|
3.05e-06
|
-2.88e-01
|
4.75e-05
|
GOBP SULFUR COMPOUND METABOLIC PROCESS
|
253
|
3.50e-15
|
2.88e-01
|
2.92e-13
|
GOBP HEPATOCYTE APOPTOTIC PROCESS
|
25
|
1.27e-02
|
-2.88e-01
|
5.22e-02
|
GOBP NEGATIVE REGULATION OF EXOCYTOSIS
|
27
|
9.65e-03
|
-2.88e-01
|
4.16e-02
|
GOCC CYTOPLASMIC SIDE OF ENDOPLASMIC RETICULUM MEMBRANE
|
10
|
1.15e-01
|
-2.88e-01
|
2.57e-01
|
GOBP HEART VALVE DEVELOPMENT
|
60
|
1.19e-04
|
-2.87e-01
|
1.16e-03
|
GOBP ZINC ION TRANSPORT
|
21
|
2.27e-02
|
-2.87e-01
|
8.10e-02
|
GOBP POSITIVE REGULATION OF CELL SIZE
|
16
|
4.68e-02
|
-2.87e-01
|
1.38e-01
|
GOBP ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION
|
32
|
4.96e-03
|
-2.87e-01
|
2.48e-02
|
GOBP ETHER METABOLIC PROCESS
|
19
|
3.04e-02
|
2.87e-01
|
1.01e-01
|
GOBP REGULATION OF PLATELET ACTIVATION
|
39
|
1.94e-03
|
-2.87e-01
|
1.17e-02
|
GOBP POSITIVE REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION
|
25
|
1.31e-02
|
-2.87e-01
|
5.32e-02
|
GOBP NEGATIVE REGULATION OF CHROMOSOME ORGANIZATION
|
82
|
7.34e-06
|
-2.87e-01
|
1.04e-04
|
GOBP POSITIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING
|
13
|
7.37e-02
|
-2.87e-01
|
1.91e-01
|
GOBP SMAD PROTEIN SIGNAL TRANSDUCTION
|
67
|
5.09e-05
|
-2.86e-01
|
5.62e-04
|
GOBP VENTRAL SPINAL CORD DEVELOPMENT
|
26
|
1.15e-02
|
-2.86e-01
|
4.82e-02
|
GOBP REGULATION OF TYPE 2 IMMUNE RESPONSE
|
22
|
2.02e-02
|
-2.86e-01
|
7.44e-02
|
GOBP LAYER FORMATION IN CEREBRAL CORTEX
|
13
|
7.42e-02
|
-2.86e-01
|
1.91e-01
|
GOBP SPINDLE ASSEMBLY
|
113
|
1.54e-07
|
-2.86e-01
|
3.34e-06
|
GOMF INTEGRIN BINDING
|
126
|
3.08e-08
|
-2.86e-01
|
7.94e-07
|
GOBP DORSAL VENTRAL AXIS SPECIFICATION
|
10
|
1.18e-01
|
-2.86e-01
|
2.60e-01
|
GOBP RESPONSE TO FLUID SHEAR STRESS
|
24
|
1.54e-02
|
-2.86e-01
|
6.05e-02
|
GOCC BETA CATENIN DESTRUCTION COMPLEX
|
13
|
7.47e-02
|
-2.86e-01
|
1.92e-01
|
GOBP POSITIVE REGULATION OF INTEGRIN MEDIATED SIGNALING PATHWAY
|
13
|
7.47e-02
|
-2.86e-01
|
1.92e-01
|
GOCC SPLICEOSOMAL TRI SNRNP COMPLEX
|
33
|
4.59e-03
|
2.85e-01
|
2.34e-02
|
GOBP MITOTIC SISTER CHROMATID SEGREGATION
|
155
|
9.24e-10
|
-2.85e-01
|
3.34e-08
|
GOCC MALE GERM CELL NUCLEUS
|
49
|
5.56e-04
|
-2.85e-01
|
4.18e-03
|
GOBP RESPONSE TO ISOQUINOLINE ALKALOID
|
10
|
1.19e-01
|
2.85e-01
|
2.61e-01
|
GOBP POSITIVE REGULATION OF MEMBRANE INVAGINATION
|
16
|
4.84e-02
|
-2.85e-01
|
1.42e-01
|
GOBP HEART FIELD SPECIFICATION
|
12
|
8.78e-02
|
-2.85e-01
|
2.15e-01
|
GOBP NEGATIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS
|
14
|
6.54e-02
|
-2.84e-01
|
1.75e-01
|
GOBP LYMPH VESSEL DEVELOPMENT
|
31
|
6.17e-03
|
-2.84e-01
|
2.96e-02
|
GOBP NEGATIVE REGULATION OF AMIDE METABOLIC PROCESS
|
21
|
2.43e-02
|
2.84e-01
|
8.51e-02
|
GOMF CYSTEINE TYPE ENDOPEPTIDASE INHIBITOR ACTIVITY INVOLVED IN APOPTOTIC PROCESS
|
20
|
2.81e-02
|
-2.84e-01
|
9.46e-02
|
GOBP CHROMOSOME LOCALIZATION
|
91
|
2.97e-06
|
-2.84e-01
|
4.65e-05
|
GOBP FIBROBLAST GROWTH FACTOR PRODUCTION
|
10
|
1.21e-01
|
-2.84e-01
|
2.64e-01
|
GOBP URETER DEVELOPMENT
|
14
|
6.63e-02
|
-2.84e-01
|
1.77e-01
|
GOCC CHROMATIN SILENCING COMPLEX
|
12
|
8.91e-02
|
-2.84e-01
|
2.18e-01
|
GOBP SINGLE STRAND BREAK REPAIR
|
11
|
1.04e-01
|
-2.83e-01
|
2.41e-01
|
GOBP GLYCEROL ETHER METABOLIC PROCESS
|
15
|
5.76e-02
|
2.83e-01
|
1.60e-01
|
GOBP HEART VALVE FORMATION
|
15
|
5.77e-02
|
-2.83e-01
|
1.60e-01
|
GOBP CELL PROLIFERATION IN BONE MARROW
|
10
|
1.21e-01
|
-2.83e-01
|
2.65e-01
|
GOMF OXIDOREDUCTASE ACTIVITY
|
533
|
9.02e-29
|
2.83e-01
|
3.24e-26
|
GOBP REGULATION OF PROTEIN LIPIDATION
|
10
|
1.22e-01
|
2.83e-01
|
2.66e-01
|
GOMF HYDRO LYASE ACTIVITY
|
44
|
1.19e-03
|
2.82e-01
|
7.87e-03
|
GOBP POSITIVE REGULATION OF MITOCHONDRIAL MEMBRANE POTENTIAL
|
12
|
9.04e-02
|
2.82e-01
|
2.20e-01
|
GOMF LYASE ACTIVITY
|
148
|
3.32e-09
|
2.82e-01
|
1.07e-07
|
GOMF CULLIN FAMILY PROTEIN BINDING
|
23
|
1.93e-02
|
2.82e-01
|
7.19e-02
|
GOBP INTRACELLULAR DISTRIBUTION OF MITOCHONDRIA
|
11
|
1.06e-01
|
2.82e-01
|
2.43e-01
|
GOBP POSITIVE REGULATION OF LAMELLIPODIUM ASSEMBLY
|
26
|
1.29e-02
|
-2.82e-01
|
5.25e-02
|
GOCC PORE COMPLEX
|
20
|
2.92e-02
|
2.82e-01
|
9.71e-02
|
GOBP SPINAL CORD DEVELOPMENT
|
56
|
2.67e-04
|
-2.82e-01
|
2.32e-03
|
GOBP MEIOTIC CHROMOSOME SEGREGATION
|
53
|
3.91e-04
|
-2.82e-01
|
3.17e-03
|
GOMF R SMAD BINDING
|
24
|
1.69e-02
|
-2.82e-01
|
6.50e-02
|
GOBP REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY
|
29
|
8.68e-03
|
-2.82e-01
|
3.83e-02
|
GOBP CENTRIOLE ASSEMBLY
|
41
|
1.81e-03
|
-2.82e-01
|
1.12e-02
|
GOBP GROOMING BEHAVIOR
|
13
|
7.89e-02
|
2.81e-01
|
2.00e-01
|
GOBP LIPID CATABOLIC PROCESS
|
230
|
2.10e-13
|
2.81e-01
|
1.30e-11
|
GOBP T HELPER 1 TYPE IMMUNE RESPONSE
|
34
|
4.52e-03
|
-2.81e-01
|
2.31e-02
|
GOCC ORGANELLE ENVELOPE
|
1020
|
1.84e-51
|
2.81e-01
|
1.99e-48
|
GOBP PHOSPHATIDYLCHOLINE METABOLIC PROCESS
|
45
|
1.10e-03
|
2.81e-01
|
7.36e-03
|
GOBP NOREPINEPHRINE SECRETION
|
12
|
9.18e-02
|
2.81e-01
|
2.22e-01
|
GOMF INTRAMOLECULAR OXIDOREDUCTASE ACTIVITY
|
42
|
1.63e-03
|
2.81e-01
|
1.02e-02
|
GOBP TRACHEA DEVELOPMENT
|
14
|
6.87e-02
|
-2.81e-01
|
1.81e-01
|
GOBP CELL CYCLE G2 M PHASE TRANSITION
|
131
|
2.89e-08
|
-2.81e-01
|
7.48e-07
|
GOBP POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE
|
65
|
9.05e-05
|
-2.81e-01
|
9.15e-04
|
GOBP TORC2 SIGNALING
|
14
|
6.90e-02
|
-2.81e-01
|
1.82e-01
|
GOBP SISTER CHROMATID SEGREGATION
|
189
|
2.98e-11
|
-2.81e-01
|
1.41e-09
|
GOBP POSITIVE REGULATION OF SYNAPTIC VESICLE ENDOCYTOSIS
|
12
|
9.24e-02
|
-2.81e-01
|
2.23e-01
|
GOBP NOREPINEPHRINE TRANSPORT
|
18
|
3.94e-02
|
2.81e-01
|
1.22e-01
|
GOCC CYTOPLASMIC DYNEIN COMPLEX
|
16
|
5.23e-02
|
-2.80e-01
|
1.50e-01
|
GOBP CELLULAR ALDEHYDE METABOLIC PROCESS
|
64
|
1.06e-04
|
2.80e-01
|
1.06e-03
|
GOMF TRANSCRIPTION REGULATOR INHIBITOR ACTIVITY
|
26
|
1.34e-02
|
-2.80e-01
|
5.43e-02
|
GOBP KETONE BIOSYNTHETIC PROCESS
|
35
|
4.19e-03
|
2.80e-01
|
2.17e-02
|
GOBP STEM CELL DIVISION
|
34
|
4.77e-03
|
-2.80e-01
|
2.40e-02
|
GOBP REGULATION OF ANIMAL ORGAN FORMATION
|
20
|
3.04e-02
|
-2.80e-01
|
1.01e-01
|
GOBP RETINAL CONE CELL DIFFERENTIATION
|
11
|
1.08e-01
|
2.80e-01
|
2.47e-01
|
GOBP CELL CELL ADHESION MEDIATED BY INTEGRIN
|
14
|
7.02e-02
|
-2.79e-01
|
1.84e-01
|
GOBP PHARYNGEAL ARCH ARTERY MORPHOGENESIS
|
12
|
9.39e-02
|
-2.79e-01
|
2.25e-01
|
GOMF REGULATORY RNA BINDING
|
36
|
3.76e-03
|
-2.79e-01
|
2.00e-02
|
GOCC CCR4 NOT COMPLEX
|
15
|
6.13e-02
|
-2.79e-01
|
1.67e-01
|
GOCC M BAND
|
20
|
3.08e-02
|
2.79e-01
|
1.01e-01
|
GOBP REGULATION OF SISTER CHROMATID SEGREGATION
|
86
|
8.01e-06
|
-2.79e-01
|
1.12e-04
|
GOBP RESPONSE TO COLD
|
31
|
7.27e-03
|
2.79e-01
|
3.37e-02
|
GOBP MITOTIC SPINDLE ASSEMBLY
|
65
|
1.05e-04
|
-2.78e-01
|
1.05e-03
|
GOCC FEMALE GERM CELL NUCLEUS
|
11
|
1.10e-01
|
-2.78e-01
|
2.50e-01
|
GOBP PROTEIN O LINKED MANNOSYLATION
|
12
|
9.57e-02
|
2.78e-01
|
2.28e-01
|
GOBP REGULATION OF ALPHA BETA T CELL DIFFERENTIATION
|
55
|
3.71e-04
|
-2.78e-01
|
3.03e-03
|
GOBP REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS
|
22
|
2.43e-02
|
-2.77e-01
|
8.51e-02
|
GOBP FATTY ACID METABOLIC PROCESS
|
318
|
2.08e-17
|
2.77e-01
|
2.32e-15
|
GOBP COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE
|
16
|
5.48e-02
|
-2.77e-01
|
1.55e-01
|
GOBP REGULATION OF RESPONSE TO CYTOKINE STIMULUS
|
132
|
3.89e-08
|
-2.77e-01
|
9.72e-07
|
GOCC GOLGI CISTERNA
|
59
|
2.32e-04
|
-2.77e-01
|
2.07e-03
|
GOBP NEPHRON TUBULE EPITHELIAL CELL DIFFERENTIATION
|
10
|
1.29e-01
|
-2.77e-01
|
2.76e-01
|
GOMF HISTONE KINASE ACTIVITY
|
23
|
2.14e-02
|
-2.77e-01
|
7.78e-02
|
GOMF LYSOPHOSPHOLIPID ACYLTRANSFERASE ACTIVITY
|
16
|
5.51e-02
|
2.77e-01
|
1.56e-01
|
GOCC CYTOSOLIC LARGE RIBOSOMAL SUBUNIT
|
53
|
4.91e-04
|
2.77e-01
|
3.78e-03
|
GOMF ATP DEPENDENT PROTEIN FOLDING CHAPERONE
|
25
|
1.66e-02
|
2.77e-01
|
6.41e-02
|
GOBP MITOTIC SISTER CHROMATID SEPARATION
|
50
|
7.18e-04
|
-2.77e-01
|
5.17e-03
|
GOBP MONOACYLGLYCEROL METABOLIC PROCESS
|
10
|
1.30e-01
|
2.77e-01
|
2.77e-01
|
GOMF POLY PURINE TRACT BINDING
|
27
|
1.29e-02
|
-2.77e-01
|
5.26e-02
|
GOBP REGULATION OF SKELETAL MUSCLE ADAPTATION
|
13
|
8.44e-02
|
2.76e-01
|
2.10e-01
|
GOBP APICAL PROTEIN LOCALIZATION
|
14
|
7.35e-02
|
-2.76e-01
|
1.90e-01
|
GOBP GERM CELL PROLIFERATION
|
10
|
1.30e-01
|
2.76e-01
|
2.78e-01
|
GOBP NEGATIVE REGULATION OF T HELPER CELL DIFFERENTIATION
|
15
|
6.40e-02
|
-2.76e-01
|
1.72e-01
|
GOBP REGULATION OF SMAD PROTEIN SIGNAL TRANSDUCTION
|
46
|
1.19e-03
|
-2.76e-01
|
7.87e-03
|
GOMF CYTOKINE BINDING
|
96
|
2.96e-06
|
-2.76e-01
|
4.65e-05
|
GOBP POSITIVE REGULATION OF EXECUTION PHASE OF APOPTOSIS
|
18
|
4.25e-02
|
-2.76e-01
|
1.28e-01
|
GOBP NEGATIVE REGULATION OF INTERLEUKIN 10 PRODUCTION
|
11
|
1.13e-01
|
-2.76e-01
|
2.53e-01
|
GOBP CELL CELL SIGNALING INVOLVED IN CARDIAC CONDUCTION
|
26
|
1.49e-02
|
2.76e-01
|
5.88e-02
|
GOBP MAINTENANCE OF CELL POLARITY
|
14
|
7.38e-02
|
-2.76e-01
|
1.91e-01
|
GOBP HEART VALVE MORPHOGENESIS
|
50
|
7.48e-04
|
-2.76e-01
|
5.35e-03
|
GOBP MITOTIC DNA INTEGRITY CHECKPOINT SIGNALING
|
72
|
5.31e-05
|
-2.76e-01
|
5.83e-04
|
GOBP NEGATIVE REGULATION OF BONE REMODELING
|
12
|
9.84e-02
|
-2.76e-01
|
2.32e-01
|
GOBP HETEROCHROMATIN FORMATION
|
100
|
1.95e-06
|
-2.76e-01
|
3.25e-05
|
GOBP VITAMIN TRANSMEMBRANE TRANSPORT
|
15
|
6.47e-02
|
2.76e-01
|
1.73e-01
|
GOBP REGULATION OF METALLOPEPTIDASE ACTIVITY
|
10
|
1.32e-01
|
-2.75e-01
|
2.79e-01
|
GOMF LNCRNA BINDING
|
23
|
2.26e-02
|
-2.75e-01
|
8.09e-02
|
GOBP REGULATION OF MESENCHYMAL CELL PROLIFERATION
|
38
|
3.40e-03
|
-2.75e-01
|
1.83e-02
|
GOCC PML BODY
|
77
|
3.13e-05
|
-2.75e-01
|
3.70e-04
|
GOBP POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION
|
25
|
1.76e-02
|
-2.74e-01
|
6.69e-02
|
GOBP CYTOKINETIC PROCESS
|
43
|
1.88e-03
|
-2.74e-01
|
1.15e-02
|
GOMF NADPLUS ADP RIBOSYLTRANSFERASE ACTIVITY
|
21
|
2.99e-02
|
-2.74e-01
|
9.93e-02
|
GOCC GERM CELL NUCLEUS
|
61
|
2.20e-04
|
-2.74e-01
|
1.97e-03
|
GOMF EXTRACELLULAR MATRIX STRUCTURAL CONSTITUENT
|
118
|
3.00e-07
|
-2.73e-01
|
6.01e-06
|
GOBP MODIFIED AMINO ACID TRANSPORT
|
28
|
1.23e-02
|
2.73e-01
|
5.10e-02
|
GOBP SYMBIONT ENTRY INTO HOST
|
70
|
7.79e-05
|
-2.73e-01
|
8.07e-04
|
GOBP REGULATION OF PROTEIN TARGETING TO MITOCHONDRION
|
15
|
6.71e-02
|
2.73e-01
|
1.78e-01
|
GOMF ACYLGLYCEROL O ACYLTRANSFERASE ACTIVITY
|
16
|
5.86e-02
|
2.73e-01
|
1.63e-01
|
GOBP REGULATION OF STEM CELL PROLIFERATION
|
76
|
3.92e-05
|
-2.73e-01
|
4.48e-04
|
GOBP NEGATIVE REGULATION OF CELL JUNCTION ASSEMBLY
|
32
|
7.55e-03
|
-2.73e-01
|
3.45e-02
|
GOBP LIPOPROTEIN LOCALIZATION
|
19
|
3.96e-02
|
2.73e-01
|
1.22e-01
|
GOMF PRE MRNA BINDING
|
35
|
5.29e-03
|
-2.72e-01
|
2.60e-02
|
GOBP POSITIVE REGULATION OF CELLULAR SENESCENCE
|
11
|
1.18e-01
|
-2.72e-01
|
2.60e-01
|
GOCC PCG PROTEIN COMPLEX
|
43
|
2.01e-03
|
-2.72e-01
|
1.20e-02
|
GOBP POSITIVE REGULATION OF CELL CYCLE G2 M PHASE TRANSITION
|
26
|
1.63e-02
|
-2.72e-01
|
6.31e-02
|
GOBP CELL FATE SPECIFICATION
|
61
|
2.38e-04
|
-2.72e-01
|
2.10e-03
|
GOBP RESPONSE TO TESTOSTERONE
|
13
|
8.94e-02
|
-2.72e-01
|
2.18e-01
|
GOBP RIBOSOME ASSEMBLY
|
59
|
3.05e-04
|
2.72e-01
|
2.57e-03
|
GOMF QUATERNARY AMMONIUM GROUP BINDING
|
28
|
1.28e-02
|
2.72e-01
|
5.23e-02
|
GOMF METAL CLUSTER BINDING
|
68
|
1.07e-04
|
2.72e-01
|
1.07e-03
|
GOMF PROTEIN SERINE THREONINE KINASE BINDING
|
20
|
3.55e-02
|
-2.72e-01
|
1.13e-01
|
GOBP NEGATIVE REGULATION OF VIRAL TRANSCRIPTION
|
16
|
6.02e-02
|
-2.71e-01
|
1.65e-01
|
GOBP TRANSLATION AT SYNAPSE
|
47
|
1.30e-03
|
2.71e-01
|
8.43e-03
|
GOBP POSITIVE REGULATION OF CARDIOCYTE DIFFERENTIATION
|
15
|
6.91e-02
|
-2.71e-01
|
1.82e-01
|
GOMF TRANSLATION ELONGATION FACTOR ACTIVITY
|
17
|
5.35e-02
|
2.71e-01
|
1.53e-01
|
GOBP SCHWANN CELL PROLIFERATION
|
11
|
1.20e-01
|
-2.70e-01
|
2.64e-01
|
GOMF LIGASE ACTIVITY
|
113
|
7.15e-07
|
2.70e-01
|
1.30e-05
|
GOCC OLIGOSACCHARYLTRANSFERASE COMPLEX
|
13
|
9.21e-02
|
2.70e-01
|
2.22e-01
|
GOBP LACTATE METABOLIC PROCESS
|
19
|
4.18e-02
|
2.70e-01
|
1.26e-01
|
GOBP POSITIVE REGULATION OF VASCULOGENESIS
|
11
|
1.21e-01
|
-2.70e-01
|
2.65e-01
|
GOMF ISOPRENOID BINDING
|
17
|
5.42e-02
|
2.70e-01
|
1.54e-01
|
GOBP REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS
|
53
|
6.91e-04
|
-2.70e-01
|
5.00e-03
|
GOBP REGULATION OF NEUTROPHIL CHEMOTAXIS
|
29
|
1.21e-02
|
-2.69e-01
|
5.00e-02
|
GOBP REGULATION OF TRIGLYCERIDE METABOLIC PROCESS
|
40
|
3.21e-03
|
2.69e-01
|
1.75e-02
|
GOBP T CELL LINEAGE COMMITMENT
|
22
|
2.88e-02
|
-2.69e-01
|
9.62e-02
|
GOBP NEUROBLAST DIVISION
|
14
|
8.13e-02
|
-2.69e-01
|
2.04e-01
|
GOMF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE ACTIVITY
|
12
|
1.07e-01
|
-2.69e-01
|
2.44e-01
|
GOBP REGULATORY NCRNA MEDIATED GENE SILENCING
|
94
|
6.67e-06
|
-2.69e-01
|
9.52e-05
|
GOBP ONE CARBON COMPOUND TRANSPORT
|
13
|
9.33e-02
|
2.69e-01
|
2.24e-01
|
GOBP REGULATION OF FATTY ACID BETA OXIDATION
|
16
|
6.28e-02
|
2.69e-01
|
1.70e-01
|
GOBP SEROTONIN METABOLIC PROCESS
|
12
|
1.07e-01
|
2.69e-01
|
2.45e-01
|
GOBP POSITIVE REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST
|
20
|
3.77e-02
|
-2.69e-01
|
1.18e-01
|
GOCC SMOOTH ENDOPLASMIC RETICULUM
|
30
|
1.10e-02
|
2.68e-01
|
4.65e-02
|
GOBP CELLULAR RESPONSE TO TYPE II INTERFERON
|
86
|
1.73e-05
|
-2.68e-01
|
2.19e-04
|
GOBP NEGATIVE REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY
|
14
|
8.25e-02
|
-2.68e-01
|
2.06e-01
|
GOBP NATURAL KILLER CELL MEDIATED IMMUNITY
|
42
|
2.66e-03
|
-2.68e-01
|
1.51e-02
|
GOBP NADP METABOLIC PROCESS
|
49
|
1.17e-03
|
2.68e-01
|
7.79e-03
|
GOBP CELL CYCLE CHECKPOINT SIGNALING
|
167
|
2.41e-09
|
-2.68e-01
|
8.08e-08
|
GOBP REGULATION OF MONOATOMIC ANION TRANSPORT
|
16
|
6.36e-02
|
-2.68e-01
|
1.71e-01
|
GOBP REGULATION OF GLOMERULAR FILTRATION
|
11
|
1.24e-01
|
-2.68e-01
|
2.70e-01
|
GOBP REGULATORY NCRNA PROCESSING
|
47
|
1.50e-03
|
-2.68e-01
|
9.47e-03
|
GOBP DOPAMINE BIOSYNTHETIC PROCESS
|
12
|
1.08e-01
|
2.68e-01
|
2.47e-01
|
GOBP CARDIAC CELL FATE COMMITMENT
|
11
|
1.24e-01
|
-2.68e-01
|
2.70e-01
|
GOBP REGULATION OF VITAMIN METABOLIC PROCESS
|
11
|
1.24e-01
|
2.68e-01
|
2.70e-01
|
GOBP ACTIN NUCLEATION
|
47
|
1.51e-03
|
-2.68e-01
|
9.53e-03
|
GOBP EPITHELIAL CELL PROLIFERATION INVOLVED IN PROSTATE GLAND DEVELOPMENT
|
10
|
1.43e-01
|
-2.67e-01
|
2.95e-01
|
GOBP PENTOSE METABOLIC PROCESS
|
12
|
1.09e-01
|
2.67e-01
|
2.48e-01
|
GOCC PHAGOCYTIC VESICLE
|
101
|
3.60e-06
|
-2.67e-01
|
5.51e-05
|
GOBP CELL PROLIFERATION IN FOREBRAIN
|
23
|
2.67e-02
|
-2.67e-01
|
9.15e-02
|
GOBP POSITIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION
|
54
|
7.04e-04
|
-2.67e-01
|
5.09e-03
|
GOBP SPHINGOLIPID MEDIATED SIGNALING PATHWAY
|
12
|
1.10e-01
|
-2.66e-01
|
2.49e-01
|
GOBP TERPENOID METABOLIC PROCESS
|
39
|
4.08e-03
|
2.66e-01
|
2.13e-02
|
GOBP REGULATION OF SPINDLE ASSEMBLY
|
26
|
1.90e-02
|
-2.66e-01
|
7.11e-02
|
GOMF AMP BINDING
|
16
|
6.58e-02
|
2.66e-01
|
1.76e-01
|
GOBP REGULATION OF RNA EXPORT FROM NUCLEUS
|
14
|
8.54e-02
|
-2.66e-01
|
2.11e-01
|
GOBP NEGATIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS
|
11
|
1.27e-01
|
-2.66e-01
|
2.73e-01
|
GOBP REGULATION OF SYNAPSE MATURATION
|
23
|
2.75e-02
|
-2.66e-01
|
9.35e-02
|
GOBP POSITIVE REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION
|
30
|
1.19e-02
|
-2.65e-01
|
4.94e-02
|
GOBP MITOTIC G1 S TRANSITION CHECKPOINT SIGNALING
|
23
|
2.76e-02
|
-2.65e-01
|
9.36e-02
|
GOBP NUCLEAR TRANSCRIBED MRNA POLY A TAIL SHORTENING
|
24
|
2.45e-02
|
-2.65e-01
|
8.56e-02
|
GOMF CYCLIN DEPENDENT PROTEIN SERINE THREONINE KINASE REGULATOR ACTIVITY
|
37
|
5.28e-03
|
-2.65e-01
|
2.60e-02
|
GOBP AMINO ACID BIOSYNTHETIC PROCESS
|
56
|
6.06e-04
|
2.65e-01
|
4.47e-03
|
GOBP MECHANOSENSORY BEHAVIOR
|
12
|
1.13e-01
|
-2.64e-01
|
2.53e-01
|
GOBP ORGANIC ACID METABOLIC PROCESS
|
698
|
2.33e-32
|
2.64e-01
|
1.00e-29
|
GOBP REGULATION OF EXTRACELLULAR MATRIX DISASSEMBLY
|
12
|
1.13e-01
|
-2.64e-01
|
2.54e-01
|
GOBP MODIFICATION OF POSTSYNAPTIC STRUCTURE
|
36
|
6.13e-03
|
-2.64e-01
|
2.94e-02
|
GOBP CATECHOLAMINE UPTAKE
|
11
|
1.30e-01
|
2.64e-01
|
2.77e-01
|
GOBP NUCLEAR CHROMOSOME SEGREGATION
|
240
|
2.04e-12
|
-2.64e-01
|
1.09e-10
|
GOBP REGULATION OF CELL FATE SPECIFICATION
|
20
|
4.11e-02
|
-2.64e-01
|
1.25e-01
|
GOMF VITAMIN BINDING
|
101
|
4.70e-06
|
2.64e-01
|
6.99e-05
|
GOBP MULTICELLULAR ORGANISMAL LEVEL IRON ION HOMEOSTASIS
|
24
|
2.55e-02
|
2.64e-01
|
8.84e-02
|
GOBP TYPE II INTERFERON PRODUCTION
|
84
|
3.02e-05
|
-2.63e-01
|
3.59e-04
|
GOBP ADULT WALKING BEHAVIOR
|
38
|
4.96e-03
|
2.63e-01
|
2.48e-02
|
GOBP AXONAL FASCICULATION
|
20
|
4.15e-02
|
2.63e-01
|
1.26e-01
|
GOBP REGULATION OF MEGAKARYOCYTE DIFFERENTIATION
|
17
|
6.03e-02
|
-2.63e-01
|
1.65e-01
|
GOCC TRANSCRIPTION REPRESSOR COMPLEX
|
68
|
1.77e-04
|
-2.63e-01
|
1.62e-03
|
GOBP SECONDARY PALATE DEVELOPMENT
|
20
|
4.19e-02
|
-2.63e-01
|
1.27e-01
|
GOMF LONG CHAIN FATTY ACID TRANSMEMBRANE TRANSPORTER ACTIVITY
|
14
|
8.87e-02
|
2.63e-01
|
2.17e-01
|
GOBP RISC COMPLEX ASSEMBLY
|
10
|
1.50e-01
|
-2.63e-01
|
3.05e-01
|
GOCC SWR1 COMPLEX
|
13
|
1.01e-01
|
2.63e-01
|
2.36e-01
|
GOBP REGULATION OF CELL COMMUNICATION BY ELECTRICAL COUPLING
|
11
|
1.32e-01
|
-2.63e-01
|
2.79e-01
|
GOBP POSITIVE REGULATION OF OLIGODENDROCYTE DIFFERENTIATION
|
22
|
3.31e-02
|
-2.62e-01
|
1.07e-01
|
GOBP PEROXISOME ORGANIZATION
|
35
|
7.23e-03
|
2.62e-01
|
3.35e-02
|
GOBP OUTFLOW TRACT SEPTUM MORPHOGENESIS
|
25
|
2.32e-02
|
-2.62e-01
|
8.22e-02
|
GOBP REGULATION OF AMINE METABOLIC PROCESS
|
25
|
2.35e-02
|
2.62e-01
|
8.29e-02
|
GOBP REGULATION OF FEEDING BEHAVIOR
|
16
|
6.99e-02
|
2.62e-01
|
1.83e-01
|
GOBP CELL REDOX HOMEOSTASIS
|
25
|
2.36e-02
|
2.62e-01
|
8.33e-02
|
GOBP TRANSMISSION OF NERVE IMPULSE
|
56
|
7.20e-04
|
2.61e-01
|
5.18e-03
|
GOBP REGULATION OF T CELL APOPTOTIC PROCESS
|
37
|
5.95e-03
|
-2.61e-01
|
2.86e-02
|
GOBP PINOCYTOSIS
|
20
|
4.32e-02
|
-2.61e-01
|
1.30e-01
|
GOBP POSITIVE REGULATION OF PROTEIN SUMOYLATION
|
15
|
7.99e-02
|
-2.61e-01
|
2.02e-01
|
GOBP TRANS SYNAPTIC SIGNALING BY LIPID
|
11
|
1.34e-01
|
-2.61e-01
|
2.82e-01
|
GOMF LIGASE ACTIVITY FORMING CARBON SULFUR BONDS
|
34
|
8.46e-03
|
2.61e-01
|
3.75e-02
|
GOBP BLASTODERM SEGMENTATION
|
21
|
3.85e-02
|
-2.61e-01
|
1.20e-01
|
GOMF NADP BINDING
|
41
|
3.90e-03
|
2.61e-01
|
2.06e-02
|
GOBP NEGATIVE REGULATION OF INTERLEUKIN 12 PRODUCTION
|
13
|
1.04e-01
|
-2.60e-01
|
2.41e-01
|
GOBP POSITIVE REGULATION OF EPIDERMIS DEVELOPMENT
|
16
|
7.16e-02
|
-2.60e-01
|
1.87e-01
|
GOBP REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT
|
23
|
3.08e-02
|
-2.60e-01
|
1.01e-01
|
GOBP POSITIVE REGULATION OF CANONICAL NF KAPPAB SIGNAL TRANSDUCTION
|
128
|
3.83e-07
|
-2.60e-01
|
7.48e-06
|
GOMF OXIDOREDUCTASE ACTIVITY ACTING ON METAL IONS
|
15
|
8.12e-02
|
2.60e-01
|
2.04e-01
|
GOBP AMINO SUGAR CATABOLIC PROCESS
|
11
|
1.35e-01
|
2.60e-01
|
2.84e-01
|
GOBP POSITIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS
|
27
|
1.94e-02
|
-2.60e-01
|
7.22e-02
|
GOBP POSITIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION
|
28
|
1.73e-02
|
-2.60e-01
|
6.60e-02
|
GOBP REGULATION OF FIBROBLAST MIGRATION
|
43
|
3.21e-03
|
-2.60e-01
|
1.75e-02
|
GOBP NEGATIVE REGULATION OF DNA BINDING
|
32
|
1.10e-02
|
-2.60e-01
|
4.67e-02
|
GOMF EPIDERMAL GROWTH FACTOR RECEPTOR BINDING
|
32
|
1.11e-02
|
-2.60e-01
|
4.67e-02
|
GOBP TRIGLYCERIDE BIOSYNTHETIC PROCESS
|
40
|
4.52e-03
|
2.60e-01
|
2.31e-02
|
GOBP ENDOPLASMIC RETICULUM MEMBRANE ORGANIZATION
|
12
|
1.20e-01
|
2.60e-01
|
2.63e-01
|
GOMF MONOATOMIC ANION MONOATOMIC CATION SYMPORTER ACTIVITY
|
18
|
5.68e-02
|
2.59e-01
|
1.59e-01
|
GOBP INTRACELLULAR SODIUM ION HOMEOSTASIS
|
18
|
5.69e-02
|
2.59e-01
|
1.59e-01
|
GOBP REGULATION OF TRANSLATIONAL INITIATION BY EIF2 ALPHA PHOSPHORYLATION
|
14
|
9.31e-02
|
-2.59e-01
|
2.24e-01
|
GOBP NEGATIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY
|
34
|
9.00e-03
|
-2.59e-01
|
3.95e-02
|
GOBP REGULATION OF CELL KILLING
|
71
|
1.63e-04
|
-2.59e-01
|
1.52e-03
|
GOBP MIDBODY ABSCISSION
|
15
|
8.26e-02
|
-2.59e-01
|
2.06e-01
|
GOBP WALKING BEHAVIOR
|
43
|
3.36e-03
|
2.59e-01
|
1.81e-02
|
GOBP PROTEIN TARGETING TO VACUOLE
|
44
|
3.05e-03
|
-2.58e-01
|
1.68e-02
|
GOBP CHAPERONE MEDIATED AUTOPHAGY
|
10
|
1.58e-01
|
2.58e-01
|
3.15e-01
|
GOBP PEROXISOMAL TRANSPORT
|
21
|
4.07e-02
|
2.58e-01
|
1.24e-01
|
GOMF MIRNA BINDING
|
27
|
2.06e-02
|
-2.58e-01
|
7.53e-02
|
GOMF DNA DNA ANNEALING ACTIVITY
|
10
|
1.59e-01
|
-2.57e-01
|
3.17e-01
|
GOBP POSITIVE REGULATION OF NEURON PROJECTION REGENERATION
|
13
|
1.08e-01
|
-2.57e-01
|
2.46e-01
|
GOBP MIDBRAIN DEVELOPMENT
|
30
|
1.48e-02
|
-2.57e-01
|
5.85e-02
|
GOBP NEGATIVE REGULATION OF RESPONSE TO OXIDATIVE STRESS
|
13
|
1.08e-01
|
2.57e-01
|
2.47e-01
|
GOBP CARTILAGE CONDENSATION
|
11
|
1.40e-01
|
-2.57e-01
|
2.91e-01
|
GOBP CELL AGGREGATION
|
11
|
1.40e-01
|
-2.57e-01
|
2.91e-01
|
GOBP MYD88 DEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY
|
12
|
1.23e-01
|
-2.57e-01
|
2.68e-01
|
GOBP POSITIVE REGULATION OF MACROPHAGE ACTIVATION
|
22
|
3.70e-02
|
-2.57e-01
|
1.16e-01
|
GOMF PHOSPHATIDYLINOSITOL MONOPHOSPHATE PHOSPHATASE ACTIVITY
|
14
|
9.64e-02
|
-2.57e-01
|
2.29e-01
|
GOBP REGULATION OF INFLAMMASOME MEDIATED SIGNALING PATHWAY
|
38
|
6.21e-03
|
-2.57e-01
|
2.96e-02
|
GOMF ATP DEPENDENT CHROMATIN REMODELER ACTIVITY
|
34
|
9.67e-03
|
-2.56e-01
|
4.17e-02
|
GOMF SINGLE STRANDED DNA BINDING
|
109
|
3.81e-06
|
-2.56e-01
|
5.78e-05
|
GOMF FATTY ACID BINDING
|
34
|
9.71e-03
|
2.56e-01
|
4.18e-02
|
GOBP CHROMOSOME SEGREGATION
|
327
|
1.87e-15
|
-2.56e-01
|
1.63e-13
|
GOBP REGULATION OF HUMORAL IMMUNE RESPONSE MEDIATED BY CIRCULATING IMMUNOGLOBULIN
|
13
|
1.10e-01
|
-2.56e-01
|
2.49e-01
|
GOBP EMBRYONIC CRANIAL SKELETON MORPHOGENESIS
|
44
|
3.31e-03
|
-2.56e-01
|
1.79e-02
|
GOMF CARBOXY LYASE ACTIVITY
|
26
|
2.40e-02
|
2.56e-01
|
8.42e-02
|
GOBP REGULATION OF SPINDLE ORGANIZATION
|
38
|
6.36e-03
|
-2.56e-01
|
3.01e-02
|
GOBP PHOSPHOLIPID EFFLUX
|
10
|
1.61e-01
|
2.56e-01
|
3.21e-01
|
GOBP RESPONSE TO GLUCAGON
|
11
|
1.42e-01
|
2.56e-01
|
2.94e-01
|
GOBP EXTRACELLULAR MATRIX ASSEMBLY
|
46
|
2.75e-03
|
-2.55e-01
|
1.55e-02
|
GOBP ERROR PRONE TRANSLESION SYNTHESIS
|
10
|
1.62e-01
|
-2.55e-01
|
3.22e-01
|
GOBP REGULATION OF CENTROSOME DUPLICATION
|
45
|
3.08e-03
|
-2.55e-01
|
1.69e-02
|
GOMF QUINONE BINDING
|
12
|
1.26e-01
|
2.55e-01
|
2.72e-01
|
GOCC TRANSPORTER COMPLEX
|
271
|
5.86e-13
|
2.55e-01
|
3.38e-11
|
GOBP ESTABLISHMENT OF ENDOTHELIAL BARRIER
|
45
|
3.13e-03
|
-2.55e-01
|
1.71e-02
|
GOBP POSITIVE REGULATION OF INTERLEUKIN 1 BETA PRODUCTION
|
43
|
3.88e-03
|
-2.55e-01
|
2.05e-02
|
GOBP COCHLEA MORPHOGENESIS
|
19
|
5.48e-02
|
-2.55e-01
|
1.55e-01
|
GOMF S ADENOSYL L METHIONINE BINDING
|
14
|
9.96e-02
|
2.54e-01
|
2.34e-01
|
GOBP REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY
|
121
|
1.41e-06
|
-2.54e-01
|
2.43e-05
|
GOBP FATTY ACID BIOSYNTHETIC PROCESS
|
119
|
1.74e-06
|
2.54e-01
|
2.92e-05
|
GOCC POLYPRENYL DIPHOSPHATE SYNTHASE COMPLEX
|
11
|
1.45e-01
|
2.54e-01
|
2.98e-01
|
GOBP REGULATION OF CELL CYCLE G2 M PHASE TRANSITION
|
98
|
1.42e-05
|
-2.54e-01
|
1.83e-04
|
GOBP CORTICAL ACTIN CYTOSKELETON ORGANIZATION
|
40
|
5.48e-03
|
-2.54e-01
|
2.68e-02
|
GOBP NEGATIVE REGULATION OF VASOCONSTRICTION
|
16
|
7.89e-02
|
-2.54e-01
|
2.00e-01
|
GOBP INNER CELL MASS CELL PROLIFERATION
|
16
|
7.90e-02
|
-2.54e-01
|
2.00e-01
|
GOBP REGULATION OF ANTIGEN PROCESSING AND PRESENTATION
|
16
|
7.90e-02
|
-2.54e-01
|
2.00e-01
|
GOBP REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION
|
17
|
7.02e-02
|
-2.54e-01
|
1.84e-01
|
GOCC POST MRNA RELEASE SPLICEOSOMAL COMPLEX
|
10
|
1.65e-01
|
-2.54e-01
|
3.25e-01
|
GOBP COPULATION
|
10
|
1.65e-01
|
2.54e-01
|
3.25e-01
|
GOMF BMP RECEPTOR BINDING
|
10
|
1.65e-01
|
-2.54e-01
|
3.25e-01
|
GOBP REGULATION OF CARDIOCYTE DIFFERENTIATION
|
27
|
2.26e-02
|
-2.54e-01
|
8.09e-02
|
GOBP SLEEP
|
19
|
5.58e-02
|
2.53e-01
|
1.57e-01
|
GOMF VOLTAGE GATED SODIUM CHANNEL ACTIVITY
|
15
|
8.93e-02
|
2.53e-01
|
2.18e-01
|
GOBP PEPTIDYL PROLINE HYDROXYLATION
|
11
|
1.46e-01
|
2.53e-01
|
2.99e-01
|
GOBP FIBROBLAST MIGRATION
|
63
|
5.09e-04
|
-2.53e-01
|
3.90e-03
|
GOBP SEROTONIN TRANSPORT
|
18
|
6.29e-02
|
2.53e-01
|
1.70e-01
|
GOBP REGULATION OF RELAXATION OF MUSCLE
|
13
|
1.14e-01
|
2.53e-01
|
2.55e-01
|
GOBP REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION
|
40
|
5.63e-03
|
-2.53e-01
|
2.74e-02
|
GOBP PEPTIDYL ARGININE MODIFICATION
|
13
|
1.14e-01
|
2.53e-01
|
2.55e-01
|
GOBP PROTEIN REFOLDING
|
23
|
3.57e-02
|
2.53e-01
|
1.14e-01
|
GOBP RRNA METHYLATION
|
17
|
7.11e-02
|
2.53e-01
|
1.86e-01
|
GOBP CYTOKINESIS
|
143
|
1.83e-07
|
-2.53e-01
|
3.86e-06
|
GOBP OSTEOBLAST DEVELOPMENT
|
14
|
1.01e-01
|
-2.53e-01
|
2.37e-01
|
GOBP PURINE NUCLEOSIDE MONOPHOSPHATE CATABOLIC PROCESS
|
11
|
1.47e-01
|
-2.53e-01
|
3.00e-01
|
GOCC ASTER
|
11
|
1.47e-01
|
-2.53e-01
|
3.00e-01
|
GOMF VOLTAGE GATED MONOATOMIC ION CHANNEL ACTIVITY INVOLVED IN REGULATION OF PRESYNAPTIC MEMBRANE POTENTIAL
|
10
|
1.67e-01
|
2.53e-01
|
3.27e-01
|
GOBP POSITIVE REGULATION OF ISOTYPE SWITCHING
|
18
|
6.36e-02
|
-2.53e-01
|
1.71e-01
|
GOBP POSTREPLICATION REPAIR
|
28
|
2.09e-02
|
-2.52e-01
|
7.61e-02
|
GOMF ATP DEPENDENT DNA DAMAGE SENSOR ACTIVITY
|
11
|
1.48e-01
|
-2.52e-01
|
3.01e-01
|
GOBP PROTEIN LOCALIZATION TO NON MOTILE CILIUM
|
10
|
1.67e-01
|
-2.52e-01
|
3.28e-01
|
GOBP CD4 POSITIVE OR CD8 POSITIVE ALPHA BETA T CELL LINEAGE COMMITMENT
|
18
|
6.42e-02
|
-2.52e-01
|
1.73e-01
|
GOMF ANNEALING ACTIVITY
|
13
|
1.16e-01
|
-2.52e-01
|
2.57e-01
|
GOBP POSITIVE REGULATION OF VASCULAR PERMEABILITY
|
14
|
1.03e-01
|
2.52e-01
|
2.39e-01
|
GOBP LEUKOCYTE MEDIATED CYTOTOXICITY
|
85
|
6.12e-05
|
-2.52e-01
|
6.61e-04
|
GOBP GLIAL CELL DERIVED NEUROTROPHIC FACTOR RECEPTOR SIGNALING PATHWAY
|
10
|
1.68e-01
|
2.52e-01
|
3.30e-01
|
GOBP REGULATION OF MOTOR NEURON APOPTOTIC PROCESS
|
18
|
6.48e-02
|
-2.51e-01
|
1.74e-01
|
GOBP CELLULAR MODIFIED AMINO ACID METABOLIC PROCESS
|
146
|
1.63e-07
|
2.51e-01
|
3.49e-06
|
GOBP REGULATION OF MITOTIC SPINDLE ASSEMBLY
|
17
|
7.29e-02
|
-2.51e-01
|
1.89e-01
|
GOBP POSITIVE REGULATION OF HOMOTYPIC CELL CELL ADHESION
|
12
|
1.32e-01
|
-2.51e-01
|
2.79e-01
|
GOBP SPECIFICATION OF ANIMAL ORGAN IDENTITY
|
24
|
3.32e-02
|
-2.51e-01
|
1.08e-01
|
GOBP REGULATION OF DNA CATABOLIC PROCESS
|
11
|
1.50e-01
|
2.51e-01
|
3.04e-01
|
GOBP POSITIVE REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN
|
16
|
8.25e-02
|
-2.51e-01
|
2.06e-01
|
GOBP REGULATION OF CELL FATE COMMITMENT
|
28
|
2.17e-02
|
-2.51e-01
|
7.86e-02
|
GOBP REGULATION OF PHOSPHOLIPASE C ACTIVITY
|
16
|
8.28e-02
|
-2.50e-01
|
2.06e-01
|
GOBP NEGATIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS
|
66
|
4.39e-04
|
-2.50e-01
|
3.47e-03
|
GOCC MITOTIC SPINDLE MICROTUBULE
|
14
|
1.05e-01
|
-2.50e-01
|
2.42e-01
|
GOBP HETEROCHROMATIN ORGANIZATION
|
12
|
1.33e-01
|
-2.50e-01
|
2.81e-01
|
GOBP REGULATION OF MEMBRANE LIPID DISTRIBUTION
|
42
|
5.07e-03
|
-2.50e-01
|
2.52e-02
|
GOBP NEGATIVE REGULATION OF BIOMINERAL TISSUE DEVELOPMENT
|
17
|
7.46e-02
|
-2.50e-01
|
1.92e-01
|
GOBP MYELOID PROGENITOR CELL DIFFERENTIATION
|
12
|
1.34e-01
|
-2.50e-01
|
2.82e-01
|
GOCC BLOC 1 COMPLEX
|
12
|
1.34e-01
|
2.50e-01
|
2.82e-01
|
GOBP RESPONSE TO ETHER
|
12
|
1.35e-01
|
-2.50e-01
|
2.83e-01
|
GOMF ATPASE COUPLED INTRAMEMBRANE LIPID TRANSPORTER ACTIVITY
|
23
|
3.84e-02
|
-2.49e-01
|
1.20e-01
|
GOBP POSITIVE REGULATION OF NON CANONICAL NF KAPPAB SIGNAL TRANSDUCTION
|
54
|
1.53e-03
|
-2.49e-01
|
9.65e-03
|
GOBP PHARYNGEAL SYSTEM DEVELOPMENT
|
26
|
2.78e-02
|
-2.49e-01
|
9.40e-02
|
GOBP POSITIVE REGULATION OF INTERLEUKIN 12 PRODUCTION
|
26
|
2.79e-02
|
-2.49e-01
|
9.41e-02
|
GOBP REGULATION OF SHORT TERM NEURONAL SYNAPTIC PLASTICITY
|
13
|
1.20e-01
|
2.49e-01
|
2.64e-01
|
GOCC ENDONUCLEASE COMPLEX
|
36
|
9.77e-03
|
2.49e-01
|
4.20e-02
|
GOBP POSITIVE REGULATION OF TYPE I INTERFERON PRODUCTION
|
72
|
2.63e-04
|
-2.49e-01
|
2.29e-03
|
GOBP REGULATION OF MACROPHAGE MIGRATION
|
37
|
8.82e-03
|
-2.49e-01
|
3.88e-02
|
GOMF HYALURONIC ACID BINDING
|
16
|
8.49e-02
|
-2.49e-01
|
2.10e-01
|
GOBP ETHER BIOSYNTHETIC PROCESS
|
10
|
1.73e-01
|
2.49e-01
|
3.37e-01
|
GOBP WATER SOLUBLE VITAMIN METABOLIC PROCESS
|
40
|
6.53e-03
|
2.49e-01
|
3.08e-02
|
GOBP NUCLEOBASE CONTAINING SMALL MOLECULE METABOLIC PROCESS
|
512
|
8.56e-22
|
2.49e-01
|
1.50e-19
|
GOMF SYNTAXIN 1 BINDING
|
16
|
8.57e-02
|
-2.48e-01
|
2.11e-01
|
GOBP TRIGLYCERIDE METABOLIC PROCESS
|
84
|
8.52e-05
|
2.48e-01
|
8.70e-04
|
GOBP FILOPODIUM ASSEMBLY
|
61
|
8.08e-04
|
-2.48e-01
|
5.70e-03
|
GOBP AMIDE METABOLIC PROCESS
|
333
|
8.36e-15
|
2.48e-01
|
6.51e-13
|
GOBP RESPONSE TO CORTICOSTEROID
|
70
|
3.36e-04
|
-2.48e-01
|
2.78e-03
|
GOMF ENDONUCLEASE ACTIVITY ACTIVE WITH EITHER RIBO OR DEOXYRIBONUCLEIC ACIDS AND PRODUCING 3 PHOSPHOMONOESTERS
|
11
|
1.55e-01
|
2.48e-01
|
3.11e-01
|
GOMF CYCLIC NUCLEOTIDE PHOSPHODIESTERASE ACTIVITY
|
22
|
4.42e-02
|
2.48e-01
|
1.32e-01
|
GOBP REGULATION OF LONG TERM SYNAPTIC DEPRESSION
|
14
|
1.09e-01
|
2.48e-01
|
2.47e-01
|
GOCC CILIARY BASE
|
31
|
1.71e-02
|
-2.48e-01
|
6.54e-02
|
GOMF CYCLOSPORIN A BINDING
|
13
|
1.22e-01
|
-2.48e-01
|
2.66e-01
|
GOBP POSITIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT
|
19
|
6.17e-02
|
-2.48e-01
|
1.68e-01
|
GOMF SIRNA BINDING
|
10
|
1.75e-01
|
-2.48e-01
|
3.39e-01
|
GOBP RESPONSE TO PLATELET DERIVED GROWTH FACTOR
|
20
|
5.55e-02
|
-2.47e-01
|
1.57e-01
|
GOBP NEGATIVE REGULATION OF PROGRAMMED NECROTIC CELL DEATH
|
17
|
7.76e-02
|
-2.47e-01
|
1.98e-01
|
GOCC MITOTIC SPINDLE POLE
|
38
|
8.36e-03
|
-2.47e-01
|
3.72e-02
|
GOBP NEGATIVE REGULATION OF CHEMOKINE PRODUCTION
|
22
|
4.47e-02
|
-2.47e-01
|
1.33e-01
|
GOCC PROTEIN COMPLEX INVOLVED IN CELL ADHESION
|
48
|
3.06e-03
|
-2.47e-01
|
1.68e-02
|
GOBP MANNOSYLATION
|
17
|
7.77e-02
|
2.47e-01
|
1.98e-01
|
GOMF SODIUM CHANNEL REGULATOR ACTIVITY
|
29
|
2.13e-02
|
2.47e-01
|
7.76e-02
|
GOMF ACTIVE MONOATOMIC ION TRANSMEMBRANE TRANSPORTER ACTIVITY
|
164
|
4.97e-08
|
2.47e-01
|
1.20e-06
|
GOBP RESPONSE TO STEROL DEPLETION
|
14
|
1.10e-01
|
2.47e-01
|
2.49e-01
|
GOBP LUNG CELL DIFFERENTIATION
|
30
|
1.94e-02
|
-2.47e-01
|
7.23e-02
|
GOMF HISTONE ACETYLTRANSFERASE BINDING
|
27
|
2.67e-02
|
-2.47e-01
|
9.13e-02
|
GOMF UNFOLDED PROTEIN BINDING
|
77
|
1.86e-04
|
2.46e-01
|
1.70e-03
|
GOBP NEGATIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT
|
24
|
3.67e-02
|
-2.46e-01
|
1.16e-01
|
GOBP ORGANOPHOSPHATE BIOSYNTHETIC PROCESS
|
442
|
8.81e-19
|
2.46e-01
|
1.12e-16
|
GOBP NEGATIVE REGULATION OF GENE EXPRESSION EPIGENETIC
|
129
|
1.40e-06
|
-2.46e-01
|
2.41e-05
|
GOBP MEMBRANE DEPOLARIZATION DURING ACTION POTENTIAL
|
23
|
4.10e-02
|
2.46e-01
|
1.25e-01
|
GOBP POSITIVE REGULATION OF HEART RATE
|
24
|
3.69e-02
|
2.46e-01
|
1.16e-01
|
GOMF METHYL CPG BINDING
|
21
|
5.10e-02
|
-2.46e-01
|
1.48e-01
|
GOBP BILE ACID BIOSYNTHETIC PROCESS
|
18
|
7.09e-02
|
2.46e-01
|
1.85e-01
|
GOBP REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE BY P53 CLASS MEDIATOR
|
12
|
1.40e-01
|
-2.46e-01
|
2.92e-01
|
GOBP FAT CELL PROLIFERATION
|
12
|
1.40e-01
|
-2.46e-01
|
2.92e-01
|
GOCC SARCOPLASMIC RETICULUM
|
74
|
2.59e-04
|
2.46e-01
|
2.26e-03
|
GOBP DEFENSE RESPONSE TO BACTERIUM
|
165
|
5.35e-08
|
-2.46e-01
|
1.29e-06
|
GOBP EMBRYONIC HEMOPOIESIS
|
27
|
2.72e-02
|
-2.46e-01
|
9.28e-02
|
GOBP GERMINAL CENTER FORMATION
|
14
|
1.12e-01
|
-2.46e-01
|
2.52e-01
|
GOMF INSULIN RECEPTOR BINDING
|
24
|
3.73e-02
|
-2.46e-01
|
1.17e-01
|
GOBP REGULATION OF CELL CYCLE CHECKPOINT
|
42
|
5.92e-03
|
-2.46e-01
|
2.85e-02
|
GOCC FILOPODIUM MEMBRANE
|
16
|
8.93e-02
|
-2.45e-01
|
2.18e-01
|
GOBP MACROPHAGE MIGRATION
|
51
|
2.44e-03
|
-2.45e-01
|
1.41e-02
|
GOBP POSITIVE REGULATION OF CYTOPLASMIC TRANSLATION
|
12
|
1.41e-01
|
-2.45e-01
|
2.93e-01
|
GOBP POSITIVE REGULATION OF NOTCH SIGNALING PATHWAY
|
34
|
1.33e-02
|
-2.45e-01
|
5.41e-02
|
GOMF HISTONE CHAPERONE ACTIVITY
|
14
|
1.12e-01
|
-2.45e-01
|
2.52e-01
|
GOBP IMMUNOLOGICAL SYNAPSE FORMATION
|
12
|
1.42e-01
|
-2.45e-01
|
2.93e-01
|
GOCC LAMELLIPODIUM
|
162
|
7.62e-08
|
-2.45e-01
|
1.77e-06
|
GOBP MONOCARBOXYLIC ACID METABOLIC PROCESS
|
491
|
1.96e-20
|
2.45e-01
|
2.95e-18
|
GOBP DNA TEMPLATED DNA REPLICATION MAINTENANCE OF FIDELITY
|
48
|
3.33e-03
|
-2.45e-01
|
1.80e-02
|
GOBP NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS
|
219
|
4.45e-10
|
2.45e-01
|
1.78e-08
|
GOBP REGULATION OF TOLL LIKE RECEPTOR 3 SIGNALING PATHWAY
|
13
|
1.27e-01
|
-2.45e-01
|
2.73e-01
|
GOBP POSITIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY
|
108
|
1.13e-05
|
-2.45e-01
|
1.50e-04
|
GOBP NEGATIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION
|
47
|
3.73e-03
|
-2.45e-01
|
1.99e-02
|
GOBP LEUKOCYTE TETHERING OR ROLLING
|
28
|
2.51e-02
|
-2.45e-01
|
8.74e-02
|
GOMF PLATELET DERIVED GROWTH FACTOR RECEPTOR BINDING
|
14
|
1.13e-01
|
-2.45e-01
|
2.54e-01
|
GOBP TOLL LIKE RECEPTOR 2 SIGNALING PATHWAY
|
16
|
9.05e-02
|
-2.45e-01
|
2.20e-01
|
GOBP SKELETAL MUSCLE CELL PROLIFERATION
|
20
|
5.86e-02
|
-2.44e-01
|
1.63e-01
|
GOBP REGULATION OF UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS
|
12
|
1.43e-01
|
-2.44e-01
|
2.95e-01
|
GOBP NEGATIVE REGULATION OF VASCULAR PERMEABILITY
|
20
|
5.87e-02
|
2.44e-01
|
1.63e-01
|
GOBP FATTY ACID TRANSMEMBRANE TRANSPORT
|
16
|
9.08e-02
|
2.44e-01
|
2.20e-01
|
GOBP CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY
|
144
|
4.35e-07
|
-2.44e-01
|
8.34e-06
|
GOBP ORGANELLE INHERITANCE
|
15
|
1.02e-01
|
-2.44e-01
|
2.37e-01
|
GOBP PANCREATIC JUICE SECRETION
|
11
|
1.61e-01
|
2.44e-01
|
3.20e-01
|
GOBP REGULATION OF T HELPER CELL DIFFERENTIATION
|
26
|
3.13e-02
|
-2.44e-01
|
1.03e-01
|
GOBP PIGMENT BIOSYNTHETIC PROCESS
|
37
|
1.03e-02
|
2.44e-01
|
4.40e-02
|
GOBP MHC CLASS II BIOSYNTHETIC PROCESS
|
12
|
1.44e-01
|
-2.44e-01
|
2.96e-01
|
GOMF RNA POLYMERASE II CTD HEPTAPEPTIDE REPEAT KINASE ACTIVITY
|
10
|
1.82e-01
|
-2.44e-01
|
3.47e-01
|
GOBP POSITIVE REGULATION OF NEURON DIFFERENTIATION
|
69
|
4.68e-04
|
-2.44e-01
|
3.63e-03
|
GOBP LIPID MODIFICATION
|
158
|
1.30e-07
|
2.44e-01
|
2.87e-06
|
GOBP REGULATION OF T CELL CYTOKINE PRODUCTION
|
23
|
4.31e-02
|
-2.44e-01
|
1.30e-01
|
GOBP NEGATIVE REGULATION OF MITOTIC CELL CYCLE
|
198
|
3.59e-09
|
-2.44e-01
|
1.15e-07
|
GOBP POSITIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION
|
37
|
1.04e-02
|
-2.44e-01
|
4.42e-02
|
GOBP POSITIVE REGULATION OF NEUROBLAST PROLIFERATION
|
28
|
2.57e-02
|
-2.44e-01
|
8.90e-02
|
GOBP G PROTEIN COUPLED ACETYLCHOLINE RECEPTOR SIGNALING PATHWAY
|
14
|
1.15e-01
|
-2.44e-01
|
2.56e-01
|
GOBP METANEPHRIC NEPHRON MORPHOGENESIS
|
14
|
1.15e-01
|
-2.43e-01
|
2.56e-01
|
GOMF O ACYLTRANSFERASE ACTIVITY
|
38
|
9.55e-03
|
2.43e-01
|
4.12e-02
|
GOBP AMP BIOSYNTHETIC PROCESS
|
12
|
1.45e-01
|
2.43e-01
|
2.98e-01
|
GOBP LYMPHOCYTE ACTIVATION INVOLVED IN IMMUNE RESPONSE
|
143
|
5.48e-07
|
-2.43e-01
|
1.02e-05
|
GOBP CHONDROITIN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS
|
19
|
6.70e-02
|
-2.43e-01
|
1.78e-01
|
GOBP MEMBRANE RAFT ORGANIZATION
|
19
|
6.70e-02
|
-2.43e-01
|
1.78e-01
|
GOBP NODAL SIGNALING PATHWAY
|
11
|
1.63e-01
|
-2.43e-01
|
3.23e-01
|
GOBP CELLULAR RESPONSE TO LITHIUM ION
|
10
|
1.84e-01
|
-2.42e-01
|
3.50e-01
|
GOBP REGULATION OF ENDOSOME SIZE
|
14
|
1.16e-01
|
2.42e-01
|
2.58e-01
|
GOBP CELL DIFFERENTIATION IN SPINAL CORD
|
24
|
3.99e-02
|
-2.42e-01
|
1.23e-01
|
GOBP NEGATIVE REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS
|
19
|
6.75e-02
|
2.42e-01
|
1.79e-01
|
GOBP NEGATIVE REGULATION OF OSTEOCLAST DIFFERENTIATION
|
24
|
3.99e-02
|
-2.42e-01
|
1.23e-01
|
GOMF DNA HELICASE ACTIVITY
|
50
|
3.10e-03
|
-2.42e-01
|
1.69e-02
|
GOBP POSITIVE REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY
|
22
|
4.96e-02
|
-2.42e-01
|
1.45e-01
|
GOBP NEGATIVE REGULATION OF GLUCOSE IMPORT
|
17
|
8.45e-02
|
-2.42e-01
|
2.10e-01
|
GOBP NEGATIVE REGULATION OF CELL CYCLE PROCESS
|
257
|
2.82e-11
|
-2.42e-01
|
1.34e-09
|
GOBP REGULATION OF GENE SILENCING BY REGULATORY NCRNA
|
24
|
4.07e-02
|
-2.41e-01
|
1.24e-01
|
GOBP VENTRICULAR SEPTUM MORPHOGENESIS
|
43
|
6.19e-03
|
-2.41e-01
|
2.96e-02
|
GOBP TRIPARTITE REGIONAL SUBDIVISION
|
12
|
1.48e-01
|
-2.41e-01
|
3.01e-01
|
GOBP MODIFICATION OF SYNAPTIC STRUCTURE
|
45
|
5.12e-03
|
-2.41e-01
|
2.53e-02
|
GOBP MITOCHONDRIAL CALCIUM ION TRANSMEMBRANE TRANSPORT
|
15
|
1.06e-01
|
2.41e-01
|
2.43e-01
|
GOBP ENDOTHELIUM DEVELOPMENT
|
125
|
3.25e-06
|
-2.41e-01
|
5.01e-05
|
GOBP DNA INTEGRITY CHECKPOINT SIGNALING
|
113
|
9.60e-06
|
-2.41e-01
|
1.30e-04
|
GOBP DNA TEMPLATED DNA REPLICATION
|
135
|
1.34e-06
|
-2.41e-01
|
2.33e-05
|
GOMF UBIQUITIN SPECIFIC PROTEASE BINDING
|
15
|
1.06e-01
|
2.41e-01
|
2.43e-01
|
GOBP VASCULAR ENDOTHELIAL CELL PROLIFERATION
|
26
|
3.34e-02
|
-2.41e-01
|
1.08e-01
|
GOCC RNA POLYMERASE II CORE COMPLEX
|
14
|
1.18e-01
|
2.41e-01
|
2.61e-01
|
GOBP POSITIVE REGULATION OF GLYCOGEN BIOSYNTHETIC PROCESS
|
14
|
1.19e-01
|
-2.41e-01
|
2.61e-01
|
GOBP POSITIVE REGULATION OF STEM CELL PROLIFERATION
|
41
|
7.63e-03
|
-2.41e-01
|
3.47e-02
|
GOBP NEGATIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION
|
42
|
7.03e-03
|
-2.40e-01
|
3.28e-02
|
GOBP REGULATION OF EPIDERMIS DEVELOPMENT
|
42
|
7.03e-03
|
-2.40e-01
|
3.28e-02
|
GOBP NEGATIVE REGULATION OF ENDOTHELIAL CELL MIGRATION
|
48
|
3.97e-03
|
-2.40e-01
|
2.08e-02
|
GOBP INTERLEUKIN 1 MEDIATED SIGNALING PATHWAY
|
24
|
4.17e-02
|
-2.40e-01
|
1.26e-01
|
GOBP MITOCHONDRION ORGANIZATION
|
458
|
1.66e-18
|
2.40e-01
|
2.02e-16
|
GOBP PEPTIDYL TYROSINE AUTOPHOSPHORYLATION
|
15
|
1.07e-01
|
-2.40e-01
|
2.45e-01
|
GOBP CENTROSOME SEPARATION
|
13
|
1.34e-01
|
-2.40e-01
|
2.82e-01
|
GOBP AXIS SPECIFICATION
|
64
|
9.02e-04
|
-2.40e-01
|
6.24e-03
|
GOMF S100 PROTEIN BINDING
|
13
|
1.34e-01
|
-2.40e-01
|
2.82e-01
|
GOCC SARCOPLASM
|
93
|
6.47e-05
|
2.40e-01
|
6.95e-04
|
GOBP MRNA SPLICE SITE RECOGNITION
|
21
|
5.71e-02
|
-2.40e-01
|
1.59e-01
|
GOBP REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY
|
29
|
2.55e-02
|
-2.40e-01
|
8.85e-02
|
GOBP NEGATIVE REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY
|
11
|
1.69e-01
|
-2.40e-01
|
3.30e-01
|
GOBP POSITIVE REGULATION OF INFLAMMASOME MEDIATED SIGNALING PATHWAY
|
22
|
5.18e-02
|
-2.40e-01
|
1.49e-01
|
GOBP ESTABLISHMENT OF PROTEIN LOCALIZATION TO VACUOLE
|
51
|
3.15e-03
|
-2.39e-01
|
1.72e-02
|
GOMF EXONUCLEASE ACTIVITY ACTIVE WITH EITHER RIBO OR DEOXYRIBONUCLEIC ACIDS AND PRODUCING 5 PHOSPHOMONOESTERS
|
50
|
3.47e-03
|
-2.39e-01
|
1.86e-02
|
GOBP EXCITATORY SYNAPSE ASSEMBLY
|
27
|
3.16e-02
|
-2.39e-01
|
1.03e-01
|
GOCC TRAPPIII PROTEIN COMPLEX
|
11
|
1.70e-01
|
2.39e-01
|
3.32e-01
|
GOBP VIRAL LIFE CYCLE
|
191
|
1.34e-08
|
-2.39e-01
|
3.70e-07
|
GOCC BASEMENT MEMBRANE
|
96
|
5.37e-05
|
-2.39e-01
|
5.89e-04
|
GOBP MONOCYTE DIFFERENTIATION
|
25
|
3.90e-02
|
-2.39e-01
|
1.21e-01
|
GOBP ORGANIC ACID BIOSYNTHETIC PROCESS
|
226
|
6.95e-10
|
2.39e-01
|
2.60e-08
|
GOBP MYELOID LEUKOCYTE CYTOKINE PRODUCTION
|
58
|
1.69e-03
|
-2.38e-01
|
1.06e-02
|
GOBP STEROL METABOLIC PROCESS
|
110
|
1.59e-05
|
2.38e-01
|
2.02e-04
|
GOBP POSITIVE REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS
|
13
|
1.37e-01
|
-2.38e-01
|
2.86e-01
|
GOBP INTERFERON BETA PRODUCTION
|
65
|
9.02e-04
|
-2.38e-01
|
6.24e-03
|
GOCC A BAND
|
36
|
1.35e-02
|
2.38e-01
|
5.43e-02
|
GOBP MACROPHAGE DIFFERENTIATION
|
52
|
2.99e-03
|
-2.38e-01
|
1.65e-02
|
GOCC RNAI EFFECTOR COMPLEX
|
16
|
9.93e-02
|
-2.38e-01
|
2.34e-01
|
GOBP PERISTALSIS
|
11
|
1.72e-01
|
2.38e-01
|
3.35e-01
|
GOBP DENDRITIC TRANSPORT
|
18
|
8.07e-02
|
-2.38e-01
|
2.03e-01
|
GOBP PHOSPHATIDIC ACID METABOLIC PROCESS
|
21
|
5.92e-02
|
2.38e-01
|
1.64e-01
|
GOBP CELL COMMUNICATION BY ELECTRICAL COUPLING
|
17
|
8.99e-02
|
-2.38e-01
|
2.19e-01
|
GOBP PROTEIN K63 LINKED DEUBIQUITINATION
|
24
|
4.40e-02
|
-2.38e-01
|
1.31e-01
|
GOBP DECIDUALIZATION
|
21
|
5.98e-02
|
-2.37e-01
|
1.65e-01
|
GOMF LONG CHAIN FATTY ACID COA LIGASE ACTIVITY
|
11
|
1.73e-01
|
2.37e-01
|
3.36e-01
|
GOMF OXIDOREDUCTASE ACTIVITY ACTING ON PEROXIDE AS ACCEPTOR
|
40
|
9.48e-03
|
2.37e-01
|
4.10e-02
|
GOBP REGULATION OF DEFENSE RESPONSE TO VIRUS
|
51
|
3.42e-03
|
-2.37e-01
|
1.84e-02
|
GOCC KERATIN FILAMENT
|
10
|
1.95e-01
|
-2.37e-01
|
3.64e-01
|
GOBP NUCLEAR MEMBRANE ORGANIZATION
|
34
|
1.69e-02
|
-2.37e-01
|
6.50e-02
|
GOBP FIBROBLAST ACTIVATION
|
19
|
7.41e-02
|
-2.37e-01
|
1.91e-01
|
GOBP NEGATIVE REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY
|
13
|
1.40e-01
|
-2.37e-01
|
2.91e-01
|
GOBP REGULATION OF INTEGRIN MEDIATED SIGNALING PATHWAY
|
18
|
8.23e-02
|
-2.37e-01
|
2.06e-01
|
GOBP REGULATION OF OSTEOBLAST DIFFERENTIATION
|
117
|
1.01e-05
|
-2.37e-01
|
1.36e-04
|
GOBP PERICARDIUM DEVELOPMENT
|
26
|
3.69e-02
|
-2.37e-01
|
1.16e-01
|
GOBP SYNAPTIC TRANSMISSION DOPAMINERGIC
|
20
|
6.72e-02
|
2.36e-01
|
1.78e-01
|
GOBP SMALL MOLECULE BIOSYNTHETIC PROCESS
|
436
|
3.23e-17
|
2.36e-01
|
3.48e-15
|
GOBP INFLAMMASOME MEDIATED SIGNALING PATHWAY
|
42
|
8.06e-03
|
-2.36e-01
|
3.61e-02
|
GOBP BINDING OF SPERM TO ZONA PELLUCIDA
|
23
|
4.98e-02
|
2.36e-01
|
1.45e-01
|
GOBP PURINE NUCLEOSIDE METABOLIC PROCESS
|
27
|
3.36e-02
|
2.36e-01
|
1.08e-01
|
GOBP STEROID BIOSYNTHETIC PROCESS
|
117
|
1.04e-05
|
2.36e-01
|
1.40e-04
|
GOBP NON CANONICAL WNT SIGNALING PATHWAY
|
49
|
4.29e-03
|
-2.36e-01
|
2.21e-02
|
GOBP NEGATIVE REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION
|
16
|
1.02e-01
|
-2.36e-01
|
2.38e-01
|
GOBP CENTROSOME DUPLICATION
|
71
|
5.93e-04
|
-2.36e-01
|
4.41e-03
|
GOBP REGULATION OF INTEGRIN ACTIVATION
|
14
|
1.27e-01
|
-2.36e-01
|
2.73e-01
|
GOBP POSITIVE REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION
|
31
|
2.32e-02
|
-2.36e-01
|
8.23e-02
|
GOMF RNA ENDONUCLEASE ACTIVITY PRODUCING 5 PHOSPHOMONOESTERS
|
27
|
3.43e-02
|
2.35e-01
|
1.10e-01
|
GOCC MYOSIN FILAMENT
|
15
|
1.15e-01
|
2.35e-01
|
2.56e-01
|
GOBP RETINOL METABOLIC PROCESS
|
13
|
1.42e-01
|
2.35e-01
|
2.94e-01
|
GOMF PROTEIN DEMETHYLASE ACTIVITY
|
26
|
3.80e-02
|
-2.35e-01
|
1.19e-01
|
GOBP CELLULAR RESPONSE TO FLUID SHEAR STRESS
|
17
|
9.34e-02
|
-2.35e-01
|
2.24e-01
|
GOBP PRIMARY AMINO COMPOUND METABOLIC PROCESS
|
15
|
1.15e-01
|
2.35e-01
|
2.56e-01
|
GOBP NEGATIVE REGULATION OF LEUKOCYTE DEGRANULATION
|
10
|
1.99e-01
|
-2.35e-01
|
3.69e-01
|
GOCC HIGH DENSITY LIPOPROTEIN PARTICLE
|
14
|
1.29e-01
|
2.35e-01
|
2.75e-01
|
GOBP PHOSPHOLIPID HOMEOSTASIS
|
15
|
1.16e-01
|
2.34e-01
|
2.57e-01
|
GOBP NEGATIVE REGULATION OF INNATE IMMUNE RESPONSE
|
69
|
7.66e-04
|
-2.34e-01
|
5.47e-03
|
GOBP POSITIVE REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL
|
22
|
5.72e-02
|
-2.34e-01
|
1.59e-01
|
GOBP VESICLE TARGETING ROUGH ER TO CIS GOLGI
|
19
|
7.71e-02
|
2.34e-01
|
1.97e-01
|
GOBP POSITIVE REGULATION OF GRANULOCYTE CHEMOTAXIS
|
22
|
5.72e-02
|
-2.34e-01
|
1.60e-01
|
GOBP RESPONSE TO LEUKEMIA INHIBITORY FACTOR
|
108
|
2.64e-05
|
-2.34e-01
|
3.19e-04
|
GOBP TRANSFORMING GROWTH FACTOR BETA PRODUCTION
|
29
|
2.91e-02
|
-2.34e-01
|
9.71e-02
|
GOBP POSITIVE REGULATION OF DIGESTIVE SYSTEM PROCESS
|
10
|
2.00e-01
|
2.34e-01
|
3.70e-01
|
GOBP CELLULAR RESPONSE TO COPPER ION
|
10
|
2.00e-01
|
-2.34e-01
|
3.70e-01
|
GOBP NEUROTRANSMITTER UPTAKE
|
26
|
3.91e-02
|
2.34e-01
|
1.21e-01
|
GOCC CHROMOSOME CENTROMERIC REGION
|
201
|
1.16e-08
|
-2.34e-01
|
3.22e-07
|
GOBP NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY
|
51
|
3.92e-03
|
-2.34e-01
|
2.06e-02
|
GOBP POSITIVE REGULATION OF GLIOGENESIS
|
73
|
5.63e-04
|
-2.34e-01
|
4.22e-03
|
GOCC CORTICAL ACTIN CYTOSKELETON
|
73
|
5.68e-04
|
-2.33e-01
|
4.24e-03
|
GOBP REGULATION OF ESTABLISHMENT OF CELL POLARITY
|
17
|
9.58e-02
|
-2.33e-01
|
2.28e-01
|
GOBP CELLULAR RESPONSE TO STEROL
|
19
|
7.84e-02
|
2.33e-01
|
1.99e-01
|
GOBP AORTA MORPHOGENESIS
|
34
|
1.86e-02
|
-2.33e-01
|
6.98e-02
|
GOBP CEREBRAL CORTEX RADIALLY ORIENTED CELL MIGRATION
|
33
|
2.05e-02
|
-2.33e-01
|
7.51e-02
|
GOCC RSC TYPE COMPLEX
|
14
|
1.31e-01
|
-2.33e-01
|
2.78e-01
|
GOBP NEUROTRANSMITTER REUPTAKE
|
19
|
7.86e-02
|
2.33e-01
|
2.00e-01
|
GOBP CEREBELLAR PURKINJE CELL LAYER FORMATION
|
15
|
1.18e-01
|
2.33e-01
|
2.61e-01
|
GOMF CYSTEINE TYPE ENDOPEPTIDASE REGULATOR ACTIVITY INVOLVED IN APOPTOTIC PROCESS
|
36
|
1.56e-02
|
-2.33e-01
|
6.12e-02
|
GOBP ALPHA BETA T CELL PROLIFERATION
|
38
|
1.30e-02
|
-2.33e-01
|
5.30e-02
|
GOBP REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY
|
14
|
1.32e-01
|
2.33e-01
|
2.79e-01
|
GOBP SMALL MOLECULE METABOLIC PROCESS
|
1319
|
1.06e-44
|
2.33e-01
|
9.75e-42
|
GOBP INTRACILIARY RETROGRADE TRANSPORT
|
10
|
2.03e-01
|
-2.32e-01
|
3.74e-01
|
GOBP REGULATION OF LEUKOCYTE APOPTOTIC PROCESS
|
76
|
4.63e-04
|
-2.32e-01
|
3.60e-03
|
GOBP CEREBRAL CORTEX CELL MIGRATION
|
44
|
7.66e-03
|
-2.32e-01
|
3.48e-02
|
GOBP PLATELET ACTIVATION
|
77
|
4.30e-04
|
-2.32e-01
|
3.41e-03
|
GOBP LUNG EPITHELIUM DEVELOPMENT
|
44
|
7.73e-03
|
-2.32e-01
|
3.50e-02
|
GOMF LAMININ BINDING
|
27
|
3.69e-02
|
-2.32e-01
|
1.16e-01
|
GOCC COLLAGEN CONTAINING EXTRACELLULAR MATRIX
|
295
|
7.95e-12
|
-2.32e-01
|
4.05e-10
|
GOBP NEGATIVE REGULATION OF INFLAMMASOME MEDIATED SIGNALING PATHWAY
|
15
|
1.20e-01
|
-2.32e-01
|
2.63e-01
|
GOCC NUCLEAR CYCLIN DEPENDENT PROTEIN KINASE HOLOENZYME COMPLEX
|
17
|
9.80e-02
|
-2.32e-01
|
2.31e-01
|
GOBP REGULATION OF CATECHOLAMINE SECRETION
|
31
|
2.55e-02
|
2.32e-01
|
8.85e-02
|
GOCC GOLGI STACK
|
81
|
3.14e-04
|
-2.32e-01
|
2.64e-03
|
GOMF MAGNESIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY
|
14
|
1.33e-01
|
2.32e-01
|
2.81e-01
|
GOBP EPITHELIAL CELL DIFFERENTIATION INVOLVED IN PROSTATE GLAND DEVELOPMENT
|
11
|
1.84e-01
|
2.32e-01
|
3.49e-01
|
GOBP NEGATIVE REGULATION OF RECEPTOR INTERNALIZATION
|
12
|
1.65e-01
|
-2.31e-01
|
3.25e-01
|
GOMF PHOSPHATIDYLINOSITOL KINASE ACTIVITY
|
22
|
6.04e-02
|
-2.31e-01
|
1.66e-01
|
GOBP MITOTIC NUCLEAR DIVISION
|
226
|
2.23e-09
|
-2.31e-01
|
7.50e-08
|
GOMF PROTEIN PHOSPHATASE 2A BINDING
|
34
|
1.96e-02
|
-2.31e-01
|
7.29e-02
|
GOCC MRNA CLEAVAGE FACTOR COMPLEX
|
22
|
6.05e-02
|
-2.31e-01
|
1.66e-01
|
GOBP OLIGOSACCHARIDE BIOSYNTHETIC PROCESS
|
14
|
1.34e-01
|
2.31e-01
|
2.82e-01
|
GOBP REGULATION OF T HELPER 17 CELL DIFFERENTIATION
|
13
|
1.50e-01
|
-2.31e-01
|
3.04e-01
|
GOBP VITAMIN TRANSPORT
|
36
|
1.66e-02
|
2.31e-01
|
6.40e-02
|
GOBP LOCOMOTOR RHYTHM
|
17
|
9.96e-02
|
2.31e-01
|
2.34e-01
|
GOBP MICROTUBULE ORGANIZING CENTER ORGANIZATION
|
138
|
2.96e-06
|
-2.31e-01
|
4.65e-05
|
GOCC PROTEIN COMPLEX INVOLVED IN CELL MATRIX ADHESION
|
12
|
1.67e-01
|
-2.31e-01
|
3.27e-01
|
GOCC BLOC COMPLEX
|
17
|
9.97e-02
|
2.31e-01
|
2.34e-01
|
GOBP PSEUDOPODIUM ORGANIZATION
|
11
|
1.85e-01
|
-2.31e-01
|
3.52e-01
|
GOBP REGULATION OF RESPONSE TO REACTIVE OXYGEN SPECIES
|
10
|
2.07e-01
|
-2.31e-01
|
3.80e-01
|
GOBP LEUKOTRIENE METABOLIC PROCESS
|
16
|
1.11e-01
|
2.30e-01
|
2.50e-01
|
GOBP POSITIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT
|
17
|
1.00e-01
|
2.30e-01
|
2.35e-01
|
GOBP NEUROMUSCULAR PROCESS CONTROLLING POSTURE
|
13
|
1.51e-01
|
2.30e-01
|
3.05e-01
|
GOBP NEUTRAL LIPID BIOSYNTHETIC PROCESS
|
49
|
5.36e-03
|
2.30e-01
|
2.63e-02
|
GOBP POSITIVE REGULATION OF ALPHA BETA T CELL ACTIVATION
|
56
|
2.92e-03
|
-2.30e-01
|
1.62e-02
|
GOMF DNA DAMAGE SENSOR ACTIVITY
|
14
|
1.36e-01
|
-2.30e-01
|
2.85e-01
|
GOCC GOLGI CIS CISTERNA
|
12
|
1.68e-01
|
-2.30e-01
|
3.29e-01
|
GOBP GLUTAMATE METABOLIC PROCESS
|
22
|
6.23e-02
|
2.30e-01
|
1.69e-01
|
GOBP TYPE I INTERFERON PRODUCTION
|
118
|
1.68e-05
|
-2.30e-01
|
2.12e-04
|
GOBP ATRIAL SEPTUM MORPHOGENESIS
|
13
|
1.52e-01
|
-2.30e-01
|
3.07e-01
|
GOBP REGULATION OF RETINOIC ACID RECEPTOR SIGNALING PATHWAY
|
14
|
1.37e-01
|
-2.30e-01
|
2.86e-01
|
GOBP REGULATION OF LEUKOCYTE MEDIATED IMMUNITY
|
170
|
2.61e-07
|
-2.29e-01
|
5.29e-06
|
GOBP AGGREPHAGY
|
15
|
1.24e-01
|
2.29e-01
|
2.70e-01
|
GOMF ADENYLYLTRANSFERASE ACTIVITY
|
23
|
5.71e-02
|
-2.29e-01
|
1.59e-01
|
GOMF HISTONE H3K9 DEMETHYLASE ACTIVITY
|
11
|
1.89e-01
|
-2.29e-01
|
3.55e-01
|
GOBP MONOCARBOXYLIC ACID BIOSYNTHETIC PROCESS
|
159
|
6.51e-07
|
2.29e-01
|
1.20e-05
|
GOBP ANOIKIS
|
29
|
3.30e-02
|
-2.29e-01
|
1.07e-01
|
GOBP NEGATIVE REGULATION OF VASCULATURE DEVELOPMENT
|
89
|
1.94e-04
|
-2.29e-01
|
1.76e-03
|
GOMF UNMETHYLATED CPG BINDING
|
10
|
2.10e-01
|
-2.29e-01
|
3.84e-01
|
GOBP GMP BIOSYNTHETIC PROCESS
|
14
|
1.39e-01
|
2.29e-01
|
2.89e-01
|
GOBP EXCRETION
|
23
|
5.78e-02
|
2.29e-01
|
1.60e-01
|
GOBP OUTFLOW TRACT MORPHOGENESIS
|
78
|
4.88e-04
|
-2.29e-01
|
3.76e-03
|
GOBP CHEMOKINE PRODUCTION
|
84
|
2.97e-04
|
-2.29e-01
|
2.52e-03
|
GOBP INORGANIC ION IMPORT ACROSS PLASMA MEMBRANE
|
84
|
2.97e-04
|
2.28e-01
|
2.53e-03
|
GOMF VINCULIN BINDING
|
13
|
1.54e-01
|
-2.28e-01
|
3.10e-01
|
GOBP POSITIVE REGULATION OF MITOTIC CELL CYCLE PHASE TRANSITION
|
84
|
3.01e-04
|
-2.28e-01
|
2.55e-03
|
GOBP RESPONSE TO PEPTIDOGLYCAN
|
12
|
1.71e-01
|
-2.28e-01
|
3.33e-01
|
GOBP REGULATION OF CHOLESTEROL STORAGE
|
17
|
1.03e-01
|
2.28e-01
|
2.40e-01
|
GOMF CELL ADHESION MOLECULE BINDING
|
231
|
2.46e-09
|
-2.28e-01
|
8.17e-08
|
GOBP REGULATION OF HEMATOPOIETIC STEM CELL PROLIFERATION
|
15
|
1.26e-01
|
-2.28e-01
|
2.72e-01
|
GOBP NEGATIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY
|
83
|
3.30e-04
|
-2.28e-01
|
2.74e-03
|
GOBP HYPEROSMOTIC RESPONSE
|
18
|
9.40e-02
|
2.28e-01
|
2.25e-01
|
GOBP GLYCEROPHOSPHOLIPID CATABOLIC PROCESS
|
24
|
5.36e-02
|
2.28e-01
|
1.53e-01
|
GOBP PROSTATE GLAND MORPHOGENESIS
|
24
|
5.36e-02
|
-2.28e-01
|
1.53e-01
|
GOBP OSTEOBLAST DIFFERENTIATION
|
168
|
3.71e-07
|
-2.28e-01
|
7.27e-06
|
GOMF E BOX BINDING
|
34
|
2.18e-02
|
-2.27e-01
|
7.86e-02
|
GOBP NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY
|
16
|
1.16e-01
|
2.27e-01
|
2.57e-01
|
GOBP CLATHRIN COAT ASSEMBLY
|
17
|
1.05e-01
|
-2.27e-01
|
2.42e-01
|
GOBP REGULATION OF MITOTIC CELL CYCLE PHASE TRANSITION
|
292
|
2.68e-11
|
-2.27e-01
|
1.29e-09
|
GOBP EMBRYONIC SKELETAL SYSTEM MORPHOGENESIS
|
69
|
1.11e-03
|
-2.27e-01
|
7.41e-03
|
GOBP PHOSPHATIDYLCHOLINE BIOSYNTHETIC PROCESS
|
19
|
8.67e-02
|
2.27e-01
|
2.13e-01
|
GOBP NEGATIVE REGULATION OF BLOOD CIRCULATION
|
18
|
9.56e-02
|
2.27e-01
|
2.28e-01
|
GOBP T CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE
|
79
|
4.94e-04
|
-2.27e-01
|
3.80e-03
|
GOBP RESPONSE TO GROWTH HORMONE
|
20
|
7.92e-02
|
-2.27e-01
|
2.00e-01
|
GOMF ATPASE COUPLED ION TRANSMEMBRANE TRANSPORTER ACTIVITY
|
17
|
1.06e-01
|
2.27e-01
|
2.43e-01
|
GOCC MITOTIC SPINDLE
|
160
|
7.78e-07
|
-2.27e-01
|
1.40e-05
|
GOMF LONG CHAIN FATTY ACYL COA HYDROLASE ACTIVITY
|
12
|
1.74e-01
|
2.27e-01
|
3.37e-01
|
GOBP STRIATED MUSCLE CONTRACTION
|
146
|
2.39e-06
|
2.26e-01
|
3.87e-05
|
GOBP POSITIVE REGULATION OF SYNAPTIC VESICLE RECYCLING
|
16
|
1.17e-01
|
-2.26e-01
|
2.59e-01
|
GOBP ORGANOPHOSPHATE METABOLIC PROCESS
|
787
|
7.03e-27
|
2.26e-01
|
2.16e-24
|
GOMF TYPE II TRANSFORMING GROWTH FACTOR BETA RECEPTOR BINDING
|
10
|
2.15e-01
|
-2.26e-01
|
3.90e-01
|
GOBP CARDIAC NEURAL CREST CELL DEVELOPMENT INVOLVED IN OUTFLOW TRACT MORPHOGENESIS
|
14
|
1.43e-01
|
-2.26e-01
|
2.95e-01
|
GOBP PLASMA MEMBRANE RAFT ORGANIZATION
|
10
|
2.15e-01
|
-2.26e-01
|
3.91e-01
|
GOBP REGULATION OF PHOSPHOLIPID METABOLIC PROCESS
|
30
|
3.21e-02
|
2.26e-01
|
1.05e-01
|
GOBP CELLULAR EXTRAVASATION
|
60
|
2.46e-03
|
-2.26e-01
|
1.42e-02
|
GOBP REGULATION OF FIBROBLAST APOPTOTIC PROCESS
|
23
|
6.06e-02
|
-2.26e-01
|
1.66e-01
|
GOBP REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION
|
89
|
2.30e-04
|
-2.26e-01
|
2.06e-03
|
GOBP REGULATION OF PROGRAMMED NECROTIC CELL DEATH
|
27
|
4.21e-02
|
-2.26e-01
|
1.27e-01
|
GOBP CD4 POSITIVE ALPHA BETA T CELL ACTIVATION
|
94
|
1.56e-04
|
-2.26e-01
|
1.47e-03
|
GOBP RENAL ABSORPTION
|
24
|
5.57e-02
|
2.26e-01
|
1.57e-01
|
GOBP RIG I SIGNALING PATHWAY
|
21
|
7.35e-02
|
-2.26e-01
|
1.90e-01
|
GOBP RESPONSE TO MITOCHONDRIAL DEPOLARISATION
|
20
|
8.07e-02
|
2.26e-01
|
2.03e-01
|
GOBP CELLULAR RESPONSE TO UV B
|
10
|
2.17e-01
|
2.26e-01
|
3.92e-01
|
GOBP MEIOTIC CELL CYCLE
|
177
|
2.32e-07
|
-2.26e-01
|
4.76e-06
|
GOBP SERTOLI CELL DIFFERENTIATION
|
20
|
8.09e-02
|
-2.25e-01
|
2.03e-01
|
GOBP SODIUM ION EXPORT ACROSS PLASMA MEMBRANE
|
10
|
2.17e-01
|
2.25e-01
|
3.93e-01
|
GOBP B CELL APOPTOTIC PROCESS
|
24
|
5.61e-02
|
-2.25e-01
|
1.58e-01
|
GOBP SPINDLE ORGANIZATION
|
171
|
3.87e-07
|
-2.25e-01
|
7.51e-06
|
GOBP REGULATION OF ACTIN NUCLEATION
|
26
|
4.70e-02
|
-2.25e-01
|
1.38e-01
|
GOMF HEPARAN SULFATE PROTEOGLYCAN BINDING
|
14
|
1.45e-01
|
-2.25e-01
|
2.98e-01
|
GOBP TROPHECTODERMAL CELL DIFFERENTIATION
|
16
|
1.19e-01
|
-2.25e-01
|
2.62e-01
|
GOMF 3 5 EXONUCLEASE ACTIVITY
|
47
|
7.68e-03
|
-2.25e-01
|
3.49e-02
|
GOBP SEQUESTERING OF TRIGLYCERIDE
|
17
|
1.09e-01
|
2.25e-01
|
2.47e-01
|
GOBP ENDOTHELIAL CELL MORPHOGENESIS
|
13
|
1.61e-01
|
-2.25e-01
|
3.20e-01
|
GOBP INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE BY P53 CLASS MEDIATOR
|
40
|
1.39e-02
|
-2.25e-01
|
5.57e-02
|
GOBP ENDODERM DEVELOPMENT
|
55
|
3.97e-03
|
-2.25e-01
|
2.08e-02
|
GOMF RNA POLYMERASE II CTD HEPTAPEPTIDE REPEAT MODIFYING ACTIVITY
|
17
|
1.09e-01
|
-2.25e-01
|
2.47e-01
|
GOMF 3 5 CYCLIC AMP PHOSPHODIESTERASE ACTIVITY
|
18
|
9.92e-02
|
2.25e-01
|
2.34e-01
|
GOBP INTERLEUKIN 6 MEDIATED SIGNALING PATHWAY
|
15
|
1.32e-01
|
-2.24e-01
|
2.80e-01
|
GOBP CONNECTIVE TISSUE REPLACEMENT
|
13
|
1.61e-01
|
-2.24e-01
|
3.21e-01
|
GOBP NEURAL NUCLEUS DEVELOPMENT
|
16
|
1.20e-01
|
-2.24e-01
|
2.64e-01
|
GOBP POSITIVE REGULATION OF BLOOD CIRCULATION
|
34
|
2.37e-02
|
2.24e-01
|
8.34e-02
|
GOBP NEGATIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY
|
45
|
9.28e-03
|
-2.24e-01
|
4.04e-02
|
GOBP SKELETAL MUSCLE FIBER DIFFERENTIATION
|
13
|
1.62e-01
|
2.24e-01
|
3.21e-01
|
GOBP RENAL SYSTEM PROCESS INVOLVED IN REGULATION OF BLOOD VOLUME
|
12
|
1.79e-01
|
-2.24e-01
|
3.43e-01
|
GOCC PRONUCLEUS
|
19
|
9.08e-02
|
-2.24e-01
|
2.20e-01
|
GOBP ODONTOGENESIS
|
85
|
3.59e-04
|
-2.24e-01
|
2.95e-03
|
GOBP POSITIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY
|
99
|
1.20e-04
|
-2.24e-01
|
1.16e-03
|
GOBP PTERIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS
|
14
|
1.48e-01
|
2.24e-01
|
3.01e-01
|
GOBP NEGATIVE REGULATION OF OLIGODENDROCYTE DIFFERENTIATION
|
12
|
1.80e-01
|
-2.23e-01
|
3.45e-01
|
GOCC PROTEIN PHOSPHATASE TYPE 2A COMPLEX
|
15
|
1.34e-01
|
2.23e-01
|
2.82e-01
|
GOBP RESPONSE TO INTERLEUKIN 1
|
64
|
2.02e-03
|
-2.23e-01
|
1.20e-02
|
GOBP DEFENSE RESPONSE TO GRAM NEGATIVE BACTERIUM
|
44
|
1.04e-02
|
-2.23e-01
|
4.45e-02
|
GOMF MISFOLDED PROTEIN BINDING
|
15
|
1.35e-01
|
2.23e-01
|
2.83e-01
|
GOBP SODIUM ION TRANSMEMBRANE TRANSPORT
|
97
|
1.48e-04
|
2.23e-01
|
1.40e-03
|
GOBP REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY
|
47
|
8.16e-03
|
-2.23e-01
|
3.65e-02
|
GOBP REGULATION OF GLIAL CELL PROLIFERATION
|
46
|
8.89e-03
|
-2.23e-01
|
3.91e-02
|
GOMF POTASSIUM CHANNEL ACTIVITY
|
65
|
1.89e-03
|
2.23e-01
|
1.15e-02
|
GOBP NEGATIVE REGULATION OF CELL KILLING
|
19
|
9.26e-02
|
-2.23e-01
|
2.23e-01
|
GOBP REGULATION OF REGULATORY NCRNA PROCESSING
|
13
|
1.64e-01
|
-2.23e-01
|
3.24e-01
|
GOBP REGULATION OF VASCULAR WOUND HEALING
|
10
|
2.22e-01
|
-2.23e-01
|
4.00e-01
|
GOMF LIGAND GATED MONOATOMIC CATION CHANNEL ACTIVITY
|
66
|
1.76e-03
|
2.23e-01
|
1.09e-02
|
GOBP SODIUM ION HOMEOSTASIS
|
29
|
3.80e-02
|
2.23e-01
|
1.19e-01
|
GOBP MEIOTIC CELL CYCLE PROCESS
|
139
|
6.02e-06
|
-2.23e-01
|
8.73e-05
|
GOBP B CELL RECEPTOR SIGNALING PATHWAY
|
43
|
1.16e-02
|
-2.23e-01
|
4.85e-02
|
GOBP REGULATION OF EPITHELIAL CELL DIFFERENTIATION
|
121
|
2.42e-05
|
-2.22e-01
|
2.96e-04
|
GOBP NEUTROPHIL HOMEOSTASIS
|
25
|
5.43e-02
|
-2.22e-01
|
1.54e-01
|
GOBP REGULATION OF MITOTIC CYTOKINESIS
|
14
|
1.50e-01
|
-2.22e-01
|
3.05e-01
|
GOBP INTERLEUKIN 12 PRODUCTION
|
42
|
1.27e-02
|
-2.22e-01
|
5.22e-02
|
GOBP REGULATION OF ALPHA BETA T CELL ACTIVATION
|
85
|
4.04e-04
|
-2.22e-01
|
3.25e-03
|
GOMF PROTEIN FOLDING CHAPERONE
|
50
|
6.63e-03
|
2.22e-01
|
3.12e-02
|
GOBP SYNAPSE MATURATION
|
37
|
1.95e-02
|
-2.22e-01
|
7.24e-02
|
GOBP COLLAGEN METABOLIC PROCESS
|
92
|
2.36e-04
|
-2.22e-01
|
2.10e-03
|
GOMF EFFLUX TRANSMEMBRANE TRANSPORTER ACTIVITY
|
14
|
1.51e-01
|
-2.22e-01
|
3.05e-01
|
GOBP NEGATIVE REGULATION OF EPITHELIAL CELL PROLIFERATION
|
130
|
1.28e-05
|
-2.22e-01
|
1.68e-04
|
GOBP REGULATION OF MODIFICATION OF SYNAPTIC STRUCTURE
|
26
|
5.03e-02
|
-2.22e-01
|
1.46e-01
|
GOMF SULFUR COMPOUND TRANSMEMBRANE TRANSPORTER ACTIVITY
|
44
|
1.10e-02
|
2.22e-01
|
4.64e-02
|
GOBP RESPONSE TO COCAINE
|
28
|
4.23e-02
|
2.22e-01
|
1.28e-01
|
GOMF 1 ACYLGLYCEROL 3 PHOSPHATE O ACYLTRANSFERASE ACTIVITY
|
10
|
2.25e-01
|
2.22e-01
|
4.02e-01
|
GOBP REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY
|
54
|
4.87e-03
|
-2.22e-01
|
2.45e-02
|
GOBP GLYCOLYTIC PROCESS THROUGH FRUCTOSE 6 PHOSPHATE
|
25
|
5.52e-02
|
2.22e-01
|
1.56e-01
|
GOBP SYNAPTIC VESICLE ENDOSOMAL PROCESSING
|
14
|
1.51e-01
|
-2.21e-01
|
3.06e-01
|
GOMF DICARBOXYLIC ACID TRANSMEMBRANE TRANSPORTER ACTIVITY
|
20
|
8.65e-02
|
2.21e-01
|
2.13e-01
|
GOBP INNATE IMMUNE RESPONSE
|
641
|
1.80e-21
|
-2.21e-01
|
2.99e-19
|
GOBP MACROPHAGE CHEMOTAXIS
|
32
|
3.03e-02
|
-2.21e-01
|
1.00e-01
|
GOBP BLOOD VESSEL ENDOTHELIAL CELL MIGRATION
|
115
|
4.32e-05
|
-2.21e-01
|
4.90e-04
|
GOBP POSITIVE REGULATION OF CALCIUM ION IMPORT
|
19
|
9.60e-02
|
-2.21e-01
|
2.28e-01
|
GOBP DETECTION OF VISIBLE LIGHT
|
12
|
1.86e-01
|
2.20e-01
|
3.52e-01
|
GOBP NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR SIGNALING PATHWAY
|
19
|
9.63e-02
|
-2.20e-01
|
2.29e-01
|
GOBP POSITIVE REGULATION OF LAMELLIPODIUM ORGANIZATION
|
32
|
3.12e-02
|
-2.20e-01
|
1.02e-01
|
GOBP RENAL FILTRATION
|
26
|
5.20e-02
|
-2.20e-01
|
1.50e-01
|
GOBP POSITIVE REGULATION OF CYTOKINESIS
|
36
|
2.23e-02
|
-2.20e-01
|
8.01e-02
|
GOBP REGULATION OF PLASMA LIPOPROTEIN PARTICLE LEVELS
|
48
|
8.37e-03
|
2.20e-01
|
3.72e-02
|
GOBP VASCULOGENESIS
|
85
|
4.58e-04
|
-2.20e-01
|
3.58e-03
|
GOBP POSITIVE REGULATION OF T CELL CYTOKINE PRODUCTION
|
16
|
1.28e-01
|
-2.20e-01
|
2.74e-01
|
GOBP EPIDERMIS MORPHOGENESIS
|
27
|
4.80e-02
|
-2.20e-01
|
1.41e-01
|
GOBP REGULATION OF CHOLESTEROL BIOSYNTHETIC PROCESS
|
18
|
1.06e-01
|
2.20e-01
|
2.44e-01
|
GOBP GAP JUNCTION ASSEMBLY
|
13
|
1.70e-01
|
-2.20e-01
|
3.32e-01
|
GOBP REGULATION OF FILOPODIUM ASSEMBLY
|
44
|
1.17e-02
|
-2.20e-01
|
4.87e-02
|
GOBP REGULATION OF VIRAL TRANSCRIPTION
|
23
|
6.83e-02
|
-2.20e-01
|
1.80e-01
|
GOBP NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN CONTAINING 2 SIGNALING PATHWAY
|
16
|
1.28e-01
|
-2.20e-01
|
2.75e-01
|
GOBP CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE
|
207
|
5.40e-08
|
-2.20e-01
|
1.29e-06
|
GOBP GLIAL CELL PROLIFERATION
|
65
|
2.22e-03
|
-2.20e-01
|
1.30e-02
|
GOBP NEGATIVE REGULATION OF CELLULAR SENESCENCE
|
22
|
7.47e-02
|
-2.20e-01
|
1.92e-01
|
GOBP DEOXYRIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS
|
11
|
2.08e-01
|
2.19e-01
|
3.81e-01
|
GOBP TRNA WOBBLE URIDINE MODIFICATION
|
14
|
1.55e-01
|
2.19e-01
|
3.12e-01
|
GOMF ARP2 3 COMPLEX BINDING
|
15
|
1.41e-01
|
-2.19e-01
|
2.93e-01
|
GOBP ANDROGEN METABOLIC PROCESS
|
17
|
1.18e-01
|
2.19e-01
|
2.60e-01
|
GOBP REFLEX
|
19
|
9.81e-02
|
2.19e-01
|
2.32e-01
|
GOBP CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION
|
73
|
1.21e-03
|
-2.19e-01
|
7.94e-03
|
GOBP POSITIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION
|
56
|
4.58e-03
|
-2.19e-01
|
2.33e-02
|
GOMF NUCLEOTIDE RECEPTOR ACTIVITY
|
12
|
1.89e-01
|
2.19e-01
|
3.56e-01
|
GOBP REGULATION OF CYTOKINESIS
|
73
|
1.22e-03
|
-2.19e-01
|
8.00e-03
|
GOBP CORTICAL CYTOSKELETON ORGANIZATION
|
50
|
7.43e-03
|
-2.19e-01
|
3.41e-02
|
GOBP T CELL MIGRATION
|
48
|
8.80e-03
|
-2.19e-01
|
3.87e-02
|
GOBP CELLULAR RESPONSE TO HYDROGEN PEROXIDE
|
54
|
5.47e-03
|
-2.19e-01
|
2.68e-02
|
GOBP I KAPPAB PHOSPHORYLATION
|
16
|
1.30e-01
|
-2.19e-01
|
2.77e-01
|
GOBP NEGATIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION
|
42
|
1.43e-02
|
-2.19e-01
|
5.70e-02
|
GOBP REGULATION OF THE FORCE OF HEART CONTRACTION
|
28
|
4.55e-02
|
2.18e-01
|
1.35e-01
|
GOBP RESPONSE TO TRANSFORMING GROWTH FACTOR BETA
|
219
|
2.70e-08
|
-2.18e-01
|
7.00e-07
|
GOBP CENTRIOLE CENTRIOLE COHESION
|
13
|
1.73e-01
|
-2.18e-01
|
3.36e-01
|
GOMF OXIDOREDUCTASE ACTIVITY ACTING ON PAIRED DONORS WITH OXIDATION OF A PAIR OF DONORS RESULTING IN THE REDUCTION OF MOLECULAR OXYGEN TO TWO MOLECULES OF WATER
|
10
|
2.32e-01
|
2.18e-01
|
4.11e-01
|
GOMF PHOSPHOTYROSINE RESIDUE BINDING
|
40
|
1.70e-02
|
-2.18e-01
|
6.52e-02
|
GOBP FACIAL NERVE MORPHOGENESIS
|
10
|
2.32e-01
|
-2.18e-01
|
4.11e-01
|
GOBP MICROTUBULE CYTOSKELETON ORGANIZATION INVOLVED IN MITOSIS
|
139
|
9.16e-06
|
-2.18e-01
|
1.26e-04
|
GOMF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE BINDING
|
18
|
1.09e-01
|
-2.18e-01
|
2.48e-01
|
GOBP THYROID HORMONE GENERATION
|
12
|
1.91e-01
|
-2.18e-01
|
3.59e-01
|
GOBP SEGMENT SPECIFICATION
|
16
|
1.31e-01
|
-2.18e-01
|
2.79e-01
|
GOMF ACID AMINO ACID LIGASE ACTIVITY
|
16
|
1.32e-01
|
2.18e-01
|
2.79e-01
|
GOBP NEGATIVE REGULATION OF FATTY ACID OXIDATION
|
12
|
1.92e-01
|
2.18e-01
|
3.59e-01
|
GOBP SNARE COMPLEX ASSEMBLY
|
12
|
1.92e-01
|
-2.18e-01
|
3.59e-01
|
GOBP MITOTIC CYTOKINETIC PROCESS
|
29
|
4.27e-02
|
-2.18e-01
|
1.28e-01
|
GOMF ATPASE REGULATOR ACTIVITY
|
44
|
1.26e-02
|
2.18e-01
|
5.16e-02
|
GOMF 5 3 EXONUCLEASE ACTIVITY
|
16
|
1.32e-01
|
-2.18e-01
|
2.79e-01
|
GOBP NUCLEOBASE BIOSYNTHETIC PROCESS
|
14
|
1.59e-01
|
2.17e-01
|
3.17e-01
|
GOBP INTERLEUKIN 1 PRODUCTION
|
88
|
4.27e-04
|
-2.17e-01
|
3.40e-03
|
GOMF RNA POLYMERASE II CORE PROMOTER SEQUENCE SPECIFIC DNA BINDING
|
20
|
9.27e-02
|
-2.17e-01
|
2.23e-01
|
GOBP GLOMERULAR MESANGIAL CELL PROLIFERATION
|
11
|
2.12e-01
|
-2.17e-01
|
3.87e-01
|
GOCC PRC1 COMPLEX
|
16
|
1.33e-01
|
-2.17e-01
|
2.81e-01
|
GOBP LYMPHOCYTE MEDIATED IMMUNITY
|
199
|
1.41e-07
|
-2.17e-01
|
3.10e-06
|
GOBP LAMELLIPODIUM ORGANIZATION
|
85
|
5.60e-04
|
-2.17e-01
|
4.20e-03
|
GOBP LIPID DIGESTION
|
11
|
2.14e-01
|
2.16e-01
|
3.89e-01
|
GOBP REGULATION OF CHEMOTAXIS
|
159
|
2.59e-06
|
-2.16e-01
|
4.16e-05
|
GOMF CHEMOKINE ACTIVITY
|
20
|
9.41e-02
|
2.16e-01
|
2.25e-01
|
GOBP LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL
|
43
|
1.42e-02
|
-2.16e-01
|
5.65e-02
|
GOBP GLUTAMINE FAMILY AMINO ACID CATABOLIC PROCESS
|
18
|
1.12e-01
|
2.16e-01
|
2.52e-01
|
GOBP REGULATION OF TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY
|
26
|
5.64e-02
|
-2.16e-01
|
1.58e-01
|
GOBP REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND
|
38
|
2.11e-02
|
-2.16e-01
|
7.69e-02
|
GOBP CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS
|
50
|
8.19e-03
|
-2.16e-01
|
3.66e-02
|
GOCC PSEUDOPODIUM
|
10
|
2.36e-01
|
-2.16e-01
|
4.15e-01
|
GOBP HYDROGEN PEROXIDE METABOLIC PROCESS
|
37
|
2.29e-02
|
2.16e-01
|
8.15e-02
|
GOBP CELL DIVISION
|
509
|
9.35e-17
|
-2.16e-01
|
9.75e-15
|
GOBP ENDOTHELIAL CELL MIGRATION
|
200
|
1.48e-07
|
-2.16e-01
|
3.21e-06
|
GOBP LEUKOCYTE DEGRANULATION
|
55
|
5.64e-03
|
-2.16e-01
|
2.74e-02
|
GOBP MITOTIC CELL CYCLE PHASE TRANSITION
|
375
|
8.45e-13
|
-2.16e-01
|
4.79e-11
|
GOBP BONE RESORPTION
|
59
|
4.17e-03
|
-2.16e-01
|
2.17e-02
|
GOMF VITAMIN TRANSMEMBRANE TRANSPORTER ACTIVITY
|
25
|
6.20e-02
|
2.16e-01
|
1.68e-01
|
GOBP ENDOPLASMIC RETICULUM ORGANIZATION
|
81
|
8.00e-04
|
2.16e-01
|
5.67e-03
|
GOBP NEGATIVE REGULATION OF MUSCLE HYPERTROPHY
|
33
|
3.24e-02
|
-2.15e-01
|
1.05e-01
|
GOBP POSITIVE REGULATION OF PROTEIN ACETYLATION
|
14
|
1.63e-01
|
-2.15e-01
|
3.23e-01
|
GOBP POTASSIUM ION EXPORT ACROSS PLASMA MEMBRANE
|
15
|
1.49e-01
|
-2.15e-01
|
3.03e-01
|
GOBP EMBRYONIC AXIS SPECIFICATION
|
29
|
4.50e-02
|
-2.15e-01
|
1.34e-01
|
GOBP REGULATION OF STEROL TRANSPORT
|
45
|
1.26e-02
|
2.15e-01
|
5.16e-02
|
GOBP POSITIVE REGULATION OF MEMBRANE POTENTIAL
|
19
|
1.05e-01
|
2.15e-01
|
2.42e-01
|
GOBP PEPTIDE BIOSYNTHETIC PROCESS
|
19
|
1.05e-01
|
2.15e-01
|
2.42e-01
|
GOBP PHASIC SMOOTH MUSCLE CONTRACTION
|
18
|
1.15e-01
|
2.15e-01
|
2.56e-01
|
GOBP REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS
|
37
|
2.39e-02
|
-2.15e-01
|
8.40e-02
|
GOBP POSITIVE REGULATION OF KERATINOCYTE PROLIFERATION
|
10
|
2.40e-01
|
2.15e-01
|
4.19e-01
|
GOBP THYROID HORMONE METABOLIC PROCESS
|
17
|
1.26e-01
|
-2.15e-01
|
2.72e-01
|
GOBP SYMPATHETIC NERVOUS SYSTEM DEVELOPMENT
|
15
|
1.50e-01
|
-2.15e-01
|
3.05e-01
|
GOBP NUCLEAR MEMBRANE REASSEMBLY
|
20
|
9.68e-02
|
-2.15e-01
|
2.29e-01
|
GOBP CELL CYCLE PHASE
|
15
|
1.50e-01
|
-2.14e-01
|
3.05e-01
|
GOBP NOSE DEVELOPMENT
|
11
|
2.18e-01
|
-2.14e-01
|
3.94e-01
|
GOBP PROTEIN TRANSMEMBRANE TRANSPORT
|
60
|
4.10e-03
|
2.14e-01
|
2.14e-02
|
GOBP POSITIVE REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS
|
10
|
2.41e-01
|
2.14e-01
|
4.20e-01
|
GOCC EXTRINSIC COMPONENT OF PRESYNAPTIC MEMBRANE
|
12
|
1.99e-01
|
-2.14e-01
|
3.69e-01
|
GOMF RNA POLYMERASE ACTIVITY
|
22
|
8.20e-02
|
2.14e-01
|
2.05e-01
|
GOBP BIOLOGICAL PROCESS INVOLVED IN INTERACTION WITH HOST
|
104
|
1.62e-04
|
-2.14e-01
|
1.51e-03
|
GOMF PHOSPHATIDYLSERINE BINDING
|
45
|
1.29e-02
|
-2.14e-01
|
5.27e-02
|
GOBP POSITIVE REGULATION OF MITOTIC SISTER CHROMATID SEPARATION
|
17
|
1.26e-01
|
-2.14e-01
|
2.73e-01
|
GOBP ADAPTIVE IMMUNE RESPONSE
|
299
|
2.10e-10
|
-2.14e-01
|
8.82e-09
|
GOBP REGULATION OF POSTSYNAPTIC DENSITY ORGANIZATION
|
18
|
1.16e-01
|
-2.14e-01
|
2.57e-01
|
GOBP ADAPTIVE IMMUNE RESPONSE BASED ON SOMATIC RECOMBINATION OF IMMUNE RECEPTORS BUILT FROM IMMUNOGLOBULIN SUPERFAMILY DOMAINS
|
232
|
2.13e-08
|
-2.14e-01
|
5.59e-07
|
GOBP POSITIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION
|
108
|
1.25e-04
|
-2.14e-01
|
1.21e-03
|
GOBP NEUTRAL LIPID METABOLIC PROCESS
|
110
|
1.09e-04
|
2.14e-01
|
1.08e-03
|
GOBP POSITIVE REGULATION OF FIBROBLAST MIGRATION
|
21
|
9.00e-02
|
-2.14e-01
|
2.19e-01
|
GOBP REGULATION OF T HELPER 17 TYPE IMMUNE RESPONSE
|
25
|
6.45e-02
|
-2.14e-01
|
1.73e-01
|
GOBP POSITIVE REGULATION OF IMMUNE EFFECTOR PROCESS
|
186
|
5.23e-07
|
-2.14e-01
|
9.81e-06
|
GOBP RESPONSE TO CYTOKINE
|
697
|
1.23e-21
|
-2.14e-01
|
2.09e-19
|
GOMF CLATHRIN BINDING
|
41
|
1.80e-02
|
-2.14e-01
|
6.77e-02
|
GOBP PROTEIN KINASE A SIGNALING
|
28
|
5.06e-02
|
-2.14e-01
|
1.47e-01
|
GOBP REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY
|
18
|
1.17e-01
|
-2.13e-01
|
2.59e-01
|
GOBP CELL ADHESION MEDIATED BY INTEGRIN
|
72
|
1.75e-03
|
-2.13e-01
|
1.08e-02
|
GOBP PROTEIN IMPORT INTO PEROXISOME MATRIX
|
14
|
1.67e-01
|
2.13e-01
|
3.28e-01
|
GOBP STEM CELL PROLIFERATION
|
105
|
1.60e-04
|
-2.13e-01
|
1.50e-03
|
GOBP NEGATIVE REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS
|
38
|
2.30e-02
|
2.13e-01
|
8.16e-02
|
GOBP CIRCADIAN SLEEP WAKE CYCLE PROCESS
|
18
|
1.18e-01
|
2.13e-01
|
2.60e-01
|
GOBP REGULATION OF STEM CELL POPULATION MAINTENANCE
|
65
|
2.99e-03
|
-2.13e-01
|
1.65e-02
|
GOBP INTEGRIN ACTIVATION
|
23
|
7.70e-02
|
-2.13e-01
|
1.97e-01
|
GOCC NUCLEAR INCLUSION BODY
|
13
|
1.84e-01
|
-2.13e-01
|
3.49e-01
|
GOBP PEPTIDYL TYROSINE DEPHOSPHORYLATION
|
29
|
4.72e-02
|
-2.13e-01
|
1.39e-01
|
GOMF MONOATOMIC ION GATED CHANNEL ACTIVITY
|
17
|
1.29e-01
|
2.13e-01
|
2.75e-01
|
GOBP POSITIVE REGULATION OF MACROPHAGE MIGRATION
|
23
|
7.78e-02
|
-2.13e-01
|
1.98e-01
|
GOMF INSULIN LIKE GROWTH FACTOR BINDING
|
15
|
1.54e-01
|
-2.12e-01
|
3.10e-01
|
GOBP ENDOTHELIAL CELL DEVELOPMENT
|
62
|
3.85e-03
|
-2.12e-01
|
2.04e-02
|
GOCC GAP JUNCTION
|
15
|
1.55e-01
|
-2.12e-01
|
3.11e-01
|
GOCC RNA POLYMERASE I COMPLEX
|
10
|
2.45e-01
|
2.12e-01
|
4.26e-01
|
GOMF FATTY ACID TRANSMEMBRANE TRANSPORTER ACTIVITY
|
16
|
1.42e-01
|
2.12e-01
|
2.94e-01
|
GOBP CONSTITUTIVE HETEROCHROMATIN FORMATION
|
11
|
2.23e-01
|
-2.12e-01
|
4.00e-01
|
GOBP NEGATIVE REGULATION OF T CELL MEDIATED IMMUNITY
|
14
|
1.69e-01
|
-2.12e-01
|
3.31e-01
|
GOBP REGULATION OF SKELETAL MUSCLE CONTRACTION
|
13
|
1.86e-01
|
2.12e-01
|
3.52e-01
|
GOBP REGULATION OF T CELL MIGRATION
|
36
|
2.79e-02
|
-2.12e-01
|
9.43e-02
|
GOMF LONG CHAIN FATTY ACID BINDING
|
14
|
1.71e-01
|
2.11e-01
|
3.33e-01
|
GOBP TRANSLATIONAL ELONGATION
|
61
|
4.34e-03
|
2.11e-01
|
2.23e-02
|
GOBP OSTEOBLAST PROLIFERATION
|
30
|
4.53e-02
|
-2.11e-01
|
1.34e-01
|
GOBP REGULATION OF COLLAGEN METABOLIC PROCESS
|
47
|
1.23e-02
|
-2.11e-01
|
5.08e-02
|
GOBP INFLAMMATORY RESPONSE TO WOUNDING
|
25
|
6.77e-02
|
-2.11e-01
|
1.79e-01
|
GOBP THYMIC T CELL SELECTION
|
18
|
1.21e-01
|
-2.11e-01
|
2.65e-01
|
GOBP NEGATIVE REGULATION OF CANONICAL NF KAPPAB SIGNAL TRANSDUCTION
|
52
|
8.56e-03
|
-2.11e-01
|
3.79e-02
|
GOBP HOMOTYPIC CELL CELL ADHESION
|
71
|
2.14e-03
|
-2.11e-01
|
1.27e-02
|
GOBP MAGNESIUM ION HOMEOSTASIS
|
13
|
1.88e-01
|
-2.11e-01
|
3.55e-01
|
GOBP PROTEIN LOCALIZATION TO MICROTUBULE ORGANIZING CENTER
|
38
|
2.46e-02
|
-2.11e-01
|
8.59e-02
|
GOBP RNA 5 END PROCESSING
|
25
|
6.84e-02
|
2.11e-01
|
1.80e-01
|
GOBP B CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE
|
64
|
3.62e-03
|
-2.10e-01
|
1.93e-02
|
GOBP POSITIVE REGULATION OF MYELOID CELL DIFFERENTIATION
|
84
|
8.68e-04
|
-2.10e-01
|
6.06e-03
|
GOBP VIRAL PROCESS
|
258
|
6.46e-09
|
-2.10e-01
|
1.92e-07
|
GOBP FEMALE GENITALIA DEVELOPMENT
|
13
|
1.89e-01
|
2.10e-01
|
3.56e-01
|
GOBP SULFUR COMPOUND TRANSPORT
|
40
|
2.14e-02
|
2.10e-01
|
7.78e-02
|
GOBP POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION
|
32
|
3.97e-02
|
-2.10e-01
|
1.23e-01
|
GOBP BIOLOGICAL PHASE
|
28
|
5.46e-02
|
-2.10e-01
|
1.55e-01
|
GOBP MITOTIC SPINDLE ORGANIZATION
|
112
|
1.28e-04
|
-2.10e-01
|
1.22e-03
|
GOBP SEMINIFEROUS TUBULE DEVELOPMENT
|
16
|
1.47e-01
|
-2.10e-01
|
3.00e-01
|
GOBP POSITIVE REGULATION OF NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY
|
12
|
2.09e-01
|
-2.10e-01
|
3.82e-01
|
GOCC RECYCLING ENDOSOME MEMBRANE
|
52
|
8.98e-03
|
2.10e-01
|
3.94e-02
|
GOBP MONOSACCHARIDE BIOSYNTHETIC PROCESS
|
79
|
1.30e-03
|
2.09e-01
|
8.41e-03
|
GOBP PROTEIN TARGETING TO LYSOSOME
|
27
|
5.96e-02
|
-2.09e-01
|
1.64e-01
|
GOMF GAMMA TUBULIN BINDING
|
31
|
4.36e-02
|
-2.09e-01
|
1.30e-01
|
GOBP NEGATIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS
|
90
|
6.04e-04
|
-2.09e-01
|
4.47e-03
|
GOBP SYNAPTIC ASSEMBLY AT NEUROMUSCULAR JUNCTION
|
10
|
2.52e-01
|
-2.09e-01
|
4.33e-01
|
GOBP NEGATIVE REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY
|
23
|
8.25e-02
|
-2.09e-01
|
2.06e-01
|
GOBP SIGNAL TRANSDUCTION IN RESPONSE TO DNA DAMAGE
|
159
|
5.47e-06
|
-2.09e-01
|
8.05e-05
|
GOBP REGULATION OF THYMOCYTE APOPTOTIC PROCESS
|
16
|
1.48e-01
|
-2.09e-01
|
3.01e-01
|
GOBP CHONDROITIN SULFATE PROTEOGLYCAN METABOLIC PROCESS
|
27
|
6.00e-02
|
-2.09e-01
|
1.65e-01
|
GOBP POSITIVE T CELL SELECTION
|
29
|
5.14e-02
|
-2.09e-01
|
1.48e-01
|
GOBP NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY
|
81
|
1.18e-03
|
-2.09e-01
|
7.81e-03
|
GOBP REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY
|
22
|
9.10e-02
|
-2.08e-01
|
2.20e-01
|
GOBP PROTEIN LOCALIZATION TO CILIUM
|
55
|
7.60e-03
|
-2.08e-01
|
3.46e-02
|
GOBP LONG TERM MEMORY
|
37
|
2.85e-02
|
2.08e-01
|
9.56e-02
|
GOBP PEPTIDE HORMONE PROCESSING
|
17
|
1.38e-01
|
-2.08e-01
|
2.87e-01
|
GOCC T TUBULE
|
64
|
4.02e-03
|
2.08e-01
|
2.10e-02
|
GOBP GANGLION DEVELOPMENT
|
12
|
2.12e-01
|
-2.08e-01
|
3.87e-01
|
GOBP SYNAPTIC VESICLE LUMEN ACIDIFICATION
|
18
|
1.27e-01
|
2.08e-01
|
2.73e-01
|
GOBP NEGATIVE REGULATION OF CELL CYCLE
|
321
|
1.72e-10
|
-2.08e-01
|
7.42e-09
|
GOBP REGULATION OF OLIGODENDROCYTE DIFFERENTIATION
|
39
|
2.48e-02
|
-2.08e-01
|
8.64e-02
|
GOCC ENDOPLASMIC RETICULUM QUALITY CONTROL COMPARTMENT
|
11
|
2.33e-01
|
2.08e-01
|
4.12e-01
|
GOBP POSITIVE REGULATION OF MESENCHYMAL CELL PROLIFERATION
|
30
|
4.91e-02
|
-2.08e-01
|
1.43e-01
|
GOBP NEGATIVE REGULATION OF CELL GROWTH INVOLVED IN CARDIAC MUSCLE CELL DEVELOPMENT
|
14
|
1.79e-01
|
-2.08e-01
|
3.43e-01
|
GOBP CYTOKINE MEDIATED SIGNALING PATHWAY
|
326
|
1.31e-10
|
-2.08e-01
|
5.80e-09
|
GOBP AMINE METABOLIC PROCESS
|
83
|
1.09e-03
|
2.08e-01
|
7.29e-03
|
GOBP REGULATION OF LEUKOCYTE MIGRATION
|
180
|
1.63e-06
|
-2.08e-01
|
2.76e-05
|
GOBP CELLULAR RESPONSE TO CHOLESTEROL
|
15
|
1.64e-01
|
2.07e-01
|
3.24e-01
|
GOBP COPII COATED VESICLE BUDDING
|
36
|
3.13e-02
|
2.07e-01
|
1.03e-01
|
GOMF LIGAND ACTIVATED TRANSCRIPTION FACTOR ACTIVITY
|
44
|
1.73e-02
|
2.07e-01
|
6.60e-02
|
GOBP POTASSIUM ION TRANSMEMBRANE TRANSPORT
|
133
|
3.71e-05
|
2.07e-01
|
4.30e-04
|
GOBP C21 STEROID HORMONE METABOLIC PROCESS
|
23
|
8.53e-02
|
2.07e-01
|
2.11e-01
|
GOBP ALPHA BETA T CELL DIFFERENTIATION
|
101
|
3.24e-04
|
-2.07e-01
|
2.70e-03
|
GOBP REGULATION OF MONONUCLEAR CELL MIGRATION
|
104
|
2.67e-04
|
-2.07e-01
|
2.32e-03
|
GOMF GABA RECEPTOR BINDING
|
12
|
2.14e-01
|
2.07e-01
|
3.89e-01
|
GOBP ISOTYPE SWITCHING TO IGG ISOTYPES
|
12
|
2.14e-01
|
-2.07e-01
|
3.90e-01
|
GOBP REGULATION OF ANIMAL ORGAN MORPHOGENESIS
|
73
|
2.24e-03
|
-2.07e-01
|
1.31e-02
|
GOBP POSITIVE REGULATION OF CELL CYCLE PROCESS
|
215
|
1.78e-07
|
-2.07e-01
|
3.76e-06
|
GOBP PROTEIN DNA COMPLEX DISASSEMBLY
|
19
|
1.18e-01
|
-2.07e-01
|
2.61e-01
|
GOMF MAP KINASE SCAFFOLD ACTIVITY
|
11
|
2.35e-01
|
-2.07e-01
|
4.14e-01
|
GOBP POSITIVE REGULATION OF CELL CYCLE PHASE TRANSITION
|
99
|
3.86e-04
|
-2.07e-01
|
3.14e-03
|
GOMF SODIUM CHANNEL ACTIVITY
|
23
|
8.66e-02
|
2.06e-01
|
2.13e-01
|
GOCC SPINDLE POLE
|
131
|
4.61e-05
|
-2.06e-01
|
5.20e-04
|
GOBP PHOSPHATIDIC ACID BIOSYNTHETIC PROCESS
|
20
|
1.10e-01
|
2.06e-01
|
2.50e-01
|
GOBP NEGATIVE REGULATION OF CARDIAC MUSCLE TISSUE GROWTH
|
28
|
5.92e-02
|
-2.06e-01
|
1.64e-01
|
GOMF ACYLGLYCEROL LIPASE ACTIVITY
|
12
|
2.17e-01
|
2.06e-01
|
3.92e-01
|
GOBP REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE
|
97
|
4.61e-04
|
-2.06e-01
|
3.60e-03
|
GOBP POSITIVE REGULATION OF ORGANELLE ASSEMBLY
|
83
|
1.19e-03
|
-2.06e-01
|
7.87e-03
|
GOBP BIOGENIC AMINE METABOLIC PROCESS
|
71
|
2.72e-03
|
2.06e-01
|
1.54e-02
|
GOMF HELICASE ACTIVITY
|
135
|
3.73e-05
|
-2.06e-01
|
4.30e-04
|
GOBP EMBRYONIC PATTERN SPECIFICATION
|
54
|
8.94e-03
|
-2.06e-01
|
3.92e-02
|
GOBP T CELL DIFFERENTIATION IN THYMUS
|
75
|
2.08e-03
|
-2.06e-01
|
1.24e-02
|
GOBP REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL
|
16
|
1.54e-01
|
-2.06e-01
|
3.11e-01
|
GOBP POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY
|
12
|
2.18e-01
|
-2.06e-01
|
3.94e-01
|
GOCC CONDENSED CHROMOSOME CENTROMERIC REGION
|
149
|
1.53e-05
|
-2.05e-01
|
1.96e-04
|
GOBP NEGATIVE REGULATION OF EPITHELIAL CELL MIGRATION
|
61
|
5.55e-03
|
-2.05e-01
|
2.71e-02
|
GOCC CHROMOSOMAL REGION
|
290
|
1.94e-09
|
-2.05e-01
|
6.66e-08
|
GOMF ARACHIDONATE COA LIGASE ACTIVITY
|
10
|
2.61e-01
|
2.05e-01
|
4.43e-01
|
GOBP GLIAL CELL MIGRATION
|
64
|
4.57e-03
|
-2.05e-01
|
2.33e-02
|
GOMF BHLH TRANSCRIPTION FACTOR BINDING
|
29
|
5.61e-02
|
-2.05e-01
|
1.58e-01
|
GOBP FORMATION OF PRIMARY GERM LAYER
|
77
|
1.89e-03
|
-2.05e-01
|
1.15e-02
|
GOBP REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST
|
29
|
5.63e-02
|
-2.05e-01
|
1.58e-01
|
GOBP RECOMBINATIONAL REPAIR
|
152
|
1.35e-05
|
-2.05e-01
|
1.75e-04
|
GOBP SPERM EGG RECOGNITION
|
26
|
7.08e-02
|
2.05e-01
|
1.85e-01
|
GOMF CYCLASE REGULATOR ACTIVITY
|
11
|
2.40e-01
|
2.05e-01
|
4.19e-01
|
GOBP SPINAL CORD MOTOR NEURON DIFFERENTIATION
|
19
|
1.23e-01
|
-2.05e-01
|
2.67e-01
|
GOMF ACTIVE TRANSMEMBRANE TRANSPORTER ACTIVITY
|
303
|
1.01e-09
|
2.04e-01
|
3.58e-08
|
GOBP REGULATION OF PEPTIDYL LYSINE ACETYLATION
|
11
|
2.40e-01
|
-2.04e-01
|
4.20e-01
|
GOBP CEREBELLAR GRANULAR LAYER DEVELOPMENT
|
11
|
2.40e-01
|
-2.04e-01
|
4.20e-01
|
GOBP FEMALE GAMETE GENERATION
|
101
|
3.91e-04
|
-2.04e-01
|
3.17e-03
|
GOBP REGULATION OF CHROMOSOME ORGANIZATION
|
214
|
2.70e-07
|
-2.04e-01
|
5.45e-06
|
GOBP HEMOGLOBIN METABOLIC PROCESS
|
20
|
1.14e-01
|
2.04e-01
|
2.54e-01
|
GOBP FRUCTOSE 6 PHOSPHATE METABOLIC PROCESS
|
16
|
1.57e-01
|
2.04e-01
|
3.15e-01
|
GOBP NEGATIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION
|
14
|
1.86e-01
|
-2.04e-01
|
3.52e-01
|
GOBP TRANSPORT OF VIRUS
|
12
|
2.21e-01
|
-2.04e-01
|
3.97e-01
|
GOBP NUCLEOSIDE DIPHOSPHATE BIOSYNTHETIC PROCESS
|
11
|
2.41e-01
|
2.04e-01
|
4.21e-01
|
GOBP LIPID DROPLET ORGANIZATION
|
31
|
4.96e-02
|
2.04e-01
|
1.45e-01
|
GOBP LYMPHOCYTE MIGRATION
|
68
|
3.69e-03
|
-2.04e-01
|
1.97e-02
|
GOBP DNA REPLICATION
|
241
|
5.43e-08
|
-2.04e-01
|
1.30e-06
|
GOBP TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY
|
78
|
1.88e-03
|
-2.04e-01
|
1.15e-02
|
GOBP NEGATIVE REGULATION OF ACTIVIN RECEPTOR SIGNALING PATHWAY
|
14
|
1.87e-01
|
-2.04e-01
|
3.54e-01
|
GOBP POSITIVE REGULATION OF MYOBLAST PROLIFERATION
|
15
|
1.72e-01
|
-2.03e-01
|
3.36e-01
|
GOCC ACROSOMAL MEMBRANE
|
14
|
1.88e-01
|
-2.03e-01
|
3.55e-01
|
GOBP TOOTH MINERALIZATION
|
21
|
1.07e-01
|
-2.03e-01
|
2.45e-01
|
GOBP TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY
|
56
|
8.56e-03
|
-2.03e-01
|
3.79e-02
|
GOCC CYTOSOLIC SMALL RIBOSOMAL SUBUNIT
|
42
|
2.28e-02
|
2.03e-01
|
8.12e-02
|
GOMF MRNA REGULATORY ELEMENT BINDING TRANSLATION REPRESSOR ACTIVITY
|
12
|
2.23e-01
|
-2.03e-01
|
4.01e-01
|
GOBP REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION
|
85
|
1.23e-03
|
-2.03e-01
|
8.03e-03
|
GOBP CORONARY ARTERY MORPHOGENESIS
|
10
|
2.67e-01
|
-2.03e-01
|
4.48e-01
|
GOBP CANONICAL NF KAPPAB SIGNAL TRANSDUCTION
|
218
|
2.56e-07
|
-2.03e-01
|
5.21e-06
|
GOBP POSITIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE
|
100
|
4.62e-04
|
-2.03e-01
|
3.60e-03
|
GOMF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY
|
89
|
9.51e-04
|
2.03e-01
|
6.50e-03
|
GOMF NEUROTROPHIN RECEPTOR BINDING
|
13
|
2.06e-01
|
-2.03e-01
|
3.78e-01
|
GOBP CHROMOSOME ORGANIZATION
|
455
|
1.52e-13
|
-2.03e-01
|
9.73e-12
|
GOBP REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY
|
23
|
9.24e-02
|
-2.03e-01
|
2.23e-01
|
GOBP HISTAMINE TRANSPORT
|
12
|
2.24e-01
|
-2.03e-01
|
4.01e-01
|
GOBP RRNA MODIFICATION
|
26
|
7.43e-02
|
2.02e-01
|
1.91e-01
|
GOBP REGULATION OF T HELPER 2 CELL DIFFERENTIATION
|
10
|
2.68e-01
|
-2.02e-01
|
4.50e-01
|
GOBP NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS
|
25
|
8.03e-02
|
-2.02e-01
|
2.02e-01
|
GOBP REGULATION OF PROTEIN COMPLEX STABILITY
|
12
|
2.25e-01
|
-2.02e-01
|
4.03e-01
|
GOBP LYMPHOCYTE APOPTOTIC PROCESS
|
75
|
2.49e-03
|
-2.02e-01
|
1.43e-02
|
GOBP POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY
|
54
|
1.02e-02
|
-2.02e-01
|
4.38e-02
|
GOBP IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE
|
13
|
2.07e-01
|
2.02e-01
|
3.80e-01
|
GOCC PLASMA MEMBRANE SIGNALING RECEPTOR COMPLEX
|
117
|
1.63e-04
|
-2.02e-01
|
1.52e-03
|
GOMF G PROTEIN BETA SUBUNIT BINDING
|
15
|
1.76e-01
|
-2.02e-01
|
3.39e-01
|
GOCC NEURONAL RIBONUCLEOPROTEIN GRANULE
|
10
|
2.69e-01
|
2.02e-01
|
4.51e-01
|
GOBP ARGININE METABOLIC PROCESS
|
13
|
2.08e-01
|
2.02e-01
|
3.81e-01
|
GOBP MEIOSIS I CELL CYCLE PROCESS
|
77
|
2.22e-03
|
-2.02e-01
|
1.31e-02
|
GOBP ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS
|
15
|
1.76e-01
|
-2.02e-01
|
3.40e-01
|
GOBP HEAD MORPHOGENESIS
|
38
|
3.15e-02
|
-2.02e-01
|
1.03e-01
|
GOBP CARDIAC NEURAL CREST CELL MIGRATION INVOLVED IN OUTFLOW TRACT MORPHOGENESIS
|
11
|
2.47e-01
|
-2.02e-01
|
4.28e-01
|
GOBP POSITIVE REGULATION OF GLIAL CELL DIFFERENTIATION
|
42
|
2.38e-02
|
-2.02e-01
|
8.37e-02
|
GOBP REGULATION OF SARCOMERE ORGANIZATION
|
11
|
2.47e-01
|
-2.02e-01
|
4.28e-01
|
GOBP CIRCADIAN SLEEP WAKE CYCLE
|
22
|
1.02e-01
|
2.01e-01
|
2.38e-01
|
GOCC DENDRITE CYTOPLASM
|
29
|
6.07e-02
|
-2.01e-01
|
1.66e-01
|
GOBP ALDEHYDE BIOSYNTHETIC PROCESS
|
25
|
8.18e-02
|
2.01e-01
|
2.05e-01
|
GOBP POSITIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION
|
93
|
8.09e-04
|
-2.01e-01
|
5.70e-03
|
GOBP VESICLE COATING
|
31
|
5.29e-02
|
2.01e-01
|
1.51e-01
|
GOBP MONONUCLEAR CELL MIGRATION
|
148
|
2.51e-05
|
-2.01e-01
|
3.06e-04
|
GOBP POSITIVE REGULATION OF SPROUTING ANGIOGENESIS
|
15
|
1.78e-01
|
-2.01e-01
|
3.43e-01
|
GOBP REGULATION OF EXECUTION PHASE OF APOPTOSIS
|
25
|
8.24e-02
|
-2.01e-01
|
2.06e-01
|
GOBP HYALURONAN CATABOLIC PROCESS
|
12
|
2.29e-01
|
-2.01e-01
|
4.07e-01
|
GOBP RESPONSE TO INTERLEUKIN 6
|
24
|
8.89e-02
|
-2.01e-01
|
2.17e-01
|
GOBP ESTABLISHMENT OR MAINTENANCE OF MONOPOLAR CELL POLARITY
|
19
|
1.30e-01
|
-2.01e-01
|
2.77e-01
|
GOMF CARBON NITROGEN LYASE ACTIVITY
|
10
|
2.72e-01
|
2.01e-01
|
4.54e-01
|
GOBP REGULATION OF LIPID CATABOLIC PROCESS
|
44
|
2.14e-02
|
2.01e-01
|
7.78e-02
|
GOBP T CELL APOPTOTIC PROCESS
|
55
|
1.02e-02
|
-2.00e-01
|
4.35e-02
|
GOBP MICROGLIA DIFFERENTIATION
|
15
|
1.79e-01
|
-2.00e-01
|
3.43e-01
|
GOBP MAGNESIUM ION TRANSPORT
|
15
|
1.79e-01
|
2.00e-01
|
3.43e-01
|
GOMF TRANSCRIPTION COREPRESSOR ACTIVITY
|
168
|
7.67e-06
|
-2.00e-01
|
1.08e-04
|
GOBP POSITIVE REGULATION OF MITOTIC CELL CYCLE
|
115
|
2.10e-04
|
-2.00e-01
|
1.89e-03
|
GOBP MITOTIC RECOMBINATION
|
22
|
1.04e-01
|
-2.00e-01
|
2.41e-01
|
GOBP COLLAGEN BIOSYNTHETIC PROCESS
|
49
|
1.54e-02
|
-2.00e-01
|
6.06e-02
|
GOCC SMN SM PROTEIN COMPLEX
|
16
|
1.66e-01
|
2.00e-01
|
3.26e-01
|
GOBP REGULATION PROTEIN CATABOLIC PROCESS AT SYNAPSE
|
11
|
2.51e-01
|
2.00e-01
|
4.32e-01
|
GOBP REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY
|
58
|
8.48e-03
|
-2.00e-01
|
3.75e-02
|
GOBP LENS FIBER CELL DIFFERENTIATION
|
28
|
6.72e-02
|
-2.00e-01
|
1.78e-01
|
GOBP POSITIVE REGULATION OF PROTEIN POLYUBIQUITINATION
|
15
|
1.80e-01
|
-2.00e-01
|
3.45e-01
|
GOBP CELL FATE COMMITMENT
|
179
|
4.17e-06
|
-2.00e-01
|
6.29e-05
|
GOBP OLEFINIC COMPOUND METABOLIC PROCESS
|
72
|
3.41e-03
|
2.00e-01
|
1.84e-02
|
GOBP ANTERIOR POSTERIOR PATTERN SPECIFICATION
|
143
|
3.84e-05
|
-2.00e-01
|
4.41e-04
|
GOBP NEGATIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION
|
34
|
4.40e-02
|
-2.00e-01
|
1.31e-01
|
GOBP SNRNA PROCESSING
|
21
|
1.13e-01
|
2.00e-01
|
2.54e-01
|
GOBP NEGATIVE REGULATION OF MIRNA METABOLIC PROCESS
|
29
|
6.30e-02
|
-2.00e-01
|
1.70e-01
|
GOCC CATALYTIC STEP 1 SPLICEOSOME
|
11
|
2.52e-01
|
-1.99e-01
|
4.33e-01
|
GOBP PITUITARY GLAND DEVELOPMENT
|
15
|
1.81e-01
|
-1.99e-01
|
3.46e-01
|
GOBP ARF PROTEIN SIGNAL TRANSDUCTION
|
20
|
1.23e-01
|
1.99e-01
|
2.67e-01
|
GOCC CYTOSOLIC RIBOSOME
|
112
|
2.71e-04
|
1.99e-01
|
2.35e-03
|
GOBP LYMPHOID PROGENITOR CELL DIFFERENTIATION
|
19
|
1.33e-01
|
-1.99e-01
|
2.80e-01
|
GOBP REGULATION OF ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY
|
22
|
1.06e-01
|
-1.99e-01
|
2.43e-01
|
GOBP PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY
|
61
|
7.17e-03
|
-1.99e-01
|
3.33e-02
|
GOBP ACTIVATION OF INNATE IMMUNE RESPONSE
|
243
|
9.51e-08
|
-1.99e-01
|
2.17e-06
|
GOBP NEGATIVE REGULATION OF HEMOPOIESIS
|
87
|
1.34e-03
|
-1.99e-01
|
8.60e-03
|
GOBP LEUKOCYTE MEDIATED IMMUNITY
|
272
|
1.71e-08
|
-1.99e-01
|
4.54e-07
|
GOBP EXTRACELLULAR STRUCTURE ORGANIZATION
|
251
|
5.95e-08
|
-1.99e-01
|
1.40e-06
|
GOBP REGULATION OF STEM CELL DIVISION
|
10
|
2.76e-01
|
-1.99e-01
|
4.58e-01
|
GOBP TRNA METABOLIC PROCESS
|
160
|
1.43e-05
|
1.99e-01
|
1.84e-04
|
GOBP GAMMA AMINOBUTYRIC ACID SIGNALING PATHWAY
|
15
|
1.82e-01
|
-1.99e-01
|
3.47e-01
|
GOBP REGULATION OF LYMPHOCYTE MIGRATION
|
48
|
1.72e-02
|
-1.99e-01
|
6.56e-02
|
GOBP NEGATIVE REGULATION OF IMMUNE RESPONSE
|
134
|
7.15e-05
|
-1.99e-01
|
7.53e-04
|
GOBP EMBRYONIC DIGESTIVE TRACT MORPHOGENESIS
|
11
|
2.53e-01
|
1.99e-01
|
4.34e-01
|
GOBP CELLULAR RESPONSE TO BIOTIC STIMULUS
|
188
|
2.68e-06
|
-1.99e-01
|
4.28e-05
|
GOBP REGULATION OF BIOMINERAL TISSUE DEVELOPMENT
|
73
|
3.33e-03
|
-1.99e-01
|
1.80e-02
|
GOBP REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY
|
141
|
4.76e-05
|
-1.99e-01
|
5.33e-04
|
GOCC CONDENSED CHROMOSOME
|
217
|
4.89e-07
|
-1.99e-01
|
9.26e-06
|
GOBP NEGATIVE REGULATION OF POST TRANSCRIPTIONAL GENE SILENCING
|
10
|
2.77e-01
|
-1.98e-01
|
4.60e-01
|
GOBP INNERVATION
|
25
|
8.60e-02
|
-1.98e-01
|
2.12e-01
|
GOCC HOPS COMPLEX
|
12
|
2.34e-01
|
-1.98e-01
|
4.14e-01
|
GOBP REGULATION OF LIPID STORAGE
|
45
|
2.14e-02
|
1.98e-01
|
7.78e-02
|
GOBP REGULATION OF PROTEIN K63 LINKED UBIQUITINATION
|
12
|
2.35e-01
|
-1.98e-01
|
4.14e-01
|
GOBP HOMEOSTASIS OF NUMBER OF CELLS WITHIN A TISSUE
|
39
|
3.23e-02
|
-1.98e-01
|
1.05e-01
|
GOBP NEUROTRANSMITTER RECEPTOR TRANSPORT TO PLASMA MEMBRANE
|
24
|
9.31e-02
|
1.98e-01
|
2.24e-01
|
GOBP GLYCOSYLCERAMIDE METABOLIC PROCESS
|
11
|
2.56e-01
|
1.98e-01
|
4.37e-01
|
GOBP INTESTINAL LIPID ABSORPTION
|
12
|
2.36e-01
|
1.98e-01
|
4.14e-01
|
GOCC CHROMOCENTER
|
15
|
1.85e-01
|
-1.98e-01
|
3.51e-01
|
GOBP REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION
|
19
|
1.36e-01
|
1.97e-01
|
2.85e-01
|
GOBP REGULATION OF CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY
|
94
|
9.55e-04
|
-1.97e-01
|
6.52e-03
|
GOMF RRNA BINDING
|
69
|
4.62e-03
|
1.97e-01
|
2.35e-02
|
GOBP SPROUTING ANGIOGENESIS
|
111
|
3.34e-04
|
-1.97e-01
|
2.77e-03
|
GOBP REGULATION OF URINE VOLUME
|
20
|
1.27e-01
|
1.97e-01
|
2.73e-01
|
GOBP PIGMENT METABOLIC PROCESS
|
49
|
1.70e-02
|
1.97e-01
|
6.52e-02
|
GOBP CGAS STING SIGNALING PATHWAY
|
15
|
1.86e-01
|
-1.97e-01
|
3.53e-01
|
GOCC AXON INITIAL SEGMENT
|
20
|
1.27e-01
|
1.97e-01
|
2.73e-01
|
GOBP MITOTIC CELL CYCLE
|
743
|
1.05e-19
|
-1.97e-01
|
1.47e-17
|
GOBP EPITHELIAL TO MESENCHYMAL TRANSITION
|
140
|
5.82e-05
|
-1.97e-01
|
6.34e-04
|
GOBP ALCOHOL BIOSYNTHETIC PROCESS
|
112
|
3.23e-04
|
1.97e-01
|
2.70e-03
|
GOBP RESPONSE TO TUMOR NECROSIS FACTOR
|
146
|
4.15e-05
|
-1.97e-01
|
4.75e-04
|
GOBP POSITIVE REGULATION OF CHEMOTAXIS
|
115
|
2.72e-04
|
-1.97e-01
|
2.35e-03
|
GOBP POSITIVE REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY
|
183
|
4.67e-06
|
-1.97e-01
|
6.95e-05
|
GOBP REGULATION OF RESPONSE TO OSMOTIC STRESS
|
15
|
1.88e-01
|
1.96e-01
|
3.55e-01
|
GOBP REGULATION OF CELL CYCLE PHASE TRANSITION
|
368
|
1.13e-10
|
-1.96e-01
|
5.11e-09
|
GOBP DENSE CORE GRANULE LOCALIZATION
|
21
|
1.19e-01
|
-1.96e-01
|
2.62e-01
|
GOBP POSITIVE REGULATION OF INTERLEUKIN 5 PRODUCTION
|
10
|
2.83e-01
|
-1.96e-01
|
4.66e-01
|
GOBP ESTABLISHMENT OR MAINTENANCE OF BIPOLAR CELL POLARITY
|
41
|
2.98e-02
|
-1.96e-01
|
9.91e-02
|
GOBP POSITIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION
|
73
|
3.79e-03
|
-1.96e-01
|
2.01e-02
|
GOBP REGULATION OF PROSTAGLANDIN SECRETION
|
11
|
2.60e-01
|
-1.96e-01
|
4.42e-01
|
GOBP FATTY ACID ELONGATION
|
12
|
2.40e-01
|
1.96e-01
|
4.19e-01
|
GOBP REGULATION OF DENDRITE EXTENSION
|
22
|
1.12e-01
|
-1.96e-01
|
2.52e-01
|
GOBP POSITIVE REGULATION OF INTERLEUKIN 2 PRODUCTION
|
31
|
5.94e-02
|
-1.96e-01
|
1.64e-01
|
GOBP ORGANIC HYDROXY COMPOUND CATABOLIC PROCESS
|
25
|
9.05e-02
|
1.96e-01
|
2.20e-01
|
GOBP REGULATION OF CELLULAR SENESCENCE
|
42
|
2.85e-02
|
-1.95e-01
|
9.56e-02
|
GOBP SOMITE DEVELOPMENT
|
62
|
7.84e-03
|
-1.95e-01
|
3.54e-02
|
GOBP POSTSYNAPTIC DENSITY ASSEMBLY
|
21
|
1.21e-01
|
-1.95e-01
|
2.65e-01
|
GOBP REGULATION OF RENAL SYSTEM PROCESS
|
17
|
1.64e-01
|
-1.95e-01
|
3.23e-01
|
GOMF PENTOSYLTRANSFERASE ACTIVITY
|
40
|
3.27e-02
|
-1.95e-01
|
1.06e-01
|
GOMF RECEPTOR SERINE THREONINE KINASE BINDING
|
22
|
1.13e-01
|
-1.95e-01
|
2.54e-01
|
GOMF HORMONE RECEPTOR BINDING
|
15
|
1.91e-01
|
-1.95e-01
|
3.59e-01
|
GOBP PERK MEDIATED UNFOLDED PROTEIN RESPONSE
|
15
|
1.91e-01
|
-1.95e-01
|
3.59e-01
|
GOBP NEGATIVE REGULATION OF COAGULATION
|
31
|
6.04e-02
|
-1.95e-01
|
1.66e-01
|
GOBP VIRAL TRANSCRIPTION
|
49
|
1.83e-02
|
-1.95e-01
|
6.87e-02
|
GOBP APOPTOTIC DNA FRAGMENTATION
|
14
|
2.07e-01
|
1.95e-01
|
3.80e-01
|
GOBP EPITHELIAL CELL APOPTOTIC PROCESS
|
133
|
1.07e-04
|
-1.95e-01
|
1.07e-03
|
GOBP POSITIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION
|
10
|
2.86e-01
|
1.95e-01
|
4.69e-01
|
GOMF SOLUTE PROTON SYMPORTER ACTIVITY
|
14
|
2.07e-01
|
1.95e-01
|
3.80e-01
|
GOCC CENTRIOLE
|
119
|
2.49e-04
|
-1.95e-01
|
2.18e-03
|
GOBP SPLICEOSOMAL COMPLEX ASSEMBLY
|
43
|
2.74e-02
|
-1.94e-01
|
9.32e-02
|
GOCC INTEGRATOR COMPLEX
|
13
|
2.25e-01
|
1.94e-01
|
4.02e-01
|
GOBP NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS NONSENSE MEDIATED DECAY
|
41
|
3.13e-02
|
-1.94e-01
|
1.03e-01
|
GOBP ACTIN FILAMENT DEPOLYMERIZATION
|
54
|
1.35e-02
|
-1.94e-01
|
5.44e-02
|
GOBP REGULATION OF GLIOGENESIS
|
106
|
5.53e-04
|
-1.94e-01
|
4.16e-03
|
GOCC EXOCYST
|
16
|
1.79e-01
|
-1.94e-01
|
3.43e-01
|
GOBP MORPHOGENESIS OF AN EPITHELIAL BUD
|
13
|
2.25e-01
|
-1.94e-01
|
4.03e-01
|
GOCC RUFFLE
|
141
|
7.16e-05
|
-1.94e-01
|
7.53e-04
|
GOMF NON MEMBRANE SPANNING PROTEIN TYROSINE KINASE ACTIVITY
|
34
|
5.04e-02
|
-1.94e-01
|
1.46e-01
|
GOBP TRNA WOBBLE BASE MODIFICATION
|
17
|
1.66e-01
|
1.94e-01
|
3.27e-01
|
GOBP FOREBRAIN NEURON DEVELOPMENT
|
21
|
1.24e-01
|
-1.94e-01
|
2.70e-01
|
GOMF CYCLIN BINDING
|
28
|
7.60e-02
|
-1.94e-01
|
1.95e-01
|
GOBP MAMMARY GLAND EPITHELIAL CELL PROLIFERATION
|
26
|
8.73e-02
|
-1.94e-01
|
2.14e-01
|
GOBP MORPHOGENESIS OF AN EPITHELIAL FOLD
|
20
|
1.34e-01
|
-1.94e-01
|
2.82e-01
|
GOCC CELL LEADING EDGE
|
353
|
4.54e-10
|
-1.94e-01
|
1.80e-08
|
GOBP NEGATIVE REGULATION OF FAT CELL DIFFERENTIATION
|
46
|
2.31e-02
|
-1.94e-01
|
8.19e-02
|
GOMF PROFILIN BINDING
|
12
|
2.45e-01
|
-1.94e-01
|
4.26e-01
|
GOBP WNT SIGNALING PATHWAY PLANAR CELL POLARITY PATHWAY
|
34
|
5.07e-02
|
-1.94e-01
|
1.47e-01
|
GOBP SPECIFICATION OF SYMMETRY
|
94
|
1.18e-03
|
-1.94e-01
|
7.85e-03
|
GOCC EXON EXON JUNCTION COMPLEX
|
21
|
1.25e-01
|
-1.94e-01
|
2.70e-01
|
GOBP CELL CYCLE PHASE TRANSITION
|
455
|
1.76e-12
|
-1.94e-01
|
9.51e-11
|
GOBP RESPONSE TO PEPTIDE
|
11
|
2.67e-01
|
-1.94e-01
|
4.48e-01
|
GOCC REPLICATION FORK
|
66
|
6.59e-03
|
-1.93e-01
|
3.10e-02
|
GOBP FLUID TRANSPORT
|
17
|
1.68e-01
|
-1.93e-01
|
3.29e-01
|
GOCC PRESYNAPTIC ENDOCYTIC ZONE MEMBRANE
|
13
|
2.28e-01
|
-1.93e-01
|
4.05e-01
|
GOBP REGULATION OF CHOLESTEROL EFFLUX
|
32
|
5.86e-02
|
1.93e-01
|
1.63e-01
|
GOBP POSITIVE REGULATION OF IMMUNE RESPONSE
|
520
|
6.18e-14
|
-1.93e-01
|
4.12e-12
|
GOBP POSITIVE REGULATION OF VACUOLE ORGANIZATION
|
24
|
1.02e-01
|
-1.93e-01
|
2.37e-01
|
GOBP NEGATIVE REGULATION OF ACTIN FILAMENT DEPOLYMERIZATION
|
43
|
2.87e-02
|
-1.93e-01
|
9.60e-02
|
GOBP PYRIDINE CONTAINING COMPOUND METABOLIC PROCESS
|
159
|
2.80e-05
|
1.93e-01
|
3.37e-04
|
GOBP PROTEIN QUALITY CONTROL FOR MISFOLDED OR INCOMPLETELY SYNTHESIZED PROTEINS
|
17
|
1.69e-01
|
1.93e-01
|
3.30e-01
|
GOBP GLYCOPROTEIN CATABOLIC PROCESS
|
26
|
8.91e-02
|
1.93e-01
|
2.18e-01
|
GOBP RIBOSOMAL SUBUNIT EXPORT FROM NUCLEUS
|
16
|
1.82e-01
|
1.93e-01
|
3.47e-01
|
GOBP RESPONSE TO ANTIBIOTIC
|
30
|
6.80e-02
|
-1.93e-01
|
1.80e-01
|
GOBP ARTERY DEVELOPMENT
|
109
|
5.22e-04
|
-1.93e-01
|
3.97e-03
|
GOBP POSITIVE REGULATION OF B CELL PROLIFERATION
|
38
|
4.02e-02
|
-1.92e-01
|
1.23e-01
|
GOBP REGULATION OF POSTSYNAPTIC DENSITY ASSEMBLY
|
13
|
2.30e-01
|
-1.92e-01
|
4.09e-01
|
GOBP REGULATION OF INNATE IMMUNE RESPONSE
|
349
|
7.84e-10
|
-1.92e-01
|
2.90e-08
|
GOBP LIPID DROPLET FORMATION
|
12
|
2.49e-01
|
1.92e-01
|
4.31e-01
|
GOCC TRANSCRIPTION FACTOR TFTC COMPLEX
|
17
|
1.71e-01
|
1.92e-01
|
3.33e-01
|
GOCC PROTEASOME CORE COMPLEX
|
17
|
1.71e-01
|
1.92e-01
|
3.33e-01
|
GOBP MICROTUBULE NUCLEATION
|
34
|
5.29e-02
|
-1.92e-01
|
1.51e-01
|
GOCC GAMMA TUBULIN COMPLEX
|
16
|
1.84e-01
|
-1.92e-01
|
3.50e-01
|
GOCC SUMO LIGASE COMPLEX
|
11
|
2.71e-01
|
-1.92e-01
|
4.53e-01
|
GOCC DYNEIN COMPLEX
|
26
|
9.06e-02
|
-1.92e-01
|
2.20e-01
|
GOBP POSITIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS
|
85
|
2.27e-03
|
1.92e-01
|
1.33e-02
|
GOMF CYTOKINE RECEPTOR BINDING
|
159
|
3.13e-05
|
-1.92e-01
|
3.70e-04
|
GOBP DEFENSE RESPONSE TO OTHER ORGANISM
|
810
|
3.62e-20
|
-1.92e-01
|
5.21e-18
|
GOBP REGULATION OF NOTCH SIGNALING PATHWAY
|
75
|
4.17e-03
|
-1.91e-01
|
2.17e-02
|
GOBP POSITIVE REGULATION OF CELL DIVISION
|
69
|
6.00e-03
|
-1.91e-01
|
2.88e-02
|
GOBP POSITIVE REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY
|
13
|
2.32e-01
|
1.91e-01
|
4.12e-01
|
GOMF BMP BINDING
|
12
|
2.51e-01
|
-1.91e-01
|
4.32e-01
|
GOBP POSITIVE REGULATION OF COLLAGEN METABOLIC PROCESS
|
29
|
7.48e-02
|
-1.91e-01
|
1.92e-01
|
GOBP RESPONSE TO MUSCLE ACTIVITY
|
17
|
1.72e-01
|
1.91e-01
|
3.36e-01
|
GOCC MICROVILLUS MEMBRANE
|
18
|
1.61e-01
|
-1.91e-01
|
3.20e-01
|
GOBP MAINTENANCE OF POSTSYNAPTIC SPECIALIZATION STRUCTURE
|
11
|
2.73e-01
|
-1.91e-01
|
4.55e-01
|
GOBP PROTEIN LOCALIZATION TO CHROMOSOME
|
99
|
1.03e-03
|
-1.91e-01
|
6.98e-03
|
GOBP NEGATIVE REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY
|
23
|
1.13e-01
|
-1.91e-01
|
2.53e-01
|
GOBP APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT
|
33
|
5.77e-02
|
-1.91e-01
|
1.60e-01
|
GOMF IRON ION BINDING
|
96
|
1.25e-03
|
1.91e-01
|
8.13e-03
|
GOBP NEGATIVE REGULATION OF HORMONE METABOLIC PROCESS
|
10
|
2.96e-01
|
-1.91e-01
|
4.80e-01
|
GOBP REGULATION OF COAGULATION
|
50
|
1.97e-02
|
-1.91e-01
|
7.32e-02
|
GOBP CELLULAR RESPONSE TO INTERLEUKIN 1
|
53
|
1.64e-02
|
-1.91e-01
|
6.34e-02
|
GOBP MISMATCH REPAIR
|
23
|
1.14e-01
|
-1.91e-01
|
2.54e-01
|
GOBP ARTERY MORPHOGENESIS
|
75
|
4.36e-03
|
-1.91e-01
|
2.23e-02
|
GOBP REGULATION OF STRIATED MUSCLE CONTRACTION
|
78
|
3.65e-03
|
1.91e-01
|
1.95e-02
|
GOBP REGULATION OF CAMP MEDIATED SIGNALING
|
22
|
1.22e-01
|
1.90e-01
|
2.66e-01
|
GOBP AUTONOMIC NERVOUS SYSTEM DEVELOPMENT
|
34
|
5.50e-02
|
-1.90e-01
|
1.56e-01
|
GOBP CHROMOSOME ORGANIZATION INVOLVED IN MEIOTIC CELL CYCLE
|
35
|
5.16e-02
|
-1.90e-01
|
1.49e-01
|
GOMF EXONUCLEASE ACTIVITY
|
73
|
4.98e-03
|
-1.90e-01
|
2.49e-02
|
GOBP HAIR FOLLICLE MATURATION
|
18
|
1.63e-01
|
-1.90e-01
|
3.22e-01
|
GOCC SYNAPTONEMAL STRUCTURE
|
19
|
1.52e-01
|
-1.90e-01
|
3.06e-01
|
GOBP SMOOTH MUSCLE CELL MIGRATION
|
103
|
8.86e-04
|
-1.90e-01
|
6.17e-03
|
GOBP POSITIVE REGULATION OF RECEPTOR RECYCLING
|
17
|
1.76e-01
|
-1.90e-01
|
3.39e-01
|
GOBP REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR
|
33
|
5.96e-02
|
-1.90e-01
|
1.64e-01
|
GOBP RESPONSE TO BACTERIUM
|
459
|
4.15e-12
|
-1.90e-01
|
2.18e-10
|
GOCC CIS GOLGI NETWORK
|
51
|
1.93e-02
|
-1.89e-01
|
7.20e-02
|
GOBP NEGATIVE REGULATION OF ERBB SIGNALING PATHWAY
|
29
|
7.75e-02
|
-1.89e-01
|
1.98e-01
|
GOBP RESPONSE TO MOLECULE OF BACTERIAL ORIGIN
|
243
|
3.87e-07
|
-1.89e-01
|
7.51e-06
|
GOCC PROTEIN FOLDING CHAPERONE COMPLEX
|
33
|
5.98e-02
|
1.89e-01
|
1.65e-01
|
GOBP NEGATIVE REGULATION OF ORGAN GROWTH
|
37
|
4.64e-02
|
-1.89e-01
|
1.37e-01
|
GOBP MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN PROGRAMMED CELL DEATH
|
33
|
6.00e-02
|
1.89e-01
|
1.65e-01
|
GOBP REGULATION OF LAMELLIPODIUM ASSEMBLY
|
36
|
4.96e-02
|
-1.89e-01
|
1.44e-01
|
GOBP CATECHOL CONTAINING COMPOUND METABOLIC PROCESS
|
44
|
3.00e-02
|
1.89e-01
|
9.94e-02
|
GOBP RESPONSE TO VITAMIN
|
29
|
7.79e-02
|
-1.89e-01
|
1.98e-01
|
GOBP PROTEIN OXIDATION
|
13
|
2.38e-01
|
-1.89e-01
|
4.17e-01
|
GOBP DEMETHYLATION
|
23
|
1.17e-01
|
-1.89e-01
|
2.58e-01
|
GOMF PHOSPHATASE INHIBITOR ACTIVITY
|
31
|
6.86e-02
|
1.89e-01
|
1.81e-01
|
GOMF METAL CATION MONOATOMIC CATION ANTIPORTER ACTIVITY
|
25
|
1.02e-01
|
1.89e-01
|
2.38e-01
|
GOBP CARDIAC VASCULAR SMOOTH MUSCLE CELL DIFFERENTIATION
|
13
|
2.38e-01
|
-1.89e-01
|
4.18e-01
|
GOMF INTRONIC TRANSCRIPTION REGULATORY REGION SEQUENCE SPECIFIC DNA BINDING
|
11
|
2.78e-01
|
1.89e-01
|
4.60e-01
|
GOBP TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY
|
179
|
1.34e-05
|
-1.89e-01
|
1.73e-04
|
GOMF ACTIVIN BINDING
|
10
|
3.01e-01
|
-1.89e-01
|
4.85e-01
|
GOMF PROTEIN SERINE THREONINE KINASE ACTIVATOR ACTIVITY
|
57
|
1.37e-02
|
-1.89e-01
|
5.49e-02
|
GOBP ALPHA BETA T CELL ACTIVATION
|
139
|
1.23e-04
|
-1.89e-01
|
1.19e-03
|
GOBP REGULATION OF DIGESTIVE SYSTEM PROCESS
|
26
|
9.59e-02
|
1.89e-01
|
2.28e-01
|
GOBP MONOSACCHARIDE CATABOLIC PROCESS
|
36
|
5.02e-02
|
1.89e-01
|
1.46e-01
|
GOBP NEGATIVE REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION
|
20
|
1.44e-01
|
1.89e-01
|
2.97e-01
|
GOBP REGULATION OF KERATINOCYTE DIFFERENTIATION
|
22
|
1.26e-01
|
-1.89e-01
|
2.72e-01
|
GOBP REGULATION OF MITOTIC NUCLEAR DIVISION
|
95
|
1.51e-03
|
-1.88e-01
|
9.53e-03
|
GOBP REGULATION OF OSTEOBLAST PROLIFERATION
|
24
|
1.10e-01
|
-1.88e-01
|
2.50e-01
|
GOBP REGULATION OF AMYLOID FIBRIL FORMATION
|
15
|
2.07e-01
|
1.88e-01
|
3.80e-01
|
GOBP CRANIAL SKELETAL SYSTEM DEVELOPMENT
|
64
|
9.28e-03
|
-1.88e-01
|
4.04e-02
|
GOBP REGULATION OF RNA POLYMERASE II REGULATORY REGION SEQUENCE SPECIFIC DNA BINDING
|
10
|
3.03e-01
|
-1.88e-01
|
4.87e-01
|
GOBP REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION
|
98
|
1.30e-03
|
-1.88e-01
|
8.44e-03
|
GOMF RNA POLYMERASE II TRANSCRIPTION REGULATORY REGION SEQUENCE SPECIFIC DNA BINDING
|
868
|
1.06e-20
|
-1.88e-01
|
1.64e-18
|
GOCC SET1C COMPASS COMPLEX
|
13
|
2.41e-01
|
1.88e-01
|
4.20e-01
|
GOBP SHORT TERM MEMORY
|
16
|
1.93e-01
|
1.88e-01
|
3.62e-01
|
GOBP POSITIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS
|
310
|
1.45e-08
|
-1.88e-01
|
3.95e-07
|
GOBP HYPERSENSITIVITY
|
11
|
2.81e-01
|
-1.88e-01
|
4.64e-01
|
GOBP SOMATIC DIVERSIFICATION OF IMMUNE RECEPTORS VIA SOMATIC MUTATION
|
14
|
2.24e-01
|
-1.88e-01
|
4.02e-01
|
GOBP NEGATIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE
|
37
|
4.84e-02
|
-1.88e-01
|
1.42e-01
|
GOMF 14 3 3 PROTEIN BINDING
|
36
|
5.16e-02
|
-1.88e-01
|
1.49e-01
|
GOMF TRNA METHYLTRANSFERASE ACTIVITY
|
29
|
8.07e-02
|
1.87e-01
|
2.03e-01
|
GOBP REGULATION OF IMMUNE EFFECTOR PROCESS
|
284
|
5.91e-08
|
-1.87e-01
|
1.40e-06
|
GOBP PIECEMEAL MICROAUTOPHAGY OF THE NUCLEUS
|
18
|
1.69e-01
|
1.87e-01
|
3.31e-01
|
GOBP GLOMERULAR MESANGIUM DEVELOPMENT
|
14
|
2.25e-01
|
-1.87e-01
|
4.03e-01
|
GOMF ASPARTIC TYPE PEPTIDASE ACTIVITY
|
16
|
1.95e-01
|
-1.87e-01
|
3.65e-01
|
GOBP POSITIVE REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION
|
16
|
1.95e-01
|
-1.87e-01
|
3.65e-01
|
GOBP ENDOCRINE PANCREAS DEVELOPMENT
|
26
|
9.89e-02
|
-1.87e-01
|
2.33e-01
|
GOMF LYSOPHOSPHATIDIC ACID ACYLTRANSFERASE ACTIVITY
|
13
|
2.43e-01
|
1.87e-01
|
4.23e-01
|
GOCC BETA CATENIN TCF COMPLEX
|
12
|
2.62e-01
|
-1.87e-01
|
4.44e-01
|
GOMF GLYCOSAMINOGLYCAN BINDING
|
159
|
4.89e-05
|
-1.87e-01
|
5.43e-04
|
GOBP REGULATION OF ACTIN FILAMENT BASED MOVEMENT
|
46
|
2.85e-02
|
1.87e-01
|
9.56e-02
|
GOBP EXTRINSIC APOPTOTIC SIGNALING PATHWAY
|
199
|
5.78e-06
|
-1.87e-01
|
8.48e-05
|
GOBP AMMONIUM ION METABOLIC PROCESS
|
19
|
1.59e-01
|
1.87e-01
|
3.17e-01
|
GOCC INNER KINETOCHORE
|
11
|
2.84e-01
|
-1.87e-01
|
4.66e-01
|
GOMF SPHINGOLIPID TRANSPORTER ACTIVITY
|
13
|
2.44e-01
|
-1.87e-01
|
4.24e-01
|
GOCC MITOCHONDRIAL CRISTA
|
12
|
2.63e-01
|
1.86e-01
|
4.45e-01
|
GOBP WATER SOLUBLE VITAMIN BIOSYNTHETIC PROCESS
|
10
|
3.07e-01
|
1.86e-01
|
4.92e-01
|
GOBP REGULATION OF STEM CELL DIFFERENTIATION
|
78
|
4.46e-03
|
-1.86e-01
|
2.28e-02
|
GOBP AORTA DEVELOPMENT
|
68
|
7.92e-03
|
-1.86e-01
|
3.56e-02
|
GOCC IMMUNOLOGICAL SYNAPSE
|
33
|
6.41e-02
|
-1.86e-01
|
1.72e-01
|
GOBP REGULATION OF DNA REPLICATION
|
108
|
8.32e-04
|
-1.86e-01
|
5.84e-03
|
GOMF EXTRACELLULAR MATRIX BINDING
|
59
|
1.34e-02
|
-1.86e-01
|
5.43e-02
|
GOMF HISTONE BINDING
|
210
|
3.49e-06
|
-1.86e-01
|
5.35e-05
|
GOBP MOLTING CYCLE PROCESS
|
86
|
2.90e-03
|
-1.86e-01
|
1.62e-02
|
GOBP REGULATION OF RESPONSE TO BIOTIC STIMULUS
|
415
|
9.73e-11
|
-1.86e-01
|
4.49e-09
|
GOBP TRNA PROCESSING
|
116
|
5.53e-04
|
1.86e-01
|
4.16e-03
|
GOMF PROLINE RICH REGION BINDING
|
19
|
1.61e-01
|
-1.86e-01
|
3.20e-01
|
GOBP RESPONSE TO FUNGUS
|
38
|
4.76e-02
|
-1.86e-01
|
1.40e-01
|
GOBP NEGATIVE REGULATION OF MACROPHAGE CYTOKINE PRODUCTION
|
11
|
2.86e-01
|
-1.86e-01
|
4.69e-01
|
GOCC OUTER MEMBRANE
|
177
|
2.10e-05
|
1.86e-01
|
2.60e-04
|
GOCC NUCLEAR CHROMOSOME
|
185
|
1.38e-05
|
-1.86e-01
|
1.79e-04
|
GOBP CARDIAC SEPTUM MORPHOGENESIS
|
68
|
8.18e-03
|
-1.86e-01
|
3.66e-02
|
GOBP CORONARY VASCULATURE MORPHOGENESIS
|
29
|
8.38e-02
|
-1.86e-01
|
2.08e-01
|
GOBP POSITIVE REGULATION OF CELL SUBSTRATE ADHESION
|
114
|
6.30e-04
|
-1.86e-01
|
4.62e-03
|
GOBP LEUKOCYTE MIGRATION
|
279
|
1.04e-07
|
-1.85e-01
|
2.35e-06
|
GOMF NUCLEAR ANDROGEN RECEPTOR BINDING
|
32
|
6.95e-02
|
-1.85e-01
|
1.82e-01
|
GOBP REGULATION OF NEUROBLAST PROLIFERATION
|
43
|
3.54e-02
|
-1.85e-01
|
1.13e-01
|
GOMF DEUBIQUITINASE ACTIVITY
|
78
|
4.68e-03
|
-1.85e-01
|
2.37e-02
|
GOBP REGULATION OF LAMELLIPODIUM ORGANIZATION
|
45
|
3.15e-02
|
-1.85e-01
|
1.03e-01
|
GOBP NEGATIVE REGULATION OF IMMUNE EFFECTOR PROCESS
|
91
|
2.27e-03
|
-1.85e-01
|
1.33e-02
|
GOBP MULTIVESICULAR BODY ORGANIZATION
|
14
|
2.30e-01
|
-1.85e-01
|
4.09e-01
|
GOBP CEREBRAL CORTEX DEVELOPMENT
|
93
|
2.05e-03
|
-1.85e-01
|
1.22e-02
|
GOBP INTERLEUKIN 10 PRODUCTION
|
47
|
2.82e-02
|
-1.85e-01
|
9.49e-02
|
GOMF CYTOKINE RECEPTOR ACTIVITY
|
61
|
1.26e-02
|
-1.85e-01
|
5.16e-02
|
GOBP RUFFLE ASSEMBLY
|
39
|
4.60e-02
|
-1.85e-01
|
1.36e-01
|
GOBP INSULIN METABOLIC PROCESS
|
13
|
2.49e-01
|
-1.85e-01
|
4.31e-01
|
GOMF OXIDOREDUCTASE ACTIVITY ACTING ON PAIRED DONORS WITH INCORPORATION OR REDUCTION OF MOLECULAR OXYGEN REDUCED FLAVIN OR FLAVOPROTEIN AS ONE DONOR AND INCORPORATION OF ONE ATOM OF OXYGEN
|
20
|
1.53e-01
|
1.85e-01
|
3.09e-01
|
GOBP AMINE CATABOLIC PROCESS
|
12
|
2.68e-01
|
1.85e-01
|
4.50e-01
|
GOBP REGULATION OF DNA DAMAGE CHECKPOINT
|
20
|
1.53e-01
|
-1.84e-01
|
3.09e-01
|
GOCC NUCLEAR REPLICATION FORK
|
37
|
5.23e-02
|
-1.84e-01
|
1.50e-01
|
GOBP LAMELLIPODIUM ASSEMBLY
|
67
|
9.11e-03
|
-1.84e-01
|
3.98e-02
|
GOBP REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION
|
35
|
5.92e-02
|
-1.84e-01
|
1.64e-01
|
GOMF GALACTOSYLTRANSFERASE ACTIVITY
|
22
|
1.35e-01
|
-1.84e-01
|
2.83e-01
|
GOBP STRIATED MUSCLE CELL PROLIFERATION
|
77
|
5.20e-03
|
-1.84e-01
|
2.57e-02
|
GOBP REGULATION OF CELL SUBSTRATE ADHESION
|
185
|
1.59e-05
|
-1.84e-01
|
2.02e-04
|
GOBP POSITIVE REGULATION OF AMINE TRANSPORT
|
32
|
7.13e-02
|
1.84e-01
|
1.86e-01
|
GOBP ESTABLISHMENT OF EPITHELIAL CELL APICAL BASAL POLARITY
|
14
|
2.33e-01
|
-1.84e-01
|
4.12e-01
|
GOBP DENDRITE MORPHOGENESIS
|
157
|
6.98e-05
|
-1.84e-01
|
7.40e-04
|
GOBP POSITIVE REGULATION OF PLASMA MEMBRANE BOUNDED CELL PROJECTION ASSEMBLY
|
96
|
1.85e-03
|
-1.84e-01
|
1.13e-02
|
GOCC PROTEIN PHOSPHATASE TYPE 1 COMPLEX
|
17
|
1.89e-01
|
-1.84e-01
|
3.56e-01
|
GOBP HOMOCYSTEINE METABOLIC PROCESS
|
12
|
2.70e-01
|
1.84e-01
|
4.51e-01
|
GOBP REGULATION OF LEUKOCYTE CHEMOTAXIS
|
92
|
2.31e-03
|
-1.84e-01
|
1.35e-02
|
GOBP CALCIUM ION TRANSPORT INTO CYTOSOL
|
23
|
1.27e-01
|
-1.84e-01
|
2.73e-01
|
GOBP CERAMIDE TRANSPORT
|
13
|
2.51e-01
|
1.84e-01
|
4.32e-01
|
GOBP CARDIOBLAST DIFFERENTIATION
|
13
|
2.51e-01
|
-1.84e-01
|
4.32e-01
|
GOBP POSITIVE REGULATION OF HEMOPOIESIS
|
157
|
7.24e-05
|
-1.84e-01
|
7.59e-04
|
GOBP NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY
|
20
|
1.55e-01
|
-1.84e-01
|
3.11e-01
|
GOMF ALDO KETO REDUCTASE NADPH ACTIVITY
|
19
|
1.66e-01
|
1.83e-01
|
3.27e-01
|
GOBP INTERLEUKIN 1 BETA PRODUCTION
|
72
|
7.15e-03
|
-1.83e-01
|
3.33e-02
|
GOCC GOLGI LUMEN
|
14
|
2.35e-01
|
-1.83e-01
|
4.14e-01
|
GOBP NEGATIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION
|
63
|
1.19e-02
|
-1.83e-01
|
4.96e-02
|
GOBP DEVELOPMENTAL INDUCTION
|
23
|
1.28e-01
|
-1.83e-01
|
2.75e-01
|
GOBP REGULATION OF CELL MATRIX ADHESION
|
103
|
1.33e-03
|
-1.83e-01
|
8.56e-03
|
GOBP REGULATION OF LYMPHOCYTE DIFFERENTIATION
|
166
|
4.80e-05
|
-1.83e-01
|
5.35e-04
|
GOBP POSITIVE REGULATION OF SMAD PROTEIN SIGNAL TRANSDUCTION
|
32
|
7.31e-02
|
-1.83e-01
|
1.90e-01
|
GOBP HEMOGLOBIN BIOSYNTHETIC PROCESS
|
14
|
2.36e-01
|
1.83e-01
|
4.14e-01
|
GOBP LEUKOCYTE APOPTOTIC PROCESS
|
100
|
1.58e-03
|
-1.83e-01
|
9.90e-03
|
GOBP MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE
|
37
|
5.41e-02
|
-1.83e-01
|
1.54e-01
|
GOBP CARTILAGE DEVELOPMENT
|
159
|
7.00e-05
|
-1.83e-01
|
7.41e-04
|
GOBP REGULATION OF GOLGI TO PLASMA MEMBRANE PROTEIN TRANSPORT
|
10
|
3.17e-01
|
1.83e-01
|
5.03e-01
|
GOMF MICROTUBULE MINUS END BINDING
|
14
|
2.36e-01
|
-1.83e-01
|
4.15e-01
|
GOBP MEGAKARYOCYTE DIFFERENTIATION
|
41
|
4.30e-02
|
-1.83e-01
|
1.29e-01
|
GOBP POSITIVE REGULATION OF NATURAL KILLER CELL DIFFERENTIATION
|
11
|
2.94e-01
|
-1.83e-01
|
4.78e-01
|
GOBP INTERLEUKIN 8 PRODUCTION
|
59
|
1.53e-02
|
-1.83e-01
|
6.02e-02
|
GOBP REGULATION OF NATURAL KILLER CELL DIFFERENTIATION
|
13
|
2.54e-01
|
-1.83e-01
|
4.35e-01
|
GOBP REGULATION OF CELLULAR RESPIRATION
|
48
|
2.87e-02
|
1.83e-01
|
9.60e-02
|
GOBP PHOSPHOLIPID CATABOLIC PROCESS
|
41
|
4.32e-02
|
1.83e-01
|
1.30e-01
|
GOBP PROTEIN LOCALIZATION TO CILIARY MEMBRANE
|
11
|
2.95e-01
|
-1.83e-01
|
4.78e-01
|
GOMF MONOATOMIC CATION TRANSMEMBRANE TRANSPORTER ACTIVITY
|
354
|
4.07e-09
|
1.83e-01
|
1.30e-07
|
GOBP VENTRICULAR SEPTUM DEVELOPMENT
|
72
|
7.47e-03
|
-1.82e-01
|
3.42e-02
|
GOMF SUMO BINDING
|
16
|
2.07e-01
|
-1.82e-01
|
3.80e-01
|
GOBP STEROID METABOLIC PROCESS
|
213
|
4.65e-06
|
1.82e-01
|
6.94e-05
|
GOMF CAMP RESPONSE ELEMENT BINDING PROTEIN BINDING
|
10
|
3.18e-01
|
-1.82e-01
|
5.05e-01
|
GOBP GPI ANCHOR METABOLIC PROCESS
|
32
|
7.44e-02
|
1.82e-01
|
1.92e-01
|
GOBP CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS
|
55
|
1.95e-02
|
-1.82e-01
|
7.24e-02
|
GOBP POSITIVE REGULATION OF DNA REPLICATION
|
44
|
3.66e-02
|
-1.82e-01
|
1.16e-01
|
GOBP PROSTATE GLAND DEVELOPMENT
|
39
|
4.91e-02
|
-1.82e-01
|
1.43e-01
|
GOMF STRUCTURAL CONSTITUENT OF SYNAPSE
|
28
|
9.53e-02
|
1.82e-01
|
2.27e-01
|
GOBP POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL MIGRATION
|
23
|
1.31e-01
|
-1.82e-01
|
2.78e-01
|
GOBP CARDIAC NEURAL CREST CELL DIFFERENTIATION INVOLVED IN HEART DEVELOPMENT
|
17
|
1.94e-01
|
-1.82e-01
|
3.62e-01
|
GOBP INNATE IMMUNE RESPONSE ACTIVATING SIGNALING PATHWAY
|
217
|
3.97e-06
|
-1.82e-01
|
6.02e-05
|
GOCC APICOLATERAL PLASMA MEMBRANE
|
16
|
2.08e-01
|
-1.82e-01
|
3.80e-01
|
GOBP NEGATIVE REGULATION OF DNA BIOSYNTHETIC PROCESS
|
30
|
8.45e-02
|
-1.82e-01
|
2.10e-01
|
GOMF RACEMASE AND EPIMERASE ACTIVITY
|
14
|
2.39e-01
|
1.82e-01
|
4.18e-01
|
GOBP CELL SURFACE RECEPTOR SIGNALING PATHWAY VIA STAT
|
113
|
8.47e-04
|
-1.82e-01
|
5.93e-03
|
GOBP MIDDLE EAR MORPHOGENESIS
|
20
|
1.59e-01
|
-1.82e-01
|
3.18e-01
|
GOMF PROTEIN SEQUESTERING ACTIVITY
|
27
|
1.02e-01
|
-1.82e-01
|
2.38e-01
|
GOBP RESPONSE TO UV C
|
12
|
2.76e-01
|
-1.82e-01
|
4.58e-01
|
GOBP EMBRYONIC CAMERA TYPE EYE MORPHOGENESIS
|
20
|
1.59e-01
|
-1.82e-01
|
3.18e-01
|
GOCC FILOPODIUM TIP
|
14
|
2.39e-01
|
-1.82e-01
|
4.18e-01
|
GOBP CIRCADIAN REGULATION OF GENE EXPRESSION
|
64
|
1.20e-02
|
-1.82e-01
|
4.97e-02
|
GOBP EMBRYONIC SKELETAL SYSTEM DEVELOPMENT
|
94
|
2.35e-03
|
-1.82e-01
|
1.37e-02
|
GOBP REGULATION OF TRANSCRIPTION OF NUCLEOLAR LARGE RRNA BY RNA POLYMERASE I
|
10
|
3.20e-01
|
1.82e-01
|
5.07e-01
|
GOCC SPINDLE
|
313
|
3.70e-08
|
-1.81e-01
|
9.29e-07
|
GOBP REGULATION OF LEUKOCYTE DEGRANULATION
|
35
|
6.34e-02
|
-1.81e-01
|
1.71e-01
|
GOBP REGULATION OF PROTEIN LOCALIZATION TO CILIUM
|
10
|
3.21e-01
|
-1.81e-01
|
5.08e-01
|
GOBP ANGIOGENESIS
|
457
|
3.78e-11
|
-1.81e-01
|
1.76e-09
|
GOBP SYNAPTIC VESICLE BUDDING
|
13
|
2.58e-01
|
-1.81e-01
|
4.40e-01
|
GOBP NEGATIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS
|
30
|
8.62e-02
|
-1.81e-01
|
2.12e-01
|
GOBP POSITIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION
|
69
|
9.36e-03
|
-1.81e-01
|
4.07e-02
|
GOBP NEGATIVE REGULATION OF TRIGLYCERIDE METABOLIC PROCESS
|
13
|
2.59e-01
|
1.81e-01
|
4.40e-01
|
GOBP REGULATION OF HEMOPOIESIS
|
328
|
1.96e-08
|
-1.81e-01
|
5.19e-07
|
GOBP NEGATIVE REGULATION OF INTERLEUKIN 6 PRODUCTION
|
38
|
5.37e-02
|
-1.81e-01
|
1.53e-01
|
GOBP POST TRANSCRIPTIONAL GENE SILENCING
|
60
|
1.55e-02
|
-1.81e-01
|
6.07e-02
|
GOBP MAINTENANCE OF CELL NUMBER
|
171
|
4.66e-05
|
-1.81e-01
|
5.24e-04
|
GOBP EPITHELIAL CELL PROLIFERATION INVOLVED IN LUNG MORPHOGENESIS
|
11
|
2.99e-01
|
-1.81e-01
|
4.84e-01
|
GOBP REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE
|
35
|
6.43e-02
|
-1.81e-01
|
1.73e-01
|
GOBP PRIMARY ALCOHOL METABOLIC PROCESS
|
43
|
4.05e-02
|
1.81e-01
|
1.24e-01
|
GOBP REGULATION OF TYPE B PANCREATIC CELL APOPTOTIC PROCESS
|
10
|
3.23e-01
|
1.81e-01
|
5.10e-01
|
GOBP HEMOSTASIS
|
130
|
3.84e-04
|
-1.81e-01
|
3.13e-03
|
GOBP NEGATIVE REGULATION OF LIPID CATABOLIC PROCESS
|
19
|
1.73e-01
|
1.80e-01
|
3.37e-01
|
GOBP CELL CYCLE PROCESS
|
1010
|
7.20e-22
|
-1.80e-01
|
1.29e-19
|
GOBP REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS
|
41
|
4.57e-02
|
-1.80e-01
|
1.35e-01
|
GOMF SCAVENGER RECEPTOR ACTIVITY
|
22
|
1.43e-01
|
-1.80e-01
|
2.96e-01
|
GOBP MYELOID CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE
|
71
|
8.67e-03
|
-1.80e-01
|
3.83e-02
|
GOMF RIBOSOMAL SMALL SUBUNIT BINDING
|
16
|
2.12e-01
|
1.80e-01
|
3.87e-01
|
GOBP PRIMITIVE HEMOPOIESIS
|
11
|
3.01e-01
|
-1.80e-01
|
4.85e-01
|
GOCC PHOSPHATIDYLINOSITOL 3 KINASE COMPLEX
|
26
|
1.12e-01
|
-1.80e-01
|
2.52e-01
|
GOBP CARDIAC MUSCLE CONTRACTION
|
117
|
7.79e-04
|
1.80e-01
|
5.55e-03
|
GOMF NITRIC OXIDE SYNTHASE BINDING
|
20
|
1.64e-01
|
-1.80e-01
|
3.24e-01
|
GOBP OLIGOPEPTIDE TRANSPORT
|
11
|
3.02e-01
|
1.80e-01
|
4.86e-01
|
GOCC MYELIN SHEATH
|
172
|
4.83e-05
|
1.80e-01
|
5.38e-04
|
GOBP REGULATION OF ERYTHROCYTE DIFFERENTIATION
|
45
|
3.70e-02
|
-1.80e-01
|
1.16e-01
|
GOBP MULTICELLULAR ORGANISMAL MOVEMENT
|
47
|
3.30e-02
|
1.80e-01
|
1.07e-01
|
GOBP POSITIVE REGULATION OF GLYCOGEN METABOLIC PROCESS
|
18
|
1.87e-01
|
-1.80e-01
|
3.54e-01
|
GOBP RIBOSOMAL LARGE SUBUNIT BIOGENESIS
|
60
|
1.62e-02
|
1.80e-01
|
6.28e-02
|
GOBP T HELPER 17 CELL DIFFERENTIATION
|
22
|
1.45e-01
|
-1.80e-01
|
2.98e-01
|
GOBP CELL SURFACE PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY
|
66
|
1.17e-02
|
-1.80e-01
|
4.87e-02
|
GOBP ESTABLISHMENT OF EPITHELIAL CELL POLARITY
|
32
|
7.89e-02
|
-1.80e-01
|
2.00e-01
|
GOBP PARAXIAL MESODERM DEVELOPMENT
|
18
|
1.88e-01
|
-1.79e-01
|
3.54e-01
|
GOMF POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR ACTIVITY
|
24
|
1.28e-01
|
1.79e-01
|
2.75e-01
|
GOBP ACTION POTENTIAL
|
121
|
6.65e-04
|
1.79e-01
|
4.84e-03
|
GOBP ENTRAINMENT OF CIRCADIAN CLOCK
|
23
|
1.37e-01
|
-1.79e-01
|
2.86e-01
|
GOBP REGULATION OF CALCIUM ION IMPORT ACROSS PLASMA MEMBRANE
|
12
|
2.82e-01
|
-1.79e-01
|
4.66e-01
|
GOBP MUCOPOLYSACCHARIDE METABOLIC PROCESS
|
65
|
1.25e-02
|
-1.79e-01
|
5.15e-02
|
GOBP POSITIVE REGULATION OF INFLAMMATORY RESPONSE
|
98
|
2.20e-03
|
-1.79e-01
|
1.29e-02
|
GOBP POSITIVE REGULATION OF CYTOKINE PRODUCTION
|
361
|
5.58e-09
|
-1.79e-01
|
1.70e-07
|
GOBP CELLULAR RESPONSE TO UV
|
78
|
6.27e-03
|
-1.79e-01
|
2.98e-02
|
GOBP TRNA METHYLATION
|
37
|
5.94e-02
|
1.79e-01
|
1.64e-01
|
GOMF TRANSMEMBRANE RECEPTOR PROTEIN KINASE ACTIVITY
|
58
|
1.83e-02
|
-1.79e-01
|
6.88e-02
|
GOBP EMBRYONIC EYE MORPHOGENESIS
|
24
|
1.29e-01
|
-1.79e-01
|
2.75e-01
|
GOBP REGULATION OF NEURON MIGRATION
|
46
|
3.57e-02
|
-1.79e-01
|
1.14e-01
|
GOBP SULFUR COMPOUND BIOSYNTHETIC PROCESS
|
110
|
1.19e-03
|
1.79e-01
|
7.87e-03
|
GOBP DOUBLE STRAND BREAK REPAIR
|
250
|
1.16e-06
|
-1.79e-01
|
2.03e-05
|
GOBP HOMOLOGOUS RECOMBINATION
|
35
|
6.70e-02
|
-1.79e-01
|
1.78e-01
|
GOBP PYRIMIDINE NUCLEOTIDE CATABOLIC PROCESS
|
12
|
2.83e-01
|
1.79e-01
|
4.66e-01
|
GOMF VOLTAGE GATED CHANNEL ACTIVITY
|
101
|
1.92e-03
|
1.79e-01
|
1.16e-02
|
GOBP REGULATION OF SKELETAL MUSCLE ACETYLCHOLINE GATED CHANNEL CLUSTERING
|
14
|
2.47e-01
|
-1.79e-01
|
4.28e-01
|
GOBP NEGATIVE REGULATION OF ERYTHROCYTE DIFFERENTIATION
|
10
|
3.28e-01
|
1.79e-01
|
5.15e-01
|
GOBP POSITIVE REGULATION OF LIPID METABOLIC PROCESS
|
114
|
1.00e-03
|
1.79e-01
|
6.81e-03
|
GOBP LIVER MORPHOGENESIS
|
28
|
1.02e-01
|
-1.78e-01
|
2.38e-01
|
GOCC P BODY
|
74
|
8.06e-03
|
-1.78e-01
|
3.61e-02
|
GOBP NEGATIVE REGULATION OF WNT SIGNALING PATHWAY
|
139
|
2.90e-04
|
-1.78e-01
|
2.48e-03
|
GOMF ACETYLCHOLINE RECEPTOR BINDING
|
13
|
2.66e-01
|
-1.78e-01
|
4.47e-01
|
GOCC JUXTAPARANODE REGION OF AXON
|
11
|
3.06e-01
|
1.78e-01
|
4.91e-01
|
GOBP POSITIVE REGULATION OF TYPE II INTERFERON PRODUCTION
|
52
|
2.64e-02
|
-1.78e-01
|
9.06e-02
|
GOBP ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY
|
191
|
2.28e-05
|
-1.78e-01
|
2.81e-04
|
GOBP POSITIVE REGULATION OF PROTEIN DEPHOSPHORYLATION
|
38
|
5.77e-02
|
-1.78e-01
|
1.60e-01
|
GOCC TOR COMPLEX
|
12
|
2.86e-01
|
1.78e-01
|
4.69e-01
|
GOBP ORGANIC HYDROXY COMPOUND BIOSYNTHETIC PROCESS
|
167
|
7.42e-05
|
1.78e-01
|
7.74e-04
|
GOMF HYDROLASE ACTIVITY ACTING ON CARBON NITROGEN BUT NOT PEPTIDE BONDS IN LINEAR AMIDES
|
61
|
1.63e-02
|
1.78e-01
|
6.32e-02
|
GOBP CYTOPLASMIC SEQUESTERING OF PROTEIN
|
16
|
2.18e-01
|
-1.78e-01
|
3.94e-01
|
GOBP REGULATION OF NECROPTOTIC PROCESS
|
22
|
1.49e-01
|
-1.78e-01
|
3.03e-01
|
GOMF O METHYLTRANSFERASE ACTIVITY
|
18
|
1.92e-01
|
1.78e-01
|
3.59e-01
|
GOMF SYMPORTER ACTIVITY
|
93
|
3.09e-03
|
1.78e-01
|
1.69e-02
|
GOBP SENSORY PERCEPTION OF LIGHT STIMULUS
|
74
|
8.34e-03
|
1.77e-01
|
3.71e-02
|
GOBP CELL KILLING
|
128
|
5.33e-04
|
-1.77e-01
|
4.04e-03
|
GOMF MICROTUBULE MOTOR ACTIVITY
|
46
|
3.74e-02
|
-1.77e-01
|
1.17e-01
|
GOBP CD40 SIGNALING PATHWAY
|
13
|
2.68e-01
|
-1.77e-01
|
4.50e-01
|
GOBP SKELETAL MUSCLE SATELLITE CELL PROLIFERATION
|
17
|
2.06e-01
|
-1.77e-01
|
3.78e-01
|
GOBP ACTIN FILAMENT BASED TRANSPORT
|
11
|
3.09e-01
|
-1.77e-01
|
4.94e-01
|
GOCC POLE PLASM
|
13
|
2.68e-01
|
-1.77e-01
|
4.50e-01
|
GOBP REGULATION OF MEMBRANE INVAGINATION
|
19
|
1.81e-01
|
-1.77e-01
|
3.46e-01
|
GOBP MEMBRANE INVAGINATION
|
63
|
1.50e-02
|
-1.77e-01
|
5.93e-02
|
GOMF PROTEIN SERINE KINASE ACTIVITY
|
14
|
2.51e-01
|
-1.77e-01
|
4.32e-01
|
GOBP MOLTING CYCLE
|
94
|
3.03e-03
|
-1.77e-01
|
1.67e-02
|
GOBP AMINOGLYCAN BIOSYNTHETIC PROCESS
|
52
|
2.73e-02
|
-1.77e-01
|
9.28e-02
|
GOCC SNO S RNA CONTAINING RIBONUCLEOPROTEIN COMPLEX
|
22
|
1.51e-01
|
1.77e-01
|
3.05e-01
|
GOBP CELLULAR RESPONSE TO XENOBIOTIC STIMULUS
|
105
|
1.75e-03
|
1.77e-01
|
1.08e-02
|
GOBP ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY
|
118
|
9.15e-04
|
-1.77e-01
|
6.30e-03
|
GOMF AMIDE BINDING
|
169
|
7.49e-05
|
1.77e-01
|
7.80e-04
|
GOBP LIPID BIOSYNTHETIC PROCESS
|
524
|
5.59e-12
|
1.77e-01
|
2.92e-10
|
GOBP REGULATION OF MICROTUBULE POLYMERIZATION
|
50
|
3.07e-02
|
-1.77e-01
|
1.01e-01
|
GOBP FORELIMB MORPHOGENESIS
|
26
|
1.19e-01
|
-1.77e-01
|
2.62e-01
|
GOBP REGULATION OF ENDOTHELIAL CELL MIGRATION
|
154
|
1.62e-04
|
-1.76e-01
|
1.51e-03
|
GOMF TAU PROTEIN BINDING
|
21
|
1.62e-01
|
1.76e-01
|
3.21e-01
|
GOMF PHOSPHATIDIC ACID BINDING
|
23
|
1.43e-01
|
1.76e-01
|
2.96e-01
|
GOBP NEGATIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION
|
41
|
5.09e-02
|
-1.76e-01
|
1.47e-01
|
GOBP TROPHOBLAST GIANT CELL DIFFERENTIATION
|
12
|
2.91e-01
|
-1.76e-01
|
4.74e-01
|
GOMF BASIC AMINO ACID TRANSMEMBRANE TRANSPORTER ACTIVITY
|
11
|
3.12e-01
|
1.76e-01
|
4.97e-01
|
GOBP IMMUNE EFFECTOR PROCESS
|
441
|
2.66e-10
|
-1.76e-01
|
1.10e-08
|
GOBP PODOSOME ASSEMBLY
|
22
|
1.53e-01
|
-1.76e-01
|
3.09e-01
|
GOBP REGULATION OF MAST CELL ACTIVATION
|
20
|
1.73e-01
|
-1.76e-01
|
3.36e-01
|
GOBP REGULATION OF EXCITATORY SYNAPSE ASSEMBLY
|
15
|
2.38e-01
|
-1.76e-01
|
4.17e-01
|
GOBP DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR
|
61
|
1.75e-02
|
-1.76e-01
|
6.66e-02
|
GOBP POSITIVE REGULATION OF CYTOSKELETON ORGANIZATION
|
165
|
9.93e-05
|
-1.76e-01
|
9.95e-04
|
GOCC U1 SNRNP
|
18
|
1.97e-01
|
1.76e-01
|
3.66e-01
|
GOBP PRO B CELL DIFFERENTIATION
|
11
|
3.13e-01
|
-1.76e-01
|
4.98e-01
|
GOBP MICROTUBULE BASED PROTEIN TRANSPORT
|
14
|
2.55e-01
|
1.76e-01
|
4.36e-01
|
GOBP C TERMINAL PROTEIN LIPIDATION
|
12
|
2.92e-01
|
-1.76e-01
|
4.76e-01
|
GOBP ALCOHOL METABOLIC PROCESS
|
249
|
1.92e-06
|
1.76e-01
|
3.20e-05
|
GOBP TRANSLATION
|
564
|
1.30e-12
|
1.76e-01
|
7.14e-11
|
GOMF TRANSCRIPTION COREPRESSOR BINDING
|
49
|
3.36e-02
|
-1.76e-01
|
1.08e-01
|
GOBP REGULATION OF ADENYLATE CYCLASE ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY
|
19
|
1.85e-01
|
1.76e-01
|
3.52e-01
|
GOBP CELL MATRIX ADHESION
|
190
|
3.10e-05
|
-1.76e-01
|
3.67e-04
|
GOBP KERATINOCYTE DIFFERENTIATION
|
76
|
8.20e-03
|
-1.76e-01
|
3.66e-02
|
GOBP L ALPHA AMINO ACID TRANSMEMBRANE TRANSPORT
|
53
|
2.72e-02
|
1.76e-01
|
9.27e-02
|
GOBP N GLYCAN PROCESSING
|
12
|
2.93e-01
|
-1.75e-01
|
4.76e-01
|
GOBP POSITIVE REGULATION OF DENDRITIC SPINE MORPHOGENESIS
|
27
|
1.15e-01
|
-1.75e-01
|
2.56e-01
|
GOBP EMBRYONIC HINDLIMB MORPHOGENESIS
|
23
|
1.46e-01
|
-1.75e-01
|
2.99e-01
|
GOBP REGULATION OF GOLGI ORGANIZATION
|
16
|
2.25e-01
|
-1.75e-01
|
4.02e-01
|
GOMF CHEMOATTRACTANT ACTIVITY
|
20
|
1.75e-01
|
-1.75e-01
|
3.39e-01
|
GOBP ORGANIC CATION TRANSPORT
|
84
|
5.56e-03
|
1.75e-01
|
2.71e-02
|
GOBP NEUTROPHIL CHEMOTAXIS
|
62
|
1.72e-02
|
-1.75e-01
|
6.56e-02
|
GOBP AMEBOIDAL TYPE CELL MIGRATION
|
392
|
3.05e-09
|
-1.75e-01
|
9.91e-08
|
GOBP POSITIVE REGULATION OF CARTILAGE DEVELOPMENT
|
25
|
1.30e-01
|
-1.75e-01
|
2.77e-01
|
GOBP GLOMERULUS DEVELOPMENT
|
63
|
1.64e-02
|
-1.75e-01
|
6.34e-02
|
GOMF GTP DEPENDENT PROTEIN BINDING
|
20
|
1.76e-01
|
-1.75e-01
|
3.39e-01
|
GOBP BLOOD VESSEL MORPHOGENESIS
|
550
|
3.01e-12
|
-1.75e-01
|
1.59e-10
|
GOBP POSITIVE REGULATION OF MRNA PROCESSING
|
31
|
9.22e-02
|
-1.75e-01
|
2.22e-01
|
GOBP CELLULAR RESPONSE TO KETONE
|
74
|
9.41e-03
|
-1.75e-01
|
4.08e-02
|
GOBP FOREBRAIN CELL MIGRATION
|
57
|
2.26e-02
|
-1.75e-01
|
8.09e-02
|
GOBP POSITIVE REGULATION OF SMOOTH MUSCLE CONTRACTION
|
22
|
1.57e-01
|
-1.75e-01
|
3.14e-01
|
GOBP REGULATION OF DNA RECOMBINATION
|
103
|
2.23e-03
|
-1.74e-01
|
1.31e-02
|
GOBP LUNG VASCULATURE DEVELOPMENT
|
10
|
3.40e-01
|
-1.74e-01
|
5.28e-01
|
GOBP INTERLEUKIN 2 PRODUCTION
|
58
|
2.18e-02
|
-1.74e-01
|
7.87e-02
|
GOBP PROTEASOME ASSEMBLY
|
12
|
2.96e-01
|
1.74e-01
|
4.80e-01
|
GOBP REGULATION OF MITOCHONDRIAL MEMBRANE PERMEABILITY
|
53
|
2.85e-02
|
1.74e-01
|
9.56e-02
|
GOBP MONONUCLEAR CELL DIFFERENTIATION
|
407
|
1.97e-09
|
-1.74e-01
|
6.70e-08
|
GOBP LYMPHOCYTE HOMEOSTASIS
|
77
|
8.37e-03
|
-1.74e-01
|
3.72e-02
|
GOBP REGULATORY T CELL DIFFERENTIATION
|
33
|
8.40e-02
|
-1.74e-01
|
2.09e-01
|
GOBP NEURON PROJECTION ARBORIZATION
|
26
|
1.26e-01
|
-1.74e-01
|
2.72e-01
|
GOBP POSITIVE REGULATION OF CELL ADHESION
|
389
|
4.73e-09
|
-1.74e-01
|
1.49e-07
|
GOBP REGULATION OF MITOTIC CELL CYCLE
|
423
|
1.07e-09
|
-1.74e-01
|
3.75e-08
|
GOBP RESPONSE TO INCREASED OXYGEN LEVELS
|
12
|
2.98e-01
|
1.74e-01
|
4.82e-01
|
GOBP REGULATION OF IMMUNE RESPONSE
|
641
|
9.20e-14
|
-1.73e-01
|
6.07e-12
|
GOBP REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS
|
126
|
7.84e-04
|
-1.73e-01
|
5.57e-03
|
GOCC TRANSCRIPTION ELONGATION FACTOR COMPLEX
|
45
|
4.45e-02
|
-1.73e-01
|
1.33e-01
|
GOCC PHOTORECEPTOR INNER SEGMENT
|
39
|
6.14e-02
|
1.73e-01
|
1.67e-01
|
GOBP RESPONSE TO HYDROGEN PEROXIDE
|
79
|
7.85e-03
|
-1.73e-01
|
3.54e-02
|
GOBP NEGATIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION
|
26
|
1.27e-01
|
-1.73e-01
|
2.73e-01
|
GOCC TELOMERASE HOLOENZYME COMPLEX
|
20
|
1.80e-01
|
1.73e-01
|
3.45e-01
|
GOBP LENS MORPHOGENESIS IN CAMERA TYPE EYE
|
19
|
1.92e-01
|
-1.73e-01
|
3.59e-01
|
GOBP PROTEIN DNA COMPLEX ASSEMBLY
|
140
|
4.16e-04
|
-1.73e-01
|
3.34e-03
|
GOCC ISWI TYPE COMPLEX
|
13
|
2.80e-01
|
-1.73e-01
|
4.63e-01
|
GOBP MEMBRANE HYPERPOLARIZATION
|
14
|
2.63e-01
|
1.73e-01
|
4.44e-01
|
GOBP POSITIVE REGULATION OF VIRAL GENOME REPLICATION
|
24
|
1.43e-01
|
-1.73e-01
|
2.95e-01
|
GOCC DNA REPAIR COMPLEX
|
20
|
1.81e-01
|
-1.73e-01
|
3.46e-01
|
GOBP NEGATIVE REGULATION OF CARDIOCYTE DIFFERENTIATION
|
11
|
3.21e-01
|
-1.73e-01
|
5.08e-01
|
GOMF VOLTAGE GATED CHLORIDE CHANNEL ACTIVITY
|
10
|
3.44e-01
|
1.73e-01
|
5.33e-01
|
GOBP REGULATION OF MYELOID CELL DIFFERENTIATION
|
169
|
1.10e-04
|
-1.73e-01
|
1.09e-03
|
GOBP REGULATION OF NEUTROPHIL MIGRATION
|
41
|
5.58e-02
|
-1.73e-01
|
1.57e-01
|
GOMF CALCIUM DEPENDENT PHOSPHOLIPID BINDING
|
31
|
9.63e-02
|
-1.73e-01
|
2.29e-01
|
GOBP PEPTIDYL THREONINE DEPHOSPHORYLATION
|
14
|
2.64e-01
|
1.73e-01
|
4.45e-01
|
GOMF NUCLEOSIDE BINDING
|
10
|
3.45e-01
|
-1.72e-01
|
5.33e-01
|
GOBP REGULATION OF CELL DIVISION
|
142
|
3.95e-04
|
-1.72e-01
|
3.19e-03
|
GOCC EXTERNAL ENCAPSULATING STRUCTURE
|
366
|
1.63e-08
|
-1.72e-01
|
4.38e-07
|
GOBP REGULATION OF LEUKOCYTE DIFFERENTIATION
|
258
|
2.00e-06
|
-1.72e-01
|
3.31e-05
|
GOBP CARDIAC MUSCLE CELL PROLIFERATION
|
58
|
2.33e-02
|
-1.72e-01
|
8.26e-02
|
GOCC CELL SUBSTRATE JUNCTION
|
169
|
1.14e-04
|
-1.72e-01
|
1.12e-03
|
GOBP VASCULATURE DEVELOPMENT
|
668
|
4.47e-14
|
-1.72e-01
|
3.07e-12
|
GOMF METHYLATION DEPENDENT PROTEIN BINDING
|
72
|
1.16e-02
|
-1.72e-01
|
4.84e-02
|
GOBP MEMBRANE PROTEIN INTRACELLULAR DOMAIN PROTEOLYSIS
|
10
|
3.46e-01
|
-1.72e-01
|
5.34e-01
|
GOBP POSITIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE PROTEIN KINASE B SIGNAL TRANSDUCTION
|
147
|
3.23e-04
|
-1.72e-01
|
2.70e-03
|
GOBP POSITIVE REGULATION OF CELL MATRIX ADHESION
|
52
|
3.19e-02
|
-1.72e-01
|
1.04e-01
|
GOBP CARDIAC MYOFIBRIL ASSEMBLY
|
18
|
2.07e-01
|
1.72e-01
|
3.80e-01
|
GOBP PHOSPHATIDYLINOSITOL 3 KINASE PROTEIN KINASE B SIGNAL TRANSDUCTION
|
255
|
2.38e-06
|
-1.72e-01
|
3.87e-05
|
GOBP MRNA CIS SPLICING VIA SPLICEOSOME
|
25
|
1.37e-01
|
-1.72e-01
|
2.86e-01
|
GOMF ALPHA TUBULIN BINDING
|
38
|
6.68e-02
|
-1.72e-01
|
1.78e-01
|
GOBP CELL CYCLE G1 S PHASE TRANSITION
|
214
|
1.53e-05
|
-1.72e-01
|
1.95e-04
|
GOBP MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS
|
42
|
5.41e-02
|
-1.72e-01
|
1.54e-01
|
GOMF ENDONUCLEASE ACTIVITY ACTIVE WITH EITHER RIBO OR DEOXYRIBONUCLEIC ACIDS AND PRODUCING 5 PHOSPHOMONOESTERS
|
35
|
7.87e-02
|
1.72e-01
|
2.00e-01
|
GOBP POSITIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS
|
483
|
1.21e-10
|
-1.72e-01
|
5.41e-09
|
GOBP POSITIVE REGULATION OF MYOBLAST DIFFERENTIATION
|
41
|
5.71e-02
|
-1.72e-01
|
1.59e-01
|
GOBP CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE
|
112
|
1.71e-03
|
-1.72e-01
|
1.06e-02
|
GOBP MESENCHYMAL STEM CELL DIFFERENTIATION
|
10
|
3.47e-01
|
-1.72e-01
|
5.35e-01
|
GOBP POSITIVE REGULATION OF B CELL MEDIATED IMMUNITY
|
31
|
9.81e-02
|
-1.72e-01
|
2.32e-01
|
GOBP IMMUNE RESPONSE REGULATING SIGNALING PATHWAY
|
351
|
3.61e-08
|
-1.72e-01
|
9.12e-07
|
GOBP RESPONSE TO HYDROPEROXIDE
|
16
|
2.35e-01
|
-1.72e-01
|
4.14e-01
|
GOBP REGULATION OF RUFFLE ASSEMBLY
|
25
|
1.38e-01
|
-1.71e-01
|
2.88e-01
|
GOBP CELLULAR LIPID METABOLIC PROCESS
|
754
|
1.83e-15
|
1.71e-01
|
1.62e-13
|
GOBP TERPENOID BIOSYNTHETIC PROCESS
|
14
|
2.67e-01
|
1.71e-01
|
4.48e-01
|
GOBP NEGATIVE REGULATION OF CALCINEURIN MEDIATED SIGNALING
|
15
|
2.51e-01
|
1.71e-01
|
4.32e-01
|
GOBP MODULATION BY HOST OF VIRAL GENOME REPLICATION
|
21
|
1.74e-01
|
-1.71e-01
|
3.37e-01
|
GOBP ACTIVATION OF IMMUNE RESPONSE
|
393
|
6.30e-09
|
-1.71e-01
|
1.88e-07
|
GOBP APPENDAGE DEVELOPMENT
|
150
|
2.99e-04
|
-1.71e-01
|
2.53e-03
|
GOBP CENTROMERE COMPLEX ASSEMBLY
|
21
|
1.74e-01
|
-1.71e-01
|
3.37e-01
|
GOBP NEGATIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS
|
48
|
4.02e-02
|
-1.71e-01
|
1.23e-01
|
GOBP BASEMENT MEMBRANE ORGANIZATION
|
37
|
7.18e-02
|
-1.71e-01
|
1.87e-01
|
GOBP POSITIVE REGULATION OF IMMUNE SYSTEM PROCESS
|
789
|
4.90e-16
|
-1.71e-01
|
4.66e-14
|
GOMF SERINE HYDROLASE ACTIVITY
|
75
|
1.05e-02
|
1.71e-01
|
4.46e-02
|
GOBP REGULATION OF DOPAMINE SECRETION
|
19
|
1.97e-01
|
1.71e-01
|
3.67e-01
|
GOBP MITOTIC INTRA S DNA DAMAGE CHECKPOINT SIGNALING
|
13
|
2.86e-01
|
-1.71e-01
|
4.69e-01
|
GOBP EMBRYONIC DIGIT MORPHOGENESIS
|
57
|
2.56e-02
|
-1.71e-01
|
8.86e-02
|
GOBP POSITIVE REGULATION OF NEUTROPHIL MIGRATION
|
31
|
9.95e-02
|
-1.71e-01
|
2.34e-01
|
GOBP PYRIMIDINE RIBONUCLEOTIDE METABOLIC PROCESS
|
23
|
1.56e-01
|
1.71e-01
|
3.13e-01
|
GOBP RAC PROTEIN SIGNAL TRANSDUCTION
|
52
|
3.31e-02
|
-1.71e-01
|
1.07e-01
|
GOCC ENDOCYTIC VESICLE
|
188
|
5.46e-05
|
-1.71e-01
|
5.98e-04
|
GOBP BONE MATURATION
|
23
|
1.56e-01
|
-1.71e-01
|
3.13e-01
|
GOBP METANEPHRIC GLOMERULUS DEVELOPMENT
|
11
|
3.27e-01
|
1.71e-01
|
5.14e-01
|
GOBP PEPTIDYL SERINE MODIFICATION
|
241
|
5.17e-06
|
-1.71e-01
|
7.64e-05
|
GOBP NEUROTRANSMITTER RECEPTOR TRANSPORT
|
31
|
9.99e-02
|
1.71e-01
|
2.35e-01
|
GOCC SPERM HEAD
|
12
|
3.06e-01
|
-1.71e-01
|
4.91e-01
|
GOBP MESODERM MORPHOGENESIS
|
48
|
4.08e-02
|
-1.71e-01
|
1.25e-01
|
GOBP AUDITORY BEHAVIOR
|
10
|
3.50e-01
|
-1.71e-01
|
5.37e-01
|
GOBP POSITIVE REGULATION OF DEFENSE RESPONSE
|
377
|
1.44e-08
|
-1.71e-01
|
3.95e-07
|
GOBP MANNOSE METABOLIC PROCESS
|
11
|
3.27e-01
|
1.71e-01
|
5.15e-01
|
GOMF OPSONIN BINDING
|
12
|
3.07e-01
|
-1.70e-01
|
4.92e-01
|
GOBP ACTIN MYOSIN FILAMENT SLIDING
|
10
|
3.51e-01
|
1.70e-01
|
5.38e-01
|
GOBP NEGATIVE REGULATION OF COMPLEMENT ACTIVATION
|
10
|
3.51e-01
|
-1.70e-01
|
5.38e-01
|
GOBP DEADENYLATION DEPENDENT DECAPPING OF NUCLEAR TRANSCRIBED MRNA
|
11
|
3.28e-01
|
-1.70e-01
|
5.16e-01
|
GOBP POSITIVE REGULATION OF BLOOD PRESSURE
|
33
|
9.08e-02
|
1.70e-01
|
2.20e-01
|
GOBP RESPONSE TO ALKALOID
|
58
|
2.52e-02
|
1.70e-01
|
8.76e-02
|
GOBP POSITIVE REGULATION OF NEURON PROJECTION DEVELOPMENT
|
191
|
5.27e-05
|
-1.70e-01
|
5.80e-04
|
GOBP REGULATION OF HORMONE BIOSYNTHETIC PROCESS
|
23
|
1.59e-01
|
-1.70e-01
|
3.17e-01
|
GOBP BASIC AMINO ACID TRANSPORT
|
14
|
2.71e-01
|
1.70e-01
|
4.53e-01
|
GOBP INTRACELLULAR IRON ION HOMEOSTASIS
|
57
|
2.67e-02
|
1.70e-01
|
9.15e-02
|
GOBP POSITIVE REGULATION OF CELL CYCLE
|
282
|
9.97e-07
|
-1.70e-01
|
1.76e-05
|
GOBP NEGATIVE REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION
|
11
|
3.30e-01
|
-1.70e-01
|
5.17e-01
|
GOBP AXO DENDRITIC PROTEIN TRANSPORT
|
10
|
3.53e-01
|
1.70e-01
|
5.39e-01
|
GOBP NEGATIVE REGULATION OF CELL MATRIX ADHESION
|
31
|
1.02e-01
|
-1.70e-01
|
2.38e-01
|
GOBP ANATOMICAL STRUCTURE REGRESSION
|
12
|
3.09e-01
|
1.70e-01
|
4.94e-01
|
GOCC METHYLOSOME
|
12
|
3.09e-01
|
1.70e-01
|
4.94e-01
|
GOBP CHAPERONE MEDIATED PROTEIN FOLDING
|
58
|
2.56e-02
|
1.70e-01
|
8.86e-02
|
GOBP CHROMATIN REMODELING
|
424
|
2.46e-09
|
-1.70e-01
|
8.17e-08
|
GOMF TOXIC SUBSTANCE BINDING
|
12
|
3.09e-01
|
1.69e-01
|
4.95e-01
|
GOBP BIOLOGICAL PROCESS INVOLVED IN SYMBIOTIC INTERACTION
|
175
|
1.15e-04
|
-1.69e-01
|
1.13e-03
|
GOBP NEGATIVE REGULATION OF CYTOKINE PRODUCTION
|
227
|
1.17e-05
|
-1.69e-01
|
1.54e-04
|
GOBP PYRUVATE METABOLIC PROCESS
|
115
|
1.75e-03
|
1.69e-01
|
1.08e-02
|
GOBP LIPID METABOLIC PROCESS
|
999
|
3.17e-19
|
1.69e-01
|
4.10e-17
|
GOMF CALCIUM DEPENDENT CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY
|
10
|
3.55e-01
|
1.69e-01
|
5.41e-01
|
GOBP BIOMINERAL TISSUE DEVELOPMENT
|
134
|
7.39e-04
|
-1.69e-01
|
5.30e-03
|
GOMF IMMUNE RECEPTOR ACTIVITY
|
78
|
9.91e-03
|
-1.69e-01
|
4.25e-02
|
GOBP NEGATIVE REGULATION OF ASTROCYTE DIFFERENTIATION
|
13
|
2.91e-01
|
-1.69e-01
|
4.75e-01
|
GOBP REGULATION OF CELL CYCLE PROCESS
|
606
|
1.61e-12
|
-1.69e-01
|
8.75e-11
|
GOMF RNA POLYMERASE III ACTIVITY
|
10
|
3.55e-01
|
1.69e-01
|
5.42e-01
|
GOBP POSITIVE REGULATION OF GLIAL CELL MIGRATION
|
13
|
2.92e-01
|
-1.69e-01
|
4.75e-01
|
GOMF INSULIN LIKE GROWTH FACTOR I BINDING
|
11
|
3.32e-01
|
-1.69e-01
|
5.20e-01
|
GOBP BIOLOGICAL PROCESS INVOLVED IN INTERSPECIES INTERACTION BETWEEN ORGANISMS
|
1133
|
2.47e-21
|
-1.69e-01
|
3.99e-19
|
GOCC CILIARY MEMBRANE
|
42
|
5.85e-02
|
-1.69e-01
|
1.62e-01
|
GOBP REGULATION OF BICELLULAR TIGHT JUNCTION ASSEMBLY
|
21
|
1.81e-01
|
-1.69e-01
|
3.46e-01
|
GOBP T HELPER CELL LINEAGE COMMITMENT
|
13
|
2.93e-01
|
-1.69e-01
|
4.76e-01
|
GOMF K48 LINKED DEUBIQUITINASE ACTIVITY
|
14
|
2.75e-01
|
-1.69e-01
|
4.57e-01
|
GOBP RESPONSE TO EPIDERMAL GROWTH FACTOR
|
40
|
6.52e-02
|
-1.69e-01
|
1.74e-01
|
GOMF TRANSITION METAL ION TRANSMEMBRANE TRANSPORTER ACTIVITY
|
32
|
9.92e-02
|
-1.68e-01
|
2.34e-01
|
GOBP VIRAL GENE EXPRESSION
|
68
|
1.64e-02
|
-1.68e-01
|
6.34e-02
|
GOBP MUSCLE CELL MIGRATION
|
116
|
1.75e-03
|
-1.68e-01
|
1.08e-02
|
GOBP VESICLE TARGETING TO FROM OR WITHIN GOLGI
|
27
|
1.30e-01
|
1.68e-01
|
2.77e-01
|
GOBP NEGATIVE REGULATION OF LOCOMOTION
|
271
|
1.95e-06
|
-1.68e-01
|
3.25e-05
|
GOBP NON PROTEINOGENIC AMINO ACID METABOLIC PROCESS
|
58
|
2.67e-02
|
1.68e-01
|
9.15e-02
|
GOBP PEPTIDE CROSS LINKING
|
11
|
3.34e-01
|
-1.68e-01
|
5.22e-01
|
GOBP T HELPER 17 CELL LINEAGE COMMITMENT
|
10
|
3.57e-01
|
-1.68e-01
|
5.43e-01
|
GOBP REGULATION OF CELL CYCLE G1 S PHASE TRANSITION
|
169
|
1.68e-04
|
-1.68e-01
|
1.55e-03
|
GOBP REGULATION OF FATTY ACID OXIDATION
|
35
|
8.56e-02
|
1.68e-01
|
2.11e-01
|
GOBP NUCLEOSIDE TRIPHOSPHATE CATABOLIC PROCESS
|
11
|
3.35e-01
|
-1.68e-01
|
5.24e-01
|
GOBP NEURONAL ION CHANNEL CLUSTERING
|
12
|
3.14e-01
|
-1.68e-01
|
5.00e-01
|
GOBP POSITIVE REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY
|
14
|
2.77e-01
|
-1.68e-01
|
4.59e-01
|
GOBP DERMATAN SULFATE PROTEOGLYCAN METABOLIC PROCESS
|
11
|
3.35e-01
|
-1.68e-01
|
5.24e-01
|
GOBP MONOAMINE TRANSPORT
|
61
|
2.36e-02
|
1.68e-01
|
8.33e-02
|
GOBP REGULATION OF NEURON DIFFERENTIATION
|
158
|
2.84e-04
|
-1.68e-01
|
2.44e-03
|
GOBP REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL
|
27
|
1.32e-01
|
-1.68e-01
|
2.79e-01
|
GOBP INNATE IMMUNE RESPONSE ACTIVATING CELL SURFACE RECEPTOR SIGNALING PATHWAY
|
70
|
1.55e-02
|
-1.67e-01
|
6.07e-02
|
GOMF PROTEIN TRANSMEMBRANE TRANSPORTER ACTIVITY
|
19
|
2.06e-01
|
1.67e-01
|
3.80e-01
|
GOBP NEGATIVE REGULATION OF STEM CELL DIFFERENTIATION
|
27
|
1.32e-01
|
-1.67e-01
|
2.79e-01
|
GOBP STEROID HORMONE BIOSYNTHETIC PROCESS
|
23
|
1.65e-01
|
1.67e-01
|
3.25e-01
|
GOBP MYELOID DENDRITIC CELL DIFFERENTIATION
|
17
|
2.32e-01
|
-1.67e-01
|
4.11e-01
|
GOBP ECTODERM DEVELOPMENT
|
12
|
3.16e-01
|
1.67e-01
|
5.02e-01
|
GOMF UDP GLYCOSYLTRANSFERASE ACTIVITY
|
96
|
4.65e-03
|
-1.67e-01
|
2.36e-02
|
GOBP SKIN MORPHOGENESIS
|
13
|
2.97e-01
|
-1.67e-01
|
4.80e-01
|
GOMF CYCLIC NUCLEOTIDE BINDING
|
28
|
1.26e-01
|
1.67e-01
|
2.72e-01
|
GOMF CIS REGULATORY REGION SEQUENCE SPECIFIC DNA BINDING
|
756
|
7.98e-15
|
-1.67e-01
|
6.29e-13
|
GOBP HAIR CYCLE PHASE
|
12
|
3.16e-01
|
-1.67e-01
|
5.03e-01
|
GOCC SMALL NUCLEAR RIBONUCLEOPROTEIN COMPLEX
|
67
|
1.81e-02
|
1.67e-01
|
6.79e-02
|
GOBP POSITIVE REGULATION OF CELL DIFFERENTIATION
|
759
|
7.61e-15
|
-1.67e-01
|
6.08e-13
|
GOBP VIRAL TRANSLATION
|
17
|
2.34e-01
|
-1.67e-01
|
4.13e-01
|
GOBP REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT
|
47
|
4.79e-02
|
1.67e-01
|
1.41e-01
|
GOBP CEREBELLAR CORTEX FORMATION
|
24
|
1.58e-01
|
1.67e-01
|
3.15e-01
|
GOBP IMMUNE RESPONSE TO TUMOR CELL
|
16
|
2.49e-01
|
-1.67e-01
|
4.30e-01
|
GOBP POSITIVE REGULATION OF RAC PROTEIN SIGNAL TRANSDUCTION
|
17
|
2.34e-01
|
-1.67e-01
|
4.14e-01
|
GOBP ORGANONITROGEN COMPOUND BIOSYNTHETIC PROCESS
|
1330
|
7.62e-24
|
1.67e-01
|
1.64e-21
|
GOBP REGULATION OF LIPOPROTEIN METABOLIC PROCESS
|
15
|
2.64e-01
|
1.67e-01
|
4.46e-01
|
GOBP RESPONSE TO CADMIUM ION
|
31
|
1.09e-01
|
1.66e-01
|
2.47e-01
|
GOBP REGULATION OF DENDRITIC SPINE MORPHOGENESIS
|
54
|
3.46e-02
|
-1.66e-01
|
1.11e-01
|
GOBP RESPONSE TO UV
|
134
|
9.05e-04
|
-1.66e-01
|
6.26e-03
|
GOBP SMOOTH MUSCLE CELL DIFFERENTIATION
|
69
|
1.71e-02
|
-1.66e-01
|
6.54e-02
|
GOBP ENDOTHELIAL CELL CHEMOTAXIS
|
26
|
1.43e-01
|
-1.66e-01
|
2.95e-01
|
GOBP PRE MIRNA PROCESSING
|
12
|
3.19e-01
|
-1.66e-01
|
5.06e-01
|
GOBP POSITIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS
|
16
|
2.50e-01
|
-1.66e-01
|
4.32e-01
|
GOBP REGULATION OF ERBB SIGNALING PATHWAY
|
60
|
2.63e-02
|
-1.66e-01
|
9.03e-02
|
GOBP POSITIVE REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY
|
62
|
2.39e-02
|
-1.66e-01
|
8.41e-02
|
GOBP POSITIVE REGULATION OF T HELPER 17 TYPE IMMUNE RESPONSE
|
14
|
2.82e-01
|
-1.66e-01
|
4.66e-01
|
GOBP DENDRITIC SPINE MAINTENANCE
|
21
|
1.88e-01
|
-1.66e-01
|
3.55e-01
|
GOMF VOLTAGE GATED POTASSIUM CHANNEL ACTIVITY
|
53
|
3.71e-02
|
1.66e-01
|
1.16e-01
|
GOBP REGULATION OF NUCLEAR TRANSCRIBED MRNA POLY A TAIL SHORTENING
|
13
|
3.01e-01
|
-1.66e-01
|
4.86e-01
|
GOBP SEGMENTATION
|
79
|
1.12e-02
|
-1.65e-01
|
4.71e-02
|
GOBP EPIDERMAL CELL DIFFERENTIATION
|
129
|
1.21e-03
|
-1.65e-01
|
7.94e-03
|
GOBP POSITIVE REGULATION OF CELL CELL ADHESION
|
233
|
1.46e-05
|
-1.65e-01
|
1.87e-04
|
GOBP OSSIFICATION
|
327
|
3.11e-07
|
-1.65e-01
|
6.19e-06
|
GOMF NADPLUS BINDING
|
16
|
2.53e-01
|
1.65e-01
|
4.34e-01
|
GOBP MICROTUBULE POLYMERIZATION
|
82
|
9.85e-03
|
-1.65e-01
|
4.23e-02
|
GOBP CELLULAR MODIFIED AMINO ACID CATABOLIC PROCESS
|
22
|
1.81e-01
|
1.65e-01
|
3.45e-01
|
GOBP SYNAPTIC VESICLE BUDDING FROM PRESYNAPTIC ENDOCYTIC ZONE MEMBRANE
|
10
|
3.67e-01
|
-1.65e-01
|
5.54e-01
|
GOBP PROTEIN LOCALIZATION TO CHROMATIN
|
37
|
8.27e-02
|
-1.65e-01
|
2.06e-01
|
GOBP METANEPHROS MORPHOGENESIS
|
16
|
2.54e-01
|
-1.65e-01
|
4.34e-01
|
GOBP GLYCOSYL COMPOUND BIOSYNTHETIC PROCESS
|
18
|
2.26e-01
|
1.65e-01
|
4.03e-01
|
GOCC HIPPOCAMPAL MOSSY FIBER TO CA3 SYNAPSE
|
45
|
5.58e-02
|
1.65e-01
|
1.57e-01
|
GOBP LONG CHAIN FATTY ACID TRANSPORT
|
42
|
6.46e-02
|
1.65e-01
|
1.73e-01
|
GOBP POSITIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT
|
67
|
1.98e-02
|
-1.65e-01
|
7.34e-02
|
GOBP POSITIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS
|
21
|
1.91e-01
|
1.65e-01
|
3.59e-01
|
GOBP NEGATIVE REGULATION OF BEHAVIOR
|
14
|
2.86e-01
|
1.65e-01
|
4.69e-01
|
GOBP POSITIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS
|
38
|
7.92e-02
|
-1.65e-01
|
2.00e-01
|
GOBP BONE GROWTH
|
29
|
1.25e-01
|
-1.65e-01
|
2.71e-01
|
GOMF CARBONATE DEHYDRATASE ACTIVITY
|
10
|
3.68e-01
|
1.65e-01
|
5.55e-01
|
GOBP LATERAL VENTRICLE DEVELOPMENT
|
12
|
3.24e-01
|
-1.65e-01
|
5.11e-01
|
GOMF SEQUENCE SPECIFIC DNA BINDING
|
1082
|
1.52e-19
|
-1.64e-01
|
2.05e-17
|
GOBP NEGATIVE REGULATION OF OSSIFICATION
|
29
|
1.25e-01
|
-1.64e-01
|
2.72e-01
|
GOBP NEGATIVE REGULATION OF CELL ACTIVATION
|
158
|
3.70e-04
|
-1.64e-01
|
3.03e-03
|
GOBP NEGATIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY
|
113
|
2.57e-03
|
-1.64e-01
|
1.47e-02
|
GOBP TYPE 2 IMMUNE RESPONSE
|
30
|
1.19e-01
|
-1.64e-01
|
2.62e-01
|
GOCC PHOTORECEPTOR CONNECTING CILIUM
|
35
|
9.28e-02
|
-1.64e-01
|
2.23e-01
|
GOBP POSITIVE REGULATION OF MEMBRANE PERMEABILITY
|
38
|
7.99e-02
|
1.64e-01
|
2.02e-01
|
GOMF PROMOTER SPECIFIC CHROMATIN BINDING
|
69
|
1.85e-02
|
-1.64e-01
|
6.93e-02
|
GOBP POSITIVE REGULATION OF PROTEIN POLYMERIZATION
|
74
|
1.47e-02
|
-1.64e-01
|
5.84e-02
|
GOBP ACTIN FILAMENT BUNDLE ORGANIZATION
|
157
|
3.98e-04
|
-1.64e-01
|
3.21e-03
|
GOBP POSITIVE REGULATION OF FIBROBLAST PROLIFERATION
|
64
|
2.34e-02
|
-1.64e-01
|
8.26e-02
|
GOBP POSITIVE REGULATION OF MRNA METABOLIC PROCESS
|
114
|
2.54e-03
|
-1.64e-01
|
1.45e-02
|
GOMF KINASE ACTIVATOR ACTIVITY
|
115
|
2.44e-03
|
-1.64e-01
|
1.41e-02
|
GOBP CELL SUBSTRATE ADHESION
|
302
|
1.05e-06
|
-1.64e-01
|
1.85e-05
|
GOBP ORGANIC HYDROXY COMPOUND METABOLIC PROCESS
|
371
|
6.72e-08
|
1.64e-01
|
1.56e-06
|
GOBP EMBRYONIC HEART TUBE DEVELOPMENT
|
73
|
1.56e-02
|
-1.64e-01
|
6.12e-02
|
GOBP POSITIVE REGULATION OF LEUKOCYTE TETHERING OR ROLLING
|
11
|
3.47e-01
|
-1.64e-01
|
5.35e-01
|
GOBP INTRACILIARY ANTEROGRADE TRANSPORT
|
14
|
2.89e-01
|
-1.64e-01
|
4.73e-01
|
GOMF HMG BOX DOMAIN BINDING
|
11
|
3.47e-01
|
-1.64e-01
|
5.35e-01
|
GOBP METANEPHROS DEVELOPMENT
|
63
|
2.48e-02
|
-1.64e-01
|
8.64e-02
|
GOBP LEUKOCYTE HOMEOSTASIS
|
111
|
2.95e-03
|
-1.64e-01
|
1.63e-02
|
GOCC POSTSYNAPTIC ACTIN CYTOSKELETON
|
16
|
2.58e-01
|
-1.63e-01
|
4.39e-01
|
GOBP REGULATION OF TRANSCRIPTION BY GLUCOSE
|
11
|
3.48e-01
|
-1.63e-01
|
5.36e-01
|
GOBP DENDRITIC SPINE MORPHOGENESIS
|
68
|
1.99e-02
|
-1.63e-01
|
7.36e-02
|
GOBP INTEGRATED STRESS RESPONSE SIGNALING
|
19
|
2.18e-01
|
-1.63e-01
|
3.94e-01
|
GOBP POSITIVE REGULATION OF BEHAVIOR
|
18
|
2.30e-01
|
1.63e-01
|
4.09e-01
|
GOBP REGULATION OF VASCULATURE DEVELOPMENT
|
250
|
9.16e-06
|
-1.63e-01
|
1.26e-04
|
GOCC TRIGLYCERIDE RICH PLASMA LIPOPROTEIN PARTICLE
|
12
|
3.27e-01
|
-1.63e-01
|
5.15e-01
|
GOBP REGULATION OF RECEPTOR CATABOLIC PROCESS
|
11
|
3.49e-01
|
-1.63e-01
|
5.36e-01
|
GOCC PROTON TRANSPORTING TWO SECTOR ATPASE COMPLEX
|
22
|
1.85e-01
|
1.63e-01
|
3.52e-01
|
GOCC PROTON TRANSPORTING V TYPE ATPASE COMPLEX
|
22
|
1.85e-01
|
1.63e-01
|
3.52e-01
|
GOBP CELL CHEMOTAXIS
|
225
|
2.59e-05
|
-1.63e-01
|
3.14e-04
|
GOBP PYRIMIDINE DEOXYRIBONUCLEOTIDE CATABOLIC PROCESS
|
10
|
3.72e-01
|
1.63e-01
|
5.58e-01
|
GOBP NEGATIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY
|
117
|
2.34e-03
|
-1.63e-01
|
1.36e-02
|
GOCC CHROMOSOME TELOMERIC REGION
|
103
|
4.28e-03
|
-1.63e-01
|
2.21e-02
|
GOBP NITRIC OXIDE MEDIATED SIGNAL TRANSDUCTION
|
19
|
2.19e-01
|
1.63e-01
|
3.94e-01
|
GOBP REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION
|
67
|
2.11e-02
|
-1.63e-01
|
7.69e-02
|
GOBP COLUMNAR CUBOIDAL EPITHELIAL CELL DIFFERENTIATION
|
92
|
6.95e-03
|
-1.63e-01
|
3.25e-02
|
GOBP LYMPH NODE DEVELOPMENT
|
22
|
1.86e-01
|
-1.63e-01
|
3.52e-01
|
GOBP POSITIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION
|
62
|
2.66e-02
|
-1.63e-01
|
9.13e-02
|
GOBP REGULATION OF MAST CELL DEGRANULATION
|
22
|
1.87e-01
|
-1.63e-01
|
3.53e-01
|
GOBP REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY
|
308
|
9.84e-07
|
-1.63e-01
|
1.74e-05
|
GOMF NEUROTRANSMITTER RECEPTOR ACTIVITY
|
30
|
1.24e-01
|
1.63e-01
|
2.69e-01
|
GOBP NEGATIVE REGULATION OF MICROTUBULE POLYMERIZATION
|
15
|
2.76e-01
|
-1.62e-01
|
4.58e-01
|
GOBP RESPONSE TO INTERLEUKIN 17
|
20
|
2.09e-01
|
-1.62e-01
|
3.81e-01
|
GOBP CELLULAR RESPONSE TO OSMOTIC STRESS
|
45
|
5.95e-02
|
1.62e-01
|
1.64e-01
|
GOBP PATTERN SPECIFICATION PROCESS
|
301
|
1.35e-06
|
-1.62e-01
|
2.33e-05
|
GOMF ABC TYPE TRANSPORTER ACTIVITY
|
37
|
8.75e-02
|
1.62e-01
|
2.15e-01
|
GOMF ATPASE COUPLED MONOATOMIC CATION TRANSMEMBRANE TRANSPORTER ACTIVITY
|
39
|
7.96e-02
|
1.62e-01
|
2.01e-01
|
GOBP ESTROGEN METABOLIC PROCESS
|
17
|
2.47e-01
|
1.62e-01
|
4.28e-01
|
GOBP IRON ION TRANSPORT
|
46
|
5.72e-02
|
1.62e-01
|
1.59e-01
|
GOBP AMIDE BIOSYNTHETIC PROCESS
|
100
|
5.12e-03
|
1.62e-01
|
2.53e-02
|
GOBP PURINE CONTAINING COMPOUND SALVAGE
|
17
|
2.47e-01
|
1.62e-01
|
4.28e-01
|
GOBP RESPONSE TO MACROPHAGE COLONY STIMULATING FACTOR
|
11
|
3.52e-01
|
-1.62e-01
|
5.39e-01
|
GOMF PEPTIDASE ACTIVATOR ACTIVITY INVOLVED IN APOPTOTIC PROCESS
|
18
|
2.34e-01
|
-1.62e-01
|
4.13e-01
|
GOBP REGULATION OF ORGANELLE ASSEMBLY
|
202
|
7.56e-05
|
-1.62e-01
|
7.86e-04
|
GOBP STEM CELL DIFFERENTIATION
|
211
|
5.27e-05
|
-1.62e-01
|
5.80e-04
|
GOCC POSTSYNAPTIC CYTOSKELETON
|
18
|
2.35e-01
|
-1.62e-01
|
4.14e-01
|
GOMF KINASE REGULATOR ACTIVITY
|
226
|
2.95e-05
|
-1.62e-01
|
3.52e-04
|
GOBP POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY
|
26
|
1.54e-01
|
1.62e-01
|
3.10e-01
|
GOBP ADULT HEART DEVELOPMENT
|
15
|
2.79e-01
|
1.61e-01
|
4.62e-01
|
GOBP REGULATION OF BONE MINERALIZATION
|
61
|
2.93e-02
|
-1.61e-01
|
9.74e-02
|
GOBP CHONDROCYTE PROLIFERATION
|
19
|
2.23e-01
|
-1.61e-01
|
4.01e-01
|
GOBP NEGATIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING
|
24
|
1.71e-01
|
-1.61e-01
|
3.34e-01
|
GOBP DOLICHOL METABOLIC PROCESS
|
13
|
3.14e-01
|
1.61e-01
|
5.00e-01
|
GOMF LIGASE ACTIVITY FORMING CARBON NITROGEN BONDS
|
37
|
8.95e-02
|
1.61e-01
|
2.18e-01
|
GOMF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY
|
846
|
2.83e-15
|
-1.61e-01
|
2.44e-13
|
GOBP CATECHOLAMINE TRANSPORT
|
49
|
5.11e-02
|
1.61e-01
|
1.48e-01
|
GOBP NON CANONICAL NF KAPPAB SIGNAL TRANSDUCTION
|
100
|
5.41e-03
|
-1.61e-01
|
2.65e-02
|
GOBP GRANULOCYTE CHEMOTAXIS
|
87
|
9.45e-03
|
-1.61e-01
|
4.10e-02
|
GOBP RETICULOPHAGY
|
16
|
2.65e-01
|
1.61e-01
|
4.46e-01
|
GOBP POSITIVE REGULATION OF DEPHOSPHORYLATION
|
49
|
5.12e-02
|
-1.61e-01
|
1.48e-01
|
GOBP VESICLE DOCKING
|
49
|
5.14e-02
|
-1.61e-01
|
1.48e-01
|
GOBP NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR
|
17
|
2.51e-01
|
-1.61e-01
|
4.32e-01
|
GOBP APICAL JUNCTION ASSEMBLY
|
55
|
3.93e-02
|
-1.61e-01
|
1.21e-01
|
GOCC CORTICAL CYTOSKELETON
|
103
|
4.87e-03
|
-1.61e-01
|
2.45e-02
|
GOBP BONE MINERALIZATION
|
104
|
4.67e-03
|
-1.61e-01
|
2.37e-02
|
GOBP DOLICHOL LINKED OLIGOSACCHARIDE BIOSYNTHETIC PROCESS
|
11
|
3.56e-01
|
1.61e-01
|
5.43e-01
|
GOBP B CELL MEDIATED IMMUNITY
|
95
|
6.87e-03
|
-1.61e-01
|
3.22e-02
|
GOCC PRERIBOSOME SMALL SUBUNIT PRECURSOR
|
11
|
3.56e-01
|
1.61e-01
|
5.43e-01
|
GOBP POSITIVE REGULATION OF ENDOTHELIAL CELL MIGRATION
|
100
|
5.59e-03
|
-1.61e-01
|
2.72e-02
|
GOMF CATALYTIC ACTIVITY ACTING ON DNA
|
206
|
7.41e-05
|
-1.60e-01
|
7.74e-04
|
GOBP VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY
|
46
|
5.98e-02
|
-1.60e-01
|
1.65e-01
|
GOBP BRAIN MORPHOGENESIS
|
29
|
1.35e-01
|
-1.60e-01
|
2.83e-01
|
GOBP POSITIVE REGULATION OF PHOSPHATASE ACTIVITY
|
23
|
1.83e-01
|
-1.60e-01
|
3.49e-01
|
GOBP SOMITOGENESIS
|
50
|
5.00e-02
|
-1.60e-01
|
1.45e-01
|
GOBP REGULATION OF MITOCHONDRIAL MEMBRANE PERMEABILITY INVOLVED IN APOPTOTIC PROCESS
|
38
|
8.75e-02
|
1.60e-01
|
2.15e-01
|
GOCC LUMENAL SIDE OF MEMBRANE
|
17
|
2.53e-01
|
-1.60e-01
|
4.34e-01
|
GOBP CYTOKINE PRODUCTION
|
640
|
6.26e-12
|
-1.60e-01
|
3.24e-10
|
GOBP ORGANELLE FISSION
|
370
|
1.37e-07
|
-1.60e-01
|
3.01e-06
|
GOBP RESPONSE TO KETONE
|
106
|
4.45e-03
|
-1.60e-01
|
2.28e-02
|
GOBP NEGATIVE REGULATION OF CELL CELL ADHESION
|
154
|
6.24e-04
|
-1.60e-01
|
4.59e-03
|
GOBP PROTEIN KINASE C SIGNALING
|
31
|
1.23e-01
|
-1.60e-01
|
2.68e-01
|
GOBP COPII COATED VESICLE CARGO LOADING
|
17
|
2.54e-01
|
1.60e-01
|
4.35e-01
|
GOBP ALANINE TRANSPORT
|
13
|
3.18e-01
|
1.60e-01
|
5.05e-01
|
GOBP OLFACTORY BULB INTERNEURON DIFFERENTIATION
|
10
|
3.82e-01
|
-1.60e-01
|
5.68e-01
|
GOBP POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION
|
21
|
2.05e-01
|
-1.60e-01
|
3.78e-01
|
GOMF 4 IRON 4 SULFUR CLUSTER BINDING
|
40
|
8.09e-02
|
1.60e-01
|
2.03e-01
|
GOBP STRIATUM DEVELOPMENT
|
15
|
2.85e-01
|
1.60e-01
|
4.68e-01
|
GOBP PROTEIN DNA COMPLEX ORGANIZATION
|
638
|
8.08e-12
|
-1.60e-01
|
4.08e-10
|
GOMF PROTEIN RNA ADAPTOR ACTIVITY
|
18
|
2.42e-01
|
-1.59e-01
|
4.21e-01
|
GOMF CYSTEINE TYPE ENDOPEPTIDASE INHIBITOR ACTIVITY
|
10
|
3.83e-01
|
-1.59e-01
|
5.69e-01
|
GOBP POSITIVE REGULATION OF TRANSFERASE ACTIVITY
|
342
|
4.43e-07
|
-1.59e-01
|
8.47e-06
|
GOBP POTASSIUM ION TRANSPORT
|
162
|
4.75e-04
|
1.59e-01
|
3.68e-03
|
GOBP POSITIVE REGULATION OF CELL ACTIVATION
|
276
|
5.51e-06
|
-1.59e-01
|
8.10e-05
|
GOBP CARBOHYDRATE DERIVATIVE METABOLIC PROCESS
|
814
|
1.84e-14
|
1.59e-01
|
1.35e-12
|
GOMF ATPASE ACTIVATOR ACTIVITY
|
25
|
1.68e-01
|
1.59e-01
|
3.30e-01
|
GOBP NEGATIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY
|
23
|
1.87e-01
|
1.59e-01
|
3.53e-01
|
GOBP GLAND MORPHOGENESIS
|
119
|
2.75e-03
|
-1.59e-01
|
1.55e-02
|
GOBP REGULATION OF POSTSYNAPSE ASSEMBLY
|
34
|
1.09e-01
|
-1.59e-01
|
2.47e-01
|
GOBP REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION
|
196
|
1.27e-04
|
-1.59e-01
|
1.22e-03
|
GOBP REGULATION OF LOCOMOTION
|
865
|
3.53e-15
|
-1.59e-01
|
2.92e-13
|
GOBP GROWTH PLATE CARTILAGE DEVELOPMENT
|
19
|
2.30e-01
|
-1.59e-01
|
4.09e-01
|
GOBP IMMUNE RESPONSE REGULATING CELL SURFACE RECEPTOR SIGNALING PATHWAY
|
204
|
9.43e-05
|
-1.59e-01
|
9.51e-04
|
GOBP POST TRANSLATIONAL PROTEIN TARGETING TO ENDOPLASMIC RETICULUM MEMBRANE
|
16
|
2.71e-01
|
1.59e-01
|
4.53e-01
|
GOMF TRANSFORMING GROWTH FACTOR BETA BINDING
|
24
|
1.78e-01
|
-1.59e-01
|
3.43e-01
|
GOBP SODIUM ION TRANSPORT
|
159
|
5.65e-04
|
1.59e-01
|
4.23e-03
|
GOBP POSITIVE REGULATION OF NEURON APOPTOTIC PROCESS
|
82
|
1.31e-02
|
-1.59e-01
|
5.32e-02
|
GOBP NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS
|
106
|
4.85e-03
|
-1.59e-01
|
2.44e-02
|
GOBP CARDIAC CONDUCTION
|
62
|
3.10e-02
|
1.59e-01
|
1.02e-01
|
GOBP REGULATION OF HEART CONTRACTION
|
166
|
4.37e-04
|
1.58e-01
|
3.46e-03
|
GOBP DNA TEMPLATED TRANSCRIPTION TERMINATION
|
23
|
1.89e-01
|
-1.58e-01
|
3.55e-01
|
GOMF HISTONE H4K12 ACETYLTRANSFERASE ACTIVITY
|
12
|
3.42e-01
|
-1.58e-01
|
5.31e-01
|
GOBP POSITIVE REGULATION OF PHOSPHORYLATION
|
541
|
3.63e-10
|
-1.58e-01
|
1.47e-08
|
GOBP REGULATION OF CELL PROJECTION ASSEMBLY
|
175
|
3.11e-04
|
-1.58e-01
|
2.62e-03
|
GOBP CELLULAR RESPONSE TO AMYLOID BETA
|
29
|
1.40e-01
|
-1.58e-01
|
2.92e-01
|
GOBP POSITIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION
|
192
|
1.61e-04
|
-1.58e-01
|
1.51e-03
|
GOBP POSITIVE REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL
|
13
|
3.23e-01
|
-1.58e-01
|
5.11e-01
|
GOBP BARBED END ACTIN FILAMENT CAPPING
|
23
|
1.89e-01
|
-1.58e-01
|
3.56e-01
|
GOMF RNA ENDONUCLEASE ACTIVITY
|
56
|
4.07e-02
|
1.58e-01
|
1.24e-01
|
GOBP REGULATION OF SPROUTING ANGIOGENESIS
|
35
|
1.06e-01
|
-1.58e-01
|
2.43e-01
|
GOCC CLATHRIN COATED ENDOCYTIC VESICLE
|
23
|
1.89e-01
|
-1.58e-01
|
3.56e-01
|
GOMF ATPASE COUPLED TRANSMEMBRANE TRANSPORTER ACTIVITY
|
77
|
1.66e-02
|
1.58e-01
|
6.41e-02
|
GOBP CLATHRIN DEPENDENT ENDOCYTOSIS
|
44
|
7.00e-02
|
-1.58e-01
|
1.83e-01
|
GOMF AMINO ACID MONOATOMIC CATION SYMPORTER ACTIVITY
|
17
|
2.60e-01
|
1.58e-01
|
4.41e-01
|
GOBP CELL CYCLE
|
1411
|
1.11e-22
|
-1.58e-01
|
2.17e-20
|
GOBP PHAGOCYTOSIS ENGULFMENT
|
47
|
6.15e-02
|
-1.58e-01
|
1.67e-01
|
GOMF LIGAND GATED CHANNEL ACTIVITY
|
87
|
1.11e-02
|
1.58e-01
|
4.68e-02
|
GOBP REGULATION OF CYTOSKELETON ORGANIZATION
|
442
|
1.55e-08
|
-1.58e-01
|
4.19e-07
|
GOBP B CELL DIFFERENTIATION
|
118
|
3.15e-03
|
-1.58e-01
|
1.72e-02
|
GOBP REGULATION OF ACTIN FILAMENT ORGANIZATION
|
232
|
3.72e-05
|
-1.58e-01
|
4.30e-04
|
GOCC MICROTUBULE END
|
30
|
1.36e-01
|
-1.58e-01
|
2.84e-01
|
GOBP MATURATION OF LSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA
|
17
|
2.61e-01
|
1.57e-01
|
4.43e-01
|
GOBP POSITIVE REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY
|
27
|
1.57e-01
|
-1.57e-01
|
3.15e-01
|
GOBP POSITIVE REGULATION OF RECEPTOR CLUSTERING
|
18
|
2.48e-01
|
-1.57e-01
|
4.29e-01
|
GOBP POSITIVE REGULATION OF LYMPHOCYTE ACTIVATION
|
236
|
3.32e-05
|
-1.57e-01
|
3.91e-04
|
GOBP REGULATION OF ACTIN FILAMENT LENGTH
|
139
|
1.40e-03
|
-1.57e-01
|
8.96e-03
|
GOBP POSITIVE REGULATION OF PROTEIN AUTOPHOSPHORYLATION
|
22
|
2.02e-01
|
-1.57e-01
|
3.74e-01
|
GOBP PROSTANOID BIOSYNTHETIC PROCESS
|
24
|
1.83e-01
|
-1.57e-01
|
3.49e-01
|
GOBP NEGATIVE REGULATION OF DENDRITIC SPINE DEVELOPMENT
|
15
|
2.93e-01
|
-1.57e-01
|
4.76e-01
|
GOMF HEPARIN BINDING
|
114
|
3.82e-03
|
-1.57e-01
|
2.02e-02
|
GOBP SUBSTRATE ADHESION DEPENDENT CELL SPREADING
|
95
|
8.29e-03
|
-1.57e-01
|
3.69e-02
|
GOBP CONNECTIVE TISSUE DEVELOPMENT
|
228
|
4.67e-05
|
-1.57e-01
|
5.24e-04
|
GOBP MICROTUBULE CYTOSKELETON ORGANIZATION
|
505
|
1.94e-09
|
-1.57e-01
|
6.66e-08
|
GOBP RESPONSE TO ACTIVITY
|
31
|
1.31e-01
|
1.57e-01
|
2.79e-01
|
GOBP T CELL CYTOKINE PRODUCTION
|
29
|
1.44e-01
|
-1.57e-01
|
2.97e-01
|
GOBP RETINAL ROD CELL DIFFERENTIATION
|
15
|
2.94e-01
|
-1.57e-01
|
4.78e-01
|
GOBP RESPONSE TO NERVE GROWTH FACTOR
|
36
|
1.04e-01
|
-1.57e-01
|
2.41e-01
|
GOBP INTRACELLULAR RECEPTOR SIGNALING PATHWAY
|
288
|
5.15e-06
|
-1.57e-01
|
7.64e-05
|
GOBP THYMOCYTE APOPTOTIC PROCESS
|
23
|
1.94e-01
|
-1.57e-01
|
3.63e-01
|
GOCC PERICENTRIC HETEROCHROMATIN
|
28
|
1.52e-01
|
-1.56e-01
|
3.07e-01
|
GOBP METANEPHRIC EPITHELIUM DEVELOPMENT
|
17
|
2.64e-01
|
-1.56e-01
|
4.46e-01
|
GOBP COCHLEA DEVELOPMENT
|
40
|
8.72e-02
|
-1.56e-01
|
2.14e-01
|
GOBP PEPTIDYL ARGININE METHYLATION
|
10
|
3.92e-01
|
1.56e-01
|
5.78e-01
|
GOMF TRANSCRIPTION REGULATOR ACTIVITY
|
1260
|
3.24e-20
|
-1.56e-01
|
4.76e-18
|
GOBP POSITIVE REGULATION OF KINASE ACTIVITY
|
277
|
8.12e-06
|
-1.56e-01
|
1.13e-04
|
GOBP NEGATIVE REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY
|
13
|
3.30e-01
|
-1.56e-01
|
5.17e-01
|
GOCC CONDENSED NUCLEAR CHROMOSOME
|
52
|
5.16e-02
|
-1.56e-01
|
1.49e-01
|
GOBP POSITIVE REGULATION OF HUMORAL IMMUNE RESPONSE
|
10
|
3.93e-01
|
-1.56e-01
|
5.78e-01
|
GOCC PROXIMAL DENDRITE
|
12
|
3.49e-01
|
-1.56e-01
|
5.37e-01
|
GOMF GROWTH FACTOR RECEPTOR BINDING
|
107
|
5.33e-03
|
-1.56e-01
|
2.62e-02
|
GOBP POSITIVE REGULATION OF INTERLEUKIN 6 PRODUCTION
|
85
|
1.30e-02
|
-1.56e-01
|
5.30e-02
|
GOBP GLYCOSYL COMPOUND METABOLIC PROCESS
|
58
|
4.02e-02
|
1.56e-01
|
1.23e-01
|
GOBP POSITIVE REGULATION OF CELL DEVELOPMENT
|
431
|
3.28e-08
|
-1.56e-01
|
8.37e-07
|
GOBP REGULATION OF CELL CYCLE
|
872
|
9.62e-15
|
-1.56e-01
|
7.40e-13
|
GOBP L AMINO ACID TRANSPORT
|
67
|
2.76e-02
|
1.56e-01
|
9.36e-02
|
GOBP NEGATIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERASE
|
18
|
2.53e-01
|
-1.56e-01
|
4.34e-01
|
GOBP POSITIVE REGULATION OF CHROMOSOME ORGANIZATION
|
99
|
7.50e-03
|
-1.56e-01
|
3.43e-02
|
GOBP POSITIVE REGULATION OF LEUKOCYTE MIGRATION
|
123
|
2.92e-03
|
-1.56e-01
|
1.62e-02
|
GOCC ENDOPLASMIC RETICULUM CHAPERONE COMPLEX
|
11
|
3.72e-01
|
1.55e-01
|
5.58e-01
|
GOBP CIRCADIAN SLEEP WAKE CYCLE NON REM SLEEP
|
10
|
3.95e-01
|
1.55e-01
|
5.80e-01
|
GOBP REGULATION OF CARDIAC MUSCLE CELL CONTRACTION
|
38
|
9.75e-02
|
1.55e-01
|
2.31e-01
|
GOBP TUBE MORPHOGENESIS
|
780
|
2.32e-13
|
-1.55e-01
|
1.40e-11
|
GOBP REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY
|
19
|
2.41e-01
|
1.55e-01
|
4.20e-01
|
GOBP TISSUE MIGRATION
|
281
|
7.80e-06
|
-1.55e-01
|
1.09e-04
|
GOMF TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE ACTIVITY
|
46
|
6.84e-02
|
-1.55e-01
|
1.80e-01
|
GOCC INHIBITORY SYNAPSE
|
17
|
2.68e-01
|
1.55e-01
|
4.49e-01
|
GOBP CELLULAR KETONE METABOLIC PROCESS
|
168
|
5.26e-04
|
1.55e-01
|
3.99e-03
|
GOBP SKIN DEVELOPMENT
|
203
|
1.41e-04
|
-1.55e-01
|
1.34e-03
|
GOBP POSITIVE REGULATION OF DNA RECOMBINATION
|
61
|
3.61e-02
|
-1.55e-01
|
1.14e-01
|
GOBP EPIGENETIC REGULATION OF GENE EXPRESSION
|
209
|
1.13e-04
|
-1.55e-01
|
1.11e-03
|
GOBP REGULATION OF RESPONSE TO EXTERNAL STIMULUS
|
791
|
1.77e-13
|
-1.55e-01
|
1.12e-11
|
GOBP NEGATIVE REGULATION OF NEUROBLAST PROLIFERATION
|
13
|
3.33e-01
|
-1.55e-01
|
5.21e-01
|
GOBP POSITIVE REGULATION OF NUCLEOTIDE CATABOLIC PROCESS
|
24
|
1.89e-01
|
1.55e-01
|
3.56e-01
|
GOBP APPENDAGE MORPHOGENESIS
|
124
|
2.93e-03
|
-1.55e-01
|
1.63e-02
|
GOBP PEPTIDE METABOLIC PROCESS
|
57
|
4.33e-02
|
1.55e-01
|
1.30e-01
|
GOBP NEGATIVE REGULATION OF WOUND HEALING
|
45
|
7.25e-02
|
-1.55e-01
|
1.88e-01
|
GOBP REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE MEDIATED BY A CHEMICAL SIGNAL
|
36
|
1.08e-01
|
1.55e-01
|
2.46e-01
|
GOCC I BAND
|
131
|
2.25e-03
|
1.55e-01
|
1.32e-02
|
GOBP LOCOMOTION
|
975
|
5.30e-16
|
-1.55e-01
|
4.96e-14
|
GOBP REGULATION OF RESPIRATORY BURST
|
11
|
3.74e-01
|
-1.55e-01
|
5.60e-01
|
GOBP INTERLEUKIN 5 PRODUCTION
|
12
|
3.54e-01
|
-1.55e-01
|
5.40e-01
|
GOMF HISTONE H3 ACETYLTRANSFERASE ACTIVITY
|
15
|
3.00e-01
|
-1.55e-01
|
4.84e-01
|
GOBP REGULATION OF CYTOPLASMIC TRANSLATION
|
28
|
1.57e-01
|
-1.55e-01
|
3.14e-01
|
GOMF PHOSPHATIDYLINOSITOL 3 KINASE BINDING
|
34
|
1.19e-01
|
-1.55e-01
|
2.61e-01
|
GOMF PROTEIN PHOSPHORYLATED AMINO ACID BINDING
|
56
|
4.56e-02
|
-1.55e-01
|
1.35e-01
|
GOMF PROTEIN CONTAINING COMPLEX DESTABILIZING ACTIVITY
|
10
|
3.98e-01
|
1.54e-01
|
5.83e-01
|
GOBP MATURATION OF 5 8S RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA
|
24
|
1.90e-01
|
1.54e-01
|
3.58e-01
|
GOBP RESPONSE TO AMYLOID BETA
|
32
|
1.31e-01
|
-1.54e-01
|
2.78e-01
|
GOBP REGULATION OF MICROTUBULE CYTOSKELETON ORGANIZATION
|
138
|
1.77e-03
|
-1.54e-01
|
1.09e-02
|
GOBP CARDIAC SEPTUM DEVELOPMENT
|
107
|
5.88e-03
|
-1.54e-01
|
2.84e-02
|
GOBP GROWTH HORMONE SECRETION
|
13
|
3.36e-01
|
1.54e-01
|
5.24e-01
|
GOBP VENTRICULAR CARDIAC MUSCLE CELL DIFFERENTIATION
|
15
|
3.01e-01
|
1.54e-01
|
4.86e-01
|
GOBP FOCAL ADHESION ASSEMBLY
|
81
|
1.65e-02
|
-1.54e-01
|
6.37e-02
|
GOBP REGULATION OF RAC PROTEIN SIGNAL TRANSDUCTION
|
29
|
1.51e-01
|
-1.54e-01
|
3.05e-01
|
GOBP BILE ACID METABOLIC PROCESS
|
28
|
1.58e-01
|
1.54e-01
|
3.16e-01
|
GOBP TIGHT JUNCTION ORGANIZATION
|
57
|
4.44e-02
|
-1.54e-01
|
1.32e-01
|
GOBP NUCLEOSIDE METABOLIC PROCESS
|
40
|
9.20e-02
|
1.54e-01
|
2.22e-01
|
GOBP DNA RECOMBINATION
|
246
|
3.33e-05
|
-1.54e-01
|
3.91e-04
|
GOBP POSITIVE REGULATION OF PROTEIN EXPORT FROM NUCLEUS
|
20
|
2.33e-01
|
-1.54e-01
|
4.13e-01
|
GOBP POSITIVE REGULATION OF STEROID METABOLIC PROCESS
|
24
|
1.92e-01
|
1.54e-01
|
3.60e-01
|
GOBP TAXIS
|
314
|
3.05e-06
|
-1.54e-01
|
4.75e-05
|
GOBP NEGATIVE REGULATION OF NEURON DIFFERENTIATION
|
61
|
3.81e-02
|
-1.54e-01
|
1.19e-01
|
GOBP REGULATION OF IMMUNE SYSTEM PROCESS
|
1135
|
5.98e-18
|
-1.54e-01
|
6.90e-16
|
GOBP PROTEIN NEDDYLATION
|
17
|
2.73e-01
|
1.54e-01
|
4.55e-01
|
GOBP INFLAMMATORY CELL APOPTOTIC PROCESS
|
17
|
2.73e-01
|
-1.54e-01
|
4.55e-01
|
GOBP REGULATION OF ACTOMYOSIN STRUCTURE ORGANIZATION
|
100
|
8.04e-03
|
-1.54e-01
|
3.61e-02
|
GOBP POSITIVE REGULATION OF MRNA CATABOLIC PROCESS
|
84
|
1.51e-02
|
-1.53e-01
|
5.95e-02
|
GOBP HETEROTYPIC CELL CELL ADHESION
|
41
|
8.92e-02
|
-1.53e-01
|
2.18e-01
|
GOBP REGULATION OF HAIR CYCLE
|
17
|
2.74e-01
|
-1.53e-01
|
4.55e-01
|
GOBP REGULATION OF CALCIUM ION IMPORT
|
36
|
1.11e-01
|
-1.53e-01
|
2.51e-01
|
GOBP REGULATION OF SKELETAL MUSCLE CELL PROLIFERATION
|
13
|
3.39e-01
|
-1.53e-01
|
5.27e-01
|
GOBP NEGATIVE REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY
|
129
|
2.68e-03
|
-1.53e-01
|
1.52e-02
|
GOCC POTASSIUM CHANNEL COMPLEX
|
59
|
4.20e-02
|
1.53e-01
|
1.27e-01
|
GOBP ATRIAL SEPTUM DEVELOPMENT
|
20
|
2.36e-01
|
-1.53e-01
|
4.15e-01
|
GOBP POLYOL METABOLIC PROCESS
|
83
|
1.61e-02
|
1.53e-01
|
6.26e-02
|
GOMF DEACETYLASE ACTIVITY
|
30
|
1.47e-01
|
1.53e-01
|
3.01e-01
|
GOBP MESENCHYMAL CELL DIFFERENTIATION
|
204
|
1.72e-04
|
-1.53e-01
|
1.59e-03
|
GOMF RNA POLYMERASE BINDING
|
59
|
4.25e-02
|
-1.53e-01
|
1.28e-01
|
GOBP NEGATIVE REGULATION OF THYMOCYTE APOPTOTIC PROCESS
|
10
|
4.03e-01
|
-1.53e-01
|
5.88e-01
|
GOBP POSITIVE REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY
|
17
|
2.77e-01
|
-1.52e-01
|
4.59e-01
|
GOMF OXIDOREDUCTASE ACTIVITY ACTING ON A SULFUR GROUP OF DONORS
|
44
|
8.04e-02
|
1.52e-01
|
2.02e-01
|
GOBP REGULATION OF ENDOCYTIC RECYCLING
|
19
|
2.50e-01
|
1.52e-01
|
4.32e-01
|
GOBP POSITIVE REGULATION OF MONONUCLEAR CELL MIGRATION
|
71
|
2.65e-02
|
-1.52e-01
|
9.11e-02
|
GOBP MIDBRAIN DOPAMINERGIC NEURON DIFFERENTIATION
|
10
|
4.04e-01
|
-1.52e-01
|
5.89e-01
|
GOMF PROTEIN TYROSINE KINASE BINDING
|
107
|
6.55e-03
|
-1.52e-01
|
3.09e-02
|
GOBP DOPAMINE TRANSPORT
|
32
|
1.36e-01
|
1.52e-01
|
2.85e-01
|
GOBP REGULATION OF ENDOTHELIAL CELL DEVELOPMENT
|
18
|
2.64e-01
|
-1.52e-01
|
4.45e-01
|
GOBP MEMBRANE FISSION
|
31
|
1.43e-01
|
-1.52e-01
|
2.95e-01
|
GOBP DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF SOUND
|
11
|
3.83e-01
|
-1.52e-01
|
5.69e-01
|
GOBP AMINOGLYCAN METABOLIC PROCESS
|
84
|
1.62e-02
|
-1.52e-01
|
6.28e-02
|
GOBP RNA METHYLATION
|
58
|
4.55e-02
|
1.52e-01
|
1.35e-01
|
GOMF MACROMOLECULE TRANSMEMBRANE TRANSPORTER ACTIVITY
|
24
|
1.98e-01
|
1.52e-01
|
3.68e-01
|
GOBP BRANCHING MORPHOGENESIS OF A NERVE
|
14
|
3.25e-01
|
-1.52e-01
|
5.13e-01
|
GOBP NEGATIVE REGULATION OF GLIAL CELL DIFFERENTIATION
|
24
|
1.98e-01
|
-1.52e-01
|
3.68e-01
|
GOBP LEUKOCYTE DIFFERENTIATION
|
494
|
8.99e-09
|
-1.52e-01
|
2.59e-07
|
GOBP NAD CATABOLIC PROCESS
|
18
|
2.65e-01
|
1.52e-01
|
4.47e-01
|
GOMF SUMO TRANSFERASE ACTIVITY
|
22
|
2.18e-01
|
-1.52e-01
|
3.94e-01
|
GOBP REGULATION OF RECEPTOR BINDING
|
13
|
3.44e-01
|
-1.52e-01
|
5.33e-01
|
GOBP NEGATIVE REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY
|
12
|
3.63e-01
|
1.52e-01
|
5.50e-01
|
GOMF PROTEIN SERINE THREONINE PHOSPHATASE ACTIVITY
|
72
|
2.64e-02
|
1.51e-01
|
9.08e-02
|
GOBP REGULATION OF OSTEOCLAST DIFFERENTIATION
|
59
|
4.45e-02
|
-1.51e-01
|
1.33e-01
|
GOBP PHOSPHOLIPID METABOLIC PROCESS
|
295
|
8.23e-06
|
1.51e-01
|
1.14e-04
|
GOBP POSITIVE REGULATION OF PHOSPHOLIPASE ACTIVITY
|
19
|
2.54e-01
|
-1.51e-01
|
4.35e-01
|
GOCC BRUSH BORDER MEMBRANE
|
61
|
4.12e-02
|
1.51e-01
|
1.25e-01
|
GOBP REGULATION OF NON CANONICAL NF KAPPAB SIGNAL TRANSDUCTION
|
77
|
2.19e-02
|
-1.51e-01
|
7.88e-02
|
GOMF STEROID HYDROXYLASE ACTIVITY
|
11
|
3.85e-01
|
1.51e-01
|
5.71e-01
|
GOCC ANCHORING JUNCTION
|
581
|
5.89e-10
|
-1.51e-01
|
2.25e-08
|
GOMF MAP KINASE TYROSINE SERINE THREONINE PHOSPHATASE ACTIVITY
|
10
|
4.08e-01
|
-1.51e-01
|
5.92e-01
|
GOCC CLATHRIN COATED ENDOCYTIC VESICLE MEMBRANE
|
13
|
3.46e-01
|
-1.51e-01
|
5.34e-01
|
GOMF SH3 DOMAIN BINDING
|
118
|
4.66e-03
|
-1.51e-01
|
2.36e-02
|
GOBP CARBOHYDRATE DERIVATIVE BIOSYNTHETIC PROCESS
|
491
|
1.18e-08
|
1.51e-01
|
3.29e-07
|
GOBP FOREBRAIN GENERATION OF NEURONS
|
40
|
9.87e-02
|
-1.51e-01
|
2.33e-01
|
GOBP TRANSEPITHELIAL TRANSPORT
|
20
|
2.43e-01
|
-1.51e-01
|
4.23e-01
|
GOCC FILOPODIUM
|
80
|
1.98e-02
|
-1.51e-01
|
7.33e-02
|
GOCC FASCIA ADHERENS
|
13
|
3.47e-01
|
-1.51e-01
|
5.35e-01
|
GOBP INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE
|
100
|
9.26e-03
|
-1.51e-01
|
4.04e-02
|
GOBP PURINE DEOXYRIBONUCLEOTIDE CATABOLIC PROCESS
|
12
|
3.66e-01
|
-1.51e-01
|
5.53e-01
|
GOBP PROTEIN DEPOLYMERIZATION
|
112
|
5.92e-03
|
-1.51e-01
|
2.85e-02
|
GOBP PROTEIN DEUBIQUITINATION
|
83
|
1.77e-02
|
-1.51e-01
|
6.70e-02
|
GOBP BONE CELL DEVELOPMENT
|
13
|
3.47e-01
|
-1.51e-01
|
5.35e-01
|
GOBP CELL SURFACE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY
|
290
|
1.09e-05
|
-1.51e-01
|
1.46e-04
|
GOCC MITOCHONDRIA ASSOCIATED ENDOPLASMIC RETICULUM MEMBRANE CONTACT SITE
|
19
|
2.56e-01
|
-1.50e-01
|
4.37e-01
|
GOBP EMBRYONIC APPENDAGE MORPHOGENESIS
|
100
|
9.40e-03
|
-1.50e-01
|
4.08e-02
|
GOBP CELLULAR RESPONSE TO CAMP
|
31
|
1.47e-01
|
-1.50e-01
|
3.01e-01
|
GOBP MUSCLE CELL PROLIFERATION
|
231
|
8.49e-05
|
-1.50e-01
|
8.69e-04
|
GOBP REGULATION OF EXTRACELLULAR MATRIX ASSEMBLY
|
20
|
2.44e-01
|
-1.50e-01
|
4.25e-01
|
GOBP REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION
|
77
|
2.26e-02
|
-1.50e-01
|
8.09e-02
|
GOMF MONOATOMIC ION TRANSMEMBRANE TRANSPORTER ACTIVITY
|
426
|
1.15e-07
|
1.50e-01
|
2.57e-06
|
GOBP CELLULAR RESPONSE TO STEROID HORMONE STIMULUS
|
139
|
2.24e-03
|
-1.50e-01
|
1.31e-02
|
GOBP AXIS ELONGATION
|
29
|
1.61e-01
|
-1.50e-01
|
3.21e-01
|
GOBP PROTEIN CATABOLIC PROCESS IN THE VACUOLE
|
22
|
2.22e-01
|
1.50e-01
|
4.00e-01
|
GOBP MYELOID LEUKOCYTE MIGRATION
|
172
|
6.89e-04
|
-1.50e-01
|
4.99e-03
|
GOMF SECONDARY ACTIVE TRANSMEMBRANE TRANSPORTER ACTIVITY
|
196
|
2.95e-04
|
1.50e-01
|
2.51e-03
|
GOMF UBIQUITIN UBIQUITIN LIGASE ACTIVITY
|
13
|
3.48e-01
|
1.50e-01
|
5.36e-01
|
GOBP REGULATION OF GLIAL CELL DIFFERENTIATION
|
69
|
3.11e-02
|
-1.50e-01
|
1.02e-01
|
GOBP REGULATION OF CARDIAC MUSCLE CELL ACTION POTENTIAL
|
27
|
1.77e-01
|
1.50e-01
|
3.41e-01
|
GOCC SARCOMERE
|
184
|
4.58e-04
|
1.50e-01
|
3.58e-03
|
GOMF PROTEIN DOMAIN SPECIFIC BINDING
|
687
|
2.75e-11
|
-1.50e-01
|
1.31e-09
|
GOBP REGULATION OF SPHINGOLIPID BIOSYNTHETIC PROCESS
|
12
|
3.68e-01
|
1.50e-01
|
5.55e-01
|
GOMF UBIQUITIN LIKE PROTEIN PEPTIDASE ACTIVITY
|
89
|
1.46e-02
|
-1.50e-01
|
5.80e-02
|
GOCC AP 3 ADAPTOR COMPLEX
|
12
|
3.69e-01
|
-1.50e-01
|
5.55e-01
|
GOBP INTERSTRAND CROSS LINK REPAIR
|
30
|
1.56e-01
|
-1.50e-01
|
3.12e-01
|
GOBP VESICLE DOCKING INVOLVED IN EXOCYTOSIS
|
32
|
1.43e-01
|
-1.50e-01
|
2.95e-01
|
GOCC CHROMOSOME
|
1070
|
2.65e-16
|
-1.50e-01
|
2.59e-14
|
GOBP VENTRICULAR TRABECULA MYOCARDIUM MORPHOGENESIS
|
16
|
3.00e-01
|
-1.50e-01
|
4.84e-01
|
GOBP NEGATIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS
|
44
|
8.60e-02
|
-1.50e-01
|
2.12e-01
|
GOCC CLATHRIN COAT OF COATED PIT
|
19
|
2.59e-01
|
-1.50e-01
|
4.40e-01
|
GOBP PHOSPHOLIPID BIOSYNTHETIC PROCESS
|
194
|
3.37e-04
|
1.50e-01
|
2.79e-03
|
GOBP VIRAL RNA GENOME REPLICATION
|
22
|
2.25e-01
|
-1.49e-01
|
4.02e-01
|
GOCC SM LIKE PROTEIN FAMILY COMPLEX
|
78
|
2.26e-02
|
1.49e-01
|
8.09e-02
|
GOBP CELLULAR RESPONSE TO TOXIC SUBSTANCE
|
51
|
6.51e-02
|
1.49e-01
|
1.74e-01
|
GOMF AXON GUIDANCE RECEPTOR ACTIVITY
|
11
|
3.91e-01
|
1.49e-01
|
5.77e-01
|
GOBP REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY
|
27
|
1.80e-01
|
-1.49e-01
|
3.44e-01
|
GOBP TRANSCYTOSIS
|
18
|
2.73e-01
|
-1.49e-01
|
4.55e-01
|
GOBP ANATOMICAL STRUCTURE ARRANGEMENT
|
16
|
3.02e-01
|
-1.49e-01
|
4.86e-01
|
GOBP POSTSYNAPTIC DENSITY ORGANIZATION
|
38
|
1.12e-01
|
-1.49e-01
|
2.52e-01
|
GOMF PHOSPHATIDYLINOSITOL 3 KINASE REGULATORY SUBUNIT BINDING
|
12
|
3.71e-01
|
-1.49e-01
|
5.58e-01
|
GOBP RHYTHMIC BEHAVIOR
|
44
|
8.73e-02
|
1.49e-01
|
2.14e-01
|
GOBP REGULATION OF TRANSLATIONAL ELONGATION
|
10
|
4.15e-01
|
1.49e-01
|
5.98e-01
|
GOBP SOMATIC STEM CELL DIVISION
|
12
|
3.72e-01
|
-1.49e-01
|
5.58e-01
|
GOBP REGULATION OF POSTSYNAPSE ORGANIZATION
|
145
|
1.98e-03
|
-1.49e-01
|
1.19e-02
|
GOBP POSITIVE REGULATION OF NEURON MIGRATION
|
23
|
2.16e-01
|
-1.49e-01
|
3.92e-01
|
GOBP REGULATION OF CELL DEVELOPMENT
|
723
|
1.27e-11
|
-1.49e-01
|
6.22e-10
|
GOBP MEMBRANE DEPOLARIZATION
|
73
|
2.81e-02
|
1.49e-01
|
9.46e-02
|
GOBP UNSATURATED FATTY ACID METABOLIC PROCESS
|
67
|
3.55e-02
|
1.49e-01
|
1.13e-01
|
GOBP SPINDLE LOCALIZATION
|
49
|
7.22e-02
|
-1.49e-01
|
1.88e-01
|
GOBP INORGANIC ANION TRANSMEMBRANE TRANSPORT
|
51
|
6.67e-02
|
1.48e-01
|
1.77e-01
|
GOBP MYELOID LEUKOCYTE ACTIVATION
|
184
|
5.25e-04
|
-1.48e-01
|
3.99e-03
|
GOBP T CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE
|
57
|
5.28e-02
|
-1.48e-01
|
1.51e-01
|
GOBP POSITIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION
|
132
|
3.28e-03
|
-1.48e-01
|
1.78e-02
|
GOBP LENS FIBER CELL DEVELOPMENT
|
11
|
3.94e-01
|
-1.48e-01
|
5.80e-01
|
GOBP VASCULAR TRANSPORT
|
17
|
2.90e-01
|
1.48e-01
|
4.73e-01
|
GOBP CELLULAR RESPONSE TO VITAMIN
|
15
|
3.20e-01
|
-1.48e-01
|
5.07e-01
|
GOBP CARDIAC LEFT VENTRICLE MORPHOGENESIS
|
16
|
3.05e-01
|
-1.48e-01
|
4.89e-01
|
GOBP ODONTOGENESIS OF DENTIN CONTAINING TOOTH
|
60
|
4.73e-02
|
-1.48e-01
|
1.39e-01
|
GOBP ACTIN POLYMERIZATION OR DEPOLYMERIZATION
|
163
|
1.13e-03
|
-1.48e-01
|
7.52e-03
|
GOCC MIDBODY
|
147
|
1.97e-03
|
-1.48e-01
|
1.18e-02
|
GOBP POSITIVE REGULATION OF INTERLEUKIN 8 PRODUCTION
|
45
|
8.59e-02
|
-1.48e-01
|
2.12e-01
|
GOBP CYTOPLASMIC TRANSLATIONAL INITIATION
|
33
|
1.41e-01
|
-1.48e-01
|
2.93e-01
|
GOBP REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY
|
138
|
2.73e-03
|
-1.48e-01
|
1.54e-02
|
GOBP MAST CELL ACTIVATION
|
54
|
6.03e-02
|
-1.48e-01
|
1.65e-01
|
GOBP NEGATIVE REGULATION OF RNA BIOSYNTHETIC PROCESS
|
946
|
2.29e-14
|
-1.48e-01
|
1.65e-12
|
GOBP REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY
|
249
|
6.25e-05
|
-1.48e-01
|
6.73e-04
|
GOBP POSITIVE REGULATION OF INTERLEUKIN 10 PRODUCTION
|
33
|
1.43e-01
|
-1.48e-01
|
2.95e-01
|
GOBP REGULATION OF CARDIAC MUSCLE CONTRACTION
|
65
|
3.98e-02
|
1.48e-01
|
1.23e-01
|
GOBP INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR
|
77
|
2.54e-02
|
-1.47e-01
|
8.82e-02
|
GOBP POSITIVE REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORT
|
29
|
1.70e-01
|
1.47e-01
|
3.31e-01
|
GOCC TRANSCRIPTION FACTOR TFIIH HOLO COMPLEX
|
12
|
3.77e-01
|
1.47e-01
|
5.63e-01
|
GOCC MANCHETTE
|
11
|
3.98e-01
|
-1.47e-01
|
5.83e-01
|
GOBP RENAL VESICLE DEVELOPMENT
|
12
|
3.78e-01
|
-1.47e-01
|
5.64e-01
|
GOCC PARALLEL FIBER TO PURKINJE CELL SYNAPSE
|
25
|
2.03e-01
|
1.47e-01
|
3.74e-01
|
GOBP REGULATION OF BASEMENT MEMBRANE ORGANIZATION
|
10
|
4.21e-01
|
-1.47e-01
|
6.03e-01
|
GOCC ADHERENS JUNCTION
|
120
|
5.45e-03
|
-1.47e-01
|
2.67e-02
|
GOCC EXTERNAL SIDE OF PLASMA MEMBRANE
|
281
|
2.36e-05
|
-1.47e-01
|
2.90e-04
|
GOBP POSITIVE REGULATION OF CIRCADIAN RHYTHM
|
14
|
3.41e-01
|
1.47e-01
|
5.30e-01
|
GOBP POSITIVE REGULATION OF JNK CASCADE
|
85
|
1.93e-02
|
-1.47e-01
|
7.20e-02
|
GOBP PEPTIDYL SERINE DEPHOSPHORYLATION
|
13
|
3.59e-01
|
-1.47e-01
|
5.45e-01
|
GOBP LENS DEVELOPMENT IN CAMERA TYPE EYE
|
61
|
4.74e-02
|
-1.47e-01
|
1.39e-01
|
GOMF TITIN BINDING
|
12
|
3.79e-01
|
1.47e-01
|
5.65e-01
|
GOBP NEGATIVE REGULATION OF DEFENSE RESPONSE TO VIRUS
|
16
|
3.10e-01
|
-1.47e-01
|
4.95e-01
|
GOBP CELL JUNCTION DISASSEMBLY
|
26
|
1.96e-01
|
-1.47e-01
|
3.65e-01
|
GOBP NEGATIVE REGULATION OF BONE MINERALIZATION
|
10
|
4.22e-01
|
-1.47e-01
|
6.04e-01
|
GOBP HEART PROCESS
|
211
|
2.49e-04
|
1.47e-01
|
2.18e-03
|
GOBP TYPE B PANCREATIC CELL DEVELOPMENT
|
15
|
3.26e-01
|
-1.47e-01
|
5.13e-01
|
GOBP GASTRULATION
|
139
|
2.89e-03
|
-1.47e-01
|
1.61e-02
|
GOBP CELL MOTILITY
|
1325
|
9.54e-19
|
-1.47e-01
|
1.19e-16
|
GOBP ORGANIC ACID TRANSMEMBRANE TRANSPORT
|
109
|
8.28e-03
|
1.47e-01
|
3.69e-02
|
GOBP LEUKOCYTE CHEMOTAXIS
|
161
|
1.36e-03
|
-1.47e-01
|
8.71e-03
|
GOBP GENITALIA MORPHOGENESIS
|
13
|
3.60e-01
|
1.47e-01
|
5.47e-01
|
GOBP PROTECTION FROM NON HOMOLOGOUS END JOINING AT TELOMERE
|
10
|
4.22e-01
|
-1.47e-01
|
6.04e-01
|
GOBP ARACHIDONIC ACID METABOLIC PROCESS
|
28
|
1.80e-01
|
1.46e-01
|
3.44e-01
|
GOBP NEGATIVE REGULATION OF CHEMOTAXIS
|
30
|
1.65e-01
|
-1.46e-01
|
3.25e-01
|
GOBP REGULATION OF WNT SIGNALING PATHWAY
|
265
|
4.27e-05
|
-1.46e-01
|
4.85e-04
|
GOBP ORGANOPHOSPHATE CATABOLIC PROCESS
|
194
|
4.50e-04
|
1.46e-01
|
3.55e-03
|
GOBP RESPONSE TO ACETYLCHOLINE
|
30
|
1.65e-01
|
-1.46e-01
|
3.26e-01
|
GOCC CELL CELL JUNCTION
|
388
|
8.24e-07
|
-1.46e-01
|
1.47e-05
|
GOBP REGULATION OF NUCLEAR DIVISION
|
113
|
7.28e-03
|
-1.46e-01
|
3.37e-02
|
GOBP ENDOSOME ORGANIZATION
|
59
|
5.21e-02
|
-1.46e-01
|
1.50e-01
|
GOCC RNA POLYMERASE III COMPLEX
|
18
|
2.83e-01
|
1.46e-01
|
4.66e-01
|
GOBP POSITIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION
|
98
|
1.25e-02
|
-1.46e-01
|
5.13e-02
|
GOMF ACETYLGLUCOSAMINYLTRANSFERASE ACTIVITY
|
36
|
1.29e-01
|
-1.46e-01
|
2.76e-01
|
GOCC CELL BODY MEMBRANE
|
26
|
1.97e-01
|
1.46e-01
|
3.67e-01
|
GOBP POSITIVE REGULATION OF LEUKOCYTE CHEMOTAXIS
|
72
|
3.22e-02
|
-1.46e-01
|
1.05e-01
|
GOBP REGULATION OF PHOSPHORYLATION
|
865
|
4.69e-13
|
-1.46e-01
|
2.75e-11
|
GOMF STEROID BINDING
|
81
|
2.31e-02
|
1.46e-01
|
8.21e-02
|
GOMF P53 BINDING
|
68
|
3.75e-02
|
-1.46e-01
|
1.17e-01
|
GOBP APOPTOTIC CELL CLEARANCE
|
34
|
1.41e-01
|
-1.46e-01
|
2.93e-01
|
GOCC SITE OF DNA DAMAGE
|
101
|
1.14e-02
|
-1.46e-01
|
4.79e-02
|
GOBP PEPTIDYL TYROSINE MODIFICATION
|
235
|
1.22e-04
|
-1.46e-01
|
1.18e-03
|
GOBP SPLICEOSOMAL SNRNP ASSEMBLY
|
33
|
1.48e-01
|
1.46e-01
|
3.01e-01
|
GOBP MICROVILLUS ASSEMBLY
|
17
|
2.98e-01
|
-1.46e-01
|
4.83e-01
|
GOBP T HELPER 17 TYPE IMMUNE RESPONSE
|
36
|
1.31e-01
|
-1.46e-01
|
2.78e-01
|
GOMF AMIDE TRANSMEMBRANE TRANSPORTER ACTIVITY
|
27
|
1.90e-01
|
1.46e-01
|
3.58e-01
|
GOMF CHROMATIN BINDING
|
533
|
1.06e-08
|
-1.46e-01
|
2.99e-07
|
GOMF MAP KINASE KINASE ACTIVITY
|
12
|
3.83e-01
|
1.45e-01
|
5.69e-01
|
GOBP RAB PROTEIN SIGNAL TRANSDUCTION
|
17
|
2.99e-01
|
1.45e-01
|
4.84e-01
|
GOBP T CELL DIFFERENTIATION
|
250
|
7.82e-05
|
-1.45e-01
|
8.09e-04
|
GOBP POSITIVE REGULATION OF EXTRACELLULAR MATRIX ASSEMBLY
|
14
|
3.46e-01
|
-1.45e-01
|
5.35e-01
|
GOBP TRNA MODIFICATION
|
80
|
2.47e-02
|
1.45e-01
|
8.63e-02
|
GOBP REGULATION OF MITOCHONDRIAL DEPOLARIZATION
|
20
|
2.61e-01
|
1.45e-01
|
4.43e-01
|
GOBP ALCOHOL CATABOLIC PROCESS
|
17
|
3.00e-01
|
1.45e-01
|
4.85e-01
|
GOBP MEMBRANE FUSION
|
122
|
5.68e-03
|
-1.45e-01
|
2.76e-02
|
GOBP VITAMIN METABOLIC PROCESS
|
70
|
3.59e-02
|
1.45e-01
|
1.14e-01
|
GOBP REGULATION OF DOUBLE STRAND BREAK REPAIR
|
113
|
7.77e-03
|
-1.45e-01
|
3.51e-02
|
GOMF PROTEIN TRANSPORTER ACTIVITY
|
26
|
2.00e-01
|
1.45e-01
|
3.70e-01
|
GOBP TUBE DEVELOPMENT
|
953
|
5.68e-14
|
-1.45e-01
|
3.82e-12
|
GOBP REGULATION OF POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR INTERNALIZATION
|
31
|
1.63e-01
|
-1.45e-01
|
3.22e-01
|
GOMF INOSITOL TRISPHOSPHATE PHOSPHATASE ACTIVITY
|
11
|
4.06e-01
|
1.45e-01
|
5.90e-01
|
GOBP REGULATION OF OSSIFICATION
|
101
|
1.20e-02
|
-1.45e-01
|
4.97e-02
|
GOBP REGULATION OF TOLL LIKE RECEPTOR 2 SIGNALING PATHWAY
|
11
|
4.06e-01
|
-1.45e-01
|
5.90e-01
|
GOBP NEGATIVE REGULATION OF CALCIUM MEDIATED SIGNALING
|
17
|
3.02e-01
|
1.45e-01
|
4.86e-01
|
GOBP REGULATION OF ACTIVATED T CELL PROLIFERATION
|
25
|
2.10e-01
|
-1.45e-01
|
3.84e-01
|
GOBP EPITHELIAL CELL DIFFERENTIATION
|
461
|
1.16e-07
|
-1.45e-01
|
2.59e-06
|
GOMF HORMONE BINDING
|
55
|
6.37e-02
|
1.45e-01
|
1.72e-01
|
GOBP NEGATIVE REGULATION OF CELL DIVISION
|
13
|
3.67e-01
|
-1.45e-01
|
5.54e-01
|
GOBP NEGATIVE REGULATION OF ANDROGEN RECEPTOR SIGNALING PATHWAY
|
13
|
3.67e-01
|
-1.45e-01
|
5.54e-01
|
GOBP REGULATION OF OXIDOREDUCTASE ACTIVITY
|
49
|
8.04e-02
|
1.44e-01
|
2.02e-01
|
GOBP MECHANORECEPTOR DIFFERENTIATION
|
62
|
4.94e-02
|
-1.44e-01
|
1.44e-01
|
GOBP MACROPHAGE ACTIVATION INVOLVED IN IMMUNE RESPONSE
|
16
|
3.17e-01
|
-1.44e-01
|
5.04e-01
|
GOBP VENOUS BLOOD VESSEL MORPHOGENESIS
|
11
|
4.07e-01
|
-1.44e-01
|
5.91e-01
|
GOBP ESTABLISHMENT OF PROTEIN LOCALIZATION TO PEROXISOME
|
20
|
2.64e-01
|
1.44e-01
|
4.45e-01
|
GOBP REGULATION OF MICROTUBULE BASED PROCESS
|
204
|
3.94e-04
|
-1.44e-01
|
3.19e-03
|
GOBP REGULATION OF TISSUE REMODELING
|
67
|
4.14e-02
|
-1.44e-01
|
1.26e-01
|
GOBP POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS
|
11
|
4.08e-01
|
-1.44e-01
|
5.92e-01
|
GOCC PRESYNAPTIC CYTOSOL
|
45
|
9.46e-02
|
-1.44e-01
|
2.26e-01
|
GOBP RHO PROTEIN SIGNAL TRANSDUCTION
|
126
|
5.27e-03
|
-1.44e-01
|
2.60e-02
|
GOBP REGULATION OF TRANSFERASE ACTIVITY
|
569
|
5.15e-09
|
-1.44e-01
|
1.61e-07
|
GOBP SMOOTHENED SIGNALING PATHWAY
|
127
|
5.11e-03
|
-1.44e-01
|
2.53e-02
|
GOBP GLYCOPHAGY
|
12
|
3.88e-01
|
-1.44e-01
|
5.73e-01
|
GOBP OLIGODENDROCYTE DIFFERENTIATION
|
87
|
2.03e-02
|
-1.44e-01
|
7.47e-02
|
GOBP SMOOTH MUSCLE CELL PROLIFERATION
|
165
|
1.44e-03
|
-1.44e-01
|
9.11e-03
|
GOBP SKIN EPIDERMIS DEVELOPMENT
|
108
|
9.84e-03
|
-1.44e-01
|
4.23e-02
|
GOBP LATERAL SPROUTING FROM AN EPITHELIUM
|
10
|
4.31e-01
|
-1.44e-01
|
6.12e-01
|
GOMF ADENYLATE CYCLASE BINDING
|
12
|
3.88e-01
|
-1.44e-01
|
5.74e-01
|
GOBP GLUTAMINE FAMILY AMINO ACID METABOLIC PROCESS
|
50
|
7.87e-02
|
1.44e-01
|
2.00e-01
|
GOBP REGULATION OF EXIT FROM MITOSIS
|
11
|
4.09e-01
|
-1.44e-01
|
5.93e-01
|
GOMF TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE ADAPTOR ACTIVITY
|
14
|
3.52e-01
|
-1.44e-01
|
5.39e-01
|
GOBP POSITIVE REGULATION OF RESPONSE TO WOUNDING
|
61
|
5.27e-02
|
-1.44e-01
|
1.51e-01
|
GOBP BLOOD VESSEL REMODELING
|
52
|
7.36e-02
|
-1.44e-01
|
1.90e-01
|
GOCC CYTOPLASMIC SIDE OF PLASMA MEMBRANE
|
133
|
4.33e-03
|
-1.43e-01
|
2.22e-02
|
GOBP PANCREAS DEVELOPMENT
|
47
|
8.90e-02
|
-1.43e-01
|
2.18e-01
|
GOMF FILAMIN BINDING
|
13
|
3.71e-01
|
-1.43e-01
|
5.57e-01
|
GOCC ACTIN FILAMENT
|
118
|
7.23e-03
|
-1.43e-01
|
3.35e-02
|
GOBP POSITIVE REGULATION OF PHOSPHOLIPID METABOLIC PROCESS
|
10
|
4.33e-01
|
1.43e-01
|
6.13e-01
|
GOBP REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION
|
103
|
1.21e-02
|
-1.43e-01
|
5.00e-02
|
GOBP RESPONSE TO GROWTH FACTOR
|
541
|
1.45e-08
|
-1.43e-01
|
3.95e-07
|
GOBP REGULATION OF STEROID HORMONE BIOSYNTHETIC PROCESS
|
16
|
3.22e-01
|
-1.43e-01
|
5.09e-01
|
GOBP REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION
|
335
|
7.22e-06
|
-1.43e-01
|
1.03e-04
|
GOBP CHONDROCYTE DIFFERENTIATION
|
94
|
1.66e-02
|
-1.43e-01
|
6.41e-02
|
GOBP INTERLEUKIN 6 PRODUCTION
|
134
|
4.30e-03
|
-1.43e-01
|
2.21e-02
|
GOBP REGULATION OF KINASE ACTIVITY
|
479
|
9.42e-08
|
-1.43e-01
|
2.15e-06
|
GOBP BILE ACID AND BILE SALT TRANSPORT
|
13
|
3.72e-01
|
-1.43e-01
|
5.58e-01
|
GOBP REGULATION OF HEPATOCYTE PROLIFERATION
|
19
|
2.81e-01
|
-1.43e-01
|
4.64e-01
|
GOBP BODY MORPHOGENESIS
|
52
|
7.48e-02
|
-1.43e-01
|
1.92e-01
|
GOBP REGULATION OF PROTEIN POLYMERIZATION
|
173
|
1.21e-03
|
-1.43e-01
|
7.96e-03
|
GOMF MONOCARBOXYLIC ACID TRANSMEMBRANE TRANSPORTER ACTIVITY
|
45
|
9.76e-02
|
1.43e-01
|
2.31e-01
|
GOBP VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DIFFERENTIATION
|
37
|
1.33e-01
|
-1.43e-01
|
2.81e-01
|
GOBP POLYAMINE METABOLIC PROCESS
|
14
|
3.55e-01
|
1.43e-01
|
5.42e-01
|
GOMF MODIFICATION DEPENDENT PROTEIN BINDING
|
170
|
1.35e-03
|
-1.43e-01
|
8.68e-03
|
GOBP DENDRITE DEVELOPMENT
|
264
|
6.86e-05
|
-1.43e-01
|
7.31e-04
|
GOBP MESENCHYME DEVELOPMENT
|
246
|
1.21e-04
|
-1.43e-01
|
1.17e-03
|
GOBP LIPID HOMEOSTASIS
|
135
|
4.26e-03
|
1.43e-01
|
2.20e-02
|
GOMF AMINO ACID TRANSMEMBRANE TRANSPORTER ACTIVITY
|
64
|
4.86e-02
|
1.43e-01
|
1.42e-01
|
GOBP NEGATIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION
|
60
|
5.65e-02
|
-1.42e-01
|
1.58e-01
|
GOBP NEGATIVE REGULATION OF OSTEOBLAST DIFFERENTIATION
|
47
|
9.13e-02
|
-1.42e-01
|
2.21e-01
|
GOBP POSITIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT
|
305
|
2.00e-05
|
-1.42e-01
|
2.49e-04
|
GOBP REGULATION OF PHOSPHOLIPASE ACTIVITY
|
28
|
1.92e-01
|
-1.42e-01
|
3.60e-01
|
GOBP REGULATION OF SYNAPSE STRUCTURE OR ACTIVITY
|
292
|
2.99e-05
|
-1.42e-01
|
3.56e-04
|
GOCC COPI VESICLE COAT
|
11
|
4.14e-01
|
-1.42e-01
|
5.97e-01
|
GOMF MODIFIED AMINO ACID TRANSMEMBRANE TRANSPORTER ACTIVITY
|
24
|
2.28e-01
|
1.42e-01
|
4.05e-01
|
GOBP HIPPO SIGNALING
|
39
|
1.25e-01
|
-1.42e-01
|
2.70e-01
|
GOBP PROTEIN HETEROOLIGOMERIZATION
|
21
|
2.60e-01
|
-1.42e-01
|
4.41e-01
|
GOBP NK T CELL DIFFERENTIATION
|
12
|
3.94e-01
|
-1.42e-01
|
5.79e-01
|
GOBP POSITIVE REGULATION OF STEROL TRANSPORT
|
32
|
1.64e-01
|
1.42e-01
|
3.24e-01
|
GOMF PHOSPHOTRANSFERASE ACTIVITY PHOSPHATE GROUP AS ACCEPTOR
|
22
|
2.49e-01
|
1.42e-01
|
4.30e-01
|
GOBP POSITIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY
|
136
|
4.29e-03
|
-1.42e-01
|
2.21e-02
|
GOBP IMMUNOGLOBULIN PRODUCTION INVOLVED IN IMMUNOGLOBULIN MEDIATED IMMUNE RESPONSE
|
46
|
9.58e-02
|
-1.42e-01
|
2.28e-01
|
GOBP BRANCHING INVOLVED IN PROSTATE GLAND MORPHOGENESIS
|
10
|
4.37e-01
|
-1.42e-01
|
6.17e-01
|
GOBP EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS
|
70
|
4.01e-02
|
-1.42e-01
|
1.23e-01
|
GOBP REGULATION OF AMPA RECEPTOR ACTIVITY
|
11
|
4.15e-01
|
-1.42e-01
|
5.99e-01
|
GOMF CALCIUM CHANNEL REGULATOR ACTIVITY
|
30
|
1.79e-01
|
-1.42e-01
|
3.43e-01
|
GOCC KINETOCHORE MICROTUBULE
|
15
|
3.42e-01
|
-1.42e-01
|
5.30e-01
|
GOBP EMBRYONIC FORELIMB MORPHOGENESIS
|
20
|
2.72e-01
|
-1.42e-01
|
4.54e-01
|
GOBP CELLULAR RESPONSE TO ALDEHYDE
|
10
|
4.38e-01
|
1.42e-01
|
6.18e-01
|
GOBP NEGATIVE REGULATION OF CELL SUBSTRATE ADHESION
|
49
|
8.62e-02
|
-1.42e-01
|
2.12e-01
|
GOBP POSITIVE REGULATION OF VASCULATURE DEVELOPMENT
|
147
|
3.05e-03
|
-1.42e-01
|
1.68e-02
|
GOBP LUNG ALVEOLUS DEVELOPMENT
|
55
|
6.92e-02
|
-1.42e-01
|
1.82e-01
|
GOBP REGULATION OF MUSCLE TISSUE DEVELOPMENT
|
40
|
1.21e-01
|
-1.42e-01
|
2.65e-01
|
GOBP SPERM FLAGELLUM ASSEMBLY
|
24
|
2.30e-01
|
1.42e-01
|
4.09e-01
|
GOBP CRANIAL NERVE STRUCTURAL ORGANIZATION
|
10
|
4.38e-01
|
-1.42e-01
|
6.18e-01
|
GOBP EAR DEVELOPMENT
|
172
|
1.38e-03
|
-1.42e-01
|
8.84e-03
|
GOBP PROTEIN FOLDING
|
147
|
3.09e-03
|
1.42e-01
|
1.69e-02
|
GOBP GABAERGIC NEURON DIFFERENTIATION
|
14
|
3.59e-01
|
1.42e-01
|
5.45e-01
|
GOBP CELL SUBSTRATE JUNCTION ORGANIZATION
|
98
|
1.56e-02
|
-1.42e-01
|
6.10e-02
|
GOBP POSITIVE REGULATION OF MEIOTIC CELL CYCLE
|
19
|
2.86e-01
|
-1.42e-01
|
4.69e-01
|
GOBP NEGATIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE II
|
720
|
1.35e-10
|
-1.41e-01
|
5.95e-09
|
GOMF POTASSIUM ION BINDING
|
11
|
4.17e-01
|
1.41e-01
|
6.00e-01
|
GOBP REGULATION OF NEURON PROJECTION REGENERATION
|
39
|
1.27e-01
|
-1.41e-01
|
2.73e-01
|
GOBP PARASYMPATHETIC NERVOUS SYSTEM DEVELOPMENT
|
15
|
3.43e-01
|
-1.41e-01
|
5.32e-01
|
GOMF CYTOKINE ACTIVITY
|
80
|
2.90e-02
|
-1.41e-01
|
9.68e-02
|
GOBP SUPRAMOLECULAR FIBER ORGANIZATION
|
669
|
5.91e-10
|
-1.41e-01
|
2.25e-08
|
GOCC CENTRIOLAR SATELLITE
|
98
|
1.57e-02
|
-1.41e-01
|
6.15e-02
|
GOBP MEMBRANE DEPOLARIZATION DURING CARDIAC MUSCLE CELL ACTION POTENTIAL
|
16
|
3.28e-01
|
1.41e-01
|
5.15e-01
|
GOBP AXON REGENERATION
|
48
|
9.07e-02
|
-1.41e-01
|
2.20e-01
|
GOBP REGULATION OF DEFENSE RESPONSE
|
589
|
5.93e-09
|
-1.41e-01
|
1.80e-07
|
GOBP CELLULAR METABOLIC COMPOUND SALVAGE
|
28
|
1.97e-01
|
1.41e-01
|
3.66e-01
|
GOBP PYRIMIDINE RIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS
|
11
|
4.18e-01
|
1.41e-01
|
6.01e-01
|
GOBP BLASTOCYST DEVELOPMENT
|
120
|
7.71e-03
|
-1.41e-01
|
3.50e-02
|
GOMF ACYLTRANSFERASE ACTIVITY TRANSFERRING GROUPS OTHER THAN AMINO ACYL GROUPS
|
173
|
1.42e-03
|
1.41e-01
|
9.03e-03
|
GOMF CARBOXYPEPTIDASE ACTIVITY
|
25
|
2.23e-01
|
-1.41e-01
|
4.01e-01
|
GOMF RECEPTOR TYROSINE KINASE BINDING
|
73
|
3.77e-02
|
-1.41e-01
|
1.18e-01
|
GOCC SECRETORY GRANULE MEMBRANE
|
59
|
6.17e-02
|
-1.41e-01
|
1.68e-01
|
GOMF ATP TRANSMEMBRANE TRANSPORTER ACTIVITY
|
12
|
3.99e-01
|
1.41e-01
|
5.84e-01
|
GOBP TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION
|
151
|
2.90e-03
|
-1.41e-01
|
1.62e-02
|
GOMF LIPASE ACTIVITY
|
79
|
3.08e-02
|
1.41e-01
|
1.02e-01
|
GOBP DEFENSE RESPONSE
|
1176
|
1.01e-15
|
-1.41e-01
|
9.22e-14
|
GOBP REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS
|
257
|
1.10e-04
|
-1.40e-01
|
1.09e-03
|
GOBP NEGATIVE REGULATION OF GENE EXPRESSION
|
904
|
1.29e-12
|
-1.40e-01
|
7.11e-11
|
GOBP PYRIMIDINE RIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS
|
13
|
3.81e-01
|
1.40e-01
|
5.67e-01
|
GOBP OSTEOCLAST DIFFERENTIATION
|
95
|
1.82e-02
|
-1.40e-01
|
6.83e-02
|
GOCC VACUOLAR PROTON TRANSPORTING V TYPE ATPASE COMPLEX
|
18
|
3.03e-01
|
1.40e-01
|
4.87e-01
|
GOBP POSITIVE REGULATION OF HORMONE BIOSYNTHETIC PROCESS
|
10
|
4.43e-01
|
-1.40e-01
|
6.22e-01
|
GOBP PURINE RIBONUCLEOSIDE METABOLIC PROCESS
|
21
|
2.66e-01
|
1.40e-01
|
4.48e-01
|
GOBP NEGATIVE REGULATION OF MUSCLE CELL DIFFERENTIATION
|
64
|
5.27e-02
|
-1.40e-01
|
1.51e-01
|
GOBP HINDLIMB MORPHOGENESIS
|
28
|
2.00e-01
|
-1.40e-01
|
3.70e-01
|
GOBP BONE REMODELING
|
80
|
3.05e-02
|
-1.40e-01
|
1.01e-01
|
GOBP PROTEIN HOMOTRIMERIZATION
|
12
|
4.01e-01
|
1.40e-01
|
5.87e-01
|
GOBP MONOCYTE CHEMOTAXIS
|
28
|
2.00e-01
|
-1.40e-01
|
3.70e-01
|
GOCC LATERAL PLASMA MEMBRANE
|
53
|
7.81e-02
|
-1.40e-01
|
1.99e-01
|
GOBP MEMBRANE REPOLARIZATION
|
41
|
1.21e-01
|
1.40e-01
|
2.65e-01
|
GOBP DNA REPAIR
|
504
|
8.94e-08
|
-1.40e-01
|
2.05e-06
|
GOBP RUFFLE ORGANIZATION
|
48
|
9.41e-02
|
-1.40e-01
|
2.25e-01
|
GOBP TERTIARY ALCOHOL METABOLIC PROCESS
|
12
|
4.02e-01
|
-1.40e-01
|
5.88e-01
|
GOBP ESTABLISHMENT OF MITOTIC SPINDLE LOCALIZATION
|
34
|
1.59e-01
|
-1.40e-01
|
3.18e-01
|
GOCC AXONEMAL MICROTUBULE
|
13
|
3.84e-01
|
-1.40e-01
|
5.70e-01
|
GOMF GATED CHANNEL ACTIVITY
|
164
|
2.09e-03
|
1.39e-01
|
1.24e-02
|
GOBP OVULATION CYCLE PROCESS
|
34
|
1.60e-01
|
-1.39e-01
|
3.19e-01
|
GOBP CARTILAGE DEVELOPMENT INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS
|
31
|
1.80e-01
|
-1.39e-01
|
3.44e-01
|
GOCC SPERM PLASMA MEMBRANE
|
10
|
4.46e-01
|
1.39e-01
|
6.25e-01
|
GOBP REGULATION OF LYSOSOME ORGANIZATION
|
12
|
4.04e-01
|
-1.39e-01
|
5.89e-01
|
GOBP NON MOTILE CILIUM ASSEMBLY
|
65
|
5.27e-02
|
-1.39e-01
|
1.51e-01
|
GOCC CATION CHANNEL COMPLEX
|
111
|
1.15e-02
|
1.39e-01
|
4.82e-02
|
GOCC COPI COATED VESICLE MEMBRANE
|
16
|
3.36e-01
|
-1.39e-01
|
5.24e-01
|
GOBP REGULATION OF CELL ADHESION
|
619
|
4.45e-09
|
-1.39e-01
|
1.41e-07
|
GOBP RETINAL METABOLIC PROCESS
|
11
|
4.25e-01
|
1.39e-01
|
6.07e-01
|
GOMF PEPTIDASE ACTIVATOR ACTIVITY
|
53
|
8.04e-02
|
-1.39e-01
|
2.02e-01
|
GOBP UROGENITAL SYSTEM DEVELOPMENT
|
48
|
9.62e-02
|
-1.39e-01
|
2.29e-01
|
GOCC ASTROCYTE PROJECTION
|
12
|
4.05e-01
|
-1.39e-01
|
5.89e-01
|
GOBP NUCLEOSIDE PHOSPHATE CATABOLIC PROCESS
|
151
|
3.30e-03
|
1.39e-01
|
1.79e-02
|
GOBP IMPORT ACROSS PLASMA MEMBRANE
|
147
|
3.77e-03
|
1.39e-01
|
2.00e-02
|
GOBP MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION
|
27
|
2.13e-01
|
1.38e-01
|
3.88e-01
|
GOMF ISOMERASE ACTIVITY
|
139
|
4.89e-03
|
1.38e-01
|
2.45e-02
|
GOBP CATECHOLAMINE SECRETION
|
39
|
1.35e-01
|
1.38e-01
|
2.83e-01
|
GOMF L AMINO ACID TRANSMEMBRANE TRANSPORTER ACTIVITY
|
46
|
1.05e-01
|
1.38e-01
|
2.42e-01
|
GOMF ORGANIC ACID BINDING
|
137
|
5.26e-03
|
1.38e-01
|
2.60e-02
|
GOBP POSITIVE REGULATION OF STEM CELL DIFFERENTIATION
|
22
|
2.62e-01
|
-1.38e-01
|
4.44e-01
|
GOBP NEGATIVE REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY
|
16
|
3.39e-01
|
-1.38e-01
|
5.27e-01
|
GOBP POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE
|
20
|
2.85e-01
|
-1.38e-01
|
4.68e-01
|
GOCC STEREOCILIUM BUNDLE
|
39
|
1.36e-01
|
-1.38e-01
|
2.85e-01
|
GOBP REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS
|
101
|
1.67e-02
|
-1.38e-01
|
6.41e-02
|
GOBP NEUROBLAST PROLIFERATION
|
69
|
4.77e-02
|
-1.38e-01
|
1.40e-01
|
GOBP NEGATIVE REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY
|
85
|
2.81e-02
|
-1.38e-01
|
9.46e-02
|
GOBP REGULATION OF LIPID BIOSYNTHETIC PROCESS
|
159
|
2.74e-03
|
1.38e-01
|
1.55e-02
|
GOBP AXON ENSHEATHMENT IN CENTRAL NERVOUS SYSTEM
|
23
|
2.53e-01
|
-1.38e-01
|
4.34e-01
|
GOMF INTRACELLULARLY CALCIUM GATED CHLORIDE CHANNEL ACTIVITY
|
14
|
3.72e-01
|
1.38e-01
|
5.58e-01
|
GOBP TUBULIN DEACETYLATION
|
21
|
2.74e-01
|
1.38e-01
|
4.56e-01
|
GOBP REGULATION OF GLYCOGEN BIOSYNTHETIC PROCESS
|
29
|
1.99e-01
|
-1.38e-01
|
3.70e-01
|
GOBP VASODILATION
|
49
|
9.55e-02
|
1.38e-01
|
2.28e-01
|
GOBP REGULATION OF MULTICELLULAR ORGANISMAL DEVELOPMENT
|
1181
|
3.35e-15
|
-1.38e-01
|
2.85e-13
|
GOBP ENGULFMENT OF APOPTOTIC CELL
|
10
|
4.51e-01
|
-1.38e-01
|
6.29e-01
|
GOBP INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS
|
55
|
7.76e-02
|
-1.38e-01
|
1.98e-01
|
GOBP APOPTOTIC MITOCHONDRIAL CHANGES
|
104
|
1.54e-02
|
1.38e-01
|
6.06e-02
|
GOBP CAMKK AMPK SIGNALING CASCADE
|
13
|
3.90e-01
|
-1.38e-01
|
5.77e-01
|
GOBP EPIGENETIC PROGRAMMING IN THE ZYGOTIC PRONUCLEI
|
12
|
4.09e-01
|
-1.38e-01
|
5.93e-01
|
GOBP REGULATION OF B CELL MEDIATED IMMUNITY
|
44
|
1.15e-01
|
-1.37e-01
|
2.56e-01
|
GOBP PURINE CONTAINING COMPOUND CATABOLIC PROCESS
|
134
|
6.08e-03
|
1.37e-01
|
2.92e-02
|
GOBP POSITIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS
|
614
|
7.46e-09
|
-1.37e-01
|
2.19e-07
|
GOMF UBIQUITIN LIKE PROTEIN READER ACTIVITY
|
21
|
2.76e-01
|
-1.37e-01
|
4.58e-01
|
GOBP REGULATION OF CELL ACTIVATION
|
461
|
4.91e-07
|
-1.37e-01
|
9.27e-06
|
GOBP NEGATIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY
|
86
|
2.79e-02
|
-1.37e-01
|
9.42e-02
|
GOBP UTERUS DEVELOPMENT
|
17
|
3.28e-01
|
-1.37e-01
|
5.15e-01
|
GOBP PROTEIN MONOUBIQUITINATION
|
47
|
1.04e-01
|
-1.37e-01
|
2.41e-01
|
GOBP NEGATIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION
|
40
|
1.34e-01
|
-1.37e-01
|
2.82e-01
|
GOBP RESPONSE TO PROGESTERONE
|
16
|
3.43e-01
|
-1.37e-01
|
5.31e-01
|
GOMF PHOSPHATASE REGULATOR ACTIVITY
|
76
|
3.91e-02
|
1.37e-01
|
1.21e-01
|
GOBP SMOOTH MUSCLE TISSUE DEVELOPMENT
|
23
|
2.56e-01
|
-1.37e-01
|
4.37e-01
|
GOBP POSITIVE REGULATION OF DEVELOPMENTAL PROCESS
|
1126
|
1.79e-14
|
-1.37e-01
|
1.33e-12
|
GOBP EPIDERMIS DEVELOPMENT
|
229
|
3.69e-04
|
-1.37e-01
|
3.02e-03
|
GOBP ANDROGEN RECEPTOR SIGNALING PATHWAY
|
37
|
1.50e-01
|
-1.37e-01
|
3.04e-01
|
GOBP NEGATIVE REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION
|
16
|
3.43e-01
|
-1.37e-01
|
5.32e-01
|
GOBP POSITIVE REGULATION OF LIPID CATABOLIC PROCESS
|
19
|
3.02e-01
|
1.37e-01
|
4.86e-01
|
GOMF TRANSFERASE ACTIVITY TRANSFERRING ONE CARBON GROUPS
|
166
|
2.40e-03
|
1.37e-01
|
1.39e-02
|
GOBP BLASTOCYST FORMATION
|
45
|
1.13e-01
|
-1.37e-01
|
2.53e-01
|
GOCC SPINDLE POLE CENTROSOME
|
16
|
3.45e-01
|
-1.37e-01
|
5.33e-01
|
GOMF POTASSIUM CHANNEL REGULATOR ACTIVITY
|
35
|
1.63e-01
|
-1.36e-01
|
3.22e-01
|
GOBP POSITIVE REGULATION OF PROTEIN IMPORT INTO NUCLEUS
|
46
|
1.10e-01
|
-1.36e-01
|
2.49e-01
|
GOBP REGULATION OF PROTEIN DEPOLYMERIZATION
|
87
|
2.81e-02
|
-1.36e-01
|
9.46e-02
|
GOMF MONOATOMIC CATION CHANNEL ACTIVITY
|
164
|
2.64e-03
|
1.36e-01
|
1.50e-02
|
GOBP NEUTROPHIL MIGRATION
|
80
|
3.53e-02
|
-1.36e-01
|
1.13e-01
|
GOMF G PROTEIN BETA GAMMA SUBUNIT COMPLEX BINDING
|
18
|
3.17e-01
|
-1.36e-01
|
5.04e-01
|
GOBP NEPHRON DEVELOPMENT
|
128
|
7.92e-03
|
-1.36e-01
|
3.56e-02
|
GOBP STRESS FIBER ASSEMBLY
|
105
|
1.61e-02
|
-1.36e-01
|
6.28e-02
|
GOMF TRANSFERASE ACTIVITY TRANSFERRING SULPHUR CONTAINING GROUPS
|
45
|
1.15e-01
|
1.36e-01
|
2.56e-01
|
GOBP TYPE B PANCREATIC CELL DIFFERENTIATION
|
18
|
3.18e-01
|
-1.36e-01
|
5.05e-01
|
GOBP DNA CATABOLIC PROCESS
|
23
|
2.59e-01
|
1.36e-01
|
4.41e-01
|
GOCC POSTSYNAPTIC SPECIALIZATION INTRACELLULAR COMPONENT
|
46
|
1.11e-01
|
-1.36e-01
|
2.51e-01
|
GOMF ALDEHYDE DEHYDROGENASE NAD P PLUS ACTIVITY
|
15
|
3.62e-01
|
1.36e-01
|
5.49e-01
|
GOBP CONVERGENT EXTENSION
|
15
|
3.63e-01
|
-1.36e-01
|
5.49e-01
|
GOBP POSITIVE REGULATION BY HOST OF VIRAL TRANSCRIPTION
|
16
|
3.47e-01
|
-1.36e-01
|
5.35e-01
|
GOBP PROTEIN NITROSYLATION
|
12
|
4.16e-01
|
-1.36e-01
|
5.99e-01
|
GOBP POSITIVE REGULATION OF CREB TRANSCRIPTION FACTOR ACTIVITY
|
10
|
4.57e-01
|
-1.36e-01
|
6.34e-01
|
GOBP REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION
|
46
|
1.11e-01
|
1.36e-01
|
2.51e-01
|
GOBP NEGATIVE REGULATION OF DEVELOPMENTAL PROCESS
|
748
|
3.60e-10
|
-1.36e-01
|
1.46e-08
|
GOBP RESPONSE TO X RAY
|
20
|
2.94e-01
|
-1.36e-01
|
4.78e-01
|
GOMF PROTEIN TYROSINE THREONINE PHOSPHATASE ACTIVITY
|
10
|
4.58e-01
|
-1.36e-01
|
6.34e-01
|
GOBP NEGATIVE REGULATION OF ORGANELLE ASSEMBLY
|
43
|
1.24e-01
|
-1.36e-01
|
2.70e-01
|
GOBP RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS
|
29
|
2.07e-01
|
1.36e-01
|
3.80e-01
|
GOBP EPIGENETIC PROGRAMMING OF GENE EXPRESSION
|
36
|
1.60e-01
|
-1.35e-01
|
3.19e-01
|
GOBP T HELPER 2 CELL DIFFERENTIATION
|
13
|
3.98e-01
|
-1.35e-01
|
5.83e-01
|
GOBP REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY
|
15
|
3.64e-01
|
-1.35e-01
|
5.51e-01
|
GOBP POSITIVE REGULATION OF LEUKOCYTE PROLIFERATION
|
118
|
1.12e-02
|
-1.35e-01
|
4.73e-02
|
GOBP REGULATION OF WOUND HEALING
|
94
|
2.36e-02
|
-1.35e-01
|
8.33e-02
|
GOBP REGULATION OF STEROID METABOLIC PROCESS
|
81
|
3.56e-02
|
1.35e-01
|
1.13e-01
|
GOBP ENDOTHELIAL CELL PROLIFERATION
|
138
|
6.21e-03
|
-1.35e-01
|
2.96e-02
|
GOBP NEGATIVE REGULATION OF NUCLEOBASE CONTAINING COMPOUND METABOLIC PROCESS
|
1128
|
3.84e-14
|
-1.35e-01
|
2.67e-12
|
GOMF RETINAL DEHYDROGENASE ACTIVITY
|
10
|
4.60e-01
|
1.35e-01
|
6.36e-01
|
GOBP NEGATIVE REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY
|
17
|
3.36e-01
|
-1.35e-01
|
5.24e-01
|
GOBP OLIGOSACCHARIDE LIPID INTERMEDIATE BIOSYNTHETIC PROCESS
|
14
|
3.82e-01
|
1.35e-01
|
5.68e-01
|
GOBP HAIR CELL DIFFERENTIATION
|
42
|
1.31e-01
|
-1.35e-01
|
2.78e-01
|
GOBP HEART TRABECULA FORMATION
|
13
|
4.00e-01
|
1.35e-01
|
5.86e-01
|
GOBP REGULATION OF MICROVILLUS ORGANIZATION
|
11
|
4.39e-01
|
-1.35e-01
|
6.19e-01
|
GOBP PROTEIN LOCALIZATION TO VACUOLE
|
70
|
5.14e-02
|
-1.35e-01
|
1.48e-01
|
GOBP HYALURONAN METABOLIC PROCESS
|
30
|
2.02e-01
|
-1.35e-01
|
3.73e-01
|
GOMF TRANSCRIPTION COREGULATOR ACTIVITY
|
433
|
1.72e-06
|
-1.35e-01
|
2.91e-05
|
GOBP CARDIAC PACEMAKER CELL DIFFERENTIATION
|
10
|
4.61e-01
|
1.35e-01
|
6.37e-01
|
GOBP POSITIVE REGULATION OF STEM CELL POPULATION MAINTENANCE
|
45
|
1.18e-01
|
-1.35e-01
|
2.61e-01
|
GOBP REGULATION OF CELL PROJECTION ORGANIZATION
|
627
|
1.08e-08
|
-1.35e-01
|
3.04e-07
|
GOBP MOTOR NEURON APOPTOTIC PROCESS
|
25
|
2.44e-01
|
-1.35e-01
|
4.25e-01
|
GOMF ORGANIC ANION TRANSMEMBRANE TRANSPORTER ACTIVITY
|
175
|
2.19e-03
|
1.34e-01
|
1.29e-02
|
GOCC NUCLEAR PERIPHERY
|
128
|
8.70e-03
|
-1.34e-01
|
3.83e-02
|
GOBP INTRACELLULAR MRNA LOCALIZATION
|
14
|
3.84e-01
|
-1.34e-01
|
5.70e-01
|
GOBP MITOCHONDRIAL CALCIUM ION HOMEOSTASIS
|
25
|
2.45e-01
|
1.34e-01
|
4.26e-01
|
GOCC PROTEIN LIPID COMPLEX
|
24
|
2.55e-01
|
1.34e-01
|
4.36e-01
|
GOCC CYTOSOLIC REGION
|
64
|
6.35e-02
|
-1.34e-01
|
1.71e-01
|
GOBP REGULATION OF DENDRITIC SPINE DEVELOPMENT
|
80
|
3.82e-02
|
-1.34e-01
|
1.19e-01
|
GOBP POSITIVE REGULATION OF NEUROGENESIS
|
266
|
1.73e-04
|
-1.34e-01
|
1.59e-03
|
GOBP OVULATION CYCLE
|
43
|
1.28e-01
|
-1.34e-01
|
2.75e-01
|
GOBP TYPE B PANCREATIC CELL APOPTOTIC PROCESS
|
13
|
4.03e-01
|
1.34e-01
|
5.88e-01
|
GOBP VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION
|
31
|
1.97e-01
|
-1.34e-01
|
3.67e-01
|
GOBP TISSUE REMODELING
|
167
|
2.86e-03
|
-1.34e-01
|
1.60e-02
|
GOBP POSITIVE REGULATION OF CELLULAR COMPONENT BIOGENESIS
|
453
|
1.15e-06
|
-1.34e-01
|
2.01e-05
|
GOBP NEGATIVE REGULATION OF TYPE I INTERFERON PRODUCTION
|
39
|
1.48e-01
|
-1.34e-01
|
3.01e-01
|
GOBP CORONARY VASCULATURE DEVELOPMENT
|
70
|
5.30e-02
|
-1.34e-01
|
1.51e-01
|
GOMF DNA BINDING TRANSCRIPTION ACTIVATOR ACTIVITY
|
332
|
2.94e-05
|
-1.34e-01
|
3.52e-04
|
GOBP ORGANELLE MEMBRANE FUSION
|
100
|
2.09e-02
|
-1.34e-01
|
7.62e-02
|
GOCC CUL4 RING E3 UBIQUITIN LIGASE COMPLEX
|
29
|
2.13e-01
|
1.34e-01
|
3.87e-01
|
GOBP ACTIN FILAMENT ORGANIZATION
|
390
|
6.26e-06
|
-1.34e-01
|
9.01e-05
|
GOBP NEGATIVE REGULATION OF IMMUNE SYSTEM PROCESS
|
379
|
8.60e-06
|
-1.34e-01
|
1.19e-04
|
GOBP LIGAND GATED ION CHANNEL SIGNALING PATHWAY
|
23
|
2.68e-01
|
-1.34e-01
|
4.49e-01
|
GOBP METHYLATION
|
169
|
2.79e-03
|
1.34e-01
|
1.57e-02
|
GOMF ATP DEPENDENT PROTEIN BINDING
|
11
|
4.43e-01
|
-1.34e-01
|
6.22e-01
|
GOBP EXTRACELLULAR VESICLE BIOGENESIS
|
23
|
2.68e-01
|
-1.33e-01
|
4.50e-01
|
GOBP GASTRULATION WITH MOUTH FORMING SECOND
|
26
|
2.39e-01
|
-1.33e-01
|
4.18e-01
|
GOBP CELL ADHESION
|
1056
|
4.20e-13
|
-1.33e-01
|
2.49e-11
|
GOBP DNA BIOSYNTHETIC PROCESS
|
157
|
3.98e-03
|
-1.33e-01
|
2.08e-02
|
GOBP SUBSTRATE DEPENDENT CELL MIGRATION
|
27
|
2.31e-01
|
-1.33e-01
|
4.09e-01
|
GOBP XENOBIOTIC TRANSMEMBRANE TRANSPORT
|
12
|
4.25e-01
|
1.33e-01
|
6.07e-01
|
GOBP ENDOCHONDRAL BONE MORPHOGENESIS
|
56
|
8.50e-02
|
-1.33e-01
|
2.11e-01
|
GOBP POSITIVE REGULATION OF ADIPOSE TISSUE DEVELOPMENT
|
10
|
4.66e-01
|
1.33e-01
|
6.42e-01
|
GOBP DETECTION OF CHEMICAL STIMULUS
|
31
|
2.00e-01
|
-1.33e-01
|
3.70e-01
|
GOMF NUCLEOSIDE DIPHOSPHATE KINASE ACTIVITY
|
12
|
4.25e-01
|
1.33e-01
|
6.07e-01
|
GOBP NEGATIVE REGULATION OF PROTEIN POLYMERIZATION
|
76
|
4.52e-02
|
-1.33e-01
|
1.34e-01
|
GOBP ANIMAL ORGAN MATURATION
|
25
|
2.50e-01
|
-1.33e-01
|
4.32e-01
|
GOBP POSITIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY
|
60
|
7.51e-02
|
-1.33e-01
|
1.93e-01
|
GOBP LIPID IMPORT INTO CELL
|
19
|
3.16e-01
|
1.33e-01
|
5.03e-01
|
GOCC CENTROSOME
|
571
|
6.72e-08
|
-1.33e-01
|
1.56e-06
|
GOBP NEGATIVE REGULATION OF CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY
|
45
|
1.23e-01
|
-1.33e-01
|
2.68e-01
|
GOBP REGULATION OF LEUKOCYTE PROLIFERATION
|
195
|
1.41e-03
|
-1.33e-01
|
9.01e-03
|
GOBP CELL ACTIVATION
|
804
|
2.14e-10
|
-1.33e-01
|
8.92e-09
|
GOMF PROTEIN CARRIER CHAPERONE
|
34
|
1.81e-01
|
1.33e-01
|
3.45e-01
|
GOMF SUMO LIGASE ACTIVITY
|
11
|
4.46e-01
|
-1.33e-01
|
6.25e-01
|
GOBP PHOSPHATIDYLINOSITOL PHOSPHATE BIOSYNTHETIC PROCESS
|
46
|
1.20e-01
|
-1.33e-01
|
2.63e-01
|
GOMF MAP KINASE PHOSPHATASE ACTIVITY
|
11
|
4.46e-01
|
-1.33e-01
|
6.25e-01
|
GOBP NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY
|
27
|
2.33e-01
|
-1.33e-01
|
4.12e-01
|
GOBP REGULATION OF NEUROGENESIS
|
378
|
1.02e-05
|
-1.33e-01
|
1.37e-04
|
GOBP RESPONSE TO VITAMIN D
|
14
|
3.90e-01
|
-1.33e-01
|
5.76e-01
|
GOBP HOMEOSTASIS OF NUMBER OF CELLS
|
325
|
4.19e-05
|
-1.33e-01
|
4.77e-04
|
GOBP ADHERENS JUNCTION ASSEMBLY
|
12
|
4.27e-01
|
-1.33e-01
|
6.08e-01
|
GOMF HSP90 PROTEIN BINDING
|
45
|
1.24e-01
|
1.33e-01
|
2.70e-01
|
GOBP POSITIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE II
|
941
|
8.87e-12
|
-1.32e-01
|
4.45e-10
|
GOBP ERBB SIGNALING PATHWAY
|
108
|
1.75e-02
|
-1.32e-01
|
6.66e-02
|
GOBP HINDBRAIN RADIAL GLIA GUIDED CELL MIGRATION
|
12
|
4.27e-01
|
1.32e-01
|
6.08e-01
|
GOBP NEGATIVE REGULATION OF OXIDATIVE STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY
|
23
|
2.72e-01
|
-1.32e-01
|
4.54e-01
|
GOBP PROTEIN LOCALIZATION TO SYNAPSE
|
85
|
3.52e-02
|
1.32e-01
|
1.13e-01
|
GOMF MITOGEN ACTIVATED PROTEIN KINASE KINASE BINDING
|
18
|
3.31e-01
|
-1.32e-01
|
5.19e-01
|
GOBP POSITIVE REGULATION OF GTPASE ACTIVITY
|
173
|
2.75e-03
|
-1.32e-01
|
1.55e-02
|
GOBP POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION
|
39
|
1.54e-01
|
-1.32e-01
|
3.09e-01
|
GOBP DIOL METABOLIC PROCESS
|
24
|
2.63e-01
|
1.32e-01
|
4.44e-01
|
GOBP REGULATION OF CELLULAR EXTRAVASATION
|
36
|
1.70e-01
|
-1.32e-01
|
3.33e-01
|
GOBP POSITIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY
|
16
|
3.61e-01
|
-1.32e-01
|
5.47e-01
|
GOBP REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY
|
208
|
1.06e-03
|
-1.32e-01
|
7.08e-03
|
GOCC GTPASE ACTIVATOR COMPLEX
|
10
|
4.70e-01
|
1.32e-01
|
6.45e-01
|
GOCC CONTRACTILE MUSCLE FIBER
|
218
|
8.07e-04
|
1.32e-01
|
5.70e-03
|
GOBP POSITIVE REGULATION OF CELL PROJECTION ORGANIZATION
|
378
|
1.15e-05
|
-1.32e-01
|
1.52e-04
|
GOCC MRNA CLEAVAGE AND POLYADENYLATION SPECIFICITY FACTOR COMPLEX
|
17
|
3.47e-01
|
-1.32e-01
|
5.35e-01
|
GOBP PEPTIDYL LYSINE ACETYLATION
|
24
|
2.64e-01
|
-1.32e-01
|
4.46e-01
|
GOBP POSITIVE REGULATION OF PROTEIN MODIFICATION PROCESS
|
669
|
8.02e-09
|
-1.32e-01
|
2.35e-07
|
GOBP REGULATION OF AMIDE METABOLIC PROCESS
|
62
|
7.33e-02
|
1.32e-01
|
1.90e-01
|
GOBP REGULATION OF DNA BINDING
|
83
|
3.84e-02
|
-1.32e-01
|
1.20e-01
|
GOMF METALLOCHAPERONE ACTIVITY
|
11
|
4.51e-01
|
1.31e-01
|
6.29e-01
|
GOBP REGULATION OF PH
|
78
|
4.50e-02
|
1.31e-01
|
1.34e-01
|
GOMF MITOGEN ACTIVATED PROTEIN KINASE KINASE KINASE BINDING
|
24
|
2.65e-01
|
-1.31e-01
|
4.47e-01
|
GOBP POSITIVE REGULATION OF MAP KINASE ACTIVITY
|
93
|
2.87e-02
|
-1.31e-01
|
9.60e-02
|
GOBP CALCIUM ION REGULATED EXOCYTOSIS OF NEUROTRANSMITTER
|
15
|
3.78e-01
|
1.31e-01
|
5.64e-01
|
GOBP GLYCEROLIPID METABOLIC PROCESS
|
303
|
8.82e-05
|
1.31e-01
|
8.97e-04
|
GOBP POSITIVE REGULATION OF PROGRAMMED CELL DEATH
|
529
|
2.75e-07
|
-1.31e-01
|
5.54e-06
|
GOMF MONOSACCHARIDE BINDING
|
68
|
6.14e-02
|
1.31e-01
|
1.67e-01
|
GOMF MONOOXYGENASE ACTIVITY
|
59
|
8.16e-02
|
1.31e-01
|
2.04e-01
|
GOCC NUCLEAR MATRIX
|
102
|
2.22e-02
|
-1.31e-01
|
7.99e-02
|
GOBP POSITIVE REGULATION OF LOCOMOTION
|
516
|
3.96e-07
|
-1.31e-01
|
7.62e-06
|
GOBP OOGENESIS
|
63
|
7.22e-02
|
-1.31e-01
|
1.88e-01
|
GOBP POSITIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION
|
43
|
1.37e-01
|
-1.31e-01
|
2.87e-01
|
GOMF PHOSPHATIDYLINOSITOL 5 PHOSPHATE BINDING
|
17
|
3.50e-01
|
1.31e-01
|
5.37e-01
|
GOBP NEGATIVE REGULATION OF NOTCH SIGNALING PATHWAY
|
32
|
2.00e-01
|
-1.31e-01
|
3.70e-01
|
GOBP REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DIFFERENTIATION
|
14
|
3.96e-01
|
-1.31e-01
|
5.82e-01
|
GOMF ORGANIC CATION TRANSMEMBRANE TRANSPORTER ACTIVITY
|
58
|
8.48e-02
|
1.31e-01
|
2.10e-01
|
GOMF PHOSPHATIDYLINOSITOL 3 5 BISPHOSPHATE BINDING
|
25
|
2.57e-01
|
1.31e-01
|
4.39e-01
|
GOBP SEX DETERMINATION
|
14
|
3.97e-01
|
1.31e-01
|
5.82e-01
|
GOMF PHOSPHOLIPASE ACTIVITY
|
62
|
7.53e-02
|
1.31e-01
|
1.93e-01
|
GOBP CELLULAR CATABOLIC PROCESS
|
851
|
1.37e-10
|
1.31e-01
|
5.98e-09
|
GOBP POSITIVE REGULATION OF VIRAL PROCESS
|
54
|
9.69e-02
|
-1.31e-01
|
2.30e-01
|
GOBP RIBOSOMAL SMALL SUBUNIT BIOGENESIS
|
96
|
2.72e-02
|
1.31e-01
|
9.27e-02
|
GOBP REGULATION OF PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR SIGNALING PATHWAY
|
13
|
4.15e-01
|
-1.31e-01
|
5.99e-01
|
GOBP WNT SIGNALING PATHWAY
|
364
|
2.01e-05
|
-1.31e-01
|
2.50e-04
|
GOBP HEMOPOIESIS
|
792
|
5.71e-10
|
-1.31e-01
|
2.20e-08
|
GOBP CELL CELL JUNCTION MAINTENANCE
|
15
|
3.82e-01
|
-1.31e-01
|
5.68e-01
|
GOMF DISORDERED DOMAIN SPECIFIC BINDING
|
31
|
2.09e-01
|
-1.30e-01
|
3.82e-01
|
GOBP MONOSACCHARIDE METABOLIC PROCESS
|
217
|
9.51e-04
|
1.30e-01
|
6.50e-03
|
GOBP ESTABLISHMENT OF CELL POLARITY
|
134
|
9.25e-03
|
-1.30e-01
|
4.03e-02
|
GOBP CARBOHYDRATE DERIVATIVE CATABOLIC PROCESS
|
207
|
1.25e-03
|
1.30e-01
|
8.13e-03
|
GOBP MACROMOLECULE METHYLATION
|
106
|
2.05e-02
|
1.30e-01
|
7.52e-02
|
GOBP REGULATION OF LONG TERM NEURONAL SYNAPTIC PLASTICITY
|
33
|
1.95e-01
|
1.30e-01
|
3.65e-01
|
GOBP SIGNALING RECEPTOR LIGAND PRECURSOR PROCESSING
|
23
|
2.80e-01
|
-1.30e-01
|
4.62e-01
|
GOBP INORGANIC ION TRANSMEMBRANE TRANSPORT
|
510
|
5.43e-07
|
1.30e-01
|
1.01e-05
|
GOBP ENZYME LINKED RECEPTOR PROTEIN SIGNALING PATHWAY
|
778
|
8.88e-10
|
-1.30e-01
|
3.24e-08
|
GOBP LONG TERM SYNAPTIC DEPRESSION
|
30
|
2.18e-01
|
1.30e-01
|
3.94e-01
|
GOBP BRANCHING INVOLVED IN BLOOD VESSEL MORPHOGENESIS
|
38
|
1.66e-01
|
-1.30e-01
|
3.26e-01
|
GOBP TONGUE DEVELOPMENT
|
16
|
3.68e-01
|
1.30e-01
|
5.55e-01
|
GOBP REGULATION OF SYNAPTIC VESICLE EXOCYTOSIS
|
42
|
1.45e-01
|
-1.30e-01
|
2.98e-01
|
GOBP RENAL SYSTEM DEVELOPMENT
|
280
|
1.93e-04
|
-1.30e-01
|
1.75e-03
|
GOBP POSITIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS
|
90
|
3.35e-02
|
-1.30e-01
|
1.08e-01
|
GOBP REGULATION OF RESPONSE TO WOUNDING
|
132
|
1.02e-02
|
-1.30e-01
|
4.36e-02
|
GOBP THYROID GLAND DEVELOPMENT
|
22
|
2.92e-01
|
1.30e-01
|
4.76e-01
|
GOBP REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE
|
145
|
7.15e-03
|
-1.30e-01
|
3.33e-02
|
GOBP PYRIMIDINE RIBONUCLEOTIDE BIOSYNTHETIC PROCESS
|
15
|
3.85e-01
|
1.30e-01
|
5.71e-01
|
GOBP ANTIBACTERIAL HUMORAL RESPONSE
|
20
|
3.16e-01
|
1.30e-01
|
5.03e-01
|
GOBP DEOXYRIBONUCLEOTIDE BIOSYNTHETIC PROCESS
|
15
|
3.85e-01
|
-1.29e-01
|
5.71e-01
|
GOMF NUCLEOSIDE DIPHOSPHATE PHOSPHATASE ACTIVITY
|
13
|
4.19e-01
|
1.29e-01
|
6.01e-01
|
GOBP POSITIVE REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY
|
12
|
4.37e-01
|
-1.29e-01
|
6.17e-01
|
GOBP REGULATION OF NERVOUS SYSTEM DEVELOPMENT
|
453
|
2.56e-06
|
-1.29e-01
|
4.13e-05
|
GOBP RIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS
|
44
|
1.37e-01
|
1.29e-01
|
2.87e-01
|
GOBP MESONEPHRIC TUBULE MORPHOGENESIS
|
51
|
1.10e-01
|
-1.29e-01
|
2.49e-01
|
GOBP EMBRYONIC ORGAN MORPHOGENESIS
|
217
|
1.04e-03
|
-1.29e-01
|
7.00e-03
|
GOBP REGULATION OF NEURON PROJECTION DEVELOPMENT
|
463
|
2.02e-06
|
-1.29e-01
|
3.34e-05
|
GOBP NEGATIVE REGULATION OF SIGNALING RECEPTOR ACTIVITY
|
25
|
2.63e-01
|
-1.29e-01
|
4.44e-01
|
GOCC CELL SURFACE
|
626
|
4.00e-08
|
-1.29e-01
|
9.95e-07
|
GOBP CELL CELL ADHESION
|
630
|
3.71e-08
|
-1.29e-01
|
9.29e-07
|
GOBP RESPONSE TO COPPER ION
|
17
|
3.56e-01
|
-1.29e-01
|
5.43e-01
|
GOBP RIBOSOME BIOGENESIS
|
286
|
1.77e-04
|
1.29e-01
|
1.62e-03
|
GOBP REGULATION OF MITOCHONDRIAL MEMBRANE POTENTIAL
|
73
|
5.65e-02
|
1.29e-01
|
1.58e-01
|
GOBP REGULATION OF OXIDATIVE STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY
|
33
|
2.00e-01
|
-1.29e-01
|
3.70e-01
|
GOBP NEGATIVE ADAPTATION OF SIGNALING PATHWAY
|
18
|
3.44e-01
|
-1.29e-01
|
5.32e-01
|
GOBP REGULATION OF INOSITOL PHOSPHATE BIOSYNTHETIC PROCESS
|
11
|
4.59e-01
|
1.29e-01
|
6.35e-01
|
GOBP IMMATURE B CELL DIFFERENTIATION
|
15
|
3.88e-01
|
-1.29e-01
|
5.73e-01
|
GOMF CHOLESTEROL BINDING
|
40
|
1.59e-01
|
1.29e-01
|
3.17e-01
|
GOBP NEGATIVE REGULATION OF CELL POPULATION PROLIFERATION
|
569
|
1.78e-07
|
-1.29e-01
|
3.76e-06
|
GOBP POSITIVE REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL
|
31
|
2.15e-01
|
-1.29e-01
|
3.90e-01
|
GOBP NEGATIVE REGULATION OF LYMPHOCYTE ACTIVATION
|
123
|
1.38e-02
|
-1.29e-01
|
5.53e-02
|
GOBP MUSCLE CONTRACTION
|
249
|
4.84e-04
|
1.29e-01
|
3.74e-03
|
GOBP POSITIVE REGULATION OF DNA METABOLIC PROCESS
|
277
|
2.36e-04
|
-1.29e-01
|
2.10e-03
|
GOBP BUNDLE OF HIS CELL TO PURKINJE MYOCYTE COMMUNICATION
|
14
|
4.05e-01
|
1.29e-01
|
5.89e-01
|
GOBP POSITIVE REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS
|
21
|
3.07e-01
|
1.29e-01
|
4.92e-01
|
GOBP SPHINGOMYELIN BIOSYNTHETIC PROCESS
|
12
|
4.40e-01
|
-1.29e-01
|
6.20e-01
|
GOMF PEPTIDASE REGULATOR ACTIVITY
|
133
|
1.05e-02
|
-1.29e-01
|
4.47e-02
|
GOBP CYTOSKELETON ORGANIZATION
|
1150
|
3.54e-13
|
-1.29e-01
|
2.12e-11
|
GOBP INTERNEURON MIGRATION
|
10
|
4.81e-01
|
-1.29e-01
|
6.55e-01
|
GOBP REGULATION OF MICROGLIAL CELL ACTIVATION
|
12
|
4.40e-01
|
1.29e-01
|
6.20e-01
|
GOCC SITE OF DOUBLE STRAND BREAK
|
77
|
5.12e-02
|
-1.29e-01
|
1.48e-01
|
GOBP MYELOID LEUKOCYTE DIFFERENTIATION
|
197
|
1.91e-03
|
-1.28e-01
|
1.16e-02
|
GOBP REGULATION OF DNA METABOLIC PROCESS
|
427
|
5.81e-06
|
-1.28e-01
|
8.48e-05
|
GOBP DOPAMINE SECRETION
|
23
|
2.87e-01
|
1.28e-01
|
4.69e-01
|
GOMF NEUROTROPHIN BINDING
|
12
|
4.41e-01
|
1.28e-01
|
6.21e-01
|
GOBP DNA METABOLIC PROCESS
|
799
|
9.40e-10
|
-1.28e-01
|
3.38e-08
|
GOBP RETROGRADE TRANSPORT VESICLE RECYCLING WITHIN GOLGI
|
10
|
4.83e-01
|
1.28e-01
|
6.56e-01
|
GOBP MACROPHAGE ACTIVATION
|
84
|
4.23e-02
|
-1.28e-01
|
1.28e-01
|
GOBP ANTIMICROBIAL HUMORAL RESPONSE
|
53
|
1.07e-01
|
1.28e-01
|
2.44e-01
|
GOBP REGULATION OF HYDROGEN PEROXIDE MEDIATED PROGRAMMED CELL DEATH
|
13
|
4.23e-01
|
1.28e-01
|
6.06e-01
|
GOBP RESPONSE TO ANGIOTENSIN
|
30
|
2.24e-01
|
-1.28e-01
|
4.02e-01
|
GOMF PROTEIN TYROSINE KINASE ACTIVITY
|
105
|
2.33e-02
|
-1.28e-01
|
8.26e-02
|
GOMF PROTEIN KINASE ACTIVITY
|
464
|
2.47e-06
|
-1.28e-01
|
4.00e-05
|
GOBP REGULATION OF EPITHELIAL CELL MIGRATION
|
215
|
1.23e-03
|
-1.28e-01
|
8.02e-03
|
GOBP CARDIAC MUSCLE CELL ACTION POTENTIAL
|
55
|
1.00e-01
|
1.28e-01
|
2.35e-01
|
GOBP REGULATION OF CHEMOKINE MEDIATED SIGNALING PATHWAY
|
10
|
4.83e-01
|
-1.28e-01
|
6.56e-01
|
GOBP NEGATIVE REGULATION OF CIRCADIAN RHYTHM
|
13
|
4.24e-01
|
-1.28e-01
|
6.06e-01
|
GOBP REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY
|
36
|
1.83e-01
|
-1.28e-01
|
3.49e-01
|
GOBP RESPONSE TO INTERLEUKIN 7
|
17
|
3.61e-01
|
-1.28e-01
|
5.47e-01
|
GOBP POSITIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION
|
820
|
6.27e-10
|
-1.28e-01
|
2.36e-08
|
GOBP POSITIVE REGULATION OF ASTROCYTE DIFFERENTIATION
|
13
|
4.24e-01
|
-1.28e-01
|
6.06e-01
|
GOBP G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY COUPLED TO CYCLIC NUCLEOTIDE SECOND MESSENGER
|
12
|
4.42e-01
|
1.28e-01
|
6.22e-01
|
GOMF VOLTAGE GATED MONOATOMIC CATION CHANNEL ACTIVITY
|
77
|
5.22e-02
|
1.28e-01
|
1.50e-01
|
GOBP EMBRYONIC PLACENTA DEVELOPMENT
|
84
|
4.27e-02
|
-1.28e-01
|
1.28e-01
|
GOBP CELLULAR RESPONSE TO LIPID
|
410
|
9.54e-06
|
-1.28e-01
|
1.30e-04
|
GOBP NEUROTRANSMITTER RECEPTOR LOCALIZATION TO POSTSYNAPTIC SPECIALIZATION MEMBRANE
|
36
|
1.84e-01
|
1.28e-01
|
3.50e-01
|
GOBP GENITALIA DEVELOPMENT
|
34
|
1.97e-01
|
1.28e-01
|
3.67e-01
|
GOBP STARTLE RESPONSE
|
23
|
2.89e-01
|
1.28e-01
|
4.72e-01
|
GOBP ASTROCYTE DIFFERENTIATION
|
72
|
6.11e-02
|
-1.28e-01
|
1.66e-01
|
GOMF PROTEIN KINASE C BINDING
|
55
|
1.01e-01
|
-1.28e-01
|
2.37e-01
|
GOBP LABYRINTHINE LAYER DEVELOPMENT
|
43
|
1.48e-01
|
-1.28e-01
|
3.01e-01
|
GOBP ACTIN MEDIATED CELL CONTRACTION
|
91
|
3.56e-02
|
1.28e-01
|
1.13e-01
|
GOBP REGULATION OF BONE RESORPTION
|
38
|
1.74e-01
|
-1.28e-01
|
3.37e-01
|
GOBP NEGATIVE REGULATION OF DNA METABOLIC PROCESS
|
103
|
2.55e-02
|
-1.27e-01
|
8.85e-02
|
GOMF NUCLEAR LOCALIZATION SEQUENCE BINDING
|
20
|
3.24e-01
|
-1.27e-01
|
5.11e-01
|
GOBP NEGATIVE REGULATION OF CELL ADHESION
|
235
|
7.89e-04
|
-1.27e-01
|
5.60e-03
|
GOBP CELL DIFFERENTIATION IN HINDBRAIN
|
20
|
3.24e-01
|
1.27e-01
|
5.11e-01
|
GOMF ACETYLATION DEPENDENT PROTEIN BINDING
|
25
|
2.71e-01
|
-1.27e-01
|
4.53e-01
|
GOBP IN UTERO EMBRYONIC DEVELOPMENT
|
447
|
4.35e-06
|
-1.27e-01
|
6.53e-05
|
GOBP OVULATION
|
16
|
3.79e-01
|
-1.27e-01
|
5.65e-01
|
GOBP ACTIVATED T CELL PROLIFERATION
|
33
|
2.07e-01
|
-1.27e-01
|
3.80e-01
|
GOMF ORGANIC ACID TRANSMEMBRANE TRANSPORTER ACTIVITY
|
120
|
1.63e-02
|
1.27e-01
|
6.32e-02
|
GOCC PERICENTRIOLAR MATERIAL
|
21
|
3.14e-01
|
-1.27e-01
|
5.00e-01
|
GOBP RESPONSE TO GONADOTROPIN
|
13
|
4.28e-01
|
1.27e-01
|
6.09e-01
|
GOBP REGULATION OF JNK CASCADE
|
129
|
1.28e-02
|
-1.27e-01
|
5.24e-02
|
GOBP POSITIVE REGULATION OF TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY
|
13
|
4.28e-01
|
-1.27e-01
|
6.09e-01
|
GOMF HYDROLASE ACTIVITY HYDROLYZING O GLYCOSYL COMPOUNDS
|
55
|
1.04e-01
|
1.27e-01
|
2.40e-01
|
GOBP POSITIVE REGULATION OF TRANSLATIONAL INITIATION
|
19
|
3.38e-01
|
-1.27e-01
|
5.27e-01
|
GOBP VIRAL BUDDING VIA HOST ESCRT COMPLEX
|
14
|
4.11e-01
|
-1.27e-01
|
5.94e-01
|
GOBP LEUKOCYTE CELL CELL ADHESION
|
295
|
1.89e-04
|
-1.27e-01
|
1.72e-03
|
GOMF AP 2 ADAPTOR COMPLEX BINDING
|
10
|
4.88e-01
|
-1.27e-01
|
6.61e-01
|
GOBP SPERMATID NUCLEUS DIFFERENTIATION
|
18
|
3.52e-01
|
-1.27e-01
|
5.39e-01
|
GOBP RENAL TUBULE DEVELOPMENT
|
80
|
5.03e-02
|
-1.27e-01
|
1.46e-01
|
GOBP POSITIVE REGULATION OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE
|
55
|
1.04e-01
|
-1.27e-01
|
2.41e-01
|
GOBP CHEMOSENSORY BEHAVIOR
|
12
|
4.48e-01
|
1.27e-01
|
6.26e-01
|
GOBP GLYCOLYTIC PROCESS THROUGH GLUCOSE 6 PHOSPHATE
|
19
|
3.40e-01
|
1.27e-01
|
5.28e-01
|
GOBP POSITIVE REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY
|
175
|
3.94e-03
|
-1.27e-01
|
2.07e-02
|
GOMF RNA METHYLTRANSFERASE ACTIVITY
|
52
|
1.15e-01
|
1.26e-01
|
2.56e-01
|
GOBP GLOMERULUS MORPHOGENESIS
|
11
|
4.68e-01
|
-1.26e-01
|
6.44e-01
|
GOBP POSITIVE REGULATION OF RNA METABOLIC PROCESS
|
1346
|
1.64e-14
|
-1.26e-01
|
1.23e-12
|
GOBP REGULATION OF HEART RATE
|
90
|
3.84e-02
|
1.26e-01
|
1.20e-01
|
GOBP REGULATION OF MEMBRANE POTENTIAL
|
337
|
7.07e-05
|
1.26e-01
|
7.46e-04
|
GOMF DNA N GLYCOSYLASE ACTIVITY
|
11
|
4.68e-01
|
1.26e-01
|
6.44e-01
|
GOBP POSITIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION
|
1035
|
1.10e-11
|
-1.26e-01
|
5.41e-10
|
GOBP ACYLGLYCEROL HOMEOSTASIS
|
22
|
3.06e-01
|
1.26e-01
|
4.91e-01
|
GOBP POSITIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS
|
39
|
1.73e-01
|
1.26e-01
|
3.36e-01
|
GOBP REGULATION OF APPETITE
|
11
|
4.69e-01
|
-1.26e-01
|
6.44e-01
|
GOMF TELOMERASE RNA BINDING
|
16
|
3.83e-01
|
1.26e-01
|
5.69e-01
|
GOBP ENERGY HOMEOSTASIS
|
66
|
7.69e-02
|
-1.26e-01
|
1.97e-01
|
GOCC PROTEASOME REGULATORY PARTICLE BASE SUBCOMPLEX
|
12
|
4.50e-01
|
-1.26e-01
|
6.28e-01
|
GOBP POSITIVE REGULATION OF LIPID LOCALIZATION
|
89
|
4.02e-02
|
1.26e-01
|
1.23e-01
|
GOBP RESPONSE TO LIPOTEICHOIC ACID
|
10
|
4.91e-01
|
-1.26e-01
|
6.63e-01
|
GOBP RECEPTOR MEDIATED ENDOCYTOSIS
|
217
|
1.43e-03
|
-1.26e-01
|
9.03e-03
|
GOBP POSITIVE REGULATION OF TELOMERASE ACTIVITY
|
29
|
2.41e-01
|
-1.26e-01
|
4.20e-01
|
GOBP NEGATIVE REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING
|
12
|
4.51e-01
|
-1.26e-01
|
6.29e-01
|
GOMF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY
|
64
|
8.20e-02
|
-1.26e-01
|
2.05e-01
|
GOBP POSITIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS
|
78
|
5.50e-02
|
1.26e-01
|
1.56e-01
|
GOBP B CELL ACTIVATION
|
209
|
1.76e-03
|
-1.26e-01
|
1.09e-02
|
GOBP EMBRYONIC DIGESTIVE TRACT DEVELOPMENT
|
21
|
3.19e-01
|
1.26e-01
|
5.05e-01
|
GOBP NEGATIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS
|
60
|
9.23e-02
|
-1.26e-01
|
2.22e-01
|
GOMF MYOSIN V BINDING
|
15
|
3.99e-01
|
-1.26e-01
|
5.85e-01
|
GOMF LIPASE ACTIVATOR ACTIVITY
|
16
|
3.84e-01
|
-1.26e-01
|
5.70e-01
|
GOBP MYELOID CELL DIFFERENTIATION
|
370
|
3.57e-05
|
-1.26e-01
|
4.15e-04
|
GOCC PROTEIN DNA COMPLEX
|
691
|
2.31e-08
|
-1.26e-01
|
6.02e-07
|
GOMF LRR DOMAIN BINDING
|
16
|
3.85e-01
|
-1.26e-01
|
5.71e-01
|
GOBP POSITIVE REGULATION OF MAST CELL DEGRANULATION
|
12
|
4.52e-01
|
-1.25e-01
|
6.29e-01
|
GOBP PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE
|
198
|
2.38e-03
|
-1.25e-01
|
1.38e-02
|
GOBP NEGATIVE REGULATION OF CAMP MEDIATED SIGNALING
|
11
|
4.71e-01
|
1.25e-01
|
6.46e-01
|
GOBP REGULATION OF CELL DIFFERENTIATION
|
1274
|
1.07e-13
|
-1.25e-01
|
6.90e-12
|
GOBP LEUKOCYTE PROLIFERATION
|
254
|
5.97e-04
|
-1.25e-01
|
4.43e-03
|
GOBP IRES DEPENDENT VIRAL TRANSLATIONAL INITIATION
|
11
|
4.72e-01
|
-1.25e-01
|
6.46e-01
|
GOBP REGULATION OF KERATINOCYTE PROLIFERATION
|
39
|
1.76e-01
|
-1.25e-01
|
3.39e-01
|
GOBP T CELL RECEPTOR SIGNALING PATHWAY
|
87
|
4.36e-02
|
-1.25e-01
|
1.30e-01
|
GOBP NEGATIVE REGULATION OF CARTILAGE DEVELOPMENT
|
22
|
3.09e-01
|
-1.25e-01
|
4.95e-01
|
GOBP REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION
|
46
|
1.42e-01
|
-1.25e-01
|
2.94e-01
|
GOBP REGULATION OF AXON REGENERATION
|
32
|
2.21e-01
|
-1.25e-01
|
3.97e-01
|
GOMF TRANSPORTER ACTIVITY
|
740
|
8.88e-09
|
1.25e-01
|
2.59e-07
|
GOBP RESPONSE TO BMP
|
115
|
2.07e-02
|
-1.25e-01
|
7.56e-02
|
GOBP RIBONUCLEOSIDE CATABOLIC PROCESS
|
11
|
4.73e-01
|
-1.25e-01
|
6.47e-01
|
GOBP PORE COMPLEX ASSEMBLY
|
18
|
3.59e-01
|
-1.25e-01
|
5.45e-01
|
GOBP NEGATIVE REGULATION OF TELOMERE MAINTENANCE
|
33
|
2.14e-01
|
-1.25e-01
|
3.89e-01
|
GOBP MAINTENANCE OF ORGANELLE LOCATION
|
11
|
4.73e-01
|
-1.25e-01
|
6.47e-01
|
GOBP DNA DAMAGE RESPONSE
|
754
|
6.76e-09
|
-1.25e-01
|
2.00e-07
|
GOBP NEURON RECOGNITION
|
37
|
1.89e-01
|
1.25e-01
|
3.56e-01
|
GOBP REGULATION OF LIPID LOCALIZATION
|
132
|
1.34e-02
|
1.25e-01
|
5.41e-02
|
GOBP REGULATION OF GTPASE ACTIVITY
|
249
|
7.11e-04
|
-1.25e-01
|
5.13e-03
|
GOBP PEPTIDYL THREONINE MODIFICATION
|
92
|
3.90e-02
|
-1.25e-01
|
1.21e-01
|
GOMF PEPTIDE RECEPTOR ACTIVITY
|
36
|
1.96e-01
|
-1.25e-01
|
3.65e-01
|
GOMF LIPOPOLYSACCHARIDE BINDING
|
23
|
3.01e-01
|
-1.25e-01
|
4.86e-01
|
GOBP CELL DIFFERENTIATION INVOLVED IN EMBRYONIC PLACENTA DEVELOPMENT
|
21
|
3.23e-01
|
-1.24e-01
|
5.11e-01
|
GOMF DEAMINASE ACTIVITY
|
21
|
3.24e-01
|
-1.24e-01
|
5.11e-01
|
GOBP NEGATIVE REGULATION OF TISSUE REMODELING
|
21
|
3.24e-01
|
-1.24e-01
|
5.11e-01
|
GOBP HEMATOPOIETIC STEM CELL PROLIFERATION
|
33
|
2.16e-01
|
-1.24e-01
|
3.92e-01
|
GOBP CELLULAR RESPONSE TO VITAMIN D
|
12
|
4.56e-01
|
-1.24e-01
|
6.33e-01
|
GOBP BROWN FAT CELL DIFFERENTIATION
|
54
|
1.15e-01
|
1.24e-01
|
2.56e-01
|
GOMF POLYUBIQUITIN MODIFICATION DEPENDENT PROTEIN BINDING
|
50
|
1.29e-01
|
-1.24e-01
|
2.75e-01
|
GOBP GRANULOCYTE MIGRATION
|
107
|
2.67e-02
|
-1.24e-01
|
9.13e-02
|
GOBP VITAMIN BIOSYNTHETIC PROCESS
|
19
|
3.49e-01
|
1.24e-01
|
5.36e-01
|
GOMF NUCLEOTIDASE ACTIVITY
|
11
|
4.76e-01
|
1.24e-01
|
6.50e-01
|
GOBP CELL SURFACE RECEPTOR PROTEIN TYROSINE KINASE SIGNALING PATHWAY
|
519
|
1.49e-06
|
-1.24e-01
|
2.54e-05
|
GOBP MRNA 3 END PROCESSING
|
36
|
1.98e-01
|
-1.24e-01
|
3.68e-01
|
GOBP PROTEIN LOCALIZATION TO POSTSYNAPSE
|
62
|
9.16e-02
|
1.24e-01
|
2.22e-01
|
GOMF HISTONE MODIFYING ACTIVITY
|
181
|
4.11e-03
|
-1.24e-01
|
2.14e-02
|
GOBP REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS
|
20
|
3.38e-01
|
1.24e-01
|
5.26e-01
|
GOMF ANTIPORTER ACTIVITY
|
96
|
3.62e-02
|
1.24e-01
|
1.15e-01
|
GOBP RENAL TUBULE MORPHOGENESIS
|
63
|
8.95e-02
|
-1.24e-01
|
2.18e-01
|
GOBP MEGAKARYOCYTE DEVELOPMENT
|
20
|
3.38e-01
|
-1.24e-01
|
5.27e-01
|
GOMF PHOSPHATIDYLINOSITOL 3 4 5 TRISPHOSPHATE BINDING
|
43
|
1.61e-01
|
-1.24e-01
|
3.20e-01
|
GOMF CELL ADHESION MEDIATOR ACTIVITY
|
32
|
2.26e-01
|
-1.24e-01
|
4.04e-01
|
GOBP ENTEROENDOCRINE CELL DIFFERENTIATION
|
20
|
3.39e-01
|
-1.24e-01
|
5.27e-01
|
GOMF METAL ION TRANSMEMBRANE TRANSPORTER ACTIVITY
|
262
|
5.95e-04
|
1.24e-01
|
4.42e-03
|
GOBP CORTICOSTEROID HORMONE SECRETION
|
12
|
4.59e-01
|
1.24e-01
|
6.35e-01
|
GOBP POSITIVE REGULATION OF B CELL ACTIVATION
|
68
|
7.86e-02
|
-1.23e-01
|
1.99e-01
|
GOBP MYELOID DENDRITIC CELL ACTIVATION
|
25
|
2.86e-01
|
-1.23e-01
|
4.69e-01
|
GOBP POSITIVE REGULATION OF BIOMINERAL TISSUE DEVELOPMENT
|
41
|
1.72e-01
|
-1.23e-01
|
3.35e-01
|
GOMF SOLUTE MONOATOMIC CATION SYMPORTER ACTIVITY
|
67
|
8.10e-02
|
1.23e-01
|
2.03e-01
|
GOBP EPITHELIAL STRUCTURE MAINTENANCE
|
18
|
3.65e-01
|
1.23e-01
|
5.52e-01
|
GOBP POSITIVE REGULATION OF MACROAUTOPHAGY
|
74
|
6.69e-02
|
-1.23e-01
|
1.78e-01
|
GOBP POSITIVE REGULATION OF OSSIFICATION
|
48
|
1.40e-01
|
-1.23e-01
|
2.91e-01
|
GOBP POSITIVE REGULATION OF LONG TERM SYNAPTIC POTENTIATION
|
28
|
2.59e-01
|
1.23e-01
|
4.41e-01
|
GOBP TORC1 SIGNALING
|
91
|
4.24e-02
|
1.23e-01
|
1.28e-01
|
GOBP REGULATION OF B CELL PROLIFERATION
|
57
|
1.08e-01
|
-1.23e-01
|
2.46e-01
|
GOBP GLYCEROLIPID BIOSYNTHETIC PROCESS
|
187
|
3.73e-03
|
1.23e-01
|
1.99e-02
|
GOBP PHOSPHORYLATION
|
1333
|
9.61e-14
|
-1.23e-01
|
6.28e-12
|
GOBP MICROTUBULE BUNDLE FORMATION
|
67
|
8.15e-02
|
-1.23e-01
|
2.04e-01
|
GOBP REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY
|
101
|
3.27e-02
|
-1.23e-01
|
1.06e-01
|
GOBP NEGATIVE REGULATION OF CATECHOLAMINE SECRETION
|
12
|
4.61e-01
|
1.23e-01
|
6.37e-01
|
GOBP REGULATION OF VASCULAR PERMEABILITY
|
39
|
1.84e-01
|
1.23e-01
|
3.50e-01
|
GOCC NUCLEAR BODY
|
654
|
1.00e-07
|
-1.23e-01
|
2.26e-06
|
GOBP NEGATIVE REGULATION OF ERK1 AND ERK2 CASCADE
|
61
|
9.72e-02
|
-1.23e-01
|
2.30e-01
|
GOBP POSITIVE REGULATION OF BMP SIGNALING PATHWAY
|
29
|
2.52e-01
|
-1.23e-01
|
4.33e-01
|
GOBP CALMODULIN DEPENDENT KINASE SIGNALING PATHWAY
|
15
|
4.11e-01
|
-1.23e-01
|
5.94e-01
|
GOBP POSITIVE REGULATION OF SIGNAL TRANSDUCTION
|
1253
|
5.51e-13
|
-1.23e-01
|
3.21e-11
|
GOBP RESPONSE TO STEROID HORMONE
|
186
|
3.98e-03
|
-1.23e-01
|
2.08e-02
|
GOBP ENDOPLASMIC RETICULUM CALCIUM ION HOMEOSTASIS
|
26
|
2.79e-01
|
-1.23e-01
|
4.62e-01
|
GOBP REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY
|
35
|
2.10e-01
|
-1.23e-01
|
3.83e-01
|
GOBP POSITIVE REGULATION OF VESICLE FUSION
|
11
|
4.82e-01
|
-1.23e-01
|
6.56e-01
|
GOCC INO80 TYPE COMPLEX
|
27
|
2.71e-01
|
1.22e-01
|
4.53e-01
|
GOBP CANONICAL WNT SIGNALING PATHWAY
|
249
|
8.99e-04
|
-1.22e-01
|
6.24e-03
|
GOBP NEGATIVE REGULATION OF ORGANELLE ORGANIZATION
|
334
|
1.26e-04
|
-1.22e-01
|
1.21e-03
|
GOBP DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION
|
31
|
2.38e-01
|
-1.22e-01
|
4.18e-01
|
GOBP CELL ADHESION MOLECULE PRODUCTION
|
10
|
5.03e-01
|
-1.22e-01
|
6.73e-01
|
GOCC STEREOCILIUM TIP
|
12
|
4.63e-01
|
1.22e-01
|
6.39e-01
|
GOBP REGULATION OF MEMBRANE PERMEABILITY
|
63
|
9.36e-02
|
1.22e-01
|
2.24e-01
|
GOBP POSITIVE REGULATION OF NUCLEOBASE CONTAINING COMPOUND METABOLIC PROCESS
|
1526
|
4.08e-15
|
-1.22e-01
|
3.34e-13
|
GOBP POSITIVE REGULATION OF ORGANELLE ORGANIZATION
|
460
|
7.80e-06
|
-1.22e-01
|
1.09e-04
|
GOBP REGULATION OF LYMPHOCYTE ACTIVATION
|
363
|
6.77e-05
|
-1.22e-01
|
7.24e-04
|
GOBP AMP METABOLIC PROCESS
|
21
|
3.33e-01
|
1.22e-01
|
5.21e-01
|
GOBP NEGATIVE REGULATION OF COLLAGEN METABOLIC PROCESS
|
14
|
4.29e-01
|
-1.22e-01
|
6.10e-01
|
GOBP REGULATION OF BONE REMODELING
|
46
|
1.52e-01
|
-1.22e-01
|
3.08e-01
|
GOBP RESPONSE TO LIPID
|
571
|
7.44e-07
|
-1.22e-01
|
1.34e-05
|
GOBP CEREBELLAR PURKINJE CELL LAYER MORPHOGENESIS
|
18
|
3.71e-01
|
1.22e-01
|
5.57e-01
|
GOBP REGULATION OF ISOTYPE SWITCHING
|
25
|
2.92e-01
|
-1.22e-01
|
4.76e-01
|
GOBP POLYPRENOL METABOLIC PROCESS
|
14
|
4.30e-01
|
1.22e-01
|
6.11e-01
|
GOMF NOTCH BINDING
|
20
|
3.46e-01
|
-1.22e-01
|
5.34e-01
|
GOCC NUCLEAR SPECK
|
301
|
2.93e-04
|
-1.22e-01
|
2.51e-03
|
GOBP OOCYTE MATURATION
|
20
|
3.46e-01
|
-1.22e-01
|
5.35e-01
|
GOBP MULTICELLULAR ORGANISMAL LEVEL CHEMICAL HOMEOSTASIS
|
61
|
1.01e-01
|
1.22e-01
|
2.36e-01
|
GOBP EYE MORPHOGENESIS
|
128
|
1.77e-02
|
-1.22e-01
|
6.69e-02
|
GOBP MAINTENANCE OF PROTEIN LOCATION
|
90
|
4.64e-02
|
-1.22e-01
|
1.37e-01
|
GOBP REGULATION OF CELL CELL ADHESION
|
364
|
7.18e-05
|
-1.22e-01
|
7.54e-04
|
GOBP NEGATIVE REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION
|
16
|
4.00e-01
|
-1.21e-01
|
5.86e-01
|
GOBP POSITIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY
|
140
|
1.33e-02
|
-1.21e-01
|
5.38e-02
|
GOBP REGULATION OF T CELL ACTIVATION
|
267
|
6.60e-04
|
-1.21e-01
|
4.81e-03
|
GOBP BONE TRABECULA MORPHOGENESIS
|
14
|
4.32e-01
|
-1.21e-01
|
6.12e-01
|
GOBP MAMMARY GLAND EPITHELIUM DEVELOPMENT
|
63
|
9.64e-02
|
-1.21e-01
|
2.29e-01
|
GOCC CLATHRIN ADAPTOR COMPLEX
|
23
|
3.15e-01
|
-1.21e-01
|
5.01e-01
|
GOBP REGULATION OF P38MAPK CASCADE
|
39
|
1.91e-01
|
-1.21e-01
|
3.58e-01
|
GOBP POSITIVE REGULATION OF SYNCYTIUM FORMATION BY PLASMA MEMBRANE FUSION
|
18
|
3.74e-01
|
-1.21e-01
|
5.60e-01
|
GOBP SIGNAL TRANSDUCTION IN ABSENCE OF LIGAND
|
62
|
9.95e-02
|
-1.21e-01
|
2.34e-01
|
GOMF ATP DEPENDENT ACTIVITY ACTING ON RNA
|
65
|
9.18e-02
|
-1.21e-01
|
2.22e-01
|
GOBP POSITIVE REGULATION OF AUTOPHAGY
|
140
|
1.36e-02
|
-1.21e-01
|
5.46e-02
|
GOMF MAP KINASE KINASE KINASE ACTIVITY
|
22
|
3.26e-01
|
-1.21e-01
|
5.13e-01
|
GOBP NEGATIVE REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY
|
21
|
3.37e-01
|
-1.21e-01
|
5.26e-01
|
GOMF CALMODULIN DEPENDENT PROTEIN KINASE ACTIVITY
|
21
|
3.37e-01
|
1.21e-01
|
5.26e-01
|
GOBP DENDRITIC SPINE DEVELOPMENT
|
123
|
2.07e-02
|
-1.21e-01
|
7.56e-02
|
GOBP EMBRYO DEVELOPMENT ENDING IN BIRTH OR EGG HATCHING
|
674
|
1.08e-07
|
-1.21e-01
|
2.42e-06
|
GOBP NEGATIVE REGULATION OF TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY
|
10
|
5.08e-01
|
-1.21e-01
|
6.78e-01
|
GOBP TOLL LIKE RECEPTOR 9 SIGNALING PATHWAY
|
14
|
4.34e-01
|
-1.21e-01
|
6.14e-01
|
GOBP NEGATIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY
|
34
|
2.23e-01
|
-1.21e-01
|
4.01e-01
|
GOBP RESPONSE TO ISCHEMIA
|
42
|
1.76e-01
|
1.21e-01
|
3.40e-01
|
GOBP AUTOPHAGIC CELL DEATH
|
13
|
4.52e-01
|
-1.21e-01
|
6.29e-01
|
GOMF MICROTUBULE BINDING
|
225
|
1.87e-03
|
-1.21e-01
|
1.15e-02
|
GOCC MICROTUBULE ORGANIZING CENTER
|
658
|
1.62e-07
|
-1.20e-01
|
3.48e-06
|
GOBP REGULATION OF CANONICAL WNT SIGNALING PATHWAY
|
211
|
2.61e-03
|
-1.20e-01
|
1.49e-02
|
GOBP REGULATION OF CARTILAGE DEVELOPMENT
|
53
|
1.30e-01
|
-1.20e-01
|
2.77e-01
|
GOCC ACTOMYOSIN
|
89
|
4.99e-02
|
-1.20e-01
|
1.45e-01
|
GOBP KERATINOCYTE PROLIFERATION
|
47
|
1.54e-01
|
-1.20e-01
|
3.09e-01
|
GOBP MUCUS SECRETION
|
16
|
4.05e-01
|
1.20e-01
|
5.89e-01
|
GOBP GLIOGENESIS
|
306
|
3.16e-04
|
-1.20e-01
|
2.65e-03
|
GOCC CELL CORTEX
|
241
|
1.36e-03
|
-1.20e-01
|
8.73e-03
|
GOBP NEGATIVE REGULATION OF MEMBRANE PERMEABILITY
|
19
|
3.65e-01
|
1.20e-01
|
5.52e-01
|
GOBP NEGATIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION
|
109
|
3.06e-02
|
-1.20e-01
|
1.01e-01
|
GOBP NEGATIVE REGULATION OF CELL DEVELOPMENT
|
216
|
2.43e-03
|
-1.20e-01
|
1.40e-02
|
GOBP INTERLEUKIN 17 PRODUCTION
|
28
|
2.72e-01
|
-1.20e-01
|
4.54e-01
|
GOBP PROXIMAL DISTAL PATTERN FORMATION
|
17
|
3.92e-01
|
-1.20e-01
|
5.78e-01
|
GOMF DNA BINDING TRANSCRIPTION REPRESSOR ACTIVITY
|
211
|
2.75e-03
|
-1.20e-01
|
1.55e-02
|
GOBP REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY
|
45
|
1.65e-01
|
-1.20e-01
|
3.25e-01
|
GOBP POSITIVE REGULATION OF GLUCONEOGENESIS
|
23
|
3.20e-01
|
1.20e-01
|
5.07e-01
|
GOBP NEGATIVE REGULATION OF KINASE ACTIVITY
|
169
|
7.32e-03
|
-1.20e-01
|
3.37e-02
|
GOBP NEGATIVE REGULATION OF CELL DIFFERENTIATION
|
526
|
2.98e-06
|
-1.20e-01
|
4.67e-05
|
GOBP SULFATION
|
11
|
4.92e-01
|
1.20e-01
|
6.65e-01
|
GOCC NUCLEAR PORE
|
73
|
7.73e-02
|
-1.20e-01
|
1.97e-01
|
GOBP POSITIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS
|
31
|
2.49e-01
|
1.20e-01
|
4.31e-01
|
GOBP POSITIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION
|
54
|
1.29e-01
|
-1.20e-01
|
2.75e-01
|
GOMF PROTEIN ARGININE N METHYLTRANSFERASE ACTIVITY
|
11
|
4.92e-01
|
1.20e-01
|
6.65e-01
|
GOBP POSITIVE REGULATION OF SMALL MOLECULE METABOLIC PROCESS
|
140
|
1.47e-02
|
1.20e-01
|
5.85e-02
|
GOBP POSITIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE I
|
31
|
2.50e-01
|
-1.20e-01
|
4.31e-01
|
GOMF METALLOENDOPEPTIDASE ACTIVITY
|
75
|
7.39e-02
|
1.19e-01
|
1.91e-01
|
GOBP EPITHELIUM DEVELOPMENT
|
901
|
1.70e-09
|
-1.19e-01
|
5.92e-08
|
GOBP N TERMINAL PROTEIN AMINO ACID ACETYLATION
|
13
|
4.56e-01
|
-1.19e-01
|
6.33e-01
|
GOBP NEGATIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION
|
30
|
2.58e-01
|
-1.19e-01
|
4.39e-01
|
GOBP RECEPTOR INTERNALIZATION
|
122
|
2.31e-02
|
-1.19e-01
|
8.19e-02
|
GOBP MAMMARY GLAND DEVELOPMENT
|
104
|
3.58e-02
|
-1.19e-01
|
1.14e-01
|
GOBP REGULATION OF NON MOTILE CILIUM ASSEMBLY
|
14
|
4.40e-01
|
-1.19e-01
|
6.20e-01
|
GOMF SINGLE STRANDED RNA BINDING
|
78
|
6.91e-02
|
-1.19e-01
|
1.82e-01
|
GOBP MESONEPHROS DEVELOPMENT
|
80
|
6.58e-02
|
-1.19e-01
|
1.75e-01
|
GOBP MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION
|
117
|
2.63e-02
|
-1.19e-01
|
9.04e-02
|
GOMF ORGANOPHOSPHATE ESTER TRANSMEMBRANE TRANSPORTER ACTIVITY
|
31
|
2.52e-01
|
1.19e-01
|
4.33e-01
|
GOBP RESPONSE TO ACID CHEMICAL
|
92
|
4.87e-02
|
-1.19e-01
|
1.43e-01
|
GOCC SIN3 TYPE COMPLEX
|
13
|
4.58e-01
|
-1.19e-01
|
6.34e-01
|
GOBP CATECHOL CONTAINING COMPOUND BIOSYNTHETIC PROCESS
|
19
|
3.69e-01
|
1.19e-01
|
5.56e-01
|
GOBP G PROTEIN COUPLED RECEPTOR INTERNALIZATION
|
13
|
4.58e-01
|
-1.19e-01
|
6.34e-01
|
GOBP PROTEIN MODIFICATION BY SMALL PROTEIN REMOVAL
|
102
|
3.81e-02
|
-1.19e-01
|
1.19e-01
|
GOBP INTERMEDIATE FILAMENT ORGANIZATION
|
12
|
4.76e-01
|
-1.19e-01
|
6.50e-01
|
GOBP GLUTAMATERGIC NEURON DIFFERENTIATION
|
12
|
4.76e-01
|
1.19e-01
|
6.50e-01
|
GOBP LIPID STORAGE
|
81
|
6.46e-02
|
1.19e-01
|
1.73e-01
|
GOBP ESTABLISHMENT OF LYMPHOCYTE POLARITY
|
10
|
5.15e-01
|
1.19e-01
|
6.84e-01
|
GOBP REGULATION OF ANATOMICAL STRUCTURE MORPHOGENESIS
|
743
|
4.37e-08
|
-1.19e-01
|
1.07e-06
|
GOBP NEGATIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS
|
268
|
8.36e-04
|
-1.19e-01
|
5.87e-03
|
GOBP TRANSMEMBRANE TRANSPORT
|
970
|
5.42e-10
|
1.19e-01
|
2.11e-08
|
GOMF LAMIN BINDING
|
16
|
4.11e-01
|
-1.19e-01
|
5.94e-01
|
GOBP NEGATIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS
|
25
|
3.05e-01
|
-1.19e-01
|
4.89e-01
|
GOBP L GLUTAMATE TRANSMEMBRANE TRANSPORT
|
24
|
3.14e-01
|
1.19e-01
|
5.01e-01
|
GOBP REGULATION OF SMALL MOLECULE METABOLIC PROCESS
|
287
|
5.66e-04
|
1.19e-01
|
4.23e-03
|
GOMF HISTONE H4K5 ACETYLTRANSFERASE ACTIVITY
|
11
|
4.96e-01
|
-1.19e-01
|
6.68e-01
|
GOBP PHOSPHATIDYLINOSITOL DEPHOSPHORYLATION
|
26
|
2.95e-01
|
-1.19e-01
|
4.79e-01
|
GOBP NEGATIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION
|
60
|
1.13e-01
|
-1.19e-01
|
2.53e-01
|
GOBP REGULATION OF EMBRYONIC DEVELOPMENT
|
71
|
8.44e-02
|
-1.19e-01
|
2.10e-01
|
GOBP T CELL ACTIVATION
|
414
|
3.82e-05
|
-1.18e-01
|
4.40e-04
|
GOMF PHOSPHATIDYLGLYCEROL BINDING
|
14
|
4.43e-01
|
1.18e-01
|
6.22e-01
|
GOBP PURINE NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS
|
21
|
3.48e-01
|
1.18e-01
|
5.35e-01
|
GOBP INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY
|
43
|
1.79e-01
|
-1.18e-01
|
3.44e-01
|
GOMF SEMAPHORIN RECEPTOR ACTIVITY
|
12
|
4.78e-01
|
-1.18e-01
|
6.52e-01
|
GOBP EPITHELIAL CELL PROLIFERATION
|
379
|
8.12e-05
|
-1.18e-01
|
8.37e-04
|
GOMF KINASE BINDING
|
749
|
4.48e-08
|
-1.18e-01
|
1.09e-06
|
GOBP SNRNA 3 END PROCESSING
|
18
|
3.85e-01
|
1.18e-01
|
5.71e-01
|
GOMF NUCLEOBASE CONTAINING COMPOUND KINASE ACTIVITY
|
28
|
2.79e-01
|
1.18e-01
|
4.62e-01
|
GOBP POSITIVE REGULATION OF LYMPHOCYTE MIGRATION
|
31
|
2.55e-01
|
-1.18e-01
|
4.35e-01
|
GOMF 5 N 7 METHYLGUANOSINE 5 TRIPHOSPHO MRNA HYDROLASE ACTIVITY
|
10
|
5.17e-01
|
1.18e-01
|
6.86e-01
|
GOBP NEURON PROJECTION REGENERATION
|
59
|
1.17e-01
|
-1.18e-01
|
2.58e-01
|
GOBP SARCOMERE ORGANIZATION
|
52
|
1.41e-01
|
1.18e-01
|
2.93e-01
|
GOBP PEPTIDYL GLUTAMIC ACID MODIFICATION
|
17
|
3.99e-01
|
1.18e-01
|
5.85e-01
|
GOBP REGULATION OF SYNCYTIUM FORMATION BY PLASMA MEMBRANE FUSION
|
23
|
3.27e-01
|
-1.18e-01
|
5.15e-01
|
GOBP REGULATION OF TELOMERASE ACTIVITY
|
38
|
2.08e-01
|
-1.18e-01
|
3.81e-01
|
GOCC SPINDLE MICROTUBULE
|
72
|
8.36e-02
|
-1.18e-01
|
2.08e-01
|
GOBP NEGATIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS
|
895
|
2.94e-09
|
-1.18e-01
|
9.60e-08
|
GOMF PDZ DOMAIN BINDING
|
96
|
4.60e-02
|
-1.18e-01
|
1.36e-01
|
GOBP ESTABLISHMENT OF PROTEIN LOCALIZATION TO POSTSYNAPTIC MEMBRANE
|
21
|
3.50e-01
|
1.18e-01
|
5.37e-01
|
GOBP T CELL SELECTION
|
39
|
2.03e-01
|
-1.18e-01
|
3.74e-01
|
GOBP SKELETAL SYSTEM DEVELOPMENT
|
393
|
6.50e-05
|
-1.18e-01
|
6.97e-04
|
GOBP REGULATION OF DENDRITE DEVELOPMENT
|
116
|
2.86e-02
|
-1.18e-01
|
9.58e-02
|
GOBP RENAL TUBULAR SECRETION
|
15
|
4.30e-01
|
1.18e-01
|
6.11e-01
|
GOBP REGULATION OF EPITHELIAL CELL PROLIFERATION
|
317
|
3.28e-04
|
-1.18e-01
|
2.73e-03
|
GOBP REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING
|
55
|
1.31e-01
|
-1.18e-01
|
2.79e-01
|
GOBP PROTEIN K63 LINKED UBIQUITINATION
|
63
|
1.07e-01
|
-1.17e-01
|
2.45e-01
|
GOBP PHAGOCYTOSIS
|
177
|
7.18e-03
|
-1.17e-01
|
3.33e-02
|
GOMF OXIDOREDUCTASE ACTIVITY ACTING ON PAIRED DONORS WITH INCORPORATION OR REDUCTION OF MOLECULAR OXYGEN NAD P H AS ONE DONOR AND INCORPORATION OF ONE ATOM OF OXYGEN
|
23
|
3.30e-01
|
1.17e-01
|
5.18e-01
|
GOBP NEGATIVE REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION
|
161
|
1.03e-02
|
-1.17e-01
|
4.41e-02
|
GOBP GLUCOSE METABOLIC PROCESS
|
170
|
8.45e-03
|
1.17e-01
|
3.75e-02
|
GOBP EMBRYONIC ORGAN DEVELOPMENT
|
364
|
1.29e-04
|
-1.17e-01
|
1.24e-03
|
GOCC ENDOPLASMIC RETICULUM EXIT SITE
|
29
|
2.75e-01
|
-1.17e-01
|
4.57e-01
|
GOMF PLUS END DIRECTED MICROTUBULE MOTOR ACTIVITY
|
12
|
4.82e-01
|
-1.17e-01
|
6.56e-01
|
GOMF ACTIN BINDING
|
369
|
1.18e-04
|
-1.17e-01
|
1.15e-03
|
GOCC ENZYME ACTIVATOR COMPLEX
|
15
|
4.32e-01
|
1.17e-01
|
6.13e-01
|
GOBP CELL PROJECTION ASSEMBLY
|
449
|
2.32e-05
|
-1.17e-01
|
2.86e-04
|
GOBP LYMPHOCYTE ACTIVATION
|
584
|
1.57e-06
|
-1.17e-01
|
2.67e-05
|
GOBP ORGANIC ANION TRANSPORT
|
286
|
6.89e-04
|
1.17e-01
|
4.99e-03
|
GOBP NUCLEAR MRNA SURVEILLANCE
|
10
|
5.22e-01
|
-1.17e-01
|
6.90e-01
|
GOMF PHOSPHATIDYLINOSITOL BINDING
|
238
|
1.94e-03
|
-1.17e-01
|
1.17e-02
|
GOCC SARCOLEMMA
|
153
|
1.27e-02
|
1.17e-01
|
5.22e-02
|
GOBP EXECUTION PHASE OF APOPTOSIS
|
66
|
1.01e-01
|
-1.17e-01
|
2.36e-01
|
GOBP SYNAPTIC VESICLE CLUSTERING
|
16
|
4.19e-01
|
-1.17e-01
|
6.01e-01
|
GOBP POSITIVE REGULATION OF SODIUM ION TRANSPORT
|
36
|
2.25e-01
|
1.17e-01
|
4.03e-01
|
GOBP SOMATIC DIVERSIFICATION OF IMMUNOGLOBULINS INVOLVED IN IMMUNE RESPONSE
|
37
|
2.19e-01
|
-1.17e-01
|
3.95e-01
|
GOBP REGULATION OF KIDNEY DEVELOPMENT
|
20
|
3.66e-01
|
1.17e-01
|
5.53e-01
|
GOCC SEH1 ASSOCIATED COMPLEX
|
13
|
4.66e-01
|
1.17e-01
|
6.42e-01
|
GOBP MYELOID LEUKOCYTE MEDIATED IMMUNITY
|
78
|
7.47e-02
|
-1.17e-01
|
1.92e-01
|
GOBP NEGATIVE REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY
|
31
|
2.61e-01
|
-1.17e-01
|
4.42e-01
|
GOBP POSITIVE REGULATION OF CATALYTIC ACTIVITY
|
715
|
1.31e-07
|
-1.17e-01
|
2.88e-06
|
GOMF MYOSIN PHOSPHATASE ACTIVITY
|
61
|
1.15e-01
|
1.17e-01
|
2.56e-01
|
GOBP EYE PHOTORECEPTOR CELL DEVELOPMENT
|
23
|
3.33e-01
|
1.17e-01
|
5.21e-01
|
GOBP POSITIVE REGULATION OF MOLECULAR FUNCTION
|
1002
|
6.24e-10
|
-1.17e-01
|
2.36e-08
|
GOBP POSITIVE REGULATION OF ORGANIC ACID TRANSPORT
|
39
|
2.08e-01
|
1.17e-01
|
3.81e-01
|
GOBP GLANDULAR EPITHELIAL CELL DIFFERENTIATION
|
49
|
1.58e-01
|
-1.17e-01
|
3.16e-01
|
GOMF EPHRIN RECEPTOR BINDING
|
30
|
2.69e-01
|
-1.17e-01
|
4.51e-01
|
GOBP NEGATIVE REGULATION OF RAS PROTEIN SIGNAL TRANSDUCTION
|
24
|
3.23e-01
|
-1.16e-01
|
5.11e-01
|
GOBP SKELETAL SYSTEM MORPHOGENESIS
|
179
|
7.31e-03
|
-1.16e-01
|
3.37e-02
|
GOCC CELL POLE
|
14
|
4.51e-01
|
-1.16e-01
|
6.29e-01
|
GOBP TRANSCRIPTION COUPLED NUCLEOTIDE EXCISION REPAIR
|
10
|
5.25e-01
|
-1.16e-01
|
6.91e-01
|
GOBP CELLULAR LIPID BIOSYNTHETIC PROCESS
|
10
|
5.25e-01
|
1.16e-01
|
6.91e-01
|
GOBP REGULATION OF LIPID METABOLIC PROCESS
|
272
|
1.00e-03
|
1.16e-01
|
6.81e-03
|
GOMF LIPID KINASE ACTIVITY
|
35
|
2.34e-01
|
-1.16e-01
|
4.14e-01
|
GOBP REGULATION OF REGULATED SECRETORY PATHWAY
|
102
|
4.32e-02
|
-1.16e-01
|
1.30e-01
|
GOMF CHEMOKINE RECEPTOR BINDING
|
30
|
2.72e-01
|
1.16e-01
|
4.54e-01
|
GOCC ACTIN FILAMENT BUNDLE
|
87
|
6.18e-02
|
-1.16e-01
|
1.68e-01
|
GOBP NEGATIVE REGULATION OF DEFENSE RESPONSE
|
179
|
7.57e-03
|
-1.16e-01
|
3.45e-02
|
GOBP NEGATIVE REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS
|
16
|
4.22e-01
|
-1.16e-01
|
6.04e-01
|
GOBP PHAGOSOME LYSOSOME FUSION
|
11
|
5.06e-01
|
1.16e-01
|
6.76e-01
|
GOBP MAST CELL CHEMOTAXIS
|
10
|
5.26e-01
|
-1.16e-01
|
6.92e-01
|
GOBP NEGATIVE REGULATION OF MYELINATION
|
10
|
5.26e-01
|
-1.16e-01
|
6.92e-01
|
GOBP EMBRYONIC HEART TUBE MORPHOGENESIS
|
53
|
1.45e-01
|
-1.16e-01
|
2.98e-01
|
GOCC NPBAF COMPLEX
|
14
|
4.53e-01
|
-1.16e-01
|
6.31e-01
|
GOBP DNA LIGATION
|
12
|
4.88e-01
|
-1.16e-01
|
6.61e-01
|
GOBP CARDIAC MUSCLE CELL CONTRACTION
|
65
|
1.07e-01
|
1.16e-01
|
2.45e-01
|
GOBP LIPID EXPORT FROM CELL
|
38
|
2.18e-01
|
-1.16e-01
|
3.94e-01
|
GOBP REGULATION OF DNA REPAIR
|
189
|
6.24e-03
|
-1.16e-01
|
2.97e-02
|
GOCC SIDE OF MEMBRANE
|
492
|
1.25e-05
|
-1.16e-01
|
1.64e-04
|
GOBP NEGATIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT
|
125
|
2.59e-02
|
-1.15e-01
|
8.94e-02
|
GOBP BLOOD VESSEL ENDOTHELIAL CELL PROLIFERATION INVOLVED IN SPROUTING ANGIOGENESIS
|
17
|
4.10e-01
|
1.15e-01
|
5.94e-01
|
GOMF PHOSPHOPROTEIN BINDING
|
97
|
4.98e-02
|
-1.15e-01
|
1.45e-01
|
GOMF OXIDOREDUCTASE ACTIVITY ACTING ON A SULFUR GROUP OF DONORS DISULFIDE AS ACCEPTOR
|
10
|
5.28e-01
|
1.15e-01
|
6.94e-01
|
GOMF TELOMERIC DNA BINDING
|
35
|
2.38e-01
|
-1.15e-01
|
4.18e-01
|
GOBP REGULATION OF ORGANELLE ORGANIZATION
|
1004
|
9.49e-10
|
-1.15e-01
|
3.39e-08
|
GOBP VENOUS BLOOD VESSEL DEVELOPMENT
|
17
|
4.11e-01
|
-1.15e-01
|
5.94e-01
|
GOBP NEGATIVE REGULATION OF DEPHOSPHORYLATION
|
32
|
2.60e-01
|
-1.15e-01
|
4.41e-01
|
GOMF MOLECULAR TAG ACTIVITY
|
12
|
4.90e-01
|
1.15e-01
|
6.63e-01
|
GOBP TRANSFORMING GROWTH FACTOR BETA1 PRODUCTION
|
10
|
5.29e-01
|
-1.15e-01
|
6.94e-01
|
GOBP FACE DEVELOPMENT
|
54
|
1.44e-01
|
-1.15e-01
|
2.96e-01
|
GOBP CELLULAR RESPONSE TO ACID CHEMICAL
|
75
|
8.52e-02
|
-1.15e-01
|
2.11e-01
|
GOBP NEURAL TUBE DEVELOPMENT
|
163
|
1.14e-02
|
-1.15e-01
|
4.80e-02
|
GOBP HETEROPHILIC CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES
|
39
|
2.14e-01
|
-1.15e-01
|
3.89e-01
|
GOBP SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR
|
138
|
2.00e-02
|
-1.15e-01
|
7.37e-02
|
GOBP REGULATION OF GLUCOSE IMPORT
|
54
|
1.44e-01
|
-1.15e-01
|
2.97e-01
|
GOBP ENDOCHONDRAL BONE GROWTH
|
25
|
3.20e-01
|
-1.15e-01
|
5.07e-01
|
GOBP ACTIVATION OF NF KAPPAB INDUCING KINASE ACTIVITY
|
10
|
5.30e-01
|
-1.15e-01
|
6.95e-01
|
GOBP POSITIVE REGULATION OF NEUROTRANSMITTER SECRETION
|
15
|
4.41e-01
|
1.15e-01
|
6.21e-01
|
GOBP PROTEIN LOCALIZATION TO PHAGOPHORE ASSEMBLY SITE
|
16
|
4.27e-01
|
1.15e-01
|
6.08e-01
|
GOBP PROTEIN N LINKED GLYCOSYLATION
|
58
|
1.31e-01
|
1.15e-01
|
2.78e-01
|
GOBP ENDONUCLEOLYTIC CLEAVAGE OF TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA
|
16
|
4.27e-01
|
1.15e-01
|
6.08e-01
|
GOBP RESPIRATORY SYSTEM DEVELOPMENT
|
206
|
4.61e-03
|
-1.15e-01
|
2.35e-02
|
GOBP ACTIVIN RECEPTOR SIGNALING PATHWAY
|
33
|
2.54e-01
|
-1.15e-01
|
4.35e-01
|
GOBP REGULATION OF CELLULAR COMPONENT BIOGENESIS
|
887
|
9.24e-09
|
-1.15e-01
|
2.66e-07
|
GOBP BASIC AMINO ACID TRANSMEMBRANE TRANSPORT
|
11
|
5.11e-01
|
1.15e-01
|
6.80e-01
|
GOCC NODE OF RANVIER
|
11
|
5.11e-01
|
1.15e-01
|
6.80e-01
|
GOBP CELL CELL ADHESION MEDIATED BY CADHERIN
|
27
|
3.03e-01
|
-1.15e-01
|
4.87e-01
|
GOBP REGULATION OF SYNAPSE ASSEMBLY
|
142
|
1.86e-02
|
-1.15e-01
|
6.97e-02
|
GOBP RAS PROTEIN SIGNAL TRANSDUCTION
|
95
|
5.39e-02
|
-1.15e-01
|
1.53e-01
|
GOBP CELLULAR RESPONSE TO LIGHT STIMULUS
|
84
|
6.99e-02
|
-1.14e-01
|
1.83e-01
|
GOBP BONE DEVELOPMENT
|
177
|
8.79e-03
|
-1.14e-01
|
3.87e-02
|
GOBP FOREGUT MORPHOGENESIS
|
10
|
5.31e-01
|
-1.14e-01
|
6.97e-01
|
GOBP NON LYTIC VIRAL RELEASE
|
12
|
4.93e-01
|
-1.14e-01
|
6.65e-01
|
GOBP REGULATION OF MYOBLAST DIFFERENTIATION
|
69
|
1.01e-01
|
-1.14e-01
|
2.36e-01
|
GOBP PYRAMIDAL NEURON DEVELOPMENT
|
10
|
5.32e-01
|
-1.14e-01
|
6.97e-01
|
GOBP GAS TRANSPORT
|
11
|
5.12e-01
|
1.14e-01
|
6.81e-01
|
GOBP NEGATIVE REGULATION OF ATP DEPENDENT ACTIVITY
|
17
|
4.15e-01
|
1.14e-01
|
5.99e-01
|
GOMF MANNOSYLTRANSFERASE ACTIVITY
|
24
|
3.33e-01
|
1.14e-01
|
5.21e-01
|
GOBP EAR MORPHOGENESIS
|
89
|
6.32e-02
|
-1.14e-01
|
1.71e-01
|
GOBP REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT
|
68
|
1.04e-01
|
-1.14e-01
|
2.41e-01
|
GOCC HETEROCHROMATIN
|
87
|
6.65e-02
|
-1.14e-01
|
1.77e-01
|
GOBP BRANCHING MORPHOGENESIS OF AN EPITHELIAL TUBE
|
147
|
1.73e-02
|
-1.14e-01
|
6.60e-02
|
GOBP B CELL PROLIFERATION
|
67
|
1.07e-01
|
-1.14e-01
|
2.46e-01
|
GOBP REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR
|
29
|
2.89e-01
|
-1.14e-01
|
4.73e-01
|
GOBP SOMATIC DIVERSIFICATION OF IMMUNOGLOBULINS
|
51
|
1.60e-01
|
-1.14e-01
|
3.19e-01
|
GOBP REGULATION OF COLLATERAL SPROUTING
|
17
|
4.17e-01
|
1.14e-01
|
6.00e-01
|
GOMF STAT FAMILY PROTEIN BINDING
|
10
|
5.34e-01
|
-1.14e-01
|
6.99e-01
|
GOBP NEGATIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION
|
17
|
4.18e-01
|
-1.13e-01
|
6.01e-01
|
GOBP REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN
|
37
|
2.32e-01
|
-1.13e-01
|
4.12e-01
|
GOBP PROTEIN POLYMERIZATION
|
240
|
2.52e-03
|
-1.13e-01
|
1.44e-02
|
GOBP EMBRYO DEVELOPMENT
|
996
|
1.98e-09
|
-1.13e-01
|
6.70e-08
|
GOBP POSTSYNAPTIC SIGNAL TRANSDUCTION
|
42
|
2.04e-01
|
-1.13e-01
|
3.76e-01
|
GOBP LONG CHAIN FATTY ACID IMPORT INTO CELL
|
17
|
4.19e-01
|
1.13e-01
|
6.01e-01
|
GOBP SECRETION BY TISSUE
|
37
|
2.33e-01
|
1.13e-01
|
4.13e-01
|
GOBP ESTABLISHMENT OF PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM
|
40
|
2.15e-01
|
1.13e-01
|
3.91e-01
|
GOBP REGULATION OF GLUCONEOGENESIS
|
43
|
1.99e-01
|
1.13e-01
|
3.70e-01
|
GOBP POSITIVE REGULATION OF VIRAL LIFE CYCLE
|
19
|
3.94e-01
|
-1.13e-01
|
5.79e-01
|
GOBP REGULATION OF NITRIC OXIDE METABOLIC PROCESS
|
62
|
1.24e-01
|
-1.13e-01
|
2.70e-01
|
GOBP REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT
|
70
|
1.02e-01
|
-1.13e-01
|
2.38e-01
|
GOMF ALKALI METAL ION BINDING
|
15
|
4.49e-01
|
1.13e-01
|
6.27e-01
|
GOBP CIRCULATORY SYSTEM DEVELOPMENT
|
1007
|
1.98e-09
|
-1.13e-01
|
6.70e-08
|
GOBP NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS
|
38
|
2.29e-01
|
-1.13e-01
|
4.07e-01
|
GOBP MAINTENANCE OF PROTEIN LOCATION IN CELL
|
64
|
1.19e-01
|
-1.13e-01
|
2.61e-01
|
GOBP REGULATION OF MEMBRANE DEPOLARIZATION
|
47
|
1.81e-01
|
1.13e-01
|
3.46e-01
|
GOBP TYPE B PANCREATIC CELL PROLIFERATION
|
26
|
3.20e-01
|
-1.13e-01
|
5.07e-01
|
GOBP REGULATION OF RYANODINE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY
|
15
|
4.50e-01
|
1.13e-01
|
6.29e-01
|
GOBP NEGATIVE REGULATION OF PROTEIN MATURATION
|
23
|
3.50e-01
|
-1.13e-01
|
5.37e-01
|
GOBP VENTRICULAR CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION
|
20
|
3.84e-01
|
1.12e-01
|
5.70e-01
|
GOBP MITOCHONDRIAL DEPOLARIZATION
|
24
|
3.41e-01
|
1.12e-01
|
5.29e-01
|
GOBP POSITIVE REGULATION OF CELL MORPHOGENESIS
|
60
|
1.32e-01
|
-1.12e-01
|
2.80e-01
|
GOBP FOREBRAIN DEVELOPMENT
|
291
|
1.02e-03
|
-1.12e-01
|
6.90e-03
|
GOBP REGULATION OF MAP KINASE ACTIVITY
|
144
|
2.02e-02
|
-1.12e-01
|
7.45e-02
|
GOBP RRNA PROCESSING
|
195
|
6.99e-03
|
1.12e-01
|
3.26e-02
|
GOBP POSITIVE REGULATION OF CHONDROCYTE DIFFERENTIATION
|
18
|
4.10e-01
|
-1.12e-01
|
5.94e-01
|
GOBP ADENYLATE CYCLASE INHIBITING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY
|
35
|
2.51e-01
|
-1.12e-01
|
4.32e-01
|
GOBP RETINA LAYER FORMATION
|
14
|
4.68e-01
|
1.12e-01
|
6.44e-01
|
GOBP REGULATION OF PLASMINOGEN ACTIVATION
|
13
|
4.84e-01
|
-1.12e-01
|
6.57e-01
|
GOCC DENDRITE MEMBRANE
|
28
|
3.05e-01
|
-1.12e-01
|
4.89e-01
|
GOMF INTRAMEMBRANE LIPID TRANSPORTER ACTIVITY
|
40
|
2.20e-01
|
-1.12e-01
|
3.96e-01
|
GOBP RIBONUCLEOSIDE METABOLIC PROCESS
|
26
|
3.23e-01
|
1.12e-01
|
5.10e-01
|
GOBP REGULATION OF PROTEIN SUMOYLATION
|
24
|
3.42e-01
|
-1.12e-01
|
5.31e-01
|
GOCC DYSTROPHIN ASSOCIATED GLYCOPROTEIN COMPLEX
|
16
|
4.38e-01
|
-1.12e-01
|
6.18e-01
|
GOBP NEGATIVE REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORT
|
19
|
3.98e-01
|
-1.12e-01
|
5.84e-01
|
GOMF NEUTRAL L AMINO ACID TRANSMEMBRANE TRANSPORTER ACTIVITY
|
31
|
2.81e-01
|
1.12e-01
|
4.64e-01
|
GOBP COLLATERAL SPROUTING
|
28
|
3.06e-01
|
1.12e-01
|
4.90e-01
|
GOMF SIGNALING RECEPTOR BINDING
|
987
|
4.01e-09
|
-1.12e-01
|
1.28e-07
|
GOBP SUBPALLIUM DEVELOPMENT
|
16
|
4.39e-01
|
1.12e-01
|
6.19e-01
|
GOBP REGULATION OF MYELOID CELL APOPTOTIC PROCESS
|
26
|
3.24e-01
|
-1.12e-01
|
5.11e-01
|
GOMF PRE MRNA INTRONIC BINDING
|
13
|
4.86e-01
|
-1.12e-01
|
6.59e-01
|
GOBP POSITIVE REGULATION OF REGULATORY T CELL DIFFERENTIATION
|
16
|
4.40e-01
|
-1.12e-01
|
6.19e-01
|
GOBP MEMBRANE DOCKING
|
70
|
1.07e-01
|
-1.12e-01
|
2.45e-01
|
GOBP DETOXIFICATION OF INORGANIC COMPOUND
|
11
|
5.22e-01
|
1.11e-01
|
6.90e-01
|
GOCC GLIAL CELL PROJECTION
|
31
|
2.83e-01
|
-1.11e-01
|
4.66e-01
|
GOMF MANNOSE BINDING
|
19
|
4.01e-01
|
1.11e-01
|
5.86e-01
|
GOBP REGULATION OF BINDING
|
282
|
1.34e-03
|
-1.11e-01
|
8.60e-03
|
GOMF CADHERIN BINDING
|
50
|
1.74e-01
|
-1.11e-01
|
3.37e-01
|
GOBP POSITIVE REGULATION OF WNT SIGNALING PATHWAY
|
114
|
4.04e-02
|
-1.11e-01
|
1.24e-01
|
GOBP REGULATION OF CLATHRIN DEPENDENT ENDOCYTOSIS
|
16
|
4.41e-01
|
1.11e-01
|
6.20e-01
|
GOBP REGULATION OF GLYCOGEN METABOLIC PROCESS
|
35
|
2.55e-01
|
-1.11e-01
|
4.36e-01
|
GOBP REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT
|
121
|
3.48e-02
|
-1.11e-01
|
1.12e-01
|
GOBP REGULATION OF NEURONAL SYNAPTIC PLASTICITY
|
56
|
1.50e-01
|
1.11e-01
|
3.05e-01
|
GOCC RECEPTOR COMPLEX
|
262
|
2.00e-03
|
-1.11e-01
|
1.20e-02
|
GOBP JNK CASCADE
|
156
|
1.68e-02
|
-1.11e-01
|
6.47e-02
|
GOBP REGULATION OF HYDROGEN PEROXIDE METABOLIC PROCESS
|
14
|
4.72e-01
|
1.11e-01
|
6.47e-01
|
GOBP NEPHRON EPITHELIUM DEVELOPMENT
|
89
|
7.06e-02
|
-1.11e-01
|
1.85e-01
|
GOBP ANATOMICAL STRUCTURE FORMATION INVOLVED IN MORPHOGENESIS
|
983
|
5.55e-09
|
-1.11e-01
|
1.70e-07
|
GOBP REGULATION OF CELL POPULATION PROLIFERATION
|
1295
|
3.68e-11
|
-1.11e-01
|
1.72e-09
|
GOCC FILAMENTOUS ACTIN
|
31
|
2.86e-01
|
-1.11e-01
|
4.69e-01
|
GOMF PURINE NUCLEOTIDE TRANSMEMBRANE TRANSPORTER ACTIVITY
|
24
|
3.47e-01
|
1.11e-01
|
5.35e-01
|
GOBP POSITIVE REGULATION OF ENDOCYTOSIS
|
154
|
1.79e-02
|
-1.11e-01
|
6.74e-02
|
GOBP REGULATION OF ACTIVIN RECEPTOR SIGNALING PATHWAY
|
22
|
3.69e-01
|
-1.11e-01
|
5.55e-01
|
GOBP POSITIVE REGULATION OF NEUROTRANSMITTER TRANSPORT
|
18
|
4.16e-01
|
1.11e-01
|
5.99e-01
|
GOBP NEURON PROJECTION ORGANIZATION
|
99
|
5.74e-02
|
-1.11e-01
|
1.60e-01
|
GOBP PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM
|
69
|
1.12e-01
|
1.11e-01
|
2.52e-01
|
GOBP LEUKOCYTE ACTIVATION INVOLVED IN INFLAMMATORY RESPONSE
|
42
|
2.15e-01
|
-1.11e-01
|
3.90e-01
|
GOBP POSITIVE REGULATION OF MAPK CASCADE
|
397
|
1.66e-04
|
-1.11e-01
|
1.54e-03
|
GOMF PROTEIN KINASE B BINDING
|
17
|
4.30e-01
|
-1.10e-01
|
6.11e-01
|
GOBP TELOMERE MAINTENANCE VIA RECOMBINATION
|
15
|
4.59e-01
|
-1.10e-01
|
6.35e-01
|
GOMF DISULFIDE OXIDOREDUCTASE ACTIVITY
|
33
|
2.73e-01
|
1.10e-01
|
4.55e-01
|
GOMF HYDROLASE ACTIVITY ACTING ON CARBON NITROGEN BUT NOT PEPTIDE BONDS IN CYCLIC AMIDES
|
11
|
5.27e-01
|
1.10e-01
|
6.93e-01
|
GOBP SKELETAL MUSCLE TISSUE REGENERATION
|
33
|
2.73e-01
|
1.10e-01
|
4.55e-01
|
GOCC PROTEIN KINASE COMPLEX
|
117
|
3.98e-02
|
-1.10e-01
|
1.23e-01
|
GOBP PROSTAGLANDIN TRANSPORT
|
20
|
3.94e-01
|
-1.10e-01
|
5.79e-01
|
GOBP MONOATOMIC ION TRANSMEMBRANE TRANSPORT
|
559
|
9.58e-06
|
1.10e-01
|
1.30e-04
|
GOBP EPITHELIAL CELL DEVELOPMENT
|
178
|
1.15e-02
|
-1.10e-01
|
4.80e-02
|
GOBP PYRIMIDINE NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS
|
18
|
4.19e-01
|
1.10e-01
|
6.01e-01
|
GOBP ACTIN FILAMENT SEVERING
|
17
|
4.33e-01
|
-1.10e-01
|
6.13e-01
|
GOBP RNA MODIFICATION
|
127
|
3.26e-02
|
1.10e-01
|
1.06e-01
|
GOCC COMPACT MYELIN
|
15
|
4.61e-01
|
1.10e-01
|
6.37e-01
|
GOMF PROTEIN PHOSPHATASE BINDING
|
158
|
1.74e-02
|
-1.10e-01
|
6.61e-02
|
GOMF GROWTH FACTOR ACTIVITY
|
81
|
8.79e-02
|
-1.10e-01
|
2.15e-01
|
GOBP REGULATION OF PHOSPHORUS METABOLIC PROCESS
|
1006
|
5.54e-09
|
-1.10e-01
|
1.70e-07
|
GOBP REGULATION OF MRNA PROCESSING
|
114
|
4.32e-02
|
-1.10e-01
|
1.30e-01
|
GOBP POSITIVE REGULATION OF CELL GROWTH INVOLVED IN CARDIAC MUSCLE CELL DEVELOPMENT
|
14
|
4.77e-01
|
1.10e-01
|
6.51e-01
|
GOBP NEGATIVE REGULATION OF POTASSIUM ION TRANSPORT
|
27
|
3.24e-01
|
-1.10e-01
|
5.11e-01
|
GOBP CARDIOBLAST PROLIFERATION
|
11
|
5.29e-01
|
1.10e-01
|
6.94e-01
|
GOMF OXYSTEROL BINDING
|
13
|
4.94e-01
|
1.10e-01
|
6.66e-01
|
GOBP REGULATION OF CELL JUNCTION ASSEMBLY
|
230
|
4.29e-03
|
-1.10e-01
|
2.21e-02
|
GOBP STRIATED MUSCLE CELL DEVELOPMENT
|
75
|
1.01e-01
|
1.09e-01
|
2.37e-01
|
GOBP REGULATION OF WNT SIGNALING PATHWAY PLANAR CELL POLARITY PATHWAY
|
16
|
4.49e-01
|
-1.09e-01
|
6.27e-01
|
GOBP POSITIVE REGULATION OF COLD INDUCED THERMOGENESIS
|
79
|
9.30e-02
|
1.09e-01
|
2.24e-01
|
GOMF KINASE INHIBITOR ACTIVITY
|
66
|
1.25e-01
|
-1.09e-01
|
2.70e-01
|
GOBP REGULATION OF PROTEIN MODIFICATION PROCESS
|
1064
|
2.61e-09
|
-1.09e-01
|
8.56e-08
|
GOMF SIGNALING ADAPTOR ACTIVITY
|
94
|
6.79e-02
|
-1.09e-01
|
1.79e-01
|
GOBP REGULATION OF NUCLEOTIDE METABOLIC PROCESS
|
84
|
8.45e-02
|
1.09e-01
|
2.10e-01
|
GOBP POSITIVE REGULATION OF CELL POPULATION PROLIFERATION
|
738
|
5.65e-07
|
-1.09e-01
|
1.05e-05
|
GOBP LIPOPROTEIN CATABOLIC PROCESS
|
16
|
4.51e-01
|
1.09e-01
|
6.29e-01
|
GOBP MAMMARY GLAND MORPHOGENESIS
|
46
|
2.02e-01
|
-1.09e-01
|
3.72e-01
|
GOBP REGULATION OF T CELL PROLIFERATION
|
130
|
3.23e-02
|
-1.09e-01
|
1.05e-01
|
GOBP MELANIN METABOLIC PROCESS
|
15
|
4.66e-01
|
-1.09e-01
|
6.42e-01
|
GOBP GMP METABOLIC PROCESS
|
19
|
4.12e-01
|
1.09e-01
|
5.95e-01
|
GOBP REGULATION OF NUCLEOTIDE BIOSYNTHETIC PROCESS
|
24
|
3.56e-01
|
1.09e-01
|
5.43e-01
|
GOMF CAMP DEPENDENT PROTEIN KINASE REGULATOR ACTIVITY
|
10
|
5.52e-01
|
1.09e-01
|
7.14e-01
|
GOBP REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS
|
142
|
2.56e-02
|
-1.09e-01
|
8.86e-02
|
GOBP NEURON MIGRATION
|
153
|
2.06e-02
|
-1.09e-01
|
7.53e-02
|
GOBP REGULATION OF UBIQUITIN PROTEIN LIGASE ACTIVITY
|
17
|
4.38e-01
|
-1.09e-01
|
6.18e-01
|
GOBP MICROTUBULE BASED PROCESS
|
691
|
1.35e-06
|
-1.09e-01
|
2.34e-05
|
GOBP GLIAL CELL DIFFERENTIATION
|
218
|
5.84e-03
|
-1.09e-01
|
2.82e-02
|
GOBP RNA EXPORT FROM NUCLEUS
|
72
|
1.12e-01
|
-1.08e-01
|
2.52e-01
|
GOMF PROTEIN SERINE THREONINE KINASE ACTIVITY
|
361
|
4.23e-04
|
-1.08e-01
|
3.37e-03
|
GOBP DETOXIFICATION
|
58
|
1.54e-01
|
1.08e-01
|
3.09e-01
|
GOBP POSITIVE REGULATION OF MYOBLAST FUSION
|
13
|
4.99e-01
|
-1.08e-01
|
6.70e-01
|
GOBP POSITIVE REGULATION OF GENE EXPRESSION
|
920
|
3.37e-08
|
-1.08e-01
|
8.58e-07
|
GOMF CHEMOREPELLENT ACTIVITY
|
26
|
3.39e-01
|
1.08e-01
|
5.27e-01
|
GOMF L ASCORBIC ACID BINDING
|
18
|
4.26e-01
|
1.08e-01
|
6.08e-01
|
GOBP NEGATIVE REGULATION OF GLIOGENESIS
|
39
|
2.42e-01
|
-1.08e-01
|
4.22e-01
|
GOCC MONOATOMIC ION CHANNEL COMPLEX
|
171
|
1.49e-02
|
1.08e-01
|
5.89e-02
|
GOCC TRANSCRIPTION REGULATOR COMPLEX
|
439
|
1.10e-04
|
-1.08e-01
|
1.09e-03
|
GOBP CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT
|
41
|
2.31e-01
|
-1.08e-01
|
4.10e-01
|
GOBP CELLULAR SENESCENCE
|
80
|
9.49e-02
|
-1.08e-01
|
2.27e-01
|
GOBP NEGATIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION
|
648
|
3.15e-06
|
-1.08e-01
|
4.88e-05
|
GOBP NEGATIVE REGULATION OF TRANSFERASE ACTIVITY
|
200
|
8.59e-03
|
-1.08e-01
|
3.80e-02
|
GOBP GLYCEROPHOSPHOLIPID METABOLIC PROCESS
|
228
|
5.07e-03
|
1.08e-01
|
2.52e-02
|
GOBP INSULIN RECEPTOR SIGNALING PATHWAY
|
124
|
3.82e-02
|
-1.08e-01
|
1.19e-01
|
GOBP PYRIMIDINE NUCLEOBASE METABOLIC PROCESS
|
15
|
4.69e-01
|
1.08e-01
|
6.44e-01
|
GOBP POSITIVE REGULATION OF GLUCOSE IMPORT
|
33
|
2.84e-01
|
-1.08e-01
|
4.67e-01
|
GOMF CYSTEINE TYPE PEPTIDASE ACTIVITY
|
131
|
3.33e-02
|
-1.08e-01
|
1.08e-01
|
GOBP REVERSE CHOLESTEROL TRANSPORT
|
11
|
5.36e-01
|
1.08e-01
|
7.01e-01
|
GOBP MYELOID CELL APOPTOTIC PROCESS
|
31
|
3.00e-01
|
-1.08e-01
|
4.84e-01
|
GOBP NUCLEOTIDE SUGAR TRANSMEMBRANE TRANSPORT
|
12
|
5.19e-01
|
-1.08e-01
|
6.87e-01
|
GOMF PHOSPHATIDYLCHOLINE BINDING
|
20
|
4.05e-01
|
1.08e-01
|
5.89e-01
|
GOMF SOLUTE SODIUM SYMPORTER ACTIVITY
|
43
|
2.23e-01
|
1.07e-01
|
4.00e-01
|
GOBP GAMMA DELTA T CELL ACTIVATION
|
15
|
4.71e-01
|
1.07e-01
|
6.46e-01
|
GOMF INSULIN LIKE GROWTH FACTOR RECEPTOR BINDING
|
13
|
5.03e-01
|
-1.07e-01
|
6.73e-01
|
GOCC VARICOSITY
|
10
|
5.57e-01
|
-1.07e-01
|
7.18e-01
|
GOBP REGULATION OF ACTION POTENTIAL
|
54
|
1.73e-01
|
1.07e-01
|
3.36e-01
|
GOMF TRANSCRIPTION COREGULATOR BINDING
|
119
|
4.36e-02
|
-1.07e-01
|
1.30e-01
|
GOBP C21 STEROID HORMONE BIOSYNTHETIC PROCESS
|
14
|
4.88e-01
|
1.07e-01
|
6.61e-01
|
GOBP ADAPTIVE THERMOGENESIS
|
137
|
3.06e-02
|
1.07e-01
|
1.01e-01
|
GOBP NUCLEOTIDE TRANSPORT
|
32
|
2.95e-01
|
-1.07e-01
|
4.78e-01
|
GOBP POSITIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY
|
55
|
1.70e-01
|
-1.07e-01
|
3.32e-01
|
GOBP REGULATION OF ACTIN FILAMENT BASED PROCESS
|
341
|
7.08e-04
|
-1.07e-01
|
5.11e-03
|
GOBP NEGATIVE REGULATION BY HOST OF VIRAL TRANSCRIPTION
|
10
|
5.58e-01
|
-1.07e-01
|
7.18e-01
|
GOBP PROTEIN METHYLATION
|
49
|
1.95e-01
|
1.07e-01
|
3.65e-01
|
GOBP ANTEROGRADE AXONAL TRANSPORT
|
46
|
2.10e-01
|
1.07e-01
|
3.83e-01
|
GOCC CORNIFIED ENVELOPE
|
14
|
4.89e-01
|
-1.07e-01
|
6.62e-01
|
GOBP FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY
|
63
|
1.43e-01
|
-1.07e-01
|
2.95e-01
|
GOBP NEGATIVE REGULATION OF PROTEIN UBIQUITINATION
|
71
|
1.20e-01
|
-1.07e-01
|
2.64e-01
|
GOMF ACTIN FILAMENT BINDING
|
184
|
1.28e-02
|
-1.07e-01
|
5.23e-02
|
GOBP REGULATION OF PROTEIN POLYUBIQUITINATION
|
25
|
3.56e-01
|
-1.07e-01
|
5.43e-01
|
GOBP CELL FATE DETERMINATION
|
20
|
4.09e-01
|
-1.07e-01
|
5.93e-01
|
GOBP CARDIAC MUSCLE ADAPTATION
|
30
|
3.13e-01
|
-1.06e-01
|
4.99e-01
|
GOBP PHOSPHOLIPID TRANSPORT
|
64
|
1.42e-01
|
-1.06e-01
|
2.94e-01
|
GOMF MECHANOSENSITIVE MONOATOMIC ION CHANNEL ACTIVITY
|
11
|
5.42e-01
|
-1.06e-01
|
7.06e-01
|
GOBP INTRACELLULAR PH REDUCTION
|
40
|
2.45e-01
|
1.06e-01
|
4.26e-01
|
GOBP HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION
|
134
|
3.39e-02
|
-1.06e-01
|
1.09e-01
|
GOBP OOCYTE DIFFERENTIATION
|
37
|
2.64e-01
|
-1.06e-01
|
4.45e-01
|
GOMF NUCLEAR ESTROGEN RECEPTOR BINDING
|
42
|
2.34e-01
|
-1.06e-01
|
4.13e-01
|
GOBP ATRIOVENTRICULAR CANAL DEVELOPMENT
|
12
|
5.24e-01
|
1.06e-01
|
6.91e-01
|
GOBP REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY
|
40
|
2.45e-01
|
-1.06e-01
|
4.26e-01
|
GOBP CYTOPLASMIC TRANSLATION
|
138
|
3.15e-02
|
1.06e-01
|
1.03e-01
|
GOBP NEGATIVE REGULATION OF PROTEIN DEPHOSPHORYLATION
|
23
|
3.78e-01
|
-1.06e-01
|
5.64e-01
|
GOBP CAMP MEDIATED SIGNALING
|
47
|
2.08e-01
|
1.06e-01
|
3.81e-01
|
GOBP NK T CELL ACTIVATION
|
10
|
5.62e-01
|
1.06e-01
|
7.21e-01
|
GOMF G PROTEIN ALPHA SUBUNIT BINDING
|
29
|
3.23e-01
|
-1.06e-01
|
5.11e-01
|
GOBP MEMBRANE REPOLARIZATION DURING CARDIAC MUSCLE CELL ACTION POTENTIAL
|
10
|
5.62e-01
|
1.06e-01
|
7.21e-01
|
GOBP MEMBRANE BIOGENESIS
|
55
|
1.74e-01
|
-1.06e-01
|
3.38e-01
|
GOMF PHOSPHOLIPASE C ACTIVITY
|
14
|
4.93e-01
|
-1.06e-01
|
6.65e-01
|
GOCC INTRACILIARY TRANSPORT PARTICLE
|
22
|
3.90e-01
|
-1.06e-01
|
5.76e-01
|
GOBP HEART MORPHOGENESIS
|
239
|
4.91e-03
|
-1.06e-01
|
2.46e-02
|
GOBP ENTERIC NERVOUS SYSTEM DEVELOPMENT
|
10
|
5.62e-01
|
-1.06e-01
|
7.21e-01
|
GOBP STEM CELL DEVELOPMENT
|
75
|
1.13e-01
|
-1.06e-01
|
2.54e-01
|
GOBP REGULATION OF AXON EXTENSION INVOLVED IN AXON GUIDANCE
|
12
|
5.26e-01
|
1.06e-01
|
6.92e-01
|
GOCC NUCLEOCYTOPLASMIC TRANSPORT COMPLEX
|
10
|
5.63e-01
|
1.06e-01
|
7.22e-01
|
GOBP NEGATIVE REGULATION OF BLOOD PRESSURE
|
42
|
2.36e-01
|
1.06e-01
|
4.15e-01
|
GOBP POSITIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION
|
51
|
1.92e-01
|
-1.06e-01
|
3.59e-01
|
GOBP CELL JUNCTION ASSEMBLY
|
384
|
3.97e-04
|
-1.06e-01
|
3.20e-03
|
GOBP ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC PROCESS
|
67
|
1.35e-01
|
-1.06e-01
|
2.83e-01
|
GOBP PROTEIN IMPORT
|
10
|
5.63e-01
|
-1.06e-01
|
7.22e-01
|
GOBP VOCALIZATION BEHAVIOR
|
15
|
4.79e-01
|
-1.06e-01
|
6.53e-01
|
GOBP DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION RESULTING IN TRANSCRIPTION
|
16
|
4.65e-01
|
1.06e-01
|
6.41e-01
|
GOCC CYTOPLASMIC SIDE OF MEMBRANE
|
161
|
2.11e-02
|
-1.05e-01
|
7.69e-02
|
GOBP CELLULAR RESPONSE TO NITROGEN COMPOUND
|
462
|
1.10e-04
|
-1.05e-01
|
1.09e-03
|
GOBP EMBRYONIC MORPHOGENESIS
|
474
|
9.02e-05
|
-1.05e-01
|
9.12e-04
|
GOBP CELL MIGRATION INVOLVED IN GASTRULATION
|
11
|
5.45e-01
|
-1.05e-01
|
7.08e-01
|
GOCC PLASMA MEMBRANE PROTEIN COMPLEX
|
373
|
4.96e-04
|
-1.05e-01
|
3.81e-03
|
GOBP LATE ENDOSOME TO VACUOLE TRANSPORT
|
24
|
3.72e-01
|
-1.05e-01
|
5.58e-01
|
GOBP ESTABLISHMENT OF SKIN BARRIER
|
22
|
3.92e-01
|
1.05e-01
|
5.78e-01
|
GOBP NEGATIVE REGULATION OF CELL SIZE
|
13
|
5.11e-01
|
-1.05e-01
|
6.80e-01
|
GOCC RIBONUCLEOPROTEIN COMPLEX
|
638
|
6.63e-06
|
1.05e-01
|
9.48e-05
|
GOCC GBAF COMPLEX
|
11
|
5.46e-01
|
-1.05e-01
|
7.09e-01
|
GOBP BRANCH ELONGATION OF AN EPITHELIUM
|
16
|
4.67e-01
|
-1.05e-01
|
6.43e-01
|
GOBP CELL COMMUNICATION INVOLVED IN CARDIAC CONDUCTION
|
38
|
2.63e-01
|
1.05e-01
|
4.45e-01
|
GOBP REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION
|
79
|
1.07e-01
|
-1.05e-01
|
2.45e-01
|
GOCC GOLGI APPARATUS SUBCOMPARTMENT
|
265
|
3.38e-03
|
-1.05e-01
|
1.82e-02
|
GOBP NEGATIVE REGULATION OF CELL GROWTH
|
162
|
2.16e-02
|
-1.05e-01
|
7.81e-02
|
GOBP POSITIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE III
|
17
|
4.55e-01
|
-1.05e-01
|
6.32e-01
|
GOCC FIBRILLAR CENTER
|
134
|
3.65e-02
|
-1.05e-01
|
1.15e-01
|
GOCC GOLGI TRANSPORT COMPLEX
|
10
|
5.66e-01
|
1.05e-01
|
7.25e-01
|
GOBP NEGATIVE REGULATION OF RESPONSE TO WOUNDING
|
65
|
1.44e-01
|
-1.05e-01
|
2.97e-01
|
GOMF MOLECULAR CONDENSATE SCAFFOLD ACTIVITY
|
33
|
2.98e-01
|
-1.05e-01
|
4.82e-01
|
GOCC PRERIBOSOME
|
100
|
7.06e-02
|
1.05e-01
|
1.85e-01
|
GOBP NEGATIVE REGULATION OF POST TRANSLATIONAL PROTEIN MODIFICATION
|
84
|
9.75e-02
|
-1.05e-01
|
2.31e-01
|
GOMF PROTEIN PHOSPHATASE 1 BINDING
|
26
|
3.56e-01
|
-1.05e-01
|
5.43e-01
|
GOBP SNO S RNA PROCESSING
|
11
|
5.48e-01
|
1.05e-01
|
7.11e-01
|
GOBP NEGATIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS
|
20
|
4.18e-01
|
-1.05e-01
|
6.01e-01
|
GOBP NEGATIVE REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY
|
16
|
4.69e-01
|
1.05e-01
|
6.44e-01
|
GOBP REGULATION OF MACROPHAGE ACTIVATION
|
43
|
2.36e-01
|
-1.04e-01
|
4.15e-01
|
GOCC SNARE COMPLEX
|
42
|
2.42e-01
|
-1.04e-01
|
4.21e-01
|
GOCC MICROTUBULE CYTOSKELETON
|
1052
|
1.49e-08
|
-1.04e-01
|
4.03e-07
|
GOBP TEMPERATURE HOMEOSTASIS
|
151
|
2.70e-02
|
1.04e-01
|
9.23e-02
|
GOMF GTPASE BINDING
|
302
|
1.86e-03
|
-1.04e-01
|
1.14e-02
|
GOBP T CELL PROLIFERATION
|
166
|
2.05e-02
|
-1.04e-01
|
7.51e-02
|
GOBP CELLULAR RESPONSE TO INORGANIC SUBSTANCE
|
139
|
3.40e-02
|
-1.04e-01
|
1.10e-01
|
GOBP CHOLESTEROL STORAGE
|
22
|
3.97e-01
|
1.04e-01
|
5.83e-01
|
GOBP HOMOLOGOUS CHROMOSOME SEGREGATION
|
33
|
3.01e-01
|
-1.04e-01
|
4.85e-01
|
GOMF LIGAND GATED CALCIUM CHANNEL ACTIVITY
|
18
|
4.44e-01
|
1.04e-01
|
6.24e-01
|
GOBP RESPONSE TO OSMOTIC STRESS
|
72
|
1.27e-01
|
1.04e-01
|
2.73e-01
|
GOBP GOLGI TO VACUOLE TRANSPORT
|
21
|
4.09e-01
|
1.04e-01
|
5.93e-01
|
GOBP REGULATION OF RESPONSE TO STRESS
|
1086
|
1.04e-08
|
-1.04e-01
|
2.95e-07
|
GOBP NEGATIVE REGULATION OF T CELL PROLIFERATION
|
56
|
1.78e-01
|
-1.04e-01
|
3.43e-01
|
GOMF GDP DISSOCIATION INHIBITOR ACTIVITY
|
16
|
4.71e-01
|
-1.04e-01
|
6.46e-01
|
GOBP SECRETORY GRANULE LOCALIZATION
|
27
|
3.50e-01
|
-1.04e-01
|
5.37e-01
|
GOBP NERVE GROWTH FACTOR SIGNALING PATHWAY
|
11
|
5.50e-01
|
-1.04e-01
|
7.13e-01
|
GOMF HYDROLASE ACTIVITY ACTING ON GLYCOSYL BONDS
|
82
|
1.04e-01
|
1.04e-01
|
2.41e-01
|
GOBP SOMATIC STEM CELL POPULATION MAINTENANCE
|
64
|
1.51e-01
|
-1.04e-01
|
3.05e-01
|
GOMF UBIQUITIN LIKE MODIFIER ACTIVATING ENZYME ACTIVITY
|
10
|
5.69e-01
|
-1.04e-01
|
7.27e-01
|
GOMF XENOBIOTIC TRANSMEMBRANE TRANSPORTER ACTIVITY
|
27
|
3.50e-01
|
1.04e-01
|
5.37e-01
|
GOBP ASTRAL MICROTUBULE ORGANIZATION
|
13
|
5.16e-01
|
-1.04e-01
|
6.85e-01
|
GOMF LOW DENSITY LIPOPROTEIN PARTICLE RECEPTOR ACTIVITY
|
10
|
5.70e-01
|
1.04e-01
|
7.27e-01
|
GOBP REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY
|
54
|
1.87e-01
|
1.04e-01
|
3.54e-01
|
GOBP CERAMIDE CATABOLIC PROCESS
|
14
|
5.01e-01
|
-1.04e-01
|
6.73e-01
|
GOBP INTRACELLULAR SIGNALING CASSETTE
|
1409
|
1.27e-10
|
-1.04e-01
|
5.66e-09
|
GOBP PROTEIN CONTAINING COMPLEX REMODELING
|
18
|
4.46e-01
|
1.04e-01
|
6.25e-01
|
GOBP CELLULAR RESPONSE TO PEPTIDE HORMONE STIMULUS
|
248
|
5.02e-03
|
-1.04e-01
|
2.50e-02
|
GOBP POSITIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT
|
32
|
3.10e-01
|
-1.04e-01
|
4.95e-01
|
GOBP REGULATION OF MYOBLAST PROLIFERATION
|
19
|
4.34e-01
|
-1.04e-01
|
6.14e-01
|
GOBP CENTRAL NERVOUS SYSTEM DEVELOPMENT
|
696
|
3.72e-06
|
-1.04e-01
|
5.66e-05
|
GOBP MALE SEX DETERMINATION
|
10
|
5.71e-01
|
1.04e-01
|
7.27e-01
|
GOMF MOLECULAR CARRIER ACTIVITY
|
82
|
1.05e-01
|
1.04e-01
|
2.43e-01
|
GOBP STRESS GRANULE ASSEMBLY
|
32
|
3.11e-01
|
-1.04e-01
|
4.97e-01
|
GOBP POSITIVE REGULATION OF HYDROLASE ACTIVITY
|
358
|
8.07e-04
|
-1.03e-01
|
5.70e-03
|
GOBP REGULATION OF TRANSLATIONAL INITIATION
|
64
|
1.53e-01
|
-1.03e-01
|
3.08e-01
|
GOBP NEGATIVE REGULATION OF MYELOID CELL DIFFERENTIATION
|
68
|
1.41e-01
|
-1.03e-01
|
2.93e-01
|
GOBP PROTEIN K48 LINKED DEUBIQUITINATION
|
22
|
4.02e-01
|
-1.03e-01
|
5.87e-01
|
GOBP TRANSLATIONAL INITIATION
|
107
|
6.51e-02
|
-1.03e-01
|
1.74e-01
|
GOBP TELOMERE ORGANIZATION
|
139
|
3.58e-02
|
-1.03e-01
|
1.14e-01
|
GOBP NEGATIVE REGULATION OF MAPK CASCADE
|
143
|
3.33e-02
|
-1.03e-01
|
1.08e-01
|
GOBP POSITIVE REGULATION OF BINDING
|
130
|
4.24e-02
|
-1.03e-01
|
1.28e-01
|
GOBP NEGATIVE REGULATION OF CELL PROJECTION ORGANIZATION
|
178
|
1.77e-02
|
-1.03e-01
|
6.70e-02
|
GOBP INNER EAR RECEPTOR CELL DEVELOPMENT
|
43
|
2.42e-01
|
-1.03e-01
|
4.22e-01
|
GOMF TUBULIN BINDING
|
315
|
1.70e-03
|
-1.03e-01
|
1.06e-02
|
GOBP KIDNEY MORPHOGENESIS
|
75
|
1.23e-01
|
-1.03e-01
|
2.67e-01
|
GOBP PEPTIDYL AMINO ACID MODIFICATION
|
709
|
3.41e-06
|
-1.03e-01
|
5.23e-05
|
GOBP NEGATIVE REGULATION OF DEVELOPMENTAL GROWTH
|
94
|
8.48e-02
|
-1.03e-01
|
2.10e-01
|
GOBP MATERNAL PLACENTA DEVELOPMENT
|
30
|
3.29e-01
|
-1.03e-01
|
5.17e-01
|
GOMF FIBROBLAST GROWTH FACTOR BINDING
|
22
|
4.04e-01
|
1.03e-01
|
5.88e-01
|
GOCC DENSE CORE GRANULE
|
33
|
3.07e-01
|
-1.03e-01
|
4.91e-01
|
GOBP HEPATOCYTE DIFFERENTIATION
|
10
|
5.73e-01
|
-1.03e-01
|
7.30e-01
|
GOBP REGULATION OF SMOOTHENED SIGNALING PATHWAY
|
81
|
1.10e-01
|
-1.03e-01
|
2.49e-01
|
GOBP NEGATIVE REGULATION OF GROWTH
|
206
|
1.12e-02
|
-1.03e-01
|
4.73e-02
|
GOCC LIPID DROPLET
|
87
|
9.83e-02
|
1.03e-01
|
2.32e-01
|
GOBP NEGATIVE REGULATION OF LEUKOCYTE PROLIFERATION
|
72
|
1.33e-01
|
-1.03e-01
|
2.80e-01
|
GOBP REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM
|
19
|
4.39e-01
|
1.03e-01
|
6.19e-01
|
GOBP CAMERA TYPE EYE MORPHOGENESIS
|
109
|
6.51e-02
|
-1.02e-01
|
1.74e-01
|
GOBP PROTEIN LOCALIZATION TO CYTOSKELETON
|
59
|
1.74e-01
|
-1.02e-01
|
3.37e-01
|
GOBP CELL JUNCTION ORGANIZATION
|
685
|
5.80e-06
|
-1.02e-01
|
8.48e-05
|
GOBP ANIMAL ORGAN FORMATION
|
53
|
1.98e-01
|
-1.02e-01
|
3.68e-01
|
GOBP NEURAL TUBE FORMATION
|
116
|
5.76e-02
|
-1.02e-01
|
1.60e-01
|
GOBP NEGATIVE REGULATION OF PHOSPHORYLATION
|
291
|
2.81e-03
|
-1.02e-01
|
1.58e-02
|
GOMF INTRAMOLECULAR TRANSFERASE ACTIVITY
|
25
|
3.77e-01
|
1.02e-01
|
5.63e-01
|
GOBP SPLICEOSOMAL TRI SNRNP COMPLEX ASSEMBLY
|
11
|
5.58e-01
|
1.02e-01
|
7.18e-01
|
GOBP COLLAGEN CATABOLIC PROCESS
|
25
|
3.77e-01
|
-1.02e-01
|
5.63e-01
|
GOBP CELL PROJECTION ORGANIZATION
|
1310
|
9.70e-10
|
-1.02e-01
|
3.44e-08
|
GOBP PROSTATE GLAND GROWTH
|
10
|
5.77e-01
|
1.02e-01
|
7.32e-01
|
GOBP NEGATIVE REGULATION OF SYNAPTIC TRANSMISSION
|
50
|
2.13e-01
|
1.02e-01
|
3.88e-01
|
GOMF MAP KINASE ACTIVITY
|
14
|
5.10e-01
|
1.02e-01
|
6.79e-01
|
GOBP RECEPTOR RECYCLING
|
48
|
2.23e-01
|
1.02e-01
|
4.00e-01
|
GOCC POSTSYNAPTIC CYTOSOL
|
42
|
2.54e-01
|
-1.02e-01
|
4.35e-01
|
GOBP SYNCYTIUM FORMATION
|
49
|
2.18e-01
|
-1.02e-01
|
3.94e-01
|
GOMF TETRAPYRROLE BINDING
|
80
|
1.16e-01
|
1.02e-01
|
2.57e-01
|
GOBP POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR
|
76
|
1.26e-01
|
-1.02e-01
|
2.72e-01
|
GOBP IMMUNE SYSTEM DEVELOPMENT
|
158
|
2.77e-02
|
-1.02e-01
|
9.36e-02
|
GOMF STRUCTURAL MOLECULE ACTIVITY
|
461
|
1.97e-04
|
1.02e-01
|
1.78e-03
|
GOBP LYMPHOCYTE COSTIMULATION
|
20
|
4.32e-01
|
-1.02e-01
|
6.12e-01
|
GOBP CELL MORPHOGENESIS
|
838
|
7.27e-07
|
-1.02e-01
|
1.32e-05
|
GOBP PROTEIN SUMOYLATION
|
41
|
2.61e-01
|
-1.02e-01
|
4.42e-01
|
GOBP SENSORY ORGAN MORPHOGENESIS
|
210
|
1.14e-02
|
-1.02e-01
|
4.78e-02
|
GOBP REGULATION OF EARLY ENDOSOME TO LATE ENDOSOME TRANSPORT
|
18
|
4.56e-01
|
-1.02e-01
|
6.33e-01
|
GOBP REGULATION OF MUSCLE HYPERTROPHY
|
74
|
1.31e-01
|
-1.01e-01
|
2.79e-01
|
GOBP GLYCEROPHOSPHOLIPID BIOSYNTHETIC PROCESS
|
145
|
3.52e-02
|
1.01e-01
|
1.13e-01
|
GOCC CLATHRIN COATED VESICLE
|
101
|
7.85e-02
|
-1.01e-01
|
1.99e-01
|
GOBP CELLULAR COMPONENT MAINTENANCE
|
64
|
1.61e-01
|
-1.01e-01
|
3.21e-01
|
GOBP POSITIVE REGULATION OF CELLULAR RESPIRATION
|
18
|
4.57e-01
|
-1.01e-01
|
6.34e-01
|
GOBP AMINE BIOSYNTHETIC PROCESS
|
29
|
3.45e-01
|
1.01e-01
|
5.34e-01
|
GOCC CORE MEDIATOR COMPLEX
|
26
|
3.72e-01
|
1.01e-01
|
5.58e-01
|
GOBP NON PROTEINOGENIC AMINO ACID BIOSYNTHETIC PROCESS
|
12
|
5.44e-01
|
-1.01e-01
|
7.08e-01
|
GOBP POSITIVE REGULATION OF DNA REPAIR
|
117
|
5.89e-02
|
-1.01e-01
|
1.63e-01
|
GOMF LIGAND GATED MONOATOMIC ANION CHANNEL ACTIVITY
|
19
|
4.45e-01
|
1.01e-01
|
6.24e-01
|
GOBP BONE MORPHOGENESIS
|
80
|
1.18e-01
|
-1.01e-01
|
2.60e-01
|
GOBP POSITIVE REGULATION OF MULTICELLULAR ORGANISM GROWTH
|
30
|
3.38e-01
|
1.01e-01
|
5.27e-01
|
GOBP POSITIVE REGULATION OF LYMPHOCYTE CHEMOTAXIS
|
11
|
5.62e-01
|
1.01e-01
|
7.21e-01
|
GOMF INTRAMOLECULAR PHOSPHOTRANSFERASE ACTIVITY
|
10
|
5.80e-01
|
1.01e-01
|
7.35e-01
|
GOBP POSITIVE REGULATION OF CHOLESTEROL EFFLUX
|
25
|
3.82e-01
|
1.01e-01
|
5.68e-01
|
GOBP RESPONSE TO XENOBIOTIC STIMULUS
|
224
|
9.40e-03
|
1.01e-01
|
4.08e-02
|
GOCC COPII COATED ER TO GOLGI TRANSPORT VESICLE
|
52
|
2.08e-01
|
1.01e-01
|
3.81e-01
|
GOBP NEGATIVE REGULATION OF LIPID TRANSPORT
|
25
|
3.83e-01
|
1.01e-01
|
5.69e-01
|
GOBP MATURATION OF 5 8S RRNA
|
34
|
3.09e-01
|
1.01e-01
|
4.94e-01
|
GOBP METENCEPHALON DEVELOPMENT
|
89
|
1.00e-01
|
-1.01e-01
|
2.36e-01
|
GOBP POSITIVE REGULATION OF PHAGOCYTOSIS
|
61
|
1.74e-01
|
-1.01e-01
|
3.37e-01
|
GOBP POSITIVE REGULATION OF MEIOTIC NUCLEAR DIVISION
|
13
|
5.30e-01
|
-1.01e-01
|
6.95e-01
|
GOBP POSITIVE REGULATION OF FAT CELL DIFFERENTIATION
|
63
|
1.68e-01
|
-1.01e-01
|
3.29e-01
|
GOCC COPII VESICLE COAT
|
15
|
5.00e-01
|
1.01e-01
|
6.71e-01
|
GOBP INTRINSIC APOPTOTIC SIGNALING PATHWAY
|
276
|
4.14e-03
|
-1.01e-01
|
2.16e-02
|
GOBP ANAGEN
|
10
|
5.82e-01
|
-1.00e-01
|
7.36e-01
|
GOBP POSITIVE REGULATION OF BONE MINERALIZATION
|
37
|
2.91e-01
|
-1.00e-01
|
4.74e-01
|
GOBP NOTOCHORD DEVELOPMENT
|
18
|
4.61e-01
|
-1.00e-01
|
6.37e-01
|
GOBP ERYTHROCYTE HOMEOSTASIS
|
146
|
3.66e-02
|
-1.00e-01
|
1.16e-01
|
GOBP REGULATION OF CATALYTIC ACTIVITY
|
1187
|
8.97e-09
|
-1.00e-01
|
2.59e-07
|
GOMF RIBOSOME BINDING
|
98
|
8.66e-02
|
1.00e-01
|
2.13e-01
|
GOCC CLATHRIN COAT
|
44
|
2.50e-01
|
-1.00e-01
|
4.32e-01
|
GOBP REGULATION OF PHAGOCYTOSIS
|
87
|
1.07e-01
|
-1.00e-01
|
2.45e-01
|
GOBP BONE TRABECULA FORMATION
|
10
|
5.84e-01
|
-1.00e-01
|
7.36e-01
|
GOMF INSULIN RECEPTOR SUBSTRATE BINDING
|
13
|
5.32e-01
|
-1.00e-01
|
6.97e-01
|
GOBP CELLULAR RESPONSE TO HORMONE STIMULUS
|
425
|
4.27e-04
|
-1.00e-01
|
3.40e-03
|
GOBP POSITIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY
|
89
|
1.03e-01
|
-1.00e-01
|
2.40e-01
|
GOMF SNARE BINDING
|
93
|
9.59e-02
|
-1.00e-01
|
2.28e-01
|
GOMF GTPASE ACTIVATOR ACTIVITY
|
217
|
1.13e-02
|
-1.00e-01
|
4.77e-02
|
GOBP REGULATION OF PROTEIN TARGETING
|
49
|
2.26e-01
|
1.00e-01
|
4.04e-01
|
GOBP CELL CELL JUNCTION ORGANIZATION
|
155
|
3.21e-02
|
-9.99e-02
|
1.05e-01
|
GOBP ANTIFUNGAL INNATE IMMUNE RESPONSE
|
15
|
5.03e-01
|
-9.99e-02
|
6.73e-01
|
GOBP ARACHIDONIC ACID SECRETION
|
15
|
5.03e-01
|
9.99e-02
|
6.73e-01
|
GOBP PROTEIN DENEDDYLATION
|
11
|
5.67e-01
|
9.98e-02
|
7.25e-01
|
GOBP HEPARAN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS
|
24
|
3.98e-01
|
9.98e-02
|
5.83e-01
|
GOMF HISTONE H3 METHYLTRANSFERASE ACTIVITY
|
37
|
2.94e-01
|
-9.97e-02
|
4.78e-01
|
GOBP RESPONSE TO CAMP
|
47
|
2.37e-01
|
-9.97e-02
|
4.17e-01
|
GOBP RESPONSE TO ETHANOL
|
43
|
2.59e-01
|
-9.95e-02
|
4.41e-01
|
GOBP REGULATION OF FAT CELL DIFFERENTIATION
|
124
|
5.61e-02
|
-9.95e-02
|
1.58e-01
|
GOBP PROTEIN LOCALIZATION TO CELL JUNCTION
|
114
|
6.69e-02
|
9.95e-02
|
1.78e-01
|
GOBP REGULATION OF BLOOD PRESSURE
|
145
|
3.90e-02
|
9.95e-02
|
1.21e-01
|
GOBP CELL MIGRATION INVOLVED IN HEART DEVELOPMENT
|
18
|
4.65e-01
|
-9.94e-02
|
6.42e-01
|
GOBP MICROVILLUS ORGANIZATION
|
20
|
4.42e-01
|
-9.94e-02
|
6.21e-01
|
GOBP WOUND HEALING
|
288
|
3.80e-03
|
-9.94e-02
|
2.01e-02
|
GOBP NEGATIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE PROTEIN KINASE B SIGNAL TRANSDUCTION
|
56
|
1.98e-01
|
-9.94e-02
|
3.69e-01
|
GOBP ENDOCYTOSIS
|
567
|
5.77e-05
|
-9.94e-02
|
6.29e-04
|
GOMF NUCLEAR RECEPTOR COACTIVATOR ACTIVITY
|
51
|
2.20e-01
|
-9.94e-02
|
3.96e-01
|
GOBP POSITIVE REGULATION OF AUTOPHAGOSOME ASSEMBLY
|
18
|
4.66e-01
|
-9.93e-02
|
6.42e-01
|
GOBP REGULATION OF EXOSOMAL SECRETION
|
16
|
4.92e-01
|
-9.93e-02
|
6.64e-01
|
GOBP NEGATIVE REGULATION OF CILIUM ASSEMBLY
|
20
|
4.42e-01
|
-9.93e-02
|
6.21e-01
|
GOBP REGULATION OF PIGMENTATION
|
13
|
5.35e-01
|
9.93e-02
|
7.00e-01
|
GOMF HYDROLASE ACTIVITY ACTING ON ESTER BONDS
|
576
|
5.16e-05
|
9.93e-02
|
5.70e-04
|
GOBP ANATOMICAL STRUCTURE HOMEOSTASIS
|
204
|
1.47e-02
|
-9.92e-02
|
5.85e-02
|
GOBP REGULATION OF GLUCOSE METABOLIC PROCESS
|
88
|
1.08e-01
|
9.92e-02
|
2.46e-01
|
GOMF CHROMATIN DNA BINDING
|
82
|
1.21e-01
|
-9.92e-02
|
2.64e-01
|
GOCC DESMOSOME
|
15
|
5.06e-01
|
-9.91e-02
|
6.76e-01
|
GOBP REGULATION OF MONOOXYGENASE ACTIVITY
|
23
|
4.11e-01
|
-9.91e-02
|
5.94e-01
|
GOBP SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION
|
385
|
8.91e-04
|
-9.90e-02
|
6.20e-03
|
GOBP ICOSANOID METABOLIC PROCESS
|
72
|
1.47e-01
|
9.89e-02
|
3.00e-01
|
GOBP REGULATION OF PROTEIN DEACETYLATION
|
29
|
3.57e-01
|
-9.89e-02
|
5.43e-01
|
GOBP HEAD DEVELOPMENT
|
550
|
8.17e-05
|
-9.88e-02
|
8.40e-04
|
GOBP RESPONSE TO L LEUCINE
|
11
|
5.71e-01
|
-9.87e-02
|
7.27e-01
|
GOBP DETECTION OF STIMULUS INVOLVED IN SENSORY PERCEPTION OF PAIN
|
25
|
3.93e-01
|
-9.87e-02
|
5.78e-01
|
GOBP ENDOPLASMIC RETICULUM TO GOLGI VESICLE MEDIATED TRANSPORT
|
116
|
6.66e-02
|
9.87e-02
|
1.77e-01
|
GOBP POSITIVE REGULATION OF COAGULATION
|
21
|
4.34e-01
|
-9.87e-02
|
6.13e-01
|
GOBP POSITIVE REGULATION OF LEUKOCYTE DEGRANULATION
|
19
|
4.57e-01
|
-9.86e-02
|
6.34e-01
|
GOMF DAMAGED DNA BINDING
|
63
|
1.77e-01
|
-9.85e-02
|
3.40e-01
|
GOBP L GLUTAMATE IMPORT
|
34
|
3.20e-01
|
9.85e-02
|
5.07e-01
|
GOMF DYNEIN INTERMEDIATE CHAIN BINDING
|
19
|
4.58e-01
|
9.84e-02
|
6.34e-01
|
GOBP CAMP METABOLIC PROCESS
|
12
|
5.55e-01
|
-9.83e-02
|
7.17e-01
|
GOBP CORPUS CALLOSUM DEVELOPMENT
|
25
|
3.95e-01
|
-9.83e-02
|
5.80e-01
|
GOMF ACETYLTRANSFERASE ACTIVITY
|
81
|
1.27e-01
|
9.83e-02
|
2.73e-01
|
GOBP ZYMOGEN ACTIVATION
|
39
|
2.88e-01
|
9.83e-02
|
4.72e-01
|
GOBP POSITIVE REGULATION OF ICOSANOID SECRETION
|
13
|
5.40e-01
|
-9.83e-02
|
7.04e-01
|
GOMF MOLECULAR SEQUESTERING ACTIVITY
|
43
|
2.65e-01
|
-9.82e-02
|
4.47e-01
|
GOMF RNA CAP BINDING
|
14
|
5.25e-01
|
-9.82e-02
|
6.91e-01
|
GOBP POSTSYNAPTIC MODULATION OF CHEMICAL SYNAPTIC TRANSMISSION
|
30
|
3.52e-01
|
-9.82e-02
|
5.39e-01
|
GOBP MULTICELLULAR ORGANISMAL LEVEL WATER HOMEOSTASIS
|
15
|
5.11e-01
|
9.81e-02
|
6.80e-01
|
GOBP UBIQUITIN RECYCLING
|
11
|
5.73e-01
|
9.81e-02
|
7.30e-01
|
GOBP REGULATION OF TELOMERE CAPPING
|
25
|
3.96e-01
|
-9.81e-02
|
5.81e-01
|
GOCC ENDOPLASMIC RETICULUM GOLGI INTERMEDIATE COMPARTMENT
|
68
|
1.63e-01
|
9.80e-02
|
3.22e-01
|
GOCC GLYCOPROTEIN COMPLEX
|
17
|
4.86e-01
|
-9.77e-02
|
6.59e-01
|
GOBP CENTRAL NERVOUS SYSTEM NEURON AXONOGENESIS
|
35
|
3.17e-01
|
-9.77e-02
|
5.04e-01
|
GOBP MIRNA MEDIATED GENE SILENCING BY INHIBITION OF TRANSLATION
|
16
|
4.99e-01
|
-9.77e-02
|
6.70e-01
|
GOMF BASAL TRANSCRIPTION MACHINERY BINDING
|
62
|
1.84e-01
|
-9.77e-02
|
3.49e-01
|
GOBP POSITIVE REGULATION OF REPRODUCTIVE PROCESS
|
57
|
2.03e-01
|
9.76e-02
|
3.74e-01
|
GOCC PRP19 COMPLEX
|
14
|
5.28e-01
|
-9.74e-02
|
6.94e-01
|
GOBP STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE
|
51
|
2.29e-01
|
-9.74e-02
|
4.07e-01
|
GOBP NEUROMUSCULAR PROCESS
|
148
|
4.11e-02
|
9.74e-02
|
1.25e-01
|
GOBP PROTEIN EXIT FROM ENDOPLASMIC RETICULUM
|
35
|
3.19e-01
|
9.74e-02
|
5.05e-01
|
GOBP MONOCARBOXYLIC ACID TRANSPORT
|
108
|
8.09e-02
|
9.73e-02
|
2.03e-01
|
GOBP PARENTAL BEHAVIOR
|
10
|
5.94e-01
|
-9.73e-02
|
7.43e-01
|
GOBP NEUTRAL AMINO ACID TRANSPORT
|
41
|
2.81e-01
|
9.73e-02
|
4.65e-01
|
GOBP EMBRYONIC CAMERA TYPE EYE DEVELOPMENT
|
30
|
3.57e-01
|
-9.72e-02
|
5.43e-01
|
GOBP MESENCHYMAL CELL MIGRATION
|
52
|
2.25e-01
|
-9.72e-02
|
4.03e-01
|
GOBP ANTEROGRADE DENDRITIC TRANSPORT
|
11
|
5.77e-01
|
-9.72e-02
|
7.32e-01
|
GOBP PROTEIN DEGLYCOSYLATION
|
13
|
5.44e-01
|
9.72e-02
|
7.08e-01
|
GOBP REGULATION OF PROTEIN IMPORT INTO NUCLEUS
|
69
|
1.63e-01
|
-9.71e-02
|
3.23e-01
|
GOBP ACTIN CROSSLINK FORMATION
|
13
|
5.44e-01
|
-9.71e-02
|
7.08e-01
|
GOBP PLACENTA DEVELOPMENT
|
133
|
5.35e-02
|
-9.71e-02
|
1.53e-01
|
GOBP POSITIVE REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY
|
23
|
4.20e-01
|
-9.71e-02
|
6.02e-01
|
GOBP REGULATION OF DNA BIOSYNTHETIC PROCESS
|
110
|
7.90e-02
|
-9.70e-02
|
2.00e-01
|
GOBP TISSUE MORPHOGENESIS
|
521
|
1.64e-04
|
-9.70e-02
|
1.53e-03
|
GOCC CYTOPLASMIC EXOSOME RNASE COMPLEX
|
15
|
5.16e-01
|
9.69e-02
|
6.85e-01
|
GOBP MITOCHONDRIAL FISSION
|
42
|
2.78e-01
|
9.69e-02
|
4.60e-01
|
GOBP NEGATIVE REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR
|
25
|
4.02e-01
|
-9.69e-02
|
5.88e-01
|
GOMF MICROTUBULE PLUS END BINDING
|
20
|
4.54e-01
|
-9.68e-02
|
6.31e-01
|
GOCC EUCHROMATIN
|
57
|
2.07e-01
|
-9.67e-02
|
3.80e-01
|
GOBP POSITIVE REGULATION OF EPITHELIAL CELL MIGRATION
|
146
|
4.40e-02
|
-9.67e-02
|
1.31e-01
|
GOMF CAMP BINDING
|
20
|
4.54e-01
|
9.67e-02
|
6.32e-01
|
GOMF ENDOPEPTIDASE REGULATOR ACTIVITY
|
94
|
1.06e-01
|
-9.67e-02
|
2.43e-01
|
GOBP RESPONSE TO SALT
|
16
|
5.04e-01
|
-9.66e-02
|
6.74e-01
|
GOBP ESTABLISHMENT OF PLANAR POLARITY INVOLVED IN NEURAL TUBE CLOSURE
|
14
|
5.31e-01
|
-9.66e-02
|
6.97e-01
|
GOMF PROTEASOME BINDING
|
18
|
4.79e-01
|
9.65e-02
|
6.52e-01
|
GOBP CARBOHYDRATE METABOLIC PROCESS
|
442
|
5.38e-04
|
9.64e-02
|
4.07e-03
|
GOCC ANAPHASE PROMOTING COMPLEX
|
20
|
4.55e-01
|
9.64e-02
|
6.33e-01
|
GOCC CUL3 RING UBIQUITIN LIGASE COMPLEX
|
38
|
3.04e-01
|
9.64e-02
|
4.89e-01
|
GOCC POSTSYNAPTIC ENDOSOME
|
25
|
4.05e-01
|
-9.63e-02
|
5.89e-01
|
GOBP ESTABLISHMENT OF ORGANELLE LOCALIZATION
|
392
|
1.12e-03
|
-9.63e-02
|
7.47e-03
|
GOCC AGGRESOME
|
26
|
3.96e-01
|
9.63e-02
|
5.81e-01
|
GOCC CYTOPLASMIC STRESS GRANULE
|
70
|
1.64e-01
|
-9.63e-02
|
3.24e-01
|
GOBP NEUROMUSCULAR JUNCTION DEVELOPMENT
|
58
|
2.06e-01
|
-9.62e-02
|
3.78e-01
|
GOMF GROWTH FACTOR BINDING
|
120
|
6.92e-02
|
-9.62e-02
|
1.82e-01
|
GOBP CELLULAR RESPONSE TO OXYGEN CONTAINING COMPOUND
|
860
|
2.09e-06
|
-9.61e-02
|
3.45e-05
|
GOMF CATALYTIC ACTIVITY ACTING ON A GLYCOPROTEIN
|
17
|
4.93e-01
|
-9.61e-02
|
6.65e-01
|
GOBP POSITIVE REGULATION OF WOUND HEALING
|
46
|
2.60e-01
|
-9.60e-02
|
4.41e-01
|
GOBP PROTEIN AUTOUBIQUITINATION
|
62
|
1.91e-01
|
-9.60e-02
|
3.59e-01
|
GOBP RESPONSE TO WOUNDING
|
402
|
1.00e-03
|
-9.60e-02
|
6.81e-03
|
GOBP POSITIVE REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR
|
13
|
5.49e-01
|
-9.59e-02
|
7.12e-01
|
GOBP REGULATION OF RESPONSE TO FOOD
|
11
|
5.82e-01
|
-9.59e-02
|
7.35e-01
|
GOBP POSITIVE REGULATION OF GLUTAMATE SECRETION
|
10
|
6.00e-01
|
9.59e-02
|
7.48e-01
|
GOBP KIDNEY EPITHELIUM DEVELOPMENT
|
119
|
7.18e-02
|
-9.57e-02
|
1.87e-01
|
GOBP REGULATION OF MUSCLE CONTRACTION
|
130
|
6.01e-02
|
9.56e-02
|
1.65e-01
|
GOBP SYNAPTIC VESICLE CYTOSKELETAL TRANSPORT
|
19
|
4.71e-01
|
9.56e-02
|
6.45e-01
|
GOBP NEGATIVE REGULATION OF CELLULAR CATABOLIC PROCESS
|
95
|
1.09e-01
|
9.54e-02
|
2.47e-01
|
GOBP INOSITOL PHOSPHATE METABOLIC PROCESS
|
32
|
3.51e-01
|
9.52e-02
|
5.38e-01
|
GOBP NUCLEAR BODY ORGANIZATION
|
15
|
5.23e-01
|
-9.52e-02
|
6.91e-01
|
GOBP POSITIVE REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY
|
17
|
4.97e-01
|
-9.52e-02
|
6.68e-01
|
GOMF G PROTEIN ACTIVITY
|
54
|
2.27e-01
|
-9.52e-02
|
4.04e-01
|
GOBP VESICLE CARGO LOADING
|
25
|
4.10e-01
|
9.52e-02
|
5.94e-01
|
GOBP MYOBLAST DIFFERENTIATION
|
96
|
1.07e-01
|
-9.52e-02
|
2.46e-01
|
GOCC PRESYNAPTIC ENDOCYTIC ZONE
|
17
|
4.97e-01
|
-9.51e-02
|
6.69e-01
|
GOBP ESTABLISHMENT OF SPINDLE ORIENTATION
|
35
|
3.30e-01
|
-9.51e-02
|
5.18e-01
|
GOBP REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY
|
122
|
7.01e-02
|
-9.51e-02
|
1.84e-01
|
GOMF THREONINE TYPE PEPTIDASE ACTIVITY
|
11
|
5.85e-01
|
9.50e-02
|
7.38e-01
|
GOBP REGULATION OF VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL
|
12
|
5.69e-01
|
9.50e-02
|
7.27e-01
|
GOBP CELL CELL JUNCTION ASSEMBLY
|
102
|
9.77e-02
|
-9.50e-02
|
2.31e-01
|
GOMF OXIDIZED DNA BINDING
|
11
|
5.86e-01
|
-9.50e-02
|
7.38e-01
|
GOBP PROTEIN LOCALIZATION TO CHROMOSOME TELOMERIC REGION
|
29
|
3.76e-01
|
-9.49e-02
|
5.62e-01
|
GOMF TBP CLASS PROTEIN BINDING
|
27
|
3.93e-01
|
9.49e-02
|
5.79e-01
|
GOCC REPLISOME
|
22
|
4.41e-01
|
-9.49e-02
|
6.20e-01
|
GOBP NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS
|
43
|
2.82e-01
|
9.49e-02
|
4.65e-01
|
GOBP CARDIAC MUSCLE CELL ACTION POTENTIAL INVOLVED IN CONTRACTION
|
38
|
3.12e-01
|
9.48e-02
|
4.97e-01
|
GOBP NEGATIVE REGULATION OF FIBROBLAST PROLIFERATION
|
40
|
3.00e-01
|
9.48e-02
|
4.84e-01
|
GOMF UBIQUITIN LIKE PROTEIN CONJUGATING ENZYME BINDING
|
36
|
3.26e-01
|
-9.47e-02
|
5.13e-01
|
GOBP REGULATION OF MONOCYTE CHEMOTAXIS
|
20
|
4.64e-01
|
-9.47e-02
|
6.40e-01
|
GOCC LEADING EDGE MEMBRANE
|
121
|
7.25e-02
|
-9.47e-02
|
1.88e-01
|
GOBP SPERM AXONEME ASSEMBLY
|
15
|
5.26e-01
|
9.46e-02
|
6.92e-01
|
GOBP REGULATION OF CELL SHAPE
|
126
|
6.69e-02
|
-9.46e-02
|
1.78e-01
|
GOCC STEREOCILIUM
|
33
|
3.47e-01
|
-9.46e-02
|
5.35e-01
|
GOCC SPERM PRINCIPAL PIECE
|
15
|
5.26e-01
|
9.46e-02
|
6.92e-01
|
GOCC EARLY ENDOSOME MEMBRANE
|
74
|
1.60e-01
|
-9.46e-02
|
3.19e-01
|
GOBP POST ANAL TAIL MORPHOGENESIS
|
20
|
4.64e-01
|
-9.45e-02
|
6.40e-01
|
GOBP PROLINE TRANSPORT
|
11
|
5.87e-01
|
9.45e-02
|
7.39e-01
|
GOBP PALLIUM DEVELOPMENT
|
130
|
6.31e-02
|
-9.45e-02
|
1.70e-01
|
GOBP NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS
|
55
|
2.26e-01
|
9.45e-02
|
4.03e-01
|
GOBP POSITIVE REGULATION BY SYMBIONT OF ENTRY INTO HOST
|
11
|
5.88e-01
|
-9.44e-02
|
7.39e-01
|
GOCC TERMINAL BOUTON
|
54
|
2.31e-01
|
9.43e-02
|
4.10e-01
|
GOMF PROTEIN TYROSINE PHOSPHATASE ACTIVITY
|
79
|
1.48e-01
|
-9.42e-02
|
3.01e-01
|
GOBP NEGATIVE REGULATION OF CALCIUM ION IMPORT
|
11
|
5.88e-01
|
-9.42e-02
|
7.40e-01
|
GOBP PYRIDINE CONTAINING COMPOUND CATABOLIC PROCESS
|
94
|
1.15e-01
|
9.42e-02
|
2.56e-01
|
GOBP MICROTUBULE DEPOLYMERIZATION
|
50
|
2.50e-01
|
-9.42e-02
|
4.31e-01
|
GOBP ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE
|
62
|
2.00e-01
|
-9.41e-02
|
3.70e-01
|
GOBP PYRAMIDAL NEURON DIFFERENTIATION
|
14
|
5.42e-01
|
-9.41e-02
|
7.06e-01
|
GOBP REGULATION OF BRANCHING INVOLVED IN URETERIC BUD MORPHOGENESIS
|
14
|
5.42e-01
|
9.41e-02
|
7.06e-01
|
GOCC CLATHRIN COATED PIT
|
67
|
1.83e-01
|
-9.40e-02
|
3.49e-01
|
GOBP POSITIVE REGULATION OF CALCINEURIN MEDIATED SIGNALING
|
19
|
4.78e-01
|
-9.40e-02
|
6.52e-01
|
GOMF S ACYLTRANSFERASE ACTIVITY
|
25
|
4.16e-01
|
9.40e-02
|
5.99e-01
|
GOBP NEURAL PRECURSOR CELL PROLIFERATION
|
163
|
3.88e-02
|
-9.40e-02
|
1.21e-01
|
GOBP ENDOSOME TO PLASMA MEMBRANE PROTEIN TRANSPORT
|
18
|
4.91e-01
|
9.39e-02
|
6.63e-01
|
GOBP NEGATIVE REGULATION OF NEUROINFLAMMATORY RESPONSE
|
10
|
6.07e-01
|
-9.38e-02
|
7.54e-01
|
GOMF EXTRACELLULAR LIGAND GATED MONOATOMIC ION CHANNEL ACTIVITY
|
22
|
4.47e-01
|
9.38e-02
|
6.25e-01
|
GOBP REGULATION OF PROTEIN AUTOPHOSPHORYLATION
|
37
|
3.24e-01
|
-9.38e-02
|
5.11e-01
|
GOBP ENDOSOME TO LYSOSOME TRANSPORT VIA MULTIVESICULAR BODY SORTING PATHWAY
|
16
|
5.17e-01
|
-9.37e-02
|
6.85e-01
|
GOBP UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS VIA THE C END DEGRON RULE PATHWAY
|
12
|
5.74e-01
|
9.36e-02
|
7.31e-01
|
GOBP EPITHELIAL TUBE MORPHOGENESIS
|
316
|
4.33e-03
|
-9.36e-02
|
2.22e-02
|
GOBP ORGANIC ACID TRANSPORT
|
233
|
1.40e-02
|
9.36e-02
|
5.61e-02
|
GOBP CELL PROJECTION MORPHOGENESIS
|
578
|
1.32e-04
|
-9.36e-02
|
1.26e-03
|
GOMF CALCIUM DEPENDENT PROTEIN KINASE ACTIVITY
|
11
|
5.91e-01
|
9.35e-02
|
7.41e-01
|
GOCC EXTRINSIC COMPONENT OF SYNAPTIC VESICLE MEMBRANE
|
20
|
4.70e-01
|
9.34e-02
|
6.44e-01
|
GOBP PROTEIN O LINKED GLYCOSYLATION
|
59
|
2.15e-01
|
-9.34e-02
|
3.90e-01
|
GOBP ANIMAL ORGAN MORPHOGENESIS
|
789
|
9.68e-06
|
-9.34e-02
|
1.31e-04
|
GOBP REGULATION OF PROTEIN LOCALIZATION TO ENDOSOME
|
15
|
5.32e-01
|
9.33e-02
|
6.97e-01
|
GOBP REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION
|
1377
|
1.07e-08
|
-9.32e-02
|
3.03e-07
|
GOBP MODULATION BY HOST OF SYMBIONT PROCESS
|
66
|
1.91e-01
|
-9.32e-02
|
3.58e-01
|
GOBP NEGATIVE REGULATION OF MACROAUTOPHAGY
|
33
|
3.55e-01
|
9.31e-02
|
5.42e-01
|
GOBP LABYRINTHINE LAYER MORPHOGENESIS
|
19
|
4.83e-01
|
-9.30e-02
|
6.56e-01
|
GOBP REGULATION OF CELL MORPHOGENESIS
|
238
|
1.38e-02
|
-9.29e-02
|
5.52e-02
|
GOBP NUCLEOSIDE DIPHOSPHATE METABOLIC PROCESS
|
115
|
8.56e-02
|
9.29e-02
|
2.11e-01
|
GOBP NEGATIVE REGULATION OF RESPONSE TO STIMULUS
|
1349
|
1.66e-08
|
-9.29e-02
|
4.44e-07
|
GOCC SWI SNF COMPLEX
|
25
|
4.22e-01
|
-9.29e-02
|
6.04e-01
|
GOMF PHOSPHATIDYLINOSITOL PHOSPHATE PHOSPHATASE ACTIVITY
|
24
|
4.31e-01
|
-9.28e-02
|
6.12e-01
|
GOBP GLUTAMINE METABOLIC PROCESS
|
22
|
4.51e-01
|
9.28e-02
|
6.29e-01
|
GOBP HEPATICOBILIARY SYSTEM DEVELOPMENT
|
117
|
8.34e-02
|
-9.28e-02
|
2.08e-01
|
GOBP AMYLOID BETA METABOLIC PROCESS
|
51
|
2.52e-01
|
9.28e-02
|
4.33e-01
|
GOBP ENDOTHELIN RECEPTOR SIGNALING PATHWAY
|
12
|
5.78e-01
|
-9.27e-02
|
7.33e-01
|
GOMF POTASSIUM CHANNEL INHIBITOR ACTIVITY
|
10
|
6.12e-01
|
-9.27e-02
|
7.57e-01
|
GOBP POSITIVE REGULATION OF RUFFLE ASSEMBLY
|
12
|
5.78e-01
|
9.27e-02
|
7.33e-01
|
GOBP PLACENTA BLOOD VESSEL DEVELOPMENT
|
30
|
3.80e-01
|
-9.26e-02
|
5.66e-01
|
GOBP NEGATIVE REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY
|
138
|
6.07e-02
|
-9.26e-02
|
1.66e-01
|
GOBP BLOOD VESSEL ENDOTHELIAL CELL DIFFERENTIATION
|
11
|
5.95e-01
|
-9.25e-02
|
7.44e-01
|
GOBP MALE GENITALIA DEVELOPMENT
|
14
|
5.49e-01
|
9.25e-02
|
7.12e-01
|
GOBP ADULT LOCOMOTORY BEHAVIOR
|
83
|
1.46e-01
|
9.24e-02
|
2.99e-01
|
GOBP CYCLIC NUCLEOTIDE METABOLIC PROCESS
|
24
|
4.34e-01
|
-9.24e-02
|
6.13e-01
|
GOBP DENDRITIC CELL MIGRATION
|
16
|
5.23e-01
|
9.23e-02
|
6.90e-01
|
GOBP ANTIMICROBIAL HUMORAL IMMUNE RESPONSE MEDIATED BY ANTIMICROBIAL PEPTIDE
|
39
|
3.19e-01
|
9.23e-02
|
5.05e-01
|
GOMF PROTEIN DISULFIDE ISOMERASE ACTIVITY
|
15
|
5.36e-01
|
9.23e-02
|
7.01e-01
|
GOMF CARBOHYDRATE DERIVATIVE TRANSMEMBRANE TRANSPORTER ACTIVITY
|
49
|
2.64e-01
|
9.22e-02
|
4.46e-01
|
GOMF ENZYME ACTIVATOR ACTIVITY
|
469
|
6.62e-04
|
-9.22e-02
|
4.82e-03
|
GOBP REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY
|
371
|
2.38e-03
|
-9.22e-02
|
1.38e-02
|
GOBP CELLULAR RESPONSE TO EXTERNAL STIMULUS
|
34
|
3.53e-01
|
-9.21e-02
|
5.39e-01
|
GOCC NUCLEAR PROTEIN CONTAINING COMPLEX
|
1107
|
3.20e-07
|
-9.21e-02
|
6.34e-06
|
GOBP REGULATION OF CELL CELL ADHESION MEDIATED BY CADHERIN
|
13
|
5.66e-01
|
-9.20e-02
|
7.25e-01
|
GOBP POSITIVE REGULATION OF DNA BIOSYNTHETIC PROCESS
|
72
|
1.78e-01
|
-9.20e-02
|
3.42e-01
|
GOBP REGULATION OF SMOOTH MUSCLE CONTRACTION
|
47
|
2.76e-01
|
-9.19e-02
|
4.58e-01
|
GOBP ENDOCARDIUM DEVELOPMENT
|
12
|
5.81e-01
|
-9.19e-02
|
7.35e-01
|
GOMF IONOTROPIC GLUTAMATE RECEPTOR BINDING
|
42
|
3.03e-01
|
-9.19e-02
|
4.87e-01
|
GOBP ACID SECRETION
|
27
|
4.09e-01
|
9.18e-02
|
5.93e-01
|
GOBP NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION
|
49
|
2.66e-01
|
-9.18e-02
|
4.48e-01
|
GOBP NEUROINFLAMMATORY RESPONSE
|
67
|
1.94e-01
|
-9.18e-02
|
3.63e-01
|
GOBP MYELOID CELL HOMEOSTASIS
|
183
|
3.25e-02
|
-9.18e-02
|
1.06e-01
|
GOMF NEUROPEPTIDE RECEPTOR BINDING
|
10
|
6.15e-01
|
-9.18e-02
|
7.60e-01
|
GOCC RNA CAP BINDING COMPLEX
|
12
|
5.82e-01
|
-9.18e-02
|
7.36e-01
|
GOBP PROTEIN LOCALIZATION TO NUCLEOLUS
|
13
|
5.67e-01
|
-9.17e-02
|
7.26e-01
|
GOCC POLYMERIC CYTOSKELETAL FIBER
|
529
|
3.33e-04
|
-9.17e-02
|
2.76e-03
|
GOBP GLUCOSE CATABOLIC PROCESS
|
23
|
4.47e-01
|
9.17e-02
|
6.25e-01
|
GOBP POSITIVE REGULATION OF PROTEIN METABOLIC PROCESS
|
1048
|
7.09e-07
|
-9.16e-02
|
1.29e-05
|
GOBP SEXUAL REPRODUCTION
|
619
|
1.11e-04
|
-9.16e-02
|
1.09e-03
|
GOBP PHENOL CONTAINING COMPOUND METABOLIC PROCESS
|
78
|
1.62e-01
|
9.16e-02
|
3.22e-01
|
GOCC NEURON PROJECTION MEMBRANE
|
44
|
2.94e-01
|
-9.15e-02
|
4.78e-01
|
GOMF PYRIMIDINE NUCLEOTIDE BINDING
|
10
|
6.17e-01
|
9.14e-02
|
7.61e-01
|
GOBP LOCOMOTORY BEHAVIOR
|
192
|
2.92e-02
|
9.14e-02
|
9.72e-02
|
GOBP SYNAPSE ORGANIZATION
|
485
|
6.01e-04
|
-9.14e-02
|
4.45e-03
|
GOBP REGULATION OF CELLULAR KETONE METABOLIC PROCESS
|
119
|
8.56e-02
|
9.14e-02
|
2.11e-01
|
GOCC PRECATALYTIC SPLICEOSOME
|
53
|
2.50e-01
|
9.13e-02
|
4.32e-01
|
GOBP LOW DENSITY LIPOPROTEIN PARTICLE CLEARANCE
|
17
|
5.15e-01
|
9.13e-02
|
6.84e-01
|
GOBP REGULATION OF GENERATION OF PRECURSOR METABOLITES AND ENERGY
|
135
|
6.74e-02
|
9.13e-02
|
1.78e-01
|
GOBP RESPONSE TO ENDOGENOUS STIMULUS
|
1172
|
1.99e-07
|
-9.12e-02
|
4.14e-06
|
GOMF RNA POLYMERASE II GENERAL TRANSCRIPTION INITIATION FACTOR BINDING
|
25
|
4.30e-01
|
-9.12e-02
|
6.11e-01
|
GOBP REGULATION OF PROTEIN ACETYLATION
|
21
|
4.69e-01
|
-9.12e-02
|
6.44e-01
|
GOBP REPLACEMENT OSSIFICATION
|
32
|
3.72e-01
|
-9.12e-02
|
5.58e-01
|
GOBP NEGATIVE REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION
|
46
|
2.85e-01
|
-9.11e-02
|
4.68e-01
|
GOBP NUCLEOBASE CONTAINING SMALL MOLECULE BIOSYNTHETIC PROCESS
|
13
|
5.70e-01
|
9.11e-02
|
7.27e-01
|
GOMF CYTOSKELETAL MOTOR ACTIVITY
|
76
|
1.71e-01
|
-9.09e-02
|
3.33e-01
|
GOBP POSITIVE REGULATION OF T CELL PROLIFERATION
|
68
|
1.96e-01
|
-9.07e-02
|
3.65e-01
|
GOBP ADENYLATE CYCLASE ACTIVATING ADRENERGIC RECEPTOR SIGNALING PATHWAY
|
19
|
4.94e-01
|
9.07e-02
|
6.66e-01
|
GOMF PROTEIN MACROMOLECULE ADAPTOR ACTIVITY
|
843
|
9.26e-06
|
-9.07e-02
|
1.27e-04
|
GOBP STEROID HORMONE MEDIATED SIGNALING PATHWAY
|
100
|
1.18e-01
|
-9.07e-02
|
2.60e-01
|
GOBP ESTABLISHMENT OF PROTEIN LOCALIZATION TO MEMBRANE
|
232
|
1.76e-02
|
9.06e-02
|
6.69e-02
|
GOMF HYDROLASE ACTIVITY ACTING ON CARBON NITROGEN BUT NOT PEPTIDE BONDS IN CYCLIC AMIDINES
|
23
|
4.52e-01
|
-9.06e-02
|
6.30e-01
|
GOBP POSITIVE REGULATION OF CILIUM ASSEMBLY
|
28
|
4.07e-01
|
-9.05e-02
|
5.91e-01
|
GOBP PROGRAMMED NECROTIC CELL DEATH
|
47
|
2.83e-01
|
-9.05e-02
|
4.66e-01
|
GOBP REGULATION OF RESPIRATORY GASEOUS EXCHANGE
|
15
|
5.44e-01
|
-9.05e-02
|
7.08e-01
|
GOBP BASEMENT MEMBRANE ASSEMBLY
|
12
|
5.87e-01
|
9.05e-02
|
7.39e-01
|
GOMF STEROL BINDING
|
54
|
2.50e-01
|
9.05e-02
|
4.32e-01
|
GOBP NEGATIVE REGULATION OF MAP KINASE ACTIVITY
|
45
|
2.94e-01
|
-9.04e-02
|
4.78e-01
|
GOMF HIGH DENSITY LIPOPROTEIN PARTICLE BINDING
|
10
|
6.21e-01
|
9.03e-02
|
7.64e-01
|
GOBP POSITIVE REGULATION OF AMINO ACID TRANSPORT
|
22
|
4.64e-01
|
9.01e-02
|
6.40e-01
|
GOBP RESPONSE TO GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR
|
10
|
6.22e-01
|
9.01e-02
|
7.65e-01
|
GOBP POSITIVE REGULATION BY HOST OF VIRAL GENOME REPLICATION
|
11
|
6.05e-01
|
-9.01e-02
|
7.52e-01
|
GOBP NEGATIVE REGULATION OF AUTOPHAGY
|
76
|
1.75e-01
|
9.00e-02
|
3.39e-01
|
GOCC SPERM MIDPIECE
|
26
|
4.27e-01
|
9.00e-02
|
6.08e-01
|
GOCC ENDOLYSOSOME
|
12
|
5.89e-01
|
9.00e-02
|
7.40e-01
|
GOBP NEGATIVE REGULATION OF MYOTUBE DIFFERENTIATION
|
15
|
5.46e-01
|
9.00e-02
|
7.09e-01
|
GOBP REGULATION OF ASTROCYTE DIFFERENTIATION
|
28
|
4.10e-01
|
-8.99e-02
|
5.94e-01
|
GOBP T CELL EXTRAVASATION
|
12
|
5.90e-01
|
-8.99e-02
|
7.40e-01
|
GOBP REPRODUCTIVE SYSTEM DEVELOPMENT
|
224
|
2.08e-02
|
-8.99e-02
|
7.58e-02
|
GOMF PROTEIN DISULFIDE REDUCTASE ACTIVITY
|
26
|
4.28e-01
|
8.98e-02
|
6.09e-01
|
GOBP NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE
|
35
|
3.58e-01
|
-8.98e-02
|
5.44e-01
|
GOBP REGULATION OF MEMBRANE LIPID METABOLIC PROCESS
|
17
|
5.22e-01
|
8.98e-02
|
6.89e-01
|
GOBP POSITIVE REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE
|
18
|
5.10e-01
|
8.97e-02
|
6.79e-01
|
GOBP MORPHOGENESIS OF AN EPITHELIUM
|
440
|
1.32e-03
|
-8.97e-02
|
8.52e-03
|
GOMF NUCLEOTIDE TRANSMEMBRANE TRANSPORTER ACTIVITY
|
27
|
4.20e-01
|
8.97e-02
|
6.02e-01
|
GOBP REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION
|
77
|
1.74e-01
|
-8.96e-02
|
3.37e-01
|
GOBP MEMBRANE PROTEIN PROTEOLYSIS
|
54
|
2.55e-01
|
-8.96e-02
|
4.36e-01
|
GOBP PHENOL CONTAINING COMPOUND BIOSYNTHETIC PROCESS
|
31
|
3.88e-01
|
8.96e-02
|
5.74e-01
|
GOBP POSITIVE REGULATION OF NATURAL KILLER CELL ACTIVATION
|
20
|
4.88e-01
|
-8.96e-02
|
6.61e-01
|
GOBP MYOBLAST PROLIFERATION
|
23
|
4.58e-01
|
-8.94e-02
|
6.34e-01
|
GOBP REGULATION OF HETEROTYPIC CELL CELL ADHESION
|
16
|
5.36e-01
|
-8.94e-02
|
7.01e-01
|
GOBP NUCLEOLAR LARGE RRNA TRANSCRIPTION BY RNA POLYMERASE I
|
20
|
4.89e-01
|
8.94e-02
|
6.62e-01
|
GOMF BIOACTIVE LIPID RECEPTOR ACTIVITY
|
10
|
6.25e-01
|
-8.94e-02
|
7.67e-01
|
GOCC CULLIN RING UBIQUITIN LIGASE COMPLEX
|
157
|
5.38e-02
|
8.93e-02
|
1.53e-01
|
GOBP NEUROTRANSMITTER RECEPTOR INTERNALIZATION
|
43
|
3.11e-01
|
-8.93e-02
|
4.97e-01
|
GOBP INTERLEUKIN 17 MEDIATED SIGNALING PATHWAY
|
10
|
6.25e-01
|
-8.93e-02
|
7.67e-01
|
GOBP PLASMA MEMBRANE ORGANIZATION
|
123
|
8.77e-02
|
-8.92e-02
|
2.15e-01
|
GOBP REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION
|
65
|
2.14e-01
|
-8.92e-02
|
3.89e-01
|
GOBP ONE CARBON METABOLIC PROCESS
|
33
|
3.76e-01
|
-8.90e-02
|
5.62e-01
|
GOBP GENOMIC IMPRINTING
|
26
|
4.32e-01
|
-8.90e-02
|
6.13e-01
|
GOBP DEVELOPMENT OF SECONDARY SEXUAL CHARACTERISTICS
|
10
|
6.26e-01
|
8.90e-02
|
7.68e-01
|
GOMF PASSIVE TRANSMEMBRANE TRANSPORTER ACTIVITY
|
250
|
1.57e-02
|
8.90e-02
|
6.14e-02
|
GOBP POSTSYNAPSE ORGANIZATION
|
232
|
2.00e-02
|
-8.89e-02
|
7.37e-02
|
GOBP ADENYLATE CYCLASE ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY
|
94
|
1.37e-01
|
-8.89e-02
|
2.86e-01
|
GOBP REGULATION OF CILIUM ASSEMBLY
|
64
|
2.19e-01
|
-8.89e-02
|
3.95e-01
|
GOBP NEGATIVE REGULATION OF NEURON PROJECTION DEVELOPMENT
|
130
|
8.06e-02
|
-8.89e-02
|
2.03e-01
|
GOMF GLYCOSYLTRANSFERASE ACTIVITY
|
193
|
3.37e-02
|
-8.88e-02
|
1.09e-01
|
GOBP REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE
|
78
|
1.76e-01
|
8.88e-02
|
3.39e-01
|
GOBP NEGATIVE REGULATION OF TRANSLATIONAL INITIATION
|
18
|
5.14e-01
|
-8.88e-02
|
6.84e-01
|
GOMF INTERLEUKIN 1 RECEPTOR BINDING
|
10
|
6.27e-01
|
8.87e-02
|
7.68e-01
|
GOBP NEURAL CREST CELL DIFFERENTIATION
|
79
|
1.73e-01
|
-8.87e-02
|
3.36e-01
|
GOBP APOPTOTIC PROCESS INVOLVED IN MORPHOGENESIS
|
23
|
4.62e-01
|
-8.87e-02
|
6.38e-01
|
GOBP NEGATIVE REGULATION OF LIPID STORAGE
|
20
|
4.93e-01
|
8.87e-02
|
6.65e-01
|
GOBP MORPHOGENESIS OF A BRANCHING STRUCTURE
|
193
|
3.41e-02
|
-8.86e-02
|
1.10e-01
|
GOBP EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT
|
34
|
3.71e-01
|
-8.86e-02
|
5.58e-01
|
GOBP REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS
|
76
|
1.82e-01
|
8.86e-02
|
3.47e-01
|
GOBP RESPONSE TO TUMOR CELL
|
28
|
4.18e-01
|
-8.85e-02
|
6.00e-01
|
GOMF HISTONE H4 METHYLTRANSFERASE ACTIVITY
|
11
|
6.11e-01
|
-8.85e-02
|
7.57e-01
|
GOBP RRNA METABOLIC PROCESS
|
220
|
2.40e-02
|
8.85e-02
|
8.42e-02
|
GOBP NEGATIVE REGULATION OF HUMORAL IMMUNE RESPONSE
|
13
|
5.81e-01
|
-8.85e-02
|
7.35e-01
|
GOMF DNA EXONUCLEASE ACTIVITY
|
20
|
4.94e-01
|
-8.84e-02
|
6.66e-01
|
GOBP REGULATION OF NUCLEOTIDE EXCISION REPAIR
|
27
|
4.27e-01
|
-8.84e-02
|
6.08e-01
|
GOBP METANEPHRIC NEPHRON EPITHELIUM DEVELOPMENT
|
14
|
5.67e-01
|
-8.84e-02
|
7.25e-01
|
GOBP MATURATION OF SSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA
|
31
|
3.95e-01
|
8.84e-02
|
5.80e-01
|
GOBP ESTABLISHMENT OF PLANAR POLARITY OF EMBRYONIC EPITHELIUM
|
15
|
5.54e-01
|
-8.83e-02
|
7.16e-01
|
GOBP REGULATION OF BLOOD CIRCULATION
|
218
|
2.51e-02
|
8.82e-02
|
8.74e-02
|
GOBP REGULATION OF HYDROLASE ACTIVITY
|
613
|
2.10e-04
|
-8.82e-02
|
1.89e-03
|
GOBP POLARIZED EPITHELIAL CELL DIFFERENTIATION
|
20
|
4.95e-01
|
-8.82e-02
|
6.67e-01
|
GOBP NEGATIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION
|
34
|
3.74e-01
|
-8.81e-02
|
5.60e-01
|
GOCC ROUGH ENDOPLASMIC RETICULUM MEMBRANE
|
15
|
5.55e-01
|
-8.80e-02
|
7.17e-01
|
GOBP CARBOHYDRATE CATABOLIC PROCESS
|
144
|
6.89e-02
|
8.79e-02
|
1.81e-01
|
GOMF GTPASE ACTIVATING PROTEIN BINDING
|
18
|
5.19e-01
|
8.79e-02
|
6.87e-01
|
GOBP POSITIVE REGULATION OF LYASE ACTIVITY
|
22
|
4.76e-01
|
8.78e-02
|
6.50e-01
|
GOMF DEMETHYLASE ACTIVITY
|
34
|
3.76e-01
|
-8.78e-02
|
5.62e-01
|
GOBP NEGATIVE REGULATION OF PHOSPHATASE ACTIVITY
|
20
|
4.97e-01
|
-8.78e-02
|
6.68e-01
|
GOBP REGULATION OF B CELL ACTIVATION
|
109
|
1.14e-01
|
-8.77e-02
|
2.55e-01
|
GOCC U12 TYPE SPLICEOSOMAL COMPLEX
|
26
|
4.39e-01
|
8.76e-02
|
6.19e-01
|
GOBP REGULATION OF BMP SIGNALING PATHWAY
|
73
|
1.96e-01
|
-8.76e-02
|
3.65e-01
|
GOBP SOMATIC DIVERSIFICATION OF IMMUNE RECEPTORS
|
58
|
2.49e-01
|
-8.76e-02
|
4.31e-01
|
GOBP POSITIVE REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING
|
39
|
3.44e-01
|
-8.75e-02
|
5.33e-01
|
GOMF ACTIN MONOMER BINDING
|
20
|
4.99e-01
|
-8.74e-02
|
6.70e-01
|
GOBP POLYOL BIOSYNTHETIC PROCESS
|
48
|
2.95e-01
|
8.74e-02
|
4.79e-01
|
GOBP REGULATION OF CELLULAR RESPONSE TO OXIDATIVE STRESS
|
23
|
4.68e-01
|
8.74e-02
|
6.44e-01
|
GOBP ADIPOSE TISSUE DEVELOPMENT
|
55
|
2.63e-01
|
-8.74e-02
|
4.44e-01
|
GOBP REGULATION OF INSULIN RECEPTOR SIGNALING PATHWAY
|
72
|
2.00e-01
|
-8.73e-02
|
3.70e-01
|
GOBP POSITIVE REGULATION OF AUTOPHAGY OF MITOCHONDRION
|
13
|
5.86e-01
|
-8.73e-02
|
7.38e-01
|
GOBP MRNA METHYLGUANOSINE CAP DECAPPING
|
15
|
5.59e-01
|
-8.73e-02
|
7.19e-01
|
GOBP POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS
|
1341
|
1.27e-07
|
-8.72e-02
|
2.81e-06
|
GOBP REGULATION OF COMPLEMENT ACTIVATION
|
15
|
5.59e-01
|
-8.71e-02
|
7.19e-01
|
GOBP CERAMIDE BIOSYNTHETIC PROCESS
|
47
|
3.02e-01
|
-8.70e-02
|
4.87e-01
|
GOBP GLAND DEVELOPMENT
|
337
|
6.28e-03
|
-8.69e-02
|
2.98e-02
|
GOBP TELOMERE CAPPING
|
35
|
3.74e-01
|
-8.69e-02
|
5.60e-01
|
GOBP RENAL SYSTEM PROCESS
|
89
|
1.57e-01
|
8.68e-02
|
3.15e-01
|
GOBP GLOMERULAR EPITHELIUM DEVELOPMENT
|
20
|
5.02e-01
|
-8.68e-02
|
6.73e-01
|
GOMF CALCIUM DEPENDENT PROTEIN BINDING
|
63
|
2.34e-01
|
-8.67e-02
|
4.14e-01
|
GOBP RESPONSE TO DIETARY EXCESS
|
28
|
4.27e-01
|
-8.67e-02
|
6.08e-01
|
GOBP REGULATION OF AMYLOID BETA FORMATION
|
33
|
3.89e-01
|
8.67e-02
|
5.75e-01
|
GOBP PURINERGIC NUCLEOTIDE RECEPTOR SIGNALING PATHWAY
|
11
|
6.19e-01
|
-8.67e-02
|
7.63e-01
|
GOBP INTRACILIARY TRANSPORT
|
38
|
3.56e-01
|
-8.65e-02
|
5.43e-01
|
GOMF METALLOCARBOXYPEPTIDASE ACTIVITY
|
16
|
5.49e-01
|
-8.65e-02
|
7.12e-01
|
GOBP MONOATOMIC CATION TRANSPORT
|
657
|
1.74e-04
|
8.64e-02
|
1.60e-03
|
GOBP POSITIVE REGULATION OF PROTEIN BINDING
|
72
|
2.05e-01
|
-8.64e-02
|
3.78e-01
|
GOCC SYNAPTIC VESICLE MEMBRANE
|
112
|
1.15e-01
|
8.64e-02
|
2.56e-01
|
GOMF CYTOSKELETAL PROTEIN BINDING
|
837
|
2.57e-05
|
-8.64e-02
|
3.13e-04
|
GOBP MEMORY
|
127
|
9.35e-02
|
8.63e-02
|
2.24e-01
|
GOBP PRIMARY NEURAL TUBE FORMATION
|
105
|
1.27e-01
|
-8.63e-02
|
2.73e-01
|
GOCC ORGANELLE MEMBRANE CONTACT SITE
|
36
|
3.71e-01
|
-8.62e-02
|
5.57e-01
|
GOMF NUCLEOSOME BINDING
|
35
|
3.78e-01
|
-8.61e-02
|
5.64e-01
|
GOBP CELLULAR RESPONSE TO RADIATION
|
139
|
8.02e-02
|
-8.61e-02
|
2.02e-01
|
GOCC SITE OF POLARIZED GROWTH
|
184
|
4.45e-02
|
-8.60e-02
|
1.33e-01
|
GOCC SMALL SUBUNIT PROCESSOME
|
68
|
2.20e-01
|
8.60e-02
|
3.97e-01
|
GOMF MDM2 MDM4 FAMILY PROTEIN BINDING
|
11
|
6.21e-01
|
8.60e-02
|
7.64e-01
|
GOBP HEART TRABECULA MORPHOGENESIS
|
33
|
3.93e-01
|
-8.59e-02
|
5.78e-01
|
GOMF SIGNALING RECEPTOR INHIBITOR ACTIVITY
|
16
|
5.52e-01
|
-8.59e-02
|
7.14e-01
|
GOBP MESENCHYMAL TO EPITHELIAL TRANSITION
|
10
|
6.38e-01
|
8.59e-02
|
7.77e-01
|
GOBP PROTEIN ACETYLATION
|
51
|
2.89e-01
|
-8.58e-02
|
4.73e-01
|
GOBP NEGATIVE REGULATION OF TRANSCRIPTION ELONGATION BY RNA POLYMERASE II
|
14
|
5.78e-01
|
-8.58e-02
|
7.33e-01
|
GOBP REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION
|
94
|
1.51e-01
|
-8.58e-02
|
3.05e-01
|
GOBP REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY
|
38
|
3.60e-01
|
8.58e-02
|
5.47e-01
|
GOBP REGULATION OF LIPID TRANSPORT
|
104
|
1.31e-01
|
8.58e-02
|
2.78e-01
|
GOMF NUCLEOTIDE SUGAR TRANSMEMBRANE TRANSPORTER ACTIVITY
|
13
|
5.92e-01
|
-8.58e-02
|
7.42e-01
|
GOBP TUBE FORMATION
|
148
|
7.22e-02
|
-8.57e-02
|
1.88e-01
|
GOBP NEGATIVE REGULATION OF BINDING
|
110
|
1.21e-01
|
-8.57e-02
|
2.65e-01
|
GOBP DE NOVO PROTEIN FOLDING
|
35
|
3.81e-01
|
8.57e-02
|
5.67e-01
|
GOBP NEGATIVE REGULATION OF T CELL APOPTOTIC PROCESS
|
20
|
5.07e-01
|
-8.57e-02
|
6.77e-01
|
GOMF KINASE ACTIVITY
|
594
|
3.94e-04
|
-8.56e-02
|
3.19e-03
|
GOBP NUCLEOPHAGY
|
23
|
4.77e-01
|
8.56e-02
|
6.51e-01
|
GOBP EPHRIN RECEPTOR SIGNALING PATHWAY
|
32
|
4.02e-01
|
-8.56e-02
|
5.88e-01
|
GOCC NUCLEOTIDE EXCISION REPAIR COMPLEX
|
13
|
5.93e-01
|
-8.56e-02
|
7.42e-01
|
GOCC CHROMOSOME TELOMERIC REPEAT REGION
|
10
|
6.40e-01
|
-8.55e-02
|
7.78e-01
|
GOCC ACTIN BASED CELL PROJECTION
|
164
|
5.94e-02
|
-8.55e-02
|
1.64e-01
|
GOBP NEURON REMODELING
|
15
|
5.67e-01
|
8.54e-02
|
7.25e-01
|
GOBP POSITIVE REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE
|
103
|
1.35e-01
|
-8.54e-02
|
2.83e-01
|
GOMF MANGANESE ION BINDING
|
53
|
2.83e-01
|
8.54e-02
|
4.66e-01
|
GOBP REGULATION OF DENDRITE MORPHOGENESIS
|
82
|
1.82e-01
|
-8.54e-02
|
3.47e-01
|
GOBP POST TRANSLATIONAL PROTEIN MODIFICATION
|
745
|
8.35e-05
|
-8.53e-02
|
8.57e-04
|
GOCC EXTRINSIC COMPONENT OF SYNAPTIC MEMBRANE
|
23
|
4.79e-01
|
-8.52e-02
|
6.53e-01
|
GOBP MITOCHONDRIAL DNA REPLICATION
|
16
|
5.56e-01
|
8.51e-02
|
7.17e-01
|
GOBP PROGESTERONE RECEPTOR SIGNALING PATHWAY
|
10
|
6.41e-01
|
-8.51e-02
|
7.79e-01
|
GOBP PROTEIN CONTAINING COMPLEX DISASSEMBLY
|
228
|
2.73e-02
|
-8.51e-02
|
9.28e-02
|
GOBP REGULATION OF NEURON MATURATION
|
15
|
5.69e-01
|
8.50e-02
|
7.27e-01
|
GOBP NOTCH SIGNALING PATHWAY
|
153
|
7.02e-02
|
-8.49e-02
|
1.84e-01
|
GOCC MICROTUBULE ASSOCIATED COMPLEX
|
105
|
1.33e-01
|
-8.49e-02
|
2.81e-01
|
GOBP ASTROCYTE DEVELOPMENT
|
31
|
4.14e-01
|
-8.49e-02
|
5.97e-01
|
GOBP NEGATIVE REGULATION OF MITOCHONDRIAL MEMBRANE POTENTIAL
|
10
|
6.42e-01
|
8.48e-02
|
7.80e-01
|
GOCC HISTONE METHYLTRANSFERASE COMPLEX
|
64
|
2.41e-01
|
-8.48e-02
|
4.21e-01
|
GOCC NEURONAL DENSE CORE VESICLE
|
22
|
4.92e-01
|
-8.47e-02
|
6.64e-01
|
GOBP NUCLEOBASE CONTAINING SMALL MOLECULE CATABOLIC PROCESS
|
19
|
5.23e-01
|
8.47e-02
|
6.90e-01
|
GOBP REGULATION OF PROTEIN BINDING
|
162
|
6.35e-02
|
-8.46e-02
|
1.71e-01
|
GOBP REGULATION OF MRNA SPLICING VIA SPLICEOSOME
|
93
|
1.59e-01
|
-8.46e-02
|
3.17e-01
|
GOBP REGULATION OF POLYSACCHARIDE BIOSYNTHETIC PROCESS
|
38
|
3.67e-01
|
-8.46e-02
|
5.54e-01
|
GOBP REGULATION OF CARBOHYDRATE METABOLIC PROCESS
|
165
|
6.14e-02
|
8.45e-02
|
1.67e-01
|
GOCC CELL TIP
|
11
|
6.27e-01
|
-8.45e-02
|
7.68e-01
|
GOMF NUCLEAR IMPORT SIGNAL RECEPTOR ACTIVITY
|
16
|
5.58e-01
|
-8.45e-02
|
7.19e-01
|
GOBP MUSCLE HYPERTROPHY
|
108
|
1.30e-01
|
-8.45e-02
|
2.77e-01
|
GOBP MICROAUTOPHAGY
|
23
|
4.83e-01
|
8.45e-02
|
6.56e-01
|
GOBP CELLULAR RESPONSE TO ORGANIC CYCLIC COMPOUND
|
371
|
5.36e-03
|
-8.45e-02
|
2.63e-02
|
GOBP BRANCHING INVOLVED IN MAMMARY GLAND DUCT MORPHOGENESIS
|
24
|
4.74e-01
|
-8.44e-02
|
6.48e-01
|
GOCC RECYCLING ENDOSOME
|
135
|
9.09e-02
|
8.44e-02
|
2.20e-01
|
GOBP CYTOSOLIC RIBOSOME ASSEMBLY
|
10
|
6.44e-01
|
8.44e-02
|
7.81e-01
|
GOBP NEUROTROPHIN TRK RECEPTOR SIGNALING PATHWAY
|
31
|
4.16e-01
|
8.44e-02
|
5.99e-01
|
GOBP GENERATION OF NEURONS
|
1238
|
8.59e-07
|
-8.42e-02
|
1.53e-05
|
GOMF PHOSPHATASE ACTIVATOR ACTIVITY
|
13
|
6.00e-01
|
8.41e-02
|
7.48e-01
|
GOBP IMMUNOGLOBULIN PRODUCTION
|
90
|
1.68e-01
|
-8.41e-02
|
3.30e-01
|
GOBP POSITIVE REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION
|
114
|
1.21e-01
|
-8.41e-02
|
2.65e-01
|
GOBP NEGATIVE REGULATION OF LIPID LOCALIZATION
|
41
|
3.52e-01
|
8.40e-02
|
5.39e-01
|
GOBP REGULATION OF NATURAL KILLER CELL ACTIVATION
|
29
|
4.34e-01
|
-8.40e-02
|
6.13e-01
|
GOMF G RICH STRAND TELOMERIC DNA BINDING
|
11
|
6.30e-01
|
-8.40e-02
|
7.70e-01
|
GOBP NUCLEOSIDE DIPHOSPHATE CATABOLIC PROCESS
|
99
|
1.49e-01
|
8.39e-02
|
3.04e-01
|
GOBP GLYCOSYL COMPOUND CATABOLIC PROCESS
|
23
|
4.86e-01
|
8.39e-02
|
6.59e-01
|
GOBP RADIAL GLIAL CELL DIFFERENTIATION
|
13
|
6.00e-01
|
8.39e-02
|
7.48e-01
|
GOBP ORGANELLE LOCALIZATION
|
508
|
1.29e-03
|
-8.39e-02
|
8.37e-03
|
GOMF HYDROLASE ACTIVITY ACTING ON CARBON NITROGEN BUT NOT PEPTIDE BONDS
|
101
|
1.46e-01
|
8.38e-02
|
2.99e-01
|
GOBP POSITIVE REGULATION OF ERK1 AND ERK2 CASCADE
|
151
|
7.62e-02
|
-8.37e-02
|
1.95e-01
|
GOBP REGULATION OF INFLAMMATORY RESPONSE
|
253
|
2.22e-02
|
-8.37e-02
|
7.98e-02
|
GOMF ENDODEOXYRIBONUCLEASE ACTIVITY PRODUCING 5 PHOSPHOMONOESTERS
|
11
|
6.31e-01
|
-8.36e-02
|
7.71e-01
|
GOBP NUCLEOBASE CONTAINING COMPOUND TRANSPORT
|
176
|
5.61e-02
|
-8.36e-02
|
1.58e-01
|
GOMF OXIDOREDUCTASE ACTIVITY ACTING ON OTHER NITROGENOUS COMPOUNDS AS DONORS
|
11
|
6.31e-01
|
8.36e-02
|
7.71e-01
|
GOCC EXTRACELLULAR EXOSOME
|
70
|
2.27e-01
|
-8.36e-02
|
4.04e-01
|
GOCC ACTIN CYTOSKELETON
|
426
|
3.23e-03
|
-8.36e-02
|
1.75e-02
|
GOBP REGULATION OF APOPTOTIC SIGNALING PATHWAY
|
359
|
6.77e-03
|
-8.35e-02
|
3.17e-02
|
GOBP WOUND HEALING SPREADING OF EPIDERMAL CELLS
|
15
|
5.76e-01
|
8.35e-02
|
7.32e-01
|
GOBP NEGATIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS
|
350
|
7.51e-03
|
-8.35e-02
|
3.43e-02
|
GOBP OLIGOSACCHARIDE METABOLIC PROCESS
|
36
|
3.86e-01
|
8.35e-02
|
5.72e-01
|
GOMF PROTEIN FOLDING CHAPERONE BINDING
|
129
|
1.02e-01
|
8.34e-02
|
2.38e-01
|
GOBP CARBOHYDRATE BIOSYNTHETIC PROCESS
|
164
|
6.57e-02
|
8.34e-02
|
1.75e-01
|
GOBP POSITIVE REGULATION OF EMBRYONIC DEVELOPMENT
|
13
|
6.03e-01
|
8.34e-02
|
7.50e-01
|
GOBP INHIBITORY POSTSYNAPTIC POTENTIAL
|
15
|
5.76e-01
|
8.34e-02
|
7.32e-01
|
GOBP DEOXYRIBONUCLEOSIDE METABOLIC PROCESS
|
11
|
6.32e-01
|
-8.34e-02
|
7.72e-01
|
GOBP NEURON DEVELOPMENT
|
996
|
1.05e-05
|
-8.34e-02
|
1.40e-04
|
GOBP RETROGRADE TRANS SYNAPTIC SIGNALING
|
11
|
6.32e-01
|
8.33e-02
|
7.72e-01
|
GOBP REGULATION OF ATP DEPENDENT ACTIVITY
|
54
|
2.90e-01
|
8.33e-02
|
4.73e-01
|
GOCC EXTRACELLULAR ORGANELLE
|
89
|
1.75e-01
|
-8.32e-02
|
3.39e-01
|
GOBP GLYCOSIDE METABOLIC PROCESS
|
13
|
6.04e-01
|
8.31e-02
|
7.51e-01
|
GOBP REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS
|
40
|
3.63e-01
|
8.31e-02
|
5.50e-01
|
GOBP REGULATION OF DEPHOSPHORYLATION
|
94
|
1.65e-01
|
-8.30e-02
|
3.25e-01
|
GOBP THYMUS DEVELOPMENT
|
43
|
3.47e-01
|
-8.29e-02
|
5.35e-01
|
GOBP REGULATION OF VESICLE FUSION
|
20
|
5.21e-01
|
-8.29e-02
|
6.89e-01
|
GOMF NF KAPPAB BINDING
|
31
|
4.25e-01
|
8.28e-02
|
6.07e-01
|
GOCC APICAL JUNCTION COMPLEX
|
106
|
1.41e-01
|
-8.28e-02
|
2.93e-01
|
GOBP NEGATIVE REGULATION OF ENDOPEPTIDASE ACTIVITY
|
89
|
1.78e-01
|
-8.27e-02
|
3.43e-01
|
GOMF JUN KINASE BINDING
|
16
|
5.67e-01
|
-8.26e-02
|
7.26e-01
|
GOMF PHOSPHATASE ACTIVITY
|
213
|
3.84e-02
|
8.25e-02
|
1.20e-01
|
GOBP LIVER REGENERATION
|
12
|
6.21e-01
|
-8.25e-02
|
7.64e-01
|
GOBP POSTSYNAPSE ASSEMBLY
|
65
|
2.51e-01
|
-8.24e-02
|
4.32e-01
|
GOBP REGULATION OF ENDOCYTOSIS
|
271
|
2.01e-02
|
-8.22e-02
|
7.42e-02
|
GOBP RNA SURVEILLANCE
|
17
|
5.57e-01
|
-8.22e-02
|
7.18e-01
|
GOBP NEGATIVE REGULATION OF BMP SIGNALING PATHWAY
|
40
|
3.68e-01
|
-8.22e-02
|
5.55e-01
|
GOBP VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL
|
26
|
4.68e-01
|
8.22e-02
|
6.44e-01
|
GOMF S ADENOSYLMETHIONINE DEPENDENT METHYLTRANSFERASE ACTIVITY
|
126
|
1.12e-01
|
8.21e-02
|
2.52e-01
|
GOBP POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY
|
65
|
2.53e-01
|
-8.21e-02
|
4.34e-01
|
GOBP POSITIVE REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS
|
22
|
5.05e-01
|
-8.21e-02
|
6.75e-01
|
GOBP LATE ENDOSOME TO LYSOSOME TRANSPORT
|
18
|
5.47e-01
|
-8.21e-02
|
7.10e-01
|
GOBP PROGRAMMED CELL DEATH INVOLVED IN CELL DEVELOPMENT
|
20
|
5.26e-01
|
-8.20e-02
|
6.92e-01
|
GOBP POSITIVE REGULATION OF TORC1 SIGNALING
|
48
|
3.26e-01
|
8.20e-02
|
5.13e-01
|
GOBP ACTIN FILAMENT BASED PROCESS
|
682
|
2.89e-04
|
-8.20e-02
|
2.48e-03
|
GOBP RESPONSE TO TEMPERATURE STIMULUS
|
125
|
1.14e-01
|
8.20e-02
|
2.55e-01
|
GOCC SYNAPTIC CLEFT
|
14
|
5.96e-01
|
-8.19e-02
|
7.44e-01
|
GOBP NEGATIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY
|
65
|
2.54e-01
|
-8.18e-02
|
4.35e-01
|
GOMF PROTEIN SERINE THREONINE TYROSINE KINASE ACTIVITY
|
35
|
4.04e-01
|
8.16e-02
|
5.88e-01
|
GOCC NUCLEAR PORE NUCLEAR BASKET
|
12
|
6.25e-01
|
-8.16e-02
|
7.67e-01
|
GOBP REGULATION OF FIBROBLAST PROLIFERATION
|
106
|
1.47e-01
|
-8.16e-02
|
3.00e-01
|
GOBP PHOSPHATE ION TRANSPORT
|
19
|
5.38e-01
|
8.16e-02
|
7.03e-01
|
GOBP REGULATION OF PROTEIN DEPHOSPHORYLATION
|
69
|
2.42e-01
|
-8.16e-02
|
4.21e-01
|
GOBP NUCLEAR RNA SURVEILLANCE
|
14
|
5.97e-01
|
-8.16e-02
|
7.46e-01
|
GOBP INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS
|
38
|
3.85e-01
|
-8.16e-02
|
5.70e-01
|
GOBP VACUOLAR TRANSPORT
|
147
|
8.85e-02
|
-8.15e-02
|
2.17e-01
|
GOCC RNA POLYMERASE II TRANSCRIPTION REPRESSOR COMPLEX
|
18
|
5.50e-01
|
-8.14e-02
|
7.12e-01
|
GOBP PROTEIN LOCALIZATION TO LYSOSOME
|
46
|
3.40e-01
|
-8.14e-02
|
5.28e-01
|
GOMF MONOATOMIC ANION TRANSMEMBRANE TRANSPORTER ACTIVITY
|
84
|
1.98e-01
|
8.14e-02
|
3.68e-01
|
GOBP CELLULAR RESPONSE TO IONIZING RADIATION
|
64
|
2.61e-01
|
-8.13e-02
|
4.42e-01
|
GOBP NUCLEAR ENVELOPE ORGANIZATION
|
51
|
3.15e-01
|
-8.13e-02
|
5.02e-01
|
GOMF CCR CHEMOKINE RECEPTOR BINDING
|
19
|
5.40e-01
|
8.13e-02
|
7.04e-01
|
GOBP NEUROGENESIS
|
1448
|
3.46e-07
|
-8.13e-02
|
6.82e-06
|
GOBP REGULATION OF VESICLE MEDIATED TRANSPORT
|
461
|
2.92e-03
|
-8.12e-02
|
1.62e-02
|
GOBP HISTONE MRNA METABOLIC PROCESS
|
17
|
5.62e-01
|
-8.12e-02
|
7.21e-01
|
GOCC ASYMMETRIC GLUTAMATERGIC EXCITATORY SYNAPSE
|
12
|
6.26e-01
|
-8.12e-02
|
7.68e-01
|
GOBP ADRENERGIC RECEPTOR SIGNALING PATHWAY
|
25
|
4.82e-01
|
8.12e-02
|
6.56e-01
|
GOBP POSITIVE REGULATION OF P38MAPK CASCADE
|
25
|
4.82e-01
|
-8.12e-02
|
6.56e-01
|
GOCC INTRACILIARY TRANSPORT PARTICLE B
|
16
|
5.74e-01
|
-8.12e-02
|
7.30e-01
|
GOBP MATURATION OF LSU RRNA
|
25
|
4.82e-01
|
8.12e-02
|
6.56e-01
|
GOBP POSTSYNAPTIC SPECIALIZATION ORGANIZATION
|
47
|
3.36e-01
|
-8.11e-02
|
5.25e-01
|
GOBP REGULATION OF PROTEIN UBIQUITINATION
|
180
|
6.09e-02
|
-8.11e-02
|
1.66e-01
|
GOCC AMPHISOME
|
12
|
6.27e-01
|
-8.11e-02
|
7.68e-01
|
GOBP MAPK CASCADE
|
620
|
6.18e-04
|
-8.10e-02
|
4.56e-03
|
GOBP CELL CELL RECOGNITION
|
39
|
3.82e-01
|
8.10e-02
|
5.68e-01
|
GOBP POSITIVE REGULATION OF DENDRITIC SPINE DEVELOPMENT
|
60
|
2.79e-01
|
-8.09e-02
|
4.62e-01
|
GOBP REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORT
|
60
|
2.79e-01
|
8.09e-02
|
4.62e-01
|
GOBP CENTRAL NERVOUS SYSTEM NEURON DEVELOPMENT
|
71
|
2.39e-01
|
-8.09e-02
|
4.18e-01
|
GOBP CRANIAL NERVE MORPHOGENESIS
|
23
|
5.02e-01
|
-8.09e-02
|
6.73e-01
|
GOBP POSITIVE REGULATION OF RNA SPLICING
|
45
|
3.48e-01
|
-8.09e-02
|
5.36e-01
|
GOBP SYNAPSE ASSEMBLY
|
200
|
4.92e-02
|
-8.08e-02
|
1.44e-01
|
GOBP APOPTOTIC SIGNALING PATHWAY
|
539
|
1.41e-03
|
-8.08e-02
|
9.00e-03
|
GOMF GLUTAMATE RECEPTOR ACTIVITY
|
11
|
6.43e-01
|
8.08e-02
|
7.80e-01
|
GOBP ENAMEL MINERALIZATION
|
14
|
6.01e-01
|
8.07e-02
|
7.48e-01
|
GOBP NEPHRON TUBULE FORMATION
|
12
|
6.28e-01
|
-8.07e-02
|
7.69e-01
|
GOBP N ACETYLGLUCOSAMINE METABOLIC PROCESS
|
13
|
6.14e-01
|
8.07e-02
|
7.59e-01
|
GOBP TRANSPOSITION
|
14
|
6.01e-01
|
-8.07e-02
|
7.48e-01
|
GOBP REGULATION OF NEUROINFLAMMATORY RESPONSE
|
21
|
5.22e-01
|
-8.07e-02
|
6.90e-01
|
GOBP POSTSYNAPTIC CYTOSKELETON ORGANIZATION
|
20
|
5.32e-01
|
-8.07e-02
|
6.97e-01
|
GOBP NEGATIVE REGULATION OF PROTEIN MODIFICATION PROCESS
|
378
|
7.32e-03
|
-8.07e-02
|
3.37e-02
|
GOBP NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS
|
36
|
4.03e-01
|
8.07e-02
|
5.88e-01
|
GOBP INFLAMMATORY RESPONSE
|
559
|
1.20e-03
|
-8.06e-02
|
7.89e-03
|
GOMF PHOSPHOLIPASE ACTIVATOR ACTIVITY
|
14
|
6.02e-01
|
-8.06e-02
|
7.49e-01
|
GOMF MYOSIN BINDING
|
62
|
2.73e-01
|
-8.05e-02
|
4.55e-01
|
GOMF DOPAMINE RECEPTOR BINDING
|
19
|
5.44e-01
|
-8.05e-02
|
7.08e-01
|
GOBP ALTERNATIVE MRNA SPLICING VIA SPLICEOSOME
|
65
|
2.62e-01
|
-8.05e-02
|
4.44e-01
|
GOBP TONIC SMOOTH MUSCLE CONTRACTION
|
11
|
6.44e-01
|
8.05e-02
|
7.81e-01
|
GOBP DETECTION OF MECHANICAL STIMULUS
|
43
|
3.62e-01
|
-8.04e-02
|
5.48e-01
|
GOBP RETINA HOMEOSTASIS
|
38
|
3.91e-01
|
8.04e-02
|
5.78e-01
|
GOCC RNA POLYMERASE II TRANSCRIPTION REGULATOR COMPLEX
|
221
|
4.00e-02
|
-8.04e-02
|
1.23e-01
|
GOCC PRERIBOSOME LARGE SUBUNIT PRECURSOR
|
19
|
5.44e-01
|
8.03e-02
|
7.08e-01
|
GOBP REGULATION OF MUSCLE ORGAN DEVELOPMENT
|
21
|
5.24e-01
|
-8.03e-02
|
6.91e-01
|
GOBP NUCLEOTIDE EXCISION REPAIR
|
73
|
2.36e-01
|
-8.03e-02
|
4.15e-01
|
GOBP NEGATIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA PRODUCTION
|
10
|
6.60e-01
|
8.03e-02
|
7.93e-01
|
GOBP MONOATOMIC ION TRANSPORT
|
772
|
1.70e-04
|
8.02e-02
|
1.57e-03
|
GOCC MEMBRANE PROTEIN COMPLEX
|
886
|
6.11e-05
|
8.01e-02
|
6.60e-04
|
GOBP RESPONSE TO MISFOLDED PROTEIN
|
16
|
5.79e-01
|
8.01e-02
|
7.34e-01
|
GOBP CARDIAC CHAMBER MORPHOGENESIS
|
123
|
1.26e-01
|
-8.00e-02
|
2.72e-01
|
GOMF PHOSPHATIDYLINOSITOL 4 5 BISPHOSPHATE BINDING
|
64
|
2.68e-01
|
-8.00e-02
|
4.50e-01
|
GOMF ENDONUCLEASE ACTIVITY
|
100
|
1.67e-01
|
8.00e-02
|
3.28e-01
|
GOCC RUFFLE MEMBRANE
|
65
|
2.65e-01
|
-8.00e-02
|
4.46e-01
|
GOBP NEGATIVE REGULATION OF MOLECULAR FUNCTION
|
657
|
5.12e-04
|
-8.00e-02
|
3.90e-03
|
GOBP REGULATION OF RESPONSE TO NUTRIENT LEVELS
|
23
|
5.07e-01
|
-8.00e-02
|
6.77e-01
|
GOMF SYNTAXIN BINDING
|
56
|
3.02e-01
|
-7.98e-02
|
4.86e-01
|
GOMF PROTEIN LYSINE DEACETYLASE ACTIVITY
|
22
|
5.17e-01
|
7.98e-02
|
6.85e-01
|
GOBP REGULATION OF BROWN FAT CELL DIFFERENTIATION
|
23
|
5.08e-01
|
7.97e-02
|
6.78e-01
|
GOMF TFIID CLASS TRANSCRIPTION FACTOR COMPLEX BINDING
|
10
|
6.63e-01
|
7.97e-02
|
7.94e-01
|
GOBP NEGATIVE REGULATION OF MYOBLAST DIFFERENTIATION
|
24
|
4.99e-01
|
-7.97e-02
|
6.70e-01
|
GOBP PROTEIN TRANSPORT WITHIN LIPID BILAYER
|
10
|
6.63e-01
|
7.96e-02
|
7.94e-01
|
GOMF OXIDOREDUCTASE ACTIVITY ACTING ON THE CH NH2 GROUP OF DONORS
|
17
|
5.70e-01
|
7.95e-02
|
7.27e-01
|
GOBP RESPONSE TO LEPTIN
|
17
|
5.70e-01
|
-7.95e-02
|
7.27e-01
|
GOBP VESICLE TRANSPORT ALONG MICROTUBULE
|
42
|
3.73e-01
|
7.95e-02
|
5.59e-01
|
GOBP CELLULAR RESPONSE TO INSULIN STIMULUS
|
189
|
6.03e-02
|
-7.94e-02
|
1.65e-01
|
GOBP NEGATIVE REGULATION BY HOST OF VIRAL PROCESS
|
10
|
6.64e-01
|
-7.93e-02
|
7.95e-01
|
GOBP ERK1 AND ERK2 CASCADE
|
247
|
3.22e-02
|
-7.93e-02
|
1.05e-01
|
GOBP POSITIVE REGULATION OF LONG TERM NEURONAL SYNAPTIC PLASTICITY
|
10
|
6.64e-01
|
7.93e-02
|
7.95e-01
|
GOCC CLATHRIN VESICLE COAT
|
29
|
4.60e-01
|
-7.93e-02
|
6.36e-01
|
GOBP CYCLIC NUCLEOTIDE BIOSYNTHETIC PROCESS
|
13
|
6.21e-01
|
-7.92e-02
|
7.64e-01
|
GOBP NEUTROPHIL MEDIATED IMMUNITY
|
26
|
4.85e-01
|
-7.92e-02
|
6.58e-01
|
GOCC POSTSYNAPTIC SPECIALIZATION MEMBRANE
|
99
|
1.74e-01
|
7.92e-02
|
3.37e-01
|
GOMF PHOSPHATIDYLETHANOLAMINE BINDING
|
13
|
6.21e-01
|
7.91e-02
|
7.64e-01
|
GOBP HEART FORMATION
|
29
|
4.61e-01
|
-7.91e-02
|
6.37e-01
|
GOBP REGULATION OF NEUROTROPHIN TRK RECEPTOR SIGNALING PATHWAY
|
16
|
5.84e-01
|
7.90e-02
|
7.37e-01
|
GOBP RHYTHMIC PROCESS
|
236
|
3.69e-02
|
-7.90e-02
|
1.16e-01
|
GOCC SPLICEOSOMAL COMPLEX
|
187
|
6.28e-02
|
-7.90e-02
|
1.70e-01
|
GOBP MORPHOGENESIS OF EMBRYONIC EPITHELIUM
|
151
|
9.45e-02
|
-7.90e-02
|
2.26e-01
|
GOBP MICROTUBULE ANCHORING
|
22
|
5.22e-01
|
7.89e-02
|
6.89e-01
|
GOBP RESPIRATORY SYSTEM PROCESS
|
36
|
4.13e-01
|
7.89e-02
|
5.96e-01
|
GOCC ZYMOGEN GRANULE
|
17
|
5.74e-01
|
-7.89e-02
|
7.30e-01
|
GOCC GOLGI TRANS CISTERNA
|
10
|
6.66e-01
|
-7.88e-02
|
7.97e-01
|
GOBP NEGATIVE REGULATION OF CELL COMMUNICATION
|
1188
|
6.19e-06
|
-7.88e-02
|
8.93e-05
|
GOBP POSITIVE REGULATION OF NON MOTILE CILIUM ASSEMBLY
|
11
|
6.51e-01
|
-7.88e-02
|
7.87e-01
|
GOBP GANGLIOSIDE BIOSYNTHETIC PROCESS
|
14
|
6.10e-01
|
-7.87e-02
|
7.56e-01
|
GOBP PTERIDINE CONTAINING COMPOUND METABOLIC PROCESS
|
30
|
4.56e-01
|
7.87e-02
|
6.33e-01
|
GOBP POSITIVE REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS
|
21
|
5.33e-01
|
-7.86e-02
|
6.98e-01
|
GOMF 5S RRNA BINDING
|
13
|
6.24e-01
|
7.86e-02
|
7.66e-01
|
GOBP CHOLESTEROL EFFLUX
|
43
|
3.73e-01
|
7.85e-02
|
5.59e-01
|
GOBP RESPONSE TO GAMMA RADIATION
|
47
|
3.52e-01
|
-7.85e-02
|
5.39e-01
|
GOBP MIRNA TRANSCRIPTION
|
70
|
2.57e-01
|
-7.84e-02
|
4.38e-01
|
GOCC NUCLEAR EXOSOME RNASE COMPLEX
|
12
|
6.38e-01
|
7.84e-02
|
7.77e-01
|
GOMF FOLIC ACID BINDING
|
12
|
6.38e-01
|
7.84e-02
|
7.77e-01
|
GOMF PALMITOYL HYDROLASE ACTIVITY
|
12
|
6.38e-01
|
7.83e-02
|
7.77e-01
|
GOBP OLIGODENDROCYTE DEVELOPMENT
|
36
|
4.16e-01
|
-7.83e-02
|
5.99e-01
|
GOBP NECROPTOTIC PROCESS
|
35
|
4.23e-01
|
-7.83e-02
|
6.05e-01
|
GOBP REGULATION OF MUSCLE CELL DIFFERENTIATION
|
143
|
1.06e-01
|
-7.83e-02
|
2.44e-01
|
GOBP ACTIVATION OF PROTEIN KINASE ACTIVITY
|
62
|
2.87e-01
|
-7.83e-02
|
4.69e-01
|
GOBP MYOTUBE DIFFERENTIATION
|
109
|
1.59e-01
|
7.83e-02
|
3.17e-01
|
GOBP T CELL HOMEOSTASIS
|
43
|
3.75e-01
|
-7.82e-02
|
5.61e-01
|
GOBP AMELOGENESIS
|
17
|
5.77e-01
|
7.82e-02
|
7.32e-01
|
GOBP REGULATION OF MRNA METABOLIC PROCESS
|
244
|
3.59e-02
|
-7.82e-02
|
1.14e-01
|
GOBP CELL PROLIFERATION IN HINDBRAIN
|
11
|
6.54e-01
|
-7.81e-02
|
7.89e-01
|
GOBP REGULATION OF PROTEIN KINASE C SIGNALING
|
16
|
5.89e-01
|
-7.80e-02
|
7.40e-01
|
GOBP OLIGOSACCHARIDE CATABOLIC PROCESS
|
10
|
6.69e-01
|
7.80e-02
|
7.99e-01
|
GOBP HINDBRAIN DEVELOPMENT
|
125
|
1.33e-01
|
-7.80e-02
|
2.80e-01
|
GOMF INORGANIC ANION TRANSMEMBRANE TRANSPORTER ACTIVITY
|
87
|
2.10e-01
|
7.79e-02
|
3.83e-01
|
GOMF GTPASE ACTIVITY
|
246
|
3.59e-02
|
-7.79e-02
|
1.14e-01
|
GOMF COPPER ION BINDING
|
45
|
3.66e-01
|
-7.79e-02
|
5.53e-01
|
GOMF MOLECULAR FUNCTION ACTIVATOR ACTIVITY
|
710
|
4.57e-04
|
-7.78e-02
|
3.58e-03
|
GOBP POSITIVE REGULATION OF CATABOLIC PROCESS
|
462
|
4.39e-03
|
-7.77e-02
|
2.25e-02
|
GOBP REGULATION OF CHONDROCYTE DIFFERENTIATION
|
40
|
3.96e-01
|
-7.77e-02
|
5.81e-01
|
GOBP REGULATION OF MEIOTIC CELL CYCLE
|
34
|
4.33e-01
|
-7.76e-02
|
6.13e-01
|
GOBP MIRNA METABOLIC PROCESS
|
87
|
2.11e-01
|
-7.76e-02
|
3.85e-01
|
GOMF ATP HYDROLYSIS ACTIVITY
|
254
|
3.36e-02
|
-7.76e-02
|
1.08e-01
|
GOBP PURINE CONTAINING COMPOUND TRANSMEMBRANE TRANSPORT
|
20
|
5.48e-01
|
7.76e-02
|
7.11e-01
|
GOMF PEPTIDYL PROLINE DIOXYGENASE ACTIVITY
|
11
|
6.56e-01
|
7.76e-02
|
7.91e-01
|
GOBP POSITIVE REGULATION OF OSTEOCLAST DIFFERENTIATION
|
25
|
5.02e-01
|
-7.76e-02
|
6.73e-01
|
GOBP NUCLEOTIDE TRANSMEMBRANE TRANSPORT
|
19
|
5.59e-01
|
7.75e-02
|
7.19e-01
|
GOMF RNA POLYMERASE CORE ENZYME BINDING
|
41
|
3.91e-01
|
-7.74e-02
|
5.77e-01
|
GOBP REACTIVE NITROGEN SPECIES METABOLIC PROCESS
|
78
|
2.38e-01
|
-7.74e-02
|
4.17e-01
|
GOBP FIBROBLAST PROLIFERATION
|
128
|
1.32e-01
|
-7.73e-02
|
2.79e-01
|
GOMF PEPTIDE LYSINE N ACETYLTRANSFERASE ACTIVITY
|
41
|
3.93e-01
|
-7.72e-02
|
5.78e-01
|
GOBP REGULATION OF CELLULAR PH
|
67
|
2.75e-01
|
7.72e-02
|
4.57e-01
|
GOBP NEGATIVE REGULATION OF HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION
|
11
|
6.58e-01
|
7.71e-02
|
7.92e-01
|
GOBP DEVELOPMENT OF PRIMARY FEMALE SEXUAL CHARACTERISTICS
|
84
|
2.22e-01
|
-7.71e-02
|
4.00e-01
|
GOMF PHOSPHORIC ESTER HYDROLASE ACTIVITY
|
283
|
2.62e-02
|
7.70e-02
|
9.01e-02
|
GOBP REGULATION OF PROGRAMMED CELL DEATH
|
1299
|
4.22e-06
|
-7.70e-02
|
6.36e-05
|
GOBP MYOBLAST MIGRATION
|
13
|
6.31e-01
|
-7.70e-02
|
7.71e-01
|
GOBP CHEMICAL HOMEOSTASIS
|
782
|
2.85e-04
|
7.69e-02
|
2.45e-03
|
GOBP REGULATION OF MUCUS SECRETION
|
11
|
6.59e-01
|
7.69e-02
|
7.92e-01
|
GOCC EXTRACELLULAR SPACE
|
807
|
2.35e-04
|
-7.68e-02
|
2.09e-03
|
GOCC MICROTUBULE
|
369
|
1.16e-02
|
-7.68e-02
|
4.85e-02
|
GOBP PROTEIN HOMOOLIGOMERIZATION
|
149
|
1.06e-01
|
7.68e-02
|
2.44e-01
|
GOBP MAST CELL MIGRATION
|
13
|
6.32e-01
|
-7.68e-02
|
7.72e-01
|
GOBP CIRCULATORY SYSTEM PROCESS
|
441
|
5.95e-03
|
7.67e-02
|
2.86e-02
|
GOCC EXTRINSIC COMPONENT OF PLASMA MEMBRANE
|
87
|
2.17e-01
|
-7.67e-02
|
3.92e-01
|
GOBP POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE
|
22
|
5.34e-01
|
7.65e-02
|
6.99e-01
|
GOBP REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY CIRCULATORY RENIN ANGIOTENSIN
|
12
|
6.46e-01
|
-7.65e-02
|
7.83e-01
|
GOMF SEQUENCE SPECIFIC SINGLE STRANDED DNA BINDING
|
14
|
6.20e-01
|
-7.65e-02
|
7.64e-01
|
GOBP ENDOCRINE SYSTEM DEVELOPMENT
|
77
|
2.46e-01
|
-7.65e-02
|
4.27e-01
|
GOBP SYNAPTIC VESICLE TRANSPORT
|
44
|
3.80e-01
|
-7.65e-02
|
5.66e-01
|
GOBP DIGESTIVE SYSTEM DEVELOPMENT
|
96
|
1.96e-01
|
-7.65e-02
|
3.65e-01
|
GOBP MRNA PROCESSING
|
422
|
7.40e-03
|
-7.63e-02
|
3.40e-02
|
GOBP BICARBONATE TRANSPORT
|
11
|
6.61e-01
|
7.63e-02
|
7.94e-01
|
GOMF MOLECULAR ADAPTOR ACTIVITY
|
972
|
6.69e-05
|
-7.63e-02
|
7.17e-04
|
GOCC EARLY ENDOSOME
|
290
|
2.59e-02
|
-7.63e-02
|
8.93e-02
|
GOBP NUCLEUS ORGANIZATION
|
123
|
1.45e-01
|
-7.62e-02
|
2.98e-01
|
GOBP NEUROPEPTIDE SIGNALING PATHWAY
|
16
|
5.98e-01
|
-7.62e-02
|
7.46e-01
|
GOCC TRANS GOLGI NETWORK MEMBRANE
|
40
|
4.05e-01
|
-7.61e-02
|
5.89e-01
|
GOBP HEMATOPOIETIC STEM CELL DIFFERENTIATION
|
30
|
4.71e-01
|
-7.61e-02
|
6.45e-01
|
GOBP NEGATIVE REGULATION OF SMOOTH MUSCLE CONTRACTION
|
14
|
6.22e-01
|
-7.61e-02
|
7.65e-01
|
GOMF INOSITOL PHOSPHATE KINASE ACTIVITY
|
10
|
6.77e-01
|
7.60e-02
|
8.04e-01
|
GOBP AMINO SUGAR METABOLIC PROCESS
|
32
|
4.57e-01
|
7.60e-02
|
6.34e-01
|
GOBP EXTRACELLULAR MATRIX CONSTITUENT SECRETION
|
12
|
6.49e-01
|
-7.60e-02
|
7.85e-01
|
GOBP NEGATIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY
|
34
|
4.45e-01
|
-7.58e-02
|
6.24e-01
|
GOBP REGULATION OF RAS PROTEIN SIGNAL TRANSDUCTION
|
50
|
3.54e-01
|
-7.58e-02
|
5.41e-01
|
GOMF TRANSCRIPTION FACTOR BINDING
|
604
|
1.58e-03
|
-7.57e-02
|
9.93e-03
|
GOBP RESPONSE TO OXYGEN CONTAINING COMPOUND
|
1153
|
1.88e-05
|
-7.56e-02
|
2.35e-04
|
GOBP NEGATIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS
|
12
|
6.50e-01
|
-7.56e-02
|
7.86e-01
|
GOMF HISTONE DEACETYLASE BINDING
|
115
|
1.62e-01
|
-7.55e-02
|
3.22e-01
|
GOMF SPHINGOLIPID BINDING
|
23
|
5.31e-01
|
7.55e-02
|
6.96e-01
|
GOMF HISTONE H3K4 METHYLTRANSFERASE ACTIVITY
|
18
|
5.79e-01
|
7.55e-02
|
7.34e-01
|
GOBP PROTEIN TARGETING
|
248
|
4.12e-02
|
7.55e-02
|
1.25e-01
|
GOCC PEPTIDASE COMPLEX
|
107
|
1.78e-01
|
7.55e-02
|
3.43e-01
|
GOBP VESICLE BUDDING FROM MEMBRANE
|
76
|
2.56e-01
|
7.54e-02
|
4.37e-01
|
GOCC MYOSIN COMPLEX
|
40
|
4.09e-01
|
7.54e-02
|
5.93e-01
|
GOBP POSITIVE REGULATION OF MITOCHONDRIAL CALCIUM ION CONCENTRATION
|
11
|
6.65e-01
|
7.54e-02
|
7.96e-01
|
GOBP RESPONSE TO INTERLEUKIN 15
|
10
|
6.80e-01
|
7.54e-02
|
8.06e-01
|
GOMF PEPTIDE HORMONE BINDING
|
26
|
5.06e-01
|
7.54e-02
|
6.76e-01
|
GOBP NEGATIVE REGULATION OF MYELOID CELL APOPTOTIC PROCESS
|
15
|
6.13e-01
|
-7.53e-02
|
7.58e-01
|
GOBP DEVELOPMENTAL MATURATION
|
266
|
3.49e-02
|
-7.53e-02
|
1.12e-01
|
GOBP NEGATIVE REGULATION OF PROTEIN SECRETION
|
66
|
2.90e-01
|
7.53e-02
|
4.74e-01
|
GOBP EYE PHOTORECEPTOR CELL DIFFERENTIATION
|
37
|
4.28e-01
|
7.53e-02
|
6.09e-01
|
GOBP AUTOPHAGY OF MITOCHONDRION
|
82
|
2.39e-01
|
7.53e-02
|
4.18e-01
|
GOBP EPITHELIAL TUBE BRANCHING INVOLVED IN LUNG MORPHOGENESIS
|
27
|
4.99e-01
|
-7.52e-02
|
6.70e-01
|
GOBP INOSITOL TRISPHOSPHATE METABOLIC PROCESS
|
15
|
6.14e-01
|
7.52e-02
|
7.59e-01
|
GOBP IMP BIOSYNTHETIC PROCESS
|
13
|
6.39e-01
|
7.52e-02
|
7.77e-01
|
GOBP MITOCHONDRION LOCALIZATION
|
49
|
3.63e-01
|
7.52e-02
|
5.49e-01
|
GOBP SPHINGOID BIOSYNTHETIC PROCESS
|
10
|
6.81e-01
|
-7.52e-02
|
8.06e-01
|
GOBP NEGATIVE REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS
|
77
|
2.55e-01
|
-7.51e-02
|
4.35e-01
|
GOBP NEGATIVE REGULATION OF PLASMA MEMBRANE BOUNDED CELL PROJECTION ASSEMBLY
|
36
|
4.35e-01
|
-7.51e-02
|
6.15e-01
|
GOMF 5 NUCLEOTIDASE ACTIVITY
|
10
|
6.81e-01
|
7.50e-02
|
8.06e-01
|
GOBP NATURAL KILLER CELL ACTIVATION
|
54
|
3.41e-01
|
-7.50e-02
|
5.29e-01
|
GOMF DELAYED RECTIFIER POTASSIUM CHANNEL ACTIVITY
|
14
|
6.27e-01
|
7.50e-02
|
7.68e-01
|
GOBP REGULATION OF PROTEIN FOLDING
|
10
|
6.82e-01
|
7.49e-02
|
8.06e-01
|
GOBP POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS
|
18
|
5.83e-01
|
-7.48e-02
|
7.36e-01
|
GOBP NEGATIVE REGULATION OF STEROID METABOLIC PROCESS
|
19
|
5.73e-01
|
7.47e-02
|
7.29e-01
|
GOBP REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC
|
51
|
3.56e-01
|
7.47e-02
|
5.43e-01
|
GOBP ER NUCLEUS SIGNALING PATHWAY
|
40
|
4.14e-01
|
7.47e-02
|
5.97e-01
|
GOBP REGULATION OF ANDROGEN RECEPTOR SIGNALING PATHWAY
|
22
|
5.44e-01
|
-7.47e-02
|
7.08e-01
|
GOCC PHAGOCYTIC CUP
|
21
|
5.55e-01
|
-7.45e-02
|
7.17e-01
|
GOBP REGULATION OF POSITIVE CHEMOTAXIS
|
18
|
5.84e-01
|
-7.45e-02
|
7.37e-01
|
GOBP STEROL TRANSPORT
|
86
|
2.33e-01
|
7.44e-02
|
4.13e-01
|
GOBP NEGATIVE REGULATION OF NON CANONICAL NF KAPPAB SIGNAL TRANSDUCTION
|
21
|
5.55e-01
|
7.44e-02
|
7.17e-01
|
GOBP LOCOMOTION INVOLVED IN LOCOMOTORY BEHAVIOR
|
13
|
6.43e-01
|
-7.43e-02
|
7.80e-01
|
GOBP REGULATION OF ATP METABOLIC PROCESS
|
68
|
2.90e-01
|
7.43e-02
|
4.73e-01
|
GOMF ATPASE BINDING
|
82
|
2.45e-01
|
7.43e-02
|
4.26e-01
|
GOBP NEGATIVE REGULATION OF INTRACELLULAR TRANSPORT
|
49
|
3.69e-01
|
7.43e-02
|
5.55e-01
|
GOCC CILIARY BASAL BODY
|
141
|
1.29e-01
|
-7.42e-02
|
2.75e-01
|
GOBP COMMISSURAL NEURON AXON GUIDANCE
|
12
|
6.56e-01
|
7.42e-02
|
7.91e-01
|
GOBP XENOBIOTIC EXPORT FROM CELL
|
11
|
6.70e-01
|
7.42e-02
|
7.99e-01
|
GOBP RIBONUCLEOPROTEIN COMPLEX BIOGENESIS
|
388
|
1.25e-02
|
7.42e-02
|
5.13e-02
|
GOMF HEAT SHOCK PROTEIN BINDING
|
131
|
1.43e-01
|
7.42e-02
|
2.95e-01
|
GOMF LIPID TRANSMEMBRANE TRANSPORTER ACTIVITY
|
32
|
4.68e-01
|
7.42e-02
|
6.44e-01
|
GOBP POSITIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY
|
35
|
4.48e-01
|
-7.41e-02
|
6.27e-01
|
GOBP MINERALOCORTICOID METABOLIC PROCESS
|
11
|
6.71e-01
|
7.41e-02
|
8.00e-01
|
GOCC MICROVILLUS
|
76
|
2.65e-01
|
-7.40e-02
|
4.46e-01
|
GOBP REGULATION OF POST TRANSLATIONAL PROTEIN MODIFICATION
|
218
|
6.05e-02
|
-7.39e-02
|
1.66e-01
|
GOBP FOREBRAIN NEURON DIFFERENTIATION
|
31
|
4.76e-01
|
-7.39e-02
|
6.50e-01
|
GOBP REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY
|
111
|
1.79e-01
|
-7.39e-02
|
3.43e-01
|
GOBP NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE
|
24
|
5.31e-01
|
-7.39e-02
|
6.96e-01
|
GOMF PHOSPHOLIPID SCRAMBLASE ACTIVITY
|
17
|
5.98e-01
|
7.39e-02
|
7.46e-01
|
GOBP MONOATOMIC ANION HOMEOSTASIS
|
23
|
5.40e-01
|
7.39e-02
|
7.04e-01
|
GOBP TRABECULA MORPHOGENESIS
|
48
|
3.76e-01
|
-7.39e-02
|
5.62e-01
|
GOBP HOMOLOGOUS CHROMOSOME PAIRING AT MEIOSIS
|
23
|
5.40e-01
|
-7.39e-02
|
7.04e-01
|
GOBP REGULATION OF MYOTUBE DIFFERENTIATION
|
38
|
4.31e-01
|
7.38e-02
|
6.12e-01
|
GOCC MLL3 4 COMPLEX
|
11
|
6.72e-01
|
7.38e-02
|
8.01e-01
|
GOCC CALCIUM CHANNEL COMPLEX
|
38
|
4.32e-01
|
7.38e-02
|
6.12e-01
|
GOMF PHOSPHATASE BINDING
|
200
|
7.27e-02
|
-7.38e-02
|
1.89e-01
|
GOBP ANATOMICAL STRUCTURE MATURATION
|
198
|
7.41e-02
|
-7.38e-02
|
1.91e-01
|
GOBP MAMMARY GLAND DUCT MORPHOGENESIS
|
34
|
4.57e-01
|
-7.37e-02
|
6.34e-01
|
GOBP REGULATION OF CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT
|
12
|
6.58e-01
|
-7.37e-02
|
7.92e-01
|
GOBP ACUTE INFLAMMATORY RESPONSE
|
60
|
3.24e-01
|
-7.37e-02
|
5.11e-01
|
GOBP RESPONSE TO HORMONE
|
576
|
2.67e-03
|
-7.37e-02
|
1.51e-02
|
GOBP LABYRINTHINE LAYER BLOOD VESSEL DEVELOPMENT
|
21
|
5.59e-01
|
-7.36e-02
|
7.19e-01
|
GOBP REPRODUCTIVE PROCESS
|
892
|
2.21e-04
|
-7.36e-02
|
1.98e-03
|
GOBP HEART DEVELOPMENT
|
563
|
3.00e-03
|
-7.36e-02
|
1.66e-02
|
GOCC TRANSFERASE COMPLEX TRANSFERRING PHOSPHORUS CONTAINING GROUPS
|
244
|
4.84e-02
|
-7.36e-02
|
1.42e-01
|
GOBP NUCLEUS LOCALIZATION
|
37
|
4.39e-01
|
-7.36e-02
|
6.19e-01
|
GOBP POSITIVE REGULATION OF LIPASE ACTIVITY
|
25
|
5.25e-01
|
-7.35e-02
|
6.91e-01
|
GOMF TRANSFERASE ACTIVITY TRANSFERRING PHOSPHORUS CONTAINING GROUPS
|
731
|
7.82e-04
|
-7.35e-02
|
5.56e-03
|
GOBP NEGATIVE REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS
|
31
|
4.79e-01
|
-7.35e-02
|
6.53e-01
|
GOMF SMALL MOLECULE SENSOR ACTIVITY
|
27
|
5.09e-01
|
7.34e-02
|
6.79e-01
|
GOCC POSTSYNAPTIC DENSITY MEMBRANE
|
84
|
2.46e-01
|
7.33e-02
|
4.26e-01
|
GOBP POSITIVE REGULATION OF PROTEIN SECRETION
|
140
|
1.35e-01
|
-7.32e-02
|
2.84e-01
|
GOBP POSITIVE REGULATION OF NUCLEAR DIVISION
|
50
|
3.71e-01
|
-7.32e-02
|
5.57e-01
|
GOBP RESPONSE TO INTERLEUKIN 4
|
28
|
5.04e-01
|
7.30e-02
|
6.74e-01
|
GOBP CYTOSOLIC TRANSPORT
|
115
|
1.77e-01
|
-7.30e-02
|
3.40e-01
|
GOMF TRANSLATION REGULATOR ACTIVITY
|
114
|
1.79e-01
|
7.30e-02
|
3.43e-01
|
GOBP RESPONSE TO ORGANIC CYCLIC COMPOUND
|
546
|
3.74e-03
|
-7.29e-02
|
1.99e-02
|
GOMF NUCLEOSIDE TRIPHOSPHATASE REGULATOR ACTIVITY
|
393
|
1.35e-02
|
-7.29e-02
|
5.44e-02
|
GOCC GTPASE COMPLEX
|
30
|
4.90e-01
|
-7.29e-02
|
6.63e-01
|
GOMF RNA POLYMERASE II SPECIFIC DNA BINDING TRANSCRIPTION FACTOR BINDING
|
329
|
2.35e-02
|
-7.29e-02
|
8.32e-02
|
GOBP PURINE NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS
|
33
|
4.69e-01
|
7.28e-02
|
6.44e-01
|
GOMF NON MEMBRANE SPANNING PROTEIN TYROSINE PHOSPHATASE ACTIVITY
|
10
|
6.90e-01
|
7.27e-02
|
8.11e-01
|
GOBP TRABECULA FORMATION
|
24
|
5.38e-01
|
7.27e-02
|
7.02e-01
|
GOBP AMINO ACID IMPORT ACROSS PLASMA MEMBRANE
|
39
|
4.32e-01
|
7.27e-02
|
6.13e-01
|
GOBP REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR
|
74
|
2.80e-01
|
-7.27e-02
|
4.63e-01
|
GOBP ECTODERMAL PLACODE DEVELOPMENT
|
14
|
6.38e-01
|
-7.26e-02
|
7.77e-01
|
GOBP RNA LOCALIZATION
|
153
|
1.22e-01
|
-7.26e-02
|
2.66e-01
|
GOBP PROTEIN AUTOPHOSPHORYLATION
|
172
|
1.01e-01
|
-7.25e-02
|
2.37e-01
|
GOBP RESPONSE TO MECHANICAL STIMULUS
|
124
|
1.64e-01
|
-7.25e-02
|
3.24e-01
|
GOBP NEGATIVE REGULATION OF PEPTIDASE ACTIVITY
|
117
|
1.76e-01
|
-7.24e-02
|
3.40e-01
|
GOMF CELL CELL ADHESION MEDIATOR ACTIVITY
|
21
|
5.66e-01
|
7.24e-02
|
7.25e-01
|
GOBP REGULATION OF CELL GROWTH INVOLVED IN CARDIAC MUSCLE CELL DEVELOPMENT
|
30
|
4.93e-01
|
-7.24e-02
|
6.65e-01
|
GOBP STRIATED MUSCLE ADAPTATION
|
48
|
3.87e-01
|
7.23e-02
|
5.72e-01
|
GOBP REGULATION OF TELOMERE MAINTENANCE
|
94
|
2.26e-01
|
-7.23e-02
|
4.04e-01
|
GOCC PHOTORECEPTOR RIBBON SYNAPSE
|
16
|
6.17e-01
|
7.22e-02
|
7.62e-01
|
GOBP RESPONSE TO HEPATOCYTE GROWTH FACTOR
|
15
|
6.29e-01
|
-7.22e-02
|
7.69e-01
|
GOBP POLYSACCHARIDE BIOSYNTHETIC PROCESS
|
59
|
3.38e-01
|
-7.22e-02
|
5.27e-01
|
GOBP MUSCLE SYSTEM PROCESS
|
355
|
1.99e-02
|
7.22e-02
|
7.37e-02
|
GOBP ADULT BEHAVIOR
|
127
|
1.61e-01
|
7.21e-02
|
3.20e-01
|
GOMF PYRIMIDINE NUCLEOTIDE SUGAR TRANSMEMBRANE TRANSPORTER ACTIVITY
|
10
|
6.93e-01
|
-7.21e-02
|
8.13e-01
|
GOMF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY
|
26
|
5.25e-01
|
-7.21e-02
|
6.91e-01
|
GOBP POSITIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION
|
81
|
2.63e-01
|
-7.21e-02
|
4.44e-01
|
GOBP GLUCOSAMINE CONTAINING COMPOUND METABOLIC PROCESS
|
17
|
6.07e-01
|
7.21e-02
|
7.54e-01
|
GOBP REGULATION OF MULTICELLULAR ORGANISM GROWTH
|
68
|
3.04e-01
|
7.21e-02
|
4.89e-01
|
GOMF SCAFFOLD PROTEIN BINDING
|
72
|
2.91e-01
|
-7.21e-02
|
4.74e-01
|
GOCC GOLGI MEMBRANE
|
245
|
5.27e-02
|
-7.20e-02
|
1.51e-01
|
GOCC NUCLEAR UBIQUITIN LIGASE COMPLEX
|
42
|
4.20e-01
|
-7.20e-02
|
6.02e-01
|
GOBP REGULATION OF CARBOHYDRATE CATABOLIC PROCESS
|
67
|
3.09e-01
|
7.20e-02
|
4.94e-01
|
GOBP PROTEIN LOCALIZATION TO MEMBRANE RAFT
|
11
|
6.80e-01
|
-7.19e-02
|
8.06e-01
|
GOCC AMPA GLUTAMATE RECEPTOR COMPLEX
|
12
|
6.66e-01
|
-7.19e-02
|
7.97e-01
|
GOCC EXTRINSIC COMPONENT OF CYTOPLASMIC SIDE OF PLASMA MEMBRANE
|
39
|
4.38e-01
|
-7.19e-02
|
6.17e-01
|
GOBP VESICLE TARGETING
|
57
|
3.48e-01
|
7.18e-02
|
5.36e-01
|
GOBP NEUROMUSCULAR PROCESS CONTROLLING BALANCE
|
53
|
3.66e-01
|
-7.18e-02
|
5.53e-01
|
GOBP CYTOPLASMIC MICROTUBULE ORGANIZATION
|
57
|
3.48e-01
|
-7.18e-02
|
5.36e-01
|
GOBP C4 DICARBOXYLATE TRANSPORT
|
23
|
5.51e-01
|
7.18e-02
|
7.13e-01
|
GOBP AMINO ACID TRANSMEMBRANE TRANSPORT
|
76
|
2.80e-01
|
7.17e-02
|
4.63e-01
|
GOMF PSEUDOURIDINE SYNTHASE ACTIVITY
|
13
|
6.55e-01
|
7.16e-02
|
7.90e-01
|
GOBP GLYCOLIPID BIOSYNTHETIC PROCESS
|
58
|
3.46e-01
|
7.16e-02
|
5.34e-01
|
GOBP NEGATIVE REGULATION OF GLUCONEOGENESIS
|
11
|
6.81e-01
|
7.16e-02
|
8.06e-01
|
GOBP REGULATION OF RECEPTOR INTERNALIZATION
|
72
|
2.94e-01
|
-7.16e-02
|
4.78e-01
|
GOMF RIBONUCLEOPROTEIN COMPLEX BINDING
|
166
|
1.12e-01
|
7.16e-02
|
2.52e-01
|
GOMF NUCLEAR RECEPTOR BINDING
|
140
|
1.45e-01
|
-7.15e-02
|
2.97e-01
|
GOBP RESPONSE TO FOOD
|
21
|
5.71e-01
|
7.15e-02
|
7.27e-01
|
GOBP RESPONSE TO IONIZING RADIATION
|
115
|
1.86e-01
|
-7.14e-02
|
3.53e-01
|
GOMF MRNA METHYLTRANSFERASE ACTIVITY
|
11
|
6.82e-01
|
7.13e-02
|
8.06e-01
|
GOCC SAGA COMPLEX
|
22
|
5.62e-01
|
7.13e-02
|
7.22e-01
|
GOBP REGULATION OF RESPIRATORY SYSTEM PROCESS
|
11
|
6.82e-01
|
-7.13e-02
|
8.06e-01
|
GOCC FANCONI ANAEMIA NUCLEAR COMPLEX
|
11
|
6.82e-01
|
-7.13e-02
|
8.06e-01
|
GOBP REGULATION OF DNA STRAND ELONGATION
|
18
|
6.01e-01
|
-7.12e-02
|
7.48e-01
|
GOCC NEUROMUSCULAR JUNCTION
|
87
|
2.53e-01
|
-7.10e-02
|
4.34e-01
|
GOBP POSITIVE REGULATION OF AMYLOID BETA FORMATION
|
17
|
6.13e-01
|
-7.09e-02
|
7.58e-01
|
GOMF HEXOSYLTRANSFERASE ACTIVITY
|
135
|
1.56e-01
|
-7.09e-02
|
3.12e-01
|
GOBP RNA CATABOLIC PROCESS
|
240
|
5.93e-02
|
-7.08e-02
|
1.64e-01
|
GOCC RETROMER COMPLEX
|
19
|
5.93e-01
|
-7.08e-02
|
7.42e-01
|
GOBP NEGATIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY
|
55
|
3.64e-01
|
-7.08e-02
|
5.51e-01
|
GOBP REGULATION OF POLYSACCHARIDE METABOLIC PROCESS
|
44
|
4.17e-01
|
-7.07e-02
|
6.00e-01
|
GOCC TRANSPORT VESICLE MEMBRANE
|
150
|
1.35e-01
|
7.07e-02
|
2.84e-01
|
GOBP RNA TEMPLATED DNA BIOSYNTHETIC PROCESS
|
58
|
3.52e-01
|
-7.06e-02
|
5.39e-01
|
GOBP NEGATIVE REGULATION OF NEURON PROJECTION REGENERATION
|
20
|
5.85e-01
|
-7.06e-02
|
7.37e-01
|
GOCC TRANSCRIPTION FACTOR TFIIH CORE COMPLEX
|
10
|
6.99e-01
|
7.06e-02
|
8.17e-01
|
GOBP SPHINGOLIPID BIOSYNTHETIC PROCESS
|
70
|
3.08e-01
|
-7.05e-02
|
4.93e-01
|
GOBP NEGATIVE REGULATION OF INSULIN SECRETION
|
44
|
4.19e-01
|
7.05e-02
|
6.01e-01
|
GOBP ORGAN GROWTH
|
180
|
1.04e-01
|
-7.04e-02
|
2.41e-01
|
GOBP RESPONSE TO AXON INJURY
|
64
|
3.31e-01
|
-7.04e-02
|
5.18e-01
|
GOMF CARDIOLIPIN BINDING
|
12
|
6.73e-01
|
7.04e-02
|
8.01e-01
|
GOBP SYNAPTIC VESICLE LOCALIZATION
|
56
|
3.64e-01
|
-7.02e-02
|
5.50e-01
|
GOBP REGULATION OF PROTEIN LOCALIZATION TO CHROMOSOME TELOMERIC REGION
|
14
|
6.49e-01
|
-7.02e-02
|
7.85e-01
|
GOBP PHOSPHATIDYLINOSITOL 3 PHOSPHATE BIOSYNTHETIC PROCESS
|
11
|
6.87e-01
|
-7.01e-02
|
8.09e-01
|
GOBP MITOCHONDRIAL GENOME MAINTENANCE
|
34
|
4.80e-01
|
7.00e-02
|
6.54e-01
|
GOBP DIGESTIVE TRACT MORPHOGENESIS
|
36
|
4.68e-01
|
-6.99e-02
|
6.44e-01
|
GOBP REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY HORMONE
|
28
|
5.22e-01
|
6.99e-02
|
6.90e-01
|
GOBP POSITIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS
|
22
|
5.70e-01
|
6.99e-02
|
7.27e-01
|
GOBP REGULATION OF NEURON PROJECTION ARBORIZATION
|
11
|
6.88e-01
|
6.99e-02
|
8.10e-01
|
GOBP NEGATIVE REGULATION OF NUCLEOTIDE CATABOLIC PROCESS
|
21
|
5.79e-01
|
6.99e-02
|
7.34e-01
|
GOBP CD4 POSITIVE ALPHA BETA T CELL CYTOKINE PRODUCTION
|
11
|
6.88e-01
|
-6.99e-02
|
8.10e-01
|
GOBP NEGATIVE REGULATION OF INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS
|
15
|
6.40e-01
|
-6.98e-02
|
7.78e-01
|
GOBP REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS
|
39
|
4.51e-01
|
-6.98e-02
|
6.29e-01
|
GOBP POSITIVE REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY
|
12
|
6.76e-01
|
6.97e-02
|
8.03e-01
|
GOMF GUANYL NUCLEOTIDE EXCHANGE FACTOR ACTIVITY
|
187
|
1.01e-01
|
-6.97e-02
|
2.36e-01
|
GOMF UBIQUITIN LIKE PROTEIN LIGASE ACTIVITY
|
297
|
3.94e-02
|
-6.97e-02
|
1.22e-01
|
GOBP STEROL HOMEOSTASIS
|
74
|
3.01e-01
|
6.96e-02
|
4.86e-01
|
GOBP NEGATIVE REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY
|
18
|
6.10e-01
|
6.96e-02
|
7.56e-01
|
GOBP POSITIVE REGULATION OF INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS
|
39
|
4.52e-01
|
6.96e-02
|
6.30e-01
|
GOBP PROTEIN LOCALIZATION TO ENDOSOME
|
29
|
5.17e-01
|
6.95e-02
|
6.86e-01
|
GOBP MORPHOGENESIS OF A POLARIZED EPITHELIUM
|
56
|
3.69e-01
|
-6.95e-02
|
5.55e-01
|
GOBP CELLULAR COMPONENT DISASSEMBLY INVOLVED IN EXECUTION PHASE OF APOPTOSIS
|
25
|
5.48e-01
|
6.94e-02
|
7.11e-01
|
GOBP CELL GROWTH
|
435
|
1.35e-02
|
-6.94e-02
|
5.43e-02
|
GOBP RRNA 3 END PROCESSING
|
10
|
7.04e-01
|
6.94e-02
|
8.20e-01
|
GOBP REGULATION OF HUMORAL IMMUNE RESPONSE
|
31
|
5.04e-01
|
-6.94e-02
|
6.74e-01
|
GOBP PLASMA MEMBRANE TUBULATION
|
18
|
6.10e-01
|
-6.94e-02
|
7.56e-01
|
GOBP POSITIVE REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY
|
14
|
6.53e-01
|
-6.94e-02
|
7.89e-01
|
GOBP POSITIVE REGULATION OF ALPHA BETA T CELL PROLIFERATION
|
17
|
6.21e-01
|
-6.93e-02
|
7.64e-01
|
GOBP EXPLORATION BEHAVIOR
|
30
|
5.12e-01
|
-6.93e-02
|
6.81e-01
|
GOMF ENZYME REGULATOR ACTIVITY
|
973
|
2.95e-04
|
-6.92e-02
|
2.51e-03
|
GOMF KINESIN BINDING
|
44
|
4.27e-01
|
-6.92e-02
|
6.08e-01
|
GOBP POSITIVE REGULATION OF CELLULAR CATABOLIC PROCESS
|
199
|
9.32e-02
|
-6.92e-02
|
2.24e-01
|
GOBP POSITIVE REGULATION OF MORPHOGENESIS OF AN EPITHELIUM
|
29
|
5.19e-01
|
6.92e-02
|
6.87e-01
|
GOBP SYNAPTIC VESICLE PRIMING
|
24
|
5.58e-01
|
6.91e-02
|
7.18e-01
|
GOBP REGULATION OF EXOCYTOSIS
|
148
|
1.47e-01
|
-6.91e-02
|
3.01e-01
|
GOBP OVARIAN FOLLICLE DEVELOPMENT
|
49
|
4.03e-01
|
-6.91e-02
|
5.88e-01
|
GOBP REGULATION OF RNA STABILITY
|
149
|
1.46e-01
|
-6.90e-02
|
3.00e-01
|
GOBP NUCLEOTIDE SUGAR METABOLIC PROCESS
|
32
|
4.99e-01
|
6.90e-02
|
6.70e-01
|
GOBP NEGATIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION
|
29
|
5.21e-01
|
-6.90e-02
|
6.88e-01
|
GOBP OLFACTORY LOBE DEVELOPMENT
|
28
|
5.28e-01
|
6.89e-02
|
6.94e-01
|
GOMF MAGNESIUM ION BINDING
|
186
|
1.06e-01
|
6.89e-02
|
2.43e-01
|
GOBP POSITIVE REGULATION OF TELOMERE MAINTENANCE
|
70
|
3.21e-01
|
-6.86e-02
|
5.08e-01
|
GOBP CELLULAR HOMEOSTASIS
|
627
|
3.57e-03
|
6.86e-02
|
1.91e-02
|
GOMF PHOSPHOLIPID BINDING
|
376
|
2.29e-02
|
-6.86e-02
|
8.15e-02
|
GOBP XENOBIOTIC TRANSPORT
|
32
|
5.02e-01
|
6.85e-02
|
6.73e-01
|
GOMF PHOSPHORUS OXYGEN LYASE ACTIVITY
|
16
|
6.36e-01
|
-6.84e-02
|
7.75e-01
|
GOBP REGULATION OF VESICLE SIZE
|
19
|
6.06e-01
|
6.84e-02
|
7.52e-01
|
GOBP MONOATOMIC ION HOMEOSTASIS
|
459
|
1.24e-02
|
6.84e-02
|
5.12e-02
|
GOBP CARDIAC CHAMBER DEVELOPMENT
|
167
|
1.28e-01
|
-6.84e-02
|
2.75e-01
|
GOMF NUCLEAR EXPORT SIGNAL RECEPTOR ACTIVITY
|
11
|
6.95e-01
|
6.84e-02
|
8.14e-01
|
GOMF HORMONE ACTIVITY
|
33
|
4.97e-01
|
-6.84e-02
|
6.68e-01
|
GOMF HISTONE H4 ACETYLTRANSFERASE ACTIVITY
|
22
|
5.79e-01
|
-6.83e-02
|
7.34e-01
|
GOMF SIGNALING RECEPTOR REGULATOR ACTIVITY
|
232
|
7.39e-02
|
-6.83e-02
|
1.91e-01
|
GOBP PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR SIGNALING PATHWAY
|
22
|
5.80e-01
|
-6.83e-02
|
7.34e-01
|
GOBP LIPOSACCHARIDE METABOLIC PROCESS
|
81
|
2.89e-01
|
6.82e-02
|
4.73e-01
|
GOMF HISTONE READER ACTIVITY
|
16
|
6.37e-01
|
-6.82e-02
|
7.76e-01
|
GOBP CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION
|
27
|
5.40e-01
|
6.82e-02
|
7.04e-01
|
GOCC EXTRINSIC COMPONENT OF MEMBRANE
|
150
|
1.50e-01
|
-6.81e-02
|
3.05e-01
|
GOBP REGULATION OF MICROTUBULE DEPOLYMERIZATION
|
35
|
4.86e-01
|
-6.81e-02
|
6.59e-01
|
GOBP PSEUDOURIDINE SYNTHESIS
|
18
|
6.17e-01
|
6.81e-02
|
7.62e-01
|
GOBP BIOLOGICAL PROCESS INVOLVED IN INTERACTION WITH SYMBIONT
|
78
|
2.99e-01
|
-6.80e-02
|
4.84e-01
|
GOBP INTRACELLULAR LIPID TRANSPORT
|
39
|
4.62e-01
|
6.80e-02
|
6.38e-01
|
GOBP CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE
|
49
|
4.10e-01
|
-6.80e-02
|
5.94e-01
|
GOMF PHOSPHATIDYLINOSITOL PHOSPHATE BINDING
|
155
|
1.45e-01
|
-6.80e-02
|
2.97e-01
|
GOBP POSITIVE REGULATION OF TOR SIGNALING
|
63
|
3.51e-01
|
6.80e-02
|
5.38e-01
|
GOMF SH2 DOMAIN BINDING
|
35
|
4.87e-01
|
-6.80e-02
|
6.60e-01
|
GOBP REGULATION OF SYSTEM PROCESS
|
480
|
1.11e-02
|
6.80e-02
|
4.70e-02
|
GOCC CILIARY TIP
|
11
|
6.96e-01
|
-6.80e-02
|
8.15e-01
|
GOMF PHOSPHATE TRANSMEMBRANE TRANSPORTER ACTIVITY
|
13
|
6.71e-01
|
6.80e-02
|
8.01e-01
|
GOBP ANGIOTENSIN ACTIVATED SIGNALING PATHWAY
|
18
|
6.18e-01
|
-6.79e-02
|
7.62e-01
|
GOBP HEART GROWTH
|
110
|
2.19e-01
|
-6.79e-02
|
3.95e-01
|
GOMF FRIZZLED BINDING
|
26
|
5.49e-01
|
-6.79e-02
|
7.12e-01
|
GOBP NEGATIVE REGULATION OF SPROUTING ANGIOGENESIS
|
15
|
6.50e-01
|
-6.77e-02
|
7.86e-01
|
GOBP PHOSPHATE ION HOMEOSTASIS
|
12
|
6.85e-01
|
6.77e-02
|
8.08e-01
|
GOBP REGULATION OF NEURON APOPTOTIC PROCESS
|
254
|
6.40e-02
|
-6.77e-02
|
1.72e-01
|
GOCC CILIARY TRANSITION ZONE
|
59
|
3.70e-01
|
-6.75e-02
|
5.57e-01
|
GOMF TRNA BINDING
|
64
|
3.51e-01
|
6.75e-02
|
5.38e-01
|
GOBP POLYAMINE BIOSYNTHETIC PROCESS
|
10
|
7.12e-01
|
6.74e-02
|
8.24e-01
|
GOBP HEMATOPOIETIC OR LYMPHOID ORGAN DEVELOPMENT
|
91
|
2.67e-01
|
-6.74e-02
|
4.48e-01
|
GOCC CUL2 RING UBIQUITIN LIGASE COMPLEX
|
19
|
6.11e-01
|
6.73e-02
|
7.57e-01
|
GOBP LATERAL MESODERM DEVELOPMENT
|
10
|
7.13e-01
|
-6.73e-02
|
8.25e-01
|
GOMF TRANSCRIPTION COACTIVATOR ACTIVITY
|
236
|
7.58e-02
|
-6.73e-02
|
1.94e-01
|
GOBP REGULATION OF STRESS GRANULE ASSEMBLY
|
11
|
6.99e-01
|
-6.73e-02
|
8.17e-01
|
GOBP PROTEIN LOCALIZATION TO CELL CORTEX
|
10
|
7.13e-01
|
-6.72e-02
|
8.25e-01
|
GOMF METALLOPEPTIDASE ACTIVITY
|
130
|
1.87e-01
|
6.71e-02
|
3.53e-01
|
GOBP REGULATION OF ORGANIC ACID TRANSPORT
|
63
|
3.57e-01
|
6.71e-02
|
5.44e-01
|
GOMF CIS TRANS ISOMERASE ACTIVITY
|
34
|
4.99e-01
|
-6.71e-02
|
6.70e-01
|
GOBP REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION
|
211
|
9.39e-02
|
-6.70e-02
|
2.25e-01
|
GOBP LONG CHAIN FATTY ACID IMPORT ACROSS PLASMA MEMBRANE
|
11
|
7.00e-01
|
6.70e-02
|
8.18e-01
|
GOBP SNRNA METABOLIC PROCESS
|
46
|
4.32e-01
|
6.70e-02
|
6.12e-01
|
GOMF PHOSPHATIDYLCHOLINE TRANSPORTER ACTIVITY
|
18
|
6.23e-01
|
-6.70e-02
|
7.65e-01
|
GOMF MYRISTOYLTRANSFERASE ACTIVITY
|
11
|
7.01e-01
|
6.69e-02
|
8.18e-01
|
GOBP AXONEMAL DYNEIN COMPLEX ASSEMBLY
|
12
|
6.88e-01
|
6.69e-02
|
8.10e-01
|
GOBP ADHERENS JUNCTION ORGANIZATION
|
44
|
4.43e-01
|
-6.69e-02
|
6.22e-01
|
GOBP NERVE DEVELOPMENT
|
70
|
3.34e-01
|
-6.68e-02
|
5.22e-01
|
GOMF DNA BINDING TRANSCRIPTION FACTOR BINDING
|
465
|
1.40e-02
|
-6.68e-02
|
5.60e-02
|
GOBP PHOTORECEPTOR CELL MAINTENANCE
|
31
|
5.20e-01
|
6.68e-02
|
6.88e-01
|
GOBP WATER TRANSPORT
|
10
|
7.15e-01
|
-6.67e-02
|
8.26e-01
|
GOBP REGULATION OF RNA SPLICING
|
162
|
1.43e-01
|
-6.67e-02
|
2.96e-01
|
GOBP REGULATION OF LONG TERM SYNAPTIC POTENTIATION
|
52
|
4.06e-01
|
6.67e-02
|
5.90e-01
|
GOBP POSITIVE REGULATION OF EPITHELIAL CELL PROLIFERATION
|
175
|
1.29e-01
|
-6.67e-02
|
2.75e-01
|
GOCC NUCLEAR OUTER MEMBRANE ENDOPLASMIC RETICULUM MEMBRANE NETWORK
|
545
|
8.13e-03
|
6.67e-02
|
3.64e-02
|
GOBP CARDIAC VENTRICLE DEVELOPMENT
|
125
|
1.99e-01
|
-6.66e-02
|
3.69e-01
|
GOBP PLASMA LIPOPROTEIN PARTICLE CLEARANCE
|
26
|
5.57e-01
|
6.66e-02
|
7.18e-01
|
GOBP FIBRINOLYSIS
|
12
|
6.90e-01
|
-6.65e-02
|
8.11e-01
|
GOBP REGULATION OF ESTABLISHMENT OF PLANAR POLARITY
|
15
|
6.56e-01
|
-6.65e-02
|
7.91e-01
|
GOBP TELENCEPHALON DEVELOPMENT
|
198
|
1.08e-01
|
-6.64e-02
|
2.46e-01
|
GOBP PROTEIN POLYUBIQUITINATION
|
233
|
8.18e-02
|
-6.63e-02
|
2.05e-01
|
GOBP RETINA VASCULATURE DEVELOPMENT IN CAMERA TYPE EYE
|
22
|
5.90e-01
|
-6.63e-02
|
7.41e-01
|
GOBP PYRIMIDINE NUCLEOTIDE BIOSYNTHETIC PROCESS
|
22
|
5.90e-01
|
-6.63e-02
|
7.41e-01
|
GOMF RNA NUCLEASE ACTIVITY
|
96
|
2.62e-01
|
-6.62e-02
|
4.44e-01
|
GOBP DEVELOPMENT OF PRIMARY SEXUAL CHARACTERISTICS
|
161
|
1.48e-01
|
-6.62e-02
|
3.01e-01
|
GOBP REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS
|
40
|
4.69e-01
|
6.62e-02
|
6.44e-01
|
GOBP REGULATION OF ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS
|
10
|
7.17e-01
|
-6.61e-02
|
8.28e-01
|
GOBP REGULATION OF NEUROTRANSMITTER RECEPTOR LOCALIZATION TO POSTSYNAPTIC SPECIALIZATION MEMBRANE
|
23
|
5.83e-01
|
6.61e-02
|
7.36e-01
|
GOBP POSITIVE REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS
|
35
|
4.99e-01
|
-6.61e-02
|
6.70e-01
|
GOMF TRANSLATION FACTOR ACTIVITY RNA BINDING
|
73
|
3.29e-01
|
6.61e-02
|
5.17e-01
|
GOBP NEGATIVE REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE
|
23
|
5.84e-01
|
6.61e-02
|
7.36e-01
|
GOBP POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY
|
106
|
2.41e-01
|
-6.60e-02
|
4.20e-01
|
GOCC INSULIN RESPONSIVE COMPARTMENT
|
11
|
7.05e-01
|
6.60e-02
|
8.20e-01
|
GOBP REGULATED EXOCYTOSIS
|
175
|
1.33e-01
|
-6.60e-02
|
2.80e-01
|
GOBP REGULATION OF STORE OPERATED CALCIUM ENTRY
|
13
|
6.81e-01
|
-6.59e-02
|
8.06e-01
|
GOBP RESPIRATORY BURST
|
21
|
6.01e-01
|
-6.59e-02
|
7.48e-01
|
GOBP NEUTROPHIL ACTIVATION INVOLVED IN IMMUNE RESPONSE
|
15
|
6.59e-01
|
6.59e-02
|
7.92e-01
|
GOBP NEGATIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT
|
43
|
4.55e-01
|
6.59e-02
|
6.32e-01
|
GOBP POSITIVE REGULATION OF CELLULAR EXTRAVASATION
|
20
|
6.10e-01
|
-6.59e-02
|
7.56e-01
|
GOBP POSITIVE REGULATION OF PROTEOLYSIS INVOLVED IN PROTEIN CATABOLIC PROCESS
|
114
|
2.25e-01
|
-6.58e-02
|
4.03e-01
|
GOBP INTRACELLULAR ZINC ION HOMEOSTASIS
|
18
|
6.29e-01
|
-6.58e-02
|
7.69e-01
|
GOBP T CELL CHEMOTAXIS
|
14
|
6.70e-01
|
6.58e-02
|
7.99e-01
|
GOBP SPERMATID DIFFERENTIATION
|
115
|
2.24e-01
|
6.58e-02
|
4.01e-01
|
GOBP SYNAPTIC TRANSMISSION GABAERGIC
|
45
|
4.46e-01
|
-6.57e-02
|
6.25e-01
|
GOBP REGULATION OF POSTSYNAPTIC MEMBRANE POTENTIAL
|
85
|
2.95e-01
|
6.57e-02
|
4.79e-01
|
GOBP ORGANIC HYDROXY COMPOUND TRANSPORT
|
190
|
1.20e-01
|
6.56e-02
|
2.63e-01
|
GOBP POSITIVE REGULATION OF HEART GROWTH
|
45
|
4.47e-01
|
6.56e-02
|
6.25e-01
|
GOBP ANIMAL ORGAN REGENERATION
|
23
|
5.86e-01
|
-6.56e-02
|
7.38e-01
|
GOBP GLANDULAR EPITHELIAL CELL DEVELOPMENT
|
24
|
5.78e-01
|
-6.55e-02
|
7.33e-01
|
GOBP COMPLEMENT ACTIVATION CLASSICAL PATHWAY
|
17
|
6.40e-01
|
-6.55e-02
|
7.78e-01
|
GOMF GENERAL TRANSCRIPTION INITIATION FACTOR BINDING
|
57
|
3.93e-01
|
-6.55e-02
|
5.78e-01
|
GOBP VIRAL RELEASE FROM HOST CELL
|
23
|
5.87e-01
|
-6.55e-02
|
7.39e-01
|
GOBP CILIUM ORGANIZATION
|
281
|
5.98e-02
|
-6.54e-02
|
1.65e-01
|
GOCC POSTSYNAPTIC RECYCLING ENDOSOME
|
13
|
6.83e-01
|
6.54e-02
|
8.06e-01
|
GOBP CELL MORPHOGENESIS INVOLVED IN NEURON DIFFERENTIATION
|
511
|
1.19e-02
|
-6.53e-02
|
4.95e-02
|
GOBP REGULATION OF NUCLEOTIDE CATABOLIC PROCESS
|
52
|
4.16e-01
|
6.53e-02
|
5.99e-01
|
GOBP NEGATIVE REGULATION OF INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY
|
12
|
6.95e-01
|
-6.53e-02
|
8.14e-01
|
GOBP ORGANOPHOSPHATE ESTER TRANSPORT
|
99
|
2.62e-01
|
-6.52e-02
|
4.44e-01
|
GOBP NEURON PROJECTION EXTENSION INVOLVED IN NEURON PROJECTION GUIDANCE
|
16
|
6.51e-01
|
6.52e-02
|
7.87e-01
|
GOBP POSITIVE REGULATION OF SYNAPSE ASSEMBLY
|
55
|
4.03e-01
|
-6.52e-02
|
5.88e-01
|
GOMF ABC TYPE XENOBIOTIC TRANSPORTER ACTIVITY
|
13
|
6.84e-01
|
-6.51e-02
|
8.07e-01
|
GOBP REGULATION OF ADIPOSE TISSUE DEVELOPMENT
|
14
|
6.73e-01
|
6.51e-02
|
8.02e-01
|
GOBP PROGRAMMED CELL DEATH IN RESPONSE TO REACTIVE OXYGEN SPECIES
|
16
|
6.52e-01
|
6.51e-02
|
7.88e-01
|
GOBP INNER EAR MORPHOGENESIS
|
73
|
3.37e-01
|
-6.51e-02
|
5.26e-01
|
GOBP N TERMINAL PROTEIN AMINO ACID MODIFICATION
|
22
|
5.98e-01
|
-6.50e-02
|
7.46e-01
|
GOBP REGULATION OF CELLULAR COMPONENT SIZE
|
328
|
4.40e-02
|
-6.49e-02
|
1.31e-01
|
GOBP PROTEIN MATURATION
|
396
|
2.74e-02
|
6.49e-02
|
9.31e-02
|
GOBP REGULATION OF SIGNALING RECEPTOR ACTIVITY
|
72
|
3.42e-01
|
-6.48e-02
|
5.30e-01
|
GOBP CELL RECOGNITION
|
95
|
2.76e-01
|
6.48e-02
|
4.58e-01
|
GOCC MICROTUBULE PLUS END
|
23
|
5.91e-01
|
-6.48e-02
|
7.41e-01
|
GOCC BRUSH BORDER
|
109
|
2.43e-01
|
6.48e-02
|
4.23e-01
|
GOBP POSITIVE REGULATION OF POST TRANSLATIONAL PROTEIN MODIFICATION
|
123
|
2.16e-01
|
-6.47e-02
|
3.91e-01
|
GOBP POSITIVE REGULATION OF CALCIUM ION TRANSPORT
|
99
|
2.67e-01
|
-6.46e-02
|
4.48e-01
|
GOBP SUPEROXIDE ANION GENERATION
|
36
|
5.03e-01
|
-6.46e-02
|
6.73e-01
|
GOBP ERYTHROCYTE MATURATION
|
17
|
6.45e-01
|
-6.46e-02
|
7.82e-01
|
GOBP FAT SOLUBLE VITAMIN METABOLIC PROCESS
|
25
|
5.76e-01
|
-6.46e-02
|
7.32e-01
|
GOBP POSITIVE REGULATION OF REGULATED SECRETORY PATHWAY
|
37
|
4.97e-01
|
-6.45e-02
|
6.69e-01
|
GOMF HSP70 PROTEIN BINDING
|
49
|
4.35e-01
|
6.45e-02
|
6.14e-01
|
GOBP DENTATE GYRUS DEVELOPMENT
|
20
|
6.17e-01
|
6.45e-02
|
7.62e-01
|
GOBP LYSOSOMAL TRANSPORT
|
112
|
2.39e-01
|
-6.45e-02
|
4.18e-01
|
GOBP POSITIVE REGULATION OF PROTEIN CATABOLIC PROCESS
|
177
|
1.39e-01
|
-6.45e-02
|
2.91e-01
|
GOCC SUPRAMOLECULAR COMPLEX
|
1039
|
5.11e-04
|
-6.45e-02
|
3.90e-03
|
GOBP GROWTH
|
834
|
1.72e-03
|
-6.45e-02
|
1.07e-02
|
GOCC DENDRITIC SPINE HEAD
|
11
|
7.11e-01
|
-6.44e-02
|
8.24e-01
|
GOCC TRANS GOLGI NETWORK TRANSPORT VESICLE MEMBRANE
|
15
|
6.66e-01
|
6.44e-02
|
7.97e-01
|
GOBP FEAR RESPONSE
|
37
|
4.98e-01
|
6.44e-02
|
6.69e-01
|
GOBP CGMP METABOLIC PROCESS
|
10
|
7.24e-01
|
-6.44e-02
|
8.33e-01
|
GOBP PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION
|
600
|
7.45e-03
|
-6.44e-02
|
3.41e-02
|
GOBP POSITIVE REGULATION OF INTERLEUKIN 13 PRODUCTION
|
10
|
7.25e-01
|
-6.43e-02
|
8.34e-01
|
GOBP CARBOHYDRATE DERIVATIVE TRANSPORT
|
64
|
3.74e-01
|
-6.43e-02
|
5.60e-01
|
GOBP CELLULAR RESPONSE TO GLUCOSE STARVATION
|
40
|
4.83e-01
|
-6.41e-02
|
6.56e-01
|
GOBP POSITIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS
|
29
|
5.50e-01
|
6.41e-02
|
7.13e-01
|
GOBP REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMOSOME
|
12
|
7.01e-01
|
-6.41e-02
|
8.18e-01
|
GOBP POSITIVE REGULATION OF ORGAN GROWTH
|
55
|
4.11e-01
|
6.41e-02
|
5.94e-01
|
GOBP GLUCAN BIOSYNTHETIC PROCESS
|
42
|
4.73e-01
|
-6.40e-02
|
6.47e-01
|
GOBP C TERMINAL PROTEIN AMINO ACID MODIFICATION
|
17
|
6.48e-01
|
6.40e-02
|
7.84e-01
|
GOMF ATP DEPENDENT ACTIVITY
|
464
|
1.87e-02
|
-6.40e-02
|
6.99e-02
|
GOBP DEVELOPMENTAL GROWTH
|
634
|
6.28e-03
|
-6.40e-02
|
2.98e-02
|
GOBP ESTABLISHMENT OF RNA LOCALIZATION
|
128
|
2.12e-01
|
-6.40e-02
|
3.86e-01
|
GOBP REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING
|
57
|
4.04e-01
|
-6.40e-02
|
5.89e-01
|
GOBP STEROID CATABOLIC PROCESS
|
12
|
7.02e-01
|
6.39e-02
|
8.18e-01
|
GOBP KERATINOCYTE MIGRATION
|
15
|
6.68e-01
|
6.39e-02
|
7.98e-01
|
GOBP PEPTIDYL LYSINE MODIFICATION
|
120
|
2.28e-01
|
-6.38e-02
|
4.05e-01
|
GOCC AXONAL GROWTH CONE
|
41
|
4.81e-01
|
6.36e-02
|
6.55e-01
|
GOBP RESPONSE TO LITHIUM ION
|
12
|
7.03e-01
|
-6.36e-02
|
8.20e-01
|
GOBP EXCITATORY POSTSYNAPTIC POTENTIAL
|
67
|
3.68e-01
|
6.36e-02
|
5.55e-01
|
GOBP NEGATIVE REGULATION OF TRANSLATION
|
102
|
2.68e-01
|
-6.35e-02
|
4.50e-01
|
GOCC MAIN AXON
|
65
|
3.76e-01
|
6.35e-02
|
5.62e-01
|
GOBP REGULATION OF INCLUSION BODY ASSEMBLY
|
16
|
6.61e-01
|
-6.34e-02
|
7.93e-01
|
GOBP POSITIVE REGULATION OF MITOTIC NUCLEAR DIVISION
|
37
|
5.05e-01
|
-6.34e-02
|
6.75e-01
|
GOBP SENSORY ORGAN DEVELOPMENT
|
443
|
2.29e-02
|
-6.33e-02
|
8.15e-02
|
GOBP REGULATION OF BODY FLUID LEVELS
|
229
|
9.95e-02
|
-6.33e-02
|
2.34e-01
|
GOCC NBAF COMPLEX
|
14
|
6.82e-01
|
6.33e-02
|
8.06e-01
|
GOBP REGULATION OF PROTEIN LOCALIZATION TO CENTROSOME
|
12
|
7.04e-01
|
6.33e-02
|
8.20e-01
|
GOBP NEGATIVE REGULATION OF CATALYTIC ACTIVITY
|
399
|
3.09e-02
|
-6.32e-02
|
1.02e-01
|
GOMF AMINOACYLTRANSFERASE ACTIVITY
|
381
|
3.51e-02
|
-6.31e-02
|
1.12e-01
|
GOBP MRNA METABOLIC PROCESS
|
622
|
7.63e-03
|
-6.31e-02
|
3.47e-02
|
GOBP SCF DEPENDENT PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS
|
39
|
4.96e-01
|
6.30e-02
|
6.68e-01
|
GOBP EXOCYTIC PROCESS
|
73
|
3.53e-01
|
-6.30e-02
|
5.39e-01
|
GOBP POSITIVE REGULATION OF EXOCYTOSIS
|
71
|
3.60e-01
|
-6.29e-02
|
5.46e-01
|
GOBP FEEDING BEHAVIOR
|
59
|
4.04e-01
|
6.29e-02
|
5.88e-01
|
GOBP POSITIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY
|
87
|
3.12e-01
|
-6.28e-02
|
4.97e-01
|
GOBP CELLULAR RESPONSE TO RETINOIC ACID
|
31
|
5.46e-01
|
-6.27e-02
|
7.09e-01
|
GOBP ER OVERLOAD RESPONSE
|
11
|
7.19e-01
|
6.26e-02
|
8.30e-01
|
GOBP NEGATIVE REGULATION OF CHONDROCYTE DIFFERENTIATION
|
17
|
6.55e-01
|
-6.26e-02
|
7.90e-01
|
GOCC SECRETORY GRANULE
|
244
|
9.31e-02
|
-6.26e-02
|
2.24e-01
|
GOBP FORMATION OF TRANSLATION PREINITIATION COMPLEX
|
10
|
7.32e-01
|
-6.25e-02
|
8.39e-01
|
GOBP REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY
|
161
|
1.72e-01
|
-6.25e-02
|
3.35e-01
|
GOBP POSITIVE REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS
|
98
|
2.87e-01
|
-6.24e-02
|
4.69e-01
|
GOBP CHAPERONE COFACTOR DEPENDENT PROTEIN REFOLDING
|
29
|
5.61e-01
|
6.23e-02
|
7.21e-01
|
GOBP ADENYLATE CYCLASE MODULATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY
|
129
|
2.22e-01
|
-6.23e-02
|
3.99e-01
|
GOCC TRANSCRIPTION FACTOR TFIID COMPLEX
|
30
|
5.55e-01
|
-6.23e-02
|
7.17e-01
|
GOMF CATALYTIC ACTIVITY ACTING ON RNA
|
303
|
6.30e-02
|
6.23e-02
|
1.70e-01
|
GOCC NUCLEOLUS
|
794
|
3.13e-03
|
-6.22e-02
|
1.71e-02
|
GOBP ORGANELLE TRANSPORT ALONG MICROTUBULE
|
76
|
3.49e-01
|
6.21e-02
|
5.37e-01
|
GOBP CELLULAR RESPONSE TO ESTROGEN STIMULUS
|
13
|
6.99e-01
|
6.21e-02
|
8.17e-01
|
GOBP REGULATION OF CELL GROWTH
|
357
|
4.48e-02
|
-6.20e-02
|
1.33e-01
|
GOBP REGULATION OF LYASE ACTIVITY
|
29
|
5.64e-01
|
6.20e-02
|
7.23e-01
|
GOBP NEGATIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT
|
14
|
6.88e-01
|
-6.20e-02
|
8.10e-01
|
GOBP TROPHOBLAST CELL MIGRATION
|
13
|
6.99e-01
|
-6.20e-02
|
8.17e-01
|
GOBP RESPONSE TO POTASSIUM ION
|
11
|
7.22e-01
|
6.19e-02
|
8.32e-01
|
GOBP REGULATION OF PROTEIN EXPORT FROM NUCLEUS
|
36
|
5.21e-01
|
-6.18e-02
|
6.89e-01
|
GOBP ICOSANOID TRANSPORT
|
37
|
5.15e-01
|
6.18e-02
|
6.84e-01
|
GOBP CENTRAL NERVOUS SYSTEM NEURON DIFFERENTIATION
|
126
|
2.32e-01
|
-6.17e-02
|
4.11e-01
|
GOBP ESTABLISHMENT OF TISSUE POLARITY
|
37
|
5.16e-01
|
-6.17e-02
|
6.85e-01
|
GOCC DNA REPLICATION FACTOR A COMPLEX
|
13
|
7.01e-01
|
6.16e-02
|
8.18e-01
|
GOBP MAINTENANCE OF LOCATION IN CELL
|
182
|
1.53e-01
|
-6.15e-02
|
3.09e-01
|
GOBP TETRAHYDROFOLATE METABOLIC PROCESS
|
19
|
6.43e-01
|
-6.14e-02
|
7.81e-01
|
GOBP REGULATION OF CELL MATURATION
|
23
|
6.10e-01
|
6.14e-02
|
7.56e-01
|
GOBP REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA
|
45
|
4.77e-01
|
6.13e-02
|
6.51e-01
|
GOCC RIBONUCLEOPROTEIN GRANULE
|
217
|
1.20e-01
|
-6.13e-02
|
2.64e-01
|
GOBP NEGATIVE REGULATION OF MRNA SPLICING VIA SPLICEOSOME
|
20
|
6.35e-01
|
-6.13e-02
|
7.75e-01
|
GOBP NON MEMBRANE BOUNDED ORGANELLE ASSEMBLY
|
373
|
4.31e-02
|
-6.12e-02
|
1.29e-01
|
GOBP CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT
|
17
|
6.62e-01
|
-6.12e-02
|
7.94e-01
|
GOBP POSTSYNAPTIC SPECIALIZATION ASSEMBLY
|
29
|
5.69e-01
|
-6.12e-02
|
7.27e-01
|
GOBP RESPONSE TO ALCOHOL
|
127
|
2.34e-01
|
-6.12e-02
|
4.14e-01
|
GOCC MEMBRANE MICRODOMAIN
|
244
|
1.01e-01
|
-6.12e-02
|
2.36e-01
|
GOBP POSITIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS
|
33
|
5.44e-01
|
-6.11e-02
|
7.08e-01
|
GOBP NEGATIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION
|
482
|
2.22e-02
|
-6.11e-02
|
7.98e-02
|
GOBP CELLULAR RESPONSE TO STRESS
|
1526
|
8.83e-05
|
-6.11e-02
|
8.97e-04
|
GOBP ERBB3 SIGNALING PATHWAY
|
14
|
6.93e-01
|
6.10e-02
|
8.13e-01
|
GOBP SENSORY PERCEPTION OF MECHANICAL STIMULUS
|
132
|
2.27e-01
|
-6.10e-02
|
4.04e-01
|
GOBP REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS
|
108
|
2.74e-01
|
-6.10e-02
|
4.56e-01
|
GOBP DEVELOPMENTAL GROWTH INVOLVED IN MORPHOGENESIS
|
223
|
1.18e-01
|
-6.09e-02
|
2.60e-01
|
GOCC NEURON PROJECTION TERMINUS
|
142
|
2.11e-01
|
6.09e-02
|
3.85e-01
|
GOBP HUMORAL IMMUNE RESPONSE
|
104
|
2.84e-01
|
6.08e-02
|
4.68e-01
|
GOBP POSITIVE REGULATION OF SYNAPTIC PLASTICITY
|
12
|
7.16e-01
|
-6.07e-02
|
8.27e-01
|
GOBP KERATINIZATION
|
11
|
7.27e-01
|
6.07e-02
|
8.35e-01
|
GOBP NEGATIVE REGULATION OF MEIOTIC CELL CYCLE
|
11
|
7.28e-01
|
6.06e-02
|
8.36e-01
|
GOBP MEMBRANE REPOLARIZATION DURING ACTION POTENTIAL
|
15
|
6.85e-01
|
-6.06e-02
|
8.08e-01
|
GOMF CYCLIN DEPENDENT PROTEIN SERINE THREONINE KINASE INHIBITOR ACTIVITY
|
11
|
7.28e-01
|
6.05e-02
|
8.36e-01
|
GOMF PROTEIN HORMONE RECEPTOR ACTIVITY
|
10
|
7.41e-01
|
-6.05e-02
|
8.45e-01
|
GOMF INTRACELLULARLY GATED CALCIUM CHANNEL ACTIVITY
|
13
|
7.06e-01
|
-6.04e-02
|
8.20e-01
|
GOBP POSITIVE REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC
|
27
|
5.87e-01
|
6.04e-02
|
7.39e-01
|
GOBP REGULATION OF MONOATOMIC ION TRANSMEMBRANE TRANSPORT
|
271
|
8.83e-02
|
6.03e-02
|
2.16e-01
|
GOBP REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS
|
18
|
6.58e-01
|
-6.03e-02
|
7.92e-01
|
GOBP NUCLEOSIDE MONOPHOSPHATE CATABOLIC PROCESS
|
18
|
6.58e-01
|
-6.03e-02
|
7.92e-01
|
GOBP CELLULAR RESPONSE TO ALCOHOL
|
72
|
3.78e-01
|
-6.02e-02
|
5.64e-01
|
GOBP LUTEINIZATION
|
12
|
7.18e-01
|
6.02e-02
|
8.29e-01
|
GOBP CELLULAR OXIDANT DETOXIFICATION
|
25
|
6.03e-01
|
6.02e-02
|
7.50e-01
|
GOBP RESPONSE TO RETINOIC ACID
|
62
|
4.13e-01
|
-6.02e-02
|
5.96e-01
|
GOCC PERINUCLEAR REGION OF CYTOPLASM
|
590
|
1.31e-02
|
-6.01e-02
|
5.33e-02
|
GOBP POSITIVE REGULATION OF RAS PROTEIN SIGNAL TRANSDUCTION
|
19
|
6.50e-01
|
-6.01e-02
|
7.86e-01
|
GOCC VOLTAGE GATED CALCIUM CHANNEL COMPLEX
|
23
|
6.18e-01
|
6.00e-02
|
7.63e-01
|
GOCC SCHAFFER COLLATERAL CA1 SYNAPSE
|
122
|
2.53e-01
|
-6.00e-02
|
4.34e-01
|
GOBP ORGAN OR TISSUE SPECIFIC IMMUNE RESPONSE
|
11
|
7.31e-01
|
-5.99e-02
|
8.38e-01
|
GOBP FATTY ACID TRANSPORT
|
72
|
3.80e-01
|
5.99e-02
|
5.66e-01
|
GOBP MAINTENANCE OF PROTEIN LOCATION IN NUCLEUS
|
22
|
6.27e-01
|
-5.99e-02
|
7.68e-01
|
GOBP CAVEOLIN MEDIATED ENDOCYTOSIS
|
10
|
7.43e-01
|
-5.98e-02
|
8.47e-01
|
GOMF TRANSLATION REPRESSOR ACTIVITY
|
27
|
5.91e-01
|
-5.98e-02
|
7.41e-01
|
GOMF SULFUR COMPOUND BINDING
|
196
|
1.50e-01
|
5.97e-02
|
3.05e-01
|
GOBP REGULATION OF HEART RATE BY CARDIAC CONDUCTION
|
32
|
5.59e-01
|
5.97e-02
|
7.19e-01
|
GOCC NEURON SPINE
|
165
|
1.88e-01
|
-5.95e-02
|
3.55e-01
|
GOMF PROTEASE BINDING
|
131
|
2.40e-01
|
-5.95e-02
|
4.20e-01
|
GOBP NUCLEAR EXPORT
|
148
|
2.13e-01
|
-5.93e-02
|
3.88e-01
|
GOMF MOLECULAR FUNCTION INHIBITOR ACTIVITY
|
333
|
6.39e-02
|
-5.93e-02
|
1.72e-01
|
GOBP AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS
|
53
|
4.56e-01
|
5.92e-02
|
6.33e-01
|
GOBP GRANULOCYTE DIFFERENTIATION
|
35
|
5.44e-01
|
5.92e-02
|
7.08e-01
|
GOMF HYDROLASE ACTIVITY HYDROLYZING N GLYCOSYL COMPOUNDS
|
26
|
6.01e-01
|
5.92e-02
|
7.48e-01
|
GOBP SENSORY SYSTEM DEVELOPMENT
|
308
|
7.51e-02
|
-5.91e-02
|
1.93e-01
|
GOBP DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING
|
53
|
4.57e-01
|
-5.91e-02
|
6.34e-01
|
GOBP GAMETE GENERATION
|
458
|
3.09e-02
|
-5.91e-02
|
1.02e-01
|
GOBP SENSORY PERCEPTION OF CHEMICAL STIMULUS
|
29
|
5.82e-01
|
-5.91e-02
|
7.35e-01
|
GOBP POSITIVE REGULATION OF MUSCLE CONTRACTION
|
34
|
5.51e-01
|
-5.91e-02
|
7.13e-01
|
GOBP RESPONSE TO PEPTIDE HORMONE
|
319
|
7.18e-02
|
-5.88e-02
|
1.87e-01
|
GOBP CELL CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES
|
143
|
2.26e-01
|
-5.88e-02
|
4.03e-01
|
GOBP RNA DECAPPING
|
18
|
6.66e-01
|
-5.88e-02
|
7.97e-01
|
GOMF OXIDOREDUCTASE ACTIVITY ACTING ON NAD P H OXYGEN AS ACCEPTOR
|
13
|
7.14e-01
|
-5.88e-02
|
8.25e-01
|
GOBP POSITIVE REGULATION OF AMIDE METABOLIC PROCESS
|
28
|
5.91e-01
|
-5.88e-02
|
7.41e-01
|
GOBP ENDOSOMAL TRANSPORT
|
251
|
1.10e-01
|
-5.87e-02
|
2.49e-01
|
GOBP MULTICELLULAR ORGANISMAL LEVEL HOMEOSTASIS
|
690
|
9.09e-03
|
-5.87e-02
|
3.98e-02
|
GOBP RNA SPLICING
|
391
|
4.76e-02
|
-5.86e-02
|
1.40e-01
|
GOBP REGULATION OF TRANSLATION AT SYNAPSE
|
11
|
7.37e-01
|
-5.85e-02
|
8.43e-01
|
GOBP SECONDARY METABOLIC PROCESS
|
34
|
5.56e-01
|
-5.84e-02
|
7.17e-01
|
GOBP PIGMENT ACCUMULATION
|
10
|
7.49e-01
|
-5.83e-02
|
8.51e-01
|
GOBP GRANULOCYTE ACTIVATION
|
32
|
5.68e-01
|
-5.83e-02
|
7.26e-01
|
GOBP NUCLEAR TRANSPORT
|
310
|
7.85e-02
|
-5.83e-02
|
1.99e-01
|
GOMF RNA POLYMERASE II GENERAL TRANSCRIPTION INITIATION FACTOR ACTIVITY
|
32
|
5.69e-01
|
5.83e-02
|
7.27e-01
|
GOBP REGULATION OF INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY
|
16
|
6.87e-01
|
-5.82e-02
|
8.09e-01
|
GOBP GANGLIOSIDE METABOLIC PROCESS
|
23
|
6.29e-01
|
-5.81e-02
|
7.70e-01
|
GOBP RESPONSE TO REACTIVE OXYGEN SPECIES
|
165
|
1.99e-01
|
-5.81e-02
|
3.69e-01
|
GOBP 3 UTR MEDIATED MRNA STABILIZATION
|
16
|
6.88e-01
|
5.81e-02
|
8.10e-01
|
GOBP POSITIVE REGULATION OF CATION CHANNEL ACTIVITY
|
35
|
5.53e-01
|
-5.80e-02
|
7.15e-01
|
GOBP REGULATION OF PROTEIN DEUBIQUITINATION
|
10
|
7.51e-01
|
5.80e-02
|
8.51e-01
|
GOBP NEGATIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION
|
123
|
2.69e-01
|
5.78e-02
|
4.50e-01
|
GOBP NEGATIVE REGULATION OF DNA RECOMBINATION
|
33
|
5.66e-01
|
-5.78e-02
|
7.25e-01
|
GOBP RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN
|
116
|
2.83e-01
|
-5.77e-02
|
4.66e-01
|
GOBP EPITHELIAL CELL CELL ADHESION
|
14
|
7.09e-01
|
5.77e-02
|
8.22e-01
|
GOBP GLIAL CELL ACTIVATION
|
48
|
4.90e-01
|
-5.76e-02
|
6.63e-01
|
GOBP RNA SPLICING VIA TRANSESTERIFICATION REACTIONS
|
252
|
1.16e-01
|
-5.76e-02
|
2.57e-01
|
GOCC EXCITATORY SYNAPSE
|
66
|
4.19e-01
|
5.76e-02
|
6.01e-01
|
GOBP POSITIVE REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS
|
89
|
3.48e-01
|
-5.76e-02
|
5.36e-01
|
GOBP NEURAL RETINA DEVELOPMENT
|
51
|
4.77e-01
|
5.76e-02
|
6.51e-01
|
GOBP REGULATION OF BILE ACID METABOLIC PROCESS
|
10
|
7.53e-01
|
5.76e-02
|
8.52e-01
|
GOBP SYNAPTIC VESICLE MATURATION
|
26
|
6.12e-01
|
5.76e-02
|
7.57e-01
|
GOBP MATURATION OF SSU RRNA
|
44
|
5.09e-01
|
5.75e-02
|
6.79e-01
|
GOBP MUSCLE CELL APOPTOTIC PROCESS
|
104
|
3.12e-01
|
-5.74e-02
|
4.98e-01
|
GOBP POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS
|
65
|
4.24e-01
|
-5.74e-02
|
6.06e-01
|
GOBP REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS
|
144
|
2.36e-01
|
-5.73e-02
|
4.14e-01
|
GOBP MUSCLE CELL DEVELOPMENT
|
208
|
1.55e-01
|
5.73e-02
|
3.11e-01
|
GOBP ERAD PATHWAY
|
97
|
3.30e-01
|
5.73e-02
|
5.17e-01
|
GOBP TOLL LIKE RECEPTOR SIGNALING PATHWAY
|
59
|
4.47e-01
|
-5.73e-02
|
6.25e-01
|
GOBP REGULATION OF KETONE BIOSYNTHETIC PROCESS
|
16
|
6.92e-01
|
5.72e-02
|
8.12e-01
|
GOMF FIBROBLAST GROWTH FACTOR RECEPTOR BINDING
|
17
|
6.83e-01
|
5.72e-02
|
8.06e-01
|
GOBP SKELETAL MUSCLE ACETYLCHOLINE GATED CHANNEL CLUSTERING
|
20
|
6.58e-01
|
-5.72e-02
|
7.92e-01
|
GOBP CARDIAC ATRIUM DEVELOPMENT
|
32
|
5.76e-01
|
-5.72e-02
|
7.32e-01
|
GOMF CARGO ADAPTOR ACTIVITY
|
19
|
6.66e-01
|
-5.71e-02
|
7.97e-01
|
GOBP POSITIVE REGULATION OF POTASSIUM ION TRANSPORT
|
39
|
5.38e-01
|
5.71e-02
|
7.02e-01
|
GOBP POSITIVE REGULATION OF LIPID TRANSPORT
|
68
|
4.17e-01
|
5.70e-02
|
6.00e-01
|
GOBP REGULATION OF PEPTIDASE ACTIVITY
|
255
|
1.19e-01
|
-5.69e-02
|
2.61e-01
|
GOBP REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY
|
20
|
6.60e-01
|
5.69e-02
|
7.93e-01
|
GOBP POSITIVE REGULATION OF PROTEOLYSIS
|
281
|
1.02e-01
|
-5.68e-02
|
2.38e-01
|
GOBP POSITIVE REGULATION OF PEPTIDASE ACTIVITY
|
133
|
2.58e-01
|
-5.68e-02
|
4.40e-01
|
GOBP P38MAPK CASCADE
|
54
|
4.70e-01
|
-5.68e-02
|
6.45e-01
|
GOBP DISRUPTION OF ANATOMICAL STRUCTURE IN ANOTHER ORGANISM
|
42
|
5.24e-01
|
-5.68e-02
|
6.91e-01
|
GOBP DETECTION OF TEMPERATURE STIMULUS INVOLVED IN SENSORY PERCEPTION OF PAIN
|
15
|
7.04e-01
|
-5.67e-02
|
8.20e-01
|
GOBP POSITIVE REGULATION OF MUSCLE CELL DIFFERENTIATION
|
68
|
4.19e-01
|
-5.67e-02
|
6.01e-01
|
GOBP POSITIVE REGULATION OF MONOCYTE CHEMOTAXIS
|
15
|
7.04e-01
|
-5.67e-02
|
8.20e-01
|
GOBP POSITIVE REGULATION OF MITOCHONDRIAL FISSION
|
22
|
6.46e-01
|
-5.66e-02
|
7.82e-01
|
GOMF HISTONE METHYLTRANSFERASE ACTIVITY
|
49
|
4.93e-01
|
-5.66e-02
|
6.65e-01
|
GOBP RESPONSE TO AUDITORY STIMULUS
|
18
|
6.78e-01
|
-5.66e-02
|
8.05e-01
|
GOBP POSITIVE REGULATION OF PROTEIN LOCALIZATION
|
447
|
4.13e-02
|
-5.65e-02
|
1.26e-01
|
GOBP VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DEVELOPMENT
|
15
|
7.05e-01
|
-5.65e-02
|
8.20e-01
|
GOMF ZINC ION BINDING
|
563
|
2.30e-02
|
-5.64e-02
|
8.17e-02
|
GOCC NON MOTILE CILIUM
|
106
|
3.17e-01
|
-5.64e-02
|
5.03e-01
|
GOBP REGULATION OF MYOBLAST FUSION
|
17
|
6.88e-01
|
-5.63e-02
|
8.10e-01
|
GOBP REGULATION OF ATP BIOSYNTHETIC PROCESS
|
15
|
7.06e-01
|
5.62e-02
|
8.20e-01
|
GOBP SEX DIFFERENTIATION
|
193
|
1.79e-01
|
-5.62e-02
|
3.43e-01
|
GOBP REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS
|
80
|
3.85e-01
|
-5.62e-02
|
5.71e-01
|
GOBP CARBOHYDRATE PHOSPHORYLATION
|
17
|
6.89e-01
|
5.62e-02
|
8.10e-01
|
GOMF CALCIUM ION BINDING
|
401
|
5.46e-02
|
-5.62e-02
|
1.55e-01
|
GOMF CYTOSKELETAL ANCHOR ACTIVITY
|
12
|
7.36e-01
|
5.61e-02
|
8.43e-01
|
GOCC CATALYTIC COMPLEX
|
1444
|
4.44e-04
|
5.61e-02
|
3.50e-03
|
GOBP STRIATED MUSCLE CELL DIFFERENTIATION
|
292
|
1.00e-01
|
5.60e-02
|
2.36e-01
|
GOMF STEROL TRANSFER ACTIVITY
|
19
|
6.73e-01
|
5.60e-02
|
8.01e-01
|
GOBP NEGATIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION
|
28
|
6.08e-01
|
-5.60e-02
|
7.55e-01
|
GOBP ORGANELLE ASSEMBLY
|
808
|
7.39e-03
|
-5.59e-02
|
3.40e-02
|
GOBP REGULATION OF MORPHOGENESIS OF A BRANCHING STRUCTURE
|
51
|
4.90e-01
|
-5.59e-02
|
6.63e-01
|
GOBP OLEFINIC COMPOUND BIOSYNTHETIC PROCESS
|
17
|
6.90e-01
|
5.59e-02
|
8.11e-01
|
GOBP POSITIVE REGULATION OF SYNAPTIC TRANSMISSION GABAERGIC
|
13
|
7.27e-01
|
5.59e-02
|
8.35e-01
|
GOBP CELLULAR RESPONSE TO METAL ION
|
121
|
2.90e-01
|
-5.58e-02
|
4.73e-01
|
GOBP VESICLE MEDIATED TRANSPORT
|
1256
|
1.04e-03
|
-5.58e-02
|
7.00e-03
|
GOBP REGULATION OF SYNAPTIC VESICLE PRIMING
|
11
|
7.49e-01
|
5.58e-02
|
8.51e-01
|
GOBP REGULATION OF CELLULAR LOCALIZATION
|
898
|
5.02e-03
|
-5.57e-02
|
2.50e-02
|
GOBP REGULATION OF PROTEIN CATABOLIC PROCESS
|
311
|
9.22e-02
|
-5.57e-02
|
2.22e-01
|
GOBP POSITIVE REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY
|
30
|
5.98e-01
|
-5.57e-02
|
7.46e-01
|
GOBP AXONAL TRANSPORT
|
61
|
4.53e-01
|
5.56e-02
|
6.30e-01
|
GOBP EYELID DEVELOPMENT IN CAMERA TYPE EYE
|
11
|
7.50e-01
|
-5.55e-02
|
8.51e-01
|
GOBP DETECTION OF STIMULUS
|
119
|
2.96e-01
|
-5.55e-02
|
4.80e-01
|
GOCC COP9 SIGNALOSOME
|
28
|
6.12e-01
|
-5.55e-02
|
7.57e-01
|
GOCC NEURON PROJECTION CYTOPLASM
|
44
|
5.25e-01
|
-5.55e-02
|
6.91e-01
|
GOBP POSITIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION
|
35
|
5.70e-01
|
-5.54e-02
|
7.27e-01
|
GOBP AMINO ACID TRANSPORT
|
122
|
2.91e-01
|
5.54e-02
|
4.75e-01
|
GOBP NEGATIVE REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION
|
23
|
6.46e-01
|
-5.53e-02
|
7.83e-01
|
GOBP DOPAMINERGIC NEURON DIFFERENTIATION
|
22
|
6.53e-01
|
-5.53e-02
|
7.89e-01
|
GOBP POSITIVE REGULATION OF CALCIUM MEDIATED SIGNALING
|
42
|
5.35e-01
|
-5.53e-02
|
7.00e-01
|
GOBP SYNAPSE PRUNING
|
14
|
7.21e-01
|
-5.51e-02
|
8.31e-01
|
GOBP POSITIVE REGULATION OF BONE RESORPTION
|
21
|
6.62e-01
|
-5.51e-02
|
7.94e-01
|
GOBP RECEPTOR METABOLIC PROCESS
|
72
|
4.19e-01
|
5.51e-02
|
6.01e-01
|
GOBP PLATELET DENSE GRANULE ORGANIZATION
|
18
|
6.86e-01
|
5.51e-02
|
8.08e-01
|
GOBP POSITIVE REGULATION OF ERBB SIGNALING PATHWAY
|
21
|
6.62e-01
|
-5.51e-02
|
7.94e-01
|
GOBP POSITIVE REGULATION OF AXON EXTENSION
|
51
|
4.97e-01
|
5.51e-02
|
6.68e-01
|
GOBP SENSORY PERCEPTION OF PAIN
|
56
|
4.76e-01
|
5.51e-02
|
6.50e-01
|
GOBP POSITIVE REGULATION OF NERVOUS SYSTEM PROCESS
|
32
|
5.90e-01
|
5.50e-02
|
7.41e-01
|
GOBP CELLULAR RESPONSE TO ARSENIC CONTAINING SUBSTANCE
|
16
|
7.04e-01
|
5.49e-02
|
8.20e-01
|
GOCC PRESYNAPTIC MEMBRANE
|
165
|
2.25e-01
|
5.49e-02
|
4.02e-01
|
GOMF PEPTIDE N ACETYLTRANSFERASE ACTIVITY
|
44
|
5.29e-01
|
-5.49e-02
|
6.94e-01
|
GOBP FEMALE SEX DIFFERENTIATION
|
94
|
3.58e-01
|
-5.49e-02
|
5.45e-01
|
GOCC NUCLEAR ENVELOPE LUMEN
|
11
|
7.54e-01
|
-5.47e-02
|
8.53e-01
|
GOBP CELLULAR RESPONSE TO LEUCINE STARVATION
|
11
|
7.54e-01
|
5.45e-02
|
8.53e-01
|
GOMF DIPEPTIDASE ACTIVITY
|
15
|
7.15e-01
|
-5.45e-02
|
8.26e-01
|
GOCC PLASMA MEMBRANE BOUNDED CELL PROJECTION CYTOPLASM
|
129
|
2.87e-01
|
-5.44e-02
|
4.69e-01
|
GOBP REGULATION OF GASTRULATION
|
12
|
7.44e-01
|
5.44e-02
|
8.48e-01
|
GOBP RESPONSE TO AMINO ACID STARVATION
|
50
|
5.06e-01
|
-5.43e-02
|
6.76e-01
|
GOCC SCF UBIQUITIN LIGASE COMPLEX
|
54
|
4.90e-01
|
5.43e-02
|
6.63e-01
|
GOBP HORMONE METABOLIC PROCESS
|
130
|
2.86e-01
|
5.43e-02
|
4.69e-01
|
GOMF ACIDIC AMINO ACID TRANSMEMBRANE TRANSPORTER ACTIVITY
|
13
|
7.35e-01
|
5.42e-02
|
8.41e-01
|
GOBP TOLL SIGNALING PATHWAY
|
10
|
7.67e-01
|
-5.42e-02
|
8.61e-01
|
GOBP REGULATION OF GLUTAMATE SECRETION
|
15
|
7.17e-01
|
-5.40e-02
|
8.28e-01
|
GOBP CRANIOFACIAL SUTURE MORPHOGENESIS
|
14
|
7.27e-01
|
-5.39e-02
|
8.35e-01
|
GOBP POSITIVE REGULATION OF STEROID BIOSYNTHETIC PROCESS
|
19
|
6.84e-01
|
5.39e-02
|
8.07e-01
|
GOBP NEGATIVE REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA
|
20
|
6.77e-01
|
5.39e-02
|
8.04e-01
|
GOBP RESPONSE TO FIBROBLAST GROWTH FACTOR
|
80
|
4.06e-01
|
-5.38e-02
|
5.90e-01
|
GOBP REGULATION OF PROTEIN KINASE A SIGNALING
|
14
|
7.27e-01
|
-5.38e-02
|
8.36e-01
|
GOBP REPRODUCTIVE BEHAVIOR
|
33
|
5.94e-01
|
-5.36e-02
|
7.43e-01
|
GOBP CELLULAR RESPONSE TO OXIDISED LOW DENSITY LIPOPROTEIN PARTICLE STIMULUS
|
10
|
7.69e-01
|
5.36e-02
|
8.63e-01
|
GOBP REGULATION OF GRANULOCYTE DIFFERENTIATION
|
14
|
7.28e-01
|
-5.36e-02
|
8.36e-01
|
GOBP MANGANESE ION TRANSPORT
|
11
|
7.58e-01
|
-5.36e-02
|
8.56e-01
|
GOMF PROTEIN HETERODIMERIZATION ACTIVITY
|
214
|
1.78e-01
|
-5.35e-02
|
3.43e-01
|
GOBP CELLULAR RESPONSE TO ESTRADIOL STIMULUS
|
14
|
7.29e-01
|
5.35e-02
|
8.36e-01
|
GOBP EXOCYTOSIS
|
276
|
1.27e-01
|
-5.35e-02
|
2.73e-01
|
GOBP MULTICELLULAR ORGANISMAL RESPONSE TO STRESS
|
72
|
4.33e-01
|
5.35e-02
|
6.13e-01
|
GOBP REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY
|
27
|
6.31e-01
|
5.35e-02
|
7.71e-01
|
GOMF TAU PROTEIN KINASE ACTIVITY
|
12
|
7.49e-01
|
5.34e-02
|
8.51e-01
|
GOCC 9PLUS2 MOTILE CILIUM
|
88
|
3.87e-01
|
5.34e-02
|
5.73e-01
|
GOBP REGULATION OF ALTERNATIVE MRNA SPLICING VIA SPLICEOSOME
|
46
|
5.32e-01
|
-5.33e-02
|
6.97e-01
|
GOBP INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS
|
75
|
4.26e-01
|
5.32e-02
|
6.07e-01
|
GOBP CALCIUM DEPENDENT CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES
|
25
|
6.45e-01
|
-5.32e-02
|
7.82e-01
|
GOCC INTERMEDIATE FILAMENT CYTOSKELETON
|
77
|
4.22e-01
|
-5.30e-02
|
6.04e-01
|
GOBP POSITIVE REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY
|
19
|
6.90e-01
|
-5.29e-02
|
8.11e-01
|
GOBP CDC42 PROTEIN SIGNAL TRANSDUCTION
|
13
|
7.41e-01
|
-5.29e-02
|
8.46e-01
|
GOBP POSITIVE REGULATION OF INSULIN SECRETION
|
88
|
3.91e-01
|
-5.29e-02
|
5.77e-01
|
GOBP PHAGOCYTOSIS RECOGNITION
|
18
|
6.98e-01
|
-5.29e-02
|
8.16e-01
|
GOBP VACUOLE FUSION
|
11
|
7.61e-01
|
-5.29e-02
|
8.58e-01
|
GOMF SPECTRIN BINDING
|
27
|
6.35e-01
|
-5.28e-02
|
7.75e-01
|
GOMF UBIQUITIN LIKE PROTEIN CONJUGATING ENZYME ACTIVITY
|
37
|
5.79e-01
|
5.28e-02
|
7.34e-01
|
GOBP RESPONSE TO RADIATION
|
332
|
9.98e-02
|
-5.27e-02
|
2.34e-01
|
GOBP NEURON APOPTOTIC PROCESS
|
303
|
1.16e-01
|
-5.27e-02
|
2.57e-01
|
GOBP RETINA MORPHOGENESIS IN CAMERA TYPE EYE
|
51
|
5.15e-01
|
5.27e-02
|
6.84e-01
|
GOBP TOR SIGNALING
|
142
|
2.79e-01
|
5.27e-02
|
4.62e-01
|
GOBP AMINE TRANSPORT
|
69
|
4.50e-01
|
5.26e-02
|
6.28e-01
|
GOBP DNA REPAIR DEPENDENT CHROMATIN REMODELING
|
20
|
6.84e-01
|
-5.26e-02
|
8.07e-01
|
GOBP PROTEIN ACTIVATION CASCADE
|
11
|
7.63e-01
|
5.26e-02
|
8.59e-01
|
GOBP POSITIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS
|
42
|
5.55e-01
|
-5.26e-02
|
7.17e-01
|
GOBP NEGATIVE REGULATION OF LONG TERM SYNAPTIC POTENTIATION
|
13
|
7.43e-01
|
-5.26e-02
|
8.47e-01
|
GOBP REGULATION OF MITOCHONDRION ORGANIZATION
|
128
|
3.05e-01
|
5.25e-02
|
4.90e-01
|
GOCC SWI SNF SUPERFAMILY TYPE COMPLEX
|
88
|
3.95e-01
|
-5.25e-02
|
5.80e-01
|
GOBP MELANOSOME ASSEMBLY
|
17
|
7.08e-01
|
5.24e-02
|
8.22e-01
|
GOBP KILLING OF CELLS OF ANOTHER ORGANISM
|
40
|
5.67e-01
|
-5.24e-02
|
7.25e-01
|
GOMF PHOSPHOLIPID TRANSFER ACTIVITY
|
18
|
7.01e-01
|
5.24e-02
|
8.18e-01
|
GOBP INTRACELLULAR STEROL TRANSPORT
|
31
|
6.14e-01
|
-5.24e-02
|
7.59e-01
|
GOBP MRNA EXPORT FROM NUCLEUS
|
55
|
5.03e-01
|
-5.22e-02
|
6.73e-01
|
GOBP ENDOPLASMIC RETICULUM TUBULAR NETWORK ORGANIZATION
|
19
|
6.94e-01
|
5.22e-02
|
8.13e-01
|
GOBP GLIAL CELL DEVELOPMENT
|
116
|
3.32e-01
|
-5.22e-02
|
5.20e-01
|
GOBP POSITIVE REGULATION OF CELL MATURATION
|
11
|
7.65e-01
|
5.21e-02
|
8.60e-01
|
GOBP REGULATION OF MRNA CATABOLIC PROCESS
|
149
|
2.73e-01
|
-5.21e-02
|
4.55e-01
|
GOBP CELLULAR RESPONSE TO ABIOTIC STIMULUS
|
233
|
1.72e-01
|
-5.21e-02
|
3.34e-01
|
GOBP PYRIMIDINE DEOXYRIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS
|
12
|
7.55e-01
|
5.21e-02
|
8.53e-01
|
GOBP REGULATION OF HEART GROWTH
|
82
|
4.16e-01
|
-5.20e-02
|
5.99e-01
|
GOBP RESPONSE TO STILBENOID
|
12
|
7.55e-01
|
5.19e-02
|
8.53e-01
|
GOBP POSITIVE REGULATION OF PROTEIN TRANSPORT
|
243
|
1.65e-01
|
-5.19e-02
|
3.25e-01
|
GOBP NEURON PROJECTION EXTENSION
|
156
|
2.65e-01
|
-5.17e-02
|
4.47e-01
|
GOBP RESPONSE TO PAIN
|
26
|
6.48e-01
|
-5.17e-02
|
7.85e-01
|
GOMF PROTEIN KINASE A CATALYTIC SUBUNIT BINDING
|
16
|
7.20e-01
|
5.17e-02
|
8.30e-01
|
GOBP RESPONSE TO LIGHT STIMULUS
|
242
|
1.67e-01
|
-5.17e-02
|
3.28e-01
|
GOBP RESPONSE TO IRON ION
|
14
|
7.38e-01
|
5.17e-02
|
8.44e-01
|
GOBP POSITIVE REGULATION OF HORMONE METABOLIC PROCESS
|
14
|
7.38e-01
|
-5.16e-02
|
8.44e-01
|
GOBP REGULATION OF ENDOCRINE PROCESS
|
31
|
6.19e-01
|
-5.16e-02
|
7.63e-01
|
GOBP NEGATIVE REGULATION OF COLD INDUCED THERMOGENESIS
|
40
|
5.73e-01
|
5.15e-02
|
7.29e-01
|
GOMF DYNEIN COMPLEX BINDING
|
20
|
6.90e-01
|
5.15e-02
|
8.11e-01
|
GOBP ACROSOME REACTION
|
16
|
7.22e-01
|
5.14e-02
|
8.31e-01
|
GOBP POSITIVE REGULATION OF FATTY ACID METABOLIC PROCESS
|
38
|
5.84e-01
|
5.14e-02
|
7.36e-01
|
GOBP RESPONSE TO INSULIN
|
221
|
1.89e-01
|
-5.14e-02
|
3.56e-01
|
GOBP POSITIVE REGULATION OF SECRETION
|
276
|
1.43e-01
|
-5.14e-02
|
2.95e-01
|
GOBP VESICLE ORGANIZATION
|
301
|
1.27e-01
|
-5.14e-02
|
2.73e-01
|
GOBP POSITIVE REGULATION OF HEAT GENERATION
|
10
|
7.79e-01
|
-5.13e-02
|
8.70e-01
|
GOBP REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS
|
109
|
3.56e-01
|
-5.13e-02
|
5.42e-01
|
GOCC NUCLEAR ENVELOPE
|
385
|
8.55e-02
|
-5.13e-02
|
2.11e-01
|
GOBP VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION
|
73
|
4.50e-01
|
-5.12e-02
|
6.28e-01
|
GOCC BASAL PART OF CELL
|
232
|
1.80e-01
|
-5.12e-02
|
3.45e-01
|
GOBP REGULATION OF ADENYLATE CYCLASE ACTIVITY
|
20
|
6.92e-01
|
-5.11e-02
|
8.13e-01
|
GOCC SAGA TYPE COMPLEX
|
35
|
6.01e-01
|
5.11e-02
|
7.48e-01
|
GOMF MITOGEN ACTIVATED PROTEIN KINASE BINDING
|
32
|
6.17e-01
|
-5.11e-02
|
7.62e-01
|
GOCC TRANS GOLGI NETWORK
|
206
|
2.07e-01
|
-5.11e-02
|
3.80e-01
|
GOBP RESPONSE TO NUTRIENT
|
66
|
4.74e-01
|
5.10e-02
|
6.49e-01
|
GOBP PROTEIN LOCALIZATION TO NUCLEUS
|
294
|
1.34e-01
|
-5.10e-02
|
2.82e-01
|
GOMF GENERAL TRANSCRIPTION INITIATION FACTOR ACTIVITY
|
43
|
5.63e-01
|
5.09e-02
|
7.23e-01
|
GOMF HISTONE METHYLTRANSFERASE BINDING
|
14
|
7.41e-01
|
-5.09e-02
|
8.46e-01
|
GOMF PROTEIN METHYLTRANSFERASE ACTIVITY
|
76
|
4.43e-01
|
5.09e-02
|
6.22e-01
|
GOMF UBIQUITIN LIKE PROTEIN LIGASE BINDING
|
306
|
1.27e-01
|
-5.08e-02
|
2.73e-01
|
GOMF DYNEIN LIGHT INTERMEDIATE CHAIN BINDING
|
20
|
6.94e-01
|
5.08e-02
|
8.14e-01
|
GOCC KINESIN COMPLEX
|
40
|
5.78e-01
|
-5.08e-02
|
7.33e-01
|
GOBP NUCLEAR MIGRATION
|
30
|
6.30e-01
|
-5.08e-02
|
7.71e-01
|
GOBP NEGATIVE REGULATION OF LIPID METABOLIC PROCESS
|
80
|
4.33e-01
|
5.07e-02
|
6.13e-01
|
GOBP PROTEOGLYCAN BIOSYNTHETIC PROCESS
|
48
|
5.44e-01
|
-5.07e-02
|
7.08e-01
|
GOBP PRODUCTION OF MOLECULAR MEDIATOR INVOLVED IN INFLAMMATORY RESPONSE
|
75
|
4.49e-01
|
-5.06e-02
|
6.27e-01
|
GOBP ENDOSOME TO LYSOSOME TRANSPORT
|
63
|
4.88e-01
|
-5.06e-02
|
6.61e-01
|
GOMF PHOSPHORIC DIESTER HYDROLASE ACTIVITY
|
69
|
4.68e-01
|
5.06e-02
|
6.44e-01
|
GOBP RESPONSE TO MONOAMINE
|
38
|
5.91e-01
|
-5.03e-02
|
7.41e-01
|
GOBP VITAMIN D METABOLIC PROCESS
|
10
|
7.83e-01
|
-5.03e-02
|
8.73e-01
|
GOBP CELL JUNCTION MAINTENANCE
|
39
|
5.87e-01
|
-5.02e-02
|
7.39e-01
|
GOBP REGULATION OF KERATINOCYTE MIGRATION
|
13
|
7.54e-01
|
-5.02e-02
|
8.53e-01
|
GOBP NEGATIVE REGULATION OF PROGRAMMED CELL DEATH
|
781
|
1.79e-02
|
-5.02e-02
|
6.75e-02
|
GOCC CATENIN COMPLEX
|
18
|
7.12e-01
|
-5.02e-02
|
8.25e-01
|
GOMF ADRENERGIC RECEPTOR BINDING
|
18
|
7.12e-01
|
5.02e-02
|
8.25e-01
|
GOBP REGULATION OF TRANSCRIPTION BY RNA POLYMERASE I
|
39
|
5.88e-01
|
-5.02e-02
|
7.39e-01
|
GOMF CHROMATIN PROTEIN ADAPTOR ACTIVITY
|
27
|
6.52e-01
|
-5.01e-02
|
7.88e-01
|
GOBP GLUCOCORTICOID METABOLIC PROCESS
|
16
|
7.28e-01
|
5.01e-02
|
8.36e-01
|
GOBP NEGATIVE REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY
|
55
|
5.21e-01
|
-5.01e-02
|
6.88e-01
|
GOBP ESTABLISHMENT OF MITOCHONDRION LOCALIZATION MICROTUBULE MEDIATED
|
22
|
6.84e-01
|
5.01e-02
|
8.07e-01
|
GOBP REGULATION OF CALCIUM ION TRANSPORT
|
208
|
2.14e-01
|
-5.01e-02
|
3.89e-01
|
GOBP NEGATIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY
|
211
|
2.11e-01
|
-5.01e-02
|
3.85e-01
|
GOMF DNA DIRECTED DNA POLYMERASE ACTIVITY
|
20
|
6.98e-01
|
-5.00e-02
|
8.17e-01
|
GOBP INORGANIC ION HOMEOSTASIS
|
395
|
8.93e-02
|
5.00e-02
|
2.18e-01
|
GOCC APICAL DENDRITE
|
23
|
6.78e-01
|
-5.00e-02
|
8.05e-01
|
GOMF RNA STEM LOOP BINDING
|
15
|
7.38e-01
|
-4.99e-02
|
8.44e-01
|
GOBP NEGATIVE REGULATION OF PROTEIN METABOLIC PROCESS
|
716
|
2.41e-02
|
-4.98e-02
|
8.47e-02
|
GOBP RECEPTOR CATABOLIC PROCESS
|
26
|
6.60e-01
|
-4.98e-02
|
7.93e-01
|
GOBP EMBRYO IMPLANTATION
|
47
|
5.55e-01
|
-4.98e-02
|
7.17e-01
|
GOBP POSITIVE REGULATION OF RECEPTOR INTERNALIZATION
|
26
|
6.61e-01
|
4.97e-02
|
7.93e-01
|
GOBP SENSORY PERCEPTION OF TASTE
|
11
|
7.75e-01
|
-4.97e-02
|
8.67e-01
|
GOMF MODIFIED AMINO ACID BINDING
|
79
|
4.46e-01
|
4.96e-02
|
6.25e-01
|
GOBP PROTEIN LOCALIZATION TO EARLY ENDOSOME
|
14
|
7.48e-01
|
4.96e-02
|
8.50e-01
|
GOCC CYTOPLASMIC REGION
|
160
|
2.80e-01
|
-4.96e-02
|
4.63e-01
|
GOBP VISUAL BEHAVIOR
|
59
|
5.11e-01
|
4.95e-02
|
6.80e-01
|
GOBP REGULATION OF GLIAL CELL MIGRATION
|
24
|
6.75e-01
|
-4.95e-02
|
8.02e-01
|
GOBP METANEPHRIC NEPHRON DEVELOPMENT
|
25
|
6.69e-01
|
-4.94e-02
|
7.99e-01
|
GOBP AMINOGLYCAN CATABOLIC PROCESS
|
20
|
7.02e-01
|
4.94e-02
|
8.19e-01
|
GOBP REGULATION OF ERAD PATHWAY
|
27
|
6.57e-01
|
4.94e-02
|
7.91e-01
|
GOBP VERY LONG CHAIN FATTY ACID BIOSYNTHETIC PROCESS
|
10
|
7.87e-01
|
4.93e-02
|
8.76e-01
|
GOCC GOLGI APPARATUS
|
1190
|
4.69e-03
|
-4.93e-02
|
2.37e-02
|
GOBP MRNA MODIFICATION
|
21
|
6.96e-01
|
-4.93e-02
|
8.14e-01
|
GOBP PHOTORECEPTOR CELL OUTER SEGMENT ORGANIZATION
|
11
|
7.77e-01
|
-4.92e-02
|
8.69e-01
|
GOBP MODULATION BY HOST OF VIRAL PROCESS
|
39
|
5.95e-01
|
-4.92e-02
|
7.44e-01
|
GOBP NEGATIVE REGULATION OF TORC1 SIGNALING
|
37
|
6.05e-01
|
4.92e-02
|
7.52e-01
|
GOBP PROTEIN HYDROXYLATION
|
24
|
6.77e-01
|
4.92e-02
|
8.04e-01
|
GOMF INOSITOL PHOSPHATE PHOSPHATASE ACTIVITY
|
18
|
7.18e-01
|
4.91e-02
|
8.29e-01
|
GOMF STRUCTURAL CONSTITUENT OF NUCLEAR PORE
|
19
|
7.11e-01
|
-4.90e-02
|
8.24e-01
|
GOBP PEPTIDYL CYSTEINE MODIFICATION
|
37
|
6.06e-01
|
4.90e-02
|
7.53e-01
|
GOBP REGULATION OF ENDOPEPTIDASE ACTIVITY
|
216
|
2.16e-01
|
-4.90e-02
|
3.91e-01
|
GOBP REGULATION OF SYNAPTIC PLASTICITY
|
199
|
2.34e-01
|
4.90e-02
|
4.14e-01
|
GOBP RESPONSE TO STEROL
|
24
|
6.78e-01
|
4.90e-02
|
8.05e-01
|
GOBP INTRACELLULAR MONOATOMIC ANION HOMEOSTASIS
|
14
|
7.51e-01
|
-4.89e-02
|
8.52e-01
|
GOMF N METHYLTRANSFERASE ACTIVITY
|
74
|
4.68e-01
|
4.89e-02
|
6.44e-01
|
GOBP ESTABLISHMENT OF PROTEIN LOCALIZATION TO ORGANELLE
|
385
|
1.01e-01
|
4.88e-02
|
2.37e-01
|
GOBP POSITIVE REGULATION OF INTRACELLULAR TRANSPORT
|
132
|
3.33e-01
|
-4.88e-02
|
5.21e-01
|
GOMF DNA POLYMERASE ACTIVITY
|
27
|
6.61e-01
|
-4.88e-02
|
7.93e-01
|
GOBP ENDOCRINE HORMONE SECRETION
|
39
|
5.98e-01
|
4.88e-02
|
7.47e-01
|
GOMF IMMUNOGLOBULIN BINDING
|
12
|
7.70e-01
|
-4.88e-02
|
8.63e-01
|
GOBP REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS
|
38
|
6.03e-01
|
4.88e-02
|
7.50e-01
|
GOBP LIPOPROTEIN BIOSYNTHETIC PROCESS
|
96
|
4.10e-01
|
4.87e-02
|
5.94e-01
|
GOMF LIPID TRANSFER ACTIVITY
|
40
|
5.94e-01
|
4.87e-02
|
7.43e-01
|
GOBP SMOOTH MUSCLE CELL APOPTOTIC PROCESS
|
28
|
6.56e-01
|
-4.87e-02
|
7.91e-01
|
GOBP RESPONSE TO DOPAMINE
|
31
|
6.40e-01
|
-4.86e-02
|
7.78e-01
|
GOBP PEPTIDYL PROLINE MODIFICATION
|
36
|
6.14e-01
|
4.85e-02
|
7.59e-01
|
GOCC CILIARY PLASM
|
86
|
4.37e-01
|
-4.85e-02
|
6.17e-01
|
GOMF ADP BINDING
|
36
|
6.15e-01
|
4.85e-02
|
7.60e-01
|
GOBP FOAM CELL DIFFERENTIATION
|
24
|
6.81e-01
|
-4.84e-02
|
8.06e-01
|
GOBP REGULATION OF RECEPTOR RECYCLING
|
26
|
6.70e-01
|
-4.83e-02
|
7.99e-01
|
GOBP RESPONSE TO ORGANOPHOSPHORUS
|
77
|
4.64e-01
|
-4.83e-02
|
6.40e-01
|
GOBP NEGATIVE REGULATION OF AMINE TRANSPORT
|
22
|
6.95e-01
|
4.83e-02
|
8.14e-01
|
GOBP CELL DIFFERENTIATION INVOLVED IN METANEPHROS DEVELOPMENT
|
13
|
7.63e-01
|
-4.83e-02
|
8.59e-01
|
GOBP CELL MIGRATION IN HINDBRAIN
|
17
|
7.31e-01
|
4.82e-02
|
8.38e-01
|
GOBP GOLGI ORGANIZATION
|
129
|
3.45e-01
|
-4.82e-02
|
5.33e-01
|
GOCC VESICLE MEMBRANE
|
542
|
5.65e-02
|
-4.82e-02
|
1.58e-01
|
GOMF NUCLEASE ACTIVITY
|
168
|
2.83e-01
|
-4.81e-02
|
4.66e-01
|
GOBP REGULATION OF MUSCLE SYSTEM PROCESS
|
214
|
2.26e-01
|
4.81e-02
|
4.04e-01
|
GOBP POSITIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS
|
50
|
5.57e-01
|
-4.80e-02
|
7.18e-01
|
GOMF PEPTIDE BINDING
|
169
|
2.83e-01
|
-4.79e-02
|
4.66e-01
|
GOBP REGULATION OF CELLULAR RESPONSE TO STRESS
|
465
|
7.81e-02
|
-4.79e-02
|
1.99e-01
|
GOBP NEUROTROPHIN SIGNALING PATHWAY
|
40
|
6.00e-01
|
4.79e-02
|
7.48e-01
|
GOMF NUCLEAR GLUCOCORTICOID RECEPTOR BINDING
|
19
|
7.18e-01
|
4.78e-02
|
8.29e-01
|
GOCC SECONDARY LYSOSOME
|
18
|
7.26e-01
|
-4.78e-02
|
8.34e-01
|
GOBP POSITIVE REGULATION OF B CELL DIFFERENTIATION
|
15
|
7.49e-01
|
4.78e-02
|
8.51e-01
|
GOCC SUPRAMOLECULAR POLYMER
|
748
|
2.77e-02
|
-4.77e-02
|
9.36e-02
|
GOCC VACUOLAR LUMEN
|
21
|
7.05e-01
|
4.77e-02
|
8.20e-01
|
GOCC LATE ENDOSOME
|
204
|
2.43e-01
|
-4.75e-02
|
4.23e-01
|
GOBP MORPHOGENESIS OF AN ENDOTHELIUM
|
19
|
7.20e-01
|
-4.75e-02
|
8.30e-01
|
GOBP REGULATION OF RECEPTOR CLUSTERING
|
25
|
6.81e-01
|
-4.75e-02
|
8.06e-01
|
GOBP NEGATIVE REGULATION OF SECRETION
|
141
|
3.32e-01
|
-4.74e-02
|
5.19e-01
|
GOBP BERGMANN GLIAL CELL DIFFERENTIATION
|
10
|
7.95e-01
|
-4.74e-02
|
8.81e-01
|
GOBP ACTIVATION INDUCED CELL DEATH OF T CELLS
|
12
|
7.76e-01
|
-4.73e-02
|
8.69e-01
|
GOBP NEGATIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT
|
33
|
6.38e-01
|
4.73e-02
|
7.77e-01
|
GOBP NEGATIVE REGULATION OF PROTEIN BINDING
|
66
|
5.07e-01
|
-4.73e-02
|
6.77e-01
|
GOBP REGULATION OF AUTOPHAGOSOME MATURATION
|
17
|
7.36e-01
|
-4.72e-02
|
8.42e-01
|
GOBP POSITIVE REGULATION OF FATTY ACID OXIDATION
|
19
|
7.22e-01
|
4.72e-02
|
8.31e-01
|
GOMF PHOSPHATIDYLINOSITOL PHOSPHATE 5 PHOSPHATASE ACTIVITY
|
11
|
7.87e-01
|
4.72e-02
|
8.76e-01
|
GOBP SEMAPHORIN PLEXIN SIGNALING PATHWAY
|
48
|
5.72e-01
|
-4.71e-02
|
7.29e-01
|
GOBP REGULATION OF SKELETAL MUSCLE SATELLITE CELL PROLIFERATION
|
11
|
7.87e-01
|
-4.71e-02
|
8.76e-01
|
GOBP HEAT GENERATION
|
15
|
7.52e-01
|
-4.71e-02
|
8.52e-01
|
GOBP VIRAL BUDDING
|
18
|
7.30e-01
|
-4.70e-02
|
8.37e-01
|
GOBP PIGMENT GRANULE LOCALIZATION
|
18
|
7.30e-01
|
-4.70e-02
|
8.37e-01
|
GOBP INTERLEUKIN 4 PRODUCTION
|
26
|
6.79e-01
|
-4.70e-02
|
8.05e-01
|
GOBP NUCLEOTIDE SUGAR BIOSYNTHETIC PROCESS
|
16
|
7.45e-01
|
4.69e-02
|
8.48e-01
|
GOBP REGULATION OF ORGAN GROWTH
|
107
|
4.03e-01
|
-4.69e-02
|
5.88e-01
|
GOCC CAJAL BODY
|
34
|
6.37e-01
|
-4.68e-02
|
7.76e-01
|
GOCC RNA POLYMERASE II HOLOENZYME
|
65
|
5.14e-01
|
4.68e-02
|
6.84e-01
|
GOBP PURINE DEOXYRIBONUCLEOTIDE METABOLIC PROCESS
|
18
|
7.31e-01
|
4.68e-02
|
8.38e-01
|
GOBP SPLEEN DEVELOPMENT
|
37
|
6.24e-01
|
-4.66e-02
|
7.66e-01
|
GOBP POSITIVE REGULATION OF PROTEIN UBIQUITINATION
|
98
|
4.26e-01
|
-4.66e-02
|
6.07e-01
|
GOBP ORGANELLE DISASSEMBLY
|
141
|
3.40e-01
|
4.66e-02
|
5.29e-01
|
GOBP RESPONSE TO NITROGEN COMPOUND
|
752
|
3.10e-02
|
-4.66e-02
|
1.02e-01
|
GOBP RESPONSE TO FORSKOLIN
|
14
|
7.63e-01
|
-4.66e-02
|
8.59e-01
|
GOBP NEUTROPHIL ACTIVATION
|
27
|
6.76e-01
|
-4.65e-02
|
8.03e-01
|
GOBP REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY
|
161
|
3.10e-01
|
-4.65e-02
|
4.95e-01
|
GOBP MOTOR NEURON AXON GUIDANCE
|
22
|
7.07e-01
|
-4.64e-02
|
8.21e-01
|
GOBP CELLULAR RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN
|
88
|
4.53e-01
|
-4.63e-02
|
6.31e-01
|
GOMF UBIQUITIN PROTEIN TRANSFERASE ACTIVATOR ACTIVITY
|
14
|
7.65e-01
|
-4.62e-02
|
8.60e-01
|
GOBP NEGATIVE REGULATION OF MULTICELLULAR ORGANISM GROWTH
|
15
|
7.57e-01
|
-4.62e-02
|
8.55e-01
|
GOBP REGULATION OF PROTEOLYSIS
|
508
|
7.69e-02
|
-4.61e-02
|
1.97e-01
|
GOMF BETA CATENIN BINDING
|
88
|
4.56e-01
|
-4.60e-02
|
6.33e-01
|
GOBP DEVELOPMENTAL CELL GROWTH
|
225
|
2.35e-01
|
-4.60e-02
|
4.14e-01
|
GOMF PROTEIN KINASE A BINDING
|
49
|
5.78e-01
|
-4.60e-02
|
7.33e-01
|
GOBP PRESYNAPSE ORGANIZATION
|
47
|
5.86e-01
|
-4.60e-02
|
7.38e-01
|
GOCC UBIQUITIN LIGASE COMPLEX
|
268
|
1.98e-01
|
4.59e-02
|
3.67e-01
|
GOBP RIBONUCLEOPROTEIN COMPLEX LOCALIZATION
|
10
|
8.02e-01
|
-4.58e-02
|
8.85e-01
|
GOBP CALCINEURIN MEDIATED SIGNALING
|
48
|
5.83e-01
|
-4.58e-02
|
7.36e-01
|
GOBP NEGATIVE REGULATION OF PROTEIN IMPORT INTO NUCLEUS
|
17
|
7.44e-01
|
4.57e-02
|
8.48e-01
|
GOBP REGULATION OF CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION
|
22
|
7.11e-01
|
-4.57e-02
|
8.24e-01
|
GOCC NURD COMPLEX
|
17
|
7.45e-01
|
-4.57e-02
|
8.48e-01
|
GOBP REGULATION OF STRIATED MUSCLE TISSUE DEVELOPMENT
|
19
|
7.31e-01
|
-4.57e-02
|
8.38e-01
|
GOBP DEVELOPMENTAL PROCESS INVOLVED IN REPRODUCTION
|
612
|
5.55e-02
|
-4.56e-02
|
1.57e-01
|
GOBP AMIDE TRANSPORT
|
265
|
2.02e-01
|
4.56e-02
|
3.74e-01
|
GOBP NUCLEAR PORE ORGANIZATION
|
15
|
7.60e-01
|
-4.56e-02
|
8.57e-01
|
GOMF TRANSLATION REGULATOR ACTIVITY NUCLEIC ACID BINDING
|
89
|
4.58e-01
|
4.56e-02
|
6.34e-01
|
GOBP VENTRICULAR SYSTEM DEVELOPMENT
|
30
|
6.66e-01
|
-4.55e-02
|
7.97e-01
|
GOBP TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING
|
71
|
5.07e-01
|
-4.55e-02
|
6.77e-01
|
GOBP VACUOLE ORGANIZATION
|
211
|
2.56e-01
|
-4.55e-02
|
4.37e-01
|
GOCC CELL PROJECTION MEMBRANE
|
247
|
2.20e-01
|
-4.55e-02
|
3.96e-01
|
GOBP INOSITOL PHOSPHATE BIOSYNTHETIC PROCESS
|
23
|
7.06e-01
|
4.54e-02
|
8.20e-01
|
GOMF UBIQUITIN PROTEIN TRANSFERASE REGULATOR ACTIVITY
|
30
|
6.67e-01
|
-4.54e-02
|
7.97e-01
|
GOBP POST TRANSCRIPTIONAL REGULATION OF GENE EXPRESSION
|
430
|
1.08e-01
|
-4.54e-02
|
2.46e-01
|
GOBP MRNA TRANSPORT
|
101
|
4.31e-01
|
-4.54e-02
|
6.12e-01
|
GOBP REGULATION OF MUSCLE ADAPTATION
|
94
|
4.48e-01
|
-4.54e-02
|
6.26e-01
|
GOBP PYRIMIDINE NUCLEOSIDE METABOLIC PROCESS
|
11
|
7.95e-01
|
-4.54e-02
|
8.81e-01
|
GOBP EMBRYONIC PLACENTA MORPHOGENESIS
|
24
|
7.01e-01
|
-4.53e-02
|
8.18e-01
|
GOBP MULTICELLULAR ORGANISMAL REPRODUCTIVE PROCESS
|
558
|
6.90e-02
|
-4.53e-02
|
1.82e-01
|
GOBP POSITIVE REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS
|
69
|
5.16e-01
|
-4.52e-02
|
6.85e-01
|
GOBP REGULATION OF SKELETAL MUSCLE CELL DIFFERENTIATION
|
21
|
7.20e-01
|
4.51e-02
|
8.30e-01
|
GOMF UBIQUITIN LIKE PROTEIN BINDING
|
110
|
4.15e-01
|
-4.50e-02
|
5.99e-01
|
GOBP INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY
|
40
|
6.23e-01
|
-4.50e-02
|
7.65e-01
|
GOBP MORPHOGENESIS OF AN EPITHELIAL SHEET
|
50
|
5.83e-01
|
-4.49e-02
|
7.36e-01
|
GOBP CALCIUM ION TRANSMEMBRANE TRANSPORT VIA HIGH VOLTAGE GATED CALCIUM CHANNEL
|
17
|
7.49e-01
|
4.48e-02
|
8.51e-01
|
GOBP SNO S RNA METABOLIC PROCESS
|
15
|
7.64e-01
|
4.48e-02
|
8.60e-01
|
GOMF ENDOPEPTIDASE ACTIVATOR ACTIVITY
|
17
|
7.49e-01
|
4.48e-02
|
8.51e-01
|
GOBP RESPONSE TO TOXIC SUBSTANCE
|
103
|
4.33e-01
|
4.47e-02
|
6.13e-01
|
GOBP REGULATION OF NERVOUS SYSTEM PROCESS
|
105
|
4.29e-01
|
4.47e-02
|
6.10e-01
|
GOBP REGULATION OF LYMPHOID PROGENITOR CELL DIFFERENTIATION
|
10
|
8.07e-01
|
-4.46e-02
|
8.89e-01
|
GOBP CIRCADIAN RHYTHM
|
176
|
3.08e-01
|
-4.46e-02
|
4.93e-01
|
GOBP FAT CELL DIFFERENTIATION
|
219
|
2.56e-01
|
-4.46e-02
|
4.37e-01
|
GOMF NUCLEAR RETINOID X RECEPTOR BINDING
|
22
|
7.17e-01
|
4.46e-02
|
8.28e-01
|
GOBP ACTIVATION OF GTPASE ACTIVITY
|
78
|
4.96e-01
|
-4.46e-02
|
6.68e-01
|
GOBP REGULATION OF AUTOPHAGY OF MITOCHONDRION
|
29
|
6.78e-01
|
-4.45e-02
|
8.05e-01
|
GOMF JUN KINASE KINASE KINASE ACTIVITY
|
10
|
8.07e-01
|
-4.45e-02
|
8.89e-01
|
GOMF DIOXYGENASE ACTIVITY
|
76
|
5.03e-01
|
4.45e-02
|
6.73e-01
|
GOBP REGULATION OF SODIUM ION TRANSPORT
|
74
|
5.09e-01
|
4.44e-02
|
6.79e-01
|
GOBP REGULATION OF STEROID BIOSYNTHETIC PROCESS
|
59
|
5.56e-01
|
4.44e-02
|
7.17e-01
|
GOCC NEURON TO NEURON SYNAPSE
|
368
|
1.46e-01
|
4.43e-02
|
2.99e-01
|
GOBP PURINE RIBONUCLEOTIDE SALVAGE
|
12
|
7.91e-01
|
4.43e-02
|
8.78e-01
|
GOBP NEGATIVE CHEMOTAXIS
|
38
|
6.37e-01
|
-4.42e-02
|
7.76e-01
|
GOMF NUCLEAR THYROID HORMONE RECEPTOR BINDING
|
28
|
6.86e-01
|
-4.42e-02
|
8.08e-01
|
GOBP POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION
|
57
|
5.64e-01
|
-4.42e-02
|
7.23e-01
|
GOBP REGULATION OF GROWTH
|
529
|
8.44e-02
|
-4.41e-02
|
2.10e-01
|
GOBP POSITIVE REGULATION OF GENE EXPRESSION EPIGENETIC
|
50
|
5.90e-01
|
4.41e-02
|
7.40e-01
|
GOMF CYCLASE ACTIVITY
|
15
|
7.68e-01
|
4.40e-02
|
8.62e-01
|
GOBP PROTEIN RNA COMPLEX ORGANIZATION
|
160
|
3.38e-01
|
4.39e-02
|
5.27e-01
|
GOBP REGULATION OF HORMONE METABOLIC PROCESS
|
34
|
6.58e-01
|
-4.39e-02
|
7.92e-01
|
GOMF SNRNA BINDING
|
39
|
6.35e-01
|
-4.39e-02
|
7.75e-01
|
GOBP POSITIVE REGULATION OF TRANSPORTER ACTIVITY
|
67
|
5.35e-01
|
-4.38e-02
|
7.00e-01
|
GOMF N6 METHYLADENOSINE CONTAINING RNA READER ACTIVITY
|
10
|
8.10e-01
|
-4.38e-02
|
8.90e-01
|
GOBP POSITIVE REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS
|
11
|
8.01e-01
|
4.38e-02
|
8.85e-01
|
GOBP DIOL BIOSYNTHETIC PROCESS
|
18
|
7.48e-01
|
4.38e-02
|
8.50e-01
|
GOBP PHOSPHATIDYLINOSITOL MEDIATED SIGNALING
|
18
|
7.48e-01
|
-4.37e-02
|
8.50e-01
|
GOBP POSITIVE REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA
|
25
|
7.05e-01
|
4.37e-02
|
8.20e-01
|
GOBP CARDIAC CELL DEVELOPMENT
|
109
|
4.32e-01
|
4.37e-02
|
6.12e-01
|
GOBP REGENERATION
|
129
|
3.93e-01
|
-4.36e-02
|
5.78e-01
|
GOBP REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS
|
50
|
5.94e-01
|
-4.36e-02
|
7.43e-01
|
GOBP GLYCOSPHINGOLIPID BIOSYNTHETIC PROCESS
|
23
|
7.18e-01
|
-4.36e-02
|
8.29e-01
|
GOBP HOMOPHILIC CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES
|
73
|
5.21e-01
|
-4.35e-02
|
6.88e-01
|
GOBP ICOSANOID SECRETION
|
27
|
6.96e-01
|
-4.35e-02
|
8.14e-01
|
GOBP COMPLEMENT ACTIVATION
|
31
|
6.75e-01
|
4.35e-02
|
8.03e-01
|
GOBP REGULATION OF ACUTE INFLAMMATORY RESPONSE
|
29
|
6.86e-01
|
4.35e-02
|
8.08e-01
|
GOBP DIGESTION
|
68
|
5.36e-01
|
4.34e-02
|
7.01e-01
|
GOBP REGULATION OF LYMPHOCYTE CHEMOTAXIS
|
15
|
7.71e-01
|
4.34e-02
|
8.64e-01
|
GOMF OXIDOREDUCTASE ACTIVITY ACTING ON THE CH NH GROUP OF DONORS
|
24
|
7.13e-01
|
4.34e-02
|
8.25e-01
|
GOBP CELLULAR RESPONSE TO NUTRIENT
|
35
|
6.57e-01
|
-4.34e-02
|
7.91e-01
|
GOCC NUCLEAR OUTER MEMBRANE
|
19
|
7.44e-01
|
4.33e-02
|
8.48e-01
|
GOBP NEGATIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS
|
47
|
6.08e-01
|
4.33e-02
|
7.54e-01
|
GOMF OXIDOREDUCTASE ACTIVITY ACTING ON PAIRED DONORS WITH INCORPORATION OR REDUCTION OF MOLECULAR OXYGEN
|
127
|
4.00e-01
|
4.33e-02
|
5.86e-01
|
GOBP ORGANELLE FUSION
|
131
|
3.93e-01
|
-4.33e-02
|
5.79e-01
|
GOBP POSITIVE REGULATION OF MYOTUBE DIFFERENTIATION
|
13
|
7.87e-01
|
4.32e-02
|
8.76e-01
|
GOBP SEQUESTERING OF CALCIUM ION
|
96
|
4.66e-01
|
-4.31e-02
|
6.42e-01
|
GOBP RESCUE OF STALLED RIBOSOME
|
23
|
7.21e-01
|
-4.31e-02
|
8.31e-01
|
GOMF AMINO ACID SODIUM SYMPORTER ACTIVITY
|
14
|
7.80e-01
|
4.31e-02
|
8.71e-01
|
GOBP AUTOPHAGOSOME ORGANIZATION
|
124
|
4.08e-01
|
-4.30e-02
|
5.93e-01
|
GOBP PIGMENT GRANULE ORGANIZATION
|
34
|
6.64e-01
|
4.30e-02
|
7.95e-01
|
GOBP DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF PAIN
|
16
|
7.66e-01
|
-4.30e-02
|
8.60e-01
|
GOBP REGULATION OF SYNAPTIC TRANSMISSION GABAERGIC
|
31
|
6.79e-01
|
-4.29e-02
|
8.05e-01
|
GOBP CEREBELLAR CORTEX DEVELOPMENT
|
53
|
5.89e-01
|
-4.29e-02
|
7.40e-01
|
GOBP ACTOMYOSIN STRUCTURE ORGANIZATION
|
205
|
2.92e-01
|
-4.28e-02
|
4.75e-01
|
GOBP EXTRACELLULAR TRANSPORT
|
18
|
7.53e-01
|
-4.28e-02
|
8.53e-01
|
GOBP REGULATION OF CELLULAR RESPONSE TO HYPOXIA
|
25
|
7.12e-01
|
4.27e-02
|
8.24e-01
|
GOBP PURINE DEOXYRIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS
|
12
|
7.98e-01
|
-4.26e-02
|
8.83e-01
|
GOBP POSITIVE REGULATION OF NITRIC OXIDE SYNTHASE BIOSYNTHETIC PROCESS
|
18
|
7.55e-01
|
-4.25e-02
|
8.53e-01
|
GOBP EXPORT FROM CELL
|
706
|
5.62e-02
|
-4.25e-02
|
1.58e-01
|
GOBP DETECTION OF TEMPERATURE STIMULUS
|
20
|
7.42e-01
|
4.25e-02
|
8.47e-01
|
GOBP LIPID LOCALIZATION
|
342
|
1.79e-01
|
4.24e-02
|
3.43e-01
|
GOCC RNA POLYMERASE COMPLEX
|
89
|
4.90e-01
|
4.24e-02
|
6.63e-01
|
GOBP ESTABLISHMENT OF MITOCHONDRION LOCALIZATION
|
30
|
6.88e-01
|
-4.23e-02
|
8.10e-01
|
GOBP POSITIVE REGULATION OF CELL JUNCTION ASSEMBLY
|
95
|
4.76e-01
|
-4.23e-02
|
6.50e-01
|
GOBP SIGNAL TRANSDUCTION INVOLVED IN REGULATION OF GENE EXPRESSION
|
15
|
7.77e-01
|
4.23e-02
|
8.69e-01
|
GOCC DENDRITIC SHAFT
|
54
|
5.91e-01
|
-4.23e-02
|
7.41e-01
|
GOBP LIPOPROTEIN METABOLIC PROCESS
|
119
|
4.27e-01
|
4.23e-02
|
6.08e-01
|
GOMF DNA POLYMERASE BINDING
|
20
|
7.44e-01
|
4.22e-02
|
8.48e-01
|
GOBP CARDIAC MUSCLE CELL DIFFERENTIATION
|
138
|
3.93e-01
|
4.22e-02
|
5.78e-01
|
GOCC CELL CELL CONTACT ZONE
|
80
|
5.15e-01
|
-4.21e-02
|
6.84e-01
|
GOBP RETROGRADE VESICLE MEDIATED TRANSPORT GOLGI TO ENDOPLASMIC RETICULUM
|
45
|
6.25e-01
|
-4.21e-02
|
7.67e-01
|
GOBP CELLULAR PROCESS INVOLVED IN REPRODUCTION IN MULTICELLULAR ORGANISM
|
237
|
2.66e-01
|
-4.21e-02
|
4.47e-01
|
GOCC SCHMIDT LANTERMAN INCISURE
|
11
|
8.09e-01
|
4.21e-02
|
8.90e-01
|
GOBP ORGANONITROGEN COMPOUND CATABOLIC PROCESS
|
1161
|
1.71e-02
|
4.20e-02
|
6.55e-02
|
GOMF SNAP RECEPTOR ACTIVITY
|
32
|
6.81e-01
|
-4.20e-02
|
8.06e-01
|
GOBP ACTIVATION OF ADENYLATE CYCLASE ACTIVITY
|
10
|
8.18e-01
|
4.19e-02
|
8.96e-01
|
GOBP MRNA CATABOLIC PROCESS
|
203
|
3.05e-01
|
-4.18e-02
|
4.90e-01
|
GOBP HORMONE MEDIATED SIGNALING PATHWAY
|
129
|
4.13e-01
|
-4.18e-02
|
5.96e-01
|
GOBP NEGATIVE REGULATION OF CATABOLIC PROCESS
|
292
|
2.20e-01
|
4.18e-02
|
3.97e-01
|
GOMF TRANSFERRIN RECEPTOR BINDING
|
10
|
8.19e-01
|
-4.17e-02
|
8.96e-01
|
GOBP REGULATION OF ANATOMICAL STRUCTURE SIZE
|
462
|
1.26e-01
|
-4.17e-02
|
2.73e-01
|
GOCC GOLGI ASSOCIATED VESICLE
|
86
|
5.04e-01
|
-4.17e-02
|
6.74e-01
|
GOMF SEQUENCE SPECIFIC MRNA BINDING
|
14
|
7.88e-01
|
-4.16e-02
|
8.76e-01
|
GOCC GLUTAMATERGIC SYNAPSE
|
622
|
7.85e-02
|
-4.16e-02
|
1.99e-01
|
GOBP REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS
|
167
|
3.55e-01
|
-4.15e-02
|
5.42e-01
|
GOCC AUTOPHAGOSOME MEMBRANE
|
40
|
6.50e-01
|
-4.15e-02
|
7.86e-01
|
GOBP POSITIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING
|
37
|
6.62e-01
|
-4.15e-02
|
7.94e-01
|
GOMF UBIQUITIN CONJUGATING ENZYME ACTIVITY
|
31
|
6.89e-01
|
4.15e-02
|
8.11e-01
|
GOBP NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE
|
13
|
7.96e-01
|
4.14e-02
|
8.82e-01
|
GOMF SEMAPHORIN RECEPTOR BINDING
|
19
|
7.55e-01
|
4.14e-02
|
8.53e-01
|
GOBP TISSUE REGENERATION
|
49
|
6.17e-01
|
4.13e-02
|
7.62e-01
|
GOBP RRNA TRANSCRIPTION
|
29
|
7.00e-01
|
4.13e-02
|
8.18e-01
|
GOBP INHIBITORY SYNAPSE ASSEMBLY
|
13
|
7.97e-01
|
-4.12e-02
|
8.82e-01
|
GOMF AMINOPEPTIDASE ACTIVITY
|
30
|
6.96e-01
|
4.12e-02
|
8.15e-01
|
GOBP REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY
|
35
|
6.73e-01
|
-4.12e-02
|
8.02e-01
|
GOMF CORE PROMOTER SEQUENCE SPECIFIC DNA BINDING
|
43
|
6.41e-01
|
-4.12e-02
|
7.78e-01
|
GOBP REGULATION OF RECEPTOR LOCALIZATION TO SYNAPSE
|
34
|
6.79e-01
|
-4.10e-02
|
8.05e-01
|
GOBP NEGATIVE REGULATION OF NEURON APOPTOTIC PROCESS
|
169
|
3.59e-01
|
-4.10e-02
|
5.45e-01
|
GOBP CELLULAR COMPONENT DISASSEMBLY
|
430
|
1.47e-01
|
-4.10e-02
|
3.00e-01
|
GOBP VACUOLAR ACIDIFICATION
|
25
|
7.23e-01
|
4.10e-02
|
8.32e-01
|
GOBP IMP METABOLIC PROCESS
|
17
|
7.70e-01
|
-4.09e-02
|
8.63e-01
|
GOMF DNA ENDONUCLEASE ACTIVITY
|
35
|
6.75e-01
|
4.09e-02
|
8.03e-01
|
GOMF PHOSPHOLIPID TRANSPORTER ACTIVITY
|
52
|
6.11e-01
|
-4.08e-02
|
7.57e-01
|
GOBP CALCIUM ION TRANSMEMBRANE IMPORT INTO CYTOSOL
|
131
|
4.21e-01
|
-4.08e-02
|
6.03e-01
|
GOBP REGULATION OF LOW DENSITY LIPOPROTEIN PARTICLE CLEARANCE
|
11
|
8.15e-01
|
-4.08e-02
|
8.94e-01
|
GOMF METALLOAMINOPEPTIDASE ACTIVITY
|
19
|
7.59e-01
|
4.07e-02
|
8.56e-01
|
GOCC NUCLEAR MEMBRANE
|
223
|
2.96e-01
|
-4.07e-02
|
4.80e-01
|
GOBP MYOTUBE CELL DEVELOPMENT
|
36
|
6.73e-01
|
4.06e-02
|
8.02e-01
|
GOCC PRESYNAPSE
|
589
|
9.44e-02
|
4.06e-02
|
2.26e-01
|
GOMF NUCLEOBASE CONTAINING COMPOUND TRANSMEMBRANE TRANSPORTER ACTIVITY
|
48
|
6.27e-01
|
4.05e-02
|
7.68e-01
|
GOBP MELANOCYTE DIFFERENTIATION
|
22
|
7.42e-01
|
-4.05e-02
|
8.47e-01
|
GOBP NEGATIVE REGULATION OF GLYCOPROTEIN BIOSYNTHETIC PROCESS
|
11
|
8.16e-01
|
-4.05e-02
|
8.94e-01
|
GOCC CUL4A RING E3 UBIQUITIN LIGASE COMPLEX
|
12
|
8.09e-01
|
4.04e-02
|
8.90e-01
|
GOBP REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE
|
23
|
7.38e-01
|
4.03e-02
|
8.44e-01
|
GOBP DNA TEMPLATED TRANSCRIPTION ELONGATION
|
106
|
4.74e-01
|
-4.03e-02
|
6.48e-01
|
GOCC CATALYTIC STEP 2 SPLICEOSOME
|
86
|
5.20e-01
|
-4.02e-02
|
6.88e-01
|
GOCC PROTEASOME ACCESSORY COMPLEX
|
23
|
7.40e-01
|
-4.00e-02
|
8.45e-01
|
GOCC ENDOSOME
|
809
|
5.51e-02
|
-4.00e-02
|
1.56e-01
|
GOMF ENDOPEPTIDASE ACTIVITY
|
230
|
2.97e-01
|
4.00e-02
|
4.81e-01
|
GOBP NEGATIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS
|
29
|
7.10e-01
|
4.00e-02
|
8.23e-01
|
GOBP INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO OXIDATIVE STRESS
|
52
|
6.19e-01
|
-3.99e-02
|
7.63e-01
|
GOBP CELLULAR RESPONSE TO PROSTAGLANDIN E STIMULUS
|
10
|
8.27e-01
|
3.99e-02
|
9.01e-01
|
GOMF NUCLEAR RETINOIC ACID RECEPTOR BINDING
|
32
|
6.97e-01
|
-3.98e-02
|
8.15e-01
|
GOBP NEURAL CREST FORMATION
|
13
|
8.04e-01
|
3.98e-02
|
8.86e-01
|
GOCC MULTIVESICULAR BODY
|
38
|
6.72e-01
|
-3.98e-02
|
8.01e-01
|
GOBP REGULATION OF CARBOHYDRATE BIOSYNTHETIC PROCESS
|
91
|
5.13e-01
|
3.97e-02
|
6.82e-01
|
GOBP NUCLEIC ACID CATABOLIC PROCESS
|
581
|
1.04e-01
|
3.97e-02
|
2.41e-01
|
GOBP POSITIVE REGULATION OF FATTY ACID TRANSPORT
|
17
|
7.77e-01
|
3.96e-02
|
8.69e-01
|
GOCC VESICLE COAT
|
56
|
6.09e-01
|
-3.96e-02
|
7.55e-01
|
GOBP GLUTAMINE FAMILY AMINO ACID BIOSYNTHETIC PROCESS
|
11
|
8.20e-01
|
3.96e-02
|
8.96e-01
|
GOBP LATE ENDOSOME TO VACUOLE TRANSPORT VIA MULTIVESICULAR BODY SORTING PATHWAY
|
15
|
7.91e-01
|
-3.96e-02
|
8.78e-01
|
GOBP SNRNA TRANSCRIPTION
|
17
|
7.78e-01
|
3.95e-02
|
8.69e-01
|
GOBP POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION
|
294
|
2.45e-01
|
-3.95e-02
|
4.26e-01
|
GOBP S ADENOSYLMETHIONINE METABOLIC PROCESS
|
16
|
7.84e-01
|
-3.95e-02
|
8.74e-01
|
GOBP HEPATOCYTE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY
|
11
|
8.21e-01
|
-3.95e-02
|
8.97e-01
|
GOBP BASE EXCISION REPAIR
|
38
|
6.74e-01
|
3.94e-02
|
8.02e-01
|
GOBP REGULATION OF DENDRITIC SPINE MAINTENANCE
|
11
|
8.22e-01
|
3.93e-02
|
8.97e-01
|
GOBP SA NODE CELL TO ATRIAL CARDIAC MUSCLE CELL COMMUNICATION
|
10
|
8.30e-01
|
3.93e-02
|
9.02e-01
|
GOCC AP TYPE MEMBRANE COAT ADAPTOR COMPLEX
|
39
|
6.72e-01
|
-3.92e-02
|
8.01e-01
|
GOBP REGULATION OF PROTEOLYSIS INVOLVED IN PROTEIN CATABOLIC PROCESS
|
198
|
3.43e-01
|
-3.92e-02
|
5.32e-01
|
GOMF CARBOHYDRATE BINDING
|
177
|
3.71e-01
|
-3.91e-02
|
5.57e-01
|
GOBP REGULATION OF RRNA PROCESSING
|
14
|
8.00e-01
|
-3.91e-02
|
8.84e-01
|
GOBP DEOXYRIBONUCLEOSIDE MONOPHOSPHATE CATABOLIC PROCESS
|
15
|
7.93e-01
|
-3.91e-02
|
8.80e-01
|
GOBP REGULATION OF SULFUR METABOLIC PROCESS
|
14
|
8.01e-01
|
3.90e-02
|
8.84e-01
|
GOBP SCHWANN CELL DIFFERENTIATION
|
49
|
6.37e-01
|
3.90e-02
|
7.76e-01
|
GOBP REGULATION OF NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS NONSENSE MEDIATED DECAY
|
11
|
8.23e-01
|
-3.89e-02
|
8.98e-01
|
GOCC CALYX OF HELD
|
25
|
7.37e-01
|
3.89e-02
|
8.43e-01
|
GOBP REGULATION OF CAMP DEPENDENT PROTEIN KINASE ACTIVITY
|
11
|
8.24e-01
|
3.88e-02
|
8.98e-01
|
GOBP NATURAL KILLER CELL DIFFERENTIATION
|
27
|
7.27e-01
|
-3.88e-02
|
8.35e-01
|
GOBP REGULATION OF SECRETION
|
488
|
1.45e-01
|
-3.87e-02
|
2.98e-01
|
GOBP ACUTE PHASE RESPONSE
|
22
|
7.54e-01
|
3.86e-02
|
8.53e-01
|
GOBP ECTOPIC GERM CELL PROGRAMMED CELL DEATH
|
15
|
7.96e-01
|
-3.86e-02
|
8.82e-01
|
GOBP RESPONSE TO HEAT
|
73
|
5.70e-01
|
3.85e-02
|
7.27e-01
|
GOBP CELL PROLIFERATION INVOLVED IN HEART MORPHOGENESIS
|
19
|
7.72e-01
|
-3.84e-02
|
8.64e-01
|
GOCC PARASPECKLES
|
10
|
8.33e-01
|
-3.84e-02
|
9.04e-01
|
GOBP AMYLOID BETA CLEARANCE
|
33
|
7.03e-01
|
3.84e-02
|
8.19e-01
|
GOBP POLY A PLUS MRNA EXPORT FROM NUCLEUS
|
18
|
7.78e-01
|
-3.84e-02
|
8.69e-01
|
GOBP NEGATIVE REGULATION OF HORMONE SECRETION
|
66
|
5.90e-01
|
3.84e-02
|
7.40e-01
|
GOBP IMPORT INTO CELL
|
719
|
8.17e-02
|
-3.84e-02
|
2.05e-01
|
GOBP DEVELOPMENT OF PRIMARY MALE SEXUAL CHARACTERISTICS
|
92
|
5.25e-01
|
-3.84e-02
|
6.91e-01
|
GOMF SIGNALING RECEPTOR COMPLEX ADAPTOR ACTIVITY
|
38
|
6.82e-01
|
-3.84e-02
|
8.06e-01
|
GOBP MUSCLE CELL FATE COMMITMENT
|
11
|
8.26e-01
|
-3.84e-02
|
9.00e-01
|
GOBP POLYSACCHARIDE CATABOLIC PROCESS
|
31
|
7.12e-01
|
3.84e-02
|
8.24e-01
|
GOBP NUCLEOSIDE CATABOLIC PROCESS
|
16
|
7.91e-01
|
3.83e-02
|
8.78e-01
|
GOBP PLASMINOGEN ACTIVATION
|
17
|
7.85e-01
|
3.83e-02
|
8.74e-01
|
GOBP POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE
|
10
|
8.34e-01
|
3.82e-02
|
9.04e-01
|
GOMF PHOSPHATIDYLINOSITOL 4 5 BISPHOSPHATE PHOSPHATASE ACTIVITY
|
10
|
8.34e-01
|
-3.82e-02
|
9.04e-01
|
GOBP ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE
|
17
|
7.85e-01
|
-3.82e-02
|
8.74e-01
|
GOBP NEGATIVE REGULATION OF GLIAL CELL PROLIFERATION
|
18
|
7.80e-01
|
-3.81e-02
|
8.71e-01
|
GOBP GLYCOSYLATION
|
175
|
3.86e-01
|
3.81e-02
|
5.71e-01
|
GOBP NEGATIVE REGULATION OF INFLAMMATORY RESPONSE
|
108
|
4.96e-01
|
-3.80e-02
|
6.68e-01
|
GOBP BODY FLUID SECRETION
|
68
|
5.90e-01
|
3.78e-02
|
7.40e-01
|
GOBP PROTEIN ACYLATION
|
82
|
5.55e-01
|
-3.78e-02
|
7.17e-01
|
GOBP SYNAPTIC VESICLE EXOCYTOSIS
|
80
|
5.59e-01
|
-3.78e-02
|
7.19e-01
|
GOBP RELEASE OF CYTOCHROME C FROM MITOCHONDRIA
|
56
|
6.25e-01
|
3.78e-02
|
7.67e-01
|
GOBP PHOSPHATIDYLINOSITOL BIOSYNTHETIC PROCESS
|
89
|
5.39e-01
|
3.77e-02
|
7.03e-01
|
GOBP RENAL WATER HOMEOSTASIS
|
11
|
8.28e-01
|
3.77e-02
|
9.02e-01
|
GOMF ADENYLATE CYCLASE ACTIVITY
|
11
|
8.29e-01
|
-3.77e-02
|
9.02e-01
|
GOBP EPITHELIAL CELL MATURATION
|
18
|
7.82e-01
|
3.77e-02
|
8.73e-01
|
GOBP REGULATION OF POSTSYNAPTIC SPECIALIZATION ASSEMBLY
|
17
|
7.88e-01
|
-3.77e-02
|
8.76e-01
|
GOMF SULFOTRANSFERASE ACTIVITY
|
27
|
7.35e-01
|
-3.76e-02
|
8.41e-01
|
GOCC CLATHRIN COAT OF TRANS GOLGI NETWORK VESICLE
|
11
|
8.29e-01
|
3.76e-02
|
9.02e-01
|
GOBP NEGATIVE REGULATION OF HIPPO SIGNALING
|
13
|
8.14e-01
|
-3.76e-02
|
8.94e-01
|
GOBP ROOF OF MOUTH DEVELOPMENT
|
84
|
5.52e-01
|
-3.76e-02
|
7.14e-01
|
GOBP PLATELET MORPHOGENESIS
|
21
|
7.66e-01
|
-3.75e-02
|
8.61e-01
|
GOBP REGULATION OF TRANSMEMBRANE TRANSPORT
|
374
|
2.16e-01
|
3.74e-02
|
3.91e-01
|
GOCC SOMATODENDRITIC COMPARTMENT
|
805
|
7.36e-02
|
-3.74e-02
|
1.90e-01
|
GOBP GLUTAMATE RECEPTOR SIGNALING PATHWAY
|
33
|
7.11e-01
|
-3.73e-02
|
8.24e-01
|
GOBP RESPONSE TO MINERALOCORTICOID
|
10
|
8.38e-01
|
-3.73e-02
|
9.08e-01
|
GOBP REGULATION OF RESPONSE TO OXIDATIVE STRESS
|
34
|
7.08e-01
|
3.72e-02
|
8.22e-01
|
GOBP REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION
|
89
|
5.45e-01
|
-3.72e-02
|
7.08e-01
|
GOBP REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY
|
25
|
7.48e-01
|
3.72e-02
|
8.50e-01
|
GOBP REGULATION OF AMYLOID BETA CLEARANCE
|
15
|
8.03e-01
|
-3.71e-02
|
8.86e-01
|
GOBP NEGATIVE REGULATION OF RNA SPLICING
|
25
|
7.48e-01
|
3.71e-02
|
8.50e-01
|
GOBP REGULATION OF CYCLASE ACTIVITY
|
27
|
7.39e-01
|
-3.71e-02
|
8.44e-01
|
GOBP MATERNAL PROCESS INVOLVED IN FEMALE PREGNANCY
|
41
|
6.82e-01
|
3.70e-02
|
8.06e-01
|
GOBP REGULATION OF MICROTUBULE BASED MOVEMENT
|
21
|
7.69e-01
|
3.70e-02
|
8.63e-01
|
GOBP SUPEROXIDE METABOLIC PROCESS
|
59
|
6.24e-01
|
-3.70e-02
|
7.66e-01
|
GOBP NEGATIVE REGULATION OF GTPASE ACTIVITY
|
22
|
7.64e-01
|
3.69e-02
|
8.60e-01
|
GOCC NSL COMPLEX
|
11
|
8.33e-01
|
-3.68e-02
|
9.04e-01
|
GOBP MYELOID CELL DEVELOPMENT
|
80
|
5.70e-01
|
-3.68e-02
|
7.27e-01
|
GOMF COMPLEMENT BINDING
|
16
|
7.99e-01
|
3.67e-02
|
8.84e-01
|
GOBP REGULATION OF FATTY ACID METABOLIC PROCESS
|
82
|
5.66e-01
|
3.67e-02
|
7.25e-01
|
GOBP POSTSYNAPSE TO NUCLEUS SIGNALING PATHWAY
|
15
|
8.06e-01
|
-3.67e-02
|
8.88e-01
|
GOBP SYNAPTIC TRANSMISSION GLUTAMATERGIC
|
77
|
5.78e-01
|
3.67e-02
|
7.33e-01
|
GOBP RESPONSE TO NUTRIENT LEVELS
|
298
|
2.79e-01
|
3.66e-02
|
4.62e-01
|
GOCC PERIKARYON
|
101
|
5.27e-01
|
3.65e-02
|
6.92e-01
|
GOBP STORE OPERATED CALCIUM ENTRY
|
19
|
7.83e-01
|
-3.65e-02
|
8.73e-01
|
GOBP REGULATION OF LEUKOCYTE TETHERING OR ROLLING
|
14
|
8.13e-01
|
-3.65e-02
|
8.93e-01
|
GOBP REGULATION OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE
|
106
|
5.17e-01
|
-3.65e-02
|
6.85e-01
|
GOBP RESPONSE TO INORGANIC SUBSTANCE
|
356
|
2.39e-01
|
-3.64e-02
|
4.19e-01
|
GOBP TRANSCRIPTION BY RNA POLYMERASE I
|
57
|
6.35e-01
|
-3.64e-02
|
7.74e-01
|
GOCC PHOSPHATASE COMPLEX
|
43
|
6.80e-01
|
-3.64e-02
|
8.06e-01
|
GOBP L GLUTAMATE IMPORT ACROSS PLASMA MEMBRANE
|
13
|
8.21e-01
|
3.63e-02
|
8.97e-01
|
GOBP POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND
|
14
|
8.14e-01
|
-3.63e-02
|
8.94e-01
|
GOBP ICOSANOID BIOSYNTHETIC PROCESS
|
32
|
7.23e-01
|
3.63e-02
|
8.32e-01
|
GOCC ACROSOMAL VESICLE
|
69
|
6.04e-01
|
3.62e-02
|
7.50e-01
|
GOBP PHAGOSOME MATURATION
|
26
|
7.50e-01
|
-3.61e-02
|
8.51e-01
|
GOCC AMPHISOME MEMBRANE
|
10
|
8.43e-01
|
-3.61e-02
|
9.11e-01
|
GOBP NEGATIVE REGULATION OF SMOOTH MUSCLE CELL APOPTOTIC PROCESS
|
14
|
8.15e-01
|
3.61e-02
|
8.94e-01
|
GOBP POSTSYNAPTIC MEMBRANE ORGANIZATION
|
44
|
6.79e-01
|
-3.60e-02
|
8.06e-01
|
GOBP ACTIN FILAMENT BASED MOVEMENT
|
114
|
5.08e-01
|
3.60e-02
|
6.77e-01
|
GOBP CEREBELLAR CORTEX MORPHOGENESIS
|
36
|
7.09e-01
|
3.59e-02
|
8.23e-01
|
GOCC ENDOPLASMIC RETICULUM TUBULAR NETWORK
|
27
|
7.47e-01
|
-3.59e-02
|
8.50e-01
|
GOMF SINGLE STRANDED DNA ENDODEOXYRIBONUCLEASE ACTIVITY
|
13
|
8.23e-01
|
-3.59e-02
|
8.98e-01
|
GOBP PROTEIN PALMITOYLATION
|
26
|
7.52e-01
|
3.59e-02
|
8.52e-01
|
GOMF SIGNAL SEQUENCE BINDING
|
39
|
6.99e-01
|
3.58e-02
|
8.17e-01
|
GOBP REGULATION OF INTRACELLULAR PROTEIN TRANSPORT
|
151
|
4.49e-01
|
-3.57e-02
|
6.27e-01
|
GOMF ALCOHOL BINDING
|
64
|
6.21e-01
|
3.57e-02
|
7.64e-01
|
GOBP MONOATOMIC ANION TRANSMEMBRANE TRANSPORT
|
50
|
6.62e-01
|
3.57e-02
|
7.94e-01
|
GOMF HYDROLASE ACTIVITY ACTING ON ACID ANHYDRIDES
|
558
|
1.52e-01
|
-3.57e-02
|
3.07e-01
|
GOBP REGULATION OF HAIR FOLLICLE DEVELOPMENT
|
12
|
8.31e-01
|
-3.55e-02
|
9.04e-01
|
GOMF ENZYME INHIBITOR ACTIVITY
|
240
|
3.45e-01
|
-3.55e-02
|
5.33e-01
|
GOMF WW DOMAIN BINDING
|
18
|
7.95e-01
|
-3.54e-02
|
8.81e-01
|
GOBP REGULATION OF NEUROTRANSMITTER SECRETION
|
70
|
6.09e-01
|
-3.54e-02
|
7.55e-01
|
GOBP NEGATIVE REGULATION OF JUN KINASE ACTIVITY
|
12
|
8.32e-01
|
3.54e-02
|
9.04e-01
|
GOBP GLUCOSE IMPORT
|
71
|
6.07e-01
|
3.54e-02
|
7.53e-01
|
GOBP HORMONE BIOSYNTHETIC PROCESS
|
36
|
7.14e-01
|
-3.53e-02
|
8.25e-01
|
GOBP CHLORIDE TRANSMEMBRANE TRANSPORT
|
31
|
7.34e-01
|
3.53e-02
|
8.40e-01
|
GOBP PEPTIDYL METHIONINE MODIFICATION
|
11
|
8.39e-01
|
3.53e-02
|
9.08e-01
|
GOBP AUDITORY RECEPTOR CELL MORPHOGENESIS
|
17
|
8.01e-01
|
-3.53e-02
|
8.85e-01
|
GOBP RESPONSE TO CHEMOKINE
|
51
|
6.63e-01
|
-3.53e-02
|
7.95e-01
|
GOMF LIPOPROTEIN PARTICLE RECEPTOR ACTIVITY
|
14
|
8.20e-01
|
-3.51e-02
|
8.96e-01
|
GOBP MATING BEHAVIOR
|
24
|
7.66e-01
|
3.51e-02
|
8.60e-01
|
GOBP CELL MATURATION
|
139
|
4.76e-01
|
-3.51e-02
|
6.50e-01
|
GOBP PROTEIN PROCESSING
|
190
|
4.05e-01
|
-3.51e-02
|
5.89e-01
|
GOBP NEGATIVE REGULATION OF NERVOUS SYSTEM PROCESS
|
14
|
8.20e-01
|
-3.51e-02
|
8.96e-01
|
GOBP TRANSITION METAL ION TRANSPORT
|
77
|
5.95e-01
|
3.50e-02
|
7.44e-01
|
GOBP MYD88 INDEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY
|
11
|
8.41e-01
|
-3.50e-02
|
9.10e-01
|
GOCC ENDOPLASMIC RETICULUM PROTEIN CONTAINING COMPLEX
|
115
|
5.18e-01
|
3.49e-02
|
6.86e-01
|
GOBP POSITIVE REGULATION OF PROTEIN TARGETING TO MEMBRANE
|
27
|
7.54e-01
|
3.49e-02
|
8.53e-01
|
GOBP POSITIVE REGULATION OF INTERLEUKIN 4 PRODUCTION
|
17
|
8.04e-01
|
3.48e-02
|
8.86e-01
|
GOBP CEREBELLAR PURKINJE CELL LAYER DEVELOPMENT
|
28
|
7.50e-01
|
3.48e-02
|
8.51e-01
|
GOMF ANKYRIN BINDING
|
18
|
7.99e-01
|
3.47e-02
|
8.83e-01
|
GOCC ATAC COMPLEX
|
13
|
8.28e-01
|
3.47e-02
|
9.02e-01
|
GOBP LEUKOCYTE MIGRATION INVOLVED IN INFLAMMATORY RESPONSE
|
16
|
8.10e-01
|
-3.47e-02
|
8.90e-01
|
GOCC INO80 COMPLEX
|
16
|
8.10e-01
|
3.47e-02
|
8.90e-01
|
GOBP ORGANIC CYCLIC COMPOUND CATABOLIC PROCESS
|
469
|
2.01e-01
|
3.46e-02
|
3.72e-01
|
GOBP REGULATION OF PROTEIN MATURATION
|
57
|
6.52e-01
|
-3.46e-02
|
7.87e-01
|
GOBP ANAPHASE PROMOTING COMPLEX DEPENDENT CATABOLIC PROCESS
|
15
|
8.17e-01
|
3.46e-02
|
8.94e-01
|
GOBP GOLGI TO PLASMA MEMBRANE PROTEIN TRANSPORT
|
36
|
7.20e-01
|
-3.45e-02
|
8.30e-01
|
GOBP ASTROCYTE ACTIVATION
|
18
|
8.00e-01
|
-3.45e-02
|
8.84e-01
|
GOBP POSITIVE REGULATION OF ATP BIOSYNTHETIC PROCESS
|
11
|
8.43e-01
|
3.45e-02
|
9.11e-01
|
GOBP LYSOSOMAL LUMEN ACIDIFICATION
|
15
|
8.18e-01
|
-3.44e-02
|
8.95e-01
|
GOBP MALE MEIOTIC NUCLEAR DIVISION
|
28
|
7.53e-01
|
-3.44e-02
|
8.52e-01
|
GOBP MOTILE CILIUM ASSEMBLY
|
38
|
7.14e-01
|
3.44e-02
|
8.25e-01
|
GOBP REGULATION OF AUTOPHAGY
|
263
|
3.39e-01
|
-3.43e-02
|
5.27e-01
|
GOBP DICARBOXYLIC ACID TRANSPORT
|
78
|
6.00e-01
|
3.43e-02
|
7.48e-01
|
GOBP PROSTANOID METABOLIC PROCESS
|
39
|
7.11e-01
|
-3.43e-02
|
8.24e-01
|
GOBP GLYCOSPHINGOLIPID METABOLIC PROCESS
|
41
|
7.05e-01
|
-3.42e-02
|
8.20e-01
|
GOBP NEGATIVE REGULATION OF PROTEOLYSIS
|
201
|
4.04e-01
|
-3.42e-02
|
5.88e-01
|
GOBP VESICLE MEDIATED TRANSPORT IN SYNAPSE
|
242
|
3.60e-01
|
-3.42e-02
|
5.47e-01
|
GOBP FERTILIZATION
|
108
|
5.39e-01
|
-3.42e-02
|
7.04e-01
|
GOBP POSITIVE REGULATION OF CYCLASE ACTIVITY
|
22
|
7.81e-01
|
-3.42e-02
|
8.72e-01
|
GOCC NUCLEOTIDE ACTIVATED PROTEIN KINASE COMPLEX
|
11
|
8.45e-01
|
3.42e-02
|
9.12e-01
|
GOBP PIGMENTATION
|
92
|
5.72e-01
|
-3.41e-02
|
7.28e-01
|
GOBP NEGATIVE REGULATION OF INTERLEUKIN 1 PRODUCTION
|
27
|
7.59e-01
|
-3.41e-02
|
8.56e-01
|
GOBP NEGATIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS
|
62
|
6.42e-01
|
-3.41e-02
|
7.80e-01
|
GOBP POSITIVE REGULATION OF TRANSPORT
|
743
|
1.16e-01
|
-3.41e-02
|
2.57e-01
|
GOCC CHLORIDE CHANNEL COMPLEX
|
21
|
7.87e-01
|
-3.41e-02
|
8.76e-01
|
GOBP TONGUE MORPHOGENESIS
|
10
|
8.52e-01
|
3.40e-02
|
9.17e-01
|
GOMF MUSCLE ALPHA ACTININ BINDING
|
12
|
8.38e-01
|
3.40e-02
|
9.08e-01
|
GOCC INTRACELLULAR PROTEIN CONTAINING COMPLEX
|
778
|
1.12e-01
|
3.38e-02
|
2.52e-01
|
GOBP SECRETION
|
735
|
1.22e-01
|
-3.38e-02
|
2.65e-01
|
GOCC MKS COMPLEX
|
14
|
8.27e-01
|
-3.38e-02
|
9.01e-01
|
GOCC PRESYNAPTIC ACTIVE ZONE MEMBRANE
|
49
|
6.83e-01
|
-3.37e-02
|
8.06e-01
|
GOBP REGULATION OF ICOSANOID SECRETION
|
16
|
8.15e-01
|
-3.37e-02
|
8.94e-01
|
GOMF NUCLEOTIDYLTRANSFERASE ACTIVITY
|
116
|
5.32e-01
|
-3.36e-02
|
6.97e-01
|
GOBP NEGATIVE REGULATION OF ADENYLATE CYCLASE ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY
|
13
|
8.35e-01
|
3.34e-02
|
9.05e-01
|
GOBP OPTIC NERVE DEVELOPMENT
|
10
|
8.55e-01
|
3.33e-02
|
9.18e-01
|
GOCC MEMBRANE COAT
|
89
|
5.89e-01
|
-3.32e-02
|
7.40e-01
|
GOBP PYRIMIDINE DEOXYRIBONUCLEOTIDE METABOLIC PROCESS
|
17
|
8.14e-01
|
-3.30e-02
|
8.93e-01
|
GOBP IMPORT INTO NUCLEUS
|
163
|
4.68e-01
|
-3.30e-02
|
6.44e-01
|
GOBP PROTEIN K11 LINKED UBIQUITINATION
|
28
|
7.63e-01
|
-3.30e-02
|
8.59e-01
|
GOMF BICARBONATE TRANSMEMBRANE TRANSPORTER ACTIVITY
|
16
|
8.20e-01
|
-3.29e-02
|
8.96e-01
|
GOBP REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION
|
482
|
2.18e-01
|
-3.29e-02
|
3.94e-01
|
GOBP REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY
|
36
|
7.33e-01
|
-3.29e-02
|
8.40e-01
|
GOBP HUMORAL IMMUNE RESPONSE MEDIATED BY CIRCULATING IMMUNOGLOBULIN
|
27
|
7.69e-01
|
-3.27e-02
|
8.63e-01
|
GOBP REGULATION OF PROTEIN LOCALIZATION TO SYNAPSE
|
29
|
7.61e-01
|
3.26e-02
|
8.57e-01
|
GOBP POSITIVE REGULATION OF GLUCOSE METABOLIC PROCESS
|
45
|
7.05e-01
|
3.26e-02
|
8.20e-01
|
GOMF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR BINDING
|
14
|
8.33e-01
|
-3.26e-02
|
9.04e-01
|
GOBP NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE
|
18
|
8.11e-01
|
-3.26e-02
|
8.91e-01
|
GOBP POSITIVE REGULATION OF PEPTIDE SECRETION
|
107
|
5.61e-01
|
-3.25e-02
|
7.21e-01
|
GOMF TRANSLATION INITIATION FACTOR ACTIVITY
|
46
|
7.03e-01
|
-3.25e-02
|
8.20e-01
|
GOBP NEGATIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION
|
17
|
8.17e-01
|
3.25e-02
|
8.94e-01
|
GOMF PROTEIN LIPID COMPLEX BINDING
|
26
|
7.75e-01
|
3.25e-02
|
8.67e-01
|
GOBP PROTEIN TRIMERIZATION
|
15
|
8.28e-01
|
-3.24e-02
|
9.01e-01
|
GOBP REGULATION OF CATABOLIC PROCESS
|
833
|
1.15e-01
|
-3.24e-02
|
2.56e-01
|
GOBP MUSCLE ATROPHY
|
10
|
8.59e-01
|
-3.24e-02
|
9.21e-01
|
GOBP CELLULAR RESPONSE TO REACTIVE OXYGEN SPECIES
|
123
|
5.35e-01
|
-3.24e-02
|
7.00e-01
|
GOBP NEGATIVE REGULATION OF MONOATOMIC ION TRANSMEMBRANE TRANSPORT
|
77
|
6.23e-01
|
3.24e-02
|
7.66e-01
|
GOMF PROTEIN TYROSINE KINASE ACTIVATOR ACTIVITY
|
22
|
7.93e-01
|
-3.24e-02
|
8.79e-01
|
GOMF SNORNA BINDING
|
30
|
7.59e-01
|
-3.23e-02
|
8.56e-01
|
GOCC PHAGOPHORE ASSEMBLY SITE
|
33
|
7.48e-01
|
-3.23e-02
|
8.50e-01
|
GOBP ESTABLISHMENT OF PIGMENT GRANULE LOCALIZATION
|
15
|
8.29e-01
|
-3.22e-02
|
9.02e-01
|
GOBP POSITIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT
|
96
|
5.86e-01
|
-3.22e-02
|
7.38e-01
|
GOBP GLYCOLIPID CATABOLIC PROCESS
|
11
|
8.53e-01
|
3.22e-02
|
9.17e-01
|
GOBP MESODERM DEVELOPMENT
|
77
|
6.26e-01
|
-3.21e-02
|
7.68e-01
|
GOCC ENDOPEPTIDASE COMPLEX
|
75
|
6.31e-01
|
3.21e-02
|
7.71e-01
|
GOBP LACTATION
|
28
|
7.69e-01
|
-3.21e-02
|
8.63e-01
|
GOBP NEUROTRANSMITTER RECEPTOR TRANSPORT ENDOSOME TO PLASMA MEMBRANE
|
10
|
8.61e-01
|
3.21e-02
|
9.22e-01
|
GOBP REGULATION OF VACUOLE ORGANIZATION
|
52
|
6.90e-01
|
-3.20e-02
|
8.11e-01
|
GOBP CARBOHYDRATE TRANSMEMBRANE TRANSPORT
|
99
|
5.84e-01
|
3.19e-02
|
7.36e-01
|
GOMF UBIQUITIN BINDING
|
90
|
6.01e-01
|
-3.19e-02
|
7.48e-01
|
GOBP DEOXYRIBONUCLEOTIDE CATABOLIC PROCESS
|
22
|
7.96e-01
|
3.19e-02
|
8.82e-01
|
GOBP CHLORIDE TRANSPORT
|
62
|
6.64e-01
|
-3.19e-02
|
7.95e-01
|
GOBP REGULATION OF TRANSPORT
|
1310
|
5.59e-02
|
-3.19e-02
|
1.57e-01
|
GOBP REGULATION OF POSTSYNAPTIC MEMBRANE NEUROTRANSMITTER RECEPTOR LEVELS
|
124
|
5.40e-01
|
3.19e-02
|
7.04e-01
|
GOBP NUCLEOLUS ORGANIZATION
|
17
|
8.21e-01
|
3.17e-02
|
8.97e-01
|
GOBP VENTRICULAR CARDIAC MUSCLE TISSUE DEVELOPMENT
|
60
|
6.71e-01
|
3.17e-02
|
8.00e-01
|
GOCC ACETYLTRANSFERASE COMPLEX
|
95
|
5.94e-01
|
3.17e-02
|
7.43e-01
|
GOBP NEGATIVE REGULATION OF PEPTIDE SECRETION
|
52
|
6.93e-01
|
3.17e-02
|
8.13e-01
|
GOBP VASCULAR ASSOCIATED SMOOTH MUSCLE CELL APOPTOTIC PROCESS
|
13
|
8.43e-01
|
3.17e-02
|
9.11e-01
|
GOBP REGULATION OF MEMBRANE REPOLARIZATION
|
30
|
7.64e-01
|
-3.16e-02
|
8.60e-01
|
GOBP MALE SEX DIFFERENTIATION
|
108
|
5.71e-01
|
-3.16e-02
|
7.27e-01
|
GOBP VESICLE LOCALIZATION
|
194
|
4.49e-01
|
-3.16e-02
|
6.27e-01
|
GOBP PYRIMIDINE CONTAINING COMPOUND CATABOLIC PROCESS
|
22
|
7.98e-01
|
-3.16e-02
|
8.83e-01
|
GOBP NEGATIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION
|
56
|
6.83e-01
|
-3.16e-02
|
8.06e-01
|
GOBP MYELIN MAINTENANCE
|
15
|
8.32e-01
|
-3.16e-02
|
9.04e-01
|
GOBP RNA 3 END PROCESSING
|
75
|
6.37e-01
|
-3.15e-02
|
7.76e-01
|
GOCC 9PLUS0 NON MOTILE CILIUM
|
87
|
6.12e-01
|
-3.15e-02
|
7.57e-01
|
GOBP REGULATION OF PHOSPHATASE ACTIVITY
|
52
|
6.94e-01
|
-3.15e-02
|
8.14e-01
|
GOCC PHAGOPHORE ASSEMBLY SITE MEMBRANE
|
16
|
8.27e-01
|
3.15e-02
|
9.01e-01
|
GOMF N ACETYLTRANSFERASE ACTIVITY
|
59
|
6.76e-01
|
-3.14e-02
|
8.04e-01
|
GOBP PROTEIN CONTAINING COMPLEX LOCALIZATION
|
222
|
4.21e-01
|
-3.14e-02
|
6.03e-01
|
GOBP STRIATED MUSCLE CELL APOPTOTIC PROCESS
|
65
|
6.62e-01
|
-3.14e-02
|
7.94e-01
|
GOBP REGULATION OF PROTEIN STABILITY
|
279
|
3.69e-01
|
-3.13e-02
|
5.56e-01
|
GOBP AUDITORY RECEPTOR CELL STEREOCILIUM ORGANIZATION
|
13
|
8.46e-01
|
3.12e-02
|
9.12e-01
|
GOMF STRUCTURAL CONSTITUENT OF CYTOSKELETON
|
58
|
6.81e-01
|
-3.12e-02
|
8.06e-01
|
GOBP MITOPHAGY
|
53
|
6.95e-01
|
3.12e-02
|
8.14e-01
|
GOBP MUSCLE STRUCTURE DEVELOPMENT
|
621
|
1.88e-01
|
-3.12e-02
|
3.55e-01
|
GOBP POSITIVE REGULATION OF HORMONE SECRETION
|
130
|
5.41e-01
|
-3.11e-02
|
7.05e-01
|
GOBP POSITIVE REGULATION OF SEQUESTERING OF CALCIUM ION
|
12
|
8.52e-01
|
-3.11e-02
|
9.17e-01
|
GOBP NEUROTRANSMITTER SECRETION
|
122
|
5.55e-01
|
-3.10e-02
|
7.17e-01
|
GOBP TELOMERE MAINTENANCE IN RESPONSE TO DNA DAMAGE
|
29
|
7.73e-01
|
-3.10e-02
|
8.65e-01
|
GOBP NEGATIVE REGULATION OF OXIDOREDUCTASE ACTIVITY
|
13
|
8.47e-01
|
3.10e-02
|
9.12e-01
|
GOMF CATALYTIC ACTIVITY ACTING ON A NUCLEIC ACID
|
487
|
2.48e-01
|
-3.07e-02
|
4.29e-01
|
GOCC NEURON PROJECTION
|
1062
|
9.46e-02
|
-3.07e-02
|
2.26e-01
|
GOBP REGULATION OF HEMATOPOIETIC STEM CELL DIFFERENTIATION
|
14
|
8.43e-01
|
-3.06e-02
|
9.11e-01
|
GOBP LYMPHOCYTE CHEMOTAXIS
|
28
|
7.80e-01
|
3.05e-02
|
8.71e-01
|
GOMF RNA POLYMERASE II C TERMINAL DOMAIN BINDING
|
11
|
8.61e-01
|
3.04e-02
|
9.22e-01
|
GOBP ENDOCRINE PROCESS
|
64
|
6.74e-01
|
3.04e-02
|
8.02e-01
|
GOMF ALPHA ACTININ BINDING
|
27
|
7.85e-01
|
3.04e-02
|
8.74e-01
|
GOMF MRNA 3 UTR AU RICH REGION BINDING
|
27
|
7.85e-01
|
-3.04e-02
|
8.74e-01
|
GOBP NEGATIVE REGULATION OF PROTEIN CATABOLIC PROCESS
|
97
|
6.06e-01
|
-3.03e-02
|
7.53e-01
|
GOMF RNA BINDING
|
977
|
1.12e-01
|
-3.03e-02
|
2.52e-01
|
GOBP REGULATION OF GLYCOGEN CATABOLIC PROCESS
|
10
|
8.68e-01
|
-3.03e-02
|
9.27e-01
|
GOBP REGULATION OF AMINO ACID TRANSMEMBRANE TRANSPORT
|
16
|
8.34e-01
|
3.02e-02
|
9.04e-01
|
GOMF 2 OXOGLUTARATE DEPENDENT DIOXYGENASE ACTIVITY
|
57
|
6.94e-01
|
-3.02e-02
|
8.14e-01
|
GOCC AUTOLYSOSOME
|
14
|
8.45e-01
|
3.01e-02
|
9.12e-01
|
GOBP PEPTIDYL LYSINE METHYLATION
|
18
|
8.25e-01
|
3.01e-02
|
9.00e-01
|
GOBP NEGATIVE REGULATION OF CELLULAR RESPONSE TO HYPOXIA
|
17
|
8.30e-01
|
3.01e-02
|
9.03e-01
|
GOBP MICROTUBULE BASED MOVEMENT
|
260
|
4.05e-01
|
-3.00e-02
|
5.90e-01
|
GOBP HYPOTHALAMUS DEVELOPMENT
|
14
|
8.46e-01
|
-2.99e-02
|
9.12e-01
|
GOBP LYTIC VACUOLE ORGANIZATION
|
87
|
6.30e-01
|
-2.99e-02
|
7.71e-01
|
GOBP AXON DEVELOPMENT
|
422
|
2.94e-01
|
-2.99e-02
|
4.78e-01
|
GOBP RETROGRADE AXONAL TRANSPORT
|
19
|
8.22e-01
|
2.99e-02
|
8.97e-01
|
GOCC CILIARY ROOTLET
|
12
|
8.58e-01
|
2.98e-02
|
9.21e-01
|
GOMF MONOATOMIC ANION CHANNEL ACTIVITY
|
51
|
7.13e-01
|
2.98e-02
|
8.25e-01
|
GOBP NEGATIVE REGULATION OF PHAGOCYTOSIS
|
19
|
8.22e-01
|
-2.98e-02
|
8.98e-01
|
GOCC ENDOPLASMIC RETICULUM
|
1396
|
6.64e-02
|
2.98e-02
|
1.77e-01
|
GOBP POSITIVE REGULATION OF MUSCLE HYPERTROPHY
|
39
|
7.48e-01
|
-2.97e-02
|
8.50e-01
|
GOMF UBIQUITIN PROTEIN TRANSFERASE INHIBITOR ACTIVITY
|
13
|
8.53e-01
|
2.97e-02
|
9.17e-01
|
GOBP MUSCLE CELL CELLULAR HOMEOSTASIS
|
22
|
8.10e-01
|
-2.96e-02
|
8.90e-01
|
GOCC INTERMEDIATE FILAMENT
|
49
|
7.21e-01
|
-2.96e-02
|
8.31e-01
|
GOCC POSTSYNAPTIC MEMBRANE
|
248
|
4.25e-01
|
2.95e-02
|
6.07e-01
|
GOBP NEGATIVE REGULATION OF TRANSPORT
|
365
|
3.35e-01
|
-2.95e-02
|
5.24e-01
|
GOBP POSITIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY
|
12
|
8.60e-01
|
2.94e-02
|
9.22e-01
|
GOBP COPPER ION HOMEOSTASIS
|
16
|
8.39e-01
|
2.94e-02
|
9.08e-01
|
GOMF GDP BINDING
|
71
|
6.69e-01
|
-2.93e-02
|
7.99e-01
|
GOCC MULTIVESICULAR BODY MEMBRANE
|
17
|
8.34e-01
|
2.93e-02
|
9.04e-01
|
GOBP SPHINGOMYELIN METABOLIC PROCESS
|
20
|
8.21e-01
|
-2.93e-02
|
8.97e-01
|
GOMF BETA TUBULIN BINDING
|
38
|
7.55e-01
|
2.93e-02
|
8.53e-01
|
GOBP CELLULAR RESPONSE TO PH
|
12
|
8.61e-01
|
2.92e-02
|
9.22e-01
|
GOBP POSITIVE REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT
|
40
|
7.49e-01
|
-2.92e-02
|
8.51e-01
|
GOCC SECRETORY VESICLE
|
414
|
3.10e-01
|
-2.92e-02
|
4.96e-01
|
GOBP PROTEASOMAL PROTEIN CATABOLIC PROCESS
|
461
|
2.86e-01
|
-2.91e-02
|
4.69e-01
|
GOCC POSTSYNAPTIC SPECIALIZATION
|
342
|
3.56e-01
|
2.91e-02
|
5.43e-01
|
GOBP SYNAPTIC VESICLE CYCLE
|
195
|
4.84e-01
|
-2.91e-02
|
6.58e-01
|
GOBP RESPONSE TO ABIOTIC STIMULUS
|
795
|
1.68e-01
|
-2.90e-02
|
3.30e-01
|
GOBP RESPONSE TO ARSENIC CONTAINING SUBSTANCE
|
23
|
8.10e-01
|
2.90e-02
|
8.90e-01
|
GOBP CILIUM OR FLAGELLUM DEPENDENT CELL MOTILITY
|
69
|
6.78e-01
|
-2.89e-02
|
8.05e-01
|
GOBP ASSOCIATIVE LEARNING
|
84
|
6.47e-01
|
2.89e-02
|
7.83e-01
|
GOBP RESPONSE TO UV B
|
16
|
8.42e-01
|
-2.89e-02
|
9.10e-01
|
GOBP PRIMARY ALCOHOL BIOSYNTHETIC PROCESS
|
11
|
8.68e-01
|
-2.88e-02
|
9.27e-01
|
GOBP RETROGRADE TRANSPORT ENDOSOME TO GOLGI
|
81
|
6.54e-01
|
-2.88e-02
|
7.89e-01
|
GOMF PROTEIN MEMBRANE ADAPTOR ACTIVITY
|
27
|
7.96e-01
|
-2.88e-02
|
8.82e-01
|
GOCC BOUNDING MEMBRANE OF ORGANELLE
|
1070
|
1.17e-01
|
2.87e-02
|
2.58e-01
|
GOBP EMBRYONIC BRAIN DEVELOPMENT
|
18
|
8.33e-01
|
-2.87e-02
|
9.04e-01
|
GOBP SENSORY PERCEPTION
|
263
|
4.25e-01
|
2.87e-02
|
6.07e-01
|
GOBP SALIVARY GLAND DEVELOPMENT
|
31
|
7.84e-01
|
2.85e-02
|
8.74e-01
|
GOBP INTRACELLULAR TRANSPORT
|
1161
|
1.06e-01
|
-2.85e-02
|
2.44e-01
|
GOCC TRANSCRIPTION EXPORT COMPLEX
|
13
|
8.60e-01
|
2.83e-02
|
9.22e-01
|
GOBP PLASMA MEMBRANE REPAIR
|
28
|
7.97e-01
|
-2.82e-02
|
8.82e-01
|
GOBP PROTEIN HOMOTETRAMERIZATION
|
44
|
7.47e-01
|
2.81e-02
|
8.50e-01
|
GOMF TROPOMYOSIN BINDING
|
13
|
8.61e-01
|
-2.81e-02
|
9.22e-01
|
GOBP REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY
|
61
|
7.05e-01
|
-2.80e-02
|
8.20e-01
|
GOBP NEGATIVE REGULATION OF TRANSPORTER ACTIVITY
|
53
|
7.25e-01
|
2.80e-02
|
8.34e-01
|
GOBP MEMBRANE LIPID METABOLIC PROCESS
|
151
|
5.55e-01
|
2.79e-02
|
7.17e-01
|
GOCC COATED VESICLE MEMBRANE
|
80
|
6.66e-01
|
-2.79e-02
|
7.97e-01
|
GOBP INSULIN SECRETION
|
183
|
5.16e-01
|
2.79e-02
|
6.85e-01
|
GOMF SERINE TYPE ENDOPEPTIDASE INHIBITOR ACTIVITY
|
45
|
7.47e-01
|
-2.78e-02
|
8.50e-01
|
GOBP INTRACELLULAR PROTEIN TRANSMEMBRANE TRANSPORT
|
27
|
8.03e-01
|
2.77e-02
|
8.86e-01
|
GOBP MUSCLE ADAPTATION
|
119
|
6.02e-01
|
-2.77e-02
|
7.49e-01
|
GOBP REGULATION OF INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY
|
28
|
8.00e-01
|
-2.77e-02
|
8.84e-01
|
GOBP REGULATION OF EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT
|
12
|
8.68e-01
|
2.77e-02
|
9.27e-01
|
GOBP HIPPOCAMPUS DEVELOPMENT
|
60
|
7.11e-01
|
2.77e-02
|
8.24e-01
|
GOBP MODULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL
|
44
|
7.52e-01
|
2.76e-02
|
8.52e-01
|
GOBP INTRACELLULAR PROTEIN TRANSPORT
|
582
|
2.59e-01
|
-2.76e-02
|
4.40e-01
|
GOBP INTERLEUKIN 13 PRODUCTION
|
12
|
8.70e-01
|
-2.74e-02
|
9.28e-01
|
GOBP SURFACTANT HOMEOSTASIS
|
22
|
8.25e-01
|
2.72e-02
|
9.00e-01
|
GOBP REGULATION OF B CELL DIFFERENTIATION
|
29
|
8.00e-01
|
2.72e-02
|
8.84e-01
|
GOBP NUCLEOTIDE SALVAGE
|
19
|
8.38e-01
|
2.71e-02
|
9.08e-01
|
GOBP PROTEIN LOCALIZATION TO NUCLEAR ENVELOPE
|
13
|
8.66e-01
|
2.71e-02
|
9.26e-01
|
GOBP PROTEASOME MEDIATED UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS
|
341
|
3.91e-01
|
-2.71e-02
|
5.77e-01
|
GOBP CELLULAR RESPONSE TO HEAT
|
43
|
7.60e-01
|
-2.70e-02
|
8.56e-01
|
GOBP REGULATION OF TRANSCRIPTION BY RNA POLYMERASE III
|
23
|
8.23e-01
|
-2.70e-02
|
8.98e-01
|
GOBP POSITIVE REGULATION OF METAPHASE ANAPHASE TRANSITION OF CELL CYCLE
|
13
|
8.66e-01
|
-2.69e-02
|
9.26e-01
|
GOBP REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE
|
33
|
7.89e-01
|
2.69e-02
|
8.77e-01
|
GOBP MICROTUBULE ANCHORING AT MICROTUBULE ORGANIZING CENTER
|
14
|
8.62e-01
|
-2.69e-02
|
9.22e-01
|
GOBP RIBOSOME DISASSEMBLY
|
29
|
8.02e-01
|
2.69e-02
|
8.85e-01
|
GOBP NEGATIVE REGULATION OF AXON REGENERATION
|
15
|
8.57e-01
|
-2.69e-02
|
9.20e-01
|
GOBP NEGATIVE REGULATION OF DIGESTIVE SYSTEM PROCESS
|
10
|
8.83e-01
|
2.68e-02
|
9.37e-01
|
GOBP ENERGY RESERVE METABOLIC PROCESS
|
87
|
6.66e-01
|
2.68e-02
|
7.97e-01
|
GOBP POSITIVE REGULATION OF FIBROBLAST APOPTOTIC PROCESS
|
12
|
8.72e-01
|
-2.68e-02
|
9.30e-01
|
GOCC HISTONE DEACETYLASE COMPLEX
|
75
|
6.89e-01
|
-2.67e-02
|
8.11e-01
|
GOBP REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING
|
16
|
8.53e-01
|
-2.67e-02
|
9.17e-01
|
GOBP REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY RENIN ANGIOTENSIN
|
20
|
8.37e-01
|
2.67e-02
|
9.06e-01
|
GOBP POSITIVE REGULATION OF BROWN FAT CELL DIFFERENTIATION
|
15
|
8.58e-01
|
2.66e-02
|
9.21e-01
|
GOCC U2 TYPE SPLICEOSOMAL COMPLEX
|
91
|
6.62e-01
|
-2.66e-02
|
7.94e-01
|
GOCC LATE ENDOSOME MEMBRANE
|
73
|
6.95e-01
|
-2.66e-02
|
8.14e-01
|
GOBP REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL
|
63
|
7.16e-01
|
-2.65e-02
|
8.27e-01
|
GOBP POSITIVE REGULATION OF MYELINATION
|
21
|
8.34e-01
|
2.65e-02
|
9.04e-01
|
GOBP INTESTINAL EPITHELIAL CELL DEVELOPMENT
|
12
|
8.74e-01
|
2.64e-02
|
9.31e-01
|
GOBP PROCESS UTILIZING AUTOPHAGIC MECHANISM
|
454
|
3.38e-01
|
-2.64e-02
|
5.26e-01
|
GOBP RESPONSE TO ESTROGEN
|
43
|
7.65e-01
|
-2.64e-02
|
8.60e-01
|
GOBP NEGATIVE REGULATION OF MONOATOMIC ION TRANSPORT
|
108
|
6.37e-01
|
2.63e-02
|
7.76e-01
|
GOMF PHOSPHATIDYLINOSITOL 4 PHOSPHATE BINDING
|
26
|
8.17e-01
|
2.63e-02
|
8.94e-01
|
GOMF PHOSPHATIDYLINOSITOL 3 PHOSPHATE BINDING
|
42
|
7.69e-01
|
-2.62e-02
|
8.63e-01
|
GOCC CLUSTER OF ACTIN BASED CELL PROJECTIONS
|
142
|
5.91e-01
|
2.62e-02
|
7.41e-01
|
GOBP RETINOIC ACID RECEPTOR SIGNALING PATHWAY
|
30
|
8.04e-01
|
2.62e-02
|
8.86e-01
|
GOBP BEHAVIORAL RESPONSE TO PAIN
|
17
|
8.52e-01
|
-2.61e-02
|
9.17e-01
|
GOBP NEGATIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE
|
31
|
8.02e-01
|
-2.61e-02
|
8.85e-01
|
GOBP LIMBIC SYSTEM DEVELOPMENT
|
78
|
6.91e-01
|
-2.61e-02
|
8.11e-01
|
GOBP REGULATION OF MACROAUTOPHAGY
|
121
|
6.21e-01
|
-2.60e-02
|
7.64e-01
|
GOBP VESICLE MEDIATED TRANSPORT BETWEEN ENDOSOMAL COMPARTMENTS
|
46
|
7.60e-01
|
-2.60e-02
|
8.57e-01
|
GOMF LIPID BINDING
|
628
|
2.69e-01
|
2.60e-02
|
4.51e-01
|
GOCC CELL BODY
|
623
|
2.73e-01
|
-2.59e-02
|
4.55e-01
|
GOBP CELLULAR COMPONENT ASSEMBLY INVOLVED IN MORPHOGENESIS
|
118
|
6.27e-01
|
2.59e-02
|
7.68e-01
|
GOBP INTESTINAL ABSORPTION
|
23
|
8.30e-01
|
2.59e-02
|
9.03e-01
|
GOBP REGULATION OF VASOCONSTRICTION
|
71
|
7.07e-01
|
-2.58e-02
|
8.21e-01
|
GOBP BIOLOGICAL PROCESS INVOLVED IN INTRASPECIES INTERACTION BETWEEN ORGANISMS
|
48
|
7.57e-01
|
2.58e-02
|
8.55e-01
|
GOCC AXOLEMMA
|
17
|
8.54e-01
|
2.57e-02
|
9.18e-01
|
GOBP CELLULAR RESPONSE TO ALKALOID
|
25
|
8.24e-01
|
-2.57e-02
|
8.98e-01
|
GOMF ENZYME SUBSTRATE ADAPTOR ACTIVITY
|
60
|
7.32e-01
|
2.56e-02
|
8.39e-01
|
GOBP NEGATIVE REGULATION OF SMALL MOLECULE METABOLIC PROCESS
|
83
|
6.87e-01
|
2.56e-02
|
8.09e-01
|
GOCC EXTRINSIC COMPONENT OF POSTSYNAPTIC MEMBRANE
|
14
|
8.69e-01
|
-2.55e-02
|
9.28e-01
|
GOBP GOLGI TO LYSOSOME TRANSPORT
|
12
|
8.79e-01
|
-2.55e-02
|
9.34e-01
|
GOBP REGULATION OF HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION
|
37
|
7.89e-01
|
2.54e-02
|
8.77e-01
|
GOBP NEGATIVE REGULATION OF AMINO ACID TRANSPORT
|
11
|
8.84e-01
|
2.54e-02
|
9.37e-01
|
GOBP CARDIAC CHAMBER FORMATION
|
10
|
8.90e-01
|
2.54e-02
|
9.40e-01
|
GOBP RESPONSE TO FATTY ACID
|
34
|
7.98e-01
|
2.53e-02
|
8.83e-01
|
GOBP NEGATIVE REGULATION OF JNK CASCADE
|
34
|
7.99e-01
|
-2.53e-02
|
8.83e-01
|
GOBP GTP METABOLIC PROCESS
|
23
|
8.34e-01
|
-2.53e-02
|
9.04e-01
|
GOBP NEGATIVE REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS
|
15
|
8.66e-01
|
-2.52e-02
|
9.26e-01
|
GOMF RIBOSOMAL LARGE SUBUNIT BINDING
|
13
|
8.75e-01
|
-2.52e-02
|
9.32e-01
|
GOMF METALLOEXOPEPTIDASE ACTIVITY
|
45
|
7.70e-01
|
-2.52e-02
|
8.63e-01
|
GOBP NUCLEOBASE METABOLIC PROCESS
|
31
|
8.09e-01
|
2.51e-02
|
8.90e-01
|
GOMF GLUCOSYLTRANSFERASE ACTIVITY
|
12
|
8.81e-01
|
2.51e-02
|
9.35e-01
|
GOMF CALMODULIN BINDING
|
155
|
5.91e-01
|
-2.50e-02
|
7.41e-01
|
GOMF D1 DOPAMINE RECEPTOR BINDING
|
10
|
8.91e-01
|
2.50e-02
|
9.40e-01
|
GOBP STEROID HORMONE SECRETION
|
19
|
8.50e-01
|
-2.50e-02
|
9.16e-01
|
GOCC EXTRINSIC COMPONENT OF ORGANELLE MEMBRANE
|
31
|
8.10e-01
|
-2.50e-02
|
8.90e-01
|
GOMF CARBOHYDRATE KINASE ACTIVITY
|
20
|
8.47e-01
|
2.50e-02
|
9.12e-01
|
GOMF TRANSMEMBRANE TRANSPORTER BINDING
|
140
|
6.11e-01
|
-2.50e-02
|
7.56e-01
|
GOBP CARDIAC VENTRICLE MORPHOGENESIS
|
69
|
7.21e-01
|
-2.49e-02
|
8.31e-01
|
GOBP NEGATIVE REGULATION OF SODIUM ION TRANSPORT
|
13
|
8.77e-01
|
2.48e-02
|
9.33e-01
|
GOBP DIENCEPHALON DEVELOPMENT
|
38
|
7.92e-01
|
-2.48e-02
|
8.78e-01
|
GOCC ENDOSOME MEMBRANE
|
262
|
4.92e-01
|
-2.47e-02
|
6.64e-01
|
GOBP NEUROTRANSMITTER GATED ION CHANNEL CLUSTERING
|
13
|
8.77e-01
|
2.47e-02
|
9.34e-01
|
GOBP MYOBLAST FUSION
|
34
|
8.03e-01
|
-2.47e-02
|
8.86e-01
|
GOBP GLYCOPROTEIN BIOSYNTHETIC PROCESS
|
221
|
5.29e-01
|
-2.46e-02
|
6.94e-01
|
GOBP NEGATIVE REGULATION OF REPRODUCTIVE PROCESS
|
44
|
7.78e-01
|
-2.46e-02
|
8.69e-01
|
GOBP REGULATION OF INTERLEUKIN 4 PRODUCTION
|
21
|
8.45e-01
|
-2.46e-02
|
9.12e-01
|
GOBP DENDRITIC CELL CHEMOTAXIS
|
10
|
8.93e-01
|
-2.46e-02
|
9.41e-01
|
GOBP POSITIVE REGULATION OF ACUTE INFLAMMATORY RESPONSE
|
16
|
8.65e-01
|
-2.46e-02
|
9.25e-01
|
GOBP PRESYNAPTIC MODULATION OF CHEMICAL SYNAPTIC TRANSMISSION
|
42
|
7.83e-01
|
-2.45e-02
|
8.74e-01
|
GOBP CARDIAC RIGHT VENTRICLE MORPHOGENESIS
|
16
|
8.65e-01
|
-2.45e-02
|
9.26e-01
|
GOBP PROTEIN EXPORT FROM NUCLEUS
|
60
|
7.43e-01
|
-2.45e-02
|
8.47e-01
|
GOBP POSITIVE REGULATION OF CELL GROWTH
|
158
|
5.97e-01
|
-2.44e-02
|
7.46e-01
|
GOBP PEPTIDYL L CYSTEINE S PALMITOYLATION
|
19
|
8.54e-01
|
2.44e-02
|
9.18e-01
|
GOBP REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE
|
193
|
5.61e-01
|
-2.43e-02
|
7.21e-01
|
GOBP RESPONSE TO MAGNESIUM ION
|
14
|
8.75e-01
|
2.42e-02
|
9.32e-01
|
GOCC COATED VESICLE
|
181
|
5.76e-01
|
-2.42e-02
|
7.32e-01
|
GOBP CARBOHYDRATE TRANSPORT
|
120
|
6.49e-01
|
2.41e-02
|
7.85e-01
|
GOBP G1 TO G0 TRANSITION
|
15
|
8.72e-01
|
2.40e-02
|
9.30e-01
|
GOBP NEGATIVE REGULATION OF MRNA CATABOLIC PROCESS
|
54
|
7.60e-01
|
2.40e-02
|
8.57e-01
|
GOBP LUNG MORPHOGENESIS
|
54
|
7.61e-01
|
-2.40e-02
|
8.57e-01
|
GOBP MITOCHONDRION DISTRIBUTION
|
23
|
8.42e-01
|
-2.40e-02
|
9.11e-01
|
GOBP SPONGIOTROPHOBLAST LAYER DEVELOPMENT
|
11
|
8.91e-01
|
2.39e-02
|
9.40e-01
|
GOBP COGNITION
|
269
|
5.01e-01
|
2.39e-02
|
6.72e-01
|
GOBP SPHINGOLIPID METABOLIC PROCESS
|
105
|
6.72e-01
|
-2.39e-02
|
8.01e-01
|
GOCC PLASMA MEMBRANE REGION
|
921
|
2.24e-01
|
-2.39e-02
|
4.01e-01
|
GOBP AUDITORY RECEPTOR CELL DEVELOPMENT
|
23
|
8.43e-01
|
-2.38e-02
|
9.11e-01
|
GOCC ATPASE COMPLEX
|
113
|
6.62e-01
|
-2.38e-02
|
7.94e-01
|
GOBP MULTIVESICULAR BODY SORTING PATHWAY
|
32
|
8.16e-01
|
-2.38e-02
|
8.94e-01
|
GOBP MAINTENANCE OF PROTEIN LOCALIZATION IN ORGANELLE
|
40
|
7.95e-01
|
-2.38e-02
|
8.81e-01
|
GOBP INTERMEDIATE FILAMENT BASED PROCESS
|
32
|
8.16e-01
|
-2.38e-02
|
8.94e-01
|
GOBP MODIFICATION DEPENDENT MACROMOLECULE CATABOLIC PROCESS
|
526
|
3.54e-01
|
-2.37e-02
|
5.41e-01
|
GOCC NUCLEAR INNER MEMBRANE
|
31
|
8.19e-01
|
-2.37e-02
|
8.96e-01
|
GOBP REGULATION OF INTRACELLULAR TRANSPORT
|
251
|
5.19e-01
|
-2.37e-02
|
6.87e-01
|
GOBP PROTEIN DESTABILIZATION
|
53
|
7.65e-01
|
-2.37e-02
|
8.60e-01
|
GOBP REGULATION OF PROTEIN TARGETING TO MEMBRANE
|
33
|
8.14e-01
|
2.37e-02
|
8.93e-01
|
GOBP NEGATIVE REGULATION OF PROTEOLYSIS INVOLVED IN PROTEIN CATABOLIC PROCESS
|
60
|
7.51e-01
|
2.37e-02
|
8.52e-01
|
GOBP POSITIVE REGULATION BY HOST OF VIRAL PROCESS
|
21
|
8.51e-01
|
2.36e-02
|
9.16e-01
|
GOBP REGULATION OF CELLULAR CATABOLIC PROCESS
|
343
|
4.54e-01
|
-2.36e-02
|
6.32e-01
|
GOBP NEGATIVE REGULATION OF INTERFERON BETA PRODUCTION
|
16
|
8.70e-01
|
-2.36e-02
|
9.29e-01
|
GOMF CALCIUM CHANNEL ACTIVITY
|
66
|
7.41e-01
|
2.36e-02
|
8.45e-01
|
GOBP POSITIVE REGULATION OF MEMBRANE DEPOLARIZATION
|
13
|
8.83e-01
|
-2.36e-02
|
9.37e-01
|
GOBP REGULATION OF LIPOPROTEIN PARTICLE CLEARANCE
|
14
|
8.79e-01
|
-2.35e-02
|
9.34e-01
|
GOBP EOSINOPHIL CHEMOTAXIS
|
12
|
8.89e-01
|
2.33e-02
|
9.40e-01
|
GOBP EOSINOPHIL MIGRATION
|
15
|
8.76e-01
|
2.32e-02
|
9.33e-01
|
GOBP POSITIVE REGULATION OF DNA BINDING
|
38
|
8.05e-01
|
-2.31e-02
|
8.87e-01
|
GOBP RETINAL GANGLION CELL AXON GUIDANCE
|
11
|
8.95e-01
|
-2.31e-02
|
9.41e-01
|
GOBP PYRIMIDINE CONTAINING COMPOUND TRANSMEMBRANE TRANSPORT
|
11
|
8.95e-01
|
2.30e-02
|
9.41e-01
|
GOBP VASCULAR PROCESS IN CIRCULATORY SYSTEM
|
194
|
5.82e-01
|
2.30e-02
|
7.35e-01
|
GOCC PARANODE REGION OF AXON
|
12
|
8.90e-01
|
2.30e-02
|
9.40e-01
|
GOBP REGULATION OF PROTEIN SECRETION
|
236
|
5.45e-01
|
-2.29e-02
|
7.08e-01
|
GOCC ORGANELLE SUBCOMPARTMENT
|
772
|
2.84e-01
|
2.29e-02
|
4.66e-01
|
GOMF G PROTEIN COUPLED GLUTAMATE RECEPTOR BINDING
|
13
|
8.87e-01
|
2.28e-02
|
9.39e-01
|
GOBP PHOTORECEPTOR CELL DEVELOPMENT
|
35
|
8.16e-01
|
2.28e-02
|
8.94e-01
|
GOCC MOTILE CILIUM
|
130
|
6.56e-01
|
2.26e-02
|
7.91e-01
|
GOBP PROTEIN PEPTIDYL PROLYL ISOMERIZATION
|
23
|
8.51e-01
|
-2.26e-02
|
9.16e-01
|
GOBP ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMOSOME
|
22
|
8.54e-01
|
-2.26e-02
|
9.18e-01
|
GOBP MACROMOLECULE CATABOLIC PROCESS
|
1175
|
2.00e-01
|
-2.25e-02
|
3.70e-01
|
GOBP NEGATIVE REGULATION OF AXONOGENESIS
|
47
|
7.90e-01
|
2.25e-02
|
8.78e-01
|
GOBP ENUCLEATE ERYTHROCYTE DIFFERENTIATION
|
13
|
8.89e-01
|
2.25e-02
|
9.40e-01
|
GOBP REGULATION OF IMMUNOGLOBULIN PRODUCTION
|
52
|
7.81e-01
|
-2.23e-02
|
8.71e-01
|
GOBP ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY
|
12
|
8.94e-01
|
2.23e-02
|
9.41e-01
|
GOBP CELLULAR RESPONSE TO CARBOHYDRATE STIMULUS
|
124
|
6.68e-01
|
-2.23e-02
|
7.98e-01
|
GOBP RETINOIC ACID BIOSYNTHETIC PROCESS
|
10
|
9.03e-01
|
-2.23e-02
|
9.46e-01
|
GOBP MALE GAMETE GENERATION
|
330
|
4.88e-01
|
-2.23e-02
|
6.61e-01
|
GOMF NUCLEOCYTOPLASMIC CARRIER ACTIVITY
|
27
|
8.41e-01
|
-2.23e-02
|
9.10e-01
|
GOCC AXON
|
547
|
3.76e-01
|
-2.22e-02
|
5.62e-01
|
GOMF EXOPEPTIDASE ACTIVITY
|
71
|
7.47e-01
|
2.21e-02
|
8.50e-01
|
GOMF SIALYLTRANSFERASE ACTIVITY
|
16
|
8.79e-01
|
2.21e-02
|
9.34e-01
|
GOBP SIGNAL RELEASE
|
397
|
4.52e-01
|
-2.21e-02
|
6.30e-01
|
GOBP EPIBOLY
|
26
|
8.46e-01
|
-2.20e-02
|
9.12e-01
|
GOCC GOLGI ASSOCIATED VESICLE MEMBRANE
|
40
|
8.10e-01
|
-2.20e-02
|
8.90e-01
|
GOBP PRESYNAPSE ASSEMBLY
|
37
|
8.17e-01
|
-2.19e-02
|
8.95e-01
|
GOBP PROTEIN CONTAINING COMPLEX ASSEMBLY
|
1223
|
2.03e-01
|
2.19e-02
|
3.74e-01
|
GOBP GOLGI TO PLASMA MEMBRANE TRANSPORT
|
59
|
7.71e-01
|
-2.19e-02
|
8.64e-01
|
GOCC CELL CORTEX REGION
|
32
|
8.30e-01
|
-2.19e-02
|
9.03e-01
|
GOBP MACROAUTOPHAGY
|
270
|
5.37e-01
|
-2.19e-02
|
7.01e-01
|
GOCC PROTEASOME COMPLEX
|
59
|
7.72e-01
|
2.19e-02
|
8.64e-01
|
GOBP POSITIVE REGULATION OF OXIDOREDUCTASE ACTIVITY
|
29
|
8.39e-01
|
2.18e-02
|
9.08e-01
|
GOBP NLS BEARING PROTEIN IMPORT INTO NUCLEUS
|
10
|
9.05e-01
|
-2.18e-02
|
9.47e-01
|
GOBP PHOSPHATIDYLINOSITOL METABOLIC PROCESS
|
132
|
6.68e-01
|
-2.17e-02
|
7.98e-01
|
GOBP REGULATION OF EXTENT OF CELL GROWTH
|
99
|
7.12e-01
|
2.15e-02
|
8.24e-01
|
GOBP ATP TRANSPORT
|
14
|
8.89e-01
|
-2.15e-02
|
9.40e-01
|
GOMF N ACYLTRANSFERASE ACTIVITY
|
73
|
7.52e-01
|
-2.14e-02
|
8.52e-01
|
GOBP EXTRAEMBRYONIC MEMBRANE DEVELOPMENT
|
11
|
9.02e-01
|
-2.14e-02
|
9.45e-01
|
GOBP REGULATION OF HORMONE LEVELS
|
384
|
4.73e-01
|
2.14e-02
|
6.48e-01
|
GOBP POSITIVE REGULATION OF DEVELOPMENTAL GROWTH
|
175
|
6.26e-01
|
2.14e-02
|
7.68e-01
|
GOBP NEGATIVE REGULATION OF TRANSMEMBRANE TRANSPORT
|
107
|
7.03e-01
|
-2.13e-02
|
8.20e-01
|
GOBP DEVELOPMENTAL PIGMENTATION
|
42
|
8.11e-01
|
-2.13e-02
|
8.91e-01
|
GOBP DNA MODIFICATION
|
18
|
8.76e-01
|
-2.13e-02
|
9.32e-01
|
GOCC DENDRITIC TREE
|
574
|
3.87e-01
|
-2.13e-02
|
5.72e-01
|
GOCC PIGMENT GRANULE
|
29
|
8.43e-01
|
2.13e-02
|
9.11e-01
|
GOBP POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT
|
72
|
7.55e-01
|
-2.13e-02
|
8.53e-01
|
GOBP REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS
|
133
|
6.73e-01
|
-2.13e-02
|
8.01e-01
|
GOBP AXONAL TRANSPORT OF MITOCHONDRION
|
14
|
8.91e-01
|
2.12e-02
|
9.40e-01
|
GOBP REGULATION OF HEAT GENERATION
|
13
|
8.95e-01
|
-2.12e-02
|
9.41e-01
|
GOMF G PROTEIN COUPLED RECEPTOR ACTIVITY
|
161
|
6.44e-01
|
-2.11e-02
|
7.81e-01
|
GOBP MAMMARY GLAND EPITHELIAL CELL DIFFERENTIATION
|
13
|
8.95e-01
|
-2.11e-02
|
9.41e-01
|
GOBP CALCIUM ION IMPORT
|
55
|
7.88e-01
|
-2.10e-02
|
8.76e-01
|
GOBP REGULATION OF MORPHOGENESIS OF AN EPITHELIUM
|
56
|
7.86e-01
|
2.10e-02
|
8.75e-01
|
GOMF PHOSPHATIDYLINOSITOL BISPHOSPHATE BINDING
|
85
|
7.38e-01
|
-2.10e-02
|
8.44e-01
|
GOBP POSITIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION
|
44
|
8.10e-01
|
-2.09e-02
|
8.90e-01
|
GOBP ACIDIC AMINO ACID TRANSPORT
|
54
|
7.91e-01
|
2.09e-02
|
8.78e-01
|
GOBP CARDIAC CONDUCTION SYSTEM DEVELOPMENT
|
18
|
8.78e-01
|
2.08e-02
|
9.34e-01
|
GOBP GAMMA DELTA T CELL DIFFERENTIATION
|
13
|
8.97e-01
|
2.07e-02
|
9.42e-01
|
GOCC CYTOPLASMIC MICROTUBULE
|
70
|
7.65e-01
|
2.07e-02
|
8.60e-01
|
GOBP RESPONSE TO PROSTAGLANDIN E
|
11
|
9.06e-01
|
2.07e-02
|
9.47e-01
|
GOBP REGULATION OF GTP BINDING
|
10
|
9.10e-01
|
2.06e-02
|
9.50e-01
|
GOBP REGULATION OF BEHAVIOR
|
55
|
7.92e-01
|
2.06e-02
|
8.78e-01
|
GOCC H4 HISTONE ACETYLTRANSFERASE COMPLEX
|
37
|
8.30e-01
|
-2.05e-02
|
9.02e-01
|
GOBP CELLULAR RESPONSE TO LEPTIN STIMULUS
|
14
|
8.95e-01
|
-2.05e-02
|
9.41e-01
|
GOBP PHOSPHOLIPASE C ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY
|
62
|
7.81e-01
|
2.04e-02
|
8.71e-01
|
GOBP ENDOCYTIC RECYCLING
|
78
|
7.55e-01
|
2.04e-02
|
8.53e-01
|
GOBP VASCULOGENESIS INVOLVED IN CORONARY VASCULAR MORPHOGENESIS
|
13
|
8.99e-01
|
-2.04e-02
|
9.43e-01
|
GOMF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY
|
81
|
7.51e-01
|
-2.04e-02
|
8.52e-01
|
GOBP HYALURONAN BIOSYNTHETIC PROCESS
|
14
|
8.96e-01
|
2.02e-02
|
9.41e-01
|
GOBP CALCIUM ION TRANSMEMBRANE TRANSPORT
|
227
|
6.01e-01
|
2.02e-02
|
7.48e-01
|
GOBP COLUMNAR CUBOIDAL EPITHELIAL CELL MATURATION
|
10
|
9.12e-01
|
-2.02e-02
|
9.51e-01
|
GOBP POSITIVE REGULATION OF MONOATOMIC ION TRANSPORT
|
177
|
6.44e-01
|
-2.02e-02
|
7.81e-01
|
GOBP MAINTENANCE OF BLOOD BRAIN BARRIER
|
18
|
8.82e-01
|
2.01e-02
|
9.37e-01
|
GOBP REGULATION OF NEUROTRANSMITTER RECEPTOR ACTIVITY
|
24
|
8.65e-01
|
2.01e-02
|
9.25e-01
|
GOBP CARDIOCYTE DIFFERENTIATION
|
174
|
6.50e-01
|
-2.00e-02
|
7.86e-01
|
GOBP PYRIMIDINE NUCLEOTIDE METABOLIC PROCESS
|
35
|
8.38e-01
|
1.99e-02
|
9.08e-01
|
GOBP GOLGI VESICLE TRANSPORT
|
265
|
5.78e-01
|
1.99e-02
|
7.33e-01
|
GOBP WHITE FAT CELL DIFFERENTIATION
|
18
|
8.84e-01
|
-1.99e-02
|
9.37e-01
|
GOBP ANGIOGENESIS INVOLVED IN WOUND HEALING
|
24
|
8.66e-01
|
-1.99e-02
|
9.26e-01
|
GOBP AUTOPHAGY OF PEROXISOME
|
14
|
8.98e-01
|
-1.99e-02
|
9.42e-01
|
GOBP ACROSOME ASSEMBLY
|
18
|
8.85e-01
|
1.97e-02
|
9.38e-01
|
GOBP VESICLE MEDIATED TRANSPORT TO THE PLASMA MEMBRANE
|
143
|
6.86e-01
|
1.96e-02
|
8.08e-01
|
GOMF MICROFILAMENT MOTOR ACTIVITY
|
24
|
8.68e-01
|
-1.95e-02
|
9.27e-01
|
GOMF ORGANIC HYDROXY COMPOUND TRANSMEMBRANE TRANSPORTER ACTIVITY
|
27
|
8.61e-01
|
-1.95e-02
|
9.22e-01
|
GOBP NEGATIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY
|
11
|
9.11e-01
|
1.94e-02
|
9.51e-01
|
GOBP PROTEIN LOCALIZATION TO PLASMA MEMBRANE
|
263
|
5.89e-01
|
-1.94e-02
|
7.40e-01
|
GOCC EXOCYTIC VESICLE
|
217
|
6.23e-01
|
1.94e-02
|
7.66e-01
|
GOBP PROTEIN TETRAMERIZATION
|
70
|
7.79e-01
|
1.94e-02
|
8.71e-01
|
GOBP POLYSACCHARIDE METABOLIC PROCESS
|
101
|
7.37e-01
|
1.94e-02
|
8.43e-01
|
GOCC BASOLATERAL PLASMA MEMBRANE
|
196
|
6.41e-01
|
-1.93e-02
|
7.79e-01
|
GOBP NEGATIVE REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS
|
47
|
8.19e-01
|
-1.93e-02
|
8.96e-01
|
GOBP NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS
|
17
|
8.91e-01
|
1.92e-02
|
9.40e-01
|
GOBP REGULATION OF LYSOSOMAL LUMEN PH
|
20
|
8.82e-01
|
1.92e-02
|
9.36e-01
|
GOCC COSTAMERE
|
19
|
8.85e-01
|
1.92e-02
|
9.38e-01
|
GOMF OUTWARD RECTIFIER POTASSIUM CHANNEL ACTIVITY
|
17
|
8.91e-01
|
1.92e-02
|
9.40e-01
|
GOBP 3 UTR MEDIATED MRNA DESTABILIZATION
|
16
|
8.95e-01
|
-1.91e-02
|
9.41e-01
|
GOBP NEUROMUSCULAR SYNAPTIC TRANSMISSION
|
20
|
8.82e-01
|
-1.91e-02
|
9.37e-01
|
GOBP MACROMOLECULE DEACYLATION
|
54
|
8.09e-01
|
1.91e-02
|
8.90e-01
|
GOBP CELLULAR RESPONSE TO PROSTAGLANDIN STIMULUS
|
12
|
9.09e-01
|
1.90e-02
|
9.50e-01
|
GOBP REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL PROLIFERATION INVOLVED IN SPROUTING ANGIOGENESIS
|
11
|
9.13e-01
|
1.90e-02
|
9.52e-01
|
GOBP REGULATION OF FATTY ACID TRANSPORT
|
26
|
8.67e-01
|
1.90e-02
|
9.26e-01
|
GOBP POSITIVE REGULATION OF SMOOTH MUSCLE CELL APOPTOTIC PROCESS
|
11
|
9.13e-01
|
-1.90e-02
|
9.52e-01
|
GOBP IONOTROPIC GLUTAMATE RECEPTOR SIGNALING PATHWAY
|
14
|
9.02e-01
|
-1.90e-02
|
9.45e-01
|
GOMF PHOSPHOSERINE RESIDUE BINDING
|
12
|
9.10e-01
|
-1.89e-02
|
9.50e-01
|
GOCC TRANS GOLGI NETWORK TRANSPORT VESICLE
|
31
|
8.56e-01
|
-1.88e-02
|
9.19e-01
|
GOBP SYNAPTIC VESICLE RECYCLING
|
90
|
7.58e-01
|
1.88e-02
|
8.56e-01
|
GOBP POSITIVE REGULATION OF PROTEIN MATURATION
|
21
|
8.82e-01
|
1.88e-02
|
9.36e-01
|
GOBP POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION
|
40
|
8.38e-01
|
1.87e-02
|
9.08e-01
|
GOBP PROTEIN LOCALIZATION TO GOLGI APPARATUS
|
29
|
8.62e-01
|
-1.87e-02
|
9.22e-01
|
GOBP POSITIVE REGULATION OF JUN KINASE ACTIVITY
|
43
|
8.32e-01
|
-1.87e-02
|
9.04e-01
|
GOBP HOMEOSTATIC PROCESS
|
1344
|
2.58e-01
|
1.86e-02
|
4.40e-01
|
GOBP EPITHELIAL CELL MORPHOGENESIS
|
36
|
8.48e-01
|
-1.85e-02
|
9.13e-01
|
GOBP MUCOSA ASSOCIATED LYMPHOID TISSUE DEVELOPMENT
|
10
|
9.19e-01
|
1.85e-02
|
9.55e-01
|
GOBP PYRIMIDINE NUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS
|
12
|
9.12e-01
|
-1.84e-02
|
9.51e-01
|
GOBP POSITIVE REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR
|
30
|
8.61e-01
|
1.84e-02
|
9.22e-01
|
GOCC APICAL PART OF CELL
|
362
|
5.49e-01
|
-1.84e-02
|
7.12e-01
|
GOBP RENAL SYSTEM PROCESS INVOLVED IN REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE
|
20
|
8.87e-01
|
-1.84e-02
|
9.39e-01
|
GOMF GLUTAMATE RECEPTOR BINDING
|
64
|
8.00e-01
|
-1.84e-02
|
8.84e-01
|
GOBP RETINOIC ACID METABOLIC PROCESS
|
13
|
9.09e-01
|
-1.83e-02
|
9.50e-01
|
GOCC NUCLEAR PORE OUTER RING
|
10
|
9.20e-01
|
1.83e-02
|
9.56e-01
|
GOCC LYSOSOMAL LUMEN
|
19
|
8.91e-01
|
1.82e-02
|
9.40e-01
|
GOBP POSITIVE REGULATION OF TELOMERE MAINTENANCE IN RESPONSE TO DNA DAMAGE
|
15
|
9.03e-01
|
-1.82e-02
|
9.46e-01
|
GOBP PROTEIN CATABOLIC PROCESS
|
864
|
3.68e-01
|
-1.82e-02
|
5.55e-01
|
GOCC BRAHMA COMPLEX
|
13
|
9.10e-01
|
-1.82e-02
|
9.50e-01
|
GOBP REGULATION OF CELL SIZE
|
176
|
6.79e-01
|
-1.81e-02
|
8.05e-01
|
GOBP ENSHEATHMENT OF NEURONS
|
149
|
7.04e-01
|
1.80e-02
|
8.20e-01
|
GOBP REGULATION OF NEUROTRANSMITTER TRANSPORT
|
84
|
7.77e-01
|
-1.79e-02
|
8.69e-01
|
GOBP DOPAMINE RECEPTOR SIGNALING PATHWAY
|
26
|
8.75e-01
|
1.78e-02
|
9.32e-01
|
GOBP MITOCHONDRIAL DNA METABOLIC PROCESS
|
25
|
8.78e-01
|
1.78e-02
|
9.34e-01
|
GOBP REGULATION OF MONOATOMIC ION TRANSPORT
|
372
|
5.58e-01
|
1.77e-02
|
7.19e-01
|
GOBP KERATINOCYTE DEVELOPMENT
|
11
|
9.19e-01
|
1.77e-02
|
9.55e-01
|
GOBP RESPONSE TO METAL ION
|
227
|
6.49e-01
|
1.76e-02
|
7.85e-01
|
GOCC DISTAL AXON
|
285
|
6.12e-01
|
-1.75e-02
|
7.57e-01
|
GOMF PROTEIN KINASE A REGULATORY SUBUNIT BINDING
|
22
|
8.87e-01
|
-1.75e-02
|
9.39e-01
|
GOBP MRNA TRANSCRIPTION
|
49
|
8.33e-01
|
-1.74e-02
|
9.04e-01
|
GOBP NEGATIVE REGULATION OF CALCIUM ION TRANSPORT
|
60
|
8.17e-01
|
1.73e-02
|
8.94e-01
|
GOMF ACTININ BINDING
|
38
|
8.54e-01
|
1.72e-02
|
9.18e-01
|
GOBP CELLULAR RESPONSE TO OXYGEN LEVELS
|
120
|
7.45e-01
|
1.72e-02
|
8.48e-01
|
GOCC HISTONE ACETYLTRANSFERASE COMPLEX
|
82
|
7.89e-01
|
-1.71e-02
|
8.77e-01
|
GOBP INNER EAR RECEPTOR CELL STEREOCILIUM ORGANIZATION
|
30
|
8.71e-01
|
-1.71e-02
|
9.30e-01
|
GOBP REACTIVE OXYGEN SPECIES METABOLIC PROCESS
|
197
|
6.80e-01
|
1.71e-02
|
8.06e-01
|
GOBP HINDBRAIN MORPHOGENESIS
|
46
|
8.43e-01
|
1.69e-02
|
9.11e-01
|
GOMF EXOGENOUS PROTEIN BINDING
|
23
|
8.89e-01
|
1.69e-02
|
9.40e-01
|
GOBP REGULATION OF CIRCADIAN RHYTHM
|
100
|
7.71e-01
|
-1.69e-02
|
8.64e-01
|
GOMF LIPOPROTEIN PARTICLE RECEPTOR BINDING
|
23
|
8.89e-01
|
1.69e-02
|
9.40e-01
|
GOBP HEPARIN METABOLIC PROCESS
|
12
|
9.19e-01
|
1.69e-02
|
9.55e-01
|
GOMF PROTEIN LYSINE N METHYLTRANSFERASE ACTIVITY
|
45
|
8.46e-01
|
-1.68e-02
|
9.12e-01
|
GOBP MUSCLE TISSUE DEVELOPMENT
|
413
|
5.62e-01
|
-1.67e-02
|
7.21e-01
|
GOBP RESPONSE TO PH
|
26
|
8.84e-01
|
-1.65e-02
|
9.37e-01
|
GOCC PRESYNAPTIC ACTIVE ZONE CYTOPLASMIC COMPONENT
|
15
|
9.12e-01
|
1.65e-02
|
9.51e-01
|
GOCC ER TO GOLGI TRANSPORT VESICLE MEMBRANE
|
23
|
8.91e-01
|
1.65e-02
|
9.40e-01
|
GOCC APICAL PLASMA MEMBRANE
|
284
|
6.33e-01
|
-1.65e-02
|
7.73e-01
|
GOBP NEGATIVE REGULATION OF MUSCLE ADAPTATION
|
12
|
9.21e-01
|
-1.65e-02
|
9.56e-01
|
GOBP POSITIVE REGULATION OF AXONOGENESIS
|
90
|
7.88e-01
|
-1.64e-02
|
8.76e-01
|
GOBP CALCIUM ION HOMEOSTASIS
|
247
|
6.57e-01
|
-1.64e-02
|
7.91e-01
|
GOBP REGULATION OF SUPEROXIDE ANION GENERATION
|
24
|
8.89e-01
|
1.64e-02
|
9.40e-01
|
GOBP NEUROTRANSMITTER TRANSPORT
|
155
|
7.25e-01
|
1.64e-02
|
8.34e-01
|
GOBP ACTIVATION OF PROTEIN KINASE B ACTIVITY
|
14
|
9.15e-01
|
1.64e-02
|
9.54e-01
|
GOCC TRANSPORT VESICLE
|
289
|
6.32e-01
|
1.64e-02
|
7.72e-01
|
GOBP REGULATION OF DEVELOPMENTAL GROWTH
|
312
|
6.20e-01
|
-1.64e-02
|
7.64e-01
|
GOBP PROTEIN AUTOPROCESSING
|
16
|
9.10e-01
|
-1.63e-02
|
9.50e-01
|
GOBP PROTEIN LOCALIZATION TO CELL CELL JUNCTION
|
22
|
8.95e-01
|
-1.63e-02
|
9.41e-01
|
GOBP SYNAPTIC VESICLE MEMBRANE ORGANIZATION
|
23
|
8.93e-01
|
1.63e-02
|
9.41e-01
|
GOBP REGULATION OF CATION CHANNEL ACTIVITY
|
77
|
8.07e-01
|
-1.61e-02
|
8.88e-01
|
GOBP PRENYLATION
|
13
|
9.20e-01
|
-1.61e-02
|
9.55e-01
|
GOBP PREPULSE INHIBITION
|
12
|
9.23e-01
|
-1.61e-02
|
9.58e-01
|
GOBP G0 TO G1 TRANSITION
|
32
|
8.75e-01
|
-1.60e-02
|
9.32e-01
|
GOBP RESPONSE TO PURINE CONTAINING COMPOUND
|
92
|
7.92e-01
|
1.60e-02
|
8.78e-01
|
GOBP REGULATION OF POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR ACTIVITY
|
10
|
9.31e-01
|
-1.59e-02
|
9.63e-01
|
GOMF PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR BINDING
|
20
|
9.02e-01
|
1.58e-02
|
9.45e-01
|
GOCC GUANYL NUCLEOTIDE EXCHANGE FACTOR COMPLEX
|
19
|
9.05e-01
|
-1.58e-02
|
9.47e-01
|
GOCC ESCRT I COMPLEX
|
10
|
9.31e-01
|
-1.58e-02
|
9.63e-01
|
GOBP POSITIVE REGULATION OF NUCLEOTIDE BIOSYNTHETIC PROCESS
|
14
|
9.19e-01
|
1.58e-02
|
9.55e-01
|
GOBP NEGATIVE REGULATION OF MRNA METABOLIC PROCESS
|
73
|
8.17e-01
|
1.57e-02
|
8.94e-01
|
GOBP GOLGI TO ENDOSOME TRANSPORT
|
11
|
9.28e-01
|
-1.57e-02
|
9.62e-01
|
GOBP NEGATIVE REGULATION OF PROTEIN LOCALIZATION
|
201
|
7.06e-01
|
-1.55e-02
|
8.20e-01
|
GOBP PROTEOLYSIS
|
1231
|
3.68e-01
|
-1.54e-02
|
5.55e-01
|
GOBP FUCOSYLATION
|
11
|
9.30e-01
|
-1.53e-02
|
9.62e-01
|
GOCC CAVEOLA
|
87
|
8.06e-01
|
1.53e-02
|
8.88e-01
|
GOBP PROTEIN TRANSPORT
|
1226
|
3.80e-01
|
-1.51e-02
|
5.66e-01
|
GOBP PROTEIN K6 LINKED UBIQUITINATION
|
14
|
9.22e-01
|
-1.50e-02
|
9.57e-01
|
GOBP PROTEOLYSIS INVOLVED IN PROTEIN CATABOLIC PROCESS
|
654
|
5.15e-01
|
-1.50e-02
|
6.84e-01
|
GOBP REGULATION OF GAMMA DELTA T CELL ACTIVATION
|
12
|
9.28e-01
|
1.50e-02
|
9.62e-01
|
GOBP AUTOPHAGOSOME MATURATION
|
56
|
8.46e-01
|
-1.50e-02
|
9.12e-01
|
GOCC SYNAPSE
|
1352
|
3.62e-01
|
-1.50e-02
|
5.49e-01
|
GOCC PLASMA MEMBRANE RAFT
|
109
|
7.88e-01
|
1.49e-02
|
8.76e-01
|
GOBP POSITIVE REGULATION OF TELOMERE CAPPING
|
16
|
9.18e-01
|
-1.49e-02
|
9.55e-01
|
GOBP POSITIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION
|
28
|
8.91e-01
|
-1.49e-02
|
9.40e-01
|
GOBP SECRETORY GRANULE ORGANIZATION
|
52
|
8.53e-01
|
1.49e-02
|
9.17e-01
|
GOMF 3 5 DNA EXONUCLEASE ACTIVITY
|
11
|
9.32e-01
|
-1.48e-02
|
9.63e-01
|
GOBP SYNAPTIC SIGNALING
|
583
|
5.44e-01
|
-1.48e-02
|
7.08e-01
|
GOCC DENDRITE TERMINUS
|
17
|
9.16e-01
|
1.47e-02
|
9.54e-01
|
GOBP INORGANIC ANION TRANSPORT
|
94
|
8.06e-01
|
-1.47e-02
|
8.88e-01
|
GOBP REGULATION OF MYELINATION
|
52
|
8.56e-01
|
-1.46e-02
|
9.19e-01
|
GOBP PROTEIN KINASE C ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY
|
16
|
9.20e-01
|
-1.45e-02
|
9.55e-01
|
GOCC MEDIATOR COMPLEX
|
36
|
8.80e-01
|
-1.45e-02
|
9.35e-01
|
GOBP NEGATIVE REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS
|
45
|
8.67e-01
|
-1.45e-02
|
9.26e-01
|
GOBP NEGATIVE REGULATION OF TOR SIGNALING
|
55
|
8.54e-01
|
-1.44e-02
|
9.17e-01
|
GOBP UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS VIA THE MULTIVESICULAR BODY SORTING PATHWAY
|
27
|
8.97e-01
|
-1.44e-02
|
9.42e-01
|
GOBP GLUTAMATE SECRETION
|
26
|
8.99e-01
|
-1.44e-02
|
9.43e-01
|
GOBP MAINTENANCE OF GASTROINTESTINAL EPITHELIUM
|
11
|
9.34e-01
|
1.43e-02
|
9.64e-01
|
GOBP TRANSCRIPTION INITIATION AT RNA POLYMERASE II PROMOTER
|
136
|
7.74e-01
|
1.43e-02
|
8.67e-01
|
GOBP POSITIVE REGULATION OF ATP DEPENDENT ACTIVITY
|
33
|
8.87e-01
|
1.42e-02
|
9.39e-01
|
GOBP CELL VOLUME HOMEOSTASIS
|
33
|
8.88e-01
|
-1.42e-02
|
9.40e-01
|
GOBP REGULATION OF AUTOPHAGOSOME ASSEMBLY
|
42
|
8.75e-01
|
1.41e-02
|
9.32e-01
|
GOBP PROTEIN STABILIZATION
|
173
|
7.51e-01
|
-1.40e-02
|
8.51e-01
|
GOBP MOTOR BEHAVIOR
|
26
|
9.02e-01
|
-1.40e-02
|
9.45e-01
|
GOBP POSITIVE REGULATION OF ACTIVATED T CELL PROLIFERATION
|
15
|
9.25e-01
|
-1.40e-02
|
9.59e-01
|
GOBP REGULATION OF SUPEROXIDE METABOLIC PROCESS
|
30
|
8.95e-01
|
-1.39e-02
|
9.41e-01
|
GOBP PRESYNAPTIC ENDOCYTOSIS
|
84
|
8.26e-01
|
1.39e-02
|
9.01e-01
|
GOBP CELLULAR RESPONSE TO OXIDATIVE STRESS
|
206
|
7.32e-01
|
-1.39e-02
|
8.39e-01
|
GOBP PROTEIN COMPLEX OLIGOMERIZATION
|
204
|
7.34e-01
|
1.38e-02
|
8.41e-01
|
GOBP SENSORY PERCEPTION OF TEMPERATURE STIMULUS
|
21
|
9.13e-01
|
1.37e-02
|
9.52e-01
|
GOMF ACYLTRANSFERASE ACTIVITY
|
560
|
5.81e-01
|
1.37e-02
|
7.35e-01
|
GOBP SYNAPTIC MEMBRANE ADHESION
|
30
|
8.97e-01
|
-1.37e-02
|
9.42e-01
|
GOBP RESPONSE TO DECREASED OXYGEN LEVELS
|
202
|
7.39e-01
|
-1.37e-02
|
8.44e-01
|
GOBP LOCALIZATION WITHIN MEMBRANE
|
612
|
5.68e-01
|
1.36e-02
|
7.26e-01
|
GOBP CELLULAR RESPONSE TO CALCIUM ION
|
56
|
8.60e-01
|
-1.36e-02
|
9.22e-01
|
GOBP CGMP MEDIATED SIGNALING
|
20
|
9.16e-01
|
1.36e-02
|
9.54e-01
|
GOCC PHOTORECEPTOR OUTER SEGMENT
|
53
|
8.64e-01
|
1.36e-02
|
9.25e-01
|
GOBP DENDRITE EXTENSION
|
33
|
8.93e-01
|
-1.35e-02
|
9.41e-01
|
GOBP REGULATION OF TRANSPORTER ACTIVITY
|
166
|
7.65e-01
|
1.35e-02
|
8.60e-01
|
GOCC NUCLEOSOME
|
39
|
8.85e-01
|
1.34e-02
|
9.38e-01
|
GOCC SYNAPTIC MEMBRANE
|
366
|
6.60e-01
|
1.34e-02
|
7.93e-01
|
GOBP AMIDE CATABOLIC PROCESS
|
11
|
9.39e-01
|
-1.34e-02
|
9.67e-01
|
GOMF PROTEIN TYROSINE SERINE THREONINE PHOSPHATASE ACTIVITY
|
30
|
9.00e-01
|
-1.32e-02
|
9.44e-01
|
GOBP INTESTINAL EPITHELIAL CELL DIFFERENTIATION
|
17
|
9.25e-01
|
-1.32e-02
|
9.59e-01
|
GOBP CYTOSKELETON DEPENDENT INTRACELLULAR TRANSPORT
|
174
|
7.65e-01
|
-1.32e-02
|
8.60e-01
|
GOBP VASCULAR WOUND HEALING
|
17
|
9.25e-01
|
-1.31e-02
|
9.59e-01
|
GOCC CLATHRIN COATED VESICLE MEMBRANE
|
40
|
8.86e-01
|
-1.31e-02
|
9.38e-01
|
GOBP PROTEIN DEPHOSPHORYLATION
|
196
|
7.53e-01
|
-1.30e-02
|
8.53e-01
|
GOBP RESPIRATORY GASEOUS EXCHANGE BY RESPIRATORY SYSTEM
|
51
|
8.73e-01
|
-1.30e-02
|
9.30e-01
|
GOBP REGULATION OF METAL ION TRANSPORT
|
319
|
6.93e-01
|
-1.29e-02
|
8.13e-01
|
GOBP REGULATION OF ER TO GOLGI VESICLE MEDIATED TRANSPORT
|
12
|
9.38e-01
|
1.29e-02
|
9.67e-01
|
GOBP NEURON PROJECTION GUIDANCE
|
173
|
7.72e-01
|
1.28e-02
|
8.64e-01
|
GOBP REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION
|
18
|
9.25e-01
|
1.28e-02
|
9.59e-01
|
GOCC ROUGH ENDOPLASMIC RETICULUM
|
37
|
8.94e-01
|
-1.27e-02
|
9.41e-01
|
GOCC PRESPLICEOSOME
|
16
|
9.30e-01
|
-1.27e-02
|
9.62e-01
|
GOBP REGULATION OF MEIOTIC NUCLEAR DIVISION
|
21
|
9.20e-01
|
1.26e-02
|
9.56e-01
|
GOBP HORMONE TRANSPORT
|
265
|
7.25e-01
|
1.26e-02
|
8.34e-01
|
GOBP NEGATIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS
|
49
|
8.79e-01
|
1.25e-02
|
9.35e-01
|
GOCC INCLUSION BODY
|
62
|
8.65e-01
|
1.25e-02
|
9.25e-01
|
GOBP POSITIVE REGULATION OF SIGNALING RECEPTOR ACTIVITY
|
22
|
9.19e-01
|
-1.25e-02
|
9.55e-01
|
GOBP NEGATIVE REGULATION OF CATION CHANNEL ACTIVITY
|
26
|
9.13e-01
|
-1.24e-02
|
9.52e-01
|
GOBP PHYSIOLOGICAL CARDIAC MUSCLE HYPERTROPHY
|
42
|
8.90e-01
|
-1.24e-02
|
9.40e-01
|
GOBP POSITIVE REGULATION OF MONOOXYGENASE ACTIVITY
|
15
|
9.34e-01
|
1.23e-02
|
9.64e-01
|
GOCC U2 TYPE CATALYTIC STEP 2 SPLICEOSOME
|
30
|
9.07e-01
|
1.23e-02
|
9.49e-01
|
GOBP NOREPINEPHRINE METABOLIC PROCESS
|
12
|
9.41e-01
|
-1.23e-02
|
9.69e-01
|
GOMF LIPID TRANSPORTER ACTIVITY
|
121
|
8.15e-01
|
1.23e-02
|
8.94e-01
|
GOMF TRANSCRIPTION COACTIVATOR BINDING
|
48
|
8.83e-01
|
-1.23e-02
|
9.37e-01
|
GOBP AXON EXTENSION
|
108
|
8.27e-01
|
1.22e-02
|
9.01e-01
|
GOMF GLUCURONOSYLTRANSFERASE ACTIVITY
|
14
|
9.37e-01
|
-1.22e-02
|
9.66e-01
|
GOMF TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE ACTIVATOR ACTIVITY
|
12
|
9.43e-01
|
-1.20e-02
|
9.70e-01
|
GOBP CRANIAL NERVE DEVELOPMENT
|
39
|
8.97e-01
|
1.20e-02
|
9.42e-01
|
GOBP REGULATION OF CARDIAC MUSCLE ADAPTATION
|
10
|
9.48e-01
|
-1.20e-02
|
9.72e-01
|
GOBP RESPONSE TO OXIDATIVE STRESS
|
326
|
7.11e-01
|
1.20e-02
|
8.24e-01
|
GOBP EXOCRINE SYSTEM DEVELOPMENT
|
41
|
8.95e-01
|
1.19e-02
|
9.41e-01
|
GOBP RESPONSE TO ESTRADIOL
|
30
|
9.10e-01
|
-1.19e-02
|
9.50e-01
|
GOBP DETECTION OF EXTERNAL STIMULUS
|
73
|
8.61e-01
|
1.19e-02
|
9.22e-01
|
GOBP REGULATION OF NEUROTRANSMITTER UPTAKE
|
14
|
9.39e-01
|
1.19e-02
|
9.67e-01
|
GOMF PROTEIN SERINE THREONINE KINASE INHIBITOR ACTIVITY
|
31
|
9.09e-01
|
1.18e-02
|
9.50e-01
|
GOMF TRANSITION METAL ION BINDING
|
744
|
5.89e-01
|
-1.17e-02
|
7.40e-01
|
GOBP PEPTIDE TRANSPORT
|
228
|
7.61e-01
|
1.17e-02
|
8.57e-01
|
GOMF GUANYL RIBONUCLEOTIDE BINDING
|
313
|
7.22e-01
|
-1.17e-02
|
8.32e-01
|
GOBP REGULATION OF SYNAPTIC VESICLE RECYCLING
|
40
|
8.98e-01
|
-1.17e-02
|
9.42e-01
|
GOBP PROTEOGLYCAN METABOLIC PROCESS
|
70
|
8.66e-01
|
1.17e-02
|
9.26e-01
|
GOBP CELLULAR RESPONSE TO GAMMA RADIATION
|
25
|
9.20e-01
|
1.17e-02
|
9.55e-01
|
GOBP NEURON MATURATION
|
55
|
8.82e-01
|
1.16e-02
|
9.36e-01
|
GOBP SPHINGOID METABOLIC PROCESS
|
16
|
9.36e-01
|
1.16e-02
|
9.65e-01
|
GOMF PEPTIDASE ACTIVITY
|
372
|
7.05e-01
|
1.15e-02
|
8.20e-01
|
GOBP REGULATION OF PRESYNAPTIC CYTOSOLIC CALCIUM ION CONCENTRATION
|
13
|
9.43e-01
|
1.14e-02
|
9.70e-01
|
GOBP COLUMNAR CUBOIDAL EPITHELIAL CELL DEVELOPMENT
|
38
|
9.03e-01
|
-1.14e-02
|
9.46e-01
|
GOBP REGULATION OF PRESYNAPSE ORGANIZATION
|
28
|
9.18e-01
|
-1.13e-02
|
9.55e-01
|
GOMF MRNA BINDING
|
298
|
7.38e-01
|
-1.13e-02
|
8.44e-01
|
GOBP NEGATIVE REGULATION OF AUTOPHAGOSOME ASSEMBLY
|
13
|
9.44e-01
|
-1.13e-02
|
9.70e-01
|
GOBP CELL CELL SIGNALING
|
868
|
5.81e-01
|
-1.11e-02
|
7.35e-01
|
GOCC PERINUCLEAR ENDOPLASMIC RETICULUM
|
26
|
9.22e-01
|
-1.11e-02
|
9.57e-01
|
GOBP AMYLOID PRECURSOR PROTEIN BIOSYNTHETIC PROCESS
|
12
|
9.47e-01
|
-1.11e-02
|
9.71e-01
|
GOBP EMBRYONIC BODY MORPHOGENESIS
|
12
|
9.47e-01
|
-1.11e-02
|
9.71e-01
|
GOMF AMYLOID BETA BINDING
|
53
|
8.89e-01
|
1.10e-02
|
9.40e-01
|
GOCC COPI COATED VESICLE
|
29
|
9.18e-01
|
1.10e-02
|
9.55e-01
|
GOBP TRANSCRIPTION BY RNA POLYMERASE III
|
49
|
8.94e-01
|
1.10e-02
|
9.41e-01
|
GOBP PROTEIN DEACETYLATION
|
42
|
9.02e-01
|
-1.10e-02
|
9.45e-01
|
GOBP PROTEIN LOCALIZATION TO MICROTUBULE
|
19
|
9.34e-01
|
-1.09e-02
|
9.64e-01
|
GOBP NUCLEAR PORE COMPLEX ASSEMBLY
|
10
|
9.53e-01
|
1.08e-02
|
9.75e-01
|
GOCC EARLY PHAGOSOME
|
14
|
9.44e-01
|
1.08e-02
|
9.70e-01
|
GOBP INCLUSION BODY ASSEMBLY
|
23
|
9.29e-01
|
-1.08e-02
|
9.62e-01
|
GOBP CELLULAR RESPONSE TO FATTY ACID
|
21
|
9.33e-01
|
-1.06e-02
|
9.64e-01
|
GOBP STRIATED MUSCLE TISSUE DEVELOPMENT
|
259
|
7.70e-01
|
-1.06e-02
|
8.63e-01
|
GOBP REGULATION OF POTASSIUM ION TRANSPORT
|
77
|
8.73e-01
|
1.05e-02
|
9.31e-01
|
GOBP NEGATIVE REGULATION OF OSTEOBLAST PROLIFERATION
|
10
|
9.54e-01
|
-1.05e-02
|
9.76e-01
|
GOBP CALCIUM ION TRANSPORT
|
307
|
7.54e-01
|
-1.04e-02
|
8.53e-01
|
GOBP RESPONSE TO ENDOPLASMIC RETICULUM STRESS
|
232
|
7.85e-01
|
-1.04e-02
|
8.74e-01
|
GOBP POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION
|
68
|
8.84e-01
|
-1.02e-02
|
9.37e-01
|
GOBP CAMERA TYPE EYE PHOTORECEPTOR CELL DIFFERENTIATION
|
26
|
9.29e-01
|
-1.02e-02
|
9.62e-01
|
GOBP PROTEIN LOCALIZATION TO CELL SURFACE
|
65
|
8.89e-01
|
1.00e-02
|
9.40e-01
|
GOBP POSITIVE REGULATION OF SYNAPTIC TRANSMISSION
|
149
|
8.33e-01
|
1.00e-02
|
9.04e-01
|
GOMF GLYCOLIPID BINDING
|
23
|
9.34e-01
|
-9.97e-03
|
9.64e-01
|
GOMF OXIDOREDUCTASE ACTIVITY ACTING ON THE CH NH GROUP OF DONORS NAD OR NADP AS ACCEPTOR
|
15
|
9.47e-01
|
9.95e-03
|
9.71e-01
|
GOBP NEGATIVE REGULATION OF HYDROLASE ACTIVITY
|
181
|
8.19e-01
|
-9.90e-03
|
8.96e-01
|
GOBP BEHAVIOR
|
547
|
6.96e-01
|
9.83e-03
|
8.14e-01
|
GOBP POST GOLGI VESICLE MEDIATED TRANSPORT
|
96
|
8.69e-01
|
-9.72e-03
|
9.28e-01
|
GOCC ZYMOGEN GRANULE MEMBRANE
|
10
|
9.58e-01
|
9.60e-03
|
9.78e-01
|
GOBP DETERMINATION OF ADULT LIFESPAN
|
40
|
9.16e-01
|
9.59e-03
|
9.54e-01
|
GOBP RENAL SYSTEM VASCULATURE DEVELOPMENT
|
27
|
9.32e-01
|
-9.56e-03
|
9.63e-01
|
GOBP REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY
|
142
|
8.46e-01
|
-9.46e-03
|
9.12e-01
|
GOMF POLY PYRIMIDINE TRACT BINDING
|
23
|
9.38e-01
|
-9.41e-03
|
9.67e-01
|
GOBP AMYLOID PRECURSOR PROTEIN METABOLIC PROCESS
|
67
|
8.94e-01
|
-9.40e-03
|
9.41e-01
|
GOBP REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS
|
28
|
9.31e-01
|
-9.40e-03
|
9.63e-01
|
GOBP ESTABLISHMENT OF PROTEIN LOCALIZATION
|
1443
|
5.58e-01
|
-9.37e-03
|
7.18e-01
|
GOBP RESPONSE TO ZINC ION
|
26
|
9.34e-01
|
9.36e-03
|
9.64e-01
|
GOBP GLUCOCORTICOID BIOSYNTHETIC PROCESS
|
10
|
9.59e-01
|
-9.35e-03
|
9.78e-01
|
GOBP POSITIVE REGULATION OF PROTEIN LOCALIZATION TO EARLY ENDOSOME
|
10
|
9.60e-01
|
9.19e-03
|
9.79e-01
|
GOBP FEMALE PREGNANCY
|
104
|
8.72e-01
|
9.17e-03
|
9.30e-01
|
GOBP REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT
|
142
|
8.51e-01
|
-9.15e-03
|
9.16e-01
|
GOBP PROTEIN LOCALIZATION TO ORGANELLE
|
847
|
6.54e-01
|
-9.14e-03
|
7.89e-01
|
GOMF CORECEPTOR ACTIVITY
|
32
|
9.29e-01
|
-9.14e-03
|
9.62e-01
|
GOMF ALANINE TRANSMEMBRANE TRANSPORTER ACTIVITY
|
13
|
9.55e-01
|
9.08e-03
|
9.76e-01
|
GOMF TRANSLATION INITIATION FACTOR BINDING
|
33
|
9.29e-01
|
8.96e-03
|
9.62e-01
|
GOBP VASCULAR ASSOCIATED SMOOTH MUSCLE CONTRACTION
|
25
|
9.38e-01
|
-8.95e-03
|
9.67e-01
|
GOBP REGULATION OF GONAD DEVELOPMENT
|
11
|
9.59e-01
|
8.86e-03
|
9.78e-01
|
GOBP MUSCLE ORGAN MORPHOGENESIS
|
79
|
8.92e-01
|
-8.86e-03
|
9.40e-01
|
GOBP SKELETAL MUSCLE ORGAN DEVELOPMENT
|
169
|
8.43e-01
|
-8.85e-03
|
9.11e-01
|
GOBP RESPONSE TO OXYGEN LEVELS
|
221
|
8.21e-01
|
8.85e-03
|
8.97e-01
|
GOMF PHOSPHOLIPASE BINDING
|
24
|
9.40e-01
|
-8.85e-03
|
9.68e-01
|
GOBP NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE
|
23
|
9.42e-01
|
-8.77e-03
|
9.69e-01
|
GOBP NITRIC OXIDE SYNTHASE BIOSYNTHETIC PROCESS
|
23
|
9.42e-01
|
-8.74e-03
|
9.69e-01
|
GOBP MALE MEIOSIS I
|
16
|
9.52e-01
|
-8.73e-03
|
9.75e-01
|
GOMF MRNA 5 UTR BINDING
|
22
|
9.44e-01
|
-8.64e-03
|
9.70e-01
|
GOBP REGULATION OF TELOMERE MAINTENANCE IN RESPONSE TO DNA DAMAGE
|
20
|
9.47e-01
|
8.61e-03
|
9.71e-01
|
GOCC CARBOXY TERMINAL DOMAIN PROTEIN KINASE COMPLEX
|
21
|
9.46e-01
|
-8.57e-03
|
9.71e-01
|
GOBP NITROGEN COMPOUND TRANSPORT
|
1553
|
5.81e-01
|
-8.53e-03
|
7.35e-01
|
GOBP VASOCONSTRICTION
|
86
|
8.93e-01
|
-8.43e-03
|
9.41e-01
|
GOBP CHEMICAL SYNAPTIC TRANSMISSION POSTSYNAPTIC
|
79
|
8.98e-01
|
8.38e-03
|
9.42e-01
|
GOBP NEGATIVE REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS
|
38
|
9.29e-01
|
-8.36e-03
|
9.62e-01
|
GOBP PHAGOLYSOSOME ASSEMBLY
|
16
|
9.54e-01
|
-8.35e-03
|
9.76e-01
|
GOBP ESTABLISHMENT OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE
|
61
|
9.10e-01
|
-8.33e-03
|
9.51e-01
|
GOBP CELLULAR RESPONSE TO LIPOPROTEIN PARTICLE STIMULUS
|
33
|
9.35e-01
|
-8.24e-03
|
9.64e-01
|
GOBP CELLULAR RESPONSE TO CADMIUM ION
|
20
|
9.49e-01
|
8.22e-03
|
9.73e-01
|
GOBP VENTRICULAR CARDIAC MUSCLE TISSUE MORPHOGENESIS
|
48
|
9.22e-01
|
-8.21e-03
|
9.57e-01
|
GOBP RESPONSE TO NICOTINE
|
16
|
9.55e-01
|
-8.19e-03
|
9.76e-01
|
GOCC ESCRT COMPLEX
|
24
|
9.45e-01
|
-8.19e-03
|
9.70e-01
|
GOBP MAMMARY GLAND ALVEOLUS DEVELOPMENT
|
16
|
9.55e-01
|
-8.18e-03
|
9.76e-01
|
GOBP NEGATIVE REGULATION OF DNA REPAIR
|
27
|
9.42e-01
|
-8.03e-03
|
9.70e-01
|
GOBP PROTEIN LOCALIZATION TO CELL PERIPHERY
|
338
|
8.01e-01
|
8.01e-03
|
8.85e-01
|
GOBP CELLULAR RESPONSE TO OXYGEN RADICAL
|
18
|
9.53e-01
|
-8.00e-03
|
9.75e-01
|
GOMF CARGO RECEPTOR ACTIVITY
|
62
|
9.13e-01
|
7.98e-03
|
9.52e-01
|
GOBP CARBOHYDRATE HOMEOSTASIS
|
212
|
8.42e-01
|
7.95e-03
|
9.11e-01
|
GOCC INTERCALATED DISC
|
60
|
9.16e-01
|
-7.91e-03
|
9.54e-01
|
GOBP CARDIAC MUSCLE TISSUE MORPHOGENESIS
|
63
|
9.14e-01
|
7.88e-03
|
9.52e-01
|
GOCC 90S PRERIBOSOME
|
25
|
9.46e-01
|
-7.80e-03
|
9.71e-01
|
GOBP AXO DENDRITIC TRANSPORT
|
81
|
9.04e-01
|
7.79e-03
|
9.46e-01
|
GOBP REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE
|
41
|
9.31e-01
|
-7.78e-03
|
9.63e-01
|
GOBP POSITIVE REGULATION OF INTERLEUKIN 17 PRODUCTION
|
16
|
9.57e-01
|
-7.76e-03
|
9.77e-01
|
GOCC GABA ERGIC SYNAPSE
|
99
|
8.94e-01
|
7.75e-03
|
9.41e-01
|
GOBP MULTI MULTICELLULAR ORGANISM PROCESS
|
117
|
8.85e-01
|
7.72e-03
|
9.38e-01
|
GOMF ORGANIC ACID SODIUM SYMPORTER ACTIVITY
|
19
|
9.54e-01
|
-7.72e-03
|
9.76e-01
|
GOBP REGULATION OF LIPASE ACTIVITY
|
38
|
9.35e-01
|
7.69e-03
|
9.64e-01
|
GOBP DEPHOSPHORYLATION
|
260
|
8.32e-01
|
7.67e-03
|
9.04e-01
|
GOBP REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION
|
78
|
9.07e-01
|
-7.66e-03
|
9.49e-01
|
GOBP CALCIUM ION IMPORT ACROSS PLASMA MEMBRANE
|
23
|
9.49e-01
|
-7.64e-03
|
9.73e-01
|
GOBP REGULATION OF CALCIUM MEDIATED SIGNALING
|
72
|
9.12e-01
|
7.56e-03
|
9.51e-01
|
GOBP REPLICATIVE SENESCENCE
|
10
|
9.67e-01
|
-7.52e-03
|
9.82e-01
|
GOBP RETINA DEVELOPMENT IN CAMERA TYPE EYE
|
123
|
8.86e-01
|
7.52e-03
|
9.38e-01
|
GOCC VACUOLAR MEMBRANE
|
232
|
8.45e-01
|
7.49e-03
|
9.12e-01
|
GOBP REGULATION OF JUN KINASE ACTIVITY
|
57
|
9.22e-01
|
7.47e-03
|
9.57e-01
|
GOBP REGULATION OF SYNAPTIC VESICLE ENDOCYTOSIS
|
31
|
9.43e-01
|
-7.45e-03
|
9.70e-01
|
GOBP RESPONSE TO CARBOHYDRATE
|
163
|
8.71e-01
|
-7.38e-03
|
9.29e-01
|
GOBP SPERM MOTILITY
|
56
|
9.24e-01
|
-7.35e-03
|
9.58e-01
|
GOBP SKELETAL MUSCLE CELL DIFFERENTIATION
|
70
|
9.16e-01
|
7.31e-03
|
9.54e-01
|
GOBP RESPONSE TO CHOLESTEROL
|
20
|
9.55e-01
|
-7.25e-03
|
9.76e-01
|
GOMF SULFATE TRANSMEMBRANE TRANSPORTER ACTIVITY
|
11
|
9.67e-01
|
-7.22e-03
|
9.82e-01
|
GOBP SMOOTH MUSCLE CONTRACTION
|
86
|
9.11e-01
|
6.97e-03
|
9.51e-01
|
GOBP CELLULAR RESPONSE TO CHEMICAL STRESS
|
260
|
8.47e-01
|
6.96e-03
|
9.13e-01
|
GOBP REGULATION OF TUBE SIZE
|
146
|
8.85e-01
|
6.96e-03
|
9.38e-01
|
GOBP PROTEIN TARGETING TO MEMBRANE
|
98
|
9.06e-01
|
-6.94e-03
|
9.47e-01
|
GOBP POSITIVE REGULATION OF MONOATOMIC ION TRANSMEMBRANE TRANSPORT
|
126
|
8.93e-01
|
-6.92e-03
|
9.41e-01
|
GOBP NEGATIVE REGULATION OF FATTY ACID METABOLIC PROCESS
|
26
|
9.51e-01
|
6.91e-03
|
9.74e-01
|
GOBP POSITIVE REGULATION OF TRANSLATION
|
117
|
8.99e-01
|
6.83e-03
|
9.43e-01
|
GOBP PIGMENT CELL DIFFERENTIATION
|
32
|
9.47e-01
|
-6.82e-03
|
9.71e-01
|
GOBP PROTEIN LOCALIZATION TO SITE OF DOUBLE STRAND BREAK
|
13
|
9.66e-01
|
-6.78e-03
|
9.82e-01
|
GOBP POSITIVE REGULATION OF MIRNA METABOLIC PROCESS
|
55
|
9.31e-01
|
-6.72e-03
|
9.63e-01
|
GOBP REGULATION OF HIPPO SIGNALING
|
21
|
9.58e-01
|
-6.71e-03
|
9.78e-01
|
GOBP ERBB2 SIGNALING PATHWAY
|
22
|
9.57e-01
|
6.70e-03
|
9.77e-01
|
GOMF INTRACELLULARLY LIGAND GATED MONOATOMIC ION CHANNEL ACTIVITY
|
21
|
9.58e-01
|
-6.62e-03
|
9.78e-01
|
GOMF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY
|
22
|
9.57e-01
|
-6.59e-03
|
9.77e-01
|
GOBP CELLULAR RESPONSE TO HYPOXIA
|
101
|
9.09e-01
|
6.59e-03
|
9.50e-01
|
GOCC AUTOPHAGOSOME
|
82
|
9.18e-01
|
6.56e-03
|
9.55e-01
|
GOBP NEGATIVE REGULATION OF MEMBRANE POTENTIAL
|
11
|
9.71e-01
|
6.43e-03
|
9.85e-01
|
GOBP AMYLOID FIBRIL FORMATION
|
26
|
9.55e-01
|
-6.41e-03
|
9.76e-01
|
GOBP REGULATION OF INSULIN SECRETION
|
158
|
8.90e-01
|
-6.38e-03
|
9.40e-01
|
GOBP REGULATION OF TRANSLATION
|
296
|
8.53e-01
|
-6.28e-03
|
9.17e-01
|
GOBP V D J RECOMBINATION
|
15
|
9.66e-01
|
6.27e-03
|
9.82e-01
|
GOMF PROTEIN HOMODIMERIZATION ACTIVITY
|
591
|
7.98e-01
|
-6.21e-03
|
8.83e-01
|
GOBP VIRION ASSEMBLY
|
26
|
9.56e-01
|
-6.20e-03
|
9.77e-01
|
GOBP MICROTUBULE BASED TRANSPORT
|
167
|
8.91e-01
|
6.18e-03
|
9.40e-01
|
GOBP NEUTROPHIL DEGRANULATION
|
11
|
9.72e-01
|
-6.10e-03
|
9.86e-01
|
GOBP LONG TERM SYNAPTIC POTENTIATION
|
95
|
9.18e-01
|
6.08e-03
|
9.55e-01
|
GOBP BRANCHING INVOLVED IN SALIVARY GLAND MORPHOGENESIS
|
21
|
9.62e-01
|
-6.01e-03
|
9.80e-01
|
GOBP SINGLE FERTILIZATION
|
80
|
9.26e-01
|
-5.99e-03
|
9.60e-01
|
GOBP TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY
|
60
|
9.36e-01
|
-5.96e-03
|
9.66e-01
|
GOBP FOLIC ACID CONTAINING COMPOUND METABOLIC PROCESS
|
25
|
9.59e-01
|
5.89e-03
|
9.78e-01
|
GOBP CALCIUM MEDIATED SIGNALING
|
141
|
9.05e-01
|
-5.85e-03
|
9.47e-01
|
GOBP PHOSPHOLIPID DEPHOSPHORYLATION
|
34
|
9.54e-01
|
5.72e-03
|
9.76e-01
|
GOMF SOLUTE INORGANIC ANION ANTIPORTER ACTIVITY
|
21
|
9.64e-01
|
-5.70e-03
|
9.81e-01
|
GOCC LYTIC VACUOLE
|
426
|
8.41e-01
|
-5.70e-03
|
9.10e-01
|
GOBP PYRIMIDINE NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS
|
12
|
9.73e-01
|
5.65e-03
|
9.86e-01
|
GOCC EXORIBONUCLEASE COMPLEX
|
21
|
9.65e-01
|
-5.53e-03
|
9.82e-01
|
GOBP EXIT FROM MITOSIS
|
23
|
9.64e-01
|
5.50e-03
|
9.81e-01
|
GOCC MLL1 2 COMPLEX
|
30
|
9.59e-01
|
5.49e-03
|
9.78e-01
|
GOMF AMINO ACID BINDING
|
41
|
9.52e-01
|
-5.48e-03
|
9.75e-01
|
GOBP PHOTORECEPTOR CELL DIFFERENTIATION
|
49
|
9.48e-01
|
-5.41e-03
|
9.72e-01
|
GOBP CILIUM MOVEMENT
|
82
|
9.33e-01
|
5.40e-03
|
9.64e-01
|
GOBP PYRIMIDINE NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS
|
16
|
9.70e-01
|
5.38e-03
|
9.85e-01
|
GOBP MAINTENANCE OF LOCATION
|
280
|
8.78e-01
|
-5.36e-03
|
9.34e-01
|
GOBP REGULATION OF AXONOGENESIS
|
149
|
9.11e-01
|
-5.32e-03
|
9.51e-01
|
GOMF WIDE PORE CHANNEL ACTIVITY
|
16
|
9.71e-01
|
-5.32e-03
|
9.85e-01
|
GOMF DNA NUCLEASE ACTIVITY
|
53
|
9.47e-01
|
5.31e-03
|
9.71e-01
|
GOBP CENTRAL NERVOUS SYSTEM PROJECTION NEURON AXONOGENESIS
|
25
|
9.63e-01
|
5.29e-03
|
9.81e-01
|
GOCC CILIUM
|
440
|
8.50e-01
|
-5.28e-03
|
9.16e-01
|
GOBP UV PROTECTION
|
10
|
9.77e-01
|
-5.25e-03
|
9.88e-01
|
GOBP REGULATION OF MITOCHONDRIAL FISSION
|
32
|
9.59e-01
|
5.22e-03
|
9.78e-01
|
GOBP PERIPHERAL NERVOUS SYSTEM AXON ENSHEATHMENT
|
29
|
9.61e-01
|
-5.19e-03
|
9.80e-01
|
GOBP NEGATIVE REGULATION OF INTERLEUKIN 1 BETA PRODUCTION
|
21
|
9.67e-01
|
-5.15e-03
|
9.83e-01
|
GOCC NUCLEAR LAMINA
|
14
|
9.73e-01
|
5.14e-03
|
9.86e-01
|
GOBP RECEPTOR LOCALIZATION TO SYNAPSE
|
78
|
9.38e-01
|
5.11e-03
|
9.67e-01
|
GOBP POSITIVE REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION
|
33
|
9.60e-01
|
-5.04e-03
|
9.79e-01
|
GOBP LEARNING
|
131
|
9.22e-01
|
-4.97e-03
|
9.57e-01
|
GOBP PYRIMIDINE CONTAINING COMPOUND METABOLIC PROCESS
|
54
|
9.50e-01
|
-4.94e-03
|
9.73e-01
|
GOBP ERYTHROCYTE DEVELOPMENT
|
43
|
9.56e-01
|
4.91e-03
|
9.76e-01
|
GOBP GOLGI RIBBON FORMATION
|
11
|
9.78e-01
|
4.80e-03
|
9.88e-01
|
GOBP HYDROGEN PEROXIDE BIOSYNTHETIC PROCESS
|
15
|
9.74e-01
|
4.79e-03
|
9.86e-01
|
GOBP GLYCOSAMINOGLYCAN CATABOLIC PROCESS
|
18
|
9.73e-01
|
4.65e-03
|
9.86e-01
|
GOBP VESICLE CYTOSKELETAL TRAFFICKING
|
55
|
9.53e-01
|
4.64e-03
|
9.75e-01
|
GOBP REGULATION OF REPRODUCTIVE PROCESS
|
114
|
9.32e-01
|
4.63e-03
|
9.63e-01
|
GOBP EXTRACELLULAR MATRIX DISASSEMBLY
|
28
|
9.67e-01
|
4.50e-03
|
9.82e-01
|
GOBP PROTEIN LOCALIZATION TO EXTRACELLULAR REGION
|
320
|
8.91e-01
|
-4.46e-03
|
9.40e-01
|
GOBP NEGATIVE REGULATION OF ORGANIC ACID TRANSPORT
|
19
|
9.73e-01
|
-4.45e-03
|
9.86e-01
|
GOMF TRANSMITTER GATED CHANNEL ACTIVITY
|
16
|
9.76e-01
|
-4.42e-03
|
9.87e-01
|
GOBP INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO HYPOXIA
|
12
|
9.79e-01
|
-4.41e-03
|
9.88e-01
|
GOBP RESPONSE TO PROSTAGLANDIN
|
13
|
9.78e-01
|
4.39e-03
|
9.88e-01
|
GOBP NEGATIVE REGULATION OF AXON EXTENSION
|
28
|
9.68e-01
|
-4.38e-03
|
9.83e-01
|
GOBP REGULATION OF TRANS SYNAPTIC SIGNALING
|
431
|
8.80e-01
|
4.26e-03
|
9.35e-01
|
GOBP REGULATION OF GLYCOPROTEIN METABOLIC PROCESS
|
38
|
9.64e-01
|
-4.25e-03
|
9.81e-01
|
GOBP PURINE NUCLEOBASE METABOLIC PROCESS
|
17
|
9.76e-01
|
-4.24e-03
|
9.87e-01
|
GOMF P TYPE TRANSMEMBRANE TRANSPORTER ACTIVITY
|
21
|
9.73e-01
|
-4.24e-03
|
9.86e-01
|
GOBP XENOBIOTIC DETOXIFICATION BY TRANSMEMBRANE EXPORT ACROSS THE PLASMA MEMBRANE
|
10
|
9.82e-01
|
4.10e-03
|
9.90e-01
|
GOMF MINUS END DIRECTED MICROTUBULE MOTOR ACTIVITY
|
10
|
9.82e-01
|
4.10e-03
|
9.90e-01
|
GOBP NEGATIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT
|
27
|
9.71e-01
|
4.05e-03
|
9.85e-01
|
GOBP NEGATIVE REGULATION OF MUSCLE CONTRACTION
|
22
|
9.74e-01
|
4.04e-03
|
9.86e-01
|
GOMF POLYSACCHARIDE BINDING
|
18
|
9.77e-01
|
-4.00e-03
|
9.87e-01
|
GOBP LOCOMOTORY EXPLORATION BEHAVIOR
|
17
|
9.77e-01
|
3.98e-03
|
9.88e-01
|
GOBP POSITIVE REGULATION OF ADENYLATE CYCLASE ACTIVITY
|
16
|
9.78e-01
|
-3.95e-03
|
9.88e-01
|
GOCC H4 H2A HISTONE ACETYLTRANSFERASE COMPLEX
|
24
|
9.74e-01
|
3.90e-03
|
9.86e-01
|
GOBP CELLULAR PIGMENTATION
|
50
|
9.62e-01
|
-3.86e-03
|
9.80e-01
|
GOBP POSITIVE REGULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL
|
31
|
9.71e-01
|
3.83e-03
|
9.85e-01
|
GOMF PURINE NUCLEOTIDE BINDING
|
1574
|
8.04e-01
|
-3.81e-03
|
8.87e-01
|
GOBP REGULATION OF PEPTIDE TRANSPORT
|
183
|
9.33e-01
|
-3.60e-03
|
9.64e-01
|
GOBP PROTEIN N LINKED GLYCOSYLATION VIA ASPARAGINE
|
17
|
9.80e-01
|
-3.52e-03
|
9.89e-01
|
GOMF RNA POLYMERASE III GENERAL TRANSCRIPTION INITIATION FACTOR ACTIVITY
|
11
|
9.84e-01
|
3.49e-03
|
9.91e-01
|
GOCC LYTIC VACUOLE MEMBRANE
|
184
|
9.35e-01
|
3.48e-03
|
9.65e-01
|
GOBP NEURON CELLULAR HOMEOSTASIS
|
60
|
9.63e-01
|
-3.47e-03
|
9.80e-01
|
GOCC NEUROTRANSMITTER RECEPTOR COMPLEX
|
21
|
9.78e-01
|
-3.47e-03
|
9.88e-01
|
GOBP REGULATION OF AMINO ACID TRANSPORT
|
35
|
9.72e-01
|
3.44e-03
|
9.86e-01
|
GOBP UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS
|
32
|
9.74e-01
|
3.36e-03
|
9.86e-01
|
GOMF TOLL LIKE RECEPTOR BINDING
|
12
|
9.84e-01
|
-3.30e-03
|
9.91e-01
|
GOBP POSITIVE REGULATION OF ERAD PATHWAY
|
20
|
9.80e-01
|
3.24e-03
|
9.89e-01
|
GOMF TRANSPORTER INHIBITOR ACTIVITY
|
34
|
9.74e-01
|
3.20e-03
|
9.86e-01
|
GOBP PROTEIN K48 LINKED UBIQUITINATION
|
74
|
9.62e-01
|
-3.17e-03
|
9.80e-01
|
GOCC ENDOPLASMIC RETICULUM LUMEN
|
68
|
9.66e-01
|
3.00e-03
|
9.82e-01
|
GOMF MRNA 3 UTR BINDING
|
94
|
9.60e-01
|
2.98e-03
|
9.79e-01
|
GOCC POSTSYNAPSE
|
727
|
8.93e-01
|
-2.95e-03
|
9.41e-01
|
GOBP DNA TEMPLATED TRANSCRIPTION INITIATION
|
167
|
9.49e-01
|
2.88e-03
|
9.73e-01
|
GOBP MEMBRANE LIPID CATABOLIC PROCESS
|
25
|
9.80e-01
|
2.83e-03
|
9.89e-01
|
GOBP VESICLE TETHERING
|
31
|
9.78e-01
|
2.82e-03
|
9.88e-01
|
GOMF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY
|
139
|
9.54e-01
|
2.81e-03
|
9.76e-01
|
GOMF MANNOSIDASE ACTIVITY
|
14
|
9.86e-01
|
-2.80e-03
|
9.92e-01
|
GOBP CERAMIDE METABOLIC PROCESS
|
71
|
9.68e-01
|
-2.80e-03
|
9.83e-01
|
GOBP REGULATION OF HORMONE SECRETION
|
217
|
9.45e-01
|
-2.75e-03
|
9.70e-01
|
GOBP POSITIVE REGULATION OF TRANSMEMBRANE TRANSPORT
|
183
|
9.50e-01
|
-2.72e-03
|
9.73e-01
|
GOBP EXPORT ACROSS PLASMA MEMBRANE
|
48
|
9.75e-01
|
2.65e-03
|
9.86e-01
|
GOMF PROTEIN DIMERIZATION ACTIVITY
|
778
|
9.01e-01
|
2.64e-03
|
9.45e-01
|
GOMF PHOSPHOTRANSFERASE ACTIVITY FOR OTHER SUBSTITUTED PHOSPHATE GROUPS
|
20
|
9.84e-01
|
-2.60e-03
|
9.91e-01
|
GOBP INTRA GOLGI VESICLE MEDIATED TRANSPORT
|
29
|
9.81e-01
|
-2.58e-03
|
9.89e-01
|
GOCC DENDRITIC GROWTH CONE
|
12
|
9.88e-01
|
2.57e-03
|
9.94e-01
|
GOBP PEPTIDE CATABOLIC PROCESS
|
17
|
9.86e-01
|
2.51e-03
|
9.92e-01
|
GOBP RESPONSE TO UV A
|
10
|
9.89e-01
|
2.51e-03
|
9.95e-01
|
GOBP POSITIVE REGULATION OF GROWTH
|
247
|
9.46e-01
|
2.50e-03
|
9.71e-01
|
GOBP RESPONSE TO CALCIUM ION
|
105
|
9.65e-01
|
2.47e-03
|
9.82e-01
|
GOCC PRESYNAPTIC ACTIVE ZONE
|
96
|
9.67e-01
|
2.46e-03
|
9.82e-01
|
GOBP GLYCOPROTEIN METABOLIC PROCESS
|
272
|
9.45e-01
|
-2.46e-03
|
9.70e-01
|
GOBP INTRACELLULAR GLUCOSE HOMEOSTASIS
|
129
|
9.62e-01
|
-2.42e-03
|
9.80e-01
|
GOBP MUSCLE ORGAN DEVELOPMENT
|
293
|
9.45e-01
|
2.36e-03
|
9.70e-01
|
GOMF PALMITOYLTRANSFERASE ACTIVITY
|
29
|
9.83e-01
|
-2.35e-03
|
9.90e-01
|
GOBP PYRIMIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS
|
30
|
9.83e-01
|
-2.30e-03
|
9.90e-01
|
GOBP RECEPTOR CLUSTERING
|
66
|
9.74e-01
|
-2.30e-03
|
9.86e-01
|
GOBP REGULATION OF RETROGRADE PROTEIN TRANSPORT ER TO CYTOSOL
|
11
|
9.90e-01
|
2.26e-03
|
9.95e-01
|
GOBP MUSCLE CELL DIFFERENTIATION
|
394
|
9.39e-01
|
2.26e-03
|
9.67e-01
|
GOBP PERIPHERAL NERVOUS SYSTEM DEVELOPMENT
|
66
|
9.75e-01
|
-2.24e-03
|
9.87e-01
|
GOCC VESICLE TETHERING COMPLEX
|
63
|
9.76e-01
|
2.20e-03
|
9.87e-01
|
GOMF LOW DENSITY LIPOPROTEIN PARTICLE BINDING
|
15
|
9.88e-01
|
2.20e-03
|
9.94e-01
|
GOBP COPPER ION TRANSPORT
|
15
|
9.88e-01
|
2.19e-03
|
9.94e-01
|
GOBP MEMBRANE LIPID BIOSYNTHETIC PROCESS
|
105
|
9.70e-01
|
2.13e-03
|
9.85e-01
|
GOBP RESPONSE TO ATP
|
25
|
9.85e-01
|
2.12e-03
|
9.92e-01
|
GOMF TRANSPORTER REGULATOR ACTIVITY
|
104
|
9.71e-01
|
-2.09e-03
|
9.85e-01
|
GOBP ENDOMEMBRANE SYSTEM ORGANIZATION
|
459
|
9.41e-01
|
-2.03e-03
|
9.69e-01
|
GOBP RESPONSE TO STARVATION
|
159
|
9.65e-01
|
2.00e-03
|
9.82e-01
|
GOBP DEOXYRIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS
|
24
|
9.87e-01
|
1.98e-03
|
9.93e-01
|
GOBP CELLULAR RESPONSE TO NUTRIENT LEVELS
|
192
|
9.63e-01
|
-1.95e-03
|
9.80e-01
|
GOBP NEGATIVE REGULATION OF B CELL PROLIFERATION
|
18
|
9.89e-01
|
1.90e-03
|
9.95e-01
|
GOBP PROTEIN DEPALMITOYLATION
|
10
|
9.92e-01
|
-1.86e-03
|
9.97e-01
|
GOBP MEMBRANE ORGANIZATION
|
630
|
9.37e-01
|
-1.86e-03
|
9.66e-01
|
GOBP RNA SPLICING VIA ENDONUCLEOLYTIC CLEAVAGE AND LIGATION
|
10
|
9.92e-01
|
1.84e-03
|
9.97e-01
|
GOBP CEREBRAL CORTEX NEURON DIFFERENTIATION
|
18
|
9.90e-01
|
-1.77e-03
|
9.95e-01
|
GOBP LYSOSOMAL MEMBRANE ORGANIZATION
|
13
|
9.91e-01
|
-1.74e-03
|
9.96e-01
|
GOCC INTERCELLULAR BRIDGE
|
75
|
9.81e-01
|
1.63e-03
|
9.89e-01
|
GOBP AXONEME ASSEMBLY
|
37
|
9.87e-01
|
1.61e-03
|
9.93e-01
|
GOBP NEGATIVE REGULATION OF RNA CATABOLIC PROCESS
|
66
|
9.83e-01
|
1.54e-03
|
9.90e-01
|
GOCC TRANSFERASE COMPLEX
|
731
|
9.44e-01
|
1.54e-03
|
9.70e-01
|
GOCC SEMAPHORIN RECEPTOR COMPLEX
|
11
|
9.93e-01
|
1.53e-03
|
9.97e-01
|
GOBP SNRNA TRANSCRIPTION BY RNA POLYMERASE II
|
13
|
9.92e-01
|
1.52e-03
|
9.97e-01
|
GOBP POST EMBRYONIC DEVELOPMENT
|
99
|
9.80e-01
|
1.48e-03
|
9.89e-01
|
GOBP POSITIVE REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS
|
15
|
9.93e-01
|
1.30e-03
|
9.97e-01
|
GOBP CALCIUM ION REGULATED EXOCYTOSIS
|
51
|
9.88e-01
|
1.25e-03
|
9.94e-01
|
GOBP RESPONSE TO OXYGEN RADICAL
|
22
|
9.92e-01
|
1.22e-03
|
9.97e-01
|
GOBP MULTICELLULAR ORGANISM GROWTH
|
182
|
9.78e-01
|
1.19e-03
|
9.88e-01
|
GOBP ADRENAL GLAND DEVELOPMENT
|
17
|
9.93e-01
|
1.18e-03
|
9.97e-01
|
GOMF G PROTEIN COUPLED RECEPTOR BINDING
|
179
|
9.81e-01
|
1.06e-03
|
9.89e-01
|
GOCC EUKARYOTIC TRANSLATION INITIATION FACTOR 3 COMPLEX
|
14
|
9.95e-01
|
-1.04e-03
|
9.98e-01
|
GOBP ORGANISM EMERGENCE FROM PROTECTIVE STRUCTURE
|
29
|
9.93e-01
|
-1.01e-03
|
9.97e-01
|
GOBP ADENOSINE METABOLIC PROCESS
|
10
|
9.96e-01
|
9.45e-04
|
9.99e-01
|
GOBP ASPARTATE TRANSMEMBRANE TRANSPORT
|
17
|
9.95e-01
|
-9.43e-04
|
9.98e-01
|
GOBP DEOXYRIBONUCLEOTIDE METABOLIC PROCESS
|
39
|
9.93e-01
|
8.36e-04
|
9.97e-01
|
GOBP POSITIVE REGULATION OF PROTEIN DEPOLYMERIZATION
|
13
|
9.96e-01
|
-8.18e-04
|
9.99e-01
|
GOBP VACUOLAR LOCALIZATION
|
65
|
9.91e-01
|
8.05e-04
|
9.96e-01
|
GOCC VACUOLE
|
508
|
9.76e-01
|
7.87e-04
|
9.87e-01
|
GOBP UDP N ACETYLGLUCOSAMINE METABOLIC PROCESS
|
11
|
9.97e-01
|
-7.40e-04
|
9.99e-01
|
GOBP MAINTENANCE OF PROTEIN LOCALIZATION IN ENDOPLASMIC RETICULUM
|
12
|
9.97e-01
|
6.67e-04
|
9.99e-01
|
GOBP TRANS SYNAPTIC SIGNALING MODULATING SYNAPTIC TRANSMISSION
|
14
|
9.97e-01
|
-6.47e-04
|
9.99e-01
|
GOBP RESPONSE TO MUSCLE STRETCH
|
21
|
9.96e-01
|
6.26e-04
|
9.99e-01
|
GOBP ENDOPLASMIC RETICULUM TO CYTOSOL TRANSPORT
|
23
|
9.97e-01
|
4.63e-04
|
9.99e-01
|
GOBP INTRACELLULAR CORTICOSTEROID RECEPTOR SIGNALING PATHWAY
|
14
|
9.98e-01
|
4.22e-04
|
9.99e-01
|
GOMF SULFURIC ESTER HYDROLASE ACTIVITY
|
10
|
9.98e-01
|
3.68e-04
|
9.99e-01
|
GOBP NEGATIVE REGULATION OF B CELL ACTIVATION
|
31
|
9.97e-01
|
3.39e-04
|
9.99e-01
|
GOBP MONOATOMIC ANION TRANSPORT
|
94
|
9.96e-01
|
3.27e-04
|
9.99e-01
|
GOBP POSITIVE CHEMOTAXIS
|
33
|
9.97e-01
|
3.23e-04
|
9.99e-01
|
GOBP NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY
|
95
|
9.97e-01
|
2.15e-04
|
9.99e-01
|
GOBP RNA PROCESSING
|
797
|
9.93e-01
|
1.78e-04
|
9.97e-01
|
GOBP REGULATION OF CALCINEURIN MEDIATED SIGNALING
|
39
|
9.99e-01
|
-1.65e-04
|
9.99e-01
|
GOCC METHYLTRANSFERASE COMPLEX
|
92
|
9.98e-01
|
1.56e-04
|
9.99e-01
|
GOBP POSITIVE REGULATION OF VASOCONSTRICTION
|
41
|
9.99e-01
|
-1.38e-04
|
9.99e-01
|
GOCC RIBBON SYNAPSE
|
27
|
9.99e-01
|
-9.25e-05
|
9.99e-01
|
GOBP MAINTENANCE OF SYNAPSE STRUCTURE
|
24
|
9.99e-01
|
8.21e-05
|
9.99e-01
|
GOMF ADENYL NUCLEOTIDE BINDING
|
1297
|
9.97e-01
|
-5.51e-05
|
9.99e-01
|
GOBP NEGATIVE REGULATION OF ENDOCYTOSIS
|
53
|
9.99e-01
|
5.22e-05
|
9.99e-01
|